Citrus Sinensis ID: 018514

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350----
Protein Sequence
MASVSVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSFL
Secondary Structure (PSIPRED)
ccccccccccccccccccccHHHHccccccccccccEEEccccccEEEEEEEEEcccccccccEEEEEEEEEEEcccEEEEEEEEEcccccEEEEEEccccccHHHHHHHHHHHcccccEEEccEEEccccccccEEEEEEEEcccccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEccccccEEEEEcccccccccccccEEEEEEccccccHHccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccHHHccccccccccccccEEccccccccEEEEEEEEcccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHcccccccc
Coil and Loop (DISEMBL)
masvsvvpasgntvgvdrlpeemndmkirddkemeatvvdgngteAGHIIVTTiggkngqpkqTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQtmrlldhpnvvslkhcffstteKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTigvchrdikpqnllvnphthqlklcdfgsakvlvkgepnisyicsryyrapelifgateyTAAIDIWSAGCVLAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikahpwhkifqkrmppeAVDLVSRLLqyspnlrstafdavgsfdssfl
Flexible Loop (DISEMBL)
masvsvvpasgntvgvdrlpeemNDMKIRDDKEMEATVVDGNGTEAGHIIVTtiggkngqpKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIkkvlqdkrykNRELQtmrlldhpnvvSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHhykmsqrmPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSFL
Low Complexity Region (SEG)
MASVSVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSFL
Disordered region (IsUnstruct)
*****************************************NGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR***************
Disordered Region (DISOPRED)
************************************************IIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSFL
Disordered Region (DISEMBL)
********ASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSFL
Disordered Region (DISPRO)
************************************TVVD**GTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSFL
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASVSVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSFL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	354	2.2.26 [Sep-21-2011]
P51139	411	Glycogen synthase kinase-	N/A	no	0.977	0.841	0.909	0.0
P43288	405	Shaggy-related protein ki	yes	no	0.977	0.854	0.908	0.0
Q40518	409	Shaggy-related protein ki	N/A	no	0.977	0.845	0.883	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.977	0.841	0.869	0.0
P43289	409	Shaggy-related protein ki	no	no	0.977	0.845	0.875	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	0.977	0.841	0.881	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	0.977	0.843	0.864	0.0
Q96287	472	Shaggy-related protein ki	no	no	0.980	0.735	0.782	1e-167
O04160	468	Shaggy-related protein ki	N/A	no	0.929	0.702	0.793	1e-164
Q39012	407	Shaggy-related protein ki	no	no	0.906	0.788	0.803	1e-159

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  668 bits (1723), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/353 (90%), Positives = 334/353 (94%), Gaps = 7/353 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEA-TVVDGNGTEAGHIIVTT 53
           MAS  V PASG      ++VGV++LPEEMNDMKIRDDKEMEA T+VDGNGTE GHIIVTT
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEAL 353

Medicago sativa (taxid: 3879)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  662 bits (1708), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/348 (90%), Positives = 329/348 (94%), Gaps = 2/348 (0%)

Query: 1   MASVSVVPASG--NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKN 58
           MASV + P  G  ++ GVD+LPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTIGG+N
Sbjct: 1   MASVGIAPNPGARDSTGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRN 60

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           GQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRLLDHP
Sbjct: 61  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHP 120

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQI RA
Sbjct: 121 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRA 180

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPEL
Sbjct: 181 LSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 240

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           IFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN
Sbjct: 241 IFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 300

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           YTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRS A D +
Sbjct: 301 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTL 348

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  652 bits (1681), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/352 (88%), Positives = 328/352 (93%), Gaps = 6/352 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           M SV + P SG      ++VGVDRLPEEMNDM+IRDDKE+EA +VDGNGTE GHIIVTTI
Sbjct: 1   MTSVGLAPVSGLRESSSHSVGVDRLPEEMNDMRIRDDKEIEAAIVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG++GQPKQTISYMAER+VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVV LKHCFFSTTEKDE+YLNLVLEYVPETVHRVIKH+ K++QRMPLI VKLY YQ
Sbjct: 121 LDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I RAL+YIH+TIGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           MNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TA +AV
Sbjct: 301 MNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAV 352

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  648 bits (1672), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 307/353 (86%), Positives = 327/353 (92%), Gaps = 7/353 (1%)

Query: 1   MASVSVVPASG-------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTT 53
           MA+  V PASG       + + VD+LP+E+  M+I+DDKEMEA VVDGN TEAGH+IVTT
Sbjct: 1   MATAGVAPASGIVDVNASSAIAVDKLPDEILGMRIKDDKEMEAHVVDGNSTEAGHVIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAER VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVV+LKHCFFSTTEKDELYLNLVLE+VPETVHRVI+H+ KM+QRMPLIYVKLY Y
Sbjct: 121 LLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIYVKLYSY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICR+LAYIHN +GV HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT+AIDIWSAGCVL ELLLGQPLFPG SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTPTREEIK 300

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           CMNPNYTEFKFPQIKAHPWHKIF+KRMPPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTALEAL 353

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  647 bits (1670), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 308/352 (87%), Positives = 326/352 (92%), Gaps = 6/352 (1%)

Query: 1   MASVSVVPA------SGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASV + P+      +GN    DRLPEEM DMKI+DDKEMEAT+V+GN TE GHIIVTTI
Sbjct: 1   MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPL+YVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I R+L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  A D++
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSL 352

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  644 bits (1662), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/354 (88%), Positives = 324/354 (91%), Gaps = 8/354 (2%)

Query: 1   MASVSVVPASG-------NTVGVDR-LPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVT 52
           MASV V P SG         +GVD  LPEEM+DMKIRDD+EMEATVVDGNGTE GHIIVT
Sbjct: 1   MASVGVAPTSGFREVLGDGEIGVDDILPEEMSDMKIRDDREMEATVVDGNGTETGHIIVT 60

Query: 53  TIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM 112
           TIGG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTM
Sbjct: 61  TIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 120

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMP+IYVKLY 
Sbjct: 121 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLYT 180

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           YQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRY
Sbjct: 181 YQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 240

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           YRAPELIFGATEYT AID+WS GCVLAELLLGQPLFPGE GVDQLVEIIKVLGTPTREEI
Sbjct: 241 YRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGTPTREEI 300

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           KCMNPNYTEFKFPQIKAHPWHKIF KRMP EAVDLVSRLLQYSPNLR  A D +
Sbjct: 301 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALDCL 354

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 305/353 (86%), Positives = 324/353 (91%), Gaps = 7/353 (1%)

Query: 1   MASVSVVPASG-------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTT 53
           MASV  +PAS         ++  ++LPE +N+MKI+DDKEMEA VVDGNGTE GHIIVTT
Sbjct: 1   MASVGTLPASSMATKQSNASICAEKLPEGINEMKIKDDKEMEAAVVDGNGTETGHIIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAER+VG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV+RV KH+ + +QRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIH  +GVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT  IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           CMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAI 353

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  589 bits (1518), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 277/354 (78%), Positives = 308/354 (87%), Gaps = 7/354 (1%)

Query: 1   MASVSVVPASGNTVGVDRLPEEMNDMKIRD-------DKEMEATVVDGNGTEAGHIIVTT 53
           +A  S VPA       D+LP+ M +MKIRD       DK+ME TVV+G+GTE G +I TT
Sbjct: 65  VAGTSNVPAVSEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTT 124

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           +GG++G+PKQTISYMA+RVVG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MR
Sbjct: 125 VGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMR 184

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L DHPNVV L+H FFSTT+KDELYLNLVLEYVPETV+R  KH+ KM+Q MP+I+V+LY Y
Sbjct: 185 LQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTY 244

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRAL Y+H  +GVCHRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPNISYICSRYY
Sbjct: 245 QICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYY 304

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+
Sbjct: 305 RAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIR 364

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TA +A  
Sbjct: 365 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACA 418

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2

 Score =  579 bits (1493), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 269/339 (79%), Positives = 301/339 (88%), Gaps = 10/339 (2%)

Query: 17  DRLPEEMNDMKIRDD----------KEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTIS 66
           D+LPE MNDM++R+D          K+ME  +V+G GTE G +I TT+GG++G+PKQTIS
Sbjct: 74  DQLPEVMNDMRLREDEPHANRGEEDKDMEPPIVNGCGTETGQVITTTVGGRDGKPKQTIS 133

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           YMA+RVVG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H 
Sbjct: 134 YMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHS 193

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           FFSTT+KDELYLNLVLE+VPETV+R +KH+ KM+Q MP+I V+LY YQICRAL Y+H  +
Sbjct: 194 FFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQHMPIILVQLYTYQICRALNYLHRVV 253

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           GVCHRDIKPQNLLVN HTHQLK+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT
Sbjct: 254 GVCHRDIKPQNLLVNTHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 313

Query: 247 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 306
            AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQ
Sbjct: 314 NAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQ 373

Query: 307 IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           IKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TA +A
Sbjct: 374 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 412

May mediate extracellular signals to regulate transcription in differentiating cells.

Brassica napus (taxid: 3708)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1

 Score =  561 bits (1446), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 258/321 (80%), Positives = 290/321 (90%)

Query: 27  KIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKC 86
           ++  DKEM A V++GN    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKC
Sbjct: 30  ELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKC 89

Query: 87  LETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP 146
           LETGE+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+EYVP
Sbjct: 90  LETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVP 149

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ 206
           ET++RV++H+   +QRMP+ YVKLY YQI R LAYIH   GVCHRD+KPQNLLV+P THQ
Sbjct: 150 ETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 209

Query: 207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
           +KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA+IDIWSAGCVLAELLLGQP
Sbjct: 210 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQP 269

Query: 267 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD 326
           LFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+D
Sbjct: 270 LFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 329

Query: 327 LVSRLLQYSPNLRSTAFDAVG 347
           L SRLLQYSP+LR TA +A  
Sbjct: 330 LASRLLQYSPSLRCTALEACA 350

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	354
224068663	409	predicted protein [Populus trichocarpa]	0.977	0.845	0.937	0.0
255548323	409	Glycogen synthase kinase-3 beta, putativ	0.977	0.845	0.940	0.0
224128207	409	predicted protein [Populus trichocarpa]	0.977	0.845	0.931	0.0
449461703	409	PREDICTED: glycogen synthase kinase-3 ho	0.977	0.845	0.923	0.0
164521171	409	serine/threonine protein kinase [Adonis	0.977	0.845	0.926	0.0
225437683	409	PREDICTED: glycogen synthase kinase-3 ho	0.977	0.845	0.926	0.0
225450484	409	PREDICTED: shaggy-related protein kinase	0.977	0.845	0.911	0.0
11182434	411	RecName: Full=Glycogen synthase kinase-3	0.977	0.841	0.909	0.0
313148	412	protein kinase [Medicago sativa]	0.977	0.839	0.909	0.0
388500422	412	unknown [Medicago truncatula]	0.977	0.839	0.906	0.0

>gi|224068663|ref|XP_002302794.1| predicted protein [Populus trichocarpa] gi|222844520|gb|EEE82067.1| predicted protein [Populus trichocarpa]

 Score =  689 bits (1778), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/352 (93%), Positives = 338/352 (96%), Gaps = 6/352 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVSVVPASG      NT GVD+LPEEMNDMKI DDKEMEA VVDGNGTE GHIIVTTI
Sbjct: 1   MASVSVVPASGLRDTLGNTTGVDKLPEEMNDMKISDDKEMEAAVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGLVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET+HRVIKH+YKMSQRMPLIYVKLYFYQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETIHRVIKHYYKMSQRMPLIYVKLYFYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEAL 352

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255548323|ref|XP_002515218.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223545698|gb|EEF47202.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis]

 Score =  687 bits (1772), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/352 (94%), Positives = 335/352 (95%), Gaps = 6/352 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVSV P SG      N  GVDRLP+EMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSVAPTSGIRDPGGNAAGVDRLPDEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ KM QRMPLIYVKLYFYQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKMGQRMPLIYVKLYFYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIHN+IGVCHRDIKP NLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHNSIGVCHRDIKPHNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTA DA+
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALDAL 352

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224128207|ref|XP_002320270.1| predicted protein [Populus trichocarpa] gi|222861043|gb|EEE98585.1| predicted protein [Populus trichocarpa]

 Score =  686 bits (1769), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/352 (93%), Positives = 339/352 (96%), Gaps = 6/352 (1%)

Query: 1   MASVSVVPA------SGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVSVVPA      SGN+ GVD+LP+EMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSVVPATGLRDRSGNSAGVDKLPDEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET+HRVIKH+ KMSQRMPLIYVKLYFY+
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETIHRVIKHYSKMSQRMPLIYVKLYFYE 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT+AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTSAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           MNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTALEAL 352

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461703|ref|XP_004148581.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3-like [Cucumis sativus] gi|449511511|ref|XP_004163975.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3-like [Cucumis sativus]

 Score =  681 bits (1757), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/352 (92%), Positives = 337/352 (95%), Gaps = 6/352 (1%)

Query: 1   MASVSVVPAS------GNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           M SVSV PAS      G+T+GVDRLP+EMNDMKIRDDKE+EATVVDGNGTE GHIIVTTI
Sbjct: 1   MTSVSVAPASMIRDHGGSTIGVDRLPDEMNDMKIRDDKEIEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAER VGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERAVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ KM+QRMPLIYVKLYFYQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKMNQRMPLIYVKLYFYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRAL+YIHN+IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV+GEPNI+YICSRYYR
Sbjct: 181 ICRALSYIHNSIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVRGEPNIAYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEAL 352

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|164521171|gb|ABY60447.1| serine/threonine protein kinase [Adonis aestivalis var. palaestina]

 Score =  677 bits (1747), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/352 (92%), Positives = 332/352 (94%), Gaps = 6/352 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVS+ P SG      N  G DRLPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSMAPPSGLRDPTGNAGGADRLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG+NGQPKQTISYMAERVVGHGSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET HRVIKH+ KM+QRMPLIYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETAHRVIKHYNKMNQRMPLIYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIH TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHGTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTA DA+
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALDAL 352

Source: Adonis aestivalis var. palaestina

Species: Adonis aestivalis

Genus: Adonis

Family: Ranunculaceae

Order: Ranunculales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225437683|ref|XP_002279596.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3 [Vitis vinifera] gi|147767229|emb|CAN75652.1| hypothetical protein VITISV_017659 [Vitis vinifera]

 Score =  675 bits (1741), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/352 (92%), Positives = 334/352 (94%), Gaps = 6/352 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVS+ PASG      NTVGVDRLP+EMNDMKIRDDKEME TVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSIAPASGLREPNGNTVGVDRLPDEMNDMKIRDDKEMEDTVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEK+ELYLNLVLEYVPETVHRVIKH+ KM+QRMP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKEELYLNLVLEYVPETVHRVIKHYNKMNQRMPMIYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIH  IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE NISYICSRYYR
Sbjct: 181 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGELNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEAL 352

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225450484|ref|XP_002280673.1| PREDICTED: shaggy-related protein kinase alpha [Vitis vinifera]

 Score =  669 bits (1726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/352 (91%), Positives = 331/352 (94%), Gaps = 6/352 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASV + P SG      +  GVDRLPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVGIAPTSGLREPSGHNAGVDRLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I RAL+YIH +IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAEL+LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TA DA+
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAMDAL 352

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|11182434|sp|P51139.2|MSK3_MEDSA RecName: Full=Glycogen synthase kinase-3 homolog MsK-3

 Score =  668 bits (1723), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/353 (90%), Positives = 334/353 (94%), Gaps = 7/353 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEA-TVVDGNGTEAGHIIVTT 53
           MAS  V PASG      ++VGV++LPEEMNDMKIRDDKEMEA T+VDGNGTE GHIIVTT
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEAL 353

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|313148|emb|CAA48472.1| protein kinase [Medicago sativa]

 Score =  668 bits (1723), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/353 (90%), Positives = 334/353 (94%), Gaps = 7/353 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEA-TVVDGNGTEAGHIIVTT 53
           MAS  V PASG      ++VGV++LPEEMNDMKIRDDKEMEA T+VDGNGTE GHIIVTT
Sbjct: 2   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 61

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 62  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 121

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY Y
Sbjct: 122 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 181

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 182 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 241

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 242 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 301

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct: 302 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEAL 354

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388500422|gb|AFK38277.1| unknown [Medicago truncatula]

 Score =  666 bits (1719), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/353 (90%), Positives = 333/353 (94%), Gaps = 7/353 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEA-TVVDGNGTEAGHIIVTT 53
           MAS  V PASG      ++V V++LPEEMNDMKIRDDKEMEA T+VDGNGTE GHIIVTT
Sbjct: 2   MASGGVAPASGFIDKNASSVAVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 61

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 62  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 121

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY Y
Sbjct: 122 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 181

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 182 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 241

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 242 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 301

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct: 302 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEAL 354

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	354
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.977	0.854	0.908	3.8e-172
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.977	0.845	0.875	1.1e-167
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.977	0.843	0.866	8.7e-166
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.974	0.730	0.786	1.6e-150
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.954	0.820	0.777	1.4e-144
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.901	0.783	0.808	1.7e-144
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.892	0.831	0.813	5.3e-143
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.932	0.783	0.752	1.5e-140
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.929	0.751	0.729	2.3e-133
UNIPROTKB|Q91757	420	gsk3b "Glycogen synthase kinas	0.855	0.721	0.677	6.6e-113

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1673 (594.0 bits), Expect = 3.8e-172, P = 3.8e-172
 Identities = 316/348 (90%), Positives = 329/348 (94%)

Query:     1 MASVSVVPASG--NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKN 58
             MASV + P  G  ++ GVD+LPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTIGG+N
Sbjct:     1 MASVGIAPNPGARDSTGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRN 60

Query:    59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
             GQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRLLDHP
Sbjct:    61 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHP 120

Query:   119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQI RA
Sbjct:   121 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRA 180

Query:   179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
             L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPEL
Sbjct:   181 LSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 240

Query:   239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
             IFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN
Sbjct:   241 IFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 300

Query:   299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
             YTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRS A D +
Sbjct:   301 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTL 348

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1631 (579.2 bits), Expect = 1.1e-167, P = 1.1e-167
 Identities = 308/352 (87%), Positives = 326/352 (92%)

Query:     1 MASVSVVPAS------GNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
             MASV + P++      GN    DRLPEEM DMKI+DDKEMEAT+V+GN TE GHIIVTTI
Sbjct:     1 MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTI 60

Query:    55 GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
             GG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRL
Sbjct:    61 GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query:   115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPL+YVKLY YQ
Sbjct:   121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQ 180

Query:   175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
             I R+L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct:   181 IFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query:   235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
             APELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct:   241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query:   295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
             MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  A D++
Sbjct:   301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSL 352

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1613 (572.9 bits), Expect = 8.7e-166, P = 8.7e-166
 Identities = 306/353 (86%), Positives = 325/353 (92%)

Query:     1 MASVSVVPASG------N-TVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTT 53
             MASV  +PAS       N ++  ++LPE +N+MKI+DDKEMEA VVDGNGTE GHIIVTT
Sbjct:     1 MASVGTLPASSMATKQSNASICAEKLPEGINEMKIKDDKEMEAAVVDGNGTETGHIIVTT 60

Query:    54 IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
             IGGKNGQPKQTISYMAER+VG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct:    61 IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query:   114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
             LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV+RV KH+ + +QRMP+IYVKLY Y
Sbjct:   121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query:   174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
             QICRALAYIH  +GVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYY
Sbjct:   181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query:   234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
             RAPELIFGATEYT  IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct:   241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query:   294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
             CMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLRSTA +A+
Sbjct:   301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAI 353

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1469 (522.2 bits), Expect = 1.6e-150, P = 1.6e-150
 Identities = 277/352 (78%), Positives = 308/352 (87%)

Query:     1 MASVSVVPASGNTVGVDRLPEEMNDMKIRD-------DKEMEATVVDGNGTEAGHIIVTT 53
             +A  S VPA       D+LP+ M +MKIRD       DK+ME TVV+G+GTE G +I TT
Sbjct:    65 VAGTSNVPAVSEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTT 124

Query:    54 IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
             +GG++G+PKQTISYMA+RVVG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MR
Sbjct:   125 VGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMR 184

Query:   114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
             L DHPNVV L+H FFSTT+KDELYLNLVLEYVPETV+R  KH+ KM+Q MP+I+V+LY Y
Sbjct:   185 LQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTY 244

Query:   174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
             QICRAL Y+H  +GVCHRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPNISYICSRYY
Sbjct:   245 QICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYY 304

Query:   234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
             RAPELIFGATEYT AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+
Sbjct:   305 RAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIR 364

Query:   294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TA +A
Sbjct:   365 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 416

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1413 (502.5 bits), Expect = 1.4e-144, P = 1.4e-144
 Identities = 265/341 (77%), Positives = 297/341 (87%)

Query:     5 SVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQT 64
             S+ P   +  G D L    +   I +DKEM A V++GN    GHII TTIGGKNG+PKQT
Sbjct:    13 SLAPQPPHLHGGDSLKRRPD---IDNDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQT 69

Query:    65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 124
             ISYMAERVVG GSFG+VFQAKCLETGE+VAIKKVLQD+RYKNRELQ MRL+DHPNVVSLK
Sbjct:    70 ISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLK 129

Query:   125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             HCFFSTT +DEL+LNLV+EYVPET++RV+KH+   +QRMP+ YVKLY YQI R LAYIH 
Sbjct:   130 HCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHT 189

Query:   185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
               GVCHRD+KPQNLLV+P THQ KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATE
Sbjct:   190 APGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 249

Query:   245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
             YT++IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+F
Sbjct:   250 YTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 309

Query:   305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             PQIKAHPWHK+F KRMPPEA+DL SRLLQYSP+LR TA +A
Sbjct:   310 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1412 (502.1 bits), Expect = 1.7e-144, P = 1.7e-144
 Identities = 258/319 (80%), Positives = 290/319 (90%)

Query:    27 KIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKC 86
             ++  DKEM A V++GN    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKC
Sbjct:    30 ELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKC 89

Query:    87 LETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP 146
             LETGE+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+EYVP
Sbjct:    90 LETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVP 149

Query:   147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ 206
             ET++RV++H+   +QRMP+ YVKLY YQI R LAYIH   GVCHRD+KPQNLLV+P THQ
Sbjct:   150 ETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 209

Query:   207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
             +KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA+IDIWSAGCVLAELLLGQP
Sbjct:   210 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQP 269

Query:   267 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD 326
             LFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+D
Sbjct:   270 LFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 329

Query:   327 LVSRLLQYSPNLRSTAFDA 345
             L SRLLQYSP+LR TA +A
Sbjct:   330 LASRLLQYSPSLRCTALEA 348

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1398 (497.2 bits), Expect = 5.3e-143, P = 5.3e-143
 Identities = 257/316 (81%), Positives = 286/316 (90%)

Query:    30 DDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLET 89
             DDKEM A VVDG+    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLET
Sbjct:     3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62

Query:    90 GEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 149
             GE VAIKKVLQD+RYKNRELQ MR++DHPNVV LKHCFFSTT KDEL+LNLV+EYVPE++
Sbjct:    63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122

Query:   150 HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
             +RV+KH+   +QRMPL+YVKLY YQI R LAYIHN  GVCHRD+KPQNLLV+P THQ+K+
Sbjct:   123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182

Query:   210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP 269
             CDFGSAK LVKGE NISYICSR+YRAPELIFGATEYT +IDIWSAGCVLAELLLGQPLFP
Sbjct:   183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242

Query:   270 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS 329
             GE+ VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIKAHPWHKIF KRMPPEA+D  S
Sbjct:   243 GENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFAS 302

Query:   330 RLLQYSPNLRSTAFDA 345
             RLLQYSP+LR TA +A
Sbjct:   303 RLLQYSPSLRCTALEA 318

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1375 (489.1 bits), Expect = 1.5e-140, P = 1.5e-140
 Identities = 253/336 (75%), Positives = 292/336 (86%)

Query:    16 VDRLPEEMNDMKIRD------DKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMA 69
             VD L  ++ + +IRD      +++ E  ++DG G E GH+I TT+ G+NGQ +QT+SY++
Sbjct:    26 VDWLTRDLAETRIRDKVETDDERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYIS 85

Query:    70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 129
             E VVG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LDHPN V+LKH FFS
Sbjct:    86 EHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFS 145

Query:   130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
              T+ +E+YLNLVLE+VPETV+RV + + + +Q MPLIYVKLY YQICRALAYIHN+ G+C
Sbjct:   146 RTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLC 205

Query:   190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI 249
             HRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+SYICSRYYRAPELIFGA+EYT AI
Sbjct:   206 HRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAI 265

Query:   250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 309
             DIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 
Sbjct:   266 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 325

Query:   310 HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             HPWHK+FQKR+PPEAVDL+ R  QYSPNLR TA +A
Sbjct:   326 HPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEA 361

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1307 (465.1 bits), Expect = 2.3e-133, P = 2.3e-133
 Identities = 240/329 (72%), Positives = 280/329 (85%)

Query:    17 DRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHG 76
             D LP+E+ ++ + DDK+M+  ++ GNGTE+G II T   G N Q  +TISY AE V+G G
Sbjct:    59 DHLPKEIREVGLGDDKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTG 118

Query:    77 SFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL 136
             SFGVVFQAKCLET E VAIKKVLQDKRYKNRELQ MR+LDHPNVV LKH FFSTTEKDEL
Sbjct:   119 SFGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDEL 178

Query:   137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ 196
             YLNLVLEYVPET++R  + + KM+Q MPLIY++LY YQICRA+ Y+H  +GVCHRDIKPQ
Sbjct:   179 YLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQ 238

Query:   197 NLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGC 256
             NLLVN  TH++K+CDFGSAK+L+ GEPNISYICSRYYRAPELIFGATEYT+AID+WS GC
Sbjct:   239 NLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGC 298

Query:   257 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 316
             V+AEL LG PLFPGE+ VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIKA PWHKIF
Sbjct:   299 VMAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIF 358

Query:   317 QKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             ++++ PEA+DL SRLLQYSPNLR TA +A
Sbjct:   359 RRQVSPEAMDLASRLLQYSPNLRCTALEA 387

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)]

 Score = 1114 (397.2 bits), Expect = 6.6e-113, P = 6.6e-113
 Identities = 208/307 (67%), Positives = 257/307 (83%)

Query:    40 DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
             D +G++   ++ T   G+    +Q ++Y   +V+G+GSFGVV+QAK  +TGE VAIKKVL
Sbjct:    31 DKDGSKVTTVVATP--GQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVL 88

Query:   100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
             QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct:    89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query:   159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
               Q +P+IYVKLY YQ+ R+LAYIH+  G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct:   149 AKQALPIIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPETAVLKLCDFGSAKQL 207

Query:   219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
             V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct:   208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query:   279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
             EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct:   268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRARTPPEAIALCSRLLEYTPTS 327

Query:   339 RSTAFDA 345
             R T  DA
Sbjct:   328 RLTPLDA 334

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IDA

GO:0060070 "canonical Wnt receptor signaling pathway" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.875	0.9774	0.8459	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.9080	0.9774	0.8543	yes	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6081	0.8276	0.7571	yes	no
A8X5H5	GSK3_CAEBR	2, ., 7, ., 1, 1, ., 2, 6	0.6734	0.8248	0.8133	N/A	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.7725	0.9604	0.8252	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.8081	0.8983	0.8368	no	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5774	0.7994	0.7648	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6734	0.8248	0.8066	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.7428	0.9717	0.8190	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.8835	0.9774	0.8459	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6413	0.8926	0.7523	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8813	0.9774	0.8418	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8696	0.9774	0.8418	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.9093	0.9774	0.8418	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7935	0.9293	0.7029	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6413	0.8926	0.7523	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8640	0.9774	0.8439	no	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6413	0.8926	0.7523	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	354
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-121
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-87
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-84
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-82
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-81
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-78
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-76
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-75
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-73
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-71
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-70
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-70
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-66
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-65
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-63
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-63
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-61
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-61
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-61
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-60
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-60
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-60
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-56
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-55
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-54
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-54
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-54
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-53
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-53
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-52
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-51
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-51
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-51
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-51
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-51
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-51
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-50
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-48
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-48
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-48
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-47
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-46
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-46
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-46
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-45
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-44
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-44
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-44
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-43
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-43
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-43
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-43
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-42
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-42
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-38
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-37
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-36
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-36
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-34
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-34
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-34
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-33
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-33
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-33
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-32
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-31
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-31
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-30
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-29
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-27
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-26
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-25
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-24
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-24
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-23
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-22
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-22
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-22
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-20
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-20
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-19
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-19
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-19
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-18
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-18
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-18
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-17
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-17
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-16
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-16
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-15
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-15
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-15
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-14
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-08
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-04
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-04
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.001
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	0.001
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	0.001
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.002
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.003

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  356 bits (914), Expect = e-121
 Identities = 152/284 (53%), Positives = 217/284 (76%), Gaps = 4/284 (1%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           SY    ++G+GSFGVV++A C++T E VAIKKVLQD +YKNREL  M+ L+H N++ LK 
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 126 CFFSTT-EKDE--LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            +++   +K+E  ++LN+V+E++P+TVH+ +KH+ + +  +PL  VKLY YQ+CRALAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   +CHRD+KPQNLL++P+TH LKLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
           T YT  ID+WS GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MNPNY + 
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           KFP +K     K+F K  P +A++ +S+ L+Y P  R    +A+
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  265 bits (680), Expect = 4e-87
 Identities = 110/294 (37%), Positives = 166/294 (56%), Gaps = 24/294 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   + +G G++GVV  A    TG  VAIKK+      L D +   RE++ +R L H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 121 VSLKHCF--FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           + L       S  + +++Y+  V E +   +H+VIK      Q +   +++ + YQI R 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRG 115

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYR 234
           L Y+H +  V HRD+KP N+LVN     LK+CDFG A+ +   E        Y+ +R+YR
Sbjct: 116 LKYLH-SANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APEL+  ++ YT AIDIWS GC+ AELL  +PLFPG   +DQL  I++VLGTP+ E++K 
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233

Query: 295 M-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           + +     +    P+    P  K+F     PEA+DL+ ++L + P  R TA +A
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEA 286

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  255 bits (654), Expect = 8e-84
 Identities = 107/289 (37%), Positives = 165/289 (57%), Gaps = 35/289 (12%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHPNVVSLK 124
           +G G++GVV++A+  +TGE VA+KK+  D   +         RE+  ++ L HPN+V L 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               +   + +LYL  V EY    + + +    K    +    +K   YQ+ R LAY H 
Sbjct: 65  DVIHT---ERKLYL--VFEYCDMDLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
           +  + HRD+KPQN+L+N     LKL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 116 SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
           +  Y+ A+DIWS GC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E      P  T+
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW----PGVTK 228

Query: 302 FK-----FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                  FP+       K+   R+ PE +DL+S++LQY+P  R +A +A
Sbjct: 229 LPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEA 276

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  251 bits (642), Expect = 4e-82
 Identities = 106/287 (36%), Positives = 163/287 (56%), Gaps = 23/287 (8%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
             +G G+ G+VF+AK  ETGE VA+KKV   +          RE++ ++   HP VV L 
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F            LV+EY+P  +  V++      + +P   VK Y   + + +AY+H 
Sbjct: 66  DVF-----PHGSGFVLVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--ICSRYYRAPELIFGA 242
             G+ HRD+KP NLL++     LK+ DFG A++  + EP +    + +R+YRAPEL++GA
Sbjct: 118 N-GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 299
            +Y   +D+W+ GC+ AELL G PLFPGE+ ++QL  + + LGTP  E    +  + P+Y
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDY 234

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            +  FP+ K  P  +IF     PEA+DL+  LL Y P+ R +A +A+
Sbjct: 235 NKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEAL 280

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  249 bits (638), Expect = 1e-81
 Identities = 110/288 (38%), Positives = 164/288 (56%), Gaps = 20/288 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKN---RELQTMRLLDHPNV 120
           Y     +G G++GVV++A+   TGE VAIKK+              RE++ ++ L+HPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + L   F     K +LYL  V E++   ++++IK   +    +P   +K Y YQ+ + LA
Sbjct: 61  IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLA 112

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           + H+  G+ HRD+KP+NLL+N     LKL DFG A+       P   Y+ +R+YRAPEL+
Sbjct: 113 FCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 298
            G   Y+  +DIWS GC+ AELL  +PLFPG+S +DQL +I + LGTP  E         
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 299 -YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
              +F FP+    P  K+F     P+A+DL+S++L Y P+ R TA  A
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQA 277

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  239 bits (612), Expect = 6e-78
 Identities = 98/285 (34%), Positives = 149/285 (52%), Gaps = 43/285 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 121
           Y     +G GSFG V+ A+  +TG+ VAIK +      +D+    RE++ ++ L HPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L   F    ++D+LYL  V+EY     +  ++K   ++S+       + Y  QI  AL 
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKKRGRLSEDE----ARFYLRQILSALE 111

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           Y+H+  G+ HRD+KP+N+L++   H +KL DFG A+ L  GE   +++ +  Y APE++ 
Sbjct: 112 YLHS-KGIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           G   Y  A+DIWS G +L ELL G+P FPG+   DQL+E+ K +G P             
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPEWD--- 222

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                              + PEA DL+ +LL   P  R TA +A
Sbjct: 223 -------------------ISPEAKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  237 bits (606), Expect = 1e-76
 Identities = 108/282 (38%), Positives = 159/282 (56%), Gaps = 21/282 (7%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 125
           VVG G++GVV + +   TGE VAIKK  +   D+  K    RE++ +R L H N+V+LK 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F     K  LYL  V EYV  T+  +++        +P   V+ Y +Q+ +A+AY H+ 
Sbjct: 68  AFRR---KGRLYL--VFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRYYRAPELIFGAT 243
             + HRDIKP+N+LV+     LKLCDFG A+ L      P   Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 301
            Y   +D+W+ GC++AELL G+PLFPG+S +DQL  I K LG   P+ +E+   NP +  
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 302 FKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
             FP+        + +  ++   A+D +   L+  P  R T 
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  232 bits (595), Expect = 7e-75
 Identities = 111/293 (37%), Positives = 157/293 (53%), Gaps = 29/293 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDH 117
           Y   + +G G++ VV++A+  ETG  VAIKK+   +R +          RE++ ++ L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN++ L   F     K    +NLV E++   + +VIK     S  +    +K Y     R
Sbjct: 62  PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC---SRYYR 234
            L Y+H+   + HRD+KP NLL+      LKL DFG A+    G PN        +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APEL+FGA  Y   +D+WS GC+ AELLL  P  PG+S +DQL +I + LGTPT E    
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 295 MN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           +   P+Y EFK       P  +IF      +A+DL+ RLL  +PN R TA  A
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQA 279

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  228 bits (583), Expect = 1e-73
 Identities = 90/284 (31%), Positives = 138/284 (48%), Gaps = 39/284 (13%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
            R +G GSFG V++AK   TG+ VA+K + +            RE++ +R L HPN+V L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F    +KD LYL  V+EY           +      +     K    QI R L Y+H
Sbjct: 64  IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGA 242
           +  G+ HRD+KP+N+L++     +K+ DFG AK L+K      +++ + +Y APE++ G 
Sbjct: 116 S-NGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y   +D+WS G +L ELL G+P F GE+ +DQL  I ++LG P   +    +      
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS----- 228

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                               EA DL+ + L   P+ R TA + +
Sbjct: 229 -----------------GSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  223 bits (570), Expect = 3e-71
 Identities = 108/287 (37%), Positives = 169/287 (58%), Gaps = 26/287 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVS 122
           + +G G+FG V+ A+  ETGE VAIKK+ +  ++ +       RE++++R L +HPN+V 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           LK  F    E DELY   V EY+   +++++K      +      ++   YQI + LA+I
Sbjct: 63  LKEVF---RENDELYF--VFEYMEGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHI 115

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H   G  HRD+KP+NLLV+     +K+ DFG A+ +    P   Y+ +R+YRAPE++  +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPN 298
           T Y++ +DIW+ GC++AEL   +PLFPG S +DQL +I  VLGTPT+++     K  +  
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK- 232

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
              F+FPQ      H++      PEA+DL+  +L++ P  R TA  A
Sbjct: 233 -LGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQA 277

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  223 bits (571), Expect = 1e-70
 Identities = 108/297 (36%), Positives = 171/297 (57%), Gaps = 31/297 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRE---LQTMRLLDH 117
           Y   + +G G++G+V++A    T E VA+KK+        D +   RE   LQ +   DH
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG--DH 66

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L +   +  +KD +YL  V EY+   +H VI+    + + +   Y+    YQ+ +
Sbjct: 67  PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRA--NILEDVHKRYI---MYQLLK 118

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS------YICSR 231
           AL YIH +  V HRD+KP N+L+N     +KL DFG A+ L + E N        Y+ +R
Sbjct: 119 ALKYIH-SGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           +YRAPE++ G+T YT  +D+WS GC+L E+LLG+PLFPG S ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 292 IKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           I+ +   +        P     P  ++   +   +A+DL+ +LL ++PN R TA +A
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEA 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  220 bits (563), Expect = 4e-70
 Identities = 94/289 (32%), Positives = 155/289 (53%), Gaps = 24/289 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 125
           +G G++G V++A+  +TGE VA+KK+  +   K        RE++ ++ L HPN+V LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIHN 184
                T K +  + +V EY+   +  ++     K ++      +K Y  Q+   L Y+H+
Sbjct: 66  I---VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES----QIKCYMKQLLEGLQYLHS 118

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGA 242
             G+ HRDIK  N+L+N     LKL DFG A+   K       + + + +YR PEL+ GA
Sbjct: 119 -NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 299
           T Y   +D+WS GC+LAEL LG+P+F G + ++QL +I ++ G+PT E    +  + P +
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWF 235

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS 348
              K  +       + F+  + P A+DL+ +LL   P  R +A  A+  
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  211 bits (539), Expect = 5e-66
 Identities = 101/294 (34%), Positives = 169/294 (57%), Gaps = 26/294 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A    TG  VAIKK+   + + +  R L+ +++L    H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 122 SLKHCFFSTT--EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +       +    +++Y+  V E +   ++++IK     +Q +   +++ + YQI R L
Sbjct: 67  GILDIIRPPSFESFNDVYI--VQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRA 235
            YIH+   V HRD+KP NLL+N     LK+CDFG A++      +      Y+ +R+YRA
Sbjct: 120 KYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++  +  YT AIDIWS GC+LAE+L  +PLFPG+  + QL  I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 296 -NP---NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            +    NY +   P     PW+K+F     P+A+DL+ ++L ++P+ R T  +A
Sbjct: 238 ISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEEA 289

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  208 bits (532), Expect = 6e-65
 Identities = 103/295 (34%), Positives = 157/295 (53%), Gaps = 24/295 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPN 119
            Y     +G G++GVV  A    +G+ VAIKK      V    +   REL+ +R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +++++         D   + +V++ +   +H +I       Q +   +++ + YQ+ R L
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGL 120

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYR 234
            YIH+   V HRD+KP NLLVN     L++ DFG A+ L             Y+ +R+YR
Sbjct: 121 KYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APEL+    EYT AID+WS GC+ AE+L  + LFPG++ V QL  I+ VLG+P+ E +  
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 295 MNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           +       Y +   P+ +  PW KIF K   PEA+DL+S++LQ+ P  R T   A
Sbjct: 239 IGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQA 291

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  203 bits (518), Expect = 7e-63
 Identities = 105/293 (35%), Positives = 169/293 (57%), Gaps = 21/293 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y+  + +G G++G+V  AK  ET E VAIKK+        D +   RE++ +R LDH NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 121 VSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++K        +  +++Y+  V E +   +H++I+     SQ +   + + + YQ+ R 
Sbjct: 67  IAIKDIMPPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRG 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPE 237
           L YIH+   V HRD+KP NLL+N +   LK+CDFG A+    KG+    Y+ +R+YRAPE
Sbjct: 121 LKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-N 296
           L+   +EYT AID+WS GC+ AELL  +PLFPG+  V QL  I ++LG+P+ E++  + N
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238

Query: 297 PNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
                +    P      + ++F     P A+DL+ ++L + P+ R T  +A+ 
Sbjct: 239 EKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALA 290

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  201 bits (513), Expect = 8e-63
 Identities = 97/285 (34%), Positives = 158/285 (55%), Gaps = 26/285 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  +   +       RE+  ++ L+HPN+V L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +   LYL  V E++   + + +         +    +K Y YQ+ + +AY H + 
Sbjct: 67  VHSENK---LYL--VFEFLDLDLKKYMDSSPLTG--LDPPLIKSYLYQLLQGIAYCH-SH 118

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL++     LKL DFG A+    G P  +Y   + + +YRAPE++ G+ 
Sbjct: 119 RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGSR 175

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 300
           +Y+  +DIWS GC+ AE++  +PLFPG+S +DQL  I + LGTP  +    +  + P+Y 
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
              FP+       K+    +  + +DL+S++L Y P  R +A  A
Sbjct: 235 P-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAA 277

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  197 bits (504), Expect = 3e-61
 Identities = 106/286 (37%), Positives = 162/286 (56%), Gaps = 30/286 (10%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHCFFS 129
           G++GVV++A+  +TGE VA+KK+  +K  +       RE+  +  L HPN+V++K     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75

Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
           +   D++Y+  V+EYV   +  +++    M Q      VK    Q+   +A++H+   + 
Sbjct: 76  SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN-WIL 128

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYT 246
           HRD+K  NLL+N +   LK+CDFG A+    G P   Y   + + +YRAPEL+ GA EY+
Sbjct: 129 HRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEYS 185

Query: 247 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 306
            AID+WS GC+ AELL  +PLFPG+S +DQL +I K+LGTPT +      P ++E    +
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPGAK 241

Query: 307 IKAHPWHKIFQ--KRMPP-----EAVDLVSRLLQYSPNLRSTAFDA 345
            K    +   Q  K+ P         DL++RLL Y P  R +A DA
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  197 bits (502), Expect = 5e-61
 Identities = 110/285 (38%), Positives = 163/285 (57%), Gaps = 31/285 (10%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 125
           +VG GS+G+V + K  ETG+ VAIKK L+   DK  K    RE++ ++ L H N+V+L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHH-----YKMSQRMPLIYVKLYFYQICRALA 180
            F     K  LYL  V E+V  TV   ++ +         ++        Y +QI R + 
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESRVRK--------YLFQILRGIE 114

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELI 239
           + H+   + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE    Y+ +R+YRAPEL+
Sbjct: 115 FCHSH-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNP 297
            G T+Y  A+DIW+ GC++ E+L G+PLFPG+S +DQL  IIK LG   P  +EI   NP
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232

Query: 298 NYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            +   + P++K   P  K F K +    +DL  + L+  P+ R +
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  198 bits (506), Expect = 5e-61
 Identities = 99/292 (33%), Positives = 159/292 (54%), Gaps = 26/292 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y     VG G++G V  A   +TG  VAIKK+ +        KR Y  REL+ ++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 119 NVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+ L   F   +  ++   + LV   +   ++ ++K      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L YIH+  G+ HRD+KP N+ VN    +LK+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 298 ----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
               NY +   PQ+    + ++F     P A+DL+ ++L   P+ R TA +A
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEA 295

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  198 bits (504), Expect = 1e-60
 Identities = 115/296 (38%), Positives = 169/296 (57%), Gaps = 25/296 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y  + V+G GS+GVV  A    TGE VAIKK+      + D     RE++ +RLL HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V +KH     + ++   + +V E +   +H+VIK +  ++      + + + YQ+ RAL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFFLYQLLRALK 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAP 236
           YIH T  V HRD+KP+N+L N    +LK+CDFG A+V     P       Y+ +R+YRAP
Sbjct: 118 YIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 237 ELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-K 293
           EL  G+  ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL  I  +LGTP+ E I +
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMP---PEAVDLVSRLLQYSPNLRSTAFDAV 346
             N     +     K  P    F ++ P   P A+ L+ RLL + P  R TA +A+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  194 bits (496), Expect = 3e-60
 Identities = 99/280 (35%), Positives = 145/280 (51%), Gaps = 25/280 (8%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLKH 125
           G G+F  V +A+  +TG+  AIK +   K +K+       RE+Q +R L  HPN++ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIK--HHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F         L LV E +   ++ +IK        +R     VK Y YQ+ ++L ++H
Sbjct: 66  VLFDRKTGR---LALVFELMDMNLYELIKGRKRPLPEKR-----VKSYMYQLLKSLDHMH 117

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
              G+ HRDIKP+N+L+      LKL DFGS + +    P   YI +R+YRAPE +    
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTEF 302
            Y   +DIW+ GCV  E+L   PLFPG + +DQ+ +I  VLGTP  E +K      +  +
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
            FP  K     K+       E +DL+ +LL Y P+ R TA
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITA 273

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  196 bits (500), Expect = 3e-60
 Identities = 105/295 (35%), Positives = 172/295 (58%), Gaps = 25/295 (8%)

Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDH 117
           T  Y+  + VG G+FG+V  A+   TG+ VAIKK+++        +   REL+ ++ L H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N++SL   F S  E  ++Y   V E +   +HR++      S+ +   +++ + YQI R
Sbjct: 69  ENIISLSDIFISPLE--DIYF--VTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILR 119

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 236
            L Y+H+  GV HRD+KP N+L+N +   LK+CDFG A++    +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAP 174

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 295
           E++    +Y   +DIWSAGC+ AE+L G+PLFPG+  V+Q   I  +LGTP  + I  + 
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234

Query: 296 NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS 348
           + N   F    P+ +  P+ + F+    P A+DL+ ++L + P  R +A +A+  
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAH 288

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  184 bits (470), Expect = 2e-56
 Identities = 101/281 (35%), Positives = 156/281 (55%), Gaps = 25/281 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 126
           +G GS+GVVF+ +  ETG+ VAIKK ++       K+   RE++ ++ L HPN+V+L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--N 184
           F     + +  L+LV EY   TV   ++ +    + +P   +K   +Q  +A+ + H  N
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGAT 243
            I   HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G T
Sbjct: 121 CI---HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 301
           +Y   +D+W+ GCV AELL GQPL+PG+S VDQL  I K LG   P  ++I   N  +  
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236

Query: 302 FKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
              P+ +   P    F   +   A+  +   LQ  P  R +
Sbjct: 237 LSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  184 bits (468), Expect = 2e-55
 Identities = 105/292 (35%), Positives = 153/292 (52%), Gaps = 27/292 (9%)

Query: 73  VGHGSFGVVFQAKCLET--GEAVAIKK---VLQDKRYKNRELQTMRLL----DHPNVVSL 123
           +G G++G+V  A+  ET   E VAIKK   V   K    R L+ ++LL     H N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 124 KHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                      +ELYL    E +   +H++I+      Q +   + + + YQI   L YI
Sbjct: 68  YDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYI 121

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNIS-YICSRYYRAPE 237
           H+   V HRD+KP NLLVN    +LK+CDFG A+       +    ++ Y+ +R+YRAPE
Sbjct: 122 HSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKC 294
           ++     YT AID+WS GC+LAELL  +P+F G+  VDQL +I++VLGTP  E    I  
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                     P I   P+  IF     P A+DL+ +LL + P  R +  +A+
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEAL 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  181 bits (460), Expect = 7e-55
 Identities = 100/284 (35%), Positives = 160/284 (56%), Gaps = 22/284 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G G++  V++ +   TGE VA+K++  D          RE+  M+ L H N+V L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
             T  K    L LV EY+ + + + +  H      +    VK + YQ+ + +A+ H    
Sbjct: 67  IHTENK----LMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN-R 120

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE 244
           V HRD+KPQNLL+N    +LKL DFG A+    G P  ++   + + +YRAP+++ G+  
Sbjct: 121 VLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEF 302
           Y+ +IDIWS GC++AE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y + 
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-KP 236

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            FP+       ++F     P  +DL+ RLLQ +P LR +A DA+
Sbjct: 237 TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDAL 279

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  178 bits (453), Expect = 1e-54
 Identities = 69/247 (27%), Positives = 121/247 (48%), Gaps = 40/247 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G G FG V+ A+  +TG+ VAIK + ++          RE++ ++ L+HPN+V L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                +DE +L LV+EY    ++  ++K +     ++    +     QI   L Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-N 111

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 245
           G+ HRD+KP+N+L++    ++KL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 304
           +   DIWS G +L EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 305 PQIKAHP 311
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  178 bits (454), Expect = 6e-54
 Identities = 97/293 (33%), Positives = 156/293 (53%), Gaps = 24/293 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 120
           +Y     +G GS+  V++ +   TG+ VA+K++ L+ +        RE   ++ L H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L H    T +     L LV EY+   + + +         + +  V+L+ +Q+ R LA
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLA 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL++    +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--C 294
           ++ G+TEY+ ++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E      
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            NP +  + FP     P      +    P   +L  + LQY P  R +A +A+
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  178 bits (454), Expect = 7e-54
 Identities = 95/289 (32%), Positives = 155/289 (53%), Gaps = 23/289 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G V++A+   TG+ VA+KK   +   +       RE+  +++L     +     
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 127 FFSTTEKD-ELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHN 184
                EK+ +  L LV EY+   + + +  + +   R +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
             GV HRD+KPQNLLV+     LK+ D G  +      P  SY   I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
           +T Y+  +DIWS GC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241

Query: 302 FK----FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            +    FPQ K     +     + PE +DL+ ++L+Y P  R +A  A+
Sbjct: 242 LRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAAL 289

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  176 bits (449), Expect = 3e-53
 Identities = 105/293 (35%), Positives = 162/293 (55%), Gaps = 40/293 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL  V E++    H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 68  IHT---ENKLYL--VFEFL----HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 119 H-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       + P  T 
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTS 230

Query: 302 FK-----FPQIKAHPWHKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAV 346
                  FP+         F K +PP   +  DL+S++L Y PN R +A  A+
Sbjct: 231 LPDYKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  177 bits (451), Expect = 3e-53
 Identities = 102/290 (35%), Positives = 153/290 (52%), Gaps = 28/290 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G+V++A+   +GE VA+KKV  D           RE+  +  L HPN+V LK  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                  D ++L  V+EY  + +  ++     M        VK    Q+ R L Y+H   
Sbjct: 75  VVGK-HLDSIFL--VMEYCEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            + HRD+K  NLL+      LK+ DFG A+    G P       + + +YRAPEL+ G T
Sbjct: 129 -IIHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCT 184

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            YT AID+W+ GC+LAELL  +PL PG+S ++QL  II++LGTP        +  P   +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244

Query: 302 FKFPQIKAHPWHKIFQKRMP--PEA-VDLVSRLLQYSPNLRSTAFDAVGS 348
           F  P+    P++ +  K  P   EA + L++ LL Y P  R+TA +A+ S
Sbjct: 245 FTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  174 bits (441), Expect = 5e-52
 Identities = 111/280 (39%), Positives = 159/280 (56%), Gaps = 24/280 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 125
           VVG G++GVV + +  ET E VAIKK          K    REL+ +R L   N+V LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F     + +LYL  V EYV + +  +++        +P   V+ Y YQ+ +A+ + H  
Sbjct: 68  AF---RRRGKLYL--VFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNIS-YICSRYYRAPELIFGAT 243
             + HRDIKP+NLL++ H   LKLCDFG A+ L +G   N + Y+ +R+YR+PEL+ GA 
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTE 301
            Y  A+D+WS GC+L EL  GQPLFPGES +DQL  I KVLG    E++K    NP +  
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236

Query: 302 FKFPQIKAHP--WHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            +FP +  HP    + +   +    +DL+  LL+ +P  R
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDR 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  172 bits (439), Expect = 2e-51
 Identities = 109/311 (35%), Positives = 153/311 (49%), Gaps = 46/311 (14%)

Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           +G G++G V++AK      G+  AIKK   DK           RE+  +R L H NVVSL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYI 182
              F    +K  +YL  + +Y    + ++IK H       +P   VK   +QI   + Y+
Sbjct: 68  VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 183 HNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA-------KVLVKGEPNISYICSRY 232
           H+   V HRD+KP N+LV    P    +K+ D G A       K L   +P +  I   +
Sbjct: 125 HSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEIIKV 283
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F G             DQL  I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 284 LGTPTREE---IKCMNPNY----TEFKFPQIKAHPWHKIFQKRMP--PEAVDLVSRLLQY 334
           LGTPT ++   IK M P Y     +FK     ++   K  +K      +  DL+ +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299

Query: 335 SPNLRSTAFDA 345
            P  R TA +A
Sbjct: 300 DPTKRITAEEA 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  171 bits (435), Expect = 2e-51
 Identities = 88/281 (31%), Positives = 128/281 (45%), Gaps = 44/281 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLK 124
            ++G GSFG V+ A   +TGE +A+K V L     +      RE++ +  L HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             + S  ++++  LN+ LEYV       +    K   ++P   ++ Y  QI   LAY+H+
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSG---GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR---YYRAPELIFG 241
             G+ HRDIK  N+LV+     +KL DFG AK L   E        R   Y+ APE+I G
Sbjct: 120 N-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
             EY  A DIWS GC + E+  G+P +         +  I   G P              
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------------- 222

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
              P+I  H         +  EA D + + L+  P  R TA
Sbjct: 223 ---PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTA 251

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  172 bits (437), Expect = 3e-51
 Identities = 94/297 (31%), Positives = 155/297 (52%), Gaps = 46/297 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 119
           +G G++G V++A+ L TG  VA+KKV    R             RE+  ++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 120 VVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +V L   C    T++ EL L LV E+V + +   +    K    +P   +K    Q+ R 
Sbjct: 63  IVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRG 119

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + ++H +  + HRD+KPQN+LV     Q+K+ DFG A++        S + + +YRAPE+
Sbjct: 120 VDFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +  ++ Y   +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE       
Sbjct: 178 LLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE------- 229

Query: 299 YTEFKFPQIKAHPWH-------KIFQKRMP---PEAVDLVSRLLQYSPNLRSTAFDA 345
                +P+  + P         + F+  +P    E +DL+ ++L ++P+ R +AF+A
Sbjct: 230 -----WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  171 bits (435), Expect = 3e-51
 Identities = 100/287 (34%), Positives = 155/287 (54%), Gaps = 28/287 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +     L LV EY  + +    K+    +  +    VK + +Q+ + LA+ H+  
Sbjct: 68  LHSDKK-----LTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N +  +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYT 300
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTPT E    ++  P+Y 
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 301 EF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            +  +P   +     +   ++     DL+  LL  +P  R +A +A+
Sbjct: 236 PYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEAL 279

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  171 bits (434), Expect = 6e-51
 Identities = 100/291 (34%), Positives = 162/291 (55%), Gaps = 23/291 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G++GVV++A+   T E +A+KK+  ++  +       RE+  ++ + H N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L+    S     E  L LV EY+   + + +      ++   LI  K Y YQI R +A
Sbjct: 64  VRLQDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI--KTYLYQILRGIA 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H+   V HRD+KPQNLL++  T+ LKL DFG A+    G P  ++   + + +YRAPE
Sbjct: 117 YCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 296
           ++ G+  Y+  +DIWS GC+ AE++  +PLFPG+S +D+L +I ++LGTP  E    +  
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233

Query: 297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            P+Y    FP+        +    + P  VDL+S++L+  P+ R TA  A+
Sbjct: 234 LPDYKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAAL 282

Length = 294

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  172 bits (438), Expect = 6e-51
 Identities = 94/310 (30%), Positives = 164/310 (52%), Gaps = 48/310 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKR---YKNRELQTMRLLDHPNVVS 122
           YM  R +G GS G+VF A   +  + VA+KK VL D +   +  RE++ +R LDH N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 123 LKHCFFST-----------TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           +      +           TE + +Y+  V EY+   +  V++        +   + +L+
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYI--VQEYMETDLANVLEQ-----GPLSEEHARLF 119

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---- 227
            YQ+ R L YIH+   V HRD+KP N+ +N     LK+ DFG A+++   +P+ S+    
Sbjct: 120 MYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYL 175

Query: 228 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL---VEII 281
              + +++YR+P L+     YT AID+W+AGC+ AE+L G+PLF G   ++Q+   +E +
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235

Query: 282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPW--HKIFQKRMP---PEAVDLVSRLLQYSP 336
            V+    R E+  + P++       ++       +  +  +P   PEA+D + ++L ++P
Sbjct: 236 PVVREEDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288

Query: 337 NLRSTAFDAV 346
             R TA +A+
Sbjct: 289 MDRLTAEEAL 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  173 bits (438), Expect = 1e-50
 Identities = 89/301 (29%), Positives = 132/301 (43%), Gaps = 48/301 (15%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHP 118
           SY   R +G GSFG V+ A+  +    VA+K + +    K+       RE+Q +  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 119 -NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N+V L   F     +DE  L LV+EYV       +         +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-------SYICS 230
           AL Y+H + G+ HRDIKP+N+L++     +KL DFG AK+L              + + +
Sbjct: 113 ALEYLH-SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 231 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLG 285
             Y APE++ G +    +++ DIWS G  L ELL G P F GE       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           TP                     A P      + +   A DL+ +LL   P  R ++   
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Query: 346 V 346
           +
Sbjct: 273 L 273

Length = 384

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  165 bits (419), Expect = 1e-48
 Identities = 94/289 (32%), Positives = 157/289 (54%), Gaps = 31/289 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLDHPNVVS 122
           +G G++GVV++ +  +TG+ VA+KK+    R ++          RE+  ++ L HPN+V 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L+       ++  LYL  + E++   + + +       Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM---QESRLYL--IFEFLSMDLKKYLDS-LPKGQYMDAELVKSYLYQILQGILFC 117

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
           H+   V HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++
Sbjct: 118 HSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 297
            G+  Y+  +DIWS G + AE+   +PLF G+S +DQL  I ++LGTPT +    +   P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           +Y    FP+ K     +   K +  + +DL+ ++L Y P  R +A  A+
Sbjct: 234 DYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  165 bits (421), Expect = 1e-48
 Identities = 96/307 (31%), Positives = 141/307 (45%), Gaps = 53/307 (17%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKHC 126
           G G+FG V++A+ ++TG  VA+KK+L     K+       RE++ ++ L HPNVV L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 127 FFSTTEKDELYLNLVLEYVPETVH---------RVIKHHYKMSQRMPLIYVKLYFYQICR 177
                +K +     V    P   H          V       SQ      +K Y  Q+  
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV---KLTESQ------IKCYMLQLLE 126

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---------- 227
            + Y+H    + HRDIK  N+L++ +   LK+ DFG A+      PN             
Sbjct: 127 GINYLHEN-HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 228 --ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
             + +R+YR PEL+ G   YT A+DIW  GCV AE+   +P+  G+S +DQL  I K+ G
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244

Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ-------KRMPPEAVDLVSRLLQYSPNL 338
           TPT E      P +     P  +       +         ++ PE +DL+S+LL   P  
Sbjct: 245 TPTEETW----PGWR--SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298

Query: 339 RSTAFDA 345
           R TA DA
Sbjct: 299 RLTASDA 305

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  167 bits (425), Expect = 1e-48
 Identities = 106/299 (35%), Positives = 157/299 (52%), Gaps = 41/299 (13%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK---VLQD----KRYKNRELQTMRLLDHPNVVS 122
           +R +G+G+FGVV+       G+ VA+KK   V Q+    KR   REL+ +    H NV+S
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 123 --------LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
                       F      +E+Y+  V E +   +H++I       Q +   +VK++ YQ
Sbjct: 64  ALDILQPPHIDPF------EEIYV--VTELMQSDLHKIIVS----PQPLSSDHVKVFLYQ 111

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-----IC 229
           I R L Y+H + G+ HRDIKP NLLVN +   LK+CDFG A+V    EP+ S      + 
Sbjct: 112 ILRGLKYLH-SAGILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVV 166

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           ++YYRAPE++ G+  YT+A+DIWS GC+ AELL  + LF  +S + QL  I  +LGTP+ 
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDA 345
           E ++                 P   +          EAV L+ R+L + P+ R +A DA
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA 285

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  162 bits (411), Expect = 5e-47
 Identities = 97/310 (31%), Positives = 150/310 (48%), Gaps = 53/310 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------------RELQTMR 113
           +G G++G V +A    TG+ VAIKKV +     N                   REL+ M 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            + H N++ L   +    E D  ++NLV++ +   + +V+    ++++      VK    
Sbjct: 76  EIKHENIMGLVDVY---VEGD--FINLVMDIMASDLKKVVDRKIRLTES----QVKCILL 126

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----VLVKGEPNISYI 228
           QI   L  +H    + HRD+ P N+ +N      K+ DFG A+                +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 229 CSR----------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
             R          +YRAPEL+ GA +Y  A+D+WS GC+ AELL G+PLFPGE+ +DQL 
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244

Query: 279 EIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
            I ++LGTP  +   + K + P YTEF   + K      IF      +A+DL+  LL+ +
Sbjct: 245 RIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD--LKTIFPNA-SDDAIDLLQSLLKLN 300

Query: 336 PNLRSTAFDA 345
           P  R +A +A
Sbjct: 301 PLERISAKEA 310

Length = 335

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  160 bits (406), Expect = 3e-46
 Identities = 98/285 (34%), Positives = 152/285 (53%), Gaps = 22/285 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 126
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 127 FFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F      D  +   LV+ ++   + +++KH      R     ++   YQ+ + L YIH  
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIHAA 137

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            G+ HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I     Y
Sbjct: 138 -GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMHY 193

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 301
           T  +DIWS GC++AE+L G+PLF G   +DQL+EI+KV GTP++E ++ +      NY +
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            K P+ +   +  +      P AV+++ ++L      R TA +A+
Sbjct: 254 -KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEAL 296

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  160 bits (406), Expect = 3e-46
 Identities = 103/309 (33%), Positives = 158/309 (51%), Gaps = 48/309 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKR-YKNRELQTMRLLDHP 118
           Y   + +G G+ G+V  A    TG+ VAIKK       V   KR Y  REL  M+L++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 119 NVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYF 172
           N++ L + F    S  E  ++YL  V+E +   + +VI+    H +MS          Y 
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVYL--VMELMDANLCQVIQMDLDHERMS----------YL 123

Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
            YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +R
Sbjct: 124 LYQMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTR 181

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           YYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  +II+ LGTP+ E 
Sbjct: 182 YYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240

Query: 292 IKCMNP---NYTEFKFPQIKAHPWHKIF------------QKRMPPEAVDLVSRLLQYSP 336
           +  + P   NY E + P+   + + ++F             K    +A DL+S++L   P
Sbjct: 241 MSRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299

Query: 337 NLRSTAFDA 345
             R +  DA
Sbjct: 300 EKRISVDDA 308

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  159 bits (404), Expect = 5e-46
 Identities = 98/292 (33%), Positives = 156/292 (53%), Gaps = 25/292 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL---DHPNV 120
           Y + + VG G++G V  A    TGE VAIKK+    Q + +  R  + + LL    H NV
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L   F S    DE     LV+ Y+   + +++ H     +      V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLCGL 130

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 238
            YIH+  G+ HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE+
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEV 185

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-- 296
           I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +   
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 297 --PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
              +Y +   P+     +  +F  +  P+AVDL+ ++L+   + R TA +A+
Sbjct: 246 AAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEAL 295

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  155 bits (393), Expect = 5e-45
 Identities = 104/294 (35%), Positives = 160/294 (54%), Gaps = 26/294 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPN 119
           SY+    +G GS+  V++      G+ VA+K V+  K  +       RE   ++ L H N
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V L H    T E     L  V EY+   + + +  H      +    V+L+ +Q+ R L
Sbjct: 65  IVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGL 116

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 236
           AYIH    + HRD+KPQNLL++ +  +LKL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 AYIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPP 172

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM 295
           +++ GAT+Y++A+DIW AGC+  E+L GQP FPG S V +QL +I  VLG PT +    +
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232

Query: 296 N--PNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           +  PNY    F   K      ++++   PP+A DL S++L   P  R +A DA+
Sbjct: 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  153 bits (388), Expect = 2e-44
 Identities = 75/277 (27%), Positives = 126/277 (45%), Gaps = 42/277 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
             +G G FG V++A+   TG+ VAIK + L+ K  K     E+Q ++   HPN+V     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           +    +KDEL+  +V+E+    ++  ++K     +Q +    +     ++ + L Y+H+ 
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            G+ HRDIK  N+L+     ++KL DFG +  L   +   + + + Y+ APE+I G   Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
               DIWS G    EL  G+P +  E    + +  I   G P               + P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPG-------------LRNP 220

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                       ++   E  D + + LQ +P  R TA
Sbjct: 221 ------------EKWSDEFKDFLKKCLQKNPEKRPTA 245

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  153 bits (387), Expect = 6e-44
 Identities = 89/305 (29%), Positives = 148/305 (48%), Gaps = 47/305 (15%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 125
            +G G++G V++A+  +TGE VA+KKV  D   +       RE++ +R L+H N+V+LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 126 CFFSTTE-----KDELYLNLVLEYVPETVHRVIKH---HYKMSQRMPLIYVKLYFYQICR 177
                 +     KD+    LV EY+   +  +++    H+          +K +  Q+  
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH------IKSFMKQLLE 127

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRA 235
            L Y H      HRDIK  N+L+N +  Q+KL DFG A++    E  P  + + + +YR 
Sbjct: 128 GLNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PEL+ G   Y  AID+WS GC+L EL   +P+F     + QL  I ++ G+P       +
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC----PAV 241

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRM------------PPEAVDLVSRLLQYSPNLRSTAF 343
            P+  +  +       ++ +  K+             P  A+DL+  +L   P+ R TA 
Sbjct: 242 WPDVIKLPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 344 DAVGS 348
           +A+ S
Sbjct: 295 EALNS 299

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  153 bits (387), Expect = 7e-44
 Identities = 96/291 (32%), Positives = 157/291 (53%), Gaps = 23/291 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L H    T +     L LV EY+ + + + +         M +  VK++ YQI R LA
Sbjct: 67  VTL-HDIVHTDKS----LTLVFEYLDKDLKQYMD---DCGNIMSMHNVKIFLYQILRGLA 118

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++ G++EY+  ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ 
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 298 N--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           N  +  + FP+ K  P       R+  E ++L+++ LQY    R +A +A+
Sbjct: 235 NDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAM 284

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  151 bits (383), Expect = 1e-43
 Identities = 94/287 (32%), Positives = 153/287 (53%), Gaps = 23/287 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L H    T    E  L LV EY+   + + + +       M +  VK++ +Q+ R L+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLS 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 118 YCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CM 295
           ++ G+TEY+  ID+W  GC+L E+  G+P+FPG +  ++L  I ++LGTPT E       
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           N  +  + FPQ +A P       R+  + +DL+S LL Y    R +A
Sbjct: 234 NEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISA 279

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  152 bits (384), Expect = 2e-43
 Identities = 92/291 (31%), Positives = 156/291 (53%), Gaps = 23/291 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  V++ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L       TEK    L LV EY+ + + + +         + +  VKL+ +Q+ R L 
Sbjct: 67  VTLHDIIH--TEKS---LTLVFEYLDKDLKQYLD---DCGNSINMHNVKLFLFQLLRGLN 118

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 295
           ++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           N  +  + +P+ +A   H     R+  +  +L+S+LLQ+    R +A +A+
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  150 bits (381), Expect = 2e-43
 Identities = 83/294 (28%), Positives = 127/294 (43%), Gaps = 60/294 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   + +G GSFG V+  +    G+   +K++       +++     E++ ++ L+HPN+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +     F    EK    L +V+EY     + + IK   K  +  P   +  +F Q+C AL
Sbjct: 62  IKYYESFE---EKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYICS 230
            Y+H +  + HRDIKPQN+ +      +KL DFG +KVL         V G P       
Sbjct: 117 KYLH-SRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP------- 167

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            YY +PEL      Y    DIWS GCVL EL   +  F GE+ + +L    K+L    + 
Sbjct: 168 -YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KG 218

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +   +   Y                       E  +LVS LLQ  P  R +   
Sbjct: 219 QYPPIPSQY---------------------SSELRNLVSSLLQKDPEERPSIAQ 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  148 bits (377), Expect = 7e-43
 Identities = 84/277 (30%), Positives = 130/277 (46%), Gaps = 52/277 (18%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V   +  +TG+  A+K     K+++ K   +   E   +  ++HP +V L +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F     + E  L LVLEY P  E +   +    + S+       + Y  +I  AL Y+H
Sbjct: 61  AF-----QTEEKLYLVLEYAPGGE-LFSHLSKEGRFSEER----ARFYAAEIVLALEYLH 110

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
           + +G+ +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 S-LGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y  A+D WS G +L E+L G+P F  E    ++ E I                     
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           +FP            + + PEA DL+S LLQ  P  R
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  150 bits (381), Expect = 1e-42
 Identities = 95/292 (32%), Positives = 154/292 (52%), Gaps = 24/292 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y     VG G++G V  A      + VA+KK+      L   R   REL+ ++ + H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 121 VSLKHCFFSTT---EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           + L   F   T     +E+YL  V   +   ++ ++K      Q++   +V+   YQ+ R
Sbjct: 77  IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLR 129

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L YIH+  G+ HRD+KP N+ VN    +L++ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +K ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 298 NYTEFKF---PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            +        P +      KIF +   P A+DL+ ++L    + R +A +A+
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEAL 296

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  150 bits (379), Expect = 2e-42
 Identities = 97/287 (33%), Positives = 152/287 (52%), Gaps = 24/287 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 126 CFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F      +E   + LV   +   ++ ++K      Q++   +V+   YQI R L YIH+
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 300
           Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 255 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 299

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  136 bits (345), Expect = 5e-38
 Identities = 86/286 (30%), Positives = 134/286 (46%), Gaps = 54/286 (18%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYK-NRELQTMRLLDHPNVVSLKHC 126
           V+G GS GVV++ +   TG+  A+KK+     ++ R +  REL+T+R  + P VV     
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F+      E  +++VLEY+   ++  ++K   K+ + +    +     QI + L Y+H  
Sbjct: 68  FYK-----EGEISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTK 118

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIF 240
             + HRDIKP NLL+N    ++K+ DFG +KVL     N    C+ +     Y +PE I 
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           G + Y+ A DIWS G  L E  LG+ P L PG+    +L++ I            C    
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CD--- 217

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                 P            +   PE  D +S  LQ  P  R +A +
Sbjct: 218 -----GPPPSLPA------EEFSPEFRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  134 bits (339), Expect = 9e-37
 Identities = 87/296 (29%), Positives = 139/296 (46%), Gaps = 34/296 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH- 125
           +G G+FG VF+A+  +T + VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 126 CFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    T     K   YL  V E+    +  ++ +    + +  L  +K     +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYL--VFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYY 134

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCM 295
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E      
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252

Query: 296 N-PNYTEFKFPQ-----IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
               + + + PQ     +K      +      P A+DL+ +LL   P  R  A  A
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYV----KDPHALDLIDKLLVLDPAKRIDADTA 304

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  134 bits (337), Expect = 1e-36
 Identities = 98/292 (33%), Positives = 150/292 (51%), Gaps = 30/292 (10%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 120
           SY     +G GS+  V++ K    G+ VA+K + LQ++        RE   ++ L H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L H    T E     L LV EYV   + + +  H      +    VKL+ +Q+ R L+
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLS 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           YIH    + HRD+KPQNLL++  T +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPD 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN 296
           ++ G+TEY+  +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    ++
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233

Query: 297 --PNYTEFKFPQIKA----HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
             P++   +F           W+K+        A DL S+LLQ  P  R +A
Sbjct: 234 SLPHFKPERFTLYSPKNLRQAWNKL---SYVNHAEDLASKLLQCFPKNRLSA 282

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  133 bits (336), Expect = 1e-36
 Identities = 81/308 (26%), Positives = 136/308 (44%), Gaps = 75/308 (24%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTM-RLLDHP 118
           +   +++G GSF  V  AK  ET +  AIK     +++++K+  Y   E + + RL  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            ++ L + F     +DE  L  VLEY P   + + I+ +  + ++      + Y  +I  
Sbjct: 63  GIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEILL 113

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRY- 232
           AL Y+H+  G+ HRD+KP+N+L++   H +K+ DFG+AKVL                   
Sbjct: 114 ALEYLHS-KGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 233 ----------------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 276
                           Y +PEL+        + D+W+ GC++ ++L G+P F G +  + 
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EY 228

Query: 277 LV--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 334
           L   +I+K                  E+ FP               PP+A DL+ +LL  
Sbjct: 229 LTFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVL 259

Query: 335 SPNLRSTA 342
            P  R   
Sbjct: 260 DPQDRLGV 267

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 8e-36
 Identities = 69/203 (33%), Positives = 108/203 (53%), Gaps = 20/203 (9%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKH 125
           ++G G+FGVV++   LETG+ VAIK++ L+  + +      +E+  ++ L HPN+V    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                  +    L ++LEY    ++ ++IK      + +    V +Y YQ+ + LAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 243
             GV HRDIK  N+L       +KL DFG A  L     +  S + + Y+ APE+I   +
Sbjct: 118 Q-GVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 244 EYTAAIDIWSAGCVLAELLLGQP 266
             + A DIWS GC + ELL G P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  128 bits (323), Expect = 1e-34
 Identities = 81/283 (28%), Positives = 134/283 (47%), Gaps = 16/283 (5%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---LL------DHPNVVSL 123
           +G G++G V++A+   +G  VA+K V          L T+R   LL      DHPN+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                ++    E  + LV E+V + +   +         +P   +K    Q  R L ++H
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
               + HRD+KP+N+LV     Q+KL DFG A++          + + +YRAPE++  +T
Sbjct: 126 -ANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    +       
Sbjct: 184 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTLPRGA 241

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           F      P        +      L+  +L ++P+ R +AF A+
Sbjct: 242 FSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  127 bits (321), Expect = 1e-34
 Identities = 83/282 (29%), Positives = 131/282 (46%), Gaps = 48/282 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL---QDKRYK------NRELQTMRLLDHPNVV 121
            ++G GSFG V++   L+ G+  A+K+V      +  +       +E+  +  L HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                 +  TE++E  L + LE VP  ++ ++     K     P   ++LY  QI   L 
Sbjct: 66  Q-----YLGTEREEDNLYIFLELVPGGSLAKL----LKKYGSFPEPVIRLYTRQILLGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           Y+H+     HRDIK  N+LV+     +KL DFG AK +V+     S+  S Y+ APE+I 
Sbjct: 117 YLHDR-NTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               Y  A DIWS GC + E+  G+P +   S ++ +  + K+  +     I        
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                     P H      +  EA D + + LQ  P+LR TA
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTA 249

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  126 bits (319), Expect = 2e-34
 Identities = 83/284 (29%), Positives = 137/284 (48%), Gaps = 50/284 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKHC 126
           +G G+FG V+ A  L+TGE +A+K++ +QD   K       E++ + LL HPN+V     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           +     ++++Y+   +EY    T+  +++H   + + +    +++Y  Q+   LAY+H +
Sbjct: 65  YGVEVHREKVYI--FMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLH-S 117

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIF 240
            G+ HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+I 
Sbjct: 118 HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 241 GAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           G     +  A DIWS GCV+ E+  G+  +   S +D   +I+  +G          +  
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGA--------GHK- 224

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                 P I           ++ PE  D + R L+  P  R TA
Sbjct: 225 ------PPIPDS-------LQLSPEGKDFLDRCLESDPKKRPTA 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  126 bits (318), Expect = 4e-34
 Identities = 89/283 (31%), Positives = 137/283 (48%), Gaps = 60/283 (21%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNR------ELQTMRLLDHPNVVSLKHCFF 128
           G++G VF AK   TG+  AIK +   D   KN+      E   +     P VV L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           S   K  LYL  V+EY+P   +  ++++   + + +     ++Y  +I  AL Y+H+  G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHS-NG 113

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISY--------ICSRYYRAPEL 238
           + HRD+KP N+L++ + H LKL DFG +KV LV+ + N++         + +  Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           I G   ++  +D WS GC+L E L+G P F GE                T EEI      
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGE----------------TPEEI------ 209

Query: 299 YTEFKFPQIKAH--PWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                F  I      W +  +  +  EA+DL+S+LL   P  R
Sbjct: 210 -----FQNILNGKIEWPEDVE--VSDEAIDLISKLLVPDPEKR 245

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  127 bits (320), Expect = 1e-33
 Identities = 92/301 (30%), Positives = 155/301 (51%), Gaps = 31/301 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 136

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253

Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTAFDA 345
            NY E + PQ     + ++F   + P           +A DL+S++L   P+ R +  +A
Sbjct: 254 RNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 346 V 346
           +
Sbjct: 313 L 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  126 bits (317), Expect = 3e-33
 Identities = 94/304 (30%), Positives = 155/304 (50%), Gaps = 37/304 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS  +         YQ+ 
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 129

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 247 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 343 FDAV 346
            +A+
Sbjct: 306 DEAL 309

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  124 bits (312), Expect = 4e-33
 Identities = 81/230 (35%), Positives = 127/230 (55%), Gaps = 17/230 (7%)

Query: 73  VGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 122
           +G G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 123 L-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   C  S T++ E  L LV E+V + +   +         +P   +K   +Q+ R L +
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDF 125

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  
Sbjct: 126 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  122 bits (308), Expect = 5e-32
 Identities = 91/304 (29%), Positives = 154/304 (50%), Gaps = 37/304 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 136

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253

Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312

Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  118 bits (298), Expect = 3e-31
 Identities = 74/214 (34%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNR---ELQTMRLLDHPN 119
           +  E+ +G G F VV++A CL  G  VA+KKV    + D + +     E+  ++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+     F    E     LN+VLE      + R+IKH  K  + +P   +  YF Q+C A
Sbjct: 64  VIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPE 237
           L ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMHSK-RIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  118 bits (298), Expect = 6e-31
 Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 55/279 (19%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 123
           + +G GSFG V   +   +G+  A+K     K+++ K+ +    E + ++ + HP +V+L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D+  L LV+EYVP  E     +  H + S R P    + Y  Q+  AL Y
Sbjct: 67  YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H+ + + +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I 
Sbjct: 117 LHS-LDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               Y  A+D W+ G ++ E+L G P F  ++   Q+ E I          ++       
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKI----------LEG------ 213

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           + +FP                P+A DL+  LLQ     R
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  115 bits (290), Expect = 4e-30
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 22/225 (9%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
            +G GSFG V + +    G+ +  K++       ++K+    E+  +R L HPN+V    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                + +    L +V+EY     + ++I+   K  + +   ++     Q+  AL   HN
Sbjct: 67  RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 185 TIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 237
                  V HRD+KP N+ ++   + +KL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            +   + Y    DIWS GC++ EL    P F       QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  115 bits (289), Expect = 1e-29
 Identities = 100/314 (31%), Positives = 151/314 (48%), Gaps = 50/314 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEA--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++AK  +  +    A+K++          RE+  +R L HPNV+SL+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLIYVKLYFYQICRALAYIH 183
           S  ++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 69  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 184 NTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNISYICSRYY 233
               V HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF---------PGESGVDQLVEIIKVL 284
           RAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241

Query: 285 GTPTR---EEIKCMNPNYTEFK-FPQ--------IKAHPWHKIFQKRMPPEAVDLVSRLL 332
           G P     E+IK M  + T  K F +        IK    HK+   +   +A  L+ +LL
Sbjct: 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLL 298

Query: 333 QYSPNLRSTAFDAV 346
              P  R T+  A+
Sbjct: 299 TMDPIKRITSEQAM 312

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  112 bits (283), Expect = 5e-29
 Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 47/282 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL--QDKRYKN---RELQTMRLLDHPNVVSLKH 125
             +G G+ GVV +     TG+ +A+K +    ++  +    REL  +   + P +V    
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F++  +     +++ +EY+       I    ++  R+P   +      + + L Y+H  
Sbjct: 67  AFYNNGD-----ISICMEYMDGGSLDKILK--EVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             + HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYT 300
           +   DIWS G  L EL  G+  +P E+       + L  I+               P   
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP--- 221

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
               P++ +  +         P+  D V+  L   P  R + 
Sbjct: 222 ----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSY 251

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 5e-29
 Identities = 82/276 (29%), Positives = 122/276 (44%), Gaps = 55/276 (19%)

Query: 76  GSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           G+FG V+ AK   TG+  AIK      ++   +  N + +   ++   + P V  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 128 FSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +S   KD  YL LV+EY+      ++        K    +P  + K Y  ++   +  +H
Sbjct: 64  YSFQSKD--YLYLVMEYLNGGDCASL-------IKTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
              G+ HRDIKP+NLL++   H LKL DFG ++    G  N  ++ +  Y APE I G  
Sbjct: 115 QR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           +     D WS GCV+ E L G P F  E+  D + + I          I     N+ E  
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRI-----NWPEEV 216

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             PEAVDL++RLL   P  R
Sbjct: 217 KEFCS-------------PEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  113 bits (284), Expect = 5e-29
 Identities = 96/312 (30%), Positives = 152/312 (48%), Gaps = 46/312 (14%)

Query: 73  VGHGSFGVVFQAKCLETGEA--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++AK  +  +    A+K++          RE+  +R L HPNV++L+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLIYVKLYFYQICRALAYIH 183
           S +++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 69  SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 184 NTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNISYICSRYY 233
               V HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF---------PGESGVDQLVEIIKVL 284
           RAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241

Query: 285 GTPTR---EEIKCMNPNY----TEFKFPQIKAHPWHKIFQK-RMPPEA--VDLVSRLLQY 334
           G P     E+I+ M P Y     +F+          K  +K ++ P++    L+ +LL  
Sbjct: 242 GFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTM 300

Query: 335 SPNLRSTAFDAV 346
            P  R T+  A+
Sbjct: 301 DPTKRITSEQAL 312

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  111 bits (281), Expect = 7e-29
 Identities = 69/237 (29%), Positives = 113/237 (47%), Gaps = 47/237 (19%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            + +G G+FG V++ K      +    VA+K + +D   +      RE + MR LDHPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYF-YQICR 177
           V L       TE++ LY  +V+EY+     +  + K+  K+S         L F  QI R
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYMEGGDLLSYLRKNRPKLSLSD-----LLSFALQIAR 113

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            + Y+ +     HRD+  +N LV      +K+ DFG ++ L   +         YYR   
Sbjct: 114 GMEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRG 162

Query: 235 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
                   APE +    ++T+  D+WS G +L E+  LG+  +PG S  ++++E +K
Sbjct: 163 GKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  111 bits (279), Expect = 1e-28
 Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 44/236 (18%)

Query: 70  ERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            + +G G+FG V++             VA+K + +D   +      RE + MR LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V L       TE++ L   +V+EY+P    +  + K+  K    + L  +  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMPGGDLLDYLRKNRPK---ELSLSDLLSFALQIARG 115

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +     HRD+  +N LV      +K+ DFG ++ L   +         YY+    
Sbjct: 116 MEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164

Query: 235 -------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
                  APE +    ++T+  D+WS G +L E+  LG+  +PG S   +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  108 bits (272), Expect = 1e-27
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 21/209 (10%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHC 126
           V+G G+  VV+ A CL   E VAIK++  +K   +     +E+Q M   +HPNVV   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS-QRMPLIYVKLYFYQICRALAYIHN 184
            F     DEL+  LV+ Y+   ++  ++K  Y        +I   L   ++ + L Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----YICSRYYRAPELI 239
             G  HRDIK  N+L+      +K+ DFG +  L  G          ++ +  + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLF 268
                Y    DIWS G    EL  G   +
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  108 bits (272), Expect = 2e-27
 Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 56/286 (19%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 128
            +G G+ G V++A    TG+ VAIKK+ L+ +  +    E+  M+   HPN+V     + 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY- 84

Query: 129 STTEKDELYLNLVLEY--------VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                    L +V+EY        +      + ++  +M++   + YV     ++ + L 
Sbjct: 85  ----LVGDELWVVMEYMDGGSLTDI------ITQNFVRMNEPQ-IAYVCR---EVLQGLE 130

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELI 239
           Y+H+   V HRDIK  N+L++     +KL DFG A  L K +    S + + Y+ APE+I
Sbjct: 131 YLHSQ-NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               +Y   +DIWS G +  E+  G+P +  E  +  L  I    G P    +K      
Sbjct: 189 KR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK------ 237

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                       W   F+        D +++ L   P  R +A + 
Sbjct: 238 --------NPEKWSPEFK--------DFLNKCLVKDPEKRPSAEEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  107 bits (270), Expect = 3e-27
 Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 45/275 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G FG V   K        A+K V          + +   E + +   +HP +V L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 126 CFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    KD+ Y+ +++EY     +  +++      +       + Y   +  A  Y+HN
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYT----ARFYIACVVLAFEYLHN 111

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
             G+ +RD+KP+NLL++     +KL DFG AK L  G+   ++  +  Y APE+I     
Sbjct: 112 -RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           Y  ++D WS G +L ELL G+P F GE   D +             +I   N      +F
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL---EF 215

Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           P              +   A DL+ +LL+ +P  R
Sbjct: 216 PNY------------IDKAAKDLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  107 bits (268), Expect = 5e-27
 Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 48/278 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           RV+G G+FG V   +  +T +  A+K     K ++    +N   E + ++ L+HP +V+L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQICRALAY 181
            + F     +DE  + LV++ +     R     Y +SQ++      VK +  +I  AL Y
Sbjct: 66  WYSF-----QDEENMYLVVDLLLGGDLR-----YHLSQKVKFSEEQVKFWICEIVLALEY 115

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +H+  G+ HRDIKP N+L++   H + + DF  A  +       S   +  Y APE++  
Sbjct: 116 LHSK-GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y+ A+D WS G    E L G+  + G S                R++I+        
Sbjct: 174 QG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK------ 213

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
               Q  A     ++      EA+D +++LL+  P  R
Sbjct: 214 ----QETADV---LYPATWSTEAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  107 bits (268), Expect = 5e-27
 Identities = 68/218 (31%), Positives = 118/218 (54%), Gaps = 30/218 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYK------NRELQTM 112
           ++   ++G G++G V+ A  + TGE +A+K+V          D R K        E++T+
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLY 171
           + LDH N+V          E  E YL++ LEYVP  ++   ++ + +  +++    V+ +
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNISYI 228
             Q+   LAY+H+  G+ HRD+K  NLLV+      K+ DFG +K    +   + N+S  
Sbjct: 114 TEQVLEGLAYLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 229 CSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQ 265
            S ++ APE+I   ++ Y+A +DIWS GCV+ E+  G+
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  106 bits (266), Expect = 1e-26
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 43/228 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           + +G G+FG V++      GE     VA+K + +    +       E   M+ L HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALA 180
            L       T+ + LY  +V EY+P      +    +       +   L    QI + + 
Sbjct: 65  RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------ 234
           Y+ +     HRD+  +N LV      +K+ DFG ++ + + +         YYR      
Sbjct: 117 YLES-KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGK 165

Query: 235 ------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 APE +    ++T+  D+WS G +L E+  LG+  +PG S  +
Sbjct: 166 LPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 3e-26
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 23/215 (10%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYKNRELQTMRLLDHPNVVSL 123
           ++G G++G V++ K + TG  VA+K +        + D + +   L  +R    PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +          L +++EY      R +     ++++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA 242
             +GV HRDIK  N+LV  +T  +KLCDFG A +L +      +++ + Y+ APE+I   
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
             Y    DIWS G  + E+  G P +   S VD  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  105 bits (264), Expect = 4e-26
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 23/208 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           K C+       E    LV+EY   +   +++ H K  Q + +  +        + LAY+H
Sbjct: 81  KGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH---GALQGLAYLH 132

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +     HRDIK  N+L+      +KL DFGSA ++    P  S++ + Y+ APE+I    
Sbjct: 133 S-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILAMD 187

Query: 244 E--YTAAIDIWSAGCVLAELLLGQ-PLF 268
           E  Y   +D+WS G    EL   + PLF
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  104 bits (261), Expect = 5e-26
 Identities = 74/240 (30%), Positives = 114/240 (47%), Gaps = 40/240 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-------QDKRYKN------RELQTMR 113
           ++   ++G GSFG V+      +GE +A+K+V           R ++      RE+  ++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L H N+V            D  +LN+ LEYVP      + ++Y          V+ +  
Sbjct: 62  ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVR 113

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-------- 225
           QI + L Y+HN  G+ HRDIK  N+LV+ +   +K+ DFG +K   K E N         
Sbjct: 114 QILKGLNYLHNR-GIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNGA 168

Query: 226 --SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             S   S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K+
Sbjct: 169 RPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 3e-25
 Identities = 83/302 (27%), Positives = 129/302 (42%), Gaps = 79/302 (26%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-------LDHPNVVSLK 124
           V+G G+FG V+  +  +TG+  A+K + +    K  ++  +R         D P +V L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +  F    +DE +L LV+EY+P  + ++ +I+         P    + Y  ++  AL  +
Sbjct: 67  YYSF----QDEEHLYLVMEYMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSV 117

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------------------VLV 219
           H  +G  HRDIKP N+L++   H +KL DFG  K                       VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 220 KGEPNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           +   +               Y APE++ G T Y    D WS G +L E+L G P F  ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 273 GVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
               L E        T  +I     N+ E  +FP              + PEA+DL+ RL
Sbjct: 235 ----LQE--------TYNKII----NWKESLRFPP----------DPPVSPEAIDLICRL 268

Query: 332 LQ 333
           L 
Sbjct: 269 LC 270

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-24
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 46/228 (20%)

Query: 71  RVVGHGSFGVVFQAKC---LETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 122
           + +G G+FG V++ K          VA+K + +D   + R     E + M+ L HPNVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETV-------HRVIKHHYKMSQRMPLIYVKLYFYQI 175
           L       TE++ LY  LVLEY+            R           + L  +  +  QI
Sbjct: 61  LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRP-VFPSPEKSTLSLKDLLSFAIQI 114

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + + Y+ +     HRD+  +N LV      +K+ DFG ++ +   +         YYR 
Sbjct: 115 AKGMEYLAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163

Query: 235 -----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                      APE +     +T+  D+WS G +L E+  LG   +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  100 bits (250), Expect = 2e-24
 Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 118
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+     F    E     LN+VLE      + R+IKH  K  + +P   V  YF Q+C 
Sbjct: 63  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 236
           AL ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.8 bits (249), Expect = 2e-24
 Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 18/217 (8%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRE--LQTMRLL---DHPNVVSLKHCF 127
           G GS+G V++ K L   +  A+K+V L     K RE  +  +R+L   +HPN++S K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 128 FSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 D   L +V+EY P   + + I    K  + +P   +   F Q+ R L  +H   
Sbjct: 69  L-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122

Query: 187 GVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            + HRD+K  N LLV      +K+ D G +KVL K     + I + +Y APE ++    Y
Sbjct: 123 KILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +   DIWS GC+L E+    P F   S  D   ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 98.8 bits (246), Expect = 5e-24
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 16/213 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNV 120
           Y   RVVG G+FG+V   +     + V IK++  ++  K+       E Q ++LL HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +     F          L +V+EY P  T+   I+   + +  +    +  +F QI  AL
Sbjct: 62  IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLAL 114

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H  + + HRD+K QN+L++ H   +K+ DFG +K+L       + + +  Y +PEL 
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            G   Y    DIW+ GCVL EL   +  F   +
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 41/277 (14%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 129
            +G GS+G V++A   ETG+ VAIK V  ++  +   +E+  ++  D P +V     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 130 TTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
            T+     L +V+EY    +V  ++K     ++ +    +    YQ  + L Y+H+    
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN-KK 120

Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTA 247
            HRDIK  N+L+N    Q KL DFG +  L        + I + ++ APE+I     Y  
Sbjct: 121 IHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNN 178

Query: 248 AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 307
             DIWS G    E+  G+P +     +  +  I                P  T    P  
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KPPPT-LSDP-- 222

Query: 308 KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                     ++  PE  D V + L   P  R +A  
Sbjct: 223 ----------EKWSPEFNDFVKKCLVKDPEERPSAIQ 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 97.0 bits (241), Expect = 3e-23
 Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 118
           ++  E+ +G G F  V++A CL   + VA+KKV    + D + +    +E+  ++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+     F    E     LN+VLE      + ++IK+  K  + +P   V  YF Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 236
           A+ ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 96.7 bits (241), Expect = 3e-23
 Identities = 85/292 (29%), Positives = 120/292 (41%), Gaps = 62/292 (21%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNR-----ELQTMRLLDHPNV 120
           Y+  RV+G G+FG     +  E    V  K+V L     K R     E+  + LL HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++  + F      D+  L + +EY    T++  I       Q      V  Y +QI  A+
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAV 114

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYICS 230
           +YIH   G+ HRDIK  N+ +      +KL DFG +K+L         V G P       
Sbjct: 115 SYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------- 165

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            YY +PEL  G  +Y    DIW+ GCVL ELL  +  F         + ++         
Sbjct: 166 -YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDA----TNPLNLV--------- 210

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
            +K +  NYT                      E + LV  LLQ  P  R TA
Sbjct: 211 -VKIVQGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTA 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 97.4 bits (242), Expect = 4e-23
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 22/205 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 132

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMD 187

Query: 244 E--YTAAIDIWSAGCVLAELLLGQP 266
           E  Y   +D+WS G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.1 bits (239), Expect = 5e-23
 Identities = 62/235 (26%), Positives = 115/235 (48%), Gaps = 28/235 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYKN--RELQTMRLLDHPNV 120
           + +G G+F   +QA+ ++TG  +A+K+V         Q++  +   +E++ M  L+HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +       +T E    + NL +E++       +   Y   +   +I    Y  Q+ R L+
Sbjct: 66  I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN---YTEQLLRGLS 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNISYICSRYYRA 235
           Y+H    + HRD+K  NLL++    +L++ DFG+A  L       GE     + +  + A
Sbjct: 118 YLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV---LGTP 287
           PE++ G  +Y  + D+WS GCV+ E+   +P +  E   + L  I K+      P
Sbjct: 177 PEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.3 bits (237), Expect = 1e-22
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 26/210 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR------ELQTMRLLDHPNVV 121
           +++G G+FG V+    ++TG  +A+K+V         K        E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               C      +D+  L++ +EY+P  +V   +K +  +++ +     + Y  QI   + 
Sbjct: 68  QYYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRYYRAP 236
           Y+H+ + + HRDIK  N+L +     +KL DFG++K L      G    S   + Y+ +P
Sbjct: 119 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
           E+I G   Y    D+WS GC + E+L  +P
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 90/314 (28%), Positives = 140/314 (44%), Gaps = 54/314 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+   T E  A+K + +D   ++ +++ TM   R+L     HP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L H  F T  KD L+   V+EYV       +  H + S R      + Y  +I   L ++
Sbjct: 61  L-HSCFQT--KDRLFF--VMEYVNGGD---LMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++  
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII--------KVLGTPTREEIK 293
              Y  A+D W+ G +L E+L GQ  F G+   D+L + I        + L    +  +K
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSILEDEVRYPRWLSKEAKSILK 228

Query: 294 CM---NPNY----TEFKFPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSPNLRS 340
                NP             IK HP      W K+ +K + P           + P ++ 
Sbjct: 229 SFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPP----------FKPKIKG 278

Query: 341 TAFDAVGSFDSSFL 354
             FD V +FD  F 
Sbjct: 279 R-FD-VSNFDDEFT 290

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 90/311 (28%), Positives = 146/311 (46%), Gaps = 52/311 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+   T E  AIK + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  C F T E    +L  V+EY+       +  H + S R      + Y  +I   L ++
Sbjct: 61  L-FCTFQTKE----HLFFVMEYLNGGD---LMFHIQSSGRFDEARARFYAAEIICGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE++ G
Sbjct: 113 H-KKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP------TREEIKCM 295
             +Y  ++D WS G +L E+L+GQ  F GE   D+L + I     P      ++E   C+
Sbjct: 171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSILN-DRPHFPRWISKEAKDCL 227

Query: 296 ------NPNYTEFKFPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF 343
                 +P         I+ HP      W ++ ++ +PP           + P ++S   
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPP----------FKPKVKS-PS 276

Query: 344 DAVGSFDSSFL 354
           DA  +FD  F 
Sbjct: 277 DA-SNFDREFT 286

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 79/286 (27%), Positives = 121/286 (42%), Gaps = 57/286 (19%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTMRLL---DHPNVVSLKH 125
           VG G +G VF AK  +TGE VA+K     +L         L    +L       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 126 CFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            F     +D+ YL L +EYVP            V+   +           + Y  ++  A
Sbjct: 69  AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----------ARFYMAEMFEA 113

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +  +H  +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE+
Sbjct: 114 VDALHE-LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEV 169

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII---KVLGTPTREEI--- 292
           + G   Y   +D WS GC+L E L G P F G +  +    +    + L  P  ++    
Sbjct: 170 LRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN 228

Query: 293 ----------KCMNPNYTEFK-FPQIKAHP------WHKIFQKRMP 321
                     K +N     F     IK HP      W+++ + + P
Sbjct: 229 LSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPP 274

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           K C+       E    LV+EY   +   +++ H K  Q + +  +    +   + LAY+H
Sbjct: 91  KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT---HGALQGLAYLH 142

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRDIK  N+L+     Q+KL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 SH-NMIHRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 244 E--YTAAIDIWSAGCVLAELLLGQP 266
           E  Y   +D+WS G    EL   +P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 95.1 bits (236), Expect = 3e-22
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 22/203 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 125
           +GHGSFG V+ A    T E VA+KK+    +  N       +E++ ++ L HPN +  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           C+       E    LV+EY   +   +++ H K  Q + +  +    +   + LAY+H+ 
Sbjct: 89  CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT---HGALQGLAYLHSH 140

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 244
             + HRDIK  N+L+     Q+KL DFGSA       P  S++ + Y+ APE+I    E 
Sbjct: 141 NMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEG 195

Query: 245 -YTAAIDIWSAGCVLAELLLGQP 266
            Y   +D+WS G    EL   +P
Sbjct: 196 QYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 4e-22
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 25/212 (11%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLL-DHPNVVSLKH 125
           V+G G++G V++A+  +TG+ VAIK  + D           E   +R   +HPN+ +   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 126 CFF---STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            F         D+L+  LV+E     +V  ++K   K  +R+   ++     +  R LAY
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 240
           +H    V HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I 
Sbjct: 129 LHEN-KVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185

Query: 241 GATE------YTAAIDIWSAGCVLAELLLGQP 266
            A +      Y A  D+WS G    EL  G+P
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 93.7 bits (233), Expect = 9e-22
 Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 22/208 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTM-------RLLDHPNVV 121
           +V+G GSFG V  AK    G+  A+ KVLQ K    K  +   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L H  F T +K    L  VL+YV       +  H +  +  P    + Y  +I  AL Y
Sbjct: 60  GL-HYSFQTADK----LYFVLDYVNGG---ELFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++ 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y   +D W  G VL E+L G P F
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 72/289 (24%), Positives = 117/289 (40%), Gaps = 59/289 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 121
           +     +G GSFG V++A    T + VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                F   ++     L +++EY    +   ++K       ++   Y+     ++   L 
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLE 112

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-------YY 233
           Y+H   G  HRDIK  N+L++     +KL DFG     V G+   S +  R       ++
Sbjct: 113 YLHEE-GKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFW 164

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
            APE+I   + Y    DIWS G    EL  G+P  P  S +  +    +VL        K
Sbjct: 165 MAPEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPK 212

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
             NP       P ++ + + K F+        D VS  L   P  R +A
Sbjct: 213 N-NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSA 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 91.0 bits (226), Expect = 3e-21
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQ--DKRYKNRELQTMRLL---DHPNVVSLKHC 126
           +G GSFGVVF+          A+K++ L   ++R +   +   R+L   D   ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F      D+  LN+V+EY     +H+++K      + +P   V  +F QI   LA++H+ 
Sbjct: 68  FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFG 241
             + HRDIK  NL ++ +   +K+ D G AK+L     N ++    + + YY +PEL   
Sbjct: 121 -KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC-E 174

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
              Y    D+W+ G VL E   G+  F   +    +++II+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 90.3 bits (224), Expect = 7e-21
 Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 43/284 (15%)

Query: 70  ERVV-GHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK---NRELQTMRLLDHPNVVSLK 124
           ERVV G G++G+V+ A+ L T   +AIK++  +D RY    + E+     L H N+V   
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYI 182
                 +E    +  + +E VP  ++  +++  +  +      I    Y  QI   L Y+
Sbjct: 72  GSD---SENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYL 124

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELI-F 240
           H+   + HRDIK  N+LVN ++  +K+ DFG++K L    P   ++  +  Y APE+I  
Sbjct: 125 HDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           G   Y A  DIWS GC + E+  G+P F                       I+   P   
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAA 220

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
            FK    K HP      + +  EA + + R  +  P+ R++A D
Sbjct: 221 MFKVGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHD 261

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 91.0 bits (226), Expect = 9e-21
 Identities = 79/295 (26%), Positives = 137/295 (46%), Gaps = 66/295 (22%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVV 121
           +++ +G++G V+  +  ET +  A+KK+ +          + +  R++ T    ++P VV
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVV 64

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           S+  C F T      +L +V+EYV       ++K+       +P+   ++YF +   AL 
Sbjct: 65  SM-FCSFETKR----HLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALE 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNI-------------- 225
           Y+HN  G+ HRD+KP NLL+    H +KL DFG +K+ L+    N+              
Sbjct: 116 YLHN-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 226 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
             +C +  Y APE+I     Y   +D W+ G +L E L+G   F G++  +   ++I   
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-- 230

Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                ++I    P   E                  +P +A DL+SRLL+ +P  R
Sbjct: 231 -----DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 89.8 bits (223), Expect = 1e-20
 Identities = 80/279 (28%), Positives = 131/279 (46%), Gaps = 47/279 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    TG  VA+KK+  D R + R      E+  MR   HPN+V +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           + S    DEL++  V+E++       I  H +M++   +  V L    + +AL+++H   
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ-IATVCL---AVLKALSFLHAQ- 134

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 245
           GV HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     Y
Sbjct: 135 GVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPY 192

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              +DIWS G ++ E++ G+P +  E  +  +            + I+   P       P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP-------P 233

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           ++K    HK+      P     + R+L   P  R+TA +
Sbjct: 234 KLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAE 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 35/263 (13%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           G G++GVV + + + TG  +A+K++       + KR       +MR +D P  V+     
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           F   E D   + + +E +  ++ +  K  Y     +P   +      I +AL Y+H+ + 
Sbjct: 70  FR--EGD---VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--- 244
           V HRD+KP N+L+N    Q+KLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPTR-------EEI-- 292
           Y    D+WS G  + EL  G+  FP +S      QL ++++      +        E   
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVE--EPSPQLPAEKFSPEFQD 239

Query: 293 ---KCMNPNYTEF-KFPQIKAHP 311
              KC+  NY E   +P++  HP
Sbjct: 240 FVNKCLKKNYKERPNYPELLQHP 262

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 3e-20
 Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 66/290 (22%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDK---RYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G++G V++A+ + TGE VAIK + L+         +E+  ++   HPN+V+    + 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 129 STTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALA 180
               +D+L+  +V+EY      + +++V +      Q   + YV       CR     LA
Sbjct: 71  R---RDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV-------CRETLKGLA 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPEL 238
           Y+H T G  HRDIK  N+L+      +KL DFG +  L     +   S+I + Y+ APE+
Sbjct: 116 YLHET-GKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEV 172

Query: 239 IFGATE----YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK 293
              A E    Y    DIW+ G    EL   Q P+F         +  ++ L   ++    
Sbjct: 173 A--AVERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS--- 219

Query: 294 CMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                   F  P++K    W  +F         D + + L   P  R TA
Sbjct: 220 -------NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTA 254

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.1 bits (218), Expect = 3e-20
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 22/218 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           + +G GSFG ++ AK     E   IK++      +++K    +E+  +  + HPN+V+  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F S  E   L++  V+EY    + + R+ +    +     ++    +F QI   L +I
Sbjct: 65  --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIF 240
           H+   + HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE I 
Sbjct: 118 HDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
               Y    DIWS GCVL EL   +  F G + + QLV
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 88.6 bits (220), Expect = 4e-20
 Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 35/221 (15%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKK-----VLQDKRYKNRELQ 110
            K+ + ++  + +G G FG V      +     TGE VA+K        Q +    RE++
Sbjct: 2   EKRHLKFI--KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIE 58

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY--KMSQRMPLIYV 168
            +R LDH N+V  K        +    L L++EY+P    R     Y  +   ++ L  +
Sbjct: 59  ILRTLDHENIVKYKGVCEKPGGRS---LRLIMEYLPSGSLR----DYLQRHRDQINLKRL 111

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------- 221
            L+  QIC+ + Y+ +     HRD+  +N+LV      +K+ DFG AKVL +        
Sbjct: 112 LLFSSQICKGMDYLGSQ-RYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVK 169

Query: 222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           EP  S I   +Y APE +  +   +A+ D+WS G  L EL 
Sbjct: 170 EPGESPI--FWY-APECLRTSKFSSAS-DVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.3 bits (219), Expect = 5e-20
 Identities = 75/277 (27%), Positives = 121/277 (43%), Gaps = 47/277 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 124
           +G G FG V   +   TG+  A KK L  KR K R+ + M L +           +VSL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALAYI 182
           + F +   KD+L L + L    +     +K+H Y + +   P      Y  QI   L ++
Sbjct: 60  YAFET---KDDLCLVMTLMNGGD-----LKYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H    + +RD+KP+N+L++ H + +++ D G A  L  G+       +  Y APE++ G 
Sbjct: 112 HQR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE 169

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y  ++D ++ GC L E++ G+  F       Q  E ++      +EE+K         
Sbjct: 170 -VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR------- 209

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                        +  +  PEA DL   LLQ  P  R
Sbjct: 210 ----TLEMAVE--YPDKFSPEAKDLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 92/312 (29%), Positives = 139/312 (44%), Gaps = 53/312 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 121
           +V+G GSFG V  AK    G+  A+K VLQ K   NR+ Q          ++ + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L H  F TTEK    L  VL++V       +  H +  +  P    + Y  +I  AL Y
Sbjct: 60  GL-HYSFQTTEK----LYFVLDFVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H +I + +RD+KP+N+L++   H + L DFG  K  +      +  C +  Y APE+I 
Sbjct: 112 LH-SINIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI- 168

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII-KVL----GTPT------R 289
               Y   +D W  G VL E+L G P F      +    I+ K L    G          
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228

Query: 290 EEIKCMNPNYTEFK--FPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           E ++         K  F +I+ HP      W  + QK++PP           ++PN+   
Sbjct: 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPP----------FNPNVEGP 278

Query: 342 AFDAVGSFDSSF 353
             D + +FD+ F
Sbjct: 279 --DDISNFDAVF 288

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 71/222 (31%), Positives = 119/222 (53%), Gaps = 21/222 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+    GE  A+K + +D    + +++ TM   R+L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L +C F T  K+ L+   V+E++       +  H +   R  L     Y  +I   L ++
Sbjct: 61  L-YCTFQT--KEHLFF--VMEFLNGGD---LMFHIQDKGRFDLYRATFYAAEIVCGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ G
Sbjct: 113 HSK-GIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +YT ++D WS G +L E+L+GQ  F G+   D+L E I+V
Sbjct: 171 -LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 85.0 bits (210), Expect = 4e-19
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y   RVVG GSFG     + + + +  A+K++   K         +E   +  + HPN+V
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + K  F     + + +L +V+EY    + + ++     K+    P   +  +F Q+C  +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPEL 238
            +IH    V HRDIK +N+ +     ++KL DFGSA++L   G    +Y+ + YY  PE 
Sbjct: 114 QHIHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170

Query: 239 IFGATEYTAAIDIWSAGCVLAEL 261
           I+    Y    DIWS GC+L EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 86.2 bits (213), Expect = 5e-19
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +++G GSFG VF A+   T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L +C F T E     L  V+EY+       +  H +   +  L     Y  +I   L ++
Sbjct: 61  L-YCTFQTKE----NLFFVMEYLNGGD---LMFHIQSCHKFDLPRATFYAAEIICGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G
Sbjct: 113 HSK-GIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
             +Y  ++D WS G +L E+L+GQ  F G 
Sbjct: 171 -QKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 83/276 (30%), Positives = 130/276 (47%), Gaps = 53/276 (19%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSLKH 125
           +G GSFG V  AK   TGE  AIK     ++L+ K+ +   +E   +  L HP +V++  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F    +++ +Y   +LE+V   V   +  H + + R P    K Y  ++  A  Y+H+ 
Sbjct: 86  SF---QDENRVYF--LLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-IC-SRYYRAPELIFGAT 243
             + +RD+KP+NLL++   H +K+ DFG AK +    P+ ++ +C +  Y APE+I  + 
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVI-QSK 190

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            +  A+D W+ G +L E + G P F  +              TP R   K +       K
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLK 233

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           FP      W   F  R    A DLV  LLQ     R
Sbjct: 234 FPN-----W---FDGR----ARDLVKGLLQTDHTKR 257

Length = 329

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 84.8 bits (210), Expect = 8e-19
 Identities = 83/295 (28%), Positives = 132/295 (44%), Gaps = 60/295 (20%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNRELQTMRLLDH---------- 117
           RV+G G++G VF  + +   + G+  A+K VL+    K   +Q  +  +H          
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMK-VLK----KATIVQKAKTAEHTRTERQVLEA 60

Query: 118 ----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
               P +V+L H  F T  K    L+L+L+YV      +  H Y+  +      V++Y  
Sbjct: 61  VRRCPFLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYIA 112

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSR 231
           +I  AL ++H  +G+ +RDIK +N+L++   H + L DFG +K  +  E     S+  + 
Sbjct: 113 EIVLALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTI 170

Query: 232 YYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            Y APE+I G +  +  A+D WS G +  ELL G   F  +   +   EI       +R 
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRR 223

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            +K   P                  F K M  EA D + +LL+  P  R  A  A
Sbjct: 224 ILKSKPP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGA 260

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 34/214 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G+FG V   +   +    A+K +       L+ +++ + E + ++ + HP ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                TE D+ +L +++EYVP   +   +++  + S    L Y      +I  AL Y+H 
Sbjct: 68  ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS----EIVCALEYLH- 118

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRAPEL 238
           +  + +RD+KP+N+L++   H +KL DFG AK L        G P         Y APE+
Sbjct: 119 SKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPEV 169

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I  +  +  A+D W+ G ++ E+L+G P F  ++
Sbjct: 170 I-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 86/310 (27%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 123
           +V+G G+FG V   +  +TG   A+KK+ + +  +  ++  +R    +L   D+P VV L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +DE YL L++EY+P  + +  ++K     ++     Y+     +   A+  
Sbjct: 67  YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIA----ETILAIDS 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNISYIC 229
           IH  +G  HRDIKP NLL++   H +KL DFG              ++L    P+     
Sbjct: 117 IH-KLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 230 SR--------------------Y-------YRAPELIFGATEYTAAIDIWSAGCVLAELL 262
                                 Y       Y APE +F  T Y    D WS G ++ E+L
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEML 233

Query: 263 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP 322
           +G P F  +               P     K +N   T  +FP           +  + P
Sbjct: 234 VGYPPFCSD--------------NPQETYRKIINWKET-LQFPD----------EVPLSP 268

Query: 323 EAVDLVSRLL 332
           EA DL+ RL 
Sbjct: 269 EAKDLIKRLC 278

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 69/208 (33%), Positives = 103/208 (49%), Gaps = 34/208 (16%)

Query: 73  VGHGSFGVVFQAKCL------ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 122
           +G G+FG V    C        TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            K   +S   ++   L LV+EY+P    R  + KH  ++  R  L    LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYY 233
           Y+ +   V HRD+  +N+LV      +K+ DFG  KVL          EP  S I   ++
Sbjct: 123 YLGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAEL 261
            APE +   ++++ A D+WS G VL EL
Sbjct: 178 YAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 83/311 (26%), Positives = 139/311 (44%), Gaps = 57/311 (18%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 125
           +G GSFG V Q +  +T    A+K + +       E+         +  ++ P +V LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             FS    ++LYL L      E     + HH +   R  L   + Y  ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLH-K 111

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATE 244
             V +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK----------------VLGTPT 288
           YT A+D W+ G +L E+L G P F  E+  +   +I++                ++G  +
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLS 229

Query: 289 REEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           R+  + +  N  +    +IK HP      W K+  K + P           + P + S+A
Sbjct: 230 RDPTRRLGYNGAQ----EIKNHPFFSQLSWKKLLMKGIQPP----------FKPAV-SSA 274

Query: 343 FDAVGSFDSSF 353
            D   +FD  F
Sbjct: 275 IDT-SNFDEEF 284

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.0 bits (205), Expect = 3e-18
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 31/213 (14%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYK--NRELQTMRLLDHPNVV 121
           V+G G++G V+       G+ +A+K+V  D        K Y+    E+  ++ L H N+V
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                 +  T  D+  +++ +E+VP  ++  ++         +P      Y  QI   +A
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVA 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI-------CSRYY 233
           Y+HN   V HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 117 YLHNN-CVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
            APE+I   + Y    DIWS GC + E+  G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.5 bits (204), Expect = 7e-18
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 30/205 (14%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDK-RYKN---RELQTMRLLDHPNVVSLKHC 126
            +G G+ GVV +     +G  +A K + L+ K   +N   REL+ +   + P +V     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 127 FFSTTE-------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           F+S  E        D   L+ VL               K + R+P   +      + R L
Sbjct: 68  FYSDGEISICMEHMDGGSLDQVL---------------KKAGRIPENILGKISIAVLRGL 112

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE +
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 170

Query: 240 FGATEYTAAIDIWSAGCVLAELLLG 264
            G T YT   DIWS G  L E+ +G
Sbjct: 171 QG-THYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 78/313 (24%), Positives = 133/313 (42%), Gaps = 55/313 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----------LQTMRLLDHPNVVS 122
           +G G+FG V+Q +  +T    A+K + + +    +E          L    L + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           LK   FS     +LYL  V +Y+       +  H +   R      K Y  ++  AL ++
Sbjct: 61  LK---FSFQTDSDLYL--VTDYMSGGE---LFWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 241
           H    + +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++  
Sbjct: 113 HKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII---------KVLGTPTREEI 292
              YT  +D WS G ++ E+  G   F  E    Q+   I          VL    R+ +
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNVLSDEGRQFV 229

Query: 293 KCM---NPNY---TEFKFPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSPNLRS 340
           K +   NP +         ++K HP      W  + +K++ P           + P + S
Sbjct: 230 KGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPP----------FKPIVDS 279

Query: 341 TAFDAVGSFDSSF 353
              + V +FD  F
Sbjct: 280 D--EDVSNFDPEF 290

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 80/323 (24%), Positives = 147/323 (45%), Gaps = 64/323 (19%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLL-----DHPNVV 121
           RV+G GS+  V   +  +T    A+ KV++ +   + E    +QT + +     +HP +V
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAM-KVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L  CF + +      L  V+E+V       +  H +  +++P  + + Y  +I  AL +
Sbjct: 60  GLHSCFQTESR-----LFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNF 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIF 240
           +H   G+ +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE++ 
Sbjct: 112 LHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII--KVLGTPTRE 290
           G  +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I  K +  P   
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 291 EIKC-------MNPNYTE-------FKFPQIKAHP------WHKIFQKRMPPEAVDLVSR 330
            +K        +N +  E         F  IK+HP      W  + QK++ P        
Sbjct: 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP------- 281

Query: 331 LLQYSPNLRSTAFDAVGSFDSSF 353
              Y PN+ S     + +FD  F
Sbjct: 282 ---YKPNIESDR--DLDNFDPQF 299

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 41/214 (19%)

Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           RV+G G FG V    +      TGE VA+K + ++   +N      E+  ++ L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K C    +E+    L L++EYVP    R  + KH   ++Q +      L+  QIC  +
Sbjct: 70  KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE-- 237
           AY+H+   + HRD+  +N+L++ +   +K+ DFG AK + +G          YYR  E  
Sbjct: 121 AYLHSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170

Query: 238 ---LIFGATE------YTAAIDIWSAGCVLAELL 262
              + + A E      ++ A D+WS G  L ELL
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 70/220 (31%), Positives = 112/220 (50%), Gaps = 23/220 (10%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTM 112
           G P++ +    +  +G GS G+V  A    TG+ VA+KK+  D R + R      E+  M
Sbjct: 18  GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R   H NVV +   + S    DEL++  V+E++       I  H +M++      +    
Sbjct: 74  RDYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVC 124

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSR 231
             + RAL+Y+HN  GV HRDIK  ++L+     ++KL DFG    + K  P   S + + 
Sbjct: 125 LSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTP 182

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           Y+ APE+I     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 50/287 (17%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----------LDHPNV 120
           ++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRA 178
           V + + F  T +K    L+L+              HY +SQ       ++ FY  +I   
Sbjct: 60  VCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQ----------------------PLFPGESGVDQ 276
           +     Y ++ D +S GC+L +LL G                          P     + 
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226

Query: 277 LVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 322
              +  +L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.5 bits (198), Expect = 2e-17
 Identities = 62/236 (26%), Positives = 115/236 (48%), Gaps = 27/236 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 121
           +++G G+FG V+     +TG  +A+K+V  D               E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               C     E+    L++ +E++P  ++   +K +  +++ +     + Y  QI   ++
Sbjct: 68  QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRYYRAP 236
           Y+H+ + + HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           E+I G   Y    DIWS GC + E+L  +P +   +  + +  I K+   PT   +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 66/224 (29%), Positives = 116/224 (51%), Gaps = 28/224 (12%)

Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     ++R+P   +      + R LAY+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 287
           Y+   DIWS G  L EL +G+ P+ P ++      E+  + G P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 21/220 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           RV+G GSFG V  A+  E+G   A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L +C F T ++    L  V+E+V       +  H + S+R      + Y  +I  AL ++
Sbjct: 61  L-YCCFQTPDR----LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I  
Sbjct: 113 HDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQ 169

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              Y  ++D W+ G +L E+L G   F  E+  D L E I
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 45/284 (15%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNRELQTMRL-------LDHPNV 120
           +V+G GSFG VF  + +   + G+  A+ KVL+    K R+    ++       ++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAM-KVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L H  F T  K  LYL L      +   R+ K      +      VK Y  ++  AL 
Sbjct: 61  VKL-HYAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALALD 112

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPELI 239
           ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 113 HLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPT---------- 288
                +T + D WS G ++ E+L G   F G+   + +  I+K  LG P           
Sbjct: 171 -NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 229

Query: 289 REEIKCMNPNYTEFKFPQ----IKAHP------WHKIFQKRMPP 322
           R   K  NP       P     IK HP      W+K++++ + P
Sbjct: 230 RALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 86/287 (29%), Positives = 136/287 (47%), Gaps = 57/287 (19%)

Query: 71  RVVGHGSFGVVF---QAKCLETGEAVAIKKVLQD----KRYKNRE-LQTMR-LLDH---- 117
           +V+G G++G VF   +    +TG+  A+K VLQ     ++ K  E  +T R +L+H    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQS 64

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPET---VHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           P +V+L H  F T  K    L+L+L+YV       H   + ++   +      V+ Y  +
Sbjct: 65  PFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE------VRFYSGE 113

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY- 232
           I  AL ++H  +G+ +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    
Sbjct: 114 IILALEHLHK-LGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIE 171

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE+I G   +  A+D WS G ++ ELL G   F  E   +   E+       +R  +
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRIL 224

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           KC  P                  F   + PEA DL+ +LL+  P  R
Sbjct: 225 KCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.7 bits (196), Expect = 5e-17
 Identities = 61/236 (25%), Positives = 117/236 (49%), Gaps = 27/236 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 121
           +++G G+FG V+     +TG  +A+K+V  D   +           E+Q ++ L H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               C     EK    L++ +EY+P  ++   +K +  +++ +     + Y  QI + ++
Sbjct: 68  QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNISYICSRYYRAP 236
           Y+H+ + + HRDIK  N+L +     +KL DFG++K    + + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           E+I G   Y    D+WS  C + E+L  +P +   +  + +  I K+   PT+  +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 79.5 bits (196), Expect = 6e-17
 Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 36/276 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G G+ G V + K + TG  +A K V    +        RELQ M     P +VS    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
            +     E  + + +E++   ++ R+    YK    +P+  +      +   L Y++N  
Sbjct: 73  LN-----ENNICMCMEFMDCGSLDRI----YKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
            + HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180

Query: 247 AAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              D+WS G  + EL LG+ P        D   + + +L                     
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           QI   P  ++     P +  D V   L   P  R T
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 79.0 bits (194), Expect = 8e-17
 Identities = 65/242 (26%), Positives = 118/242 (48%), Gaps = 27/242 (11%)

Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLL 115
           I++   +++G G+FG V+    ++TG  +A K+V  D               E+Q ++ L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
            H  +V    C     EK    L + +EY+P  +V   +K +  +++ +   Y +    Q
Sbjct: 62  QHERIVQYYGCLRDRAEKT---LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR----Q 114

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICS 230
           I   ++Y+H+ + + HRDIK  N+L +     +KL DFG++K L    + G    S   +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            Y+ +PE+I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT  
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNP 228

Query: 291 EI 292
           ++
Sbjct: 229 QL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.0 bits (195), Expect = 9e-17
 Identities = 73/283 (25%), Positives = 119/283 (42%), Gaps = 50/283 (17%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFF 128
           G G+ G V + +   TG   A+K +  D     ++   REL+  +    P +V     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 129 STTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              ++    + + +EY     +     +V K   ++ ++   +  K+    + + L+Y+H
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK---VLGKIAE-SVLKGLSYLH 122

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELI 239
            +  + HRDIKP N+L+     Q+KLCDFG     V GE   S    +  + +Y APE I
Sbjct: 123 -SRKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGTPT------- 288
            G   Y+   D+WS G  L E+   +  FP E     G  +L+  I  +  P        
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 289 ----REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFQKRMP 321
                EE K     C+  + T    P  +  HPW K   K+  
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHPNV 120
           Y+  + +G GSFG     K  E G+   IK++    +  K  +   +E+  +  + HPN+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQR---MPLIYVKLYFYQIC 176
           V  +  F    E   LY+  V++Y     +++ I      +QR    P   +  +F QIC
Sbjct: 62  VQYQESF---EENGNLYI--VMDYCEGGDLYKKIN-----AQRGVLFPEDQILDWFVQIC 111

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRA 235
            AL ++H+   + HRDIK QN+ +      +KL DFG A+VL    E   + I + YY +
Sbjct: 112 LALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I     Y    DIW+ GCVL E+ 
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 29/219 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           +V+G G+FG V   +   + +  A+K + + +  K         E   M   +   +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            H  F    +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  AL  IH
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----WARFYTAEVVLALDAIH 159

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPEL 238
           + +G  HRD+KP N+L++   H LKL DFG+    +K + N    C        Y +PE+
Sbjct: 160 S-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPEV 214

Query: 239 IF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           +    G   Y    D WS G  L E+L+G   F  +S V
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 22/208 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 121
           +V+G GSFG V  AK    G   A+K VLQ K    ++ Q          ++ L HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L H  F T EK    L  VL+YV       +  H +  +       + Y  ++  A+ Y
Sbjct: 60  GL-HYSFQTAEK----LYFVLDYVNGGE---LFFHLQRERCFLEPRARFYAAEVASAIGY 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H ++ + +RD+KP+N+L++   H + L DFG  K  V+ E   S  C +  Y APE + 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VL 168

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y   +D W  G VL E+L G P F
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 80/326 (24%), Positives = 143/326 (43%), Gaps = 70/326 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 61  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 281
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229

Query: 282 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPPEAVDL 327
                     L    +E + C      +  F  I+ HP      W  + QK++ P     
Sbjct: 230 VKAASVLKSFLNKDPKERLGCH----PQTGFADIQGHPFFRNVDWDLMEQKQVVPP---- 281

Query: 328 VSRLLQYSPNLRSTAFDAVGSFDSSF 353
                 + PN+ S  F  + +FD+ F
Sbjct: 282 ------FKPNI-SGEF-GLDNFDAQF 299

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 66/229 (28%), Positives = 119/229 (51%), Gaps = 23/229 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K   ++ +++ L  V +    + + L Y+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI-LGKVSI---AVIKGLTYLRE 121

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y+   DIWS G  L E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 42/289 (14%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQ----TMRLLDHPNVVSLKHC 126
           +G G+FG V +     +G  +A+K++    D++ + R L      MR  D P +V     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 127 FFSTTEKD-----ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            F   E D     EL +++ L+   + V+ V+K        +P   +        +AL Y
Sbjct: 72  LF--REGDCWICMEL-MDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNY 122

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-- 239
           +   + + HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I  
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR---EEIKCM 295
                Y    D+WS G  L E+  G+  +P   S  DQL +++K  G P      E +  
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPILSNSEEREF 239

Query: 296 NPNYTEF-------------KFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +P++  F             K+ ++  HP+ K +++R    A  +   L
Sbjct: 240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQRIL 288

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.6 bits (191), Expect = 3e-16
 Identities = 73/279 (26%), Positives = 118/279 (42%), Gaps = 47/279 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 122
           RV+G G FG V   +   TG+  A KK L+ KR K R+ + M L        ++   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 180
           L + +     KD L L L L    +     +K H Y M            Y  +I   L 
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGD-----LKFHIYNMGNPGFDEERAVFYAAEITCGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
            +H    + +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++ 
Sbjct: 117 DLHRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               YT + D W  GC++ E++ G+  F          E +K      REE++       
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERRVKEDQ 221

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           E              + ++    A  +  +LL   P  R
Sbjct: 222 E-------------EYSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 67/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTM 112
           G P+  +    +  +G GS G+V  A    +G+ VA+KK+  D R + R      E+  M
Sbjct: 16  GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIM 71

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R   H NVV + + +      DEL++  V+E++       I  H +M++      +    
Sbjct: 72  RDYQHENVVEMYNSYLV---GDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVC 122

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSR 231
             + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P   S + + 
Sbjct: 123 LAVLKALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           Y+ APELI     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 181 YWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 84/319 (26%), Positives = 144/319 (45%), Gaps = 64/319 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+   T E  AIK + +D   ++ ++  TM   R+L     HP + +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L HC F T ++    L  V+EYV   + + ++ +     S++      + Y  ++  AL 
Sbjct: 61  L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALM 110

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELI 239
           ++H   GV +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y APE I
Sbjct: 111 FLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-I 167

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD------------------QLVEII 281
               EY  ++D W+ G ++ E++ GQP F  ++  D                  + V I+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSIL 227

Query: 282 KVLGTPTREE-IKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQY 334
           K   T    + + C+     E     IK HP      W  + Q+++ P           +
Sbjct: 228 KAFMTKNPNKRLGCVASQGGE---DAIKQHPFFKEIDWVLLEQRKIKPP----------F 274

Query: 335 SPNLRSTAFDAVGSFDSSF 353
            P +++     V +FD  F
Sbjct: 275 KPKIKTKR--DVNNFDQDF 291

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 19/218 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 124
           V+G GSFG V  A+   T E  AIK      V+QD   +    E + + L D P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +H +   +        Y  +I   L ++H 
Sbjct: 67  HSCFQTV--DRLYF--VMEYVNGGD---LMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I    
Sbjct: 120 R-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AYQ 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.9 bits (189), Expect = 6e-16
 Identities = 71/253 (28%), Positives = 121/253 (47%), Gaps = 28/253 (11%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             HPN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 73  NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 119

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPEL 235

Query: 290 EEIKCMNPNYTEF 302
           +  + ++  + +F
Sbjct: 236 QNPEKLSAIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 41/276 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           ++  +V GH S G ++  K L+    V   K  +  R + + L+ +R    P +V+L + 
Sbjct: 17  FLVRKVSGHDS-GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--QSPFLVTLHYA 73

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           F + T+     L+L+L+Y+       +  H    +R     V++Y  +I  AL ++H  +
Sbjct: 74  FQTDTK-----LHLILDYINGGE---LFTHLSQRERFKEQEVQIYSGEIVLALEHLHK-L 124

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELIFGA-T 243
           G+ +RDIK +N+L++ + H + L DFG +K   + E   +Y  C    Y AP+++ G   
Sbjct: 125 GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            +  A+D WS G ++ ELL G   F  +   +   EI       +R  +K   P      
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKSEPP------ 230

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           +PQ             M   A D++ RLL   P  R
Sbjct: 231 YPQ------------EMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 76.8 bits (189), Expect = 8e-16
 Identities = 84/318 (26%), Positives = 139/318 (43%), Gaps = 61/318 (19%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQ---------DKRYKNRELQTMRLLDHP 118
           +V+G G +G VFQ + +   +TG+  A+K VL+         D  +   E   +  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V L    F T  K    L L+LEY+   E    + +    M           Y  +I 
Sbjct: 61  FIVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEIS 110

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRA 235
            AL ++H   G+ +RD+KP+N+L++   H +KL DFG  K  +         C    Y A
Sbjct: 111 LALEHLH-QQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK-------VLGTPT 288
           PE I   + +  A+D WS G ++ ++L G P F  E+    + +I+K        L    
Sbjct: 169 PE-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEA 227

Query: 289 REEIKCM---NPNYTEFKFP----QIKAHP------WHKIFQKRMPPEAVDLVSRLLQYS 335
           R+ +K +   NP+      P    ++++HP      W  +  +++ P           + 
Sbjct: 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPP----------FK 277

Query: 336 PNLRSTAFDAVGSFDSSF 353
           P L+S   + V  FDS F
Sbjct: 278 PLLQSE--EDVSQFDSKF 293

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.8 bits (186), Expect = 8e-16
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 119
           +Y   RVVG GS+G V   +    G+   IKK+       ++++   +E Q +  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V+ +  +    E   LY+ +      +  H++ +   K+   +P   V  +F QI  AL
Sbjct: 61  IVAYRESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKL---LPENQVVEWFVQIAMAL 115

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 238
            Y+H    + HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL
Sbjct: 116 QYLHEK-HILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 239 IFGATEYTAAIDIWSAGCVLAEL 261
            F    Y    D+W+ GC + E+
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 8e-16
 Identities = 67/242 (27%), Positives = 103/242 (42%), Gaps = 47/242 (19%)

Query: 73  VGHGSFGVVFQAKCLETGE---AVAIK-----KVLQDKRYKNRELQTMRLLDHPNVVSLK 124
           +GHG+FG V +   L        VA+K      +   K+   RE   M  LDHP +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                  + + L   LV+E  P   + + +K      + +P+  +K   +Q+   +AY+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLE 112

Query: 184 NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 234
           +   V HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SKHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 235 ----APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVEIIKVLGTP 287
               APE I     +++  D+WS G  L E    G   +    G +   ++E  + L  P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Query: 288 TR 289
             
Sbjct: 221 EE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 76.4 bits (188), Expect = 8e-16
 Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 48/282 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
           +G G++G V++     TG  +A+K++   L + ++     EL  +     P +V     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           F      E  + + +EY+       +      ++ +P   ++   Y + + L ++     
Sbjct: 69  FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-----FGA 242
           + HRD+KP N+LVN +  Q+KLCDFG +  LV      +  C  Y  APE I        
Sbjct: 124 IIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPNY 299
             YT   D+WS G  + E+ LG+  +P E+  +   QL  I+   G P       +   Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           +                      +A D V++ L   PN R T
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 27/206 (13%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHC 126
           ++GHG+ G V++A  L T   +A+K +  D     ++    EL+ +   D P ++     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 127 FFSTTEKDELYLNLVLEYVPE---TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           FF      E  +++  E++      V+R I  H  +  R+ +  VK         L Y+ 
Sbjct: 68  FFV-----ENRISICTEFMDGGSLDVYRKIPEH--VLGRIAVAVVK--------GLTYLW 112

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + HRD+KP N+LVN    Q+KLCDFG +  LV      +Y+ +  Y APE I G  
Sbjct: 113 -SLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-E 168

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFP 269
           +Y    D+WS G    EL LG+  +P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYP 194

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 28/253 (11%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR----ELQTMRL 114
           G PK+   Y     +G G+ G VF A  + TG+ VAIK++   K+ K      E+  M+ 
Sbjct: 15  GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           L +PN+V+    F      DEL+  +V+EY+       +     M +             
Sbjct: 73  LKNPNIVNFLDSFLV---GDELF--VVMEYLAGGSLTDVVTETCMDEAQ--------IAA 119

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H    V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPEL 235

Query: 290 EEIKCMNPNYTEF 302
           +  + ++P + +F
Sbjct: 236 QNPEKLSPIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 47/279 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           + S    +EL++  ++E++       I    ++++      +      + +AL Y+H+  
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHSQ- 136

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 245
           GV HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I   T Y
Sbjct: 137 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPY 194

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              +DIWS G ++ E++ G+P +  +S V  +  +        R+              P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------P 233

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
             K    HKI      P   D + R+L   P  R+TA +
Sbjct: 234 PPKLKNAHKI-----SPVLRDFLERMLTREPQERATAQE 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 64/234 (27%), Positives = 115/234 (49%), Gaps = 28/234 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVS 122
           RV+G GS+  V   +  +  +  A+K V ++  + + ++  ++   H        P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF +T+      L LV+EYV       +  H +  +++P  + + Y  +IC AL ++
Sbjct: 61  LHSCFQTTSR-----LFLVIEYVNGGD---LMFHMQRQRKLPEEHARFYAAEICIALNFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  +      S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 289
             EY  ++D W+ G ++ E++ G+  F      P  +  D L ++I  L  P R
Sbjct: 171 -EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 22/208 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 122
           RV+G G FG V   +   TG+  A KK L+ KR K R+ ++M L     L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 180
           L + +     KD L L L L    +     +K H Y M +          Y  +IC  L 
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGD-----LKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
            +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++ 
Sbjct: 117 DLHQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               YT + D W+ GC+L E++ GQ  F
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 27/210 (12%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-----------DHPNV 120
           ++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRA 178
           V + + F +    D+L   L L    +        HY +SQ       ++ FY  +I   
Sbjct: 60  VCMTYAFHT---PDKLCFILDLMNGGDL-------HYHLSQHGVFSEKEMRFYATEIILG 109

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +   T Y ++ D +S GC+L +LL G   F
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 78/318 (24%), Positives = 129/318 (40%), Gaps = 65/318 (20%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM----RLLD------HPNVV 121
           V+G G FG V  A+  +TGE  AIK + +       E++++    R+ +      HP +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           +L  CF     +D +    V+EY         +H                    Y   + 
Sbjct: 66  NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHT---------DVFSEPRAVFYAACVV 111

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
             L Y+H    + +RD+K  NLL++     +K+ DFG  K  +      S  C +  + A
Sbjct: 112 LGLQYLHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG---ESGVDQLV-EIIKVLGTPTREE 291
           PE++   T YT A+D W  G ++ E+L+G+  FPG   E   D +V + ++     +RE 
Sbjct: 170 PEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREA 228

Query: 292 IKCM------NPN----YTEFKFPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYS 335
           I  M      NP       E     +K  P      W  +  +++ P           + 
Sbjct: 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPP----------FV 278

Query: 336 PNLRSTAFDAVGSFDSSF 353
           P ++      V +FD  F
Sbjct: 279 PTIKGPE--DVSNFDEEF 294

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 81/316 (25%), Positives = 134/316 (42%), Gaps = 60/316 (18%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM------RLLDHPNVVSLK 124
           V+G GSFG V  A+   T E  AIK + +D   ++ +++ TM       L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +H +   +    +   Y  +I   L ++H+
Sbjct: 67  HSCFQTM--DRLYF--VMEYVNGGD---LMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I    
Sbjct: 120 K-GIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-AYQ 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGE-------SGVDQLVEIIKVLGTPTREEIKCMN 296
            Y  ++D W+ G +L E+L GQP F GE       S ++  V   K L   ++E +    
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL---SKEAVSICK 233

Query: 297 PNYTEFKFP------------QIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSPNL 338
              T  K P             I+ H       W K+ ++ + P           + P +
Sbjct: 234 GLLT--KHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPP----------FKPKV 281

Query: 339 RSTAFDAVGSFDSSFL 354
           +     +  +FD  F 
Sbjct: 282 KGRR--SAENFDKFFT 295

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 39/235 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 119
           Y   +V+G G+FG V   +   + +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           VV L  C F    +D+ YL +V+EY+P      +  +Y + ++    + K Y  ++  AL
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYTAEVVLAL 155

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYIC 229
             IH ++G+ HRD+KP N+L++ H H LKL DFG+   + +          G P+     
Sbjct: 156 DAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD----- 208

Query: 230 SRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 209 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 26/210 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY--KNRELQTM-------RLLDHPNVV 121
           +V+G GSFG V  A+  +  E     KVLQ K    K  E   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L H  F T +K    L  VL+Y+   E  + + +    +  R      + Y  +I  AL
Sbjct: 60  GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASAL 109

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
            Y+H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE+
Sbjct: 110 GYLH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +     Y   +D W  G VL E+L G P F
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 76/307 (24%), Positives = 127/307 (41%), Gaps = 75/307 (24%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR----ELQTMRLLDHPNVVSL 123
           +++G G  G VF  +   TG+  A+K   K    KR K +    E + +  LDHP + +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F + T     YL LV++Y P   + R+++      + +     + Y  ++  AL Y+
Sbjct: 67  YASFQTET-----YLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYL 119

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDF-------------------GSAKVLVKGEP 223
           H  +G+ +RD+KP+N+L++   H + L DF                   GS +  V   P
Sbjct: 120 HL-LGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 224 NISYICS-----------RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           + ++                Y APE+I G   + +A+D W+ G +L E+L G   F G +
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
             +    I+K                  E  FP              +   A DL+ +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269

Query: 333 QYSPNLR 339
              P+ R
Sbjct: 270 VKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 73.2 bits (179), Expect = 9e-15
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 22/206 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G++G V++A+ + TGE  AIK +     +D     +E+  M+   H N+V+    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
           S   +D+L++   +E+      + I H         + YV     +  + L Y+H+  G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVS---RETLQGLYYLHSK-GK 127

Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 244
            HRDIK  N+L+  + H +KL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 245 -YTAAIDIWSAGCVLAELL-LGQPLF 268
            Y    DIW+ G    EL  L  P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 85/319 (26%), Positives = 135/319 (42%), Gaps = 97/319 (30%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           + +G G+FG V  A  ++T    A+K  L+ K   NR        E   +   D+  VV 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   ++S  +KD LY   V++Y+P  + +  +I+      +  P +  + Y  ++  A+ 
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIE 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG---------SAKVLVKG--------EP 223
            +H  +G  HRDIKP N+L++   H +KL DFG         ++K   KG        EP
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173

Query: 224 NI-------------------------------SYICSRYYRAPELIFGATEYTAAIDIW 252
           +                                S + +  Y APE++     YT   D W
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWW 232

Query: 253 SAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 312
           S G +L E+L+GQP F              +  TPT  ++K +N   T    PQ+K    
Sbjct: 233 SVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK---- 274

Query: 313 HKIFQKRMPPEAVDLVSRL 331
                  + PEAVDL+++L
Sbjct: 275 -------LSPEAVDLITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   +HP +V L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIH 183
           +   +     L +++E+ P      I          P I V      ICR    AL Y+H
Sbjct: 79  YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV------ICRQMLEALQYLH 127

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 242
            ++ + HRD+K  N+L+      +KL DFG SAK +   +   S+I + Y+ APE++   
Sbjct: 128 -SMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 243 T----EYTAAIDIWSAGCVLAELLLGQP 266
           T     Y    DIWS G  L E+   +P
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 60/240 (25%), Positives = 108/240 (45%), Gaps = 30/240 (12%)

Query: 73  VGHGSFGVVFQAKCLETGEA-VAIKKVL-------QDKRYKNRELQTM--------RLLD 116
           +G G+FG V++ +    G+  +A+K++        +DKR +++ +  +          L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVL-EYVPETVHRVI---KHHYKMSQRMPLIYVKLYF 172
           HPN+V     F    E D LY+ + L E  P   H      K      +R+  I+V    
Sbjct: 68  HPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV---- 120

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            Q+  AL Y+H    + HRD+ P N+++     ++ + DFG AK         S + +  
Sbjct: 121 -QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y  PE++     Y    D+W+ GC+L ++   QP F   + +    +I++ +  P  E +
Sbjct: 179 YSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 39/235 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 119
           Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  AL
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLAL 155

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYIC 229
             IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+     
Sbjct: 156 DAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD----- 208

Query: 230 SRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 209 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 32/209 (15%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           G G+FG V++A+  ETG   A K +       L+D      E+  +    HPN+V L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 127 FFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +F    +++L+  +++E+      +++   ++      Q   +        Q+  AL ++
Sbjct: 71  YFY---ENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVC------RQMLEALNFL 119

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI-- 239
           H+   V HRD+K  N+L+      +KL DFG SAK     +   ++I + Y+ APE++  
Sbjct: 120 HSHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177

Query: 240 --FGATEYTAAIDIWSAGCVLAELLLGQP 266
             F    Y    DIWS G  L EL   +P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 70/268 (26%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 123
           +V+G G+FG V   +  +TG+  A+K +L+ + +K  +L  ++    +L   D P VVSL
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +D  YL L++E++P  + +  +IK+    S+ +     + Y  +   A+  
Sbjct: 67  YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYD-TFSEDV----TRFYMAECVLAIEA 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNISYIC 229
           +H  +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I 
Sbjct: 117 VHK-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174

Query: 230 SRY------------------------------------YRAPELIFGATEYTAAIDIWS 253
           +R                                     Y APE IF    Y    D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWS 233

Query: 254 AGCVLAELLLGQPLFPGESGVDQLVEII 281
            G ++ E L+G P F  E+  +   +II
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKII 261

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 31/214 (14%)

Query: 71  RVVGHGSFGVVFQAK-CLETGE--AVAIKKVLQDKRYKNREL-----QTMRLLDHPNVVS 122
           R +G G FG V+Q        E  AVA+K          RE        MR  DHP++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++  V+E  P    R      K    + L  + LY YQ+  ALAY+
Sbjct: 72  L----IGVITENPVWI--VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYL 123

Query: 183 HNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
            +   V HRDI  +N+LV +P    +KL DFG ++ L   E    Y  S+      + AP
Sbjct: 124 ESKRFV-HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMAP 177

Query: 237 ELIFGATEYTAAIDIWSAG-CVLAELLLG-QPLF 268
           E I     +T+A D+W  G C+   L+LG +P  
Sbjct: 178 ESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 70/277 (25%), Positives = 128/277 (46%), Gaps = 45/277 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD-------H--PNVVSL 123
           +G G+ G V++ +  +TG  +A+K++   +R  N+E     L+D       H  P +V  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVKLYFYQICRALAYI 182
              F + ++     + + +E +   + +++K   ++   +P  I  K+    I +AL Y+
Sbjct: 80  YGYFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMT-VAIVKALHYL 130

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFG 241
               GV HRD+KP N+L++  +  +KLCDFG +  LV  +    S  C+ Y  APE I  
Sbjct: 131 KEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDP 188

Query: 242 AT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT-----PTREE-- 291
                +Y    D+WS G  L EL  GQ  FP ++   +   + K+L       P  E   
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246

Query: 292 -------IKCMNPNYTEF-KFPQIKAHPWHKIFQKRM 320
                    C+  ++ +  K+ ++  HP+ + ++   
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 22/210 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 122
           RV+G G FG V   +   TG+  A K+ L+ KR K R+ ++M L     L+  N   VV+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 180
           L + +     KD L L L +    +     +K H Y M            Y  +I   L 
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGD-----LKFHIYNMGNPGFEEERALFYAAEILCGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
            +H      +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++ 
Sbjct: 117 DLHRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
               YT + D W  GC++ E++ GQ  F G
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 71.4 bits (175), Expect = 6e-14
 Identities = 81/331 (24%), Positives = 135/331 (40%), Gaps = 95/331 (28%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKK----VLQDKR---YKNRELQTMRLLDHPNVVSLK 124
           +VG G FG V   +   TG+  A+K     VL  +    +   E   + + + P +  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           + F    +KD LYL  V+EY P  + +  + ++  +  + M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-------KVLVK---GEPNISYICSRY 232
           H  +G  HRDIKP+N+L++   H +KL DFGSA        V  K   G P+        
Sbjct: 119 H-QMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPD-------- 168

Query: 233 YRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQ-PL------------------- 267
           Y APE++      G   Y    D WS G +  E++ G+ P                    
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228

Query: 268 -FPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKR 319
            FP +  V    +++I+ L    +E +           +  +  HP      W+ I +  
Sbjct: 229 KFPEDPKVSSDFLDLIQSLLCGQKERL----------GYEGLCCHPFFSKIDWNNI-RNS 277

Query: 320 MPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD 350
           +PP           + P L+S   D   +FD
Sbjct: 278 LPP-----------FVPTLKSD--DDTSNFD 295

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 58/282 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG+  A+K + ++             ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F      D   L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 58  TALKYSF---QTHD--RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 213

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L++ LL+  P  R
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 71  RVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDKRYKNR-------ELQTMRLLDHPNVVS 122
           R +G GSFG V  A    E    VAIK+  + K  K +       E + +  ++HP  V+
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   F     KDE YL LVLE+V   +        + ++R P      Y  QI     Y+
Sbjct: 96  LYGSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
             ++ + +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++  
Sbjct: 148 Q-SLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF 268
                AA D W+ G  + E+L+G P F
Sbjct: 203 VGHGKAA-DWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 39/232 (16%)

Query: 56  GKNGQPKQTISYMA-ERV--VGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNR 107
                P    S    ERV  +G G+ G V++     TG   A+K +  +     +R   R
Sbjct: 62  ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR 121

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRM 163
           E++ +R ++HPNVV     F    E     + ++LE++     E  H  I     ++   
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGE-----IQVLLEFMDGGSLEGTH--IADEQFLAD-- 172

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-E 222
                     QI   +AY+H    + HRDIKP NLL+N     +K+ DFG +++L +  +
Sbjct: 173 -------VARQILSGIAYLHRR-HIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMD 223

Query: 223 PNISYICSRYYRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQPLFP 269
           P  S + +  Y +PE I      GA +  A  DIWS G  + E  LG+  FP
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 70/253 (27%), Positives = 121/253 (47%), Gaps = 28/253 (11%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL+  +V+EY+       +     M +             
Sbjct: 73  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEGQ--------IAA 119

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPEL 235

Query: 290 EEIKCMNPNYTEF 302
           +  + ++  + +F
Sbjct: 236 QNPERLSAVFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.1 bits (176), Expect = 1e-13
 Identities = 69/248 (27%), Positives = 115/248 (46%), Gaps = 37/248 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G+G FG VF  K   T E    K +      +R K++   E+  MR L H N+
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V     F +   + +LY+  ++E+     + R I+  YKM  ++    +     Q+  AL
Sbjct: 75  VRYIDRFLNKANQ-KLYI--LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 180 AYIHNTIG------VCHRDIKPQNLLVNPHTHQL----------------KLCDFGSAKV 217
           AY HN         V HRD+KPQN+ ++     +                K+ DFG +K 
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 218 LVKGEPNISYIC--SRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           +  G  ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+  F   +  
Sbjct: 192 I--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249

Query: 275 DQLVEIIK 282
            QL+  +K
Sbjct: 250 SQLISELK 257

Length = 1021

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 25/239 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 124
           +G G FG V   +   TG+  A KK L  KR K +  + M LL+         P +V+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALAYI 182
           + F S T     +L LV+  +       +K+H Y + +R + +  V  Y  QI   + ++
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGD---LKYHIYNVGERGLEMERVIHYSAQITCGILHL 111

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H ++ + +RD+KP+N+L++      +L D G A  L  G+       +  Y APE I   
Sbjct: 112 H-SMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
             Y+  +D ++ GC + E++ G+  F       + V   ++      +E+K  + N+TE
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 76/282 (26%), Positives = 123/282 (43%), Gaps = 57/282 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 58  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L+S LL+  P  R
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.4 bits (169), Expect = 2e-13
 Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 28/253 (11%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL+  +V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEGQ--------IAA 120

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236

Query: 290 EEIKCMNPNYTEF 302
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 32/213 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-----RLLDHPN---VVS 122
           RV+G G FG V   +   TG+  A KK L+ KR K R+ + M     R+L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKM------SQRMPLIYVKLYFYQI 175
           L + +     KD L L L +    +     +K H Y M       QR        Y  ++
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGD-----LKFHIYNMGNPGFDEQR-----AIFYAAEL 111

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           C  L  +     + +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y A
Sbjct: 112 CCGLEDLQRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMA 169

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           PE+I    +YT + D W  GC++ E++ GQ  F
Sbjct: 170 PEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 78/281 (27%), Positives = 123/281 (43%), Gaps = 58/281 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-----LL--DHPNVVSL 123
           +V+G G+FG V   K   TG+  A+K + + +  K  E    R     L+  D   + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 124 KHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            + F     +DE  L LV++Y V   +  ++    K   R+P    + Y  ++  A+  +
Sbjct: 67  HYAF-----QDENNLYLVMDYYVGGDLLTLLS---KFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYICSRY 232
           H  +G  HRDIKP N+L++ + H ++L DFGS   L+           G P+  YI    
Sbjct: 119 HQ-LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPEI 174

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
            +A E   G   Y    D WS G  + E+L G+  F  ES V+   +I+           
Sbjct: 175 LQAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------- 221

Query: 293 KCMNPNYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                N+ E F+FP              +  EA DL+ RL+
Sbjct: 222 -----NHKEHFQFPPD---------VTDVSEEAKDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.5 bits (170), Expect = 8e-13
 Identities = 69/250 (27%), Positives = 100/250 (40%), Gaps = 59/250 (23%)

Query: 88  ETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN 139
            TG  VAIK +  D         R++ RE      L HPN+V+L      + E     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
            V EYVP    R ++        +P         Q+  ALA  HN  G+ HRD+KPQN++
Sbjct: 56  AVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111

Query: 200 VN-----PHTHQLKLCDFG------------SAKVLVKGEPNISYICSRYYRAPELIFGA 242
           V+     PH    K+ DFG             A +    E     + +  Y APE + G 
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTE----VLGTPTYCAPEQLRGE 164

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
              T   D+++ G +  E L GQ +  G S    + EI+           + ++P   + 
Sbjct: 165 PV-TPNSDLYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--DV 207

Query: 303 KFPQ-IKAHP 311
             P  I  HP
Sbjct: 208 SLPPWIAGHP 217

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++A+ L TGE  A+K +      D     +E+  ++   H N+V+    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIHN 184
           S   +++L+  + +EY      + I H       + + YV       CR     LAY+H 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYV-------CRETLQGLAYLH- 123

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           + G  HRDIK  N+L+  +   +KL DFG +AK+        S+I + Y+ APE+   A 
Sbjct: 124 SKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAV 180

Query: 244 E----YTAAIDIWSAGCVLAELLLGQP 266
           E    Y    DIW+ G    EL   QP
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 16/221 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 130
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  NV+    C + T
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64

Query: 131 TE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           T     +DE YL LV++Y       ++    K   R+P    + Y  ++  A+  IH   
Sbjct: 65  TLHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF---- 240
            V HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 123 YV-HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           G  +Y    D WS G  + E+L G+  F  ES V+   +I+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 19/218 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 124
           V+G GSFG V  A+   T E  AIK      V+QD   +    E + + L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +  +   R    +   Y  +I   L ++H+
Sbjct: 67  HSCFQTM--DRLYF--VMEYVNGGD---LMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I    
Sbjct: 120 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-AYQ 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 65.3 bits (160), Expect = 4e-12
 Identities = 64/265 (24%), Positives = 112/265 (42%), Gaps = 63/265 (23%)

Query: 95  IKKVLQDKRYKNREL---QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----- 146
           ++K+++ K +   E    Q M+  D+PN + L +    TT K  +   L+++Y+      
Sbjct: 45  VQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLF 97

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ 206
           + +        K   ++    VK    Q+  AL  +H    + H DIK +N+L +    +
Sbjct: 98  DLL--------KKEGKLSEAEVKKIIRQLVEALNDLHKHNII-HNDIKLENVLYDRAKDR 148

Query: 207 LKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTAAIDIWSAGCVLAEL 261
           + LCD+G  K  + G P      S Y     Y +PE I G   Y  + D W+ G +  EL
Sbjct: 149 IYLCDYGLCK--IIGTP------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYEL 199

Query: 262 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP 321
           L G+   P +   D   E +         +++ +     + K P          F K + 
Sbjct: 200 LTGK--HPFKEDED---EEL---------DLESLLKRQ-QKKLP----------FIKNVS 234

Query: 322 PEAVDLVSRLLQYSPNLRSTAFDAV 346
             A D V  +L+Y+ N R T ++ +
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEI 259

Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 21/217 (9%)

Query: 67  YMAERVVGHGSFGVVFQA-KCLETGEAVAIKKV-LQDKR---YKNRELQTMRLLDHPNVV 121
           Y+   +VG       F A +  +  E V  K V L D+R   Y   EL  +   DH  +V
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128

Query: 122 SLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRA 178
             KH  F   + D+  L L++EY     +++ IK   ++ + +P     V L FYQI  A
Sbjct: 129 --KH--FDDFKSDDKLL-LIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVLA 181

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRA 235
           L  +H+   + HRD+K  N+ + P T  +KL DFG +K     V  +   S+  + YY A
Sbjct: 182 LDEVHSR-KMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL +    Y+   D+WS G +L ELL     F G S
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 21/240 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ETG  +A  KV+  K  +       E+  +   DHPN+V L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +      E  L +++E+        +    +     P I  ++   Q   AL Y+H    
Sbjct: 72  YY-----ENNLWILIEFCAGGAVDAVMLELERPLTEPQI--RVVCKQTLEALNYLHEN-K 123

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 244
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 124 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 245 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y    D+WS G  L E+   +P     + +  L++I K    PT  +    +  + +F
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSEFKDF 241

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 16/219 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   RV+G G+ G V  AK +  GE  A+K V        DK     E+  +   D  ++
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 121 VSLKHCFFSTTEKDE---LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           V     F     ++    L + LVL+Y     + + IK   K ++        L F Q+ 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYY 233
            A+ ++H+   + HRDIK  N+L+  +   +KL DFG +K+    V  +   ++  + YY
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            APE I+    Y+   D++S G +L ELL  +  F GE+
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 14/217 (6%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-----MRLL 115
           P  + ++     +G G++G VF+    + G   A+K +L      + E++        L 
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           DHPNVV     ++    K+   L LVLE     +V  ++K   K  +RM    +    ++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYY 233
               L ++H    + HRD+K  N+L+      +KL DFG SA++        + + + ++
Sbjct: 133 ALMGLQHLHVNKTI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190

Query: 234 RAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQP 266
            APE+I       + Y A  D+WS G    EL  G P
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 39/227 (17%)

Query: 82  FQAKCLE--TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN 139
           F   C++  T E V IK     +     E   +R ++HP+++ LK  F         Y  
Sbjct: 107 FAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--------TYNK 156

Query: 140 LVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
                +P   ++   + Y  ++R + +  +      + RA+ Y+H    + HRDIK +N+
Sbjct: 157 FTCLILPR--YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENI 213

Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY--------RAPELIFGATEYTAAID 250
            +N H   + L DFG+A   V    N      +YY         APEL+     Y  A+D
Sbjct: 214 FIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGPAVD 265

Query: 251 IWSAGCVLAELLLGQPLFPGESGVD-------QLVEIIKVLGTPTRE 290
           IWSAG VL E+         + G+D       Q+  II+  GT   E
Sbjct: 266 IWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312

Length = 391

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 58/282 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG          E +  K  +     ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 57

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 58  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 107

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 213

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L++ LL+  P  R
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 75/322 (23%), Positives = 117/322 (36%), Gaps = 107/322 (33%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           + +G G+FG V   + ++T    A+K  L+      R        E   +   D+  VV 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   ++S  +KD LY   V++Y+P  + +  +I+              + Y  ++  A+ 
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRLGI-----FEEDLARFYIAELTCAIE 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPH----------------THQLKL--------------- 209
            +H  +G  HRDIKP N+L++                  TH  K                
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 210 --------CDFGSAKVLVK------------GEPNISYICSRYYRAPELIFGATEYTAAI 249
                   C     +   K            G PN        Y APE++   T YT   
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQLC 225

Query: 250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 309
           D WS G +L E+L+GQP F  +              TP   ++K +N   T    P    
Sbjct: 226 DWWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWE-TTLHIP---- 266

Query: 310 HPWHKIFQKRMPPEAVDLVSRL 331
                  Q ++  EA DL+ RL
Sbjct: 267 ------SQAKLSREASDLILRL 282

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)

Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             K      TE     + L++E++P     E + R  K+   + Q++       Y  QIC
Sbjct: 70  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLK------YAVQIC 119

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----- 231
           + + Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   E +  Y   +     
Sbjct: 120 KGMDYLGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDS 174

Query: 232 --YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             ++ APE +  +  Y A+ D+WS G  L ELL
Sbjct: 175 PVFWYAPECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 44/252 (17%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---ELQTM---RLLDHPNVVSLKH 125
           ++G G+FG V +A   +  E  A+K V    +Y      E+Q M   R  D  +   L  
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 126 C--FFSTTEKDELYLNLVL-EYVPETVHRVIKH----HYKMSQRMPLIYVKLYFYQICRA 178
              +F   + +  ++ +V+ +Y P  +  ++KH    H  ++Q           +Q   A
Sbjct: 196 IQRYF---QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ---------IIFQTGVA 243

Query: 179 LAYIHNTIGVCHRDIKPQNLL-------VNPHTHQ--------LKLCDFGSAKVLVKGEP 223
           L Y H  + + H D+KP+N+L       V+P T++        +++CD G      +   
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHS 301

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             + + +R+YR+PE++ G   +  + D+WS GC++ EL  G+ L+     ++ L  + K 
Sbjct: 302 RTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360

Query: 284 LGT-PTREEIKC 294
           LG  P+    +C
Sbjct: 361 LGRLPSEWAGRC 372

Length = 467

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 25/203 (12%)

Query: 79  GVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHCFFSTTE 132
            +V  AK   T   VA+KK+  D   K        E+ T R L HPN++     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
             ELY  +V   +   +   ++K H+   + +P + +      +  AL YIH+  G  HR
Sbjct: 71  DSELY--VVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK-GFIHR 125

Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------EPNISYICSRYYRAPELIFGAT 243
            +K  ++L++     + L     +  ++K         +   S + +  + +PE++    
Sbjct: 126 SVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 244 E-YTAAIDIWSAGCVLAELLLGQ 265
           + Y    DI+S G    EL  G 
Sbjct: 185 QGYNEKSDIYSVGITACELANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 14/205 (6%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKHCF 127
           +G G++G V++    + G   A+K +L      + E++        L +HPNVV     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +   +     L LVLE     +V  ++K      QR+    +    Y     L ++HN  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            + HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 246 T----AAIDIWSAGCVLAELLLGQP 266
                A  D+WS G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHC 126
            VVG+G++G V++ + ++TG+  AIK   V +D+  + +    M  +   H N+ +    
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 127 FFSTT---EKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           F   +     D+L+  LV+E+     V + V     +  K        ++     +I R 
Sbjct: 82  FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKED------WIAYICREILRG 133

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAP 236
           LA++H    V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ AP
Sbjct: 134 LAHLH-AHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAP 190

Query: 237 ELIF----GATEYTAAIDIWSAGCVLAELLLGQP 266
           E+I         Y    DIWS G    E+  G P
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 22/224 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-----LLDHPN--VVSL 123
           +V+G G+FG V   K     +  A+K + + +  K  E    R     L++  N  + +L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            + F     +DE  L LV++Y       ++    K   R+P    + Y  ++  A+  +H
Sbjct: 67  HYAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF- 240
             +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 120 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 241 ---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              G  +Y    D WS G  + E+L G+  F  ES V+   +I+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 52/244 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 126
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    +L   +   +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 127 FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           F+S  +K  LYL  ++E++P  + +  ++K      +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIHQ 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------------------------- 213
            +G  HRDIKP NLL++   H +KL DFG                               
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 214 ---SAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               A+   K    ++Y  + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 269 PGES 272
             E+
Sbjct: 237 CSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 66/291 (22%), Positives = 116/291 (39%), Gaps = 46/291 (15%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE--- 132
           GS G VF A      + V +K  +  K     E   ++ ++HP+V+ +K    S      
Sbjct: 77  GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134

Query: 133 -----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
                  +LY  L                   S+ +P+    +   QI   L Y+H    
Sbjct: 135 VLPHYSSDLYTYLTKR----------------SRPLPIDQALIIEKQILEGLRYLHAQ-R 177

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
           + HRD+K +N+ +N    Q+ + D G+A+  V     +    +    APE +    +Y +
Sbjct: 178 IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNS 235

Query: 248 AIDIWSAGCVLAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEI 292
             DIWSAG VL E+L             P    +S    L++II  L       P     
Sbjct: 236 KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTA 342
           + +   + E+   + + +  +  FQ+  +P +   LV ++L +   +R +A
Sbjct: 296 R-LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA 345

Length = 357

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 64/248 (25%), Positives = 107/248 (43%), Gaps = 57/248 (22%)

Query: 73  VGHGSFGVVFQAK-----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLL-DHPNVV 121
           +G G+FG V +A+            VA+K +  D   K+      E++ M+++  H N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYF-- 172
           +L       T++  LY+  V+EY             R    +       P     L    
Sbjct: 80  NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE-TLTQKD 133

Query: 173 -----YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
                YQ+ R + ++ +     HRD+  +N+LV    H +K+ DFG A+       +I +
Sbjct: 134 LVSFAYQVARGMEFLASK-KCIHRDLAARNVLVT-EDHVMKIADFGLAR-------DIHH 184

Query: 228 ICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
           I   YYR            APE +F    YT   D+WS G +L E+  LG   +PG   V
Sbjct: 185 I--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-V 240

Query: 275 DQLVEIIK 282
           ++L +++K
Sbjct: 241 EELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 34/218 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKK-----VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
             +G G+FG V++   L+    VA+K          KR   +E + ++  DHPN+V L  
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-- 183
                 +K  +Y+  V+E VP     ++    K   R+ +  +          + Y+   
Sbjct: 58  -IGVCVQKQPIYI--VMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------AP 236
           N I   HRD+  +N LV    + LK+ DFG    + + E    Y  S   +       AP
Sbjct: 113 NCI---HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAP 164

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 272
           E L +G   YT+  D+WS G +L E   LG   +PG S
Sbjct: 165 EALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 52/244 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 126
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    +L   + + +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 127 FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           F+S  +K  LYL  ++E++P  + +  ++K      +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE------------PN-------- 224
            +G  HRDIKP NLL++   H +KL DFG    L K              P+        
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 225 ----------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
                            S + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 269 PGES 272
             E+
Sbjct: 237 CSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 37/228 (16%)

Query: 73  VGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLK 124
           +G GSFGVV + +   +G     VA+K +  DK         +E   M  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 125 HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
               +        L +V E  P     + + +    H+       +  +  Y  QI   +
Sbjct: 63  GVVLTHP------LMMVTELAPLGSLLDRLRKDALGHF------LISTLCDYAVQIANGM 110

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
            Y+ +   + HRD+  +N+L+     ++K+ DFG  + L + E +  Y+   + +     
Sbjct: 111 RYLESKRFI-HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAW 166

Query: 235 -APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEI 280
            APE +   T ++ A D+W  G  L E+   G+  + G SG   L +I
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 40/260 (15%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 127
           +VG+G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 128 FSTTE---KDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    D+L+  LV+E+    +V  +IK+       +   ++     +I R L+++H
Sbjct: 73  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH 128

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 240
               V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 129 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 185

Query: 241 ---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
                  Y    D+WS G    E+  G P       +  L  I +             NP
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------------NP 232

Query: 298 NYTEFKFPQIKAHPWHKIFQ 317
                  P++K+  W K FQ
Sbjct: 233 A------PRLKSKKWSKKFQ 246

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 72  LKDTK-----LWIIMEYLGG------GSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATE 244
             + HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 30/226 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE     VAIK + ++   K       E   M  +DHP+VV
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     S+       + L+ + +P    +  V  H   +  +  L +      QI + +
Sbjct: 73  RLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV----QIAKGM 122

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
           +Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 123 SYLEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 181 ESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 70/297 (23%), Positives = 119/297 (40%), Gaps = 65/297 (21%)

Query: 70  ERVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 119
            R +G GSFG+V++  AK +  GE    VAIK V ++   + R     E   M+  +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR---------MPLIYVKL 170
           VV L      +T +  L   +V+E + +   +     Y  S+R          P    K 
Sbjct: 71  VVRLLG--VVSTGQPTL---VVMELMAKGDLK----SYLRSRRPEAENNPGLGPPTLQKF 121

Query: 171 YFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
                +I   +AY+       HRD+  +N +V      +K+ DFG  +       +I   
Sbjct: 122 IQMAAEIADGMAYLAAK-KFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DIYE- 171

Query: 229 CSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
            + YYR            APE +     +T   D+WS G VL E+  L +  + G S  +
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN-E 228

Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
           ++++ +   G     E  C +      +        W   +  +M P  +++VS L 
Sbjct: 229 EVLKFVIDGGHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 22/202 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  P     +     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLGG------GSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177

Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 66/242 (27%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIK--------KVLQDKRYKNR 107
           P   + ++ E  +G G+FG V++ +        +  +VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQ----- 161
           E + M  L HPN+V    C      K++    L  EY+    +H  +  +   S      
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 162 -----RMPLIYVKLY--FYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 212
                +  L          QI   + Y+  H+     HRD+  +N LV      +K+ DF
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG-LTVKISDF 168

Query: 213 GSAKVLVKGEPNISYICSRYYR------------APELI-FGATEYTAAIDIWSAGCVLA 259
           G ++ +   +         YYR             PE I +G  ++T   DIWS G VL 
Sbjct: 169 GLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLW 217

Query: 260 EL 261
           E+
Sbjct: 218 EI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 26/207 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     +K+ ++   E   M   DHPN++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     T  K  +   +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMK 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 121 YLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 177

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 55/227 (24%), Positives = 107/227 (47%), Gaps = 20/227 (8%)

Query: 67  YMAERVVGHGSFGVVF--QAKCLETGEAVAIKKVL-------QDKRYKNRELQTMRLLDH 117
           Y+ ++ +G GSFG V+  + K     E + + K +        +    N+E Q +  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           P +V     F    E+D   +  + EY     +   ++      + +    V  +F Q+ 
Sbjct: 62  PAIVKFHASFL---ERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRA 235
             + Y+H    + HRD+K +N+ +    + LK+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQR-RILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PE +     Y +  DIWS GC+L E+      F G++ +  ++ I++
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 44/229 (19%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDH 117
           P++++    ER +G G FG V+      T + VA+K +           +E Q M+ L H
Sbjct: 4   PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYV-----------PETVHRVIKHHYKMSQRMPLI 166
             +V L   +   +E++ +Y+  V EY+            E     +     M+      
Sbjct: 61  DKLVQL---YAVCSEEEPIYI--VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA----- 110

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
                  QI   +AY+ +     HRD+  +N+LV  +    K+ DFG A+++   E   +
Sbjct: 111 -------QIAEGMAYLESR-NYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTA 160

Query: 227 YICSRY---YRAPELI-FGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
              +++   + APE   +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 161 REGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 22/202 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG V++     T E VAIK + L++   +     +E+  +   D P +      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL   Y+     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLGG------GSALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y    DIWS G    EL  G+P
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 50/294 (17%)

Query: 76  GSFGVVFQAKCLETGEAV---AIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           GS G VF   C + G+      I K +   +   RE+  ++ + H  +++L H +     
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155

Query: 133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD 192
               + + V   +P+    +  +  +    +PL        ++  ALAY+H   G+ HRD
Sbjct: 156 ---RWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQAITIQRRLLEALAYLHGR-GIIHRD 210

Query: 193 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTA 247
           +K +N+ ++   + + L DFG+A  L       +  C  +       +PEL+     Y A
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266

Query: 248 AIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---- 302
             DIWSAG VL E+ +    LF  +         +K   +  R  I+CM  +  EF    
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQ---------VKSSSSQLRSIIRCMQVHPLEFPQNG 317

Query: 303 ---------KFPQIKAHPWH--KIFQKRMPPEAVD-LVSRLLQYSPNLRSTAFD 344
                    ++  +   P+    + +K      V+ L++++L +    R +A D
Sbjct: 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD 371

Length = 392

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 60/235 (25%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRL---LDHPNVVSL 123
           R++G G  G V+ A        VA+KK+ +D       K R L+  ++   L HP +V +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIK-----------HHYKMSQRMPLIYVKLY 171
              +   ++ D +Y    + Y+   T+  ++K              K S       V  +
Sbjct: 68  ---YSICSDGDPVYYT--MPYIEGYTLKSLLKSVWQKESLSKELAEKTS-------VGAF 115

Query: 172 ---FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV----------L 218
              F++IC  + Y+H+  GV HRD+KP N+L+      + L D+G+A            +
Sbjct: 116 LSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDI 173

Query: 219 VKGEPNISY---------ICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELL 262
              E NI Y         + +  Y APE + G  A+E T   DI++ G +L ++L
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225

Length = 932

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 72  VVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 121
            +G G FG VF AK      E GE + + K LQ  + +N      REL   R L H NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYV-KLYF-YQI 175
            L        E +  Y  ++LEY      +   R  K   +  +  PL    K+    QI
Sbjct: 72  RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
              + ++ N   V HRD+  +N LV   + Q +       KV +       Y  S YY+ 
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYYKL 175

Query: 235 ----------APELIFGATEYTAAIDIWSAGCVLAEL 261
                     APE +    +++   D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.2 bits (133), Expect = 8e-09
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 32/229 (13%)

Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVV 121
           +++M E  +G G FGVV   K       VAIK + +    +     E + M  L HP +V
Sbjct: 6   LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L   +   T++  LY+  V E++     ++ + +   K+S+ M L   +     +C  +
Sbjct: 63  QL---YGVCTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGM 113

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YY 233
            Y+       HRD+  +N LV+  T  +K+ DFG  + ++  E    Y  S        +
Sbjct: 114 EYLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKW 167

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII 281
             PE +F  ++Y++  D+WS G ++ E+   G+  F  +S   ++VE+I
Sbjct: 168 SPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 19/161 (11%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKN--RELQTMR----LLDHPNVVSLKHCFF 128
           G+FG V+  +     +  A+K V + D   KN   ++Q  R    L   P +V L   ++
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           S    + +YL  V+EY+     + + H Y    + M + Y+     ++  AL Y+H   G
Sbjct: 72  SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-G 124

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           + HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 16/95 (16%)

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           Q+  A+ YIH   G+ HRDIK +N+LVN     + L DFG+A    +G    S+    +Y
Sbjct: 268 QLLSAIDYIHGE-GIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPFHY 320

Query: 234 --------RAPELIFGATEYTAAIDIWSAGCVLAE 260
                    APE++ G   YT ++DIWSAG V+ E
Sbjct: 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 56/244 (22%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKC--LETGEA---VAIKKVLQD------KRYKNREL 109
            + TI     R +G G+FG VF  +C  LE       VA+ K L++      ++   RE 
Sbjct: 3   QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-------YKMSQ 161
           + +    H N+V         TE D     +V EY+    +++ ++ H            
Sbjct: 60  ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 162 RM-PLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            M  L   +L     QI   + Y+ +   V HRD+  +N LV  +   +K+ DFG ++ +
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV-HRDLATRNCLVG-YDLVVKIGDFGMSRDV 172

Query: 219 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELLL--G 264
                   Y    YYR             PE I     +T   D+WS G VL E+     
Sbjct: 173 --------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGK 222

Query: 265 QPLF 268
           QP +
Sbjct: 223 QPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 16/165 (9%)

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 286
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
             +E  +   P+YT  +  Q     WH    +R  P   +LV  L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 15/168 (8%)

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 286
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQ 333
             ++  +   P     +  +I    W    ++R      V+++  LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 38/227 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 127
           R +G G FG V++     T   VA+K +            E Q M+ L HP ++ L   +
Sbjct: 12  RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---Y 67

Query: 128 FSTTEKDELYL-------NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
              T ++ +Y+         +LEY+     R +    K+ Q   LI +     Q+   +A
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL----KLPQ---LIDMAA---QVASGMA 117

Query: 181 YI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           Y+   N I   HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + A
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTA 172

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
           PE       ++   D+WS G +L E++  G+  +PG +   V Q V+
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 36/217 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR----ELQTMRLLDHPNVVSLKH 125
           ER +G G FG V++         VAIK +  D   K +    E+Q ++ L H +++SL  
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHY------KMSQRMPLIYVKLYFYQICRAL 179
            F   +  + +Y+      + E + +     +      ++     LI +     Q+   +
Sbjct: 68  -FAVCSVGEPVYI------ITELMEKGSLLAFLRSPEGQVLPVASLIDMA---CQVAEGM 117

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICSRYYR 234
           AY+       HRD+  +N+LV       K+ DFG A+++     +  +  I Y     + 
Sbjct: 118 AYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY----KWT 171

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 270
           APE       ++   D+WS G +L E+   GQ  +PG
Sbjct: 172 APEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.9 bits (127), Expect = 5e-08
 Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 54/242 (22%)

Query: 71  RVVGHGSFGVVFQAKCLE-----TGEA-VAIKK-----VLQDKRYKNRELQTMRLLDHPN 119
             +G G+FG V++    +     +G   VA+K        Q+K+   +E   M   +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 120 VVS-LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF---Y 173
           +V  L  C       +  Y  +++E +   + +   ++         PL+ +K       
Sbjct: 61  IVKLLGVCL----LNEPQY--IIMELMEGGDLLS-YLRDARVERFGPPLLTLKELLDICL 113

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNISYIC 229
            + +   Y+     + HRD+  +N LV+   +     +K+ DFG A+ + K         
Sbjct: 114 DVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--------- 163

Query: 230 SRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
           S YYR            APE L+ G   +T   D+WS G ++ E+L LGQ  +P  +  +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Query: 276 QL 277
            L
Sbjct: 222 VL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 26/207 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++V+G G FG VF+      G    AVAIK +      K R     E   M    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     T  K  +   ++ EY+    + + ++ H        L+ +      I   + 
Sbjct: 70  RLEGVV--TKFKPAM---IITEYMENGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMK 121

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +   HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S       + A
Sbjct: 122 YLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTA 178

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 179 PEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 23/202 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPN---VVSLK 124
           +G G FG V   +   TG+  A KK L  KR K R+     +   R+L   +   +VSL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVKLYFY--QICRALAY 181
           + F + T+     L LV+  +     R   H Y + +  P     +  FY  QI   L +
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRY--HIYNVDEENPGFPEPRACFYTAQIISGLEH 112

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIF 240
           +H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL+ 
Sbjct: 113 LHQR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 241 GATEYTAAIDIWSAGCVLAELL 262
           G  EY  ++D ++ G  L E++
Sbjct: 171 G-EEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 27/71 (38%), Positives = 39/71 (54%), Gaps = 9/71 (12%)

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             QI  AL  +H+T G+ HRD+KPQN++ +  +   K+ D G+A  L  G   I+YI   
Sbjct: 261 MRQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKE 316

Query: 232 Y-----YRAPE 237
           +     Y APE
Sbjct: 317 FLLDPRYAAPE 327

Length = 566

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 41/281 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEA---VAIKKV-----LQDKRYKNRELQTMRLLDHPNVVS 122
           RV+G G FG V+    +++       A+K +     L++     +E   M+   HPNV+S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAY 181
           L           E    +VL Y+    H  +++  +     P +   + F  Q+ + + Y
Sbjct: 61  L----LGICLPSEGSPLVVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL--I 239
           + +   V HRD+  +N +++  +  +K+ DFG A+ +   E    Y     +   +L   
Sbjct: 114 LASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVK 167

Query: 240 FGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           + A E      +T   D+WS G +L EL+  G P +P     D  V +++  G    +  
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQPE 225

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 333
            C +P Y      ++    WH   +  M P   +LVSR+ Q
Sbjct: 226 YCPDPLY------EVMLSCWHP--KPEMRPTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 29/208 (13%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V + +    G+    VAIK +     DK+  +   E   M   DHPN++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + ++ EY+   ++ + ++ +    +      V +    I   + 
Sbjct: 69  RLEGVVTKSRP-----VMIITEYMENGSLDKFLREN--DGKFTVGQLVGM-LRGIASGMK 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY------ICSRYYR 234
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+  
Sbjct: 121 YLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW-T 175

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 176 APEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYK-NREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE     VAIK++ +    K N+E+      M  +D+P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E    +   +           +  +  QI + 
Sbjct: 73  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY-----------LLNWCVQIAKG 121

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+     V HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 122 MNYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 180 LESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 30/201 (14%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G FGVV   K     + VAIK + +    ++    E + M  L HPN+V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67

Query: 130 TTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            T++  ++  +V EY+         R  K        + +         +C A+ Y+ + 
Sbjct: 68  CTKQRPIF--IVTEYMANGCLLNYLRERKGKLGTEWLLDMC------SDVCEAMEYLESN 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-----APELIF 240
            G  HRD+  +N LV    + +K+ DFG A+ ++  +    Y  S+  +     AP  +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173

Query: 241 GATEYTAAIDIWSAGCVLAEL 261
             + +++  D+WS G ++ E+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 26/216 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEA-----VAIKKVLQDKRYKNR-----ELQTMRLL-DHPN 119
           + +G G+FG V +A      ++     VA+K +        R     EL+ M  L +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRA 178
           +V+L     + T    + +  + EY       ++    +  +    +   L F YQ+ + 
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           +A++ +   + HRD+  +N+L+  H   +K+CDFG A+ ++     +    +R    + A
Sbjct: 154 MAFLASKNCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           PE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 212 PESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 37/216 (17%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHC 126
           ++G G+FG VF+   L+    VA+K   +D  +  K + L   R+L   DHPN+V L   
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 127 FFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
               T++  +Y  +V+E VP     +  R  K   K  Q +       +       +AY+
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAP 236
            +     HRD+  +N LV    + LK+ DFG    + + E +  Y  S        + AP
Sbjct: 110 ESK-NCIHRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAP 163

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           E L +G   Y++  D+WS G +L E   LG   +PG
Sbjct: 164 EALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            L     S T      + LV + +P     + VH   +H   +  ++ L +      QI 
Sbjct: 73  RLLGVCLSPT------IQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWC----VQIA 119

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---Y 233
           + + Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    +
Sbjct: 120 KGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLL--GQP 266
            A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 178 MALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 73/300 (24%), Positives = 132/300 (44%), Gaps = 55/300 (18%)

Query: 73  VGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 119
           +G G FG V  A+ L       +    VA+K +  D   K+      E++ M+++  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV---------IKHHYKMSQ--RMPLIYV 168
           +++L     + T+   LY+  ++EY  +   R          +++ Y +++     + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 169 KLY--FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
            L    YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +   NI 
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVT-ENNVMKIADFG----LARDVNNID 191

Query: 227 YICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
           Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF 249

Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQYSPN 337
           +++K  G    +   C N  Y   +        WH I   R    + V+ + R+L  + N
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 54/290 (18%)

Query: 71  RVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 121
           R++G G FG V +A+      + + VA+K +  D    +      RE   M+  DHPNV+
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ------RMPLIYVKLYFYQI 175
            L      +  K  L + +V+  +P   H  +     MS+       +PL  +  +   I
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSRYY 233
              + Y+ +     HRD+  +N ++N     + +C  DFG +K +  G+         YY
Sbjct: 123 ASGMEYLSSK-NFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YY 169

Query: 234 R---APELIFG--ATE------YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEII 281
           R   A +L     A E      YT   D+W+ G  + E++  GQ  + G    +    +I
Sbjct: 170 RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229

Query: 282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           K  G   ++   C+   Y      ++    W    + R  P    L  +L
Sbjct: 230 K--GNRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 61/237 (25%), Positives = 91/237 (38%), Gaps = 50/237 (21%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQ 110
           P+  I Y   R +G G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 3   PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 111 TMRLLDHPNVVSL--------KHC----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 158
            M   DHPN+V L          C    + +  + +E   +          H        
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 159 MSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 216
               +PL   +      Q+   +AY+     V HRD+  +N LV  +   +K+ DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSR 178

Query: 217 VLVKGEPNISYICSRYYRA------------PELIFGATEYTAAIDIWSAGCVLAEL 261
                  NI    + YY+A            PE IF    YT   D+W+ G VL E+
Sbjct: 179 -------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 45/151 (29%), Positives = 69/151 (45%), Gaps = 15/151 (9%)

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L     S   +D ++L  VL++        +  H      +P   VK +  ++  
Sbjct: 45  PNMVCLHKYIVS---EDSVFL--VLQHAEGGK---LWSHISKFLNIPEECVKRWAAEMVV 96

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAP 236
           AL  +H    VC RD+ P N+L++   H ++L  F       + E +         Y AP
Sbjct: 97  ALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSR---WSEVEDSCDGEAVENMYCAP 151

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPL 267
           E + G +E T A D WS G +L ELL G+ L
Sbjct: 152 E-VGGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 19/108 (17%)

Query: 173 YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 223
            Q+ + + ++   N I   HRD+  +N+L+       K+CDFG A+        +VKG  
Sbjct: 219 SQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            +       + APE IF    YT   D+WS G +L E+  LG+  +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 26/199 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 130 TTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            T++  +Y  +V EY+         R     ++ SQ + +         +C  +AY+ + 
Sbjct: 68  CTKQRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQLLEMC------KDVCEGMAYLESK 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGA 242
               HRD+  +N LV+     +K+ DFG ++ ++  E   S + S++   +  PE +   
Sbjct: 120 -QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLY 175

Query: 243 TEYTAAIDIWSAGCVLAEL 261
           +++++  D+W+ G ++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 53/238 (22%), Positives = 105/238 (44%), Gaps = 49/238 (20%)

Query: 71  RVVGHGSFGVVFQAKCLE-TGEA----VAIKKVLQDK-----RYKNRELQTMRLLDHPNV 120
           + +G G FG V +A      G A    VA+K + ++      R    E   ++ ++HP+V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL---------- 170
           + L   + + ++   L L  ++EY     +  ++   + S+++   Y+            
Sbjct: 66  IKL---YGACSQDGPLLL--IVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 171 --------------YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 216
                         + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175

Query: 217 VLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            + + +  +     R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 45/222 (20%)

Query: 72  VVGHGSFGVVFQAKCLETG----EAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 122
           ++  G+FG +F    ++      E V +K V              E   +  L H N++ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 123 LKHCFFSTTEKDELYL------NLVL-----EYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           + H      E   +        NL L             + +      S +  L+++ + 
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL------STQQ-LVHMAI- 124

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-- 229
             QI   ++Y+H   GV H+DI  +N +++    Q+K+ D   ++ L   +    Y C  
Sbjct: 125 --QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCLG 176

Query: 230 ---SRYYR--APELIFGATEYTAAIDIWSAGCVLAELL-LGQ 265
              +R  +  A E +    EY++A D+WS G +L EL+ LGQ
Sbjct: 177 DNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 36/202 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---ELQTMRLLDHPNVVSLKHCFFS 129
           +G G FG V        G+ VA+K +  D         E   M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 130 TTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             + + LY  +V EY+      + +    +    ++Q++       +   +C  + Y+  
Sbjct: 71  --QGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQL------GFALDVCEGMEYLEE 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 239
                HRD+  +N+LV   +  L  K+ DFG AK     E +      +    + APE +
Sbjct: 121 K-NFVHRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL 171

Query: 240 FGATEYTAAIDIWSAGCVLAEL 261
               +++   D+WS G +L E+
Sbjct: 172 -REKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 22/168 (13%)

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K +P+  Y+  
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK-DPD--YVRK 232

Query: 231 RYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKV 283
              R      APE IF    YT   D+WS G +L E+  LG   +PG       V+I + 
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284

Query: 284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                +E  +   P Y   +   I    WH   + R  P   +LV  L
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR--PTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 21/152 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNR------ELQTMRLLDHPNVVSL 123
           + +G G+FG V  A+ ++T    A+K + + D   +N+      E   +   D+  VV L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              ++S  +KD LY   V++Y+P  + +  +I+         P    + Y  ++  A+  
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMGI-----FPEDLARFYIAELTCAVES 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 213
           +H  +G  HRDIKP N+L++   H +KL DFG
Sbjct: 117 VHK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL------ 123
           +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F+  TE    Y NL L+Y+ E             Q +  + +     QI  A+ Y+ 
Sbjct: 74  EPPFYIITEF-MTYGNL-LDYLREC----------NRQEVNAVVLLYMATQISSAMEYLE 121

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 240
                 HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + APE + 
Sbjct: 122 KK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL- 177

Query: 241 GATEYTAAIDIWSAGCVLAEL-LLGQPLFPG 270
              +++   D+W+ G +L E+   G   +PG
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 7/116 (6%)

Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            S+ +  + +  + YQ+ R + ++ +   V HRD+  +N+L+      +K+CDFG A+ +
Sbjct: 230 GSEGLTTLDLLSFTYQVARGMEFLASKNCV-HRDLAARNVLLA-QGKIVKICDFGLARDI 287

Query: 219 VKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           +     +S         + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 19/108 (17%)

Query: 173 YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 223
           YQ+ + ++++   N I   HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 221 YQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            +       + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 277 RLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 122
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 123 --LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
             L  C  ST +       LV + +P     ++ +  +   R+    +  +  QI + ++
Sbjct: 73  RLLGICLTSTVQ-------LVTQLMPYGC--LLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 237
           Y+   + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E
Sbjct: 124 YLEE-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            I     +T   D+WS G  + EL+
Sbjct: 182 SIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 47.2 bits (112), Expect = 4e-06
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 37/225 (16%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDH 117
           P++T+     + +G G FG V+          VAIK + Q          E   M+ L H
Sbjct: 4   PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQI 175
           P +V L    ++   ++ +Y+  + EY+    +  +    K  + + L   KL     QI
Sbjct: 61  PRLVRL----YAVVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQI 111

Query: 176 CRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 231
              +A+I   N I   HRD++  N+LV+  T   K+ DFG A+++   E    Y      
Sbjct: 112 AEGMAFIERKNYI---HRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGA 163

Query: 232 ----YYRAPELI-FGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                + APE I +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 164 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 81/336 (24%), Positives = 134/336 (39%), Gaps = 79/336 (23%)

Query: 73  VGHGSFGVVFQAKCLETGE-------AVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 119
           +G G FG V  A+ +   +        VA+K +  D   K+      E++ M+++  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP----------LIYVK 169
           +++L     + T+   LY+  ++EY  +   R     Y  ++R P          L   +
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLR----EYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 170 LYF-------YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L F       YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +  
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVT-EDNVMKIADFG----LARDV 184

Query: 223 PNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
            NI Y            + APE +F    YT   D+WS G +L E+  LG   +PG   V
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-V 242

Query: 275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR--------------- 319
           ++L +++K       E  +   P     +   I    WH +  +R               
Sbjct: 243 EELFKLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295

Query: 320 --MPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF 353
                E +DL     QYSP    +        DS F
Sbjct: 296 VTSTDEYLDLSVPFEQYSPGCPDSPSSCSSGDDSVF 331

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 75/309 (24%), Positives = 133/309 (43%), Gaps = 73/309 (23%)

Query: 73  VGHGSFGVVFQAKCLETGE-------AVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 119
           +G G FG V  A+ +   +        VA+K +  D   K+      E++ M+++  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP--------------L 165
           +++L     + T+   LY+  ++EY  +   R     Y  ++R P               
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLR----EYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 166 IYVKLYF---YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           +  K      YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG A+      
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR------ 188

Query: 223 PNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFP 269
            +I +I   YY+            APE +F    YT   D+WS G +L E+  LG   +P
Sbjct: 189 -DIHHI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYP 244

Query: 270 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLV 328
           G   V++L +++K  G    +   C N  Y   +        WH +  +R    + V+ +
Sbjct: 245 GVP-VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDL 296

Query: 329 SRLLQYSPN 337
            R+L  + N
Sbjct: 297 DRILALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 46.4 bits (110), Expect = 9e-06
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 26/208 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E V+G G FG V + +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALA 180
            L+     T  +  + +   +E      +  +    + +  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 234
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S        + 
Sbjct: 121 YLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.2 bits (109), Expect = 9e-06
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 31/222 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 122
           + +G G FG V + +  +       AV   K+    R +      E   M+  DHPNV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-------MPLIYVKLYFYQI 175
           L      T E +     +V+  +P   H  + H + +  R       +P   +  +   I
Sbjct: 65  LIGVCLQTVESEGYPSPVVI--LPFMKHGDL-HSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
              + Y+ ++    HRD+  +N ++N + + + + DFG +K +  G+    Y   R  + 
Sbjct: 122 ASGMEYL-SSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKM 176

Query: 236 PELIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPG 270
           P + + A E      YT   D+WS G  + E+   GQ  +PG
Sbjct: 177 P-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 17/175 (9%)

Query: 165 LIYVKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L Y+ L  + YQ+   + ++ +   V HRD+  +N+L+      +K+CDFG A+ +++  
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGLARDIMRDS 293

Query: 223 PNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             IS         + APE IF    YT   D+WS G +L E+  LG   +P     +Q  
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352

Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLL 332
             IK          +   P +   +  +I    W + F+ R    + V LV  LL
Sbjct: 353 NAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 47/192 (24%), Positives = 75/192 (39%), Gaps = 46/192 (23%)

Query: 94  AIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------KHCFFSTTEKDELY-LNLVL-EY 144
           A     +D     +E++ +  L  PN+  L               E  E   LN  L ++
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCM-IMEYMENGDLNQFLQKH 113

Query: 145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNP 202
           V ET    +  + K      L+Y+     QI   + Y+   N +   HRD+  +N LV  
Sbjct: 114 VAETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV---HRDLATRNCLVGK 165

Query: 203 HTHQLKLCDFGSAKVLVKGEPNISYICSRYY----RAP--------ELIFGATEYTAAID 250
             + +K+ DFG ++ L        Y    YY    RAP        E +    ++T   D
Sbjct: 166 -NYTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSD 214

Query: 251 IWSAGCVLAELL 262
           +W+ G  L E+L
Sbjct: 215 VWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 61/248 (24%), Positives = 112/248 (45%), Gaps = 55/248 (22%)

Query: 73  VGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDKRYKN-----RELQTMRLLD-HPN 119
           +G G FG V +A+         +    VA+K +  +   K+      E++ M+L+  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP--------------- 164
           +++L       T++  LY+  ++EY  +   R     +  ++R P               
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLR----EFLRARRPPGPDYTFDITKVPEEQ 130

Query: 165 LIYVKLY--FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L +  L    YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +G 
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFG----LARGV 184

Query: 223 PNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
            +I Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP-V 242

Query: 275 DQLVEIIK 282
           ++L ++++
Sbjct: 243 EELFKLLR 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 48/231 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ-------TMRLLDHPNV 120
           +++G G FG V + + L   +   +K   K ++   +   E++        M+  DHPNV
Sbjct: 5   KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRM-------PLIYVKLYFY 173
           + L    F  +   ++   +V+  +P   H  + H + +  R+       PL  +  +  
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVI--LPFMKHGDL-HSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSR 231
            I   + Y+ N     HRD+  +N ++      + +C  DFG +K +  G+         
Sbjct: 121 DIALGMEYLSNR-NFIHRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD--------- 167

Query: 232 YYRAPELI-----FGATE------YTAAIDIWSAGCVLAELL-LGQPLFPG 270
           YYR   +      + A E      YT+  D+W+ G  + E+   GQ  +PG
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 43/196 (21%)

Query: 93  VAIKKVLQD--KRYKN---RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 147
           VA+K +  D  K  +N   +E++ M  L +PN++ L          D+  L ++ EY+  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL----LGVCVSDDP-LCMITEYMEN 101

Query: 148 ------TVHRVIKHHYKMSQRMPLIYVKLYFY---QICRALAYIHNTIGVCHRDIKPQNL 198
                    R I+  +  +  +P + +    Y   QI   + Y+  ++   HRD+  +N 
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL-ASLNFVHRDLATRNC 160

Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------------APELIFGATEYT 246
           LV  H + +K+ DFG ++ L  G+         YYR            A E I    ++T
Sbjct: 161 LVGNH-YTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMAWESIL-LGKFT 209

Query: 247 AAIDIWSAGCVLAELL 262
            A D+W+ G  L E+ 
Sbjct: 210 TASDVWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 61/291 (20%), Positives = 102/291 (35%), Gaps = 57/291 (19%)

Query: 71  RVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +GHG+FG V++              VA+K + +    ++      E   M   +H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V        + E+   +  ++LE +     +      +     P            R +A
Sbjct: 72  V---RLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 181 ----YIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYR 234
               Y+       HRDI  +N L+         K+ DFG A+ + +         + YYR
Sbjct: 127 KGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------ASYYR 176

Query: 235 -----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVEI 280
                       P   F    +T+  D+WS G +L E+  LG   +PG +   V + V  
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236

Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
              L  P      C  P Y      +I    W    + R  P    ++ R+
Sbjct: 237 GGRLDPPK----GCPGPVY------RIMTDCWQHTPEDR--PNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 31/208 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 121
           +++G G FG V +   +  G+++ I    K +QD+  +         +  M  LDH  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 122 SLKH-CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ++       L LV +  P    +  V +H   +  +  L +      QI + 
Sbjct: 73  RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC----VQIAKG 121

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYR 234
           + Y+     + HR++  +N+L+      +++ DFG A +L   +    Y       ++  
Sbjct: 122 MYYLEEH-RMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
              ++FG   YT   D+WS G  + E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 129
           ++G G FG V Q +   TG+ VA+K +  D   +    E   M  L H N+V L      
Sbjct: 13  IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
                   L +V+E + +  + V     +    + +I +  +   +   + Y+ +   + 
Sbjct: 71  NG------LYIVMELMSKG-NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLV 122

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI 249
           HRD+  +N+LV+      K+ DFG A+V   G  N        + APE +    ++++  
Sbjct: 123 HRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL-KHKKFSSKS 178

Query: 250 DIWSAGCVLAELL-LGQPLFP 269
           D+WS G +L E+   G+  +P
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 10/90 (11%)

Query: 158 KMSQRMP-----LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 212
           K+   MP     +  +K    Q+   L  +H  IG+ HRDIKP+NLLV     Q+K+ DF
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVTVDG-QVKIIDF 353

Query: 213 GSAKVLVKG---EPNISYICSRYYRAPELI 239
           G+A  +  G    P    +  RY    EL+
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 50/223 (22%)

Query: 73  VGHGSFGVVFQAKCL-------ETGEAV-AIKKVLQDKRYK-NRELQTMRLLDHPNVVSL 123
           +G G+FG VF A+C        +   AV A+K+  +  R    RE + + +L H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH---------YKMSQRMPLIYVKLYFY 173
              F+    +    L +V EY+    ++R ++ H          +      L   ++   
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 174 --QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             QI   + Y+  ++   HRD+  +N LV      +K+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYL-ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176

Query: 232 YYRA------------PELIFGATEYTAAIDIWSAGCVLAELL 262
           YYR             PE I    ++T   DIWS G VL E+ 
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 29/121 (23%)

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QI   + Y+ +++   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYL-SSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 234 R------------APELIFGATEYTAAIDIWSAGCVLAELLL---GQPLFPGESGVDQLV 278
           R            A E I    ++T A D+W+ G  L E+L+    QP   GE   +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251

Query: 279 E 279
           E
Sbjct: 252 E 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 36/205 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 59

Query: 128 FSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              T+K  +Y  +V+E V      T  R      K+ + + ++            + Y+ 
Sbjct: 60  GVCTQKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQMV------ENAAAGMEYLE 111

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------AP 236
           +   + HRD+  +N LV    + LK+ DFG    + + E +  Y  +   +       AP
Sbjct: 112 SKHCI-HRDLAARNCLVT-EKNVLKISDFG----MSREEEDGVYASTGGMKQIPVKWTAP 165

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAE 260
           E L +G   Y++  D+WS G +L E
Sbjct: 166 EALNYG--RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 8/116 (6%)

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--ICSR 231
           Q+  A+ YIH+   + HRDIK +N+ +N    ++ L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVL 284
              +PE++ G   Y    DIWS G +L ++L       G+ G     QL++II  L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 34/207 (16%)

Query: 73  VGHGSFGVVFQA--KCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           +G G+FG V +   K  +    VAIK VL+++  K+      RE + M  LD+P +V + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                  E + L   LV+E      +++ +         + +  V    +Q+   + Y+ 
Sbjct: 61  ---IGVCEAEALM--LVMEMASGGPLNKFLS---GKKDEITVSNVVELMHQVSMGMKYLE 112

Query: 184 NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-------YRA 235
               V HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + A
Sbjct: 113 GKNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYA 166

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++++  D+WS G  + E  
Sbjct: 167 PECI-NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 40.4 bits (94), Expect = 9e-04
 Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 23/214 (10%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVS 122
           S    + +G+G FG V+        + VA+K +            E Q M+ L H  +V 
Sbjct: 7   SLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L    ++   ++ +Y+  V EY+ + ++   +K     + ++P + V +   Q+   +AY
Sbjct: 66  L----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMA-AQVAAGMAY 117

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 238
           I   +   HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE 
Sbjct: 118 IER-MNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEA 174

Query: 239 -IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 270
            ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 73/317 (23%), Positives = 130/317 (41%), Gaps = 79/317 (24%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQ 110
            ++ I+ + E  +G GSFG+V++  A+ +  GEA   VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLI 166
            M+     +VV L         K +  L +V+E +     ++  R ++   + +   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 167 YVKLYFY---QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            ++       +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAEL--LLGQPLFP 269
                   YYR            APE +     +T + D+WS G VL E+  L  QP + 
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223

Query: 270 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS 329
           G S  +Q+++ +             M+  Y +         P         P    DL+ 
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255

Query: 330 RLLQYSPNLRSTAFDAV 346
              Q++P +R T  + V
Sbjct: 256 MCWQFNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 35/217 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G  +  AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHH------YKMSQRMPLIYV 168
           +L        E    YL L +EY P           RV++           +  +    +
Sbjct: 72  NL----LGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
             +   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 127 LHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 182

Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 183 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 39.7 bits (92), Expect = 0.001
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 37/214 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G FG V+      T + VAIK +           +E Q M+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 130 TTEKDELYLNLVLEYVPE-TVHRVIKH----HYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              ++ +Y+  V E++ + ++   +K     + K+ Q + +        QI   +AYI  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA------QIADGMAYIER 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYRAPEL 238
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +       + APE 
Sbjct: 121 -MNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 174

Query: 239 -IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 270
            ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 51/225 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           E V+G G+FG V +A   + G  +  AIK + +     D R    EL+ + +L  HPN++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 122 SL-KHCFFSTTEKDELYLNLVLEYVP--------------ETVHRVIKHH---YKMSQRM 163
           +L   C      ++  YL + +EY P              ET     K H     ++ + 
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            L +       +   + Y+     + HRD+  +N+LV  +    K+ DFG    L +GE 
Sbjct: 121 LLQFAS----DVATGMQYLSEKQFI-HRDLAARNVLVGENLAS-KIADFG----LSRGEE 170

Query: 224 NISYICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAELL 262
              Y+     R P + + A E      YT   D+WS G +L E++
Sbjct: 171 --VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 69/296 (23%), Positives = 111/296 (37%), Gaps = 63/296 (21%)

Query: 73  VGHGSFGVVFQAKCLETGEAVA--IKKVLQDKRYKN------RELQTMRLLDHPNVVS-L 123
           +G+G FG V   +    G + A  + K L+     +      +E+Q  R L+HPNV+  L
Sbjct: 3   IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 124 KHCFFSTTEKDELYLNLVLEYVP----------ETVHRVIKHHYKMSQRMPLIYVKLYFY 173
             C  S       YL LVLE+ P                      + QRM          
Sbjct: 62  GQCIESIP-----YL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMA--------C 107

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 232
           ++   L ++H    + H D+  +N  +      +K+ D+G A      +  I+  C    
Sbjct: 108 EVASGLLWLHQADFI-HSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVP 165

Query: 233 --YRAPEL--IFGATEYTAAI----DIWSAGCVLAEL--LLGQPLFPGESGVDQLVEIIK 282
             + APEL  I G            +IWS G  + EL     QP +P  S    L ++++
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSDEQVLKQVVR 224

Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ-KRMPPE---AVDLVSRLLQY 334
                  ++IK   P           +  W+++ Q   + PE     + V  LL Y
Sbjct: 225 ------EQDIKLPKPQ-----LDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 61/249 (24%), Positives = 112/249 (44%), Gaps = 44/249 (17%)

Query: 64  TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMR 113
           T+ +M E  +G   FG V++         E  +AVAIK  L+DK     R + +    MR
Sbjct: 6   TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62

Query: 114 L-LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHR--VIKHHYK----------- 158
             L HPN+V    C      K++  L+++  Y   + +H   V++  +            
Sbjct: 63  SRLQHPNIV----CLLGVVTKEQP-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            S   P  +V +   QI   + ++ ++  V H+D+  +N+LV    + +K+ D G  + +
Sbjct: 118 KSTLEPADFVHI-VTQIAAGMEFL-SSHHVVHKDLATRNVLVFDKLN-VKISDLGLFREV 174

Query: 219 VKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 273
              +       S +  R+     +++G  +++   DIWS G VL E+   G   + G S 
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232

Query: 274 VDQLVEIIK 282
            D ++E+I+
Sbjct: 233 QD-VIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 74/327 (22%), Positives = 125/327 (38%), Gaps = 86/327 (26%)

Query: 72  VVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 123
           V+G G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +  F +  E     L +V  ++     + +I  H+     M  + +      + +AL YI
Sbjct: 65  RATFIADNE-----LWVVTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYI 117

Query: 183 HNTIGVCHRDIKPQNLLVN-----------------PHTHQLKLC-DFG--SAKVLVKGE 222
           H+ +G  HR +K  ++L++                  H  +L++  DF   S KVL    
Sbjct: 118 HH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL---- 172

Query: 223 PNISYICSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           P +S         PE++    + Y A  DI+S G    EL  G   F        L+E  
Sbjct: 173 PWLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-- 221

Query: 282 KVLGT------------------PTR--------EEIKCMNPNYTEFKFPQIKAHPWHKI 315
           K+ GT                  P+R        E      P  +     +  +HP+++ 
Sbjct: 222 KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNRT 278

Query: 316 FQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           F     P     V + LQ +P+ R +A
Sbjct: 279 FS----PHFHHFVEQCLQRNPDARPSA 301

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	354
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
PRK10345	210	hypothetical protein; Provisional	99.83
smart00090	237	RIO RIO-like kinase.	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.59
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.47
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
KOG3087	229	consensus Serine/threonine protein kinase [General	99.42
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.37
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.35
COG4248	637	Uncharacterized protein with protein kinase and he	99.31
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.31
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.19
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.14
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.14
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.13
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.03
PRK09902	216	hypothetical protein; Provisional	98.95
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.91
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.91
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.81
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.75
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.54
PF01636	239	APH: Phosphotransferase enzyme family This family	98.5
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.42
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.39
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.38
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.33
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.28
KOG2270	520	consensus Serine/threonine protein kinase involved	98.23
PLN02876	822	acyl-CoA dehydrogenase	98.1
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.1
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.03
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.93
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.86
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.86
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.75
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.7
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.7
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.62
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.6
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.57
PRK05231	319	homoserine kinase; Provisional	97.55
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.52
PRK10593	297	hypothetical protein; Provisional	97.49
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.34
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.33
PLN02236	344	choline kinase	97.31
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.26
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.23
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.1
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.09
PRK12396	409	5-methylribose kinase; Reviewed	96.88
PTZ00384	383	choline kinase; Provisional	96.83
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.8
PLN02756	418	S-methyl-5-thioribose kinase	96.72
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.62
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.06
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	95.63
PRK11768	325	serine/threonine protein kinase; Provisional	95.55
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.31
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.73
PHA03111	444	Ser/Thr kinase; Provisional	94.43
PTZ00296	442	choline kinase; Provisional	94.29
PRK10271	188	thiK thiamine kinase; Provisional	94.15

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.1e-64  Score=432.28  Aligned_cols=301  Identities=73%  Similarity=1.179  Sum_probs=283.8

Q ss_pred             ceeEEeecCCCCCCCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeeccee
Q 018514           47 GHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC  126 (354)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  126 (354)
                      +....+...+..+.+....+|.-.+++|+|+||.||+|...++++.||||+...+.+...+|+.+|+.++|||||++..+
T Consensus         6 ~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~   85 (364)
T KOG0658|consen    6 GHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYF   85 (364)
T ss_pred             eeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEE
Confidence            34445555666666667778999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCc
Q 018514          127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (354)
Q Consensus       127 ~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~  206 (354)
                      |....+.+..++.+||||++.+|.+.+++....+..++.-.++-+++||++||+|||+. ||+||||||.|+|+|.+.+.
T Consensus        86 f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~  164 (364)
T KOG0658|consen   86 FSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGV  164 (364)
T ss_pred             EEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCe
Confidence            88877666778899999999999999998777788999999999999999999999998 99999999999999999889


Q ss_pred             EEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 018514          207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  286 (354)
Q Consensus       207 vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  286 (354)
                      +||||||.|+.+..+.++.+..+|..|+|||.+.+...|+.+.||||.||++.||+.|++.|.|.+..+++..|++.+|.
T Consensus       165 LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  165 LKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             EEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      |+.+++.+++..+.+++++.+....|...+....++++.+|+.++|+++|.+|.+|.|++.|
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            99999999999999999999999999998999999999999999999999999999999987

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.6e-57  Score=382.54  Aligned_cols=273  Identities=36%  Similarity=0.634  Sum_probs=239.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .|+.+.++|+|+||+||+|+++.||+.||||++....      ....||+++|++++|+|+|.++.+|     .....++
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence            5888899999999999999999999999999996432      2345899999999999999999999     5556689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +|+|||+.++++.+.+..   ..++.+.+..+++|++.|+.|+|++ ++|||||||+||||+.++ .+||||||+|+.+.
T Consensus        78 LVFE~~dhTvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNG-VVKLCDFGFARTLS  152 (396)
T ss_pred             EEeeecchHHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCC-cEEeccchhhHhhc
Confidence            999999999888888754   6789999999999999999999999 999999999999999988 89999999999887


Q ss_pred             -cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh--ccC
Q 018514          220 -KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CMN  296 (354)
Q Consensus       220 -~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--~~~  296 (354)
                       ++...+.++.|.+|+|||.+.++..|+..+||||+||++.||++|.+.|++.++.+++..|.+.+|...+....  ..+
T Consensus       153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence             55555667889999999999998899999999999999999999999999999999999999999999987654  445


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +.|-..++|......--..--..++..+.+|+++||+.||.+|++.++++.|
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            6677777776654432222233478899999999999999999999999987

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-58  Score=405.68  Aligned_cols=274  Identities=36%  Similarity=0.661  Sum_probs=245.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++|.++++||.|.||.||+|+.+.+|+.||||+++..-     ....||++.|++|. ||||+++.+++.+    ...++
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d----~~~~L   85 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD----NDRIL   85 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----cCceE
Confidence            57999999999999999999999999999999886542     23348999999998 9999999998843    22279


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++|||||+.+|+++++.+   +..|++..++.|++||+.||+|+|.+ |+.|||+||+|||+.... .|||+|||+|+..
T Consensus        86 ~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~-~iKiaDFGLARev  160 (538)
T KOG0661|consen   86 YFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGND-VIKIADFGLAREV  160 (538)
T ss_pred             eeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccc-eeEeccccccccc
Confidence            999999999999999987   48899999999999999999999999 999999999999999765 7999999999998


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc--C
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--N  296 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~  296 (354)
                      ....+.+.++.|.+|+|||+++....|+.+.||||+|||++|+.+-++.|+|.++.+++.+|...+|.|....+...  .
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            88888888899999999999999889999999999999999999999999999999999999999999998876541  2


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...-.+++|.....+....++. .+.++.++|.+||.|||.+||||.++|+|
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            3334567777777777666666 89999999999999999999999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.9e-56  Score=368.66  Aligned_cols=273  Identities=37%  Similarity=0.663  Sum_probs=238.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .+|...++||+|.||.||+|++..+|+.||||+++...      ....||++.|+.++|+||+.++++|     .....+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            36888999999999999999999999999999996542      2235899999999999999999999     666668


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      .+|+||++.+|...++...   ..++...+..|+.++++||+|||++ .|+||||||.|+||++++ .+||+|||+|+.+
T Consensus        77 ~lVfEfm~tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDG-QLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCC-cEEeecccchhcc
Confidence            9999999999999998764   6789999999999999999999999 999999999999999998 8999999999987


Q ss_pred             ccCCCc-cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...... ...+.|.+|+|||.+.|.+.|+..+||||.|||+.||+.|.+.|++.++.+++..|.+.+|.|.++.|+.+..
T Consensus       152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            654433 3347899999999999999999999999999999999999999999999999999999999999999987754


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      -.+...+...+.......| ...++++.+|+.+||.+||.+|+||.|+|+|
T Consensus       232 lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            3333333333333333333 3478889999999999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-55  Score=402.78  Aligned_cols=243  Identities=31%  Similarity=0.530  Sum_probs=216.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+.       .+...+|+++.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            4799999999999999999999999999999998652       34456899999999999999999999     78888


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +|||.|+|. ++|..++++    .+++++..++.+++||+.||.|||++ +|+|||||..|+|++.+. .|||+|||+|.
T Consensus        93 VYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENM-NVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcC-cEEecccceee
Confidence            999999999 577777764    37899999999999999999999999 999999999999999988 79999999999


Q ss_pred             eccc-CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .+.. ++...+.+|||.|.|||++.... ++..+||||+||+||.||+|++||...+-.+.+..|...            
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------------  233 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------------  233 (592)
T ss_pred             eecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------------
Confidence            8864 46677899999999999997555 899999999999999999999999988877777777663            


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                           ++.            ++..+|.++++||.+||+.||.+|||++++|.|
T Consensus       234 -----~Y~------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 -----EYS------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -----Ccc------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 222            334589999999999999999999999999987

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-55  Score=393.17  Aligned_cols=280  Identities=37%  Similarity=0.618  Sum_probs=236.9

Q ss_pred             CCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        60 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      .+...+.|+.+++||+|.||.||+|++..+|+.||+|+++.+.      ....||+.+|++|.||||+++.+..+..   
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---  188 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---  188 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---
Confidence            4455667999999999999999999999999999999997654      2345899999999999999999987553   


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ....+|||+|||+.+|..++...   .-.|++.++..++.||+.||+|||++ ||+|||||.+|||||.++ .+||+|||
T Consensus       189 ~~~siYlVFeYMdhDL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G-~LKiaDFG  263 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDHDLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNG-VLKIADFG  263 (560)
T ss_pred             CCceEEEEEecccchhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCC-CEEecccc
Confidence            34558999999999998888753   25799999999999999999999999 999999999999999988 89999999


Q ss_pred             CceecccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          214 SAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       214 ~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      +|+++....  ..+..+.|.+|+|||.+++...|+..+|+||.||||.||++|++.|++.++.+++..|.+.+|.|..+.
T Consensus       264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            999765443  345678899999999999999999999999999999999999999999999999999999999999998


Q ss_pred             HhccC-CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMN-PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      |+... +.+..++....-...... ..+.++....+|+..||..||.+|.||.++|.+
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cccccCCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            77221 222222222111112222 245689999999999999999999999999976

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-55  Score=385.13  Aligned_cols=250  Identities=33%  Similarity=0.487  Sum_probs=208.1

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----------hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      .+.|.+.+.||+|+||.|-+|..+.+|+.||||++....           ....+|+++|++|+|||||++.+.|     
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-----  245 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-----  245 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----
Confidence            346999999999999999999999999999999985431           1224899999999999999999988     


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC--CCcEEE
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKL  209 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~--~~~vkl  209 (354)
                      ....+.||||||++| .|.+.+-..    +.+.+...+.+++||+.|+.|||++ ||+||||||+|||+..+  .-.+||
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEe
Confidence            555568999999996 777766653    6788888899999999999999999 99999999999999765  227999


Q ss_pred             EeccCceecccCCCccccccccccccchhccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Q 018514          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGT  286 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~  286 (354)
                      +|||+|+...++....+.+|||.|.|||++.+..  .+..++|||||||++|-+++|.+||.+..... ...+|.++--.
T Consensus       321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA  400 (475)
T ss_pred             cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence            9999999988777778899999999999996543  24458999999999999999999998765444 55555443111


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                               +....+..+|.++++||+.||..||++|||+.|+|+|
T Consensus       401 -------------------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  401 -------------------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             -------------------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                                     1111234589999999999999999999999999998

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-54  Score=375.71  Aligned_cols=245  Identities=30%  Similarity=0.515  Sum_probs=208.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+.+..+.||+|..|+||+|+++.+++.+|+|++..+     ++...+|+++++..+|||||+++++|+....    .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3677889999999999999999999999999999432     2334589999999999999999999976442    488


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      |+||||++ +|...++..    +++++..+..++.++++||.|||+..+||||||||+|||++..+ .|||||||.+..+
T Consensus       155 I~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~l  229 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGIL  229 (364)
T ss_pred             eehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHh
Confidence            99999995 777777654    77999999999999999999999633999999999999999988 8999999999988


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CcHHHHHHHHHHhCCCCHHHHh
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-----SGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      .+. ...+++||..|||||.+.+.. |+.++||||||++++|+.+|+.||...     +..+.+..|+..   +++.   
T Consensus       230 vnS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---ppP~---  301 (364)
T KOG0581|consen  230 VNS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---PPPR---  301 (364)
T ss_pred             hhh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---CCCC---
Confidence            666 556789999999999998776 999999999999999999999999874     334444444432   1111   


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCC-CCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                            ++.. +|+++++|+..||++||.+|||+.|+++|
T Consensus       302 ----------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  302 ----------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ----------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                                  2232 79999999999999999999999999998

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-54  Score=368.86  Aligned_cols=278  Identities=33%  Similarity=0.546  Sum_probs=243.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhh------hHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ...+|+....|++|.||.||+|+++.+++.||+|+++.+...      ..||+.+|.+++|||||.+..+...   .+-.
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d  150 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMD  150 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccc
Confidence            345799999999999999999999999999999999765432      2489999999999999999887643   3333


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .+|||||||..+|.+++..-.   +++...+++.++.|+++|++|||.+ .|+||||||+|+|++..| .+||+|||+|+
T Consensus       151 ~iy~VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G-~lKiaDFGLAR  225 (419)
T KOG0663|consen  151 KIYIVMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKG-ILKIADFGLAR  225 (419)
T ss_pred             eeeeeHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCC-cEEecccchhh
Confidence            489999999999999888653   7899999999999999999999999 999999999999999888 79999999999


Q ss_pred             ecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .+..... .+..+.|.+|+|||.+.+.+.|+...|+||+|||+.||+++++.|.+.+..+++..|++.+|.|....|+..
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            8865533 445678999999999999999999999999999999999999999999999999999999999999988765


Q ss_pred             C--CCCcccCCCCccCCCcccccCCC-CCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 N--PNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~--~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .  +....+.++..+.......|... ++....+|++.+|.+||.+|.||.++|+|
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            4  33334666666666666777664 78999999999999999999999999987

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7e-53  Score=397.80  Aligned_cols=284  Identities=53%  Similarity=1.005  Sum_probs=251.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecC---CCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT---EKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~~~~i  140 (354)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++..+.....+|+.+++.++||||++++++|....   .....++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            34799999999999999999999999999999999777666778999999999999999988775432   123456889


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      ||||+++++...+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.+++.+||+|||+|.....
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            999999999888876655567899999999999999999999998 9999999999999997765799999999987655


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.|..+.+....+.+.
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~  303 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA  303 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence            55555678899999999987766689999999999999999999999999999999999999999999998888888888


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ++.++......|...++...+.++.+||.+||++||.+|||+.|++.|
T Consensus       304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            888888777777777888899999999999999999999999999988

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-54  Score=370.19  Aligned_cols=276  Identities=41%  Similarity=0.708  Sum_probs=240.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .|...+.||.|+||.|+.|.+..+|+.||||++...      .....||+++|+.++|+||+.+.+.+.......-.-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            467789999999999999999999999999998622      23445899999999999999999988663434455589


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +|+|+|+.+|...++..    +.++...+..+++||++||.|+|+. +++||||||+|++++.+. .+||+|||+|+...
T Consensus       103 iV~elMetDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADC-DLKICDFGLARYLD  176 (359)
T ss_pred             EehhHHhhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCC-CEEeccccceeecc
Confidence            99999998988888863    4599999999999999999999998 999999999999999998 79999999999775


Q ss_pred             c---CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          220 K---GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       220 ~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .   ....+..+.|.+|.|||.+.....|+...||||.||||.||++|++.|.|.+..+++..|...+|.|..+.+....
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            4   2333567789999999999888889999999999999999999999999999999999999999999998877655


Q ss_pred             C---CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 P---NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~---~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .   ..--...+..+..+|...|+ +.++.+.+|+.+||.+||.+|+||+|+|+|
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            2   11122467778888888887 689999999999999999999999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-55  Score=364.58  Aligned_cols=254  Identities=31%  Similarity=0.496  Sum_probs=213.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEccc------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..+|++.++||.|.||.||++++..+|..+|.|.+.-      .++....|+.+|++|+|||||++++.-+.   ++...
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence            3479999999999999999999999999999998852      23444579999999999999999883322   22333


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--cCC--ceecCCCCCCeeeeCCCCcEEEEec
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--TIG--VCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~~--iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      ++||||||+ |+|...+++..+..+.+++..+++++.|++.||.++|+  . .  |+||||||.|||++.+| .|||+||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~g-vvKLGDf  172 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANG-VVKLGDF  172 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCC-ceeeccc
Confidence            789999999 69999999999999999999999999999999999999  4 4  99999999999999888 8999999


Q ss_pred             cCceecccCCCc-cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          213 GSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       213 g~a~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      |+++.+...... .+.+|||.||+||.+.+.+ |+.++||||+||++|||+.-.+||.+.+=.+.-.+|.++--+|.++ 
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~-  250 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD-  250 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH-
Confidence            999987655433 4689999999999997766 9999999999999999999999999987666666666642221111 


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                                ...|.++..+|..|+..||..||+...++..+.
T Consensus       251 --------------------------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  251 --------------------------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             --------------------------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                                      236899999999999999999999666555443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-53  Score=365.05  Aligned_cols=245  Identities=31%  Similarity=0.503  Sum_probs=211.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .++|++.++||+|+||+||+++.+.+++.+|+|++++..       .....|..+|..++||.||++...|     ++..
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence            457999999999999999999999999999999986542       3345799999999999999999888     6666


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+|+|+||+.| .|...|.+.    ..+++..++.++.+|+.||.|||+. |||||||||+|||+|.+| .|+|+|||+|
T Consensus        99 kLylVld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~G-Hi~LtDFgL~  172 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQG-HIKLTDFGLC  172 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCC-cEEEeccccc
Confidence            79999999997 777777653    7899999999999999999999999 999999999999999999 5999999999


Q ss_pred             eec-ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          216 KVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       216 ~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      +.. ..+....+.+||+.|||||++.+.+ |+..+|+||||+++|||++|.+||.+.+.......|.+.-..        
T Consensus       173 k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~--------  243 (357)
T KOG0598|consen  173 KEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP--------  243 (357)
T ss_pred             hhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC--------
Confidence            854 3445556789999999999998776 999999999999999999999999999988888888764201        


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC----CHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS----TAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp----ta~e~l~~  348 (354)
                                          ..+..++.+++++++++|+.||++|.    .+.++-+|
T Consensus       244 --------------------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  244 --------------------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             --------------------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                                11233789999999999999999996    56666555

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-52  Score=365.65  Aligned_cols=247  Identities=31%  Similarity=0.523  Sum_probs=204.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .++|.+.+.||+|+||+||+|+++.++..||||.+...      .+....|+.+|+.++|||||.++++.     ....+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence            45799999999999999999999999999999988554      23445799999999999999999998     56667


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC-C----CcEEEEe
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-T----HQLKLCD  211 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~-~----~~vkl~D  211 (354)
                      +|+|||||. |+|..++...    +.+++.+++.++.||+.||++||++ +||||||||+||||+.. .    ..+||+|
T Consensus        84 i~lVMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            999999999 5888888875    5899999999999999999999999 99999999999999764 1    2589999


Q ss_pred             ccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       212 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ||+|+.+.++....+.+|+|.|||||++.... |+.|+|+||+|+++|+|++|++||...+..+.+..+.+.-...+.  
T Consensus       159 FGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~--  235 (429)
T KOG0595|consen  159 FGFARFLQPGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV--  235 (429)
T ss_pred             cchhhhCCchhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc--
Confidence            99999998888788899999999999997555 999999999999999999999999998888877755543211111  


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                                              ++..+++...+++...|+.+|..|.+..+-..
T Consensus       236 ------------------------~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  236 ------------------------LPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             ------------------------hhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence                                    12224555556666666666666666555443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-51  Score=371.86  Aligned_cols=245  Identities=31%  Similarity=0.542  Sum_probs=216.2

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|...+.||.|+|++|++|+++.+++.||||++.+.       .....+|-.+|.+| .||.|++++..|     .|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD  145 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD  145 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence            344799999999999999999999999999999988543       23445788899999 899999999888     66


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+|+|+||++ |.|+++|.+.    +.|++..++.++.||+.||+|||++ |||||||||+|||+|.++ .+||+|||
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dm-hikITDFG  219 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDG-HIKITDFG  219 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCC-cEEEeecc
Confidence            777999999999 6888888875    7899999999999999999999998 999999999999999999 69999999


Q ss_pred             CceecccCCC--------------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 018514          214 SAKVLVKGEP--------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (354)
Q Consensus       214 ~a~~~~~~~~--------------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  279 (354)
                      .|+.+.....              ...++||..|.+||+|.... .++.+|||+|||++|+|+.|.+||.+.++...+++
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk  298 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK  298 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence            9987643211              14589999999999996554 89999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      |++.-                             -.|++++++.+.+|++++|..||.+|+|++++.+|
T Consensus       299 I~~l~-----------------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  299 IQALD-----------------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHhc-----------------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            98851                             22456789999999999999999999999999998

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6e-51  Score=375.92  Aligned_cols=272  Identities=35%  Similarity=0.587  Sum_probs=228.7

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhH---HHHHHHHHcC-C-----CCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLD-H-----PNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|.+.+.||+|.||+|.+|.+..+++.||||+++.......   .|+.+|..|+ |     -|+|+++++|     ....
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence            78999999999999999999999999999999987765544   5889999986 3     5899999999     6677


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee-CCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-PHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~-~~~~~vkl~Dfg~a  215 (354)
                      ++|||+|.+..+|.++++.+..  .+++...++.++.||+.||.+||.. ||||+||||+|||+. .+...|||+|||.|
T Consensus       262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccc
Confidence            7999999999999999998764  5699999999999999999999998 999999999999994 34447999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ......  ....+.+..|+|||++.+.+ |+.+.||||||||+.||++|.+.|++.+..++++.|+..+|.|+...+...
T Consensus       339 c~~~q~--vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFESQR--VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccCCc--ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            875443  33778899999999999888 999999999999999999999999999999999999999999999877533


Q ss_pred             CCCCcccCC-CCc---------------------------------cCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC
Q 018514          296 NPNYTEFKF-PQI---------------------------------KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  341 (354)
Q Consensus       296 ~~~~~~~~~-~~~---------------------------------~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt  341 (354)
                      ......+.- ...                                 ....|...........+.+||++||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            322222211 000                                 1222333333334467999999999999999999


Q ss_pred             HHHHhhc
Q 018514          342 AFDAVGS  348 (354)
Q Consensus       342 a~e~l~~  348 (354)
                      +.++|+|
T Consensus       496 p~qal~H  502 (586)
T KOG0667|consen  496 PAQALNH  502 (586)
T ss_pred             HHHHhcC
Confidence            9999998

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-51  Score=353.09  Aligned_cols=281  Identities=33%  Similarity=0.626  Sum_probs=233.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh------hhHHHHHHHHHcCCCC-eeecceeeeecCC-CCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPN-VVSLKHCFFSTTE-KDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~-~~~~  136 (354)
                      ..|...++||+|+||+||+|+.+.+|+.||+|+++.+..      ...+|+.+|+.++|+| |+.+.+++..... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            458888899999999999999999999999999975533      2358999999999999 9999998855431 2233


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .+++|+||+..+|..++.........++...++.+++||+.||+|||++ +|+||||||+||+|++++ .+||+|||+|+
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr  168 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSG-VLKLADFGLAR  168 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCC-cEeeeccchHH
Confidence            6889999999999999988664435677789999999999999999999 999999999999999987 89999999998


Q ss_pred             ecc-cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ... +.......++|..|+|||++.+...|+...||||+|||++||+++++.|.+.++.+++..|.+.+|.|....|+..
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            665 3344556788999999999999988999999999999999999999999999999999999999999999887654


Q ss_pred             CCCCccc-CCCCcc-CCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEF-KFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~-~~~~~~-~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..-...- .++... ...+... .+..+++..+++.+||+++|.+|.||+.+|.|
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~-~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSI-LPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccccCcCCCCccchHHh-ccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            3211110 222222 1122222 23345799999999999999999999999998

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-50  Score=370.67  Aligned_cols=243  Identities=32%  Similarity=0.515  Sum_probs=220.3

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      -|++.+.||.|+.|.|.+|++..||+..|||++...       ....++|+-+|+.+.|||+++++++|     ++..++
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~l   87 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHL   87 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceE
Confidence            499999999999999999999999999999999765       45677999999999999999999999     677779


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      |+|.||++| .|++++...    +++++..++++++||+.|+.|+|.. +|+||||||+|+|+|.++ .|||+|||.|..
T Consensus        88 ylvlEyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~-nIKIADFGMAsL  161 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKN-NIKIADFGMASL  161 (786)
T ss_pred             EEEEEecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhccc-CEeeeccceeec
Confidence            999999995 788887764    7899999999999999999999998 999999999999999988 599999999998


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      -.++.-..+.+|+|.|.|||++.+.++.+.++||||+|||||.||||+.||++.+....+.++.++.             
T Consensus       162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-------------  228 (786)
T KOG0588|consen  162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-------------  228 (786)
T ss_pred             ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-------------
Confidence            8777777889999999999999999988999999999999999999999999877777777765531             


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                          |            +++..+|+++++||.+||..||++|+|.+|+++|
T Consensus       229 ----f------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  229 ----F------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ----c------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                1            1345689999999999999999999999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-50  Score=335.05  Aligned_cols=236  Identities=29%  Similarity=0.471  Sum_probs=208.9

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      -..++|+..+.||.|+||.|.+++.+.+|..+|+|++....       +...+|-.+|+.+.||+++++++.|     .+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence            44568999999999999999999999999999999986542       2234699999999999999999888     67


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ..+++|||||.+| .+.+.++..    +++++..++.++.||+.||+|||+. +|++|||||+|||+|.+| .+||+|||
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G-~iKitDFG  189 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNG-HIKITDFG  189 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCC-cEEEEecc
Confidence            7779999999996 777777763    7899999999999999999999998 999999999999999999 59999999


Q ss_pred             CceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      .|+.....  ..+.+|||.|+|||++...+ |+.++|.|||||++|||+.|.+||...++.....+|....         
T Consensus       190 FAK~v~~r--T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~---------  257 (355)
T KOG0616|consen  190 FAKRVSGR--TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK---------  257 (355)
T ss_pred             ceEEecCc--EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc---------
Confidence            99877543  67889999999999997766 9999999999999999999999999999988888887741         


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  340 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp  340 (354)
                                          -.|+..+++++++||+++|+.|-.+|.
T Consensus       258 --------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  258 --------------------VKFPSYFSSDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             --------------------ccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence                                124456899999999999999999993

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=361.50  Aligned_cols=245  Identities=33%  Similarity=0.496  Sum_probs=211.2

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---------hhhhHHHHHHHHHcC-CCCeeecceeeeecCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  133 (354)
                      .+.|.+.+.||+|.||+|+.|.+..+|+.||+|++...         .....+|+.+++.++ ||||++++.++     .
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~-----~   90 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF-----A   90 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-----e
Confidence            45799999999999999999999999999999976442         223347999999999 99999999988     3


Q ss_pred             CeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC-CCcEEEEe
Q 018514          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCD  211 (354)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~-~~~vkl~D  211 (354)
                      ....+++|||||.| .|.+.+..    .+++.+..++.+++||+.|++|||++ ||+||||||+|||++.+ + .+||+|
T Consensus        91 t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~-~~Kl~D  164 (370)
T KOG0583|consen   91 TPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEG-NLKLSD  164 (370)
T ss_pred             cCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCC-CEEEec
Confidence            44449999999996 88888876    27889999999999999999999999 99999999999999988 6 799999


Q ss_pred             ccCceec-ccCCCccccccccccccchhccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          212 FGSAKVL-VKGEPNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       212 fg~a~~~-~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      ||++... .......+.+||+.|+|||++.+.. ..+.++||||+||+||.|++|..||...+.......|.+.      
T Consensus       165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~------  238 (370)
T KOG0583|consen  165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG------  238 (370)
T ss_pred             cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC------
Confidence            9999877 4555667889999999999998766 4578999999999999999999999997777777765442      


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCC-CHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM-PPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 .+.            ++..+ |+++.+|+++||..||.+|+|+.+++.|
T Consensus       239 -----------~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  239 -----------EFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             -----------Ccc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                       111            23346 9999999999999999999999999965

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.4e-49  Score=351.19  Aligned_cols=273  Identities=33%  Similarity=0.627  Sum_probs=224.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+|++.+.||.|+||.||+|.+..++..||+|++....     ....+|+.+++.++||||+++++++     ....+.+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence            46999999999999999999999999999999885321     2345799999999999999999987     4445689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+.++|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        80 lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~  154 (288)
T cd07871          80 LVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARAKS  154 (288)
T ss_pred             EEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEECcCcceeecc
Confidence            99999999988877653   24578899999999999999999998 999999999999999887 79999999997643


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC-
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  297 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  297 (354)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++.+.++.... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            322 223456789999999987666689999999999999999999999999998899999999999998887765432 


Q ss_pred             -CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 -NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 -~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       .+....++.....++.. ....++.++.+||++||++||.+|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         235 EEFRSYLFPQYRAQPLIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhhccccCccCCCchHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             22222233322233322 223578999999999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-50  Score=351.45  Aligned_cols=250  Identities=31%  Similarity=0.503  Sum_probs=204.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .+|...+.||+|+||.||++.+..+|+..|||.+...    .+...+|+.+|.+++|||||++++......  + ..++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeEe
Confidence            4699999999999999999999888999999988665    344678999999999999999988642221  1 46889


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC-CCCcEEEEeccCceec
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVL  218 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~-~~~~vkl~Dfg~a~~~  218 (354)
                      .|||+++ +|.+++....   ..+++..++.+++||+.||+|||++ ||+|+||||+|||++. ++ .+||+|||++...
T Consensus        94 ~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNG-DVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCC-eEEeccCcccccc
Confidence            9999995 8888887653   2699999999999999999999999 9999999999999998 46 7999999999866


Q ss_pred             cc----CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHHh
Q 018514          219 VK----GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       219 ~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ..    ........||+.|||||++.......+++|||||||++.||+||.+||... .....+..+...-         
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~---------  239 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED---------  239 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------
Confidence            53    222346789999999999975333446999999999999999999999873 3333333332210         


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                               ..         ..++..+|.++++||.+||..||.+||||.++|+|.
T Consensus       240 ---------~~---------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  240 ---------SL---------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ---------CC---------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                     01         124566899999999999999999999999999985

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.8e-49  Score=357.40  Aligned_cols=248  Identities=33%  Similarity=0.525  Sum_probs=209.3

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-------hhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|.++..||+|+||.||+|+-+.||..+|+|++++..-       ....|-.+|...++|+||+++..|     .+.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            45689999999999999999999999999999999976432       223578888889999999999999     888


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .++|+||||++| ++..+|..    .+.+++.+++.++.+++.|++.||.. |+|||||||+|+|||..| .+||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~G-HiKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKG-HIKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCC-CEeeccccc
Confidence            889999999996 66666665    37899999999999999999999998 999999999999999999 599999999


Q ss_pred             ceeccc-----------------------CCC-------------------------ccccccccccccchhccCCCCCC
Q 018514          215 AKVLVK-----------------------GEP-------------------------NISYICSRYYRAPELIFGATEYT  246 (354)
Q Consensus       215 a~~~~~-----------------------~~~-------------------------~~~~~g~~~y~aPE~~~~~~~~~  246 (354)
                      |..+..                       ...                         ....+|||.|||||++.+.. |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            854311                       000                         01457999999999998877 99


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHH
Q 018514          247 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD  326 (354)
Q Consensus       247 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  326 (354)
                      ..+|+|||||||||||.|.+||.+.++.+...+|+.+-..               +.+|          -...++.++.+
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP----------~~~~~s~eA~D  421 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFP----------EEVDLSDEAKD  421 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCC----------CcCcccHHHHH
Confidence            9999999999999999999999999999999999885210               1111          11236899999


Q ss_pred             HHHHhcCcCCCCCCC---HHHHhhc
Q 018514          327 LVSRLLQYSPNLRST---AFDAVGS  348 (354)
Q Consensus       327 ll~~~l~~dp~~Rpt---a~e~l~~  348 (354)
                      ||.+||+ ||.+|.-   ++|+.+|
T Consensus       422 LI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  422 LITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             HHHHHhc-CHHHhcCcccHHHHhcC
Confidence            9999999 9999985   7787776

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-51  Score=336.73  Aligned_cols=250  Identities=30%  Similarity=0.421  Sum_probs=214.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEccc------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..+.|.+.+.||+|.|+.||++.+..+|+.+|+|++..      +.+..++|+.+-+.|+||||+++.+.+     ....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence            34579999999999999999999999999999997742      345667899999999999999998877     6677


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC--CCCcEEEEecc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFG  213 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~--~~~~vkl~Dfg  213 (354)
                      +.|||+|++.| .|...+-.+    .-+++..+..+++||+.+|.|+|.+ ||||||+||+|+++-+  ++.-+||+|||
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccc
Confidence            78999999997 555555443    4478889999999999999999999 9999999999999943  34469999999


Q ss_pred             CceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      +|..+..+..-....|||.|||||++...+ |+..+|||+.|++||-|+.|.+||.+.+....+.+|++.--..+.    
T Consensus       159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~----  233 (355)
T KOG0033|consen  159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS----  233 (355)
T ss_pred             eEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC----
Confidence            999888666666789999999999998777 999999999999999999999999999999999998875211111    


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      .     ....+++++++|+++||..||.+|+||.|+|.|
T Consensus       234 ----------------~-----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  234 ----------------P-----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             ----------------c-----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence                            1     234589999999999999999999999999988

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-48  Score=342.89  Aligned_cols=263  Identities=27%  Similarity=0.444  Sum_probs=215.5

Q ss_pred             CCCCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           58 NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        58 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ...+.....|++.+.||.|..++||+|++..+++.||||++..+.     ....+|+..+..++||||++++.+|..   
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv---   95 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV---   95 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe---
Confidence            445556678999999999999999999999999999999996443     345689999999999999999998844   


Q ss_pred             CCeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                        +..+|+||+||. |++.+.++....  ..+++..++.+++++++||.|||.+ |.||||||+.||||+.+| .|||+|
T Consensus        96 --~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG-~VkLad  169 (516)
T KOG0582|consen   96 --DSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDG-TVKLAD  169 (516)
T ss_pred             --cceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCC-cEEEcC
Confidence              444999999999 589999988764  5599999999999999999999999 999999999999999998 899999


Q ss_pred             ccCceecccCCCc-----cccccccccccchhc-cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 018514          212 FGSAKVLVKGEPN-----ISYICSRYYRAPELI-FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  285 (354)
Q Consensus       212 fg~a~~~~~~~~~-----~~~~g~~~y~aPE~~-~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  285 (354)
                      ||.+..+......     ...+||++|||||++ .....|+.|+||||||++..||.+|..||....+.+.+..-.+  +
T Consensus       170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n  247 (516)
T KOG0582|consen  170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--N  247 (516)
T ss_pred             ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--C
Confidence            9987655433221     356899999999995 4445599999999999999999999999999888776644333  3


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .|+.....                 ....+-.+.++..++.++..||+.||++||||+++|+|
T Consensus       248 ~pp~~~t~-----------------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  248 DPPTLLTS-----------------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCCCcccc-----------------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            33311100                 00111123467899999999999999999999999987

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-49  Score=358.98  Aligned_cols=244  Identities=28%  Similarity=0.477  Sum_probs=212.0

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .|....+||+|+.|.||.|....+++.||||++...    ++...+|+.+|+..+|+|||.+++.|...     ..+|+|
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWVV  348 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWVV  348 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEEE
Confidence            588889999999999999999999999999998543    34456899999999999999999998655     338999


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||++| +|.+.+..     ..+++.+++.++++++.||+|||.+ ||+|||||.+|||++.++ .+||+|||+|..+..
T Consensus       349 MEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCC-cEEEeeeeeeecccc
Confidence            999997 65555554     4589999999999999999999999 999999999999999998 799999999987755


Q ss_pred             CC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       221 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      .. ...+.+|||+|||||++.... |+++.||||||++++||+-|.+||-..++...+..|... |.|...         
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk---------  490 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK---------  490 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC---------
Confidence            54 566889999999999995544 999999999999999999999999998888888877664 222221         


Q ss_pred             cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      .++.+|+++++||.+||+.|+.+|++|.|+|+|
T Consensus       491 ----------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 ----------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ----------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                            234589999999999999999999999999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=351.01  Aligned_cols=250  Identities=30%  Similarity=0.470  Sum_probs=205.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCce-EEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEA-VAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ...+.+.||+|+||+||++.+  .|.. ||+|++...      ...+.+|+.+|.+++|||||++++++.....    .+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~  115 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SL  115 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ce
Confidence            455667799999999999999  4556 999998643      2356789999999999999999998843321    48


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-ceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-VCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~-iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +|||||+++ +|..++...  ....++...+..++.||++||.|||++ + ||||||||+|||++.+...+||+|||+++
T Consensus       116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence            999999995 777777653  347899999999999999999999998 9 99999999999999885479999999998


Q ss_pred             ecccC-CCccccccccccccchhccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          217 VLVKG-EPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       217 ~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ..... .......||+.|||||++.+ ...|+.++||||||+++|||+||+.||.+.........+......|+      
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~------  266 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP------  266 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------
Confidence            76544 23334789999999999975 34599999999999999999999999999887555555544322222      


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                           ++...++.+..++.+||..||.+||+..+++..|+.
T Consensus       267 ---------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~  302 (362)
T KOG0192|consen  267 ---------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES  302 (362)
T ss_pred             ---------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence                                 233478999999999999999999999999988764

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-49  Score=348.52  Aligned_cols=254  Identities=30%  Similarity=0.433  Sum_probs=208.0

Q ss_pred             CCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------------------hhhHHHHHHHHHcCCCCee
Q 018514           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------------RYKNRELQTMRLLDHPNVV  121 (354)
Q Consensus        60 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------~~~~~e~~~l~~l~h~~iv  121 (354)
                      ..+...+|++.+.||+|.||.|-+|++..+++.||||++.+..                  +...+|+.+|+++.|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3445668999999999999999999999999999999884321                  2335799999999999999


Q ss_pred             ecceeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee
Q 018514          122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (354)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~-~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili  200 (354)
                      +++.+.-+   +....+|||+|||..+-   +.-.. ..++ +++.++++++++++.||+|||.+ |||||||||+|+|+
T Consensus       172 ~LiEvLDD---P~s~~~YlVley~s~G~---v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl  243 (576)
T KOG0585|consen  172 KLIEVLDD---PESDKLYLVLEYCSKGE---VKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLL  243 (576)
T ss_pred             EEEEeecC---cccCceEEEEEeccCCc---cccCC-CCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEE
Confidence            99998733   44556999999999541   11111 1234 89999999999999999999999 99999999999999


Q ss_pred             eCCCCcEEEEeccCceecccCC------CccccccccccccchhccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 018514          201 NPHTHQLKLCDFGSAKVLVKGE------PNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (354)
Q Consensus       201 ~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~g~~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~  271 (354)
                      +.++ +|||+|||.+.....+.      .....+|||.|+|||.+.+.   ...+.+.||||+||+||.|+.|..||.+.
T Consensus       244 ~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  244 SSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             cCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            9997 89999999998663321      22357899999999999763   33577999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       272 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                      ...+.+.+|+..                 ...+|.          .+.+..++++||++||++||++|.+..++..|.
T Consensus       323 ~~~~l~~KIvn~-----------------pL~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  323 FELELFDKIVND-----------------PLEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             hHHHHHHHHhcC-----------------cccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            888888888763                 111221          123689999999999999999999999998884

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.1e-47  Score=344.64  Aligned_cols=275  Identities=32%  Similarity=0.543  Sum_probs=213.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....     ....+|+.+++.++||||+++++++     .+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence            357999999999999999999999899999999985432     2345799999999999999999987     444568


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+.+++.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTG-ELKLADFGLARAK  153 (303)
T ss_pred             EEEEECCCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECCCCcceec
Confidence            999999999988877653   25688999999999999999999998 999999999999999887 7999999998754


Q ss_pred             ccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ... .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+..+ .+.+..+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            322 1223456789999999987666689999999999999999999999987544 35566666666666655443322


Q ss_pred             C--CCcccCCCCccCCCcccccC-CCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 P--NYTEFKFPQIKAHPWHKIFQ-KRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~--~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .  .+............+...+. ...++.+.+|+++||+.||++|||+.++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            1  01000111111111111111 1356889999999999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.5e-47  Score=340.43  Aligned_cols=272  Identities=38%  Similarity=0.686  Sum_probs=218.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||.||+|+++.+++.||+|++...      .....+|+.+++.++||||+++++++     ......+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            699999999999999999999999999999988643      22345799999999999999999887     4455689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+.+++...+...   ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHND-VLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence            99999998776666543   35689999999999999999999998 999999999999999887 79999999997654


Q ss_pred             cCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       220 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......|++.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+....+....+..+...+.....
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            322  122356899999999997655 89999999999999999999999999888888888888777777665543221


Q ss_pred             --CCcccCCCCc-cCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 --NYTEFKFPQI-KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 --~~~~~~~~~~-~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        .+.....+.. ....+...+...+|.++.+||++||++||++|||++++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              1111111111 11122233344578999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-47  Score=349.80  Aligned_cols=276  Identities=39%  Similarity=0.686  Sum_probs=218.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||.||+|.+..+|..||+|++...      .....+|+++++.++||||+++++++......+...++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            599999999999999999999999999999987532      12345799999999999999999987655444445689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||++++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            99999999988877653    5689999999999999999999998 999999999999999887 79999999997543


Q ss_pred             cCCC----ccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          220 KGEP----NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       220 ~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ....    .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.++...+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2211    1235689999999998542 4489999999999999999999999999888888888888888887765543


Q ss_pred             cCCCCccc---CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .......-   ........++...+ ..+++.+.++|.+||+.||++|||++++++|
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            32110000   00000001111111 2468899999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3e-47  Score=341.36  Aligned_cols=276  Identities=33%  Similarity=0.558  Sum_probs=217.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcC-CCceEEEEEcccch------hhhHHHHHHHHHc---CCCCeeecceeeeecCCCCe
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~  135 (354)
                      +|++.+.||+|+||+||+|++.. ++..||+|.+....      ....+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            69999999999999999999854 46889999875321      2234577777665   69999999998754443445


Q ss_pred             eEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..+++||||+++++.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            5689999999999888886543  24588999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .............|++.|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            8765444444567899999999996554 899999999999999999999999999988999999988887776654322


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ... ....+......+. ..+...+++.+.+++.+||+.||++|||+.++|+|
T Consensus       237 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         237 VAL-PRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hcc-cchhccCCCCCCH-HHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            110 0111111111111 12233578999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.9e-49  Score=354.50  Aligned_cols=242  Identities=32%  Similarity=0.515  Sum_probs=211.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+..      ....+|+++++.++||||+.+++.|     +...++|
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~~   77 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHLW   77 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceEE
Confidence            6888999999999999999999999999999885432      2346899999999999999999998     6667799


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +|.|||.|+|...+...    +.++++.++.++.|++.||.|||++ +|.|||+||.|||++.++ .+|+||||+|+...
T Consensus        78 vVte~a~g~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   78 VVTEYAVGDLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGG-TLKLCDFGLARAMS  151 (808)
T ss_pred             EEehhhhhhHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCC-ceeechhhhhhhcc
Confidence            99999999999988874    7799999999999999999999999 999999999999999887 79999999999876


Q ss_pred             cCCCc-cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .+... ....|||.|||||.+.+.+ |+..+|+|||||++|||++|++||...+..+....|...-              
T Consensus       152 ~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~--------------  216 (808)
T KOG0597|consen  152 TNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP--------------  216 (808)
T ss_pred             cCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC--------------
Confidence            65433 3567999999999997666 9999999999999999999999998877666666665421              


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                         .            .++...+..+.+||+.+|.+||.+|.|-.+++.|
T Consensus       217 ---v------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 ---V------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ---C------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence               0            1223579999999999999999999999999988

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=351.37  Aligned_cols=246  Identities=28%  Similarity=0.455  Sum_probs=209.1

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhh-------hHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-------KNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  133 (354)
                      ...++|++.++||+|.||+|+++..+.+++.+|||.++++.-.       ...|-+++... +||.++.++.+|     .
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----Q  439 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----Q  439 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----c
Confidence            3456899999999999999999999999999999998765432       23466666655 599999999999     6


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...++|+||||+.|+.   +.+ ....+.+++..++.|+..++.||.|||++ |||+||||.+|||+|.+| .+||+|||
T Consensus       440 T~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eG-h~kiADFG  513 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEG-HVKIADFG  513 (694)
T ss_pred             cCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccC-cEEecccc
Confidence            6777999999999874   222 22247899999999999999999999999 999999999999999999 59999999


Q ss_pred             Cceecc-cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          214 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       214 ~a~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      +++.-. .+....+.+|||.|||||++.+.. |+..+|+|||||+||||+.|..||.+.++.+.+..|...         
T Consensus       514 lcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d---------  583 (694)
T KOG0694|consen  514 LCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND---------  583 (694)
T ss_pred             cccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------
Confidence            998654 555677899999999999997665 999999999999999999999999999999998888662         


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH-----HHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----FDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta-----~e~l~~  348 (354)
                              +            ..++..+|.++.++|+++|+.+|++|.-+     .++..|
T Consensus       584 --------~------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h  624 (694)
T KOG0694|consen  584 --------E------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH  624 (694)
T ss_pred             --------C------------CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence                    1            12445589999999999999999999965     555544

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-48  Score=314.30  Aligned_cols=249  Identities=30%  Similarity=0.455  Sum_probs=217.6

Q ss_pred             CCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        60 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      .....++|.+.+.||.|.||.||+|+.+.++..||+|++.+.+       ....+|+++...|+||||++++++|     
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----   91 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----   91 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----
Confidence            4445678999999999999999999999999999999986543       3345799999999999999999999     


Q ss_pred             CCeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                      .+....|+++||.+ |.+...+....  ..++++..++.+++|++.||.|+|.+ +++||||||+|+|++.++ .+||+|
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~-~lkiAd  167 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAG-ELKIAD  167 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCC-CeeccC
Confidence            56666999999999 58888877433  46789999999999999999999998 999999999999999988 799999


Q ss_pred             ccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       212 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ||.+.... .....+.+||..|.+||+..+.. ++..+|+|++|++.||++.|.+||.+.+..+.+.+|.+.        
T Consensus       168 fGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--------  237 (281)
T KOG0580|consen  168 FGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--------  237 (281)
T ss_pred             CCceeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--------
Confidence            99997554 45566889999999999997666 899999999999999999999999998888888888773        


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                               ++.            ++..++.++.++|.+||..+|.+|.+..|++.|
T Consensus       238 ---------~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  238 ---------DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ---------ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                     222            334589999999999999999999999999987

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-46  Score=338.86  Aligned_cols=273  Identities=33%  Similarity=0.641  Sum_probs=222.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+|++.+.||+|+||.||+|++..+++.||+|.+....     ....+|+.+++.++||||+++++++.     .....+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence            46999999999999999999999899999999886332     23457999999999999999999873     344589


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+.+++.+.+...   ...++...++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  155 (309)
T cd07872          81 LVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  155 (309)
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence            99999999888777653   24578899999999999999999998 999999999999999887 79999999987543


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....++.....
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            222 2223467889999999876666899999999999999999999999999888889999999998888776544321


Q ss_pred             --CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 --YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        +..+..+......+.. ....+++++.++|.+||+.||.+|||+.|++.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         236 DEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence              1222223222222222 123478999999999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-46  Score=346.72  Aligned_cols=275  Identities=31%  Similarity=0.549  Sum_probs=217.1

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  136 (354)
                      ..+|++.+.||+|+||.||+|.+..+|..||+|++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            45799999999999999999999999999999998532      2234479999999999999999998743321 1223


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .+++||||+.+++...+.      ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus       100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~  171 (359)
T cd07876         100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  171 (359)
T ss_pred             eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEecCCCcc
Confidence            578999999998777664      3478889999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ............+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+.+.++.+.........
T Consensus       172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         172 TACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             ccccCccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            654444444567899999999996655 8999999999999999999999999988888888888888887765433221


Q ss_pred             ----------CCCcccCCCCccCCCcc----cccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 ----------PNYTEFKFPQIKAHPWH----KIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ----------~~~~~~~~~~~~~~~~~----~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                +.+....+... ...|.    .......++++.+||.+||++||++|||+.|+|.|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEEL-FPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhh-ccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                      11111110000 00110    11223357889999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-48  Score=323.34  Aligned_cols=247  Identities=26%  Similarity=0.449  Sum_probs=215.0

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------------hhhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      .|.-.+.||.|..++|.++.++.+|..+|+|++...            .+...+|+.+|+++ .||+|+++.+.|     
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence            588889999999999999999999999999988321            12223699999987 699999999998     


Q ss_pred             CCeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                      +...++++|+|.|+ |.|.+++...    -.+++...+.|++|++.|++|||.+ +||||||||+|||++++. +|||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~-~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNM-NIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeecccc-ceEEec
Confidence            66777999999999 6888888764    5789999999999999999999998 999999999999999887 799999


Q ss_pred             ccCceecccCCCccccccccccccchhcc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 018514          212 FGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  286 (354)
Q Consensus       212 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  286 (354)
                      ||+|+.+..+......+|||+|.|||.+.     +.+.|+...|+||+|++||.|+.|.+||....+.-++..|+...-.
T Consensus       167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ  246 (411)
T ss_pred             cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence            99999999998888999999999999983     4566899999999999999999999999988888888888775222


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...                    ..|     .++|...++||.+||+.||++|.|++|+|+|
T Consensus       247 F~s--------------------peW-----adis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  247 FRS--------------------PEW-----ADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             cCC--------------------cch-----hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            211                    223     3479999999999999999999999999998

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.8e-46  Score=333.18  Aligned_cols=276  Identities=29%  Similarity=0.512  Sum_probs=218.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHc---CCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|++.+.||+|+||+||+|++..+|+.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4899999999999999999999999999999885321      1234577776655   799999999987655444556


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ..+++|||+.+++...+....  ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            688999999998888776532  24589999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ............++..|+|||++.+.. ++.++|||||||++|+|++|.+||.+......+..+....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            665444444567889999999996655 8999999999999999999999999888888888888887777665443211


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .. ....+.......+ ......++..+.++|.+||++||++|||+.+++.|
T Consensus       236 ~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         236 TL-PRGAFSPRGPRPV-QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cc-cccccCCCCCCch-HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            10 0001111111111 12233578899999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3e-46  Score=334.17  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=200.6

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      |++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++|+||+++.+++     .+..+.+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence            888999999999999999999999999999875321       1234799999999999999998887     4445689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|...+....  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~  152 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRG-HIRISDLGLAVQI  152 (285)
T ss_pred             EEEEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeCCCcEEc
Confidence            99999986 6666654322  24689999999999999999999998 999999999999999887 7999999999876


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.......           
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  220 (285)
T cd05631         153 PEGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED-----------  220 (285)
T ss_pred             CCCCeecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-----------
Confidence            4444444567899999999997554 8999999999999999999999998765433333332221110           


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                    ...++..++.++.+|+++||+.||.+||+     ++++++|
T Consensus       221 --------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 --------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             --------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                          11233457899999999999999999997     8999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.3e-46  Score=343.43  Aligned_cols=276  Identities=30%  Similarity=0.519  Sum_probs=219.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  136 (354)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            45799999999999999999999999999999998642      1234579999999999999999987743221 2234


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ..++||||+++++...+.      ..++...+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus       103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCC-cEEEEeCCCcc
Confidence            578999999998877764      2478888999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+....
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            665444444567899999999996655 8999999999999999999999999999888899998888888776544332


Q ss_pred             CCC----------cccCCCC---ccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNY----------TEFKFPQ---IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~----------~~~~~~~---~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...          ..+.+..   ....++........+..+.++|.+||+.||.+|||+.++|+|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            211          1111000   001112222233356789999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3e-46  Score=344.44  Aligned_cols=276  Identities=31%  Similarity=0.537  Sum_probs=219.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  136 (354)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            45799999999999999999999889999999988542      1233479999999999999999998754322 2234


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ..++||||+++++...+.      ..++...++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~-~~kl~Dfg~~~  167 (355)
T cd07874          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  167 (355)
T ss_pred             eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCC-CEEEeeCcccc
Confidence            578999999998777664      3478888999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+...++.+..+.+....
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            665444444567899999999996654 8999999999999999999999999988888888888888888776554433


Q ss_pred             CCCcc----------cCCCCc---cCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTE----------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~----------~~~~~~---~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....          ..++..   ...++........+..+.++|.+||+.||++|||+.|+++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            21111          111100   00111122233456789999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.4e-46  Score=347.14  Aligned_cols=277  Identities=35%  Similarity=0.557  Sum_probs=219.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||+||+|.+..+|+.||+|++...      .....+|+++++.++|+||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            378899999999999999999889999999988532      12345799999999999999999987543322223689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+.+++...+..    ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence            9999999888777654    35789999999999999999999998 999999999999999887 79999999997653


Q ss_pred             cCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       220 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.++...+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  122346788999999997766689999999999999999999999999999999999999999888776543221


Q ss_pred             CCcccCCCCccCC-Cc--ccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAH-PW--HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~-~~--~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ............. .+  ...+....++++.+||.+||++||.+|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            1100000000000 00  011234468999999999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-46  Score=336.16  Aligned_cols=240  Identities=26%  Similarity=0.398  Sum_probs=202.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            699999999999999999999989999999998532       12345799999999999999998877     455678


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~  150 (291)
T cd05612          77 YMLMEYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEG-HIKLTDFGFAKK  150 (291)
T ss_pred             EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence            999999985 777777653    5688999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  .....|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+....             
T Consensus       151 ~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------  214 (291)
T cd05612         151 LRDR--TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-------------  214 (291)
T ss_pred             ccCC--cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            5332  23456899999999996655 8999999999999999999999998877666555554320             


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                      ..++..++..+.++|++||+.||.+|++     ++++++|
T Consensus       215 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 ----------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ----------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                            0123446899999999999999999995     9999988

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=345.67  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=209.3

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      .+++.+.||+|.||.||.|.++.+ ..||+|.++..   ...+.+|+.+|++|+|+|||++++++..     +..++|||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEE
Confidence            467788999999999999999533 37999988653   3445689999999999999999999843     22489999


Q ss_pred             eecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+. |+|.++|+..  ....+...+...++.|||+|++||+++ ++|||||...|||++.+. .+||+|||+|+...++
T Consensus       281 E~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence            9999 7999999873  246788999999999999999999999 999999999999999887 8999999999954443


Q ss_pred             CCccc--cccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          222 EPNIS--YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       222 ~~~~~--~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .....  ..-+..|.|||.+.... ++.++|||||||+||||+| |+.||.+.+..+.+..+.+...-|.+         
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---------  426 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---------  426 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---------
Confidence            32222  22356799999996555 9999999999999999998 99999999999999988876544433         


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                         ..+|+++.+++..||+.+|++|||.+.+...|++.
T Consensus       427 -------------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  427 -------------------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             -------------------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence                               35899999999999999999999999998887764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-47  Score=343.49  Aligned_cols=247  Identities=29%  Similarity=0.479  Sum_probs=218.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++|..++++|.|+||.+++++++.++..+++|++...      ++...+|+.++++++|||||.+.+.|.    .+..++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            4799999999999999999999999999999998533      234567999999999999999999883    344459


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +|||+||+| ++.+.++...  ...++++.+..|+.|++.|+.|||++ +|+|||||+.|||++.++ .|||+|||+|+.
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~  155 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDK-KVKLGDFGLAKI  155 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccC-ceeecchhhhhh
Confidence            999999996 7888887765  56799999999999999999999998 999999999999999988 689999999998


Q ss_pred             cccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       218 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      +.+.. ...+.+||+.||+||.+.+.+ |+.++|||||||++|||++-+++|...+-.....+|.+....|..       
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp-------  227 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP-------  227 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-------
Confidence            87776 566789999999999997666 999999999999999999999999999988888888887544433       


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                           ...+.+++.+++.||..+|..||+|.++|.+
T Consensus       228 ---------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  228 ---------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                                 3478999999999999999999999999987

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=340.53  Aligned_cols=248  Identities=33%  Similarity=0.541  Sum_probs=213.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...|.+.+.||.|.||.||+|+++.+|+.+|+|.+.+..       ....+|+.+|+++. ||||+.+.+.|     ++.
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcC
Confidence            346999999999999999999999999999999986442       35668999999998 99999999998     555


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC---CcEEEEe
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT---HQLKLCD  211 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~---~~vkl~D  211 (354)
                      ..+++|||+|.| .|.+.+...     .+++..+..++.|++.++.|||+. ||+||||||+|+|+....   ..+|++|
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEee
Confidence            579999999995 777777765     399999999999999999999998 999999999999995442   2799999


Q ss_pred             ccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       212 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ||++.....+......+||+.|+|||++...+ |+..+||||+|+++|.|++|.+||.+.+......++...-.      
T Consensus       183 FGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------  255 (382)
T KOG0032|consen  183 FGLAKFIKPGERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------  255 (382)
T ss_pred             CCCceEccCCceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC------
Confidence            99999887766677889999999999995544 99999999999999999999999999988777776655311      


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    .+....|     ..++..+++++++||..||.+|+||.++|+|
T Consensus       256 --------------~f~~~~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 --------------DFTSEPW-----DDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             --------------CCCCCCc-----cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                          1222223     4579999999999999999999999999998

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-48  Score=342.29  Aligned_cols=243  Identities=26%  Similarity=0.432  Sum_probs=205.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .|+..+.||+|.||.||+|.+..+++.||+|++..+     ....++|+.+|.+++++||.+++++|+....     +++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lwi   88 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LWI   88 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HHH
Confidence            588889999999999999999999999999998644     3445689999999999999999999965443     899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||.| ++.+.++..    ..+.+..+..++++++.||.|||.+ +.+|||||+.|||+..++ .+||+|||.+..+.
T Consensus        89 iMey~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESG-DVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHhcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccC-cEEEEecceeeeee
Confidence            9999996 666666642    4458888899999999999999999 999999999999999886 89999999997765


Q ss_pred             cCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .... ..+++|||+|||||++.+. .|+.++||||||++.+||++|.+|+....+...+..|.+..  |           
T Consensus       163 ~~~~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~--P-----------  228 (467)
T KOG0201|consen  163 NTVKRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA--P-----------  228 (467)
T ss_pred             chhhccccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC--C-----------
Confidence            4432 3678999999999999744 49999999999999999999999998877655544443311  0           


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     ..++..+|+.+++|+..||.+||+.||+|.++|+|
T Consensus       229 ---------------P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  229 ---------------PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ---------------CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                           11233578999999999999999999999999987

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-46  Score=338.97  Aligned_cols=242  Identities=29%  Similarity=0.417  Sum_probs=202.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     .+..
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence            457999999999999999999999999999999886432       2345799999999999999999988     4455


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  165 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKG-HVKVTDFGFA  165 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence            68999999985 777777653    5688999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...            
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------  230 (329)
T PTZ00263        166 KKVPDR--TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG------------  230 (329)
T ss_pred             eEcCCC--cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence            865432  23457899999999996655 799999999999999999999999877765554444321            


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                           .            ..++..++..+.+||++||+.||.+|++     +++++.|
T Consensus       231 -----~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        231 -----R------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----C------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 0            0122336899999999999999999997     7999988

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-47  Score=331.44  Aligned_cols=244  Identities=26%  Similarity=0.451  Sum_probs=217.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      -+|++.+.||+|.||.|-+|.+...|+.||||.++++.       -...+|+++|..|+||||++++.+|     ++..-
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCce
Confidence            36999999999999999999998999999999886543       2345899999999999999999998     66666


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +.|||||.. |.|++++...    +.+++..++.+++||++|+.|+|.+ +++|||||.+|||+|.++ .+||+|||++.
T Consensus       128 IvivMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~-NiKIADFGLSN  201 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNN-NIKIADFGLSN  201 (668)
T ss_pred             EEEEEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCC-Ceeeeccchhh
Confidence            999999999 5899998875    6799999999999999999999999 999999999999999988 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .+.......+++|+|-|.+||++.+.+.-++.+|.||||++||.|+.|..||++.+-..++.+|....-.          
T Consensus       202 ly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr----------  271 (668)
T KOG0611|consen  202 LYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR----------  271 (668)
T ss_pred             hhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc----------
Confidence            8877777788999999999999998887899999999999999999999999999887777777553111          


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                          ...-+.++.-||+-||..||.+|.|.+++..|+
T Consensus       272 --------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 --------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             --------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                                122468899999999999999999999999885

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-46  Score=345.28  Aligned_cols=268  Identities=23%  Similarity=0.308  Sum_probs=206.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~  144 (354)
                      .+|++.+.||+|+||.||+|.+..+++.||+|....  ....+|+++++.++||||++++++|.     .....++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEEec
Confidence            469999999999999999999999999999997643  34568999999999999999999883     34458899999


Q ss_pred             ccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC--C
Q 018514          145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--E  222 (354)
Q Consensus       145 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~--~  222 (354)
                      +.++|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++......  .
T Consensus       165 ~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        165 YKTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCC-CEEEEeCCccccccccccc
Confidence            999888777653    5688999999999999999999998 999999999999999887 7999999998653221  1


Q ss_pred             CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-------SGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       223 ~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...       +...++..+....+.++.......
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             ccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            223457899999999996654 899999999999999999999876543       234566777777666543311000


Q ss_pred             CCCCc--------ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYT--------EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~--------~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....        ...........|...  ..++.++.++|.+||++||.+||||.|+|+|
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00000        000000111122221  1257789999999999999999999999987

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.5e-46  Score=338.81  Aligned_cols=237  Identities=26%  Similarity=0.418  Sum_probs=195.3

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++     ....++++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999886432       2234689999999999999998887     44556899999


Q ss_pred             eccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc-C
Q 018514          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  221 (354)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~-~  221 (354)
                      |+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..... .
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            9986 66666654    35789999999999999999999998 999999999999999887 799999999875322 2


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  211 (323)
T ss_pred             CcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence            2333567899999999996554 899999999999999999999999876655444433221                 0


Q ss_pred             cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                  ..++..+++++.++|++||+.||++||     ++.++++|
T Consensus       212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         212 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence                        012345789999999999999999999     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.5e-45  Score=329.86  Aligned_cols=274  Identities=31%  Similarity=0.599  Sum_probs=220.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++     ....+.
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence            347999999999999999999999899999999885332     2345799999999999999999988     344568


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+.+++...+...   ...+++..++.++.||+.||+|||+. ||+|+||||+||+++.++ .++|+|||++...
T Consensus        80 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  154 (301)
T cd07873          80 TLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAK  154 (301)
T ss_pred             EEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence            999999999888877653   25688999999999999999999998 999999999999999887 7999999998754


Q ss_pred             ccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||...+..+....+...++.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            3222 122345688999999987666688999999999999999999999999888888888888888887766554322


Q ss_pred             --CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 --NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 --~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        .+.....+....... ......+++.+.++|.+||+.||.+|||++++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         235 NEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              111122222111111 12234578999999999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.7e-45  Score=327.68  Aligned_cols=273  Identities=34%  Similarity=0.535  Sum_probs=215.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||.||+|.+..+|+.+|+|.+....      ....+|+.+++.++||||+++++++     .+...++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            4899999999999999999999999999999885421      2345799999999999999999987     4455689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +++||+++++.+.+...   ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            99999999888777643   25689999999999999999999998 999999999999999887 79999999987553


Q ss_pred             cCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       220 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .... .....+++.|+|||.+.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            3221 22345688899999987766679999999999999999998877 555666677777888777777665543322


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .......+..............+++++.++|.+||+.||.+|||+++++.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            111111111111111122334578999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.3e-45  Score=326.45  Aligned_cols=274  Identities=33%  Similarity=0.588  Sum_probs=214.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|++|.||+|.+..++..||+|++....      ....+|+.+++.++||||+++++++.     +..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            4899999999999999999998899999999885321      23457999999999999999999883     445689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+.+++.+.+..... ...+++..++.++.||+.||+|||++ |++|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            9999999888877765332 35689999999999999999999998 999999999999999887 79999999987543


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+....+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            221 1223456888999999876666789999999999999999999999988877777777777776665544322111


Q ss_pred             Ccc-cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~-~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ... ..++...... .......+++++.++|++||+.||.+|||+.++++|
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         233 PDYKNTFPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHHhhccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000 0011111111 111233478999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.3e-45  Score=331.61  Aligned_cols=275  Identities=31%  Similarity=0.529  Sum_probs=206.2

Q ss_pred             EeEeeeccceEEEEEEEc--CCCceEEEEEcccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           70 ERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      .++||+|+||+||+|++.  .+++.+|+|.+....  ....+|+.+++.++||||+++++++...   .....+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence            357999999999999965  367889999886432  3356799999999999999998887542   334588999999


Q ss_pred             cccHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC---CCCcEEEEeccCcee
Q 018514          146 PETVHRVIKHHYK-----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  217 (354)
Q Consensus       146 ~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~---~~~~vkl~Dfg~a~~  217 (354)
                      ++++...+.....     ....+++..++.++.||+.||+|||++ ||+||||||+|||++.   ..+.+||+|||++..
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            9998887764321     123589999999999999999999998 9999999999999942   223799999999976


Q ss_pred             cccCC----CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHh
Q 018514          218 LVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEIIKVL  284 (354)
Q Consensus       218 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~  284 (354)
                      .....    ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+...         ...+..+....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            54322    123456799999999997766689999999999999999999999975432         35677788888


Q ss_pred             CCCCHHHHhccCCCCc------ccC---CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          285 GTPTREEIKCMNPNYT------EFK---FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~------~~~---~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +.+....+.....-..      .+.   ........+........+..+.++|++||++||.+|||++|+|+|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            8777765543321100      000   000000001011111246789999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-45  Score=336.57  Aligned_cols=274  Identities=33%  Similarity=0.581  Sum_probs=218.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  137 (354)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            47999999999999999999999999999999986432      234479999999999999999988743221 22344


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .+++++++++++...+..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~~~~~~~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCC-CEEEcCCcccee
Confidence            789999998888776653     5689999999999999999999998 999999999999999887 799999999986


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..........
T Consensus       168 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            5432  33457899999999997755689999999999999999999999998888888888888877777665433322


Q ss_pred             CCccc---CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....   ..+......+.. .....++.+.+||.+||+.||.+|||+.++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11110   011111111211 123467889999999999999999999999988

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-46  Score=323.94  Aligned_cols=248  Identities=28%  Similarity=0.456  Sum_probs=208.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..+|++++.||.|.-|+||+|+.+.++..+|+|++.+..       ...+-|.+||+.++||.++.+|+.|     +.+.
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence            347999999999999999999999999999999995432       2233588999999999999999999     7778


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      +.|++||||+| +|..+.+.  +..+.+++..++.++.+++.||+|||.. |||+|||||+||||.++| .|.|+||.++
T Consensus       151 ~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredG-HIMLsDFDLS  226 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDG-HIMLSDFDLS  226 (459)
T ss_pred             eeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCC-cEEeeecccc
Confidence            89999999997 55554443  3468899999999999999999999998 999999999999999999 5999999987


Q ss_pred             eeccc---------------------------------C-C-----------------------Cccccccccccccchh
Q 018514          216 KVLVK---------------------------------G-E-----------------------PNISYICSRYYRAPEL  238 (354)
Q Consensus       216 ~~~~~---------------------------------~-~-----------------------~~~~~~g~~~y~aPE~  238 (354)
                      .....                                 . .                       ....++||-.|.|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            54200                                 0 0                       0113568899999999


Q ss_pred             ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCC
Q 018514          239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK  318 (354)
Q Consensus       239 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (354)
                      +.+.. .+.++|+|+|||++|||+.|..||.+.+..+.+.+|+..-                 ..++..          .
T Consensus       307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-----------------l~Fp~~----------~  358 (459)
T KOG0610|consen  307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP-----------------LKFPEE----------P  358 (459)
T ss_pred             eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC-----------------CcCCCC----------C
Confidence            98877 8999999999999999999999999999999999887631                 122221          2


Q ss_pred             CCCHHHHHHHHHhcCcCCCCCCC----HHHHhhc
Q 018514          319 RMPPEAVDLVSRLLQYSPNLRST----AFDAVGS  348 (354)
Q Consensus       319 ~~s~~l~~ll~~~l~~dp~~Rpt----a~e~l~~  348 (354)
                      .++..+++||+++|.+||++|..    |.|+.+|
T Consensus       359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             cchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence            47899999999999999999998    9999887

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-45  Score=335.42  Aligned_cols=248  Identities=29%  Similarity=0.450  Sum_probs=203.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+++++.++||||+++++++     .+..+.
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999986432       2234689999999999999999887     445568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~  150 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASG-HIKLTDFGLSKG  150 (333)
T ss_pred             EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence            999999985 787777542    5688999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+........         
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------  218 (333)
T cd05600         151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---------  218 (333)
T ss_pred             ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------
Confidence            533  23356789999999999766 489999999999999999999999988776666555543211000         


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                            .+...      .....++.++.++|.+||+.+|.+||++.+++.|
T Consensus       219 ------~~~~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 ------RPVYD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ------CCCCC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                  00000      0012468999999999999999999999999988

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3e-44  Score=342.43  Aligned_cols=274  Identities=23%  Similarity=0.367  Sum_probs=208.0

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCC------CeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~  134 (354)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++...   .....|+.+++.++|.      ++++++++|..    +
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence            467999999999999999999999999999999986432   2334688888877654      57787776632    2


Q ss_pred             eeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC---------
Q 018514          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---------  205 (354)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~---------  205 (354)
                      ..++|+||++++++|.+.+...    ..+++..++.++.||+.||+|||++.|||||||||+|||++.++.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            3468899999998888877653    568999999999999999999997339999999999999986542         


Q ss_pred             ------cEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 018514          206 ------QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (354)
Q Consensus       206 ------~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  279 (354)
                            .+||+|||.+....  .......||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  49999999886432  2234567899999999997665 89999999999999999999999999988888888


Q ss_pred             HHHHhCCCCHHHHhccCCC-----CcccC--CCCccCCCcccc-----c-CCCCCHHHHHHHHHhcCcCCCCCCCHHHHh
Q 018514          280 IIKVLGTPTREEIKCMNPN-----YTEFK--FPQIKAHPWHKI-----F-QKRMPPEAVDLVSRLLQYSPNLRSTAFDAV  346 (354)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~-----~-~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l  346 (354)
                      +.+.++.++..+.......     +....  .+......+...     . ....++.+.+||.+||++||.+||||+|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            8888888776543211000     00000  000000000000     0 001246788999999999999999999999


Q ss_pred             hc
Q 018514          347 GS  348 (354)
Q Consensus       347 ~~  348 (354)
                      +|
T Consensus       437 ~H  438 (467)
T PTZ00284        437 TH  438 (467)
T ss_pred             cC
Confidence            97

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.9e-45  Score=334.87  Aligned_cols=256  Identities=23%  Similarity=0.368  Sum_probs=198.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.+++.+ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP--   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence            457999999999999999999752     345689999986432     2345799999999 899999999876432  


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhh-----------------------------------------------------
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYK-----------------------------------------------------  158 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~-----------------------------------------------------  158 (354)
                        ...+++||||+++ +|.+++.....                                                     
T Consensus        84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence              2347899999995 88877764321                                                     


Q ss_pred             -----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC---ccccccc
Q 018514          159 -----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICS  230 (354)
Q Consensus       159 -----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~  230 (354)
                           ...++++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++........   .....++
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence                 123578888999999999999999998 999999999999999887 799999999976533221   1123456


Q ss_pred             cccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccC
Q 018514          231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  309 (354)
Q Consensus       231 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (354)
                      +.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+.........                       
T Consensus       240 ~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-----------------------  295 (338)
T cd05102         240 LKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-----------------------  295 (338)
T ss_pred             ccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-----------------------
Confidence            7899999996655 8999999999999999997 99999876543333322221000                       


Q ss_pred             CCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          310 HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       310 ~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                          ...+..+++.+.+++.+||+.||.+|||+.++++.|++++
T Consensus       296 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         296 ----MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                0012346899999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.1e-45  Score=337.12  Aligned_cols=245  Identities=27%  Similarity=0.408  Sum_probs=198.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||+||+|++..+++.||+|++....       ....+|+.++..++|+||+++++++     .+..++
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            6999999999999999999999999999999986432       2344689999999999999999888     455568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||++| +|.+.+...    ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~-~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence            999999986 777777643    5789999999999999999999998 999999999999999887 799999999875


Q ss_pred             cccCC------------------------------------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHH
Q 018514          218 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (354)
Q Consensus       218 ~~~~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~el  261 (354)
                      .....                                    .....+||+.|+|||++.+.. ++.++|||||||++|||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~el  229 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHH
Confidence            42210                                    012347899999999997655 89999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCC---C
Q 018514          262 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN---L  338 (354)
Q Consensus       262 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~---~  338 (354)
                      ++|..||.+.+..+....+.......               .++.          ...+++++.++|.+|+. +|.   .
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMNWKETL---------------IFPP----------EVPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCcCcc---------------cCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence            99999998877766666654421100               0110          01368999999999775 444   4


Q ss_pred             CCCHHHHhhc
Q 018514          339 RSTAFDAVGS  348 (354)
Q Consensus       339 Rpta~e~l~~  348 (354)
                      ||+++|+++|
T Consensus       284 r~~~~ei~~h  293 (363)
T cd05628         284 APGVEEIKTN  293 (363)
T ss_pred             CCCHHHHhCC
Confidence            6899999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-45  Score=334.11  Aligned_cols=243  Identities=29%  Similarity=0.419  Sum_probs=201.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCC-ceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|.+.+.||+|+||.||+|.+..++ ..||+|.+....       ....+|+.+++.++||||+++++++     .+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~  102 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD  102 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence            3457999999999999999999876554 689999885431       2334799999999999999999988     44


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ..++++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~ikL~DFG  176 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDG-FIKMTDFG  176 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEecCC
Confidence            4568999999975 777777653    5689999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+....         
T Consensus       177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------  244 (340)
T PTZ00426        177 FAKVVDT--RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------  244 (340)
T ss_pred             CCeecCC--CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence            9986533  234567899999999996654 7999999999999999999999998877655555543310         


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                          ..++..+++.+.++|++||+.||.+|+     +++++++|
T Consensus       245 --------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 --------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                                012344789999999999999999995     89999988

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-45  Score=335.66  Aligned_cols=271  Identities=23%  Similarity=0.347  Sum_probs=202.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~  144 (354)
                      ..|++.+.||+|+||.||+|++..++..||+|+....  ....|+.+++.++||||+++++++.     .....++||||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEE-----eCCeeEEEEEc
Confidence            4699999999999999999999989999999976433  2346899999999999999999884     33457899999


Q ss_pred             ccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCc
Q 018514          145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (354)
Q Consensus       145 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~  224 (354)
                      +.+++.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.........
T Consensus       139 ~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        139 YSSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             cCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence            999988887653   35789999999999999999999998 999999999999999887 7999999999754443344


Q ss_pred             cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCc---------HHHHHHHHHHhCCCCHHHHhc
Q 018514          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESG---------VDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       225 ~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ....||+.|+|||++.+.. ++.++|||||||++|||+++. ++|.....         ...+..+...++..+......
T Consensus       214 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            4567899999999996655 899999999999999999854 44443221         223444444444333221100


Q ss_pred             cCCCC--cccCCCCccCCCc---ccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNY--TEFKFPQIKAHPW---HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~--~~~~~~~~~~~~~---~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....  ..+........++   ...-...++.++.++|.+||++||.+||||.|+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            00000  0000000000111   001112467889999999999999999999999998

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=289.50  Aligned_cols=272  Identities=35%  Similarity=0.601  Sum_probs=230.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|.-.++||+|.||+||+|+++.+++.||+|.++.+.      ....+|+.+++.++|.|||++++..     ..+.-+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence            4667789999999999999999999999999987543      3345899999999999999998876     3444488


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +|+|||...|..+....   ++.++.+.++.++.|+++||.|+|++ ++.||||||.|.+|+.++ .+||+|||+++.+.
T Consensus        78 lvfe~cdqdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ng-elkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNG-ELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhhHHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence            99999999887777654   57899999999999999999999999 999999999999999998 89999999998764


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      -.- .....+.|.+|.+|.++.+..-|+...|+||.||++.|+.. |++.|++.+..+++..|...+|.|..+.|+.+..
T Consensus       153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            332 22345669999999999999989999999999999999995 9999999999999999999999999998887654


Q ss_pred             CCcccCCCCccC-CCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      -.+....|.... ..|... -..++..-+++++++|.-+|..|++|+.+++|
T Consensus       233 lpdyk~yp~ypattswsqi-vp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQI-VPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCCcccCCccccchHHHH-hhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            444444443332 335443 34477888999999999999999999999987

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-45  Score=338.10  Aligned_cols=245  Identities=31%  Similarity=0.495  Sum_probs=199.7

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||+||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence            6999999999999999999999999999999986431       2234699999999999999999988     455668


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            999999985 777776542    5689999999999999999999998 999999999999999887 799999999875


Q ss_pred             cccCCC---------------------------------------ccccccccccccchhccCCCCCCCchhHHHHHHHH
Q 018514          218 LVKGEP---------------------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  258 (354)
Q Consensus       218 ~~~~~~---------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il  258 (354)
                      ......                                       ....+||+.|+|||++.+.. ++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHH
Confidence            422110                                       01246899999999986554 89999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCC
Q 018514          259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  338 (354)
Q Consensus       259 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~  338 (354)
                      |+|++|..||.+.+..+....+......               ..++.          ...+++++.++|++||. +|.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINWKET---------------LQFPD----------EVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcCCCc---------------cCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence            9999999999887766655554331100               00110          11368999999999997 9999


Q ss_pred             CCC---HHHHhhc
Q 018514          339 RST---AFDAVGS  348 (354)
Q Consensus       339 Rpt---a~e~l~~  348 (354)
                      |++   +.+++.|
T Consensus       284 R~~~~~~~~ll~h  296 (364)
T cd05599         284 RLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCHHHHhcC
Confidence            998   9999987

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-44  Score=321.82  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=201.3

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .|++.+.||+|+||+||++.+..+++.||+|++....       ....+|+.+++.++||||+++++++     .....+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            3889999999999999999998899999999885431       2234699999999999999998887     444568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|...+....  ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            999999985 6666655422  35689999999999999999999998 999999999999999877 799999999987


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...........|++.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+.......+...+....         
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------  221 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------
Confidence            64443334457899999999996554 89999999999999999999999987665444333333211100         


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                      ..++..++..+.+++.+||..||.+||     ++++++.|
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 ----------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ----------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                            112334789999999999999999999     89999887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-45  Score=336.49  Aligned_cols=245  Identities=31%  Similarity=0.516  Sum_probs=202.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|.+.+.||+|+||+||+|++..+|+.||+|++....       ....+|+++++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            6999999999999999999999999999999986432       2345799999999999999999887     455668


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~  150 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADG-HIKLADFGLCKK  150 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence            999999985 777777653    5789999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCC------------------------------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 018514          218 LVKGE------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  267 (354)
Q Consensus       218 ~~~~~------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  267 (354)
                      .....                              ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCCC
Confidence            54332                              123456899999999997664 89999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-HHHHh
Q 018514          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-AFDAV  346 (354)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-a~e~l  346 (354)
                      |...+.......+......               ...+.          ...+++++.++|.+||. ||.+|++ +++++
T Consensus       230 f~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         230 FYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            9887766555555431100               01111          11268999999999998 9999999 99999


Q ss_pred             hc
Q 018514          347 GS  348 (354)
Q Consensus       347 ~~  348 (354)
                      +|
T Consensus       284 ~h  285 (350)
T cd05573         284 SH  285 (350)
T ss_pred             cC
Confidence            98

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.4e-45  Score=330.80  Aligned_cols=237  Identities=26%  Similarity=0.412  Sum_probs=194.4

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      +.||+|+||.||++++..+|..||+|++....       ....+|+.+++.++||||++++++|     .....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            46999999999999999999999999986432       2234689999999999999999887     34456899999


Q ss_pred             eccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC-
Q 018514          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  221 (354)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-  221 (354)
                      |+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            9986 66655544    35689999999999999999999998 999999999999999887 7999999998753222 


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E  211 (323)
T ss_pred             CccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            2223456899999999996554 899999999999999999999999877665554444321                 0


Q ss_pred             cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                  ..++..+++++.++|.+||+.||.+|+     ++.++++|
T Consensus       212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         212 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence                        012345789999999999999999998     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.8e-45  Score=331.27  Aligned_cols=237  Identities=25%  Similarity=0.400  Sum_probs=193.9

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++.+++     .+...+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            36899999999999999999999999986432       2334689999999999999998887     44556899999


Q ss_pred             eccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC-
Q 018514          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  221 (354)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-  221 (354)
                      |+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            9986 66665544    35689999999999999999999998 999999999999999887 7999999998753222 


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D  211 (328)
T ss_pred             cccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence            2223456899999999996554 899999999999999999999999876654444333210                 0


Q ss_pred             cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                  ..++..+++++.++|++||+.||.+|+     ++.++++|
T Consensus       212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         212 ------------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             ------------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                        012345789999999999999999997     89999988

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-44  Score=335.37  Aligned_cols=249  Identities=25%  Similarity=0.425  Sum_probs=203.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++     .+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            345799999999999999999999999999999998542       12345789999999999999999887     455


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .++++||||+++ +|.+.+..     ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~~kL~DfG~  188 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCC-CEEEEeccc
Confidence            668999999985 77776653     3588999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCC--CccccccccccccchhccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKGE--PNISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +.......  ......||+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+....+..+......   
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---  265 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS---  265 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc---
Confidence            97654322  123457899999999986532   3788999999999999999999999887766655555431100   


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCC--CCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~--Rpta~e~l~~  348 (354)
                                  ..++.          ...+|.++.++|++||+.+|.+  |+|++++++|
T Consensus       266 ------------~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 ------------LTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ------------CCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                        01110          1236899999999999999988  9999999988

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-44  Score=343.08  Aligned_cols=247  Identities=29%  Similarity=0.396  Sum_probs=203.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCC-CceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .|.+.+.||+|+||.||+|.+..+ +..||+|.+....    ....+|+.+++.++||||+++++++     .....+++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEE
Confidence            599999999999999999998777 7789999764332    2345799999999999999999988     33445899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+.+ +|.+.+........++++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~  220 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS  220 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence            9999985 88888776555556789999999999999999999998 999999999999999887 79999999998664


Q ss_pred             cCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          220 KGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       220 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ....   .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+......          
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----------  289 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----------  289 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence            3321   23456899999999996654 899999999999999999999999887765555544331100          


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                        .++..++.++.++|.+||+.||++||++.+++.+
T Consensus       290 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 ------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                              0123478999999999999999999999999875

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-45  Score=338.41  Aligned_cols=245  Identities=29%  Similarity=0.479  Sum_probs=197.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||+||+|.+..+++.||||++....       ....+|+++++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence            6999999999999999999999999999999885432       2335699999999999999999988     455568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      |+||||+++ +|.+.+...    ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~-~~kl~DfGla~~  150 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGG-HIKLSDFGLSTG  150 (377)
T ss_pred             EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence            999999985 777777542    5689999999999999999999998 999999999999999887 799999999863


Q ss_pred             cccCC------------------------------------------------CccccccccccccchhccCCCCCCCch
Q 018514          218 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTAAI  249 (354)
Q Consensus       218 ~~~~~------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~  249 (354)
                      .....                                                ......||+.|+|||++.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~  229 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQEC  229 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCce
Confidence            21100                                                001246899999999996554 89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHH
Q 018514          250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  329 (354)
Q Consensus       250 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~  329 (354)
                      |||||||++|||++|..||.+.+..+.+..+.....               ...++.          ...++.++.++|.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli~  284 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLIR  284 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHHH
Confidence            999999999999999999988776665555543110               001111          1136899999999


Q ss_pred             HhcCcCCCCC---CCHHHHhhc
Q 018514          330 RLLQYSPNLR---STAFDAVGS  348 (354)
Q Consensus       330 ~~l~~dp~~R---pta~e~l~~  348 (354)
                      +||+ +|.+|   +|+.+++.|
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcC
Confidence            9998 77765   599999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=303.03  Aligned_cols=262  Identities=27%  Similarity=0.391  Sum_probs=208.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .+|++.+.||.|||+-||+++...++..+|+|++.-.    .+...+|++..++++|||+++++++............|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            3799999999999999999999999999999988533    344558999999999999999998876666556677899


Q ss_pred             EEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~--iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++|+. |+|++.+......+..+++.++..|+.++++||.+||+. .  ++||||||.|||+...+ .++|.|||.++.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSG-LPVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCC-ceEEEeccCccc
Confidence            999998 689999998877777899999999999999999999998 7  99999999999999876 899999999875


Q ss_pred             cccCCC----------ccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 018514          218 LVKGEP----------NISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  285 (354)
Q Consensus       218 ~~~~~~----------~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  285 (354)
                      ..-.-.          -....+|..|+|||.+.-  ....+.++|||||||++|.|+.|..||...         .+..+
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~Gg  249 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQGG  249 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcCC
Confidence            421111          123457888999999832  223688999999999999999999999521         11111


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                      .....      -....+.+|+          ...+|..+.++|+.||+.||.+||++.+++.+++++.
T Consensus       250 SlaLA------v~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  250 SLALA------VQNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             eEEEe------eeccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            11000      0001111221          1237899999999999999999999999999998763

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-45  Score=328.48  Aligned_cols=235  Identities=29%  Similarity=0.477  Sum_probs=192.8

Q ss_pred             eeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        73 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      ||+|+||.||+|++..+++.||+|++....       ....+|+.++++++||||+++++++     .+....++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999999999999999886421       2234689999999999999998887     4445689999999


Q ss_pred             cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC-CC
Q 018514          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  223 (354)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-~~  223 (354)
                      .+ +|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...... ..
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            86 77777654    25689999999999999999999998 999999999999999887 7999999998754222 22


Q ss_pred             ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccC
Q 018514          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  303 (354)
Q Consensus       224 ~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  303 (354)
                      .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...                    
T Consensus       150 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--------------------  208 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--------------------  208 (312)
T ss_pred             cccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--------------------
Confidence            23456899999999996654 899999999999999999999999887665554444321                    


Q ss_pred             CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC---CHHHHhhc
Q 018514          304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS---TAFDAVGS  348 (354)
Q Consensus       304 ~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp---ta~e~l~~  348 (354)
                               ...++..+++.+.++|.+||+.||.+||   ++.+++.|
T Consensus       209 ---------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         209 ---------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence                     0012345789999999999999999997   57888876

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.7e-46  Score=313.09  Aligned_cols=278  Identities=35%  Similarity=0.585  Sum_probs=222.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCC----ceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ..|++...||+|.||.||+|....++    +.+|||+++...      ...-||+.+++.++|||++.+..+|...    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            46999999999999999999655443    268999997552      2345899999999999999999888542    


Q ss_pred             eeEEEEEEeeccccHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC----CCcEEE
Q 018514          135 ELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----THQLKL  209 (354)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~----~~~vkl  209 (354)
                      +..+++++||.+-+|+..++.+.. ....++...++.|+.||+.|+.|||++ -|+||||||.||++..+    | .|||
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG-~VKI  177 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERG-RVKI  177 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccC-eeEe
Confidence            556899999999999999986553 235688899999999999999999999 89999999999999766    5 8999


Q ss_pred             EeccCceecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------cHHH
Q 018514          210 CDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---------GVDQ  276 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---------~~~~  276 (354)
                      +|||+++.+.+.-..    ...+.|.+|+|||.+.+...|+++.||||+|||+.||+|-.+.|.+..         ..++
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            999999877554322    245669999999999999999999999999999999999999997632         4578


Q ss_pred             HHHHHHHhCCCCHHHHhccCCCCcc-cCCCCccCCCcccc-----c--CCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          277 LVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKI-----F--QKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~--~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +.+|.+.+|.|....|+.+..-... .....+..+.|.+.     +  .+.-++...+|+.+||++||.+|.|++++++|
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            9999999999999988765432211 01111121222221     1  22235669999999999999999999999998

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.9e-44  Score=342.35  Aligned_cols=253  Identities=27%  Similarity=0.384  Sum_probs=206.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC---CCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~  135 (354)
                      .+|++.+.||+|+||+||+|++..+|+.||||++...      .....+|+.++..++|+||+++...+.....   ...
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            4799999999999999999999999999999988543      1234578999999999999998776643322   122


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+++||||+.+ +|.+.+.........+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~-~vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence            357899999994 88888877665567899999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccC---CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          215 AKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       215 a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      +......   .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....      
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------  262 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------  262 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------
Confidence            9765332   1223457899999999996655 89999999999999999999999987765554444332100      


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                            ..++..+++++.+++.+||+.||.+||++.+++.|
T Consensus       263 ----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        263 ----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                                  01234578999999999999999999999999987

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.9e-44  Score=328.36  Aligned_cols=240  Identities=27%  Similarity=0.435  Sum_probs=194.5

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHH---HHcCCCCeeecceeeeecCCCCee
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTM---RLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      |++.+.||+|+||.||+|.+..+|+.||+|++....       ....+|.+++   +.++||||+++++++     ....
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            788999999999999999999999999999986432       1223454444   566899999999988     4445


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..|+||||+.+ +|...+.     ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence            68999999996 5555443     25689999999999999999999998 999999999999999887 7999999998


Q ss_pred             eecccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          216 KVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       216 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ...... .......|++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..+....+....          
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------  217 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------  217 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            753222 2233467899999999996554 8999999999999999999999998877666555543310          


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                         ..++..+++.+.++|.+||+.||.+||     ++.++++|
T Consensus       218 -------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 -------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                               012344789999999999999999999     68888887

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.9e-44  Score=326.00  Aligned_cols=268  Identities=26%  Similarity=0.419  Sum_probs=200.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ++|++.+.||+|+||.||++++..+|..+|+|.+...     .....+|+++++.++||||+++++++.     +....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   79 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEIS   79 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEEE
Confidence            4799999999999999999999999999999988643     133557999999999999999999874     334588


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+++ +|.+.+...    ..+++..+..++.|++.||.|||+..+|+||||||+||+++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  154 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (331)
T ss_pred             EEeecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccc
Confidence            99999996 777777653    46889999999999999999999853699999999999999887 7999999998765


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc---
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---  295 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---  295 (354)
                      ... ......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+... +   ++.+........   
T Consensus       155 ~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~---~~~~~~~~~~~~~~~  228 (331)
T cd06649         155 IDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-I---FGRPVVDGEEGEPHS  228 (331)
T ss_pred             ccc-ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H---hcccccccccCCccc
Confidence            332 233456899999999996654 8999999999999999999999997766543322 2   222111000000   


Q ss_pred             -CCC----Ccc---cCCCC------------ccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 -NPN----YTE---FKFPQ------------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 -~~~----~~~---~~~~~------------~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       ...    ...   .....            +....-.......+++++.+||.+||++||++|||+.++++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             000    000   00000            000000000012368899999999999999999999999998

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.5e-44  Score=326.59  Aligned_cols=242  Identities=29%  Similarity=0.433  Sum_probs=196.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCC-CeeecceeeeecCCCCeeE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHP-NVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~  137 (354)
                      +|++.+.||+|+||.||+|++..+++.||+|++....       .....|..++..+.|+ +|+++++++     .+...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            4899999999999999999999999999999986432       2234688888888765 577777776     33445


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++||||+.+ +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            8999999985 776666542    5688999999999999999999998 999999999999999887 79999999986


Q ss_pred             ecc-cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            432 222233457899999999997655 8999999999999999999999998877666655553310           


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH-----HHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----FDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta-----~e~l~~  348 (354)
                                        ..++..+++++.+++++||+.||.+|+++     .++++|
T Consensus       218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                              11234578999999999999999999986     788776

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-44  Score=333.79  Aligned_cols=272  Identities=23%  Similarity=0.336  Sum_probs=207.2

Q ss_pred             ccceEEEeEeeeccceEEEEEEEc--CCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ..+|.+.+.||.|+||.||+|...  .++..||+|.+... ....+|+++++.++||||+++++++     ......+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence            346999999999999999999764  34678999988654 3345799999999999999999887     344568999


Q ss_pred             EeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||++.+++...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++......
T Consensus       165 ~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence            99999988888743    36789999999999999999999998 999999999999999887 7999999999765433


Q ss_pred             CC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCCHHHHhcc
Q 018514          222 EP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       222 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ..   .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+..   ....+..+.+.++..+.+.....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            22   23457899999999996655 8999999999999999999999997643   34566667766655443211100


Q ss_pred             C----CCCcccCCCCccCCCccccc-CCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 N----PNYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~----~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .    ..+..+.........+...+ ...++.++.++|++||++||++|||+.++|.|
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0    00000110000000111111 12467889999999999999999999999988

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-44  Score=335.09  Aligned_cols=246  Identities=28%  Similarity=0.455  Sum_probs=196.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .|++++.||+|+||+||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            5899999999999999999999999999999986432       2345799999999999999999988     445568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+++ +|.+.+...    ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            999999985 777777653    5688999999999999999999998 999999999999999887 799999998753


Q ss_pred             cccCC------------------------------------------------CccccccccccccchhccCCCCCCCch
Q 018514          218 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTAAI  249 (354)
Q Consensus       218 ~~~~~------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~  249 (354)
                      .....                                                ......||+.|+|||++.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCcc
Confidence            21000                                                011346899999999996654 89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHH
Q 018514          250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  329 (354)
Q Consensus       250 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~  329 (354)
                      |||||||++|||++|..||...+..+....+......               ...+          ....+++++.++|.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIP----------PQVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCC----------CCCCCCHHHHHHHH
Confidence            9999999999999999999887765554444321100               0011          11237899999999


Q ss_pred             HhcCc--CCCCCCCHHHHhhc
Q 018514          330 RLLQY--SPNLRSTAFDAVGS  348 (354)
Q Consensus       330 ~~l~~--dp~~Rpta~e~l~~  348 (354)
                      +|+..  +|..|+++.+++.|
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHccCcccccCCCCHHHHhcC
Confidence            96654  55559999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-43  Score=318.35  Aligned_cols=281  Identities=32%  Similarity=0.565  Sum_probs=218.3

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.+. ||||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6999999999999999999999999999999875432      23457999999995 6999999988755444344567


Q ss_pred             EEEEeeccccHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+++++.+.+...... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.+.+.+||+|||++..
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999999988887654332 45689999999999999999999998 9999999999999998344899999999875


Q ss_pred             cccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       218 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ..... ......+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+.......+....+.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            53221 12233567889999998765667999999999999999999999999988888888888877766655443221


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .......++...... .......++.++.++|.+||.+||.+|||+.+++.|
T Consensus       241 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         241 KLRDWHEFPQWKPQD-LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hccchhhcCcccchh-HHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            111111111111000 011123478999999999999999999999999987

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-44  Score=336.48  Aligned_cols=245  Identities=28%  Similarity=0.452  Sum_probs=197.3

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .|++.+.||+|+||+||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence            5999999999999999999999999999999986432       2345799999999999999999988     444568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+++ +|.+.+...    ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            999999985 777777543    5688999999999999999999998 999999999999999887 799999999743


Q ss_pred             cccC------------------------------------------------CCccccccccccccchhccCCCCCCCch
Q 018514          218 LVKG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTAAI  249 (354)
Q Consensus       218 ~~~~------------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~  249 (354)
                      ....                                                .......||+.|+|||++.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCee
Confidence            2100                                                0011246899999999996655 89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHH
Q 018514          250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  329 (354)
Q Consensus       250 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~  329 (354)
                      |||||||++|||++|++||.+.+..+....+.......               ..+          ....+++++.++|.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p----------~~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL---------------HIP----------PQAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------CCC----------CcccCCHHHHHHHH
Confidence            99999999999999999998877665555444321100               000          11247899999999


Q ss_pred             HhcCcCCCCCCC---HHHHhhc
Q 018514          330 RLLQYSPNLRST---AFDAVGS  348 (354)
Q Consensus       330 ~~l~~dp~~Rpt---a~e~l~~  348 (354)
                      +|+ .+|.+|++   +.+++.|
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcC
Confidence            986 59999997   9999887

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-43  Score=321.12  Aligned_cols=276  Identities=34%  Similarity=0.551  Sum_probs=219.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..+|++.+.||.|+||.||+|.+..+|+.||+|.+....      ....+|+.++++++|+||+++++++...   ....
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            347999999999999999999999999999999885332      1234799999999999999999887432   2245


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++||||+.+++.+.+....   ..+++..++.++.||+.||.|||+. |++||||||+||+++.++ .+||+|||.+..
T Consensus        83 ~~lv~e~~~~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~  157 (309)
T cd07845          83 IFLVMEYCEQDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKG-CLKIADFGLART  157 (309)
T ss_pred             EEEEEecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccceeee
Confidence            78999999998888776532   5689999999999999999999998 999999999999999887 799999999986


Q ss_pred             cccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       218 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ..... ......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....++...
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            64332 22233457789999998766668999999999999999999999999999999999999988887766554322


Q ss_pred             CC--CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..  ...+..+......+... ...+++.+.++|++||++||++|||+.+++.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            11  11111111111111111 12368999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=325.96  Aligned_cols=249  Identities=32%  Similarity=0.465  Sum_probs=220.4

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      +..+-|.+.+.||+|.|++|-+|++.-+|+.||||++.+..      ....+|++.|+.++|||||++|.+.     ...
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ   89 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ   89 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence            44557999999999999999999999999999999985432      3345799999999999999999987     344


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .-+|+|+|.-++ +|.+++..+.   ..+.+..+++++.||+.|+.|+|.. .+|||||||+||.+-...+-|||+|||+
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccc
Confidence            448999999985 8998887664   7899999999999999999999997 9999999999998877666899999999


Q ss_pred             ceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      +..+.++....+.+|+..|-|||++++.....+++||||||||||.|++|++||...++.+.+..|+.+...        
T Consensus       166 SNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--------  237 (864)
T KOG4717|consen  166 SNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--------  237 (864)
T ss_pred             cccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc--------
Confidence            999988888889999999999999999987788999999999999999999999999999999888775222        


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                           .+..++.+-++||..||..||.+|.+.+++..+
T Consensus       238 ---------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  238 ---------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ---------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                                 223488999999999999999999999999765

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-44  Score=336.28  Aligned_cols=245  Identities=27%  Similarity=0.415  Sum_probs=197.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+++++.++|+||+++++.+     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            599999999999999999999999999999998542       22345799999999999999999887     445568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|..
T Consensus        77 ~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            999999985 787777653    5688999999999999999999998 999999999999999887 799999999743


Q ss_pred             cccC--------------------------------------------CCccccccccccccchhccCCCCCCCchhHHH
Q 018514          218 LVKG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTAAIDIWS  253 (354)
Q Consensus       218 ~~~~--------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Diws  253 (354)
                      ....                                            .......||+.|+|||++.+.. ++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeee
Confidence            2100                                            0001246899999999996555 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcC
Q 018514          254 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ  333 (354)
Q Consensus       254 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~  333 (354)
                      |||++|+|++|+.||.+.+..+....+......               ...          .....+++++.++|.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~----------~~~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHI----------PSQAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccC----------CCCCCCCHHHHHHHHHHh-
Confidence            999999999999999887765554443321000               000          011247899999999977 


Q ss_pred             cCCCCCC---CHHHHhhc
Q 018514          334 YSPNLRS---TAFDAVGS  348 (354)
Q Consensus       334 ~dp~~Rp---ta~e~l~~  348 (354)
                      .+|.+|+   |+.+++.|
T Consensus       284 ~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         284 CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             cCHhhcCCCCCHHHHhCC
Confidence            5999999   99999988

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-45  Score=303.01  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=211.1

Q ss_pred             CCCCCCCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhh-----hHHHHHHHHH-cCCCCeeecceeee
Q 018514           55 GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-----KNRELQTMRL-LDHPNVVSLKHCFF  128 (354)
Q Consensus        55 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~e~~~l~~-l~h~~iv~~~~~~~  128 (354)
                      ++....+....+...+..||+|..|+||+++.+.+|..+|||.+......     ....+.++.. .+.|+||+.+++|.
T Consensus        82 ~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   82 GGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             cCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            33334444455677888999999999999999999999999999654322     2234444433 35899999999996


Q ss_pred             ecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEE
Q 018514          129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (354)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vk  208 (354)
                      ...+     .+|.||.|...+..+++...   +++++..+-++...+++||.||.++.||+|||+||+|||+|..| .||
T Consensus       162 ~n~d-----V~IcMelMs~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niK  232 (391)
T KOG0983|consen  162 TNTD-----VFICMELMSTCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIK  232 (391)
T ss_pred             eCch-----HHHHHHHHHHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEE
Confidence            6544     77899999877777777654   67999999999999999999998876999999999999999988 799


Q ss_pred             EEeccCceecccCCCccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhC
Q 018514          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLG  285 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~  285 (354)
                      |||||++.++.+...+....|-+.|||||.+..  ...|+.++||||||++++||.||..||.+. .+.+.+..+.+...
T Consensus       233 lCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP  312 (391)
T KOG0983|consen  233 LCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP  312 (391)
T ss_pred             eecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC
Confidence            999999999988888888899999999999953  456899999999999999999999999884 45566666655211


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       |..                         ....++|+.+++|+..||+.|+.+||...++|+|
T Consensus       313 -P~L-------------------------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 -PLL-------------------------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             -CCC-------------------------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence             111                         0123489999999999999999999999999998

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-43  Score=322.29  Aligned_cols=273  Identities=31%  Similarity=0.526  Sum_probs=203.1

Q ss_pred             eEeeeccceEEEEEEEcC--CCceEEEEEcccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeecc
Q 018514           71 RVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP  146 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~  146 (354)
                      .+||+|+||+||+|++..  ++..||+|.+....  ....+|+.+++.++||||+++++++...   .....++||||++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeeeC
Confidence            579999999999999653  56789999886542  2456799999999999999999987542   3345789999999


Q ss_pred             ccHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee----CCCCcEEEEeccCcee
Q 018514          147 ETVHRVIKHHYK-----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKV  217 (354)
Q Consensus       147 ~~l~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~----~~~~~vkl~Dfg~a~~  217 (354)
                      +++...+.....     ....+++..++.++.||+.||.|||+. ||+||||||+||++.    .++ .+||+|||++..
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~  161 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKIADMGFARL  161 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCC-cEEEeeccceec
Confidence            998887764321     123588999999999999999999998 999999999999993    333 799999999986


Q ss_pred             cccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHh
Q 018514          218 LVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEIIKVL  284 (354)
Q Consensus       218 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~  284 (354)
                      ......    .....+|+.|+|||++.+...++.++|||||||++|+|+||.+||.....         ...+..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            543321    22356789999999997766689999999999999999999999975432         34566677777


Q ss_pred             CCCCHHHHhccCCCCc--c----cCCCCccCC---CcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          285 GTPTREEIKCMNPNYT--E----FKFPQIKAH---PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~--~----~~~~~~~~~---~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +.+....+........  .    +........   ..........+..+.++|.+||+.||.+|||+.|+|+|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            7666655543221100  0    000000000   00011112346789999999999999999999999987

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.6e-44  Score=332.54  Aligned_cols=249  Identities=27%  Similarity=0.440  Sum_probs=201.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...+|++.+.||+|+||.||+|++..+++.+|+|++...       .....+|+.+++.++||||+++++++     .+.
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            345799999999999999999999999999999988532       22345799999999999999999988     455


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .++++||||+++ +|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~-~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEEeccc
Confidence            668999999985 78777753     3578999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCC--ccccccccccccchhccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~~~--~~~~~g~~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +........  .....||+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+....+..+.......  
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--  266 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL--  266 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc--
Confidence            986543221  23457899999999986532   37889999999999999999999998877666665554421100  


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCC--CCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~--Rpta~e~l~~  348 (354)
                                   .++.          ...++..+.+++..||+.++.+  |+|+.++++|
T Consensus       267 -------------~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 -------------NFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -------------CCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                         0110          1136899999999999865544  8999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-43  Score=317.30  Aligned_cols=272  Identities=39%  Similarity=0.723  Sum_probs=222.3

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||.||+|.+..+|..||+|++....      ....+|+.+++.++||||+++++++     .+..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            4899999999999999999998899999999886432      2445799999999999999999987     4455689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +|+||++++|.+.+....   ..+++..++.++.||+.||+|||+. |++|+||||+||+++.++ .++|+|||.+....
T Consensus        76 ~v~e~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            999999778888876543   6689999999999999999999998 999999999999999877 79999999987664


Q ss_pred             cCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          220 KGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       220 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  .....++..|+|||.+.+...++.++||||||+++|+|++|.+||.+.++...+..+...++.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            4331  23456788999999987666678999999999999999999999998888888888888888887766554321


Q ss_pred             --CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 --NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 --~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        .+....++......|... ....+..+.++|++||+.||++|||+++++.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEI-FPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHh-CCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              222223333333333322 23467999999999999999999999999988

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-45  Score=333.37  Aligned_cols=251  Identities=18%  Similarity=0.283  Sum_probs=198.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ....+...||+|.||+||+|+|  .| .||||++..+      -+.+++|+.++++-+|.||+-+.|++     ....+ 
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~w--hG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~~-  462 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRW--HG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPPL-  462 (678)
T ss_pred             HHhhccceeccccccceeeccc--cc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCce-
Confidence            3567889999999999999998  44 3999998643      24567899999999999999999988     33333 


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .||+.+|.| +|+.++....   ..|.....+.|++||+.|+.|||.+ +|||||||..|||+.+++ +|||+|||++..
T Consensus       463 AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~-kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDL-KVKIGDFGLATV  537 (678)
T ss_pred             eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCC-cEEEecccceee
Confidence            899999998 7888777654   6788899999999999999999999 999999999999999886 899999999864


Q ss_pred             cc---cCCCccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          218 LV---KGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       218 ~~---~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ..   .+.......|...|||||+++-  ...|++++||||||+++|||++|..||...+....+-.+-++...+.... 
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~-  616 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK-  616 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh-
Confidence            31   2222334566778999999853  33489999999999999999999999984443333333322222222211 


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                             .....++++++|+..||.+++++||+..++|..|+.++
T Consensus       617 -----------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  617 -----------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             -----------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence                                   12346789999999999999999999999999776654

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.9e-44  Score=326.42  Aligned_cols=237  Identities=28%  Similarity=0.483  Sum_probs=192.8

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||+||+|++..+++.||+|++....       ....+|..++..+ +||||+++++++     .+...+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999986432       2233577777766 699999999988     4445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc-
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~-  220 (354)
                      ||+++ +|...+..    ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            99996 66666554    25689999999999999999999998 999999999999999887 799999999875422 


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~----------------  212 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----------------  212 (320)
T ss_pred             CCcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            22333457899999999996554 8999999999999999999999998877666555543310                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH------HHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------FDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta------~e~l~~  348 (354)
                                   ..++..++.++.++|++||+.||.+||++      ++++.|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 -------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                         01223478999999999999999999998      777776

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-44  Score=330.82  Aligned_cols=247  Identities=25%  Similarity=0.425  Sum_probs=201.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|.+.+.||+|+||+||+|++..+|+.||+|++....       ....+|+.+++.++|+||+++++++     .+..+.
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence            6999999999999999999999999999999986432       2345789999999999999998887     445568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+++ +|.+++...   ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~  151 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTG-HIKLADFGSAAR  151 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence            999999975 787777654   25789999999999999999999998 999999999999999887 799999999986


Q ss_pred             cccCCCc--cccccccccccchhccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          218 LVKGEPN--ISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       218 ~~~~~~~--~~~~g~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      .......  ....||+.|+|||++..     ...++.++|||||||++|+|++|..||...+....+..+......    
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~----  227 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF----  227 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc----
Confidence            6433222  23468999999999853     334788999999999999999999999887766665555432000    


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 ..++.          ...+++++.++|++||+ +|.+|||+.+++.|
T Consensus       228 -----------~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         228 -----------LKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -----------cCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                       00110          12378999999999998 99999999999987

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.4e-44  Score=329.45  Aligned_cols=237  Identities=27%  Similarity=0.421  Sum_probs=193.4

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+++++.++||||+++.+++     .....+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986431       2234688899999999999998887     44456899999


Q ss_pred             eccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc-
Q 018514          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (354)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~-  220 (354)
                      |+.+ +|...+..    ...+++..++.++.||+.||+|||+ . ||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~-~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKD  149 (325)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCCCCeEEECCCC-CEEEecCCCCeecCCC
Confidence            9996 66655543    3568999999999999999999997 6 999999999999999887 799999999875432 


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------  211 (325)
T cd05594         150 GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------  211 (325)
T ss_pred             CcccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            22223456899999999996654 899999999999999999999999876654444433221                 


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                      .            ..++..+++++.++|++||+.||++|+     ++.++++|
T Consensus       212 ~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 E------------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             C------------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            0            012345789999999999999999997     99999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7e-44  Score=318.03  Aligned_cols=243  Identities=22%  Similarity=0.324  Sum_probs=193.4

Q ss_pred             eeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        73 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      ||+|+||+||++.+..+|+.+|+|.+....       .....|+++++.++|+||+++.+++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999986432       2234689999999999999998877     4445589999999


Q ss_pred             cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC-
Q 018514          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  223 (354)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~-  223 (354)
                      ++ +|...+.........+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            85 67666654433456789999999999999999999998 999999999999999877 799999999976544322 


Q ss_pred             ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccC
Q 018514          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  303 (354)
Q Consensus       224 ~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  303 (354)
                      .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+........               
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  217 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS---------------  217 (280)
T ss_pred             ccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC---------------
Confidence            22356889999999997654 89999999999999999999999976543322222222110000               


Q ss_pred             CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       304 ~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                ..++..++..+.+++.+||+.||++||     |++++++|
T Consensus       218 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         218 ----------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             ----------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence                      012345789999999999999999999     88999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4e-44  Score=327.37  Aligned_cols=247  Identities=28%  Similarity=0.437  Sum_probs=195.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccch--------hhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 018514           66 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  133 (354)
                      +|++.+.||+|+||+||+|++.   .+++.||+|++....        ....+|+.+++.+ .|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4899999999999999999864   468899999885421        2234689999999 599999998887     4


Q ss_pred             CeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEec
Q 018514          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      ....+++||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCC-CEEEeeC
Confidence            45568999999986 777776542    5689999999999999999999998 999999999999999887 7999999


Q ss_pred             cCceecccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          213 GSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       213 g~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      |++.......  ......||+.|+|||++.+...++.++|||||||++|+|++|..||...........+......    
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  225 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----  225 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence            9997643322  2234578999999999976655789999999999999999999999754322211111111000    


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                           ....++..+++.+.++|.+||+.||++||     +++++++|
T Consensus       226 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 ---------------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                                 00112345789999999999999999999     78899987

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.2e-44  Score=351.48  Aligned_cols=256  Identities=29%  Similarity=0.408  Sum_probs=205.4

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ....+|++.+.||.|+||+||+|++..++..+|+|.+...      ...+.+|+.+++.++||||++++++|...   ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence            3445799999999999999999999999999999987532      23345799999999999999999987543   23


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc------CCceecCCCCCCeeeeCC-----
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT------IGVCHRDIKPQNLLVNPH-----  203 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~------~~iiH~Dlkp~Nili~~~-----  203 (354)
                      ..+||||||+.+ +|...+.........+++..++.|+.||+.||+|||+.      .+|+||||||+||||+.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            458899999985 88888877655557899999999999999999999984      049999999999999642     


Q ss_pred             -----------CCcEEEEeccCceecccCCCccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 018514          204 -----------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (354)
Q Consensus       204 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~  271 (354)
                                 ...+||+|||++.............||+.|+|||++.+. ..++.++|||||||++|+|++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                       124899999999866444334456789999999998643 34789999999999999999999999876


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       272 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +....+..........                            .....+.++.+||..||+.+|.+||++.++|.|
T Consensus       247 ~~~~qli~~lk~~p~l----------------------------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        247 NNFSQLISELKRGPDL----------------------------PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CcHHHHHHHHhcCCCC----------------------------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            6555444333211000                            012357899999999999999999999999976

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-43  Score=326.22  Aligned_cols=276  Identities=32%  Similarity=0.559  Sum_probs=218.0

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  136 (354)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+...      .....+|+.+++.++||||++++++|..... .+..
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            35799999999999999999999999999999988532      1233469999999999999999998754321 2234


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ..++||||+.+++...+..      .++...+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        95 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~  166 (353)
T cd07850          95 DVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  166 (353)
T ss_pred             cEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCccce
Confidence            5789999999988877653      278889999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ............+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+...++.++.+......
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            765444334456788999999996654 8999999999999999999999999988888888888888888776544322


Q ss_pred             CCCcccC--CCCccCCCccc------------ccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFK--FPQIKAHPWHK------------IFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~--~~~~~~~~~~~------------~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....+.  .+......+..            ..+...+..+.++|.+||+.||++|||+.|+|.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111110  00000011111            1122356789999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.8e-44  Score=319.44  Aligned_cols=276  Identities=36%  Similarity=0.596  Sum_probs=222.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .+|++.+.||.|+||.||+|.+..+++.+|+|.++...      ....+|+.+++.++||||+++++++...   +....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            46999999999999999999999899999999886432      1234699999999999999999887442   22568


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+.++|.+.+....   ..+++..++.++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++...
T Consensus        82 ~lv~e~~~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRG-ILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcCcCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence            9999999998888776543   3689999999999999999999998 999999999999999887 7999999999866


Q ss_pred             ccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ... .......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+....+..+....+.+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            443 2223455688899999987665578999999999999999999999999888888888888888887776654321


Q ss_pred             --CCcccCCCCccCCCcccccCCC-CCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 --NYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 --~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        ..............+...++.. +++.+.++|++||+.||++|||+.|++.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence              1111111222222333344444 68999999999999999999999999987

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-43  Score=326.18  Aligned_cols=246  Identities=26%  Similarity=0.352  Sum_probs=192.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ...+|+..+.||+|+||+||+|++..+|+.||||++...     .....+|+++++.++|+||+++++++     .+...
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~  146 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE  146 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence            345799999999999999999999999999999998543     23345799999999999999999987     44556


Q ss_pred             EEEEEeecccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++||||+.++ |..        ....++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       147 ~~lv~e~~~~~~L~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DfG~~~  216 (353)
T PLN00034        147 IQVLLEFMDGGSLEG--------THIADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAK-NVKIADFGVSR  216 (353)
T ss_pred             EEEEEecCCCCcccc--------cccCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEcccccce
Confidence            89999999974 321        13456778889999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCC-CccccccccccccchhccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          217 VLVKGE-PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       217 ~~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ...... ......||..|+|||.+...    ...+.++|||||||++|+|++|+.||......+....+.......    
T Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----  292 (353)
T PLN00034        217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----  292 (353)
T ss_pred             ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----
Confidence            654322 22345789999999987432    224568999999999999999999997433222211111110000    


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                           .......++.++.+||.+||+.||++|||+.|+++|
T Consensus       293 ---------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 ---------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                 001223478999999999999999999999999998

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=323.89  Aligned_cols=276  Identities=35%  Similarity=0.637  Sum_probs=217.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...     .....+|+.+++.++|+||+++++.+...........+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            5799999999999999999999999999999988532     12234699999999999999999876544434445689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +++||+.+++.+.+..     ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus        85 lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~  157 (336)
T cd07849          85 IVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD  157 (336)
T ss_pred             EEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence            9999999988776653     5689999999999999999999998 999999999999999887 79999999987653


Q ss_pred             cCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          220 KGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       220 ~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .....    ....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+...++.+..+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32211    23467889999999866555899999999999999999999999988877788888887887776655432


Q ss_pred             CCCCcccC---CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFK---FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~---~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ........   .+.....+|.. ....++.++.++|.+||+.||.+|||+.++++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNK-LFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHH-HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            21111000   11111111211 122468899999999999999999999999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.5e-44  Score=324.29  Aligned_cols=242  Identities=29%  Similarity=0.415  Sum_probs=196.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-------hhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      +|++.+.||+|+||.||+|++..+++.||+|++.....       ....|..++..+ .|++|+++.+++     .+...
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            48899999999999999999999999999999865321       223466777766 578899988887     44456


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++||||+++ +|...+...    ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            8999999985 776666542    5688999999999999999999998 999999999999999887 79999999987


Q ss_pred             eccc-CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            5432 22233457899999999997655 8999999999999999999999998877666655554320           


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH-----HHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----FDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta-----~e~l~~  348 (354)
                                        ..++..++.++.+++.+||+.||.+|+++     .++++|
T Consensus       218 ------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         218 ------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                              01234578999999999999999999984     677766

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.2e-43  Score=313.10  Aligned_cols=272  Identities=35%  Similarity=0.651  Sum_probs=211.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++|+|++++++++     ......+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEEE
Confidence            6999999999999999999999899999999875321      2345799999999999999999988     3445588


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+++++...+...   ...+++..++.++.||+.||+|||+. |++|+||||+||+++.++ .++|+|||++....
T Consensus        77 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07847          77 LVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQG-QIKLCDFGFARILT  151 (286)
T ss_pred             EEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCC-cEEECccccceecC
Confidence            99999998655554332   34689999999999999999999998 999999999999999887 79999999998764


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ... ......++..|+|||.+.+...++.++||||||+++|+|++|.+||.+.+..+....+.+.++.............
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            433 2223457788999999876566889999999999999999999999988877777777776665544322211110


Q ss_pred             --CcccCCCCccC-CCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 --YTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 --~~~~~~~~~~~-~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        +.....+.... .++. .....++..+.+|+.+||+.||++|||+.+++.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         232 QFFKGLSIPEPETREPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccCCCcccccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence              01111111100 0111 1123478999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-43  Score=314.58  Aligned_cols=272  Identities=36%  Similarity=0.612  Sum_probs=214.6

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      |++.+.||+|+||.||+|.+..+++.+|+|++....     ....+|+.+++++. |+|++++++++...   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            678899999999999999999899999999886431     12236888888885 99999999987442   1245799


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      ||||+.+++.+.+....   ..+++..++.++.|++.||+|||+. |++||||+|+||+++. + .+||+|||++.....
T Consensus        78 v~e~~~~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            99999998888776532   5689999999999999999999998 9999999999999998 5 899999999987654


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC-C
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y  299 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  299 (354)
                      ........++..|+|||.+.....++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+........... .
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444444567889999998765555789999999999999999999999998888888888888777776553322111 1


Q ss_pred             cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..+.++...... .......++..+.++|.+||++||++|||+.+++.|
T Consensus       232 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         232 MNYNFPSKKGTG-LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccCccccccc-HHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            111111111111 111223578999999999999999999999999987

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-44  Score=340.26  Aligned_cols=251  Identities=26%  Similarity=0.471  Sum_probs=201.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcC-CCCeeecce-eeeecCCCC-eeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKH-CFFSTTEKD-ELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~-h~~iv~~~~-~~~~~~~~~-~~~~  138 (354)
                      ++++.+.|.+|||+.||+|++...|..||+|++....    +...+|+++|++|+ |+|||.+++ ........+ ...+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            6899999999999999999998888999999885432    33458999999997 999999999 443333334 4567


Q ss_pred             EEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~--iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .|.||||. |+|.+++..+...  .|++.++++|++|+++|+++||.. .  |||||||-+||||+.++ ..||||||.+
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g-~~KLCDFGSa  193 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADG-NYKLCDFGSA  193 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCC-CEEeCccccc
Confidence            79999999 5999999987754  499999999999999999999986 6  99999999999999888 7999999998


Q ss_pred             eecccCCCc----------cccccccccccchhcc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 018514          216 KVLVKGEPN----------ISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (354)
Q Consensus       216 ~~~~~~~~~----------~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  283 (354)
                      +........          ....-|+.|+|||++.  .....++|+|||||||+||.||....||.......    |.. 
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Iln-  268 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILN-  268 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEe-
Confidence            654322211          1234589999999983  23347999999999999999999999997653321    111 


Q ss_pred             hCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                      ..+.+|.          ...++..+.+||+.||+.||.+||++-++++++-.
T Consensus       269 ----------------g~Y~~P~----------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  269 ----------------GNYSFPP----------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             ----------------ccccCCC----------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                            1122222          13478999999999999999999999999988643

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-43  Score=331.40  Aligned_cols=270  Identities=25%  Similarity=0.331  Sum_probs=202.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|....  ....+|++++++++|+||+++++++..     ....++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence            3469999999999999999999999999999996432  234579999999999999999988733     344789999


Q ss_pred             eccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC
Q 018514          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (354)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~  223 (354)
                      ++.++|...+....   ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++........
T Consensus       241 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KYRSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWS  315 (461)
T ss_pred             ccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCC-CEEEcccCCceecccccc
Confidence            99998888876532   4689999999999999999999998 999999999999999887 799999999976533221


Q ss_pred             ---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCCHHH--
Q 018514          224 ---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREE--  291 (354)
Q Consensus       224 ---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~--  291 (354)
                         .....||+.|+|||++.+.. ++.++|||||||++|||++|..|+....       -...+.++++.........  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence               22356899999999997655 8999999999999999999876543321       1234444544433221110  


Q ss_pred             ------HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 ------IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                            .............+......|....  .++.++.+||++||++||.+|||+.|+|+|
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                  0000000000111222222343221  367899999999999999999999999998

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5e-44  Score=325.15  Aligned_cols=237  Identities=28%  Similarity=0.454  Sum_probs=194.0

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||.||+|++..+++.||+|++....       .....|.++++.+ +||||+++++++     .+...+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            36899999999999999999999999986532       1233577788765 799999999988     4445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc-
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~-  220 (354)
                      ||+.+ +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            99986 776666542    5688999999999999999999998 999999999999999887 799999999875432 


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~----------------  212 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD----------------  212 (321)
T ss_pred             CccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            22233456899999999986554 8999999999999999999999999887766665554310                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-------CHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-------TAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-------ta~e~l~~  348 (354)
                                   ..++..++.++.++|++||+.||.+|+       ++.++++|
T Consensus       213 -------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 -------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                         012223689999999999999999999       89999987

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.3e-43  Score=316.39  Aligned_cols=272  Identities=37%  Similarity=0.630  Sum_probs=216.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh---------hhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.+.....         ...+|+++++.++|+||+++++++     .+..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence            48899999999999999999988999999999864321         234689999999999999999988     3355


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +.++||||+.++|.+.+....   ..+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            689999999778888876532   3689999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ....... .....+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.++.+.+..+...++.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            6644322 223356778999999866566789999999999999999999999888888888888887777776665433


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...............+.. ......+..+.++|.+||++||++|||+.+++.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLK-QIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccccCCcchh-hhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            222111111111111111 1223468899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7e-44  Score=324.43  Aligned_cols=237  Identities=28%  Similarity=0.469  Sum_probs=193.1

Q ss_pred             eEeeeccceEEEEEEEc---CCCceEEEEEcccch--------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           71 RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +.||+|+||.||+|++.   .+++.||+|++....        ....+|+.+++.++||||+++++++     .....++
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence            67999999999999864   468899999886421        2234699999999999999999887     3444689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQG-HVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence            99999996 77666654    35678889999999999999999998 999999999999999887 7999999998754


Q ss_pred             ccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+....             
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-------------  216 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-------------  216 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            322 2233456899999999996654 7899999999999999999999998877655554443310             


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                      ..++..+++.+.++|++||+.||++||     ++.++++|
T Consensus       217 ----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 ----------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                            012334789999999999999999999     89999887

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8e-44  Score=329.57  Aligned_cols=250  Identities=27%  Similarity=0.448  Sum_probs=200.7

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...+|++.+.||+|+||.||+|++..+++.+|+|++...       .....+|..+++.++||||+++++++     .+.
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  115 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            345899999999999999999999999999999988532       12345789999999999999999887     445


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .++++||||+++ +|.+++..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~-~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCC-CEEEEeCCc
Confidence            668999999985 77777653     3588999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCC--CccccccccccccchhccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKGE--PNISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +.......  ......||+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+......   
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---  265 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---  265 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc---
Confidence            98664322  123457899999999986432   3788999999999999999999999887766655555432110   


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCC--CCCHHHHhhcc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAFDAVGSF  349 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~--Rpta~e~l~~l  349 (354)
                                  ..++.          ...++..+.++|.+||..++.+  |+++.++++|.
T Consensus       266 ------------~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         266 ------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ------------ccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                        01110          1247899999999999844433  78999999984

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.2e-43  Score=315.28  Aligned_cols=273  Identities=34%  Similarity=0.611  Sum_probs=214.7

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||.|++|.||+|++..+|..||+|.+..+.      ....+|++++++++||||+++++++     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            4899999999999999999999899999999886432      2345799999999999999999987     3445689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+.+++...+....  ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++ .+||+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            999999988877776532  35689999999999999999999998 999999999999999887 79999999987553


Q ss_pred             cCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .... .....++..|+|||.+.+...++.++||||||+++|+|+||+.||.+.+......++.+..+.+....++.....
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            3221 223346788999999876665788999999999999999999999998888888888888887765543211100


Q ss_pred             C-cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 Y-TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~-~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      . ....++........ .....+++++.++|.+||+.||.+|||+.+++.|
T Consensus       232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         232 PDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0 00001111111111 1123478999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-45  Score=330.09  Aligned_cols=239  Identities=24%  Similarity=0.391  Sum_probs=201.6

Q ss_pred             EEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeecc-
Q 018514           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-  146 (354)
Q Consensus        68 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-  146 (354)
                      .-++.||+|+.|.||+|+.  .++.||||+++.-   .+-+++-|++|+||||+.+.+++     ....++|||||||. 
T Consensus       127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el---kETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL---KETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhhccCcccceeeeec--cCceehhHHHhhh---hhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccc
Confidence            3457899999999999987  7789999988543   33577889999999999999998     67788999999999 


Q ss_pred             ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCccc
Q 018514          147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS  226 (354)
Q Consensus       147 ~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~  226 (354)
                      |-|...|+..    .+++......|..+|+.|+.|||.+ .|||||||.-||||..+. .|||+|||.++..........
T Consensus       197 GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMS  270 (904)
T KOG4721|consen  197 GQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMS  270 (904)
T ss_pred             ccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhh
Confidence            6788888764    6778888899999999999999999 999999999999999887 799999999988776666678


Q ss_pred             cccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCC
Q 018514          227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  306 (354)
Q Consensus       227 ~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (354)
                      +.||..|||||++.+.+ .+.|+|||||||+|||||||..||..-+....+    =                       .
T Consensus       271 FaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w-----------------------G  322 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W-----------------------G  322 (904)
T ss_pred             hhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeE----E-----------------------e
Confidence            89999999999998777 899999999999999999999999754421110    0                       1


Q ss_pred             ccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          307 IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       307 ~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      .......-..+..++.-|+-||++||+..|..||+..+++.||+
T Consensus       323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            11122222345568899999999999999999999999999986

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6e-43  Score=314.18  Aligned_cols=275  Identities=34%  Similarity=0.585  Sum_probs=214.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++|++.+.||.|++|+||+|.+..+|+.||+|.+....      ....+|+++++.++||||+++++++     .+..+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence            36999999999999999999998899999999885421      2345799999999999999999988     344568


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+++++...+....  ...+++..++.++.||+.||+|||++ +++|+||+|+||+++.++..+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            9999999988887775432  23467888999999999999999998 99999999999999866557999999999754


Q ss_pred             ccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ..... .....+++.|+|||.+.+...++.++||||||+++|+|++|.+||...+..+.+.++....+.+....+.....
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            33221 22345688899999987655578999999999999999999999998888888888888777776655432211


Q ss_pred             CCccc-CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~-~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..... ..+..... ........+++++.+++.+||+.||++||++.++++|
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        234 LPDYKSAFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             chhhhhhcccCCCC-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            10000 00000000 0011234578999999999999999999999999987

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-43  Score=321.98  Aligned_cols=237  Identities=30%  Similarity=0.474  Sum_probs=189.9

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHH-cCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||.||+|++..+++.||+|+++...       .....|..++.. .+||||+++++++     ....++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            36999999999999999999999999886532       122345556654 4899999999887     4445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||++| +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            99985 77666654    25689999999999999999999998 999999999999999887 7999999999754332


Q ss_pred             C-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      . ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------------  212 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR----------------  212 (316)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            2 233457899999999996655 8999999999999999999999998877655554442210                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH-HHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF-DAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~-e~l~~  348 (354)
                                   ..++..++.++.++|.+||+.||++||++. ++++|
T Consensus       213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                         012334789999999999999999999865 66665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.4e-43  Score=321.68  Aligned_cols=237  Identities=29%  Similarity=0.475  Sum_probs=193.1

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||+||+|.+..+++.||+|++....       ....+|..+++.+ +||||+++++++     .+...+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999986532       2234677888877 699999999987     4445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc-
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~-  220 (354)
                      ||+.+ +|...+..    ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            99986 66666554    25789999999999999999999998 999999999999999887 799999999865322 


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ........|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            22233456899999999996655 899999999999999999999999877655554444321                 


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH-----HHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----FDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta-----~e~l~~  348 (354)
                                  ...++..++..+.++|++||+.||.+|||+     .++++|
T Consensus       212 ------------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         212 ------------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                        001233478999999999999999999999     999887

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.7e-43  Score=317.97  Aligned_cols=258  Identities=19%  Similarity=0.266  Sum_probs=197.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcC----------------CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeec
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLE----------------TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  123 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~  123 (354)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|.+....     ....+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            479999999999999999998642                34479999886431     234579999999999999999


Q ss_pred             ceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 018514          124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK---------------MSQRMPLIYVKLYFYQICRALAYIHNTIG  187 (354)
Q Consensus       124 ~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~  187 (354)
                      ++++..     ....++||||+.+ +|.+.+.....               ....+++..+..++.||+.||.|||+. |
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~  158 (304)
T cd05096          85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-N  158 (304)
T ss_pred             EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-C
Confidence            998833     3447999999985 88877754321               113467788999999999999999998 9


Q ss_pred             ceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-
Q 018514          188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  263 (354)
Q Consensus       188 iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-  263 (354)
                      |+||||||+|||++.++ .+||+|||++........   .....++..|+|||++.+.. ++.++||||||+++|+|++ 
T Consensus       159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHc
Confidence            99999999999999887 799999999976543321   11234477899999986554 8999999999999999986 


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH
Q 018514          264 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  342 (354)
Q Consensus       264 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta  342 (354)
                       +..||.+.+..+.+..+...........                     ....+..++..+.+++.+||+.||.+|||+
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQGRQV---------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhccccc---------------------cccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence             5678887766555544433211100000                     000123468899999999999999999999


Q ss_pred             HHHhhccCc
Q 018514          343 FDAVGSFDS  351 (354)
Q Consensus       343 ~e~l~~l~~  351 (354)
                      .++.+.|++
T Consensus       296 ~~i~~~l~~  304 (304)
T cd05096         296 SDIHAFLTE  304 (304)
T ss_pred             HHHHHHHhC
Confidence            999988764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-43  Score=321.65  Aligned_cols=237  Identities=27%  Similarity=0.468  Sum_probs=190.6

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHH-cCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||.||+|++..+|+.||+|.+....       .....|..++.. ++||||+++++++     .+..++++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986432       223356777765 4899999999888     4455689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+.+ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||++......
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            99986 77666654    25688999999999999999999998 999999999999999887 7999999998743222


Q ss_pred             -CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                       .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~----------------  212 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT----------------  212 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Confidence             2233467899999999996654 8999999999999999999999998776655444432210                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH-HHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF-DAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~-e~l~~  348 (354)
                                   ..++..++.++.++|++||+.||++||++. ++++|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         213 -------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                         012233789999999999999999999984 67655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-43  Score=328.00  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=198.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCC-----ceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      .++|.+.+.||+|+||.||+|.+...|     ..||+|.+....     ....+|+.+++.+ +|+||+++++++     
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-----  111 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC-----  111 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence            457999999999999999999875443     579999986432     2345799999999 899999999987     


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhh-----------------------------------------------------
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYK-----------------------------------------------------  158 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~-----------------------------------------------------  158 (354)
                      ......++||||+.+ +|.+++.....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            344458999999985 88887754321                                                     


Q ss_pred             -------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCc-
Q 018514          159 -------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-  224 (354)
Q Consensus       159 -------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~-  224 (354)
                                   ...++++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++......... 
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence                         123578888999999999999999998 999999999999999876 7999999999765433211 


Q ss_pred             --cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcc
Q 018514          225 --ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (354)
Q Consensus       225 --~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (354)
                        ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||........+..+......               
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~---------------  333 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ---------------  333 (374)
T ss_pred             eccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC---------------
Confidence              1123456799999996555 8999999999999999997 99999876544433333321100               


Q ss_pred             cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                  ...+..+++++.+++.+||+.||.+|||+.++++.|+.++
T Consensus       334 ------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         334 ------------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ------------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                        0012236899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-43  Score=320.14  Aligned_cols=237  Identities=28%  Similarity=0.469  Sum_probs=190.5

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHH-cCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||+||+|++..+++.||+|++....       .....|..++.. ++||||+++++++     .+...+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999886532       223356777765 4899999999887     3444589999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+++ +|...+...    ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 ey~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            99985 777776542    5688999999999999999999998 999999999999999887 7999999998754222


Q ss_pred             -CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                       .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------------  212 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN----------------  212 (316)
T ss_pred             CCceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Confidence             2233457899999999996655 8999999999999999999999998877655444432210                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH-HHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF-DAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~-e~l~~  348 (354)
                                   ..++..++.++.++|.+||+.||++||++. +++.|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         213 -------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             -------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence                         001223688999999999999999999997 77665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.5e-43  Score=325.92  Aligned_cols=254  Identities=22%  Similarity=0.322  Sum_probs=197.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEE-----cCCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      ..+|++.+.||+|+||+||+|++     ..++..||+|+++...     ....+|+.+++.+ +||||+++++++     
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----  108 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----  108 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            34799999999999999999975     3456789999885432     2345799999999 899999999988     


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhh-----------------------------------------------------
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYK-----------------------------------------------------  158 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~-----------------------------------------------------  158 (354)
                      .+....++||||+++ +|.+.+.....                                                     
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            344457899999995 88887764321                                                     


Q ss_pred             ------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          159 ------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       159 ------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                                        ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~  266 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGR-ITKICDFGLARDIRN  266 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence                              012478888999999999999999998 999999999999999876 799999999976543


Q ss_pred             CCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          221 GEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       221 ~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ....   ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||........+.+......           
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-----------  334 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-----------  334 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-----------
Confidence            3211   1223456799999996655 8999999999999999998 8899987654444333322100           


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                      ....+...+.++.+++.+||+.||++|||+.++++.|+..
T Consensus       335 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 ----------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ----------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                            0001123578999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=311.91  Aligned_cols=273  Identities=33%  Similarity=0.611  Sum_probs=212.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+....     ....+|+++++.++|+||+++++++     .+..+.+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence            57999999999999999999998899999999885432     2234799999999999999999987     4455689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+.++|.+.+....   ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus        80 lv~e~~~~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~  154 (291)
T cd07844          80 LVFEYLDTDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence            999999998888776542   4688999999999999999999998 999999999999999887 79999999986542


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ... ......++..|+|||.+.+...++.++||||+|+++|+|++|..||.... ..+.+..+.+..+.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            211 11223467889999998765558899999999999999999999997765 4566667777777776665543322


Q ss_pred             CC--cccCCCCccCCCcccccCCCCC--HHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NY--TEFKFPQIKAHPWHKIFQKRMP--PEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~--~~~~~~~~~~~~~~~~~~~~~s--~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..  .....+.......... ...++  .++.+++.+||+.||++|||+.+++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINH-APRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccccccCChhHHHh-CcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            11  1111111111111111 11234  889999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9e-44  Score=323.75  Aligned_cols=237  Identities=27%  Similarity=0.434  Sum_probs=189.7

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccchh-------hhHHHHH-HHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||+||+|++..+|+.||+|++.....       ...+|.. +++.++||||+++++++     .+....++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            469999999999999999999999999864321       1123333 56789999999998887     3445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            99996 67666654    35789999999999999999999998 999999999999999887 7999999998753222


Q ss_pred             -CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                       .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------  212 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP----------------  212 (323)
T ss_pred             CCccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             2233456899999999996655 8999999999999999999999998877655555443310                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH----HHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----FDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta----~e~l~~  348 (354)
                                   ..+...+++.+.++|++||+.||.+||++    .++++|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         213 -------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence                         01223468999999999999999999998    477765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.4e-43  Score=310.72  Aligned_cols=249  Identities=33%  Similarity=0.556  Sum_probs=201.0

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhh------hHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      |++.+.||+|+||+||++++..+++.+|+|.+......      ..+|+.++++++||||+++++.+..     ....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            88999999999999999999999999999998654321      2348999999999999999998844     455789


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec-
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-  218 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~-  218 (354)
                      ||||+.+ +|.+.+..    ...++...+..++.||+.||++||++ ||+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             cccccccccccccccc----cccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccccc
Confidence            9999998 88888873    36789999999999999999999998 999999999999999777 7999999999763 


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..........++..|+|||++.....++.++||||||+++|+|++|..||...........+.+............    
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  225 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ----  225 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc----
Confidence            2223334567789999999986344589999999999999999999999988744444444433322222111000    


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                        ....+..+.++|++||+.||++|||+.++++|
T Consensus       226 ------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  226 ------------------SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             ------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ------------------cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                              01123899999999999999999999999987

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.3e-43  Score=313.17  Aligned_cols=247  Identities=26%  Similarity=0.391  Sum_probs=197.4

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      |++.+.||+|+||+||++.+..+++.+|+|.+....       ....+|+.+++.++|+|++++.+.+     ......+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence            788899999999999999999999999999875431       2234699999999999999998887     3445689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|.+.+....  ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~  152 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHG-HIRISDLGLAVHV  152 (285)
T ss_pred             EEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeccceeec
Confidence            99999985 7777665432  24689999999999999999999998 999999999999999887 7999999999765


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..........|+..|+|||++.+.. ++.++||||||+++|+|++|..||..................            
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------------  219 (285)
T cd05630         153 PEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------  219 (285)
T ss_pred             CCCccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------------
Confidence            4443334457899999999996655 899999999999999999999999865432111111110000            


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                   ....+...+++++.+++++||+.||++|||     ++++++|
T Consensus       220 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         220 -------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             -------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                         001123447899999999999999999999     8999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.9e-43  Score=322.31  Aligned_cols=238  Identities=25%  Similarity=0.450  Sum_probs=189.1

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||.||+|++..+++.||+|+++...       ....+|..+++.+ +||||+++++++     .+...+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46999999999999999999999999986431       2234688888888 799999999988     4445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc-c
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K  220 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~-~  220 (354)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.... .
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            99986 66666544    25799999999999999999999998 999999999999999887 79999999987532 2


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHHHH
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  292 (354)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.....        .+.+.+....         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            23334567899999999996654 89999999999999999999999963211        1111111110         


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC------HHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST------AFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt------a~e~l~~  348 (354)
                                       .  ...++..++..+.++|++||+.||.+|+|      +.++++|
T Consensus       220 -----------------~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         220 -----------------K--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -----------------C--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                             0  00123457899999999999999999997      6888877

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.7e-43  Score=311.46  Aligned_cols=247  Identities=24%  Similarity=0.354  Sum_probs=199.8

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      |+..+.||+|+||+||+|.+..+++.+|+|.+....       ....+|+++++.++|+||+++.+++     ......+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence            788899999999999999999999999999885421       2235699999999999999998887     3445689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++|||+.+ +|...+....  ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~  152 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYG-HIRISDLGLAVKI  152 (285)
T ss_pred             EEEEeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCC-CEEEecCCcceec
Confidence            99999996 6665554322  34689999999999999999999998 999999999999999887 7999999999765


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..........|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.........+........          
T Consensus       153 ~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----------  221 (285)
T cd05632         153 PEGESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----------  221 (285)
T ss_pred             CCCCcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----------
Confidence            4443334557899999999996655 89999999999999999999999987665444433333211110          


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                     ..+...++.++.+|+.+||+.||++||+     +.+++.|
T Consensus       222 ---------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         222 ---------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ---------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                           0123447899999999999999999999     8888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-43  Score=320.04  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=198.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||+||++++..+++.||+|++...       .....+|..+++.++|+||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence            699999999999999999999999999999998642       12345688899999999999999888     445568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  151 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNG-HIRLADFGSCLR  151 (331)
T ss_pred             EEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence            999999975 787777543   35689999999999999999999998 999999999999999887 799999999876


Q ss_pred             cccCCCc--cccccccccccchhccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          218 LVKGEPN--ISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       218 ~~~~~~~--~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .......  ....||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+..+....+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------  225 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------  225 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------
Confidence            5433221  23468999999999863    23478899999999999999999999988766555554433110      


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCC--CCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~--Rpta~e~l~~  348 (354)
                               .+.++.         ....++..+.++|++||+.++.+  |+++.++++|
T Consensus       226 ---------~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         226 ---------HFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ---------cccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                     000110         11237899999999999765444  8899999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-43  Score=316.67  Aligned_cols=278  Identities=36%  Similarity=0.602  Sum_probs=211.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcC--CCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|.+.+.||+|+||.||+|.+..  ++..||+|.+....       ....+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            48899999999999999999988  78999999987632       3345799999999999999999988432   235


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC----CCCcEEEEe
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP----HTHQLKLCD  211 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~----~~~~vkl~D  211 (354)
                      .+++||||+++++.+.+........ .+++..++.++.||+.||.|||+. +|+||||||+||+++.    ++ .+||+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            6899999999988887765544333 789999999999999999999998 9999999999999998    66 799999


Q ss_pred             ccCceecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---------HHHH
Q 018514          212 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---------DQLV  278 (354)
Q Consensus       212 fg~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~  278 (354)
                      ||++........    .....++..|+|||.+.+...++.++|||||||++|+|++|.+||.+....         ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876533222    123456888999999877666899999999999999999999999765432         3456


Q ss_pred             HHHHHhCCCCHHHHhccCCC--Ccc----cCCCCccCCCcccccC--CCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          279 EIIKVLGTPTREEIKCMNPN--YTE----FKFPQIKAHPWHKIFQ--KRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~~~--~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+...++.+....+......  +..    ..............+.  ...+..+.+++.+||++||++|||+.++++|
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            66666666665544321111  000    0000000000001111  2578899999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-43  Score=327.74  Aligned_cols=245  Identities=27%  Similarity=0.420  Sum_probs=197.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||+||+|++..+++.||+|++....       ....+|+.++..++||||+++++.+     .+..++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999986421       2334689999999999999999887     455668


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||++| +|.+.+...    ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~-~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence            999999986 777777643    5689999999999999999999998 999999999999999887 799999999864


Q ss_pred             cccCC------------------------------------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHH
Q 018514          218 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (354)
Q Consensus       218 ~~~~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~el  261 (354)
                      .....                                    ......||+.|+|||++.+.. ++.++|||||||++|||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel  229 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeec
Confidence            42110                                    011346899999999996655 89999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC
Q 018514          262 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  341 (354)
Q Consensus       262 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt  341 (354)
                      ++|..||.+.+.......+......               ..++.          ...+++++.++|.+|+ .||.+|++
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~  283 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMNWKET---------------LVFPP----------EVPISEKAKDLILRFC-TDSENRIG  283 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCCc---------------eecCC----------CCCCCHHHHHHHHHhc-cChhhcCC
Confidence            9999999887776665555431100               00110          0126899999999987 49999995


Q ss_pred             ---HHHHhhc
Q 018514          342 ---AFDAVGS  348 (354)
Q Consensus       342 ---a~e~l~~  348 (354)
                         +.++++|
T Consensus       284 ~~~~~ei~~h  293 (360)
T cd05627         284 SNGVEEIKSH  293 (360)
T ss_pred             CCCHHHHhcC
Confidence               7888887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9.6e-43  Score=311.12  Aligned_cols=273  Identities=34%  Similarity=0.636  Sum_probs=217.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +|++.+.||.|++|.||+|++..+|..||+|.+...     .....+|+.+++.++|+||+++++++.     +....++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence            489999999999999999999999999999988643     233457999999999999999999883     3445799


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      ||||+++++.+.+..... ...+++..+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            999999988887765432 34689999999999999999999998 999999999999999887 799999999875432


Q ss_pred             CC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       221 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      .. ......++..|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+....+......+....+.... ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            21 12234568889999998776667899999999999999999999999988888888888877777766554332 11


Q ss_pred             ccc--CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 TEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 ~~~--~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..+  ..+......+ ..+...++..+.+++.+||+.||.+||++.++++|
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         232 PEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             chhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            111  1111111111 11223468899999999999999999999999986

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.2e-43  Score=320.60  Aligned_cols=277  Identities=36%  Similarity=0.644  Sum_probs=218.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .+|.+.+.||+|+||+||+|++..+++.||+|.+...      .....+|+.+++.++|+||+++++++...........
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4699999999999999999999999999999987532      2234469999999999999999998754433333458


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++++||+.++|.+.+..    ...+++..+..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++...
T Consensus        85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~  158 (337)
T cd07858          85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTT  158 (337)
T ss_pred             EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECcCcccccc
Confidence            99999999988877764    35689999999999999999999998 999999999999999887 7999999999765


Q ss_pred             ccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ... .......++..|+|||.+.....++.++|||||||++|+|++|.+||.+.+.......+....+.+..+.+.....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            433 1223446788899999986554589999999999999999999999998887788888888888777665432211


Q ss_pred             CCccc---CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....   ..+......+. .....+++++.++|++||+.||++|||++++++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            10000   00111111111 1223578999999999999999999999999998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=303.70  Aligned_cols=255  Identities=28%  Similarity=0.386  Sum_probs=206.7

Q ss_pred             cccceEEE-eEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEE
Q 018514           63 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        63 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .+++|++. ++||-|-.|.|..|.++.+|+.+|+|++.. .....+|+++-=.. .|||||.++++|.. ...+..++.|
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rkcLLi  136 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYEN-SYQGRKCLLI  136 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCceeeEe
Confidence            45567765 579999999999999999999999998754 44456788774443 79999999998743 3357788999


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC--CCcEEEEeccCcee
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKV  217 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~--~~~vkl~Dfg~a~~  217 (354)
                      |||.+.| .|++.+..+.  .+.+++..+..|++||+.|+.|||+. +|.||||||+|+|....  +..+||+|||+|+.
T Consensus       137 VmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEecccccccc
Confidence            9999996 7777776654  36799999999999999999999998 99999999999999543  22699999999987


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCHHHHh
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG----VDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ........+.+.||+|.|||++ +...|+...|+||+||+||-|++|.+||.+...    ..+-.+|....-.++.+.|.
T Consensus       214 t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs  292 (400)
T KOG0604|consen  214 TQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS  292 (400)
T ss_pred             cCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence            6655556677889999999999 445599999999999999999999999987542    23344444433333333322


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                               .+|++++++|+.+|..+|++|.|+.++++|
T Consensus       293 -------------------------~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  293 -------------------------CVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -------------------------HHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                                     379999999999999999999999999987

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.7e-43  Score=312.05  Aligned_cols=244  Identities=17%  Similarity=0.219  Sum_probs=197.0

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      ..||+|+++.||+|.+  +|+.||+|.+....       ....+|+.++++++||||+++++++.... .+..++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5799999999999998  78899999986432       23458999999999999999999875422 23445889999


Q ss_pred             eccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCC
Q 018514          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (354)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~  222 (354)
                      |+.+ +|.+.+...    ..+++.....++.|++.||.|||+..+++||||||+||+++.++ .+||+|||++...... 
T Consensus       103 y~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~-  176 (283)
T PHA02988        103 YCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP-  176 (283)
T ss_pred             eCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc-
Confidence            9996 787777653    56888899999999999999999743899999999999999887 7999999998754322 


Q ss_pred             CccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcc
Q 018514          223 PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (354)
Q Consensus       223 ~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (354)
                       .....++..|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......+              
T Consensus       177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  241 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--------------  241 (283)
T ss_pred             -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence             2345678899999998652 458999999999999999999999998877655555443321110              


Q ss_pred             cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                   .++...++.+.+++.+||+.||++|||+.++++.|+.
T Consensus       242 -------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        242 -------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             -------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence                         0122368999999999999999999999999998865

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.7e-44  Score=293.03  Aligned_cols=304  Identities=29%  Similarity=0.541  Sum_probs=248.3

Q ss_pred             CCCCCCchhhccccccccccccceeecCCCCCCceeEEeecCCCCCCCccccceEEEeEeeeccceEEEEEEEcCCCceE
Q 018514           14 VGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAV   93 (354)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v   93 (354)
                      .+++|+-.++|..+.++.++.|..+.+-.                    ..++|++.+++|+|.|+.||.|.+..+++.+
T Consensus         7 ~s~ARvya~vn~~rp~eYWdYE~~~i~wg--------------------~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~   66 (338)
T KOG0668|consen    7 PSVARVYADVNEERPREYWDYESLVIDWG--------------------NQDDYEIVRKVGRGKYSEVFEGINITNNEKC   66 (338)
T ss_pred             chhhhhhhhccccCchhhcchhheeeecc--------------------ccchHHHHHHHcCccHhhHhcccccCCCceE
Confidence            56688889999999999998887655332                    2247999999999999999999998999999


Q ss_pred             EEEEcccc-hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHH
Q 018514           94 AIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY  171 (354)
Q Consensus        94 avK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~  171 (354)
                      +||+++.- .....+|+.+|+.|. ||||+++++...+..   .....+|+||....-...+      ...++...++.+
T Consensus        67 ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---SktpaLiFE~v~n~Dfk~l------y~tl~d~dIryY  137 (338)
T KOG0668|consen   67 VIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKTPSLIFEYVNNTDFKQL------YPTLTDYDIRYY  137 (338)
T ss_pred             EEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccCchhHhhhhccccHHHH------hhhhchhhHHHH
Confidence            99998653 455679999999997 999999998875433   3345789999997433222      256788899999


Q ss_pred             HHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhH
Q 018514          172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDI  251 (354)
Q Consensus       172 ~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di  251 (354)
                      +.|+++||.|+|+. ||+|||+||.|++||.....++|+|||+|.+..++..-.-.+.+..|--||.+-..+.|+..-|+
T Consensus       138 ~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~  216 (338)
T KOG0668|consen  138 IYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDM  216 (338)
T ss_pred             HHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHH
Confidence            99999999999998 99999999999999998889999999999988877766677889999999999888889999999


Q ss_pred             HHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHh-----ccCCCCcccCCCCccCCCcccccCC----CCC
Q 018514          252 WSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIK-----CMNPNYTEFKFPQIKAHPWHKIFQK----RMP  321 (354)
Q Consensus       252 wslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~----~~s  321 (354)
                      |||||++..|++.+.| |.+.++.+++..|.+.+|......+.     .+.+.+.++ .+.....+|..-++.    -++
T Consensus       217 WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~  295 (338)
T KOG0668|consen  217 WSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDI-LGRHSRKPWSRFINSENQHLVS  295 (338)
T ss_pred             HHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhH-hhccccccHHHhCCccccccCC
Confidence            9999999999998766 56788999999999998876654331     122333221 233455566654432    367


Q ss_pred             HHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          322 PEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       322 ~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +++.+|+.++|.+|.++|+||+|+++|
T Consensus       296 peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  296 PEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             hHHHHHHHHHHhhccccccchHHHhcC
Confidence            999999999999999999999999988

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2e-43  Score=321.80  Aligned_cols=237  Identities=25%  Similarity=0.411  Sum_probs=189.4

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccchh-------hhHHH-HHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRE-LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||+||+|++..+++.||+|++.....       ...+| ..+++.++||||+++++++     .....+++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            369999999999999999999999999864321       11123 3356778999999998887     4445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc-
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~-  220 (354)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            99996 67666654    35688899999999999999999998 999999999999999887 799999999875422 


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------------  212 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP----------------  212 (325)
T ss_pred             CCCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------------
Confidence            22233557899999999996654 8999999999999999999999998877666555543310                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH----HHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF----DAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~----e~l~~  348 (354)
                                   ..+...++..+.++|.+||+.||.+|+++.    ++++|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~  251 (325)
T cd05602         213 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNH  251 (325)
T ss_pred             -------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence                         012234789999999999999999999987    55554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=306.12  Aligned_cols=245  Identities=27%  Similarity=0.480  Sum_probs=199.7

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|.+.+.||+|++|.||+|.+..+++.+|+|.+....         ....+|++++++++||||+++++++     .+..
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDDE   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccCC
Confidence            5999999999999999999998899999999875321         2345799999999999999999988     3444


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++|+||+++ +|.+.+...    ..+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~-~~~l~dfg~~  151 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  151 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence            68999999986 777776643    4688999999999999999999998 999999999999999877 7999999998


Q ss_pred             eecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       216 ~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .........    ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+....       
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------  223 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-------  223 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-------
Confidence            765332211    2345678899999997655 8999999999999999999999998765544433332210       


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                          ....++..++..+.++|++||..+|.+|||+.++++|.
T Consensus       224 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         224 --------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             --------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                                01123345789999999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.1e-43  Score=318.65  Aligned_cols=268  Identities=25%  Similarity=0.395  Sum_probs=198.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....     ....+|+++++.++||||+++++++..     ..+++
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   79 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   79 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence            47999999999999999999999999999999875431     235579999999999999999998843     34589


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|.+.+...    ..+++..+..++.|++.||.|||+..+|+|+||||+||+++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~  154 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (333)
T ss_pred             EEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhh
Confidence            99999985 888777653    46889999999999999999999743799999999999999887 7999999998755


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC-
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  297 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  297 (354)
                      ... ......|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||......... .+.   +.+.......... 
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~---~~~~~~~~~~~~~~  228 (333)
T cd06650         155 IDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMF---GCPVEGDPAESETS  228 (333)
T ss_pred             hhh-ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHh---cCcccCCccccccC
Confidence            332 223456889999999996554 899999999999999999999999765543222 111   1111100000000 


Q ss_pred             -----------CCcccCCCCcc--------CCCccccc-CCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 -----------NYTEFKFPQIK--------AHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 -----------~~~~~~~~~~~--------~~~~~~~~-~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 .+.....+...        .......+ ...++.++.+||.+||++||++|||+.|++.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                       00000000000        00000001 12367899999999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.4e-44  Score=323.28  Aligned_cols=237  Identities=27%  Similarity=0.448  Sum_probs=192.5

Q ss_pred             eEeeeccceEEEEEEEc---CCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      +.||+|+||.||++++.   .+|+.+|+|++....      ....+|++++++++||||+++++++     .+...+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            57999999999999863   578999999986432      2334689999999999999999887     344568999


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence            999985 77776654    35689999999999999999999998 999999999999999887 799999999876543


Q ss_pred             C-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          221 G-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       221 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      . .......|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+....+.+..               
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------------  214 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------------  214 (318)
T ss_pred             CCCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            3 2233467899999999996554 7899999999999999999999998877655555443310               


Q ss_pred             cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                        .            .++..+++.+.++|++||+.||++||+     ..+++.|
T Consensus       215 --~------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         215 --L------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             --C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence              0            122347899999999999999999999     5556665

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.9e-43  Score=308.37  Aligned_cols=251  Identities=21%  Similarity=0.341  Sum_probs=202.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+..+.   ....+|+++++.++|+||+++++++     .....++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEE
Confidence            36999999999999999999999899999999986543   2345799999999999999999887     334457899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+++ +|.+.+....  ...+++..++.++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence            999984 7877775432  34688899999999999999999998 999999999999999877 799999999976543


Q ss_pred             CCCcc--ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~~--~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .....  ...++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....             
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  222 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-------------  222 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            32211  122356799999986554 8899999999999999998 999998766544433332210             


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                     ....+..++.++.+++.+||+.||++|||+.++++.|+++|
T Consensus       223 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         223 ---------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence                           01123457899999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.9e-43  Score=310.43  Aligned_cols=240  Identities=23%  Similarity=0.347  Sum_probs=188.5

Q ss_pred             eeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        73 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      ||+|+||+||++++..+|+.+|+|.+....       .....|+++++.++||||+++.+++     .+..++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999999999999999885321       1233589999999999999998887     4455689999999


Q ss_pred             cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCc
Q 018514          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (354)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~  224 (354)
                      .| +|...+....  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            86 7766665432  24588889999999999999999998 999999999999999887 7999999999876554444


Q ss_pred             cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCC
Q 018514          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  304 (354)
Q Consensus       225 ~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  304 (354)
                      ....|++.|+|||++.+.. ++.++|||||||++|+|++|..||...........+......          .   ....
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----------~---~~~~  217 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE----------D---EVKF  217 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc----------c---cccc
Confidence            4457889999999997666 899999999999999999999999765432222222111000          0   0000


Q ss_pred             CCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHh
Q 018514          305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV  346 (354)
Q Consensus       305 ~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l  346 (354)
                                 ....++.++.+++++||+.||++||++.|++
T Consensus       218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             -----------ccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence                       1124789999999999999999999996544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=328.46  Aligned_cols=243  Identities=29%  Similarity=0.503  Sum_probs=210.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .|.-++.||.|+||.||-|++..+.+.||||++....       +.+.+|+..|++++|||++.+.+||.....     .
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence            4777889999999999999999999999999985432       234479999999999999999999965433     6


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      |+|||||-|+-.+++..+.   +++-+-.+..|+.+.+.||+|||+. +.||||||..|||++..+ .|||+|||.|...
T Consensus       102 WLVMEYClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPG-LVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCC-eeeeccccchhhc
Confidence            8999999998888888765   7888899999999999999999999 999999999999999888 8999999999765


Q ss_pred             ccCCCccccccccccccchhcc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKGEPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .   +..+++|||+|||||++.  ..+.|+-++||||||++..||.-.++|+.+.+....+..|.+.             
T Consensus       177 ~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-------------  240 (948)
T KOG0577|consen  177 A---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------------  240 (948)
T ss_pred             C---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-------------
Confidence            4   345789999999999984  3456999999999999999999999999999999888888764             


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                            ..|......|        |..|..|+..||+.-|++|||++++|.|
T Consensus       241 ------esPtLqs~eW--------S~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  241 ------ESPTLQSNEW--------SDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ------CCCCCCCchh--------HHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                  1222333444        6899999999999999999999999988

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.1e-42  Score=308.27  Aligned_cols=272  Identities=35%  Similarity=0.596  Sum_probs=208.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ..+|++.+.||+|+||.||+|.+..+|..||+|.+....     ....+|+.+++.++|+||+++.+++     .+..+.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~   78 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeE
Confidence            357999999999999999999998899999999885432     2345799999999999999999987     344568


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+.+++...+...   ...+++..++.++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++...
T Consensus        79 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~  153 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLG-ELKLADFGLARAK  153 (291)
T ss_pred             EEEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCC-cEEEecccccccc
Confidence            899999998887776543   24578888999999999999999998 999999999999999887 7999999998754


Q ss_pred             ccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .... ......+++.|+|||.+.+...++.++||||||+++|+|++|..||...+. .+.+.++....+.|.........
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            2221 122345688899999987655578899999999999999999999976543 45666666667766655433221


Q ss_pred             C--CCccc----CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 P--NYTEF----KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~--~~~~~----~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .  .+...    ..+......|...   ..+..+.+++.+||..||.+|||+.+++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRL---SRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhcccc---CCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            1  00000    0011111111110   136789999999999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.1e-42  Score=309.29  Aligned_cols=260  Identities=25%  Similarity=0.355  Sum_probs=205.7

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeE
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|.+....   ....+|+.+++.+ +||||+++++++......+..+
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            34568999999999999999999999999999999875422   3445789999998 6999999999886655455667


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++||||+++ +|.+.+.........+++..++.++.|++.||.|||+. +++||||||+||+++.++ .++|+|||++.
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~  172 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEG-GVKLVDFGVSA  172 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCC-CEEEccCCcee
Confidence            8999999985 77777765444456789999999999999999999998 999999999999999887 69999999987


Q ss_pred             ecccCC-CccccccccccccchhccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          217 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       217 ~~~~~~-~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ...... ......|++.|+|||.+..    ...++.++|||||||++|+|++|..||........+..+...   .    
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~----  245 (286)
T cd06638         173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---P----  245 (286)
T ss_pred             ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---C----
Confidence            654322 2233468899999999843    233788999999999999999999999776543333222110   0    


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                  .+.       ...+...+..+.++|.+||+.||++|||+.++++|+
T Consensus       246 ------------~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         246 ------------PPT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ------------CCc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                        000       001223578899999999999999999999999985

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-42  Score=316.49  Aligned_cols=242  Identities=28%  Similarity=0.423  Sum_probs=194.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      +|+..+.||+|+||+||+|++..+|+.||+|++....       .....|..+++.+. |++|+++.+++     .+...
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            3788899999999999999999999999999886432       12335778888776 46777787776     34445


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++||||+++ +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~-~ikL~Dfg~~~  149 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEecccccc
Confidence            8999999985 776666542    5689999999999999999999998 999999999999999887 79999999987


Q ss_pred             ecccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            54322 2233456899999999996655 8999999999999999999999998877665555554310           


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH-----HHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----FDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta-----~e~l~~  348 (354)
                                        ..++..++.++.+++.+||+.||.+|+++     .++++|
T Consensus       218 ------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         218 ------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             ------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence                              01234478999999999999999999974     566665

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=308.71  Aligned_cols=273  Identities=37%  Similarity=0.666  Sum_probs=216.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+++++.++|+||+++++++..     ....+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            699999999999999999999989999999987532      2334579999999999999999998843     44589


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ++|||+++++...+...   ...+++..+..++.||+.||+|||+. +++|+||+|+||+++.++ .+||+|||++....
T Consensus        77 iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESG-VLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence            99999998766655433   25589999999999999999999998 999999999999999877 79999999987664


Q ss_pred             cCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       220 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......++..|+|||++.+...++.++||||||+++|+|++|.+||.+.+..+.+..+....+............
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            443  223456788899999997764589999999999999999999999998887777777777777666654433221


Q ss_pred             --CCcccCCCCcc-CCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 --NYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 --~~~~~~~~~~~-~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        .+.....+... ...+...++..++.++.++|++||..+|++|||+++++.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence              11111111111 1112223444568999999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.8e-43  Score=309.35  Aligned_cols=249  Identities=20%  Similarity=0.245  Sum_probs=197.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+|++.+.||+|+||.||+|.+.   ..+..||+|.+....     ....+|+.+++.++||||+++++++.     ...
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence            46999999999999999999875   345689999886542     23457999999999999999999873     334


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++||||+++ +|.+++...   ...+++..++.++.||+.||+|||++ |++||||||+||+++.++ .++++|||.+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~-~~~l~dfg~~  154 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDL-VCKISGFRRL  154 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCC-cEEECCCccc
Confidence            58999999996 666666543   24689999999999999999999998 999999999999999887 7999999987


Q ss_pred             eecccCCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          216 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       216 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      .........  ....++..|+|||.+.+.. ++.++|||||||++||+++ |..||.+.+..+.+..+......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------  227 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------  227 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------
Confidence            643222111  1223456899999986654 8999999999999999875 99999887765554444321100      


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                            ..+..++..+.+++.+||+.+|.+|||+.++++.|...
T Consensus       228 ----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 ----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                                  01234688999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=308.91  Aligned_cols=272  Identities=33%  Similarity=0.601  Sum_probs=213.9

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      |++.+.||.|++|.||+|.+..+|..||+|++..+.      ....+|+++++.++|||++++++++     .+..+.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence            677899999999999999999999999999886432      2345799999999999999999987     34456899


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      +|||+++++.+.+.....  ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            999998888887765431  4689999999999999999999998 999999999999999877 799999999875432


Q ss_pred             CC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       221 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      .. ......++..|+|||.+.+...++.++||||||+++|+|++|.+||...+....+..+.+..+.+....+.......
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            21 11233567889999988665557889999999999999999999999888888888888887777765542211100


Q ss_pred             c-ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 T-EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 ~-~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      + ...++....... ......++..+.++|.+||+.||.+|||+.++++|
T Consensus       232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         232 DYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0 000111111111 11234578999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.3e-42  Score=309.02  Aligned_cols=273  Identities=36%  Similarity=0.646  Sum_probs=210.7

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++||||+++++++     .+....+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            6999999999999999999998889999999875321      2345799999999999999999988     4556689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +|+||+.+++...+...   ...+++..++.++.|++.||+|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence            99999998654444322   24589999999999999999999998 999999999999999887 79999999987654


Q ss_pred             cCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .... .....++..|+|||.+.+...++.++||||||+++|+|++|.+||...+..+....+....+.............
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            3322 223457888999999876555788999999999999999999999888777777777776665443322111100


Q ss_pred             --CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 --YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        ......+......-.......++..+.+++.+||+.+|.+||++.++++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence              01111111111111111234578999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.4e-43  Score=319.00  Aligned_cols=237  Identities=27%  Similarity=0.413  Sum_probs=187.6

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccchh-------hhHHHH-HHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNREL-QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||+||+|++..+|+.||+|++.....       ...+|. .+++.++||||+++++++     .+....++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            469999999999999999999999999854321       122333 457889999999998887     4445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc-
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~-  220 (354)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            99986 66655543    35688999999999999999999998 999999999999999887 799999999875322 


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P-------------  212 (321)
T ss_pred             CCccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence            22233456899999999996554 899999999999999999999999887655544443221   0             


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH----HHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF----DAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~----e~l~~  348 (354)
                                   ..++...+..+.++|.+||+.||.+|+++.    ++++|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         213 -------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence                         012334688999999999999999999764    66554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.9e-43  Score=318.58  Aligned_cols=238  Identities=26%  Similarity=0.483  Sum_probs=187.1

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||+||+|++..+++.||+|++....       ....+|..++.++ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986431       2234677777766 899999999988     3445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc-
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~-  220 (354)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            99996 66555543    35789999999999999999999998 999999999999999887 799999999875322 


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHHHH
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  292 (354)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....        ...+.+....         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence            22233467899999999997655 89999999999999999999999953211        1111111110         


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH------HHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------FDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta------~e~l~~  348 (354)
                             .            ...++..++..+.++|++||+.||.+||++      .++++|
T Consensus       220 -------~------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 -------K------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -------C------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence                   0            011344578999999999999999999984      688877

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-42  Score=317.66  Aligned_cols=276  Identities=36%  Similarity=0.647  Sum_probs=220.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .+|++.+.||.|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++.+++.... .+..++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            57999999999999999999999999999999886431      23346999999999999999988764433 345578


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+.+++.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence            99999999888777654    25589999999999999999999998 999999999999999887 7999999998765


Q ss_pred             ccCCC-----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          219 VKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       219 ~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      .....     .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.++...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            33221     1234678899999998665558999999999999999999999999988888888888888888776654


Q ss_pred             ccCCCCcc---cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ........   -.++......|.. +...++.++.++|++||+.||++|||+.+++.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            33211100   0122222223322 223468999999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.9e-42  Score=310.32  Aligned_cols=281  Identities=29%  Similarity=0.498  Sum_probs=214.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC---C
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---K  133 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~  133 (354)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++++.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999999999999999885331      123469999999999999999987654322   2


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      .....++||||+.+++.+.+...   ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++ .+||+|||
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDG-ILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCC-cEEECcCC
Confidence            33457899999999888777543   24689999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCc-----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          214 SAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       214 ~a~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      ++.........     ....++..|+|||.+.+...++.++||||||+++|+|++|.+||.+.+.......+....+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99765432211     2345678899999987666578899999999999999999999998887777777777777666


Q ss_pred             HHHHhccC--CCCcccCCCCccCCCccccc-CCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          289 REEIKCMN--PNYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+.++...  ..+.....+..........+ ....+..+.++|.+||+.||.+|||++++++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            55443221  01111111111111111111 11246788999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-42  Score=308.84  Aligned_cols=274  Identities=33%  Similarity=0.599  Sum_probs=215.6

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      |.+.+.||+|+||.||+|.+..+++.+|+|.+....      ....+|+++++.++|+|++++++++...   .....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            678899999999999999999889999999986542      2345799999999999999999887432   1256899


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |+||+++++.+.+....   ..+++..++.++.||+.||+|||+. |++|+||+|+||+++.++ .++|+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            99999998887776532   4789999999999999999999998 999999999999999887 799999999987644


Q ss_pred             CC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          221 GE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       221 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..  ......++..|+|||.+.+...++.++||||||+++|+|++|..||...+....+..+....+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            33  1223456788999998866555889999999999999999999999998888888888887777766655432221


Q ss_pred             --CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 --YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        .................+...++..+.+++++||+.+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              11111111000111111222248999999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.1e-43  Score=319.69  Aligned_cols=237  Identities=26%  Similarity=0.427  Sum_probs=188.9

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHH-HHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||+||+|++..+|+.+|+|++....       ....+|.. +++.++||||+++++.+     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            46899999999999999999999999986432       11223433 46778999999998887     4445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc-
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~-  220 (354)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            99996 66655543    35789999999999999999999998 999999999999999887 799999999875322 


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~----------------  212 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP----------------  212 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            22233457899999999996655 8999999999999999999999998877655554443310                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH----HHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF----DAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~----e~l~~  348 (354)
                                   ..+....+..+.++|++||+.||.+||++.    ++++|
T Consensus       213 -------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         213 -------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             -------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence                         011234689999999999999999999874    67665

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-42  Score=310.21  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=201.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCC-----ceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....     ....+|+.+++.++||||+++++++.     +
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            46999999999999999999976554     679999886432     23457999999999999999998873     3


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~  201 (354)
                      ....+++|||+.+ +|.+++......            ...+++..++.++.|++.||+|||++ |++|+||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEc
Confidence            3447899999985 888888754221            14578889999999999999999998 999999999999999


Q ss_pred             CCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 018514          202 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (354)
Q Consensus       202 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  277 (354)
                      .++ .++|+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+..
T Consensus       159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 799999999976533221   22345578899999986554 8999999999999999998 99999887765544


Q ss_pred             HHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       278 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ..+......                            ..+..++.++.+++.+||+.||.+||++.+++++|.+
T Consensus       237 ~~i~~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EMIRSRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            443321100                            0123478999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.6e-42  Score=316.63  Aligned_cols=277  Identities=30%  Similarity=0.523  Sum_probs=210.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCC-------
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-------  133 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-------  133 (354)
                      .+|.+.+.||.|+||.||+|.+..+|..||+|++....    ....+|+++++.++||||+++++++......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            47999999999999999999999999999999885432    3345799999999999999998876443211       


Q ss_pred             --CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          134 --DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       134 --~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                        +..+.++||||+++++.+.+..     ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++..++|+|
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECC
Confidence              1235789999999887776653     4688999999999999999999998 9999999999999986665799999


Q ss_pred             ccCceecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 018514          212 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (354)
Q Consensus       212 fg~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  287 (354)
                      ||.+........    .....++..|+|||.+.....++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999976532211    1223568889999987665558899999999999999999999999888777777766655444


Q ss_pred             CHHHHhccCCCCcccCC--CCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          288 TREEIKCMNPNYTEFKF--PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .................  ......++. .+...++.++.++|.+||+.||.+|||+.+++.|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLR-DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHH-HHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            43322211111000000  000011111 1223578999999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-42  Score=308.00  Aligned_cols=250  Identities=25%  Similarity=0.375  Sum_probs=197.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++||||+++++++.     ....+++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence            4699999999999999999999889999999988543    233457999999999999999998873     3345889


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNG-DVKLADFGVAAKIT  157 (267)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence            9999996 77776654    25689999999999999999999998 999999999999999887 79999999997653


Q ss_pred             cCC-CccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          220 KGE-PNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ... ......++..|+|||.+..  ...++.++|+|||||++|+|++|..||....+......+...             
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------  224 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------  224 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence            322 2234567889999998842  333678999999999999999999998655433222111110             


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                          .+..+.     +.  ....++..+.++|++||+.||++|||++++++|+
T Consensus       225 ----~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         225 ----NFQPPK-----LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ----CCCCCC-----Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                000000     00  1123688999999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=322.56  Aligned_cols=237  Identities=26%  Similarity=0.440  Sum_probs=189.0

Q ss_pred             eeeccceEEEEEEEcCCCceEEEEEcccchh-------hhHHHHHHHHHc---CCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        73 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      ||+|+||+||+|++..+++.||+|++.....       ...+|..++...   .||||+++++++     .+...+++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            6999999999999999999999999854321       112355566554   699999998887     4455689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            99985 77666654    35789999999999999999999998 999999999999999887 7999999998754322


Q ss_pred             -CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                       .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------  213 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK----------------  213 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223345789999999999766668999999999999999999999998876655544442210                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC----CHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS----TAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp----ta~e~l~~  348 (354)
                       ..++           ...+++++.++|++||+.||.+||    ++.++++|
T Consensus       214 -~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         214 -VRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             -CCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence             0011           123689999999999999999998    68888886

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.4e-42  Score=310.20  Aligned_cols=279  Identities=32%  Similarity=0.544  Sum_probs=216.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC---CC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~  134 (354)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++....      ....+|+++++.++||||+++++.+.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999999999999999875321      234579999999999999999887654332   23


Q ss_pred             eeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...+++|+||+.+++...+...   ...+++..++.++.|++.||+|||++ ||+|+||||+||+++.++ .++|+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            4567899999998877766542   35789999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCc------------cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 018514          215 AKVLVKGEPN------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (354)
Q Consensus       215 a~~~~~~~~~------------~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  282 (354)
                      +.........            ....+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9755332211            1234578899999986665588999999999999999999999999888888888888


Q ss_pred             HhCCCCHHHHhccCCCCccc--CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          283 VLGTPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..+.+....+..........  .........+... ...+++.+.++|.+||+.||.+|||+.+++.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            77777665544322111000  0000000111111 12356889999999999999999999999987

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.6e-42  Score=315.99  Aligned_cols=238  Identities=25%  Similarity=0.458  Sum_probs=188.9

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||+||+|++..+++.||+|++....       ....+|..++.++ .||||+++++++     .+...+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986432       2234688888887 699999999988     4445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc-c
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K  220 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~-~  220 (354)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.... .
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            99986 66666554    25689999999999999999999998 999999999999999887 79999999987532 2


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||....      ..+.+.+....  .        
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~--------  218 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K--------  218 (327)
T ss_pred             CCceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence            22334567899999999996655 8999999999999999999999996422      11222222110  0        


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH------HHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------FDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta------~e~l~~  348 (354)
                                        ...++..++..+.++|++||+.||.+|+++      .++++|
T Consensus       219 ------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         219 ------------------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence                              001234578999999999999999999984      588776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.2e-42  Score=307.61  Aligned_cols=250  Identities=27%  Similarity=0.427  Sum_probs=197.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHH-HHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQT-MRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++....     .....|+.. ++.+.||||+++++++.     .....+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcEE
Confidence            6999999999999999999999999999999886432     122235544 66678999999999884     334489


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ++|||++++|.+++.........+++..++.++.|++.||+|||++.+++||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecccccccc
Confidence            99999999998888765555567999999999999999999999855899999999999999887 79999999997654


Q ss_pred             cCCCccccccccccccchhccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhcc
Q 018514          220 KGEPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       220 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .........++..|+|||.+.+.   ..++.++|+|||||++|+|++|..||.... ..+.+..+.....          
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------  225 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS----------  225 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC----------
Confidence            43333345678889999988542   336889999999999999999999996532 2233333222100          


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                               +.        .....+|.++.++|.+||..+|.+|||+.++++|
T Consensus       226 ---------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         226 ---------PQ--------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ---------CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     00        0012368999999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.7e-42  Score=300.48  Aligned_cols=245  Identities=26%  Similarity=0.420  Sum_probs=200.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...      .....+|+++++.++||||+++++++     .+....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence            488999999999999999999999999999987532      23345789999999999999999987     3445689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|.+.+....  ...++...++.++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~-~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence            99999985 8887776532  35788999999999999999999998 999999999999999887 7999999998765


Q ss_pred             ccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ..... .....+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+.....            
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  218 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------  218 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            44322 22346788899999997655 78999999999999999999999987775554444332110            


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                             +         .++..++..+.+++.+||+.+|++||++.+++++
T Consensus       219 -------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 -------P---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -------C---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                   0         1122468999999999999999999999999987

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2e-42  Score=316.04  Aligned_cols=249  Identities=25%  Similarity=0.405  Sum_probs=198.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||+||++++..+++.+|+|++....       ....+|+.++..++|+||+++++++     .+...+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence            6999999999999999999999999999999985421       2245688899999999999998887     445568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+...   ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~  151 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSCLK  151 (332)
T ss_pred             EEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence            999999985 888877653   25689999999999999999999998 999999999999999887 799999999876


Q ss_pred             cccCCC--ccccccccccccchhccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          218 LVKGEP--NISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       218 ~~~~~~--~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ......  .....||+.|+|||++..    ...++.++|||||||++|||++|+.||...+..+....+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------  225 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------  225 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc------
Confidence            533222  123568999999999852    33478899999999999999999999988776666655543210      


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCC--CCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~--Rpta~e~l~~  348 (354)
                               .+.++.         ....+++++.++|++||+.++.+  |++++++++|
T Consensus       226 ---------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 ---------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                     001110         11247899999999999765544  7899999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=305.48  Aligned_cols=274  Identities=26%  Similarity=0.499  Sum_probs=216.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhh---HHHHHHHHHcCC--C----CeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDH--P----NVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~e~~~l~~l~h--~----~iv~~~~~~~~~~~~~  134 (354)
                      ..+|.+...+|+|.||.|-.+.+..++..||||+++.-....   .-|+++|+++.+  |    -++++.++|     +.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            457999999999999999999999999999999997654333   358999999942  2    367777777     66


Q ss_pred             eeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC-----------
Q 018514          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-----------  203 (354)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~-----------  203 (354)
                      ..+.|||+|.++-++.+++..+.  ..+++...++.+++|++.+++|||+. +++|.||||+|||+.+.           
T Consensus       163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCc
Confidence            67799999999999999998754  46789999999999999999999998 99999999999997211           


Q ss_pred             --------CCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 018514          204 --------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (354)
Q Consensus       204 --------~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  275 (354)
                              ...|+|+|||.|+....  .....+.|..|.|||++++-+ ++..+||||+||||+|++||...|+..++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    12599999999986533  346678899999999998877 9999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhccC--CCCc--ccCCCCccCCC-----cc------ccc--CCCCCHHHHHHHHHhcCcCCCC
Q 018514          276 QLVEIIKVLGTPTREEIKCMN--PNYT--EFKFPQIKAHP-----WH------KIF--QKRMPPEAVDLVSRLLQYSPNL  338 (354)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~-----~~------~~~--~~~~s~~l~~ll~~~l~~dp~~  338 (354)
                      .++.+...+|+.+...+....  ..+.  ..++++.....     ++      ...  ......++.+||++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            999999999988877665431  0000  11111110000     00      000  0112246999999999999999


Q ss_pred             CCCHHHHhhc
Q 018514          339 RSTAFDAVGS  348 (354)
Q Consensus       339 Rpta~e~l~~  348 (354)
                      |+|+.|+|.|
T Consensus       397 RiTl~EAL~H  406 (415)
T KOG0671|consen  397 RITLREALSH  406 (415)
T ss_pred             cccHHHHhcC
Confidence            9999999988

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.3e-42  Score=304.90  Aligned_cols=255  Identities=29%  Similarity=0.449  Sum_probs=202.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ++|++.+.||+|+||.||+|++..+++.||+|.+...       .....+|+++++.++||||+++++++..     ...
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence            4699999999999999999999999999999976421       1234579999999999999999998743     345


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++++||+++ +|.+++.........+++..+..++.|++.||+|||++ |++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~d~g~~~  154 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence            7899999995 77777765544456689999999999999999999998 999999999999999887 79999999987


Q ss_pred             ecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhc
Q 018514          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       217 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ....... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ...+.........++      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  227 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------  227 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence            6543221 12346788899999986554 78999999999999999999999865432 122222222111111      


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                          .....++..+.+++.+||+.+|++||++.++++.|..+-
T Consensus       228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                                011236789999999999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-41  Score=305.15  Aligned_cols=258  Identities=24%  Similarity=0.334  Sum_probs=205.2

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|.+...   .....+|+.+++.+ +|||++++++++...........
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            356799999999999999999999999999999988543   23445788899988 89999999998865543344568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+. |++|+||||+||+++.++ .+||+|||++..
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~-~~kl~dfg~~~~  177 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQ  177 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEeecccchh
Confidence            899999986 78777765544456789999999999999999999998 999999999999999887 799999999876


Q ss_pred             cccCC-CccccccccccccchhccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          218 LVKGE-PNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       218 ~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ..... ......++..|+|||.+....    .++.++|||||||++|+|++|+.||........+..+.+..   ..   
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~~---  251 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---PP---  251 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---CC---
Confidence            54322 122346788899999985432    25789999999999999999999998766544444332210   00   


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                          ....+...+..+.++|.+||+.+|++||++.++++|
T Consensus       252 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         252 --------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             --------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                                000112356889999999999999999999999987

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-42  Score=305.46  Aligned_cols=272  Identities=38%  Similarity=0.665  Sum_probs=217.7

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      |.+.+.||.|++|+||+|++..+++.|++|.+....     ....+|+..+++++ |+|++++++++.     +....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence            678899999999999999998889999999875432     23346889999999 999999999883     3455899


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      ||||+.+++.+.+....  ...+++..+..++.|++.+|.|||++ |++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999888888776543  34689999999999999999999998 999999999999999877 799999999987655


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC-
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY-  299 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-  299 (354)
                      ........++..|+|||.+.....++.++|+||||+++++|++|.+||...+..+....+...++.+....+....... 
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            4444456678899999998666668999999999999999999999999998888888888888888766543221111 


Q ss_pred             -cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 -TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 -~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       .....+....... ..+....+..+.++|++||+.||++|||+.|++.|
T Consensus       232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         232 KLGFRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence             1111111111111 11122347899999999999999999999999987

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.3e-42  Score=315.46  Aligned_cols=249  Identities=27%  Similarity=0.401  Sum_probs=198.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||.||++++..+++.||+|.+....       ....+|..++..++|+||+++++++     .+..+.
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999885421       2234688889999999999999887     455668


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      |+||||+.| +|.+.+...   ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~  151 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNG-HIRLADFGSCLK  151 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence            999999985 787777653   25689999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCc--cccccccccccchhccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          218 LVKGEPN--ISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       218 ~~~~~~~--~~~~g~~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .......  ....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||...+..+....+......     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----  226 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER-----  226 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc-----
Confidence            5433221  235689999999998542    34788999999999999999999999887765555544331100     


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCC--CCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~--Rpta~e~l~~  348 (354)
                                +.++.         ....++.++.++|.+||+.++++  |++++++++|
T Consensus       227 ----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 ----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                      00110         11236899999999999876654  5689999987

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=304.07  Aligned_cols=297  Identities=26%  Similarity=0.412  Sum_probs=229.8

Q ss_pred             CCCCCceeEEeecCCCCCCCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhH---HHHHHHHHcC--
Q 018514           42 NGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLD--  116 (354)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~e~~~l~~l~--  116 (354)
                      ...-.|.+....++.    ....++|.+.++||.|.|++||+|.|..+.+.||+|+.+....+.+   .|+++|++++  
T Consensus        59 ~dY~kGGYHpV~IGD----~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~  134 (590)
T KOG1290|consen   59 EDYRKGGYHPVRIGD----VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG  134 (590)
T ss_pred             hhhhcCCCceeeccc----cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence            333445555555443    3344689999999999999999999999999999999987765543   6999999883  


Q ss_pred             ---C---CCeeecceeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 018514          117 ---H---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (354)
Q Consensus       117 ---h---~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH  190 (354)
                         |   .+||++++.|.. .+.+..++|||+|+++.+|+.+|....  .+.++...++.|++||+.||.|||+.+||||
T Consensus       135 Dp~~~~~~~VV~LlD~Fkh-sGpNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIH  211 (590)
T KOG1290|consen  135 DPNDPGKKCVVQLLDHFKH-SGPNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIH  211 (590)
T ss_pred             CCCCCCCceeeeeecccee-cCCCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence               2   479999998754 457888999999999999999998754  4779999999999999999999999999999


Q ss_pred             cCCCCCCeeee---------------------------------------------------------------------
Q 018514          191 RDIKPQNLLVN---------------------------------------------------------------------  201 (354)
Q Consensus       191 ~Dlkp~Nili~---------------------------------------------------------------------  201 (354)
                      .||||+|||+.                                                                     
T Consensus       212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~  291 (590)
T KOG1290|consen  212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL  291 (590)
T ss_pred             cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence            99999999973                                                                     


Q ss_pred             ---------------------------------------------CC---------------------------C-----
Q 018514          202 ---------------------------------------------PH---------------------------T-----  204 (354)
Q Consensus       202 ---------------------------------------------~~---------------------------~-----  204 (354)
                                                                   ..                           .     
T Consensus       292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~  371 (590)
T KOG1290|consen  292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP  371 (590)
T ss_pred             ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence                                                         00                           0     


Q ss_pred             -------------------CcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCC
Q 018514          205 -------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  265 (354)
Q Consensus       205 -------------------~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  265 (354)
                                         -+|||+|||-|.....  ..+....|..|+|||++.+.+ |++.+||||++|++|||+||.
T Consensus       372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGD  448 (590)
T KOG1290|consen  372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGD  448 (590)
T ss_pred             cccccccccCCCCCCCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCc
Confidence                               0377888887766432  233456788999999999887 999999999999999999999


Q ss_pred             CCCCC------CCcHHHHHHHHHHhCCCCHHHHhccCCCCcccC-------CCCccCCCccc------ccCCCCCHHHHH
Q 018514          266 PLFPG------ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK-------FPQIKAHPWHK------IFQKRMPPEAVD  326 (354)
Q Consensus       266 ~pf~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~s~~l~~  326 (354)
                      ..|..      ..+.+.++.|+..+|..+......-.-.-+-|.       +...+..+...      .++.....++.+
T Consensus       449 yLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsd  528 (590)
T KOG1290|consen  449 YLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSD  528 (590)
T ss_pred             eeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHH
Confidence            98864      236788999999999999876643322212221       11111111111      122334568999


Q ss_pred             HHHHhcCcCCCCCCCHHHHhhc
Q 018514          327 LVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       327 ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ||.-||+++|++||||.++|+|
T Consensus       529 FL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  529 FLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             HHHHHHhcCccccccHHHHhcC
Confidence            9999999999999999999987

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.7e-42  Score=308.89  Aligned_cols=250  Identities=22%  Similarity=0.322  Sum_probs=200.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      .+|.+.+.||+|+||.||+|.+..     ++..||+|.+....     ....+|+++++.++|+||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-----   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence            469999999999999999998743     35789999986432     345579999999999999999998743     


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhh----------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHY----------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~  203 (354)
                      ....++||||+.+ +|.+.+....          .....+++..+..++.|++.||.|||++ |++||||||+||+++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~  158 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCC
Confidence            3458999999985 8888876542          1234578889999999999999999998 99999999999999988


Q ss_pred             CCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 018514          204 THQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVE  279 (354)
Q Consensus       204 ~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  279 (354)
                      + .++|+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....
T Consensus       159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             C-eEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            7 799999999976533221   12334567899999996655 8999999999999999998 9999987776555444


Q ss_pred             HHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      +......                            ..+..++..+.+++.+||+.||.+|||+.|+++.|+
T Consensus       237 ~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ITQGRLL----------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHcCCcC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            4321000                            012346899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.1e-42  Score=307.55  Aligned_cols=280  Identities=31%  Similarity=0.496  Sum_probs=218.0

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC----
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE----  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----  132 (354)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+++++.++|||++++++.+....+    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            3457999999999999999999999899999999885432      233579999999999999999888744321    


Q ss_pred             -CCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          133 -KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       133 -~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                       .+..++++|+||+++++...+...   ...+++..++.++.|++.||+|||+. ||+|+||||+||+++.++ .+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~kl~d  159 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKG-QIKLAD  159 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-cEEeCc
Confidence             122368999999999887776643   24689999999999999999999998 999999999999999887 799999


Q ss_pred             ccCceecccCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          212 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       212 fg~a~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      ||++........  .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            999976543321  122345778999999866555789999999999999999999999988888888888888777776


Q ss_pred             HHHhccCCC--CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          290 EEIKCMNPN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..++.....  +............+.. ....++..+.+++.+||+.||++|||+.+++.|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            654432211  1000000000011111 223478999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=306.28  Aligned_cols=271  Identities=39%  Similarity=0.712  Sum_probs=217.7

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      |++.+.||.|++|.||+|.+..+|+.+++|.+....      ....+|+.+++.++|+||+++++.+     .+....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence            667889999999999999998899999999885432      2345799999999999999999887     33455899


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |+||+++++...+....   ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            99999998888776532   5789999999999999999999998 999999999999999877 799999999976644


Q ss_pred             CC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC--
Q 018514          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  297 (354)
Q Consensus       221 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  297 (354)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+.+..+...++.+....+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            33 222345778899999997764689999999999999999999999999888888888888888877766554433  


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ....+.++....... ......++.++.++|.+||++||.+||++.+++.|
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         231 RNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111112221111111 11223478999999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-42  Score=304.25  Aligned_cols=260  Identities=27%  Similarity=0.401  Sum_probs=207.1

Q ss_pred             CccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHc-CCCCeeecceeeeecCC-CCe
Q 018514           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE-KDE  135 (354)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~  135 (354)
                      +...++|++.+.||+|++|.||+|.+..+++.+++|.+....   ....+|+.+++++ .|+||+++++++..... .+.
T Consensus         2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            345578999999999999999999998889999999886442   3456799999998 79999999998866543 345


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~-~~~l~d~~~  159 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNA-EVKLVDFGV  159 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCC-eEEECCCcc
Confidence            668999999996 77777766544457789999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCC-CccccccccccccchhccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~~-~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +....... ......++..|+|||.+..    ...++.++||||||+++|+|++|..||...........+....   . 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~-  235 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---P-  235 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---C-
Confidence            87653322 2234567889999998743    2346789999999999999999999998665554444433210   0 


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     +.     +  ......+..+.++|++||..||++|||+.++++|
T Consensus       236 ---------------~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         236 ---------------PT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ---------------CC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                           00     0  0112357899999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.6e-42  Score=305.79  Aligned_cols=253  Identities=20%  Similarity=0.275  Sum_probs=197.3

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ...+|++.+.||+|+||.||+|.+..     ++..||+|++....     ....+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            34579999999999999999998642     35679999885422     2244789999999999999999887     


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~  205 (354)
                      ......++||||+++ +|.+++......      ...++...+..++.|++.||+|||+. |++|+||||+||+++.++ 
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~-  156 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-  156 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCC-
Confidence            344458899999985 888877653221      23457788899999999999999998 999999999999999887 


Q ss_pred             cEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 018514          206 QLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (354)
Q Consensus       206 ~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~  281 (354)
                      .++|+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            799999999875433221   11234467899999986554 8999999999999999998 789998776554444332


Q ss_pred             HHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ... .                           ...+..++..+.+++.+||+.||++|||+.+++++|++
T Consensus       236 ~~~-~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGG-L---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCC-c---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            210 0                           01123467899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.6e-42  Score=302.01  Aligned_cols=245  Identities=27%  Similarity=0.461  Sum_probs=199.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +|++.+.||.|+||.||++++..++..+|+|.+...     .....+|+.+++.++|+||+++.+++     .+..++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            489999999999999999999999999999987532     23345689999999999999999987     44556899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +|||+++ ++.+.+....  ...+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999985 7777665432  35678999999999999999999998 999999999999999887 79999999997654


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+......            
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------  218 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK------------  218 (255)
T ss_pred             ccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC------------
Confidence            322 223456788999999986554 899999999999999999999999876654444433221000            


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      .++..++..+.+++.+||+.||.+|||+.+++..
T Consensus       219 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 ----------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                            0123467899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.4e-42  Score=313.23  Aligned_cols=272  Identities=33%  Similarity=0.524  Sum_probs=213.3

Q ss_pred             cceE-EEeEeeeccceEEEEEEEcCCCceEEEEEcccchh------------------hhHHHHHHHHHcCCCCeeecce
Q 018514           65 ISYM-AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------------------YKNRELQTMRLLDHPNVVSLKH  125 (354)
Q Consensus        65 ~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~e~~~l~~l~h~~iv~~~~  125 (354)
                      ++|. +.+.||.|+||+||+|.+..+++.||+|++.....                  ...+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4676 45779999999999999998999999998854311                  2347999999999999999999


Q ss_pred             eeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC
Q 018514          126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (354)
Q Consensus       126 ~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~  205 (354)
                      ++     ....+.++||||+.+++.+.+..    ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ 
T Consensus        88 ~~-----~~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~-  156 (335)
T PTZ00024         88 VY-----VEGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKG-  156 (335)
T ss_pred             EE-----ecCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCC-
Confidence            87     34456899999999998888764    25689999999999999999999998 999999999999999887 


Q ss_pred             cEEEEeccCceecccC---------------CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 018514          206 QLKLCDFGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (354)
Q Consensus       206 ~vkl~Dfg~a~~~~~~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  270 (354)
                      .++|+|||.+......               .......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            7999999998765411               1111234577899999997666679999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .++.+.+..+....+.+....+...........+.......... .....+.++.++|.+||+.||++|||+++++.|
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            98888888888888877765444322110000000100111111 123468899999999999999999999999987

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.5e-42  Score=315.75  Aligned_cols=256  Identities=23%  Similarity=0.356  Sum_probs=197.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      .++|++.+.||.|+||.||+|.+..     +++.||+|++....     ....+|+.+++++ +|+||+++++++...  
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence            3479999999999999999997543     45789999886421     2334699999999 799999999877432  


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhh-----------------------------------------------------
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYK-----------------------------------------------------  158 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~-----------------------------------------------------  158 (354)
                        ...++++|||+++ +|.+.+.....                                                     
T Consensus        84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence              3347899999996 77777754221                                                     


Q ss_pred             ----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC---cccccccc
Q 018514          159 ----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSR  231 (354)
Q Consensus       159 ----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~  231 (354)
                          ...++++..+..++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||++........   .....++.
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCc
Confidence                013688999999999999999999998 999999999999999877 799999999976533221   11234467


Q ss_pred             ccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCC
Q 018514          232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  310 (354)
Q Consensus       232 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (354)
                      .|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+........                         
T Consensus       240 ~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------------------  293 (337)
T cd05054         240 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-------------------------  293 (337)
T ss_pred             cccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC-------------------------
Confidence            799999997665 8999999999999999998 9999976544333322222100                         


Q ss_pred             CcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          311 PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       311 ~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                        ....+...++++.+++.+||+.+|++||++.+++++|..++
T Consensus       294 --~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         294 --RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             --CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              00012346789999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.4e-42  Score=302.10  Aligned_cols=249  Identities=24%  Similarity=0.320  Sum_probs=199.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ++|++.++||+|+||.||+|.+. ++..||+|.+...   .....+|+.+++.++|+||+++++++     .+....+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEEE
Confidence            47999999999999999999864 5667999987643   23445799999999999999998877     344457899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+.+ +|.+.+....  ...++...+..++.|++.||+|||+. +++||||||+||+++.++ .++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05072          80 TEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESL-MCKIADFGLARVIED  155 (261)
T ss_pred             EecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCC-cEEECCCccceecCC
Confidence            999975 8888776532  35678888999999999999999998 999999999999999887 799999999986543


Q ss_pred             CCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...........+.....            
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------  222 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR------------  222 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            2211  1233466799999986554 7899999999999999998 9999987765555444432110            


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                            .          .....++.++.+++.+||..+|++|||++++++.|++.
T Consensus       223 ------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 ------M----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ------C----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                  0          01123688999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-42  Score=312.26  Aligned_cols=251  Identities=22%  Similarity=0.313  Sum_probs=195.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCce--EEEEEcccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+|++.+.||+|+||.||+|.+..++..  +|+|.+...     .....+|++++.++ +|+||+++++++     ....
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence            4799999999999999999998777754  577766532     12345799999999 899999999987     4445


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~  203 (354)
                      ..++||||+++ +|.+++.....            ....+++..++.++.||+.||+|||++ |++||||||+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~~  160 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN  160 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecCC
Confidence            58999999984 88888865431            123578999999999999999999998 99999999999999988


Q ss_pred             CCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 018514          204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (354)
Q Consensus       204 ~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  282 (354)
                      + .+||+|||++.............++..|+|||.+.+.. ++.++|||||||++|+|+| |..||...+..+....+..
T Consensus       161 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             C-cEEeCccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            7 79999999986432211122223456799999985554 8899999999999999998 9999977665443332211


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ..                            ....+..+++++.+++.+||+.+|++||++.+++..|..
T Consensus       239 ~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         239 GY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             CC----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            00                            000122367899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.5e-42  Score=310.69  Aligned_cols=252  Identities=21%  Similarity=0.284  Sum_probs=196.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCc--eEEEEEcccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++..     .+...+|+.+++++ +||||+++++++     .+..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            369999999999999999999877664  4688877532     12345799999999 799999999887     3444


Q ss_pred             EEEEEEeecc-ccHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC
Q 018514          137 YLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (354)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~  203 (354)
                      ..++++||++ ++|.+.+.....            ....+++..++.++.|++.||+|||++ ||+||||||+||+++.+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~  155 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGEN  155 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCC
Confidence            5889999998 488888865321            123588899999999999999999998 99999999999999987


Q ss_pred             CCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 018514          204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (354)
Q Consensus       204 ~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  282 (354)
                      + .+||+|||++..............+..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+..
T Consensus       156 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         156 L-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             C-eEEECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            7 79999999986432211112222355699999986555 8999999999999999997 9999987766554444322


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ..                            ....+..++..+.+++.+||+.+|.+|||++++++.|...
T Consensus       234 ~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         234 GY----------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             CC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            10                            0012234789999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-42  Score=312.63  Aligned_cols=276  Identities=39%  Similarity=0.670  Sum_probs=221.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||.|++|.||+|++..+++.||+|++....      ....+|+.+++.++|+||+++.+++..........++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5899999999999999999998889999999885432      3455799999999999999999987554323334689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ++|||+++++.+.+...    ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            99999998887777643    4789999999999999999999998 999999999999999887 79999999998765


Q ss_pred             cCC----CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          220 KGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       220 ~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ...    ......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            443    1334567889999999977646899999999999999999999999999988889999998888887655421


Q ss_pred             CC-CCccc-C-CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NP-NYTEF-K-FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~-~~~~~-~-~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .. ....+ . .+......|... ...++..+.++|.+||++||.+|||+.+++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11 00000 0 111112222222 23478999999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.2e-41  Score=299.20  Aligned_cols=246  Identities=28%  Similarity=0.462  Sum_probs=203.3

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...      .....+|+.+++.++|||++++++.+     .+....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence            489999999999999999999999999999987532      22345799999999999999998877     3445689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+++ +|.+.+....  ...+++..+..++.|++.+|+|||++ |++|+||+|+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999986 8888876532  34588999999999999999999998 99999999999999876657899999999877


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..........++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.....             
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-------------  218 (256)
T ss_pred             CCCccccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence            5554444567888999999996554 78999999999999999999999987765554444332100             


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     ..++..++.++.+++.+||+.||.+|||+.+++.|
T Consensus       219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                           01223478999999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=319.36  Aligned_cols=267  Identities=27%  Similarity=0.364  Sum_probs=199.9

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..+++|.-.+.||+|+||.||+|.. .+|..||||++....    ..+.+|++++.+++|||+|+++|++.+...    .
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~  146 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----H  146 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----e
Confidence            4556788889999999999999985 455899999885432    347789999999999999999999954332    4


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--GVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .++|+||+. |+|.+.+......  ++++....+|+.++++||+|||...  .||||||||+|||+|.+. ..||+|||+
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGL  223 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGL  223 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccC
Confidence            789999999 6888888765422  8899999999999999999999964  399999999999999988 799999999


Q ss_pred             ceeccc-CCCcccc-ccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHH-HhCCCCH
Q 018514          215 AKVLVK-GEPNISY-ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES--GVDQLVEIIK-VLGTPTR  289 (354)
Q Consensus       215 a~~~~~-~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~-~~~~~~~  289 (354)
                      |..... ....... .||.+|+|||..... ..+.++||||||+++.||+||+.+.....  ....+..+.. .+...  
T Consensus       224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--  300 (361)
T KOG1187|consen  224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--  300 (361)
T ss_pred             cccCCccccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--
Confidence            965543 3222233 799999999999664 48999999999999999999998876532  1111222211 10000  


Q ss_pred             HHHhccCCCCcccCCCCccCCCcc-cccCC-CCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWH-KIFQK-RMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                   ....+.+.... ..+.. ..-..+..+..+|++.+|.+||++.++++.|...
T Consensus       301 -------------~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  301 -------------KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             -------------chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence                         11111111111 11110 0123467788899999999999999999888543

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.1e-42  Score=304.54  Aligned_cols=256  Identities=20%  Similarity=0.284  Sum_probs=197.0

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCc--eEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  137 (354)
                      |.+.+.||+|+||.||+|++..++.  .+|+|.++..      .....+|+.+++.++|+||+++++.++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999877665  5899987532      2234578999999999999999987654332 12234


Q ss_pred             EEEEEeeccc-cHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          138 LNLVLEYVPE-TVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .+++|||+.+ +|.+.+....  .....+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCC-CEEECCCCc
Confidence            6889999984 7777664322  1234588999999999999999999998 999999999999999877 799999999


Q ss_pred             ceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +........   .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+...- .    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~----  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-R----  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-C----
Confidence            986543321   11234567899999986554 8999999999999999999 889998766544433332210 0    


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                             ...+..++..+.+++.+||+.||.+|||+.++++.|++++
T Consensus       233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                                   0012346789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-41  Score=302.25  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=200.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHc-CCCCeeecceeeeecCCC-CeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK-DELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~~  138 (354)
                      .+.|++.+.||+|+||.||+|.+..+++.+|+|.+...   .....+|+.+++.+ +|+||+++++++...... ....+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            45799999999999999999999999999999988543   23345788899988 699999999988654322 23468


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++|||+.+ +|.+.+....  ...+++..+..++.|++.||+|||++ +|+|+||||+||+++.++ .++|+|||++..
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~  160 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCC-CEEEccCCCcee
Confidence            899999985 7777776532  35688999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCC-CccccccccccccchhccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          218 LVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       218 ~~~~~-~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ..... ......|+..|+|||++.+    ...++.++|||||||++|+|++|..||...........+...   +     
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~-----  232 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P-----  232 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence            53321 2234567889999999853    224788999999999999999999999765543333222110   0     


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 .        .......++..+.+++.+||..||.+|||+.++++|
T Consensus       233 -----------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         233 -----------A--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -----------C--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                       0        001122367899999999999999999999999987

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9.1e-42  Score=300.32  Aligned_cols=246  Identities=20%  Similarity=0.307  Sum_probs=196.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|++.+.||+|+||.||++.+. .+..+|+|.+...   .....+|+.+++.++||||+++++++     ......++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEE
Confidence            36999999999999999999875 4567999987643   23456799999999999999999887     334458999


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+++ +|.+.+....   ..+++..+..++.|++.||+|||++ ||+|+||||+||+++.++ .+||+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence            999985 7777665432   4588999999999999999999998 999999999999999877 799999999875533


Q ss_pred             CCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  ....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+......           
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-----------  220 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-----------  220 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------
Confidence            2221  1223456799999986554 8999999999999999999 89999887766655554331100           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                       ..+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus       221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                             011235789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-44  Score=297.15  Aligned_cols=279  Identities=30%  Similarity=0.522  Sum_probs=226.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecC---CCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTT---EKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~  135 (354)
                      ..|.-..++|+|.||.||+|+.+.+|+.||+|++..+.      ....+|+++|..++|+|++.++..+....   ..+.
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            35888889999999999999999999999998764322      22348999999999999999877664332   2345


Q ss_pred             eEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..+|+||++|..+|..++....   .+++...+.+++.++++||.|+|+. .|+|||+||+|+||+.++ .+||+|||++
T Consensus        97 ~t~ylVf~~cehDLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dg-ilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEHDLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDG-ILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhhhHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCc-eEEeeccccc
Confidence            5689999999999988887653   6789999999999999999999998 999999999999999988 8999999999


Q ss_pred             eecccCCCc-----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          216 KVLVKGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       216 ~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +.+......     ...+.|..|.+||.+.+.+.|+++.|||..||++.||.+|.+.|.+.++..++..|...+|....+
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            766443322     234568999999999999999999999999999999999999999999999999999999999988


Q ss_pred             HHhccCC--CCcccCCCCccCCCcccccCC----CCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 EIKCMNP--NYTEFKFPQIKAHPWHKIFQK----RMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~----~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      -|+....  -+..+..+.......+.....    .-.+++.+|+.+||..||.+|+++++++.|
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            7765432  222222232222222211100    124689999999999999999999999987

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.7e-41  Score=315.90  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=198.2

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCC-----CceEEEEEcccch-----hhhHHHHHHHHHcC-CCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  132 (354)
                      .++|++.+.||+|+||.||+|.+...     +..||+|++....     +...+|+++++++. ||||+++++++     
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~-----  110 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC-----  110 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence            45799999999999999999987433     3469999986432     23457999999996 99999999988     


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhh-----------------------------------------------------
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYK-----------------------------------------------------  158 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~-----------------------------------------------------  158 (354)
                      .+....++|||||.+ +|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            444558999999985 88777754321                                                     


Q ss_pred             ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCee
Q 018514          159 ---------------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (354)
Q Consensus       159 ---------------------------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nil  199 (354)
                                                             ....+++..+..++.||+.||+|||+. +|+||||||+||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nil  269 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEE
Confidence                                                   013477888899999999999999998 9999999999999


Q ss_pred             eeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 018514          200 VNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (354)
Q Consensus       200 i~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  275 (354)
                      ++.++ .+||+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.......
T Consensus       270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            99877 799999999976533221   12334577899999986655 8999999999999999997 999997654433


Q ss_pred             HHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                      .+.........                           ...+..++.++.+++.+||+.||++|||+.++.+.|+.++
T Consensus       348 ~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 TFYNKIKSGYR---------------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHHHHHhcCCC---------------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            33322221000                           0012346899999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=324.82  Aligned_cols=242  Identities=29%  Similarity=0.491  Sum_probs=200.0

Q ss_pred             EeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeeccc
Q 018514           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE  147 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~  147 (354)
                      +||+|.||+||-|+|..+...+|||.+...    .+...+|+.+-++|+|.|||++++++     ....++-|.||-.+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            799999999999999999999999988643    34556899999999999999999997     555578899999996


Q ss_pred             -cHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC-
Q 018514          148 -TVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  223 (354)
Q Consensus       148 -~l~~~l~~~~~~~~~~--~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~-  223 (354)
                       +|.++++...   +++  ++.++..+.+||+.||.|||++ .|||||||-+|||++.-.+.+||+|||.++.+..-.+ 
T Consensus       657 GSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence             7777776653   566  8889999999999999999999 9999999999999988777999999999987754333 


Q ss_pred             ccccccccccccchhcc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCccc
Q 018514          224 NISYICSRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  302 (354)
Q Consensus       224 ~~~~~g~~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  302 (354)
                      ..++.||..|||||++. +.+.|+.++|||||||++.||.||++||......+..  +.+.                   
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-------------------  791 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-------------------  791 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-------------------
Confidence            34678999999999995 4456999999999999999999999999765543321  1111                   


Q ss_pred             CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        +   ...-...++..+|.+++.||.+|+.+||.+||+|.++|+.
T Consensus       792 --G---myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  792 --G---MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             --c---ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence              0   0111122456689999999999999999999999999864

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.5e-41  Score=299.84  Aligned_cols=249  Identities=26%  Similarity=0.441  Sum_probs=203.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||.|+||.||+|.+..++..+|+|.+...      .....+|+.+++.++|+||+++++++..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            488999999999999999999999999999987532      1234468999999999999999887643   2344578


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-----~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ++|||+++ +|.+.+........++++..++.++.||+.||+|||     +. +++|+||+|+||+++.++ .+||+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCC-CEEEeccc
Confidence            99999985 888888776555678999999999999999999999     87 999999999999999877 79999999


Q ss_pred             CceecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          214 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       214 ~a~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------  226 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--------  226 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--------
Confidence            9987654432 33456889999999986554 8899999999999999999999998776433333322110        


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 .         ..++..++..+.+++.+||..+|.+|||+.++++|
T Consensus       227 -----------~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 -----------F---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -----------C---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                       0         01233468999999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.2e-42  Score=306.70  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=198.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|.+.+.||.|+||+||++.+.     .++..+|+|.+....    ....+|+.+++.++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            46999999999999999999853     345678999886432    2355799999999999999999987     344


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhh---------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYK---------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~  205 (354)
                      ...++||||+.+ +|.+++.....         ....+++..++.++.|++.||+|||++ |++||||||+||+++.++ 
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~-  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL-  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCC-
Confidence            558999999984 88887765431         123589999999999999999999998 999999999999999887 


Q ss_pred             cEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 018514          206 QLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (354)
Q Consensus       206 ~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~  281 (354)
                      .++|+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            799999999975533221   11233467899999986544 8999999999999999998 999998776655544443


Q ss_pred             HHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      .....                            ..+..++.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       237 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~  278 (288)
T cd05093         237 QGRVL----------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN  278 (288)
T ss_pred             cCCcC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            31000                            0123468899999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-41  Score=299.79  Aligned_cols=246  Identities=19%  Similarity=0.293  Sum_probs=196.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|++.+.||+|+||+||++.+.. +..+|+|.+....   ....+|+.+++.++||||+++++++.     .....+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence            369999999999999999998743 4569999886432   33567999999999999999999873     33447899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+.+ +|.+.+....   ..+++..++.++.||+.||+|||+. |++|+||||+||+++.++ .+||+|||.+.....
T Consensus        78 ~e~~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05113          78 TEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence            999985 7777776532   3689999999999999999999998 999999999999999877 799999999876543


Q ss_pred             CCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+.+....           
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-----------  220 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence            3211  1223456799999996554 8999999999999999998 99999876655544444331100           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                       ..+...+..+.+++.+||+.||.+|||+.++++.++
T Consensus       221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                             011235789999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-41  Score=305.22  Aligned_cols=245  Identities=26%  Similarity=0.421  Sum_probs=197.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .+|++.+.||+|+||.||+|.+..++..+|+|.+...    .....+|+.+++.++|+|++++++.+..     ....++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence            4799999999999999999999889999999988543    2344578999999999999999998743     345899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+.+ +|.+.+..     ..++...+..++.|++.||+|||+. ||+||||||+||+++.++ .++|+|||++....
T Consensus        95 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~  167 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (296)
T ss_pred             eecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEECccccchhcc
Confidence            9999985 77776643     4578889999999999999999998 999999999999999877 79999999987543


Q ss_pred             cCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .... .....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+... +.+           
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~-----------  234 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP-----------  234 (296)
T ss_pred             ccccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC-----------
Confidence            3221 22346788999999986544 789999999999999999999999876654333222110 000           


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    ....+..++..+.+++.+||..||++|||+.++++|
T Consensus       235 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         235 --------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             --------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence                          001123478899999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-42  Score=302.90  Aligned_cols=256  Identities=20%  Similarity=0.302  Sum_probs=199.3

Q ss_pred             eEEEeEeeeccceEEEEEEEcCC---CceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCee
Q 018514           67 YMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  136 (354)
                      |.+.+.||+|+||.||+|.+..+   +..||+|.+..+.      ....+|+..++.++||||+++++.+..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999997643   4789999886432      234578999999999999999987754332 2334


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ..++++||+.+ +|...+.....  ....+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCC-eEEECCcc
Confidence            57899999995 77777654321  234689999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          214 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       214 ~a~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      ++.........   ....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-----  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            99865433211   1223456799999985544 8999999999999999999 889998766555443332210     


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                             ....+..++..+.+++.+||+.||++|||+.+++++|+.++
T Consensus       233 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         233 -----------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             -----------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                                   00122347899999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.7e-41  Score=297.16  Aligned_cols=246  Identities=32%  Similarity=0.479  Sum_probs=203.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|+..+.||.|+||.||.+++..++..+++|.+...      .....+|+.++++++|+||+++++++     .+...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence            589999999999999999999999999999987532      12345799999999999999999988     3445689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++|||+++ +|.+.+....  ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            99999985 8888776543  35689999999999999999999998 999999999999999887 7999999999765


Q ss_pred             ccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+...  ...         
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~---------  219 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT---------  219 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence            4433 223456789999999986654 789999999999999999999999877666555554331  000         


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                       ..+..++.++.+++.+||+.+|.+||++.++++++
T Consensus       220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                             01134689999999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.8e-41  Score=296.37  Aligned_cols=246  Identities=27%  Similarity=0.429  Sum_probs=199.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .|++.+.||+|++|.||++.+..+++.+|+|.+....      ....+|+++++.++|+|++++.+.+.    .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            3899999999999999999999899999999885321      23457899999999999999887652    2334578


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++|||+++ ++.+.+....  ...+++.++..++.|++.||++||+. |++||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999985 7777776532  35689999999999999999999998 999999999999999877 7999999999765


Q ss_pred             ccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .... ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+.....            
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------  219 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------  219 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            4322 223446788999999986654 78999999999999999999999987665444433332110            


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      ...+..+++.+.+++.+||+.||.+|||+.+++.|
T Consensus       220 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 ----------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                            01223478999999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.8e-42  Score=305.34  Aligned_cols=250  Identities=25%  Similarity=0.417  Sum_probs=197.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +|++.+.||+|+||.||+|.+..+|..+|+|.+...     .....+|+.++++++||||+++++++.     ...+.++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence            689999999999999999999889999999987542     123457999999999999999999873     3456899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ +|..++... .....+++..+..++.||+.||.|||+..+|+|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence            9999997 666665542 12347899999999999999999999633999999999999999876 79999999987653


Q ss_pred             cCCCccccccccccccchhccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          220 KGEPNISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       220 ~~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ... .....+++.|+|||.+.+..     .++.++|+|||||++|+|++|..||...........+........      
T Consensus       155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  227 (286)
T cd06622         155 ASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------  227 (286)
T ss_pred             CCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC------
Confidence            322 22345788899999985432     257899999999999999999999976554333333222111110      


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                         ..++..++.++.++|.+||+.+|++||++.+++.|
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         228 -------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                               01223478999999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=299.76  Aligned_cols=249  Identities=22%  Similarity=0.300  Sum_probs=199.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|++.+.||+|++|.||+|.+. ++..||+|.+...   .....+|+.+++.++||||+++++++     ......+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeeee
Confidence            46999999999999999999864 4567999988653   23455799999999999999998876     333447899


Q ss_pred             Eeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+. ++|.+.+....  ...+++..+..++.|++.||.+||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENN-ICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence            99995 58888876543  35689999999999999999999998 999999999999999887 799999999987643


Q ss_pred             CCCcc--ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~~--~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .....  ....+..|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+.......+......           
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  223 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-----------  223 (261)
T ss_pred             CcccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            22111  112235799999986554 8999999999999999999 99999877665555444321100           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                       ..+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       224 -----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 -----------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                             01234679999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.7e-42  Score=311.00  Aligned_cols=246  Identities=23%  Similarity=0.379  Sum_probs=193.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCce----EEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|++.+.||+|+||+||+|++..+++.    ||+|.+...     .....+|+.+++.++||||+++++++...      
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~------   81 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS------   81 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC------
Confidence            699999999999999999998766654    899988532     23345789999999999999999987431      


Q ss_pred             EEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..+++++|+. |++.+.+....   ..++...+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~-~~kl~DfG~a  156 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQ-HVKITDFGLA  156 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCC-cEEEcccccc
Confidence            2568999988 47877776532   4678889999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCcc---ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          216 KVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       216 ~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ..........   ...++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+. ..+......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~-----  229 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGER-----  229 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCC-----
Confidence            8664333222   122356799999996554 8999999999999999997 9999977654332 232221000     


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                  .+          .+..++.++.+++.+||..||.+|||+.+++.+|..
T Consensus       230 ------------~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~  267 (316)
T cd05108         230 ------------LP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  267 (316)
T ss_pred             ------------CC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                        00          112367899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-41  Score=300.89  Aligned_cols=249  Identities=25%  Similarity=0.332  Sum_probs=198.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ++|++.++||+|+||.||+|++..+ ..||+|.+....   ....+|+.+++.++||||+++++.+.     . ...++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence            4799999999999999999998655 459999886432   34567999999999999999987651     1 236899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+++ +|.+.+....  ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence            999985 8887776532  24578899999999999999999998 999999999999999887 799999999976543


Q ss_pred             CCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  ....++..|+|||...+.. ++.++||||||+++|+|++ |..||.+....+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------  222 (262)
T ss_pred             cccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-----------
Confidence            3221  1234566799999986555 8999999999999999999 88999877655544433221000           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                       .....++..+.+++.+||+.||++|||+.++++.|++.|
T Consensus       223 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         223 -----------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             -----------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                             012236889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=298.73  Aligned_cols=245  Identities=27%  Similarity=0.420  Sum_probs=206.0

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhH-------HHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...+|..+++||+|.||+|-+|+.+.+|+.+|+|+++++.-...       -|-++|+..+||.+..+...|     ...
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence            34579999999999999999999999999999999876543322       467899999999999987777     555


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+|+||||..| .|.-.+.+    ...+++..++.+...|+.||.|||++ +||.||||.+|.++|.+| .|||+|||+
T Consensus       241 drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDG-HIKitDFGL  314 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDG-HIKITDFGL  314 (516)
T ss_pred             ceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCC-ceEeeeccc
Confidence            569999999996 55555554    36799999999999999999999998 999999999999999999 599999999


Q ss_pred             ceec-ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          215 AKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       215 a~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ++.- ..+....+++|||.|.|||++. ...|+.++|+|.+||+||||++|+.||.+.+....+..|...          
T Consensus       315 CKE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------  383 (516)
T KOG0690|consen  315 CKEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------  383 (516)
T ss_pred             chhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------
Confidence            9753 3445566889999999999995 555999999999999999999999999988877766666542          


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                             ++            .|+..++++++.|+..+|..||.+|.     .|.|+.+|
T Consensus       384 -------d~------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  384 -------DL------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             -------hc------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                   22            24567999999999999999999998     35555554

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-41  Score=303.82  Aligned_cols=240  Identities=29%  Similarity=0.475  Sum_probs=200.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+...       .....+|++++++++||||+++++++     .+....
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence            699999999999999999999999999999988542       12345799999999999999999987     445568


Q ss_pred             EEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||++ ++|.+.+...    ..+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .+||+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            99999996 5887777653    5789999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  .....+++.|+|||.+.+.. .+.++||||||+++|+|++|..||...+.......+...  .           
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-----------  214 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K-----------  214 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------
Confidence            6443  33456788999999986554 789999999999999999999999877644444443321  0           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                      ..++..++..+.++|.+||+.||.+|+     +++++++|
T Consensus       215 ----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 ----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                            012334689999999999999999999     89999987

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.1e-42  Score=299.57  Aligned_cols=241  Identities=22%  Similarity=0.320  Sum_probs=190.0

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      +.||+|+||.||+|.+..+++.+|+|.+...     .....+|+++++.++||||+++++++     ......++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence            3689999999999999889999999987533     23355799999999999999999987     3344588999999


Q ss_pred             cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCc
Q 018514          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (354)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~  224 (354)
                      .+ +|.+.+...   ...+++..++.++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++.........
T Consensus        76 ~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            86 777776542   24688999999999999999999998 999999999999999887 7999999998754332111


Q ss_pred             c---ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          225 I---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       225 ~---~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .   ...++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+.......+.....               
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---------------  214 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---------------  214 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------
Confidence            1   112245699999986555 8999999999999999998 8899976654433332222100               


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                   ...+...+..+.+++.+||+.||++|||+.++++.|.
T Consensus       215 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 -------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                         0112346889999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=298.97  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=200.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ++|++.+.||.|+||.||+|.+..+++.+++|.+...    .....+|+.+++.++||||+++++++     .+...+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence            4799999999999999999999888999999988643    23456799999999999999999887     33445899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +|||+++ ++.+.+...   ...+++..+..++.|++.||+|||++ +++|+||+|+||+++.++ .++|+|||.+....
T Consensus        78 ~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDG-DVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCC-CEEECccccchhhh
Confidence            9999996 666665543   25689999999999999999999998 999999999999999887 79999999987654


Q ss_pred             cCC-CccccccccccccchhccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ... ......++..|+|||.+.+.  ..++.++|+||||+++|+|++|.+||...+.......+......+.        
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  224 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP--------  224 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc--------
Confidence            322 22345678889999998654  2478899999999999999999999988765555443332100000        


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                               ..       ......+.++.+++++||..+|.+|||+.+++.|
T Consensus       225 ---------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         225 ---------KL-------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ---------cc-------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                     00       0112357889999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=301.31  Aligned_cols=249  Identities=23%  Similarity=0.309  Sum_probs=198.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCC---CceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+|++.+.||+|+||.||+|.+..+   ...||+|.+....     ....+|+.+++.++||||+++++.+     .+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence            4699999999999999999998644   4579999885432     2334699999999999999999877     3344


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..+++|||+.+ +|.+.+....   ..+++..++.++.|++.||+|||++ +|+|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~-~~~l~dfg~~  153 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-CEEECccchh
Confidence            47899999986 7877776532   4789999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          216 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       216 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .........   ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----  227 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-----  227 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            876422211   1223456799999986544 8999999999999999997 99999776655544444321100     


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                             ..+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus       228 -----------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 -----------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                                   01224688999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.3e-42  Score=303.12  Aligned_cols=249  Identities=22%  Similarity=0.329  Sum_probs=202.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ..+|++.+.||.|+||.||+|.+.. +..+|+|.+....    ....+|+.+++.++|+||+++++++     .+....+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence            3479999999999999999999876 8889999986543    3445799999999999999998877     3444588


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+++ +|.+++....  ...++...++.++.||+.||.|||++ |++|+||||+||+++.++ .+||+|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~  154 (261)
T cd05148          79 IITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLI  154 (261)
T ss_pred             EEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCc-eEEEccccchhhc
Confidence            99999986 8888887532  35688999999999999999999998 999999999999999887 7999999999765


Q ss_pred             ccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ..... .....++..|+|||.+.... ++.++||||||+++|+|++ |..||...+..+.+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------  223 (261)
T ss_pred             CCccccccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------
Confidence            33221 11233466799999986554 8899999999999999998 89999887765555554431110          


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                        ..+..+++.+.+++.+||+.||++|||+.++++.|++
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 ------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                              0123468999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.6e-41  Score=302.28  Aligned_cols=253  Identities=20%  Similarity=0.292  Sum_probs=198.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      ..+|.+.+.||+|+||.||+|.+..     ++..||+|.+....     ....+|+.+++.++|+||+++++++..    
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE----   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence            3579999999999999999999976     67889999875432     234578999999999999999998743    


Q ss_pred             CeeEEEEEEeeccc-cHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--CcE
Q 018514          134 DELYLNLVLEYVPE-TVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQL  207 (354)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--~~v  207 (354)
                       ....++||||+.+ +|.+++.....   ....+++..+..++.||+.||+|||++ +++||||||+||+++.++  ..+
T Consensus        81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcce
Confidence             3346899999975 88888866432   123588999999999999999999998 999999999999998653  258


Q ss_pred             EEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 018514          208 KLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (354)
Q Consensus       208 kl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~  283 (354)
                      ||+|||++........   ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999976532211   11223356799999996555 8999999999999999997 99999876655443322211


Q ss_pred             hCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                       ..                           ..++..++..+.+++.+||+.+|++|||+.+++++|..
T Consensus       238 -~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         238 -GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             -Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence             00                           01223478999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.2e-41  Score=302.47  Aligned_cols=245  Identities=28%  Similarity=0.443  Sum_probs=199.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .+|++.+.||.|++|.||+|.+..+|+.||+|.+....    ....+|+.+++.++||||+++++.+     .....+++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence            46999999999999999999999999999999885432    2345799999999999999999987     34456899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      |+||+.+ +|...+..     ..+++..+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++....
T Consensus        94 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~  166 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccchhcc
Confidence            9999986 66665543     4588999999999999999999998 999999999999999877 79999999987553


Q ss_pred             cCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .... .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+... ..+.          
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~----------  234 (296)
T cd06655         167 PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE----------  234 (296)
T ss_pred             cccccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc----------
Confidence            3322 22346788999999986554 789999999999999999999999887765544433221 0000          


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     ...+..+++.+.++|++||..||++|||+.+++.|
T Consensus       235 ---------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         235 ---------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ---------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                           00123478999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=306.31  Aligned_cols=246  Identities=27%  Similarity=0.410  Sum_probs=204.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      -|.+.++||+|+||.||+|.++.+|..+|||++..+.  +...+|+.++++++.|++|++|+.||...+     +|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence            4889999999999999999999999999999987554  455689999999999999999999977655     899999


Q ss_pred             ecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC-
Q 018514          144 YVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  221 (354)
Q Consensus       144 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-  221 (354)
                      ||+ |++.+.++.+   +++++++.+..+++..++||+|||.. .-||||||..|||++.++ ..||+|||.|..+... 
T Consensus       109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccc-hhhhhhccccchhhhhH
Confidence            999 6777777765   48899999999999999999999997 889999999999999998 6999999999765332 


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ....+..|||.|||||++..-. |+.++||||||++..||.-|++||..-.+...+..|-.   .|++           .
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT---~PPP-----------T  248 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT---KPPP-----------T  248 (502)
T ss_pred             HhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC---CCCC-----------C
Confidence            2344678999999999996554 89999999999999999999999976554433322211   1110           0


Q ss_pred             cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      |+            .++.-|.++.+|+++||-..|++|.||.++++|
T Consensus       249 F~------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  249 FK------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CC------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            00            112247899999999999999999999999998

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.3e-41  Score=310.14  Aligned_cols=271  Identities=22%  Similarity=0.337  Sum_probs=193.5

Q ss_pred             EEeEeeec--cceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           69 AERVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        69 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ++++||+|  +|++||++.++.+|+.||+|++....      ....+|+.+++.++||||+++++++.     .....++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence            45789999  78999999999999999999986431      23457999999999999999999884     3345889


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ ++.+++....  ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            9999985 7777776533  24588999999999999999999998 999999999999999887 79999998654332


Q ss_pred             cCCC--------ccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC----
Q 018514          220 KGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT----  286 (354)
Q Consensus       220 ~~~~--------~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----  286 (354)
                      ....        .....++..|+|||++.+. ..++.++|||||||++|+|++|..||..................    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            1111        1123456779999998653 34889999999999999999999999875544433332221000    


Q ss_pred             ---CCHHHHh-cc-----CCCCcccCC----CCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          287 ---PTREEIK-CM-----NPNYTEFKF----PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       287 ---~~~~~~~-~~-----~~~~~~~~~----~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                         .+.+.+. ..     .....+...    .......-...+...+++.+.+||++||++||++|||++++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence               0000000 00     000000000    00000000111234568899999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.5e-41  Score=303.41  Aligned_cols=248  Identities=27%  Similarity=0.399  Sum_probs=196.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +.|++.+.||.|+||.||+|++..++..+++|.+....    ....+|+.+++.++||||+++++++..     ....++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence            46999999999999999999999999999999986432    234468999999999999999998743     345899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ ++...+...   ...+++..+..++.|++.+|+|||+. |++||||||+||+++.++ .++|+|||++....
T Consensus        87 v~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence            9999997 454444332   24688999999999999999999998 999999999999999877 79999999986543


Q ss_pred             cCC-CccccccccccccchhccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          220 KGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ... ......+++.|+|||.+.+    ...++.++|||||||++|+|++|..||...+......++...  .++      
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~------  233 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP------  233 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc------
Confidence            221 1234567889999999852    233678999999999999999999999776654444333221  000      


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 .       ...+..++.++.++|.+||+.||++||++.++++|
T Consensus       234 -----------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 -----------T-------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -----------c-------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                       0       00123467899999999999999999999999987

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.9e-41  Score=297.87  Aligned_cols=253  Identities=32%  Similarity=0.506  Sum_probs=201.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++..       .....+|+++++.++|+|++++++++.     ....
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence            4799999999999999999999889999999987421       234457999999999999999999884     3345


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++||||+++ +|...+.........+++..+..++.|++.||+|||+. |++||||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCC-cEEEeccceee
Confidence            7899999985 88888876544456789999999999999999999998 999999999999999887 79999999987


Q ss_pred             ecccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCHHHHh
Q 018514          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       217 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~  293 (354)
                      ...... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......  +....+...          
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC----------  223 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------
Confidence            653322 123356788899999986554 889999999999999999999999654311  111111110          


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                               ..+.        .....++..+.++|.+||..+|++|||+.++++.|.+.
T Consensus       224 ---------~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         224 ---------DYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ---------CCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                     0000        01124678999999999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.8e-42  Score=302.19  Aligned_cols=255  Identities=30%  Similarity=0.480  Sum_probs=200.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ++|++.+.||+|+||.||+|.+..++..+|+|.+...       .....+|+.+++.++||||+++++++.     ....
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence            3689999999999999999999889999999977532       123447999999999999999999884     3345


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .+++|||+.+ +|.+.+.........+++..++.++.||+.||.|||++ |++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~  154 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence            8899999996 78887775444456789999999999999999999998 999999999999999887 79999999987


Q ss_pred             ecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.....  ..+.+.+.          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~----------  221 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIE----------  221 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhh----------
Confidence            6543322 22346788999999986554 7899999999999999999999997543221  11111100          


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                           ....+.        .....++..+.+++.+||+.||++|||+.++++.+..+
T Consensus       222 -----~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         222 -----QCDYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             -----cCCCCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                 000000        01123688999999999999999999999998877654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=301.85  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=199.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCC-----CceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.++||||+++++++     .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence            34799999999999999999998643     3789999985432     2344789999999999999999987     3


Q ss_pred             CeeEEEEEEeecc-ccHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCc
Q 018514          134 DELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (354)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~  206 (354)
                      .....++||||++ ++|.+.+......      ...+++..+..++.|++.||.|||+. +++||||||+||+++.++ .
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~-~  157 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDL-T  157 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCC-C
Confidence            3455889999998 5888888654321      23478889999999999999999998 999999999999999887 7


Q ss_pred             EEEEeccCceecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 018514          207 LKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (354)
Q Consensus       207 vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  282 (354)
                      +||+|||++.......   ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            9999999987553322   112334577899999986554 8999999999999999998 9999987765554443321


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      . ..                           ..++...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       237 ~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         237 G-GH---------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             C-CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            0 00                           01223368999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-41  Score=300.09  Aligned_cols=243  Identities=30%  Similarity=0.503  Sum_probs=196.0

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------------hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      +|.+...||.|++|.||+|.+..++..+|+|.+....             ....+|+.+++.++||||+++++++     
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS-----   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence            4788899999999999999998889999999875321             2345789999999999999999887     


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                      .+..+.+++|||+++ +|.+.+...    ..+++..+..++.|++.||+|||+. |++||||+|+||+++.++ .++|+|
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCC-CEEecc
Confidence            334458899999986 777777653    5688889999999999999999998 999999999999999887 799999


Q ss_pred             ccCceecccCCC-------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 018514          212 FGSAKVLVKGEP-------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  284 (354)
Q Consensus       212 fg~a~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  284 (354)
                      ||.+........       .....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+....+..+....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA  228 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence            999876642211       11235788899999986554 7899999999999999999999998766544433322210


Q ss_pred             CCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                         .         ..++..++..+.++|++||+.||.+||++.++++|
T Consensus       229 -------------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         229 -------------------S---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -------------------C---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                               0         01223478999999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=301.92  Aligned_cols=242  Identities=26%  Similarity=0.405  Sum_probs=199.3

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +|++.+.||.|++|.||+|.+..+++.+|+|.+....     ....+|+.+++.++|+||+++.+++.     +....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence            6889999999999999999999999999999885432     23457999999999999999999873     3356899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      |+||+.+ +|.+.+..     .++++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  149 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEG-DVKLADFGVSGQLT  149 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence            9999986 77776654     3789999999999999999999998 999999999999999887 79999999998765


Q ss_pred             cC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .. .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+....              
T Consensus       150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------------  214 (274)
T cd06609         150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--------------  214 (274)
T ss_pred             ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--------------
Confidence            43 2233456788899999997665 8999999999999999999999998766444333332210              


Q ss_pred             CcccCCCCccCCCcccccCCC-CCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~-~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    ...+... ++..+.+++.+||..||++|||+++++.|
T Consensus       215 --------------~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         215 --------------PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             --------------CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                          0001112 68899999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-41  Score=311.55  Aligned_cols=275  Identities=37%  Similarity=0.680  Sum_probs=215.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||.||+|.+..+|+.+|+|++...      .....+|+.+++++ +||||+++++++..   .+.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            345799999999999999999999888999999987432      22344699999999 99999999988733   234


Q ss_pred             eEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ...++||||+.++|...+..     ..+++..++.++.||+.||+|||+. ||+|+||||+||+++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~-~~kl~d~g~~  154 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDC-RVKLADFGLA  154 (337)
T ss_pred             ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccch
Confidence            45789999999988777654     2678888999999999999999998 999999999999999888 7999999998


Q ss_pred             eecccCC------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          216 KVLVKGE------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       216 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      .......      ......++..|+|||.+.+...++.++||||||+++|+|++|+.||.+....+....+....+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            7653322      1123467889999999866666789999999999999999999999998888888888888877776


Q ss_pred             HHHhccCCCCcccC---CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFK---FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..+..+.......-   .......... .....++.++.++|.+||+.||++|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            55443221111100   0111111111 1223378999999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.1e-41  Score=295.55  Aligned_cols=246  Identities=21%  Similarity=0.323  Sum_probs=197.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      .+|.+.+.||+|+||.||++..  .|..+|+|.+..+.  ....+|+.+++.++|+|+++++++++.    .....+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEE
Confidence            3699999999999999999986  57889999886543  235579999999999999999887643    223478999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+++ +|.+.+....  ...+++..+..++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence            99985 8888776533  24578899999999999999999998 999999999999999887 7999999998754332


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .  ....++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||...+..+....+.+.                 
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-----------------  215 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----------------  215 (256)
T ss_pred             C--CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            2  2233456799999986554 8899999999999999997 99999766544443333221                 


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                 +....+..+++.+.+++.+||+.+|.+|||+.++++.|++
T Consensus       216 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         216 -----------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                       0011223478999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-41  Score=298.55  Aligned_cols=275  Identities=33%  Similarity=0.587  Sum_probs=213.0

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHc---CCCCeeecceeeeecCCCCeeE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      |++.+.||+|+||.||+|++..++..+|+|.+....      ....+|+.+++++   +|+|++++++++......+...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678999999999999999998889999999986321      1233577777666   5999999999986654444556


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++++|||+.+++.+.+....  ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            89999999998888776543  23589999999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...........++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||...+..+.+..+......+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            65444434455788899999997655 78999999999999999999999999888888888877665554433221110


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       .....++......+ ......++..+.++|.+||+.||.+||++.+++.|
T Consensus       236 -~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         236 -LPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             -cchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence             00001111111111 11223467889999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.7e-41  Score=304.97  Aligned_cols=271  Identities=37%  Similarity=0.708  Sum_probs=213.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++...      .....+|+++++.++||||+++.++|...    ...
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~   84 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LED   84 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CCc
Confidence            45799999999999999999999999999999987432      23445799999999999999999887432    224


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .++++||+++++...+..     .+++...+..++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||.+..
T Consensus        85 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI  157 (328)
T ss_pred             EEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence            789999998888776653     4578888999999999999999998 999999999999999877 799999999875


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......++..|+|||.+.+...++.++||||||+++|+|++|..||...+.......+.+.++.++.+.......
T Consensus       158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            432  223446788899999986655589999999999999999999999998887777788888888877665543221


Q ss_pred             CC-ccc--CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NY-TEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~-~~~--~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .. ..+  ..+.....++.. ....++..+.++|++||+.+|++|||+.+++.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSE-KFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhhHHHHhhccccCCCcHHH-HcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            10 000  011111111111 123478999999999999999999999999988

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-41  Score=332.83  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=192.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++..+       .....+|+++++.++||||+++++++     .+...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence            4799999999999999999999999999999998643       12345799999999999999999887     34445


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEE
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKM-------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl  209 (354)
                      .+++|||++| +|.+.+......       ....+...+..++.||+.||+|||++ ||+||||||+||+++.++ .++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg-~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFG-EVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCC-CEEE
Confidence            8999999986 787777643211       23456677889999999999999998 999999999999999887 7999


Q ss_pred             EeccCceecccCC-------------------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 018514          210 CDFGSAKVLVKGE-------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (354)
Q Consensus       210 ~Dfg~a~~~~~~~-------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  270 (354)
                      +|||++.......                   ......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999997652110                   011246899999999997665 89999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHH-Hhhcc
Q 018514          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD-AVGSF  349 (354)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e-~l~~l  349 (354)
                      .+.......  .....+..                   ..     ....+++.+.+++.+||+.||++|+++.+ +++.|
T Consensus       234 ~~~~ki~~~--~~i~~P~~-------------------~~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L  287 (932)
T PRK13184        234 KKGRKISYR--DVILSPIE-------------------VA-----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL  287 (932)
T ss_pred             cchhhhhhh--hhccChhh-------------------cc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            443322111  10000000                   00     01247899999999999999999976544 44433

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-41  Score=299.50  Aligned_cols=271  Identities=38%  Similarity=0.672  Sum_probs=219.4

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      |++.+.||+|++|.||+|++..+++.+|+|.+....      ....+|+.+++.++|+|++++++++.     +....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence            677889999999999999999899999999886532      23346899999999999999999873     3456899


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |+||++++|.+.+....   ..+++..+..++.|++.||+|||++ ||+||||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            99999999988887643   4689999999999999999999998 999999999999999877 799999999876543


Q ss_pred             CC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       221 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      .. ......++..|+|||.+.+...++.++||||||+++|+|++|.+||.+.+....+..+....+.+....+.......
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            32 22234457789999998766468999999999999999999999999998888889999888888877665432221


Q ss_pred             -cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 -TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 -~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       ....++......+...+ ..++..+.++|++||..||++||++.+++.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence             12223332222222222 2358899999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.9e-41  Score=306.43  Aligned_cols=275  Identities=36%  Similarity=0.609  Sum_probs=215.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCC--CceEEEEEcccc------hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLET--GEAVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|++.+.||+|+||.||++.+..+  +..||+|++...      .....+|+.+++++ +||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            489999999999999999999877  889999987542      12345699999998 5999999988653322 2334


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++++++|++++|...+..    ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++.
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            5788999999988887754    35689999999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCCC-----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          217 VLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       217 ~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .......     .....|+..|+|||.+.+...++.++||||||+++|+|++|.+||...+....+..+...++.++.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6543221     12346788999999886655589999999999999999999999999888889999999998888765


Q ss_pred             HhccCCCCcc---cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +.........   ..........+. ......+..+.+++.+||+.||++|||+.+++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            4433211000   000111111111 1123468899999999999999999999999977

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-41  Score=325.99  Aligned_cols=276  Identities=20%  Similarity=0.285  Sum_probs=193.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCC-ceEEEE------------------Ecccc---hhhhHHHHHHHHHcCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETG-EAVAIK------------------KVLQD---KRYKNRELQTMRLLDHPNVV  121 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK------------------~~~~~---~~~~~~e~~~l~~l~h~~iv  121 (354)
                      ..+|++.+.||+|+||+||+|..+... ...+.|                  .+...   .....+|+.++++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            457999999999999999998764332 112222                  11111   12345799999999999999


Q ss_pred             ecceeeeecCCCCeeEEEEEEeeccccHHHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee
Q 018514          122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (354)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili  200 (354)
                      ++++++.     +....++|++++.+++...+.... ..........++.++.||+.||+|||++ ||+||||||+|||+
T Consensus       227 ~l~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILR-----SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEE-----ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEE
Confidence            9999873     344578999999988887765432 1123345677888999999999999998 99999999999999


Q ss_pred             eCCCCcEEEEeccCceecccCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCC--CCcHH
Q 018514          201 NPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPG--ESGVD  275 (354)
Q Consensus       201 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~--~~~~~  275 (354)
                      +.++ .+||+|||++........  .....||..|+|||++.+.. ++.++|||||||++|||++|..+ |..  .....
T Consensus       301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9887 799999999986644322  23457899999999997655 89999999999999999998754 432  23445


Q ss_pred             HHHHHHHHhCCCCHHHHhccCCCCccc---CCCCccCCCccccc-CCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          276 QLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+.++...++.+..+........+..+   .+.... ......+ ...++.++.++|.+||++||.+||||.|+|.|
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            566666555433222100000000000   000000 0000001 12367889999999999999999999999987

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-41  Score=307.88  Aligned_cols=274  Identities=34%  Similarity=0.556  Sum_probs=215.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  137 (354)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.++++++||||+++.+++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            57999999999999999999998899999999885431      234469999999999999999987743321 12234


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .+++++++++++.+.+..     ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||++..
T Consensus        97 ~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~  169 (345)
T cd07877          97 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  169 (345)
T ss_pred             EEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence            788999998888776653     4588999999999999999999998 999999999999999887 799999999875


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......++..|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+....+.+..........
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            432  223456788999999986655588999999999999999999999998888888888888877777665543322


Q ss_pred             CCccc---CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....   ..+......+.. .....++++.++|.+||+.||.+|||+.+++.|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            11100   001111111111 112368899999999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.1e-41  Score=298.75  Aligned_cols=248  Identities=25%  Similarity=0.470  Sum_probs=197.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      +|+..+.||+|+||.||++.+..+++.+|+|++....          ....+|+++++.++|+||+++++++     .+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            4788899999999999999999999999999885322          2345799999999999999999987     445


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++|+||+.+ +|.+.+...    .++++..+..++.|++.||.|||++ |++|+||+|+||+++.++..++|+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            568899999996 777777542    5688999999999999999999998 9999999999999987765799999999


Q ss_pred             ceecccCCC-----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +........     .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+......   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  226 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA---  226 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence            876543211     12345788899999986544 789999999999999999999999765433222222111000   


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                           .....++..+++++.+++.+||..+|.+|||+.+++.|
T Consensus       227 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         227 ---------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ---------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                                 00011234478999999999999999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.6e-41  Score=304.66  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=199.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCC-----CceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  131 (354)
                      ...+|++.+.||+|+||.||++.+...     ...+|+|.+....     ....+|+.+++.+ +|+||+++++++    
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----   85 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC----   85 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence            345799999999999999999997643     3679999886432     2244789999999 899999999887    


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  198 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Ni  198 (354)
                       .....++++|||+.+ +|...+....            .....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus        86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Ni  163 (293)
T cd05053          86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNV  163 (293)
T ss_pred             -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeE
Confidence             333458999999985 8887776432            2345688999999999999999999998 999999999999


Q ss_pred             eeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 018514          199 LVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGV  274 (354)
Q Consensus       199 li~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  274 (354)
                      +++.++ .+||+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....
T Consensus       164 l~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         164 LVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             EEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            999877 899999999976543321   11223456799999986554 8999999999999999997 99999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       275 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      +....+....                            ....+...+..+.+++.+||..||.+|||+.++++.|++.
T Consensus       242 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         242 ELFKLLKEGY----------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            5444332210                            0001224678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-41  Score=307.36  Aligned_cols=273  Identities=34%  Similarity=0.600  Sum_probs=212.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  137 (354)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4799999999999999999999889999999988542      1224579999999999999999998744321 12234


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++|+||+..++....      ...+++..+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++..
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH  166 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence            6899999987665443      24688999999999999999999998 999999999999999887 799999999875


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            432  223446788899999987655588999999999999999999999998887788888888777777665443321


Q ss_pred             CCcc-c--CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTE-F--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~-~--~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .... +  ..+......+... ....++.+.++|++||+.||.+||++.+++.|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             cchHHHHhhcCCcccchHHHH-hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1100 0  0111111111111 12468899999999999999999999999987

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.3e-41  Score=301.04  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=199.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHc-CCCCeeecceeeeecCC-CCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE-KDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~  138 (354)
                      .+.|++.+.||.|+||.||+|.+..+++.+|+|.+....   .....|+.+++++ +|+||+++++++..... ....+.
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            357999999999999999999999999999999885432   2345688888888 69999999998754322 234568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++|||+++ +|.+++....  ...+++..++.++.||+.||+|||++ ||+|+||+|+||+++.++ .++|+|||++..
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~-~~~l~dfg~~~~  170 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCcchhh
Confidence            999999986 7777776533  34578889999999999999999998 999999999999999887 799999999875


Q ss_pred             cccC-CCccccccccccccchhccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          218 LVKG-EPNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       218 ~~~~-~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      .... .......+++.|+|||.+..    ...++.++|||||||++|+|++|..||....+......+...   ..    
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~----  243 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP----  243 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC----
Confidence            4322 12234568889999999853    234788999999999999999999999765543333222110   00    


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                  +        ......++..+.++|.+||+.||.+|||+.++++|
T Consensus       244 ------------~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         244 ------------P--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ------------C--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                        0        00112468999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.3e-41  Score=303.56  Aligned_cols=270  Identities=24%  Similarity=0.387  Sum_probs=198.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +|++.+.||+|+||.||++.+..++..+|+|.+....     ....+|++++++++||||+++++++.     ...++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEEE
Confidence            5999999999999999999999999999999875431     23457999999999999999999883     3445899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ +|.+.+...    ..+++..+..++.|++.||.|||+..+++|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999986 777777653    56899999999999999999999733899999999999999887 79999999987553


Q ss_pred             cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH-H-hccCC
Q 018514          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE-I-KCMNP  297 (354)
Q Consensus       220 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~-~~~~~  297 (354)
                      ... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+... ...+........... . .....
T Consensus       152 ~~~-~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DSM-ANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ccc-cccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence            322 23456788999999986554 8899999999999999999999997655322 222221110000000 0 00000


Q ss_pred             CCcc----cC----CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTE----FK----FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~----~~----~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...+    ..    ................++.++.+++.+||..||++|||+.+++.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000    00    000000000000112367899999999999999999999999988

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-41  Score=307.54  Aligned_cols=274  Identities=34%  Similarity=0.609  Sum_probs=212.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC-CeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~  137 (354)
                      ++|++.+.||+|+||.||+|.+..+|..||+|++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            4799999999999999999999999999999988532      12344799999999999999999887433211 1234


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++||||+++++...+..     ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        95 ~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~  167 (343)
T cd07880          95 FYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  167 (343)
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccccc
Confidence            689999998787776653     4689999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+.+..+.++.........
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            5332  22346688899999986645588999999999999999999999998887777777777666665544332221


Q ss_pred             CCccc---CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....   ..+....... ..+...+++.+.++|.+||+.||++|||+.+++.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             hhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            10000   0000000000 11234578899999999999999999999999976

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=303.01  Aligned_cols=249  Identities=25%  Similarity=0.377  Sum_probs=199.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .++|++.+.||.|+||+||++.+..++..+|+|.+....    ....+|+++++.++||||+++++.+.     .....+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence            357999999999999999999998889999999885432    23447999999999999999999873     344589


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+++ +|.+.+...   ...+++..++.++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~  153 (280)
T cd06611          79 ILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDG-DVKLADFGVSAKN  153 (280)
T ss_pred             EEeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCC-CEEEccCccchhh
Confidence            99999996 676666543   25689999999999999999999998 999999999999999887 7999999988654


Q ss_pred             ccCC-CccccccccccccchhccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          219 VKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      .... ......+++.|+|||.+..    ...++.++|+||||+++|+|++|..||...+....+..+....  +      
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~------  225 (280)
T cd06611         154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--P------  225 (280)
T ss_pred             cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--C------
Confidence            3322 2234567889999999742    2336789999999999999999999998776555444432210  0      


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 +..       ..+..++.++.++|.+||+.||.+||++.++++|
T Consensus       226 -----------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 -----------PTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -----------CCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                       000       0123468899999999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=298.02  Aligned_cols=244  Identities=21%  Similarity=0.315  Sum_probs=195.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +|++.+.||+|+||.||++.+. ++..+|+|.+...   .....+|+++++.++||||+++++++     .+..+.++||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence            6899999999999999999875 4667999988643   22445799999999999999998877     3444588999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+++ +|.+.+....   ..+++..++.++.|++.||+|||+. |++||||||+||+++.++ .+||+|||++......
T Consensus        79 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~  153 (256)
T cd05059          79 EYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD  153 (256)
T ss_pred             ecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence            99985 7887776532   4688999999999999999999998 999999999999999887 7999999998765432


Q ss_pred             CCcc--ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          222 EPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       222 ~~~~--~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ....  ...++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+.....             
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------  219 (256)
T cd05059         154 QYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-------------  219 (256)
T ss_pred             cccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence            2111  122345799999986554 8999999999999999998 8999987665554443322110             


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                     ...+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       220 ---------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 ---------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                           011234689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.4e-41  Score=302.12  Aligned_cols=250  Identities=20%  Similarity=0.303  Sum_probs=196.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEc----CCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|++.+.||+|+||+||+|.+.    .++..+|+|.+....     ....+|+.+++.++||||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence            46999999999999999999853    355789999886321     23457999999999999999999873     33


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhh-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYK-------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~  201 (354)
                      ...+++|||+.+ +|.+.+.....             ....+++..+..++.|++.||+|||++ |++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~  158 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIG  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEc
Confidence            447899999985 78777753221             123578888999999999999999998 999999999999999


Q ss_pred             CCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 018514          202 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (354)
Q Consensus       202 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  277 (354)
                      .++ .+||+|||++........   .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+.....
T Consensus       159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 799999999976533221   12234466799999986554 8999999999999999998 99999876654443


Q ss_pred             HHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       278 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      ..+.... .+                           ..+..+++.+.+++.+||+.||.+||++.+++++|.
T Consensus       237 ~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         237 EMVRKRQ-LL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HHHHcCC-cC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            3332210 00                           022347899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-41  Score=302.40  Aligned_cols=244  Identities=25%  Similarity=0.439  Sum_probs=191.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +|++.+.||+|+||.||+|.+..++..||+|.+..+.     ....+|++++++++||||+++++++..     ....++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            5888999999999999999999999999999885431     234479999999999999999998843     344789


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      ||||++++.....       ..+++..+..++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999997543322       3468888999999999999999998 999999999999999887 799999999976543


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      . ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........   ............         
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  216 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---------  216 (279)
T ss_pred             c-cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence            3 233457889999999996655 89999999999999999999999965322110   011111100000         


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                            .+.        ......++++.+++.+||+.||.+||+++++++|
T Consensus       217 ------~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 ------PPV--------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ------CCC--------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                  000        0112367899999999999999999999999988

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.2e-41  Score=303.56  Aligned_cols=252  Identities=22%  Similarity=0.319  Sum_probs=199.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|.+.+.||+|+||.||+|++..     ++..+++|.+....    ....+|+.+++.++|+||+++++++     .+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence            469999999999999999998643     44568899886442    3456799999999999999999987     344


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~  202 (354)
                      ...++||||+++ +|.+++.....            ....+++..++.++.||+.||+|||++ ||+||||||+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEcc
Confidence            458999999984 88888765421            224588999999999999999999998 9999999999999998


Q ss_pred             CCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 018514          203 HTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (354)
Q Consensus       203 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  278 (354)
                      ++ .++|+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+...
T Consensus       159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            87 799999999975533221   12344577899999986554 8999999999999999998 999998776655443


Q ss_pred             HHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .+....                   .         ...+...+..+.+++.+||+.||.+|||+.++++.|++.
T Consensus       237 ~~~~~~-------------------~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         237 CITQGR-------------------V---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HHhCCC-------------------C---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            332210                   0         001233678999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-41  Score=308.90  Aligned_cols=275  Identities=34%  Similarity=0.617  Sum_probs=215.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  136 (354)
                      .++|++.+.||+|++|.||+|++..++..||+|++...      .....+|+.+++.++|||++++.+++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            34799999999999999999999989999999987532      1223469999999999999999887643322 2233


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ..++|+||++++|.+.+..     .++++..++.++.|++.||+|||+. ||+||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~-~~kL~dfg~~~  166 (343)
T cd07851          94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEccccccc
Confidence            5789999998888887764     5689999999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .....  .....++..|+|||.+.+...++.++||||||+++|+|++|+.||.+.+....+..+....+.++...+....
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            65332  2344678889999998665457899999999999999999999999888888888888877777765543332


Q ss_pred             CCCc-cc--CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYT-EF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~-~~--~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .... .+  ..+......+.. ....++..+.++|.+||+.||++|||+.+++.|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             chhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            1100 00  001111111111 123468999999999999999999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.5e-41  Score=300.85  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=196.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .+|++.+.||+|+||.||+|++..+++.||+|.++...    ....+|+.+++.++||||+++++.+.     .....++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence            47999999999999999999999999999999885432    23457899999999999999998873     3445889


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ +|.+.+...    ..+++..++.++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06645          84 CMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNG-HVKLADFGVSAQIT  157 (267)
T ss_pred             EEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence            9999996 777766542    5789999999999999999999998 999999999999999887 79999999987553


Q ss_pred             cCC-Cccccccccccccchhcc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          220 KGE-PNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ... ......|+..|+|||.+.  ....++.++|+|||||++|+|++|..||....+...........            
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~------------  225 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN------------  225 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC------------
Confidence            322 123456889999999974  23337889999999999999999999997655433332221110            


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                           +..+.     +.  ....++..+.+++.+||+.+|++|||++++++|
T Consensus       226 -----~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         226 -----FQPPK-----LK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -----CCCCc-----cc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                 00000     00  011357889999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-41  Score=304.32  Aligned_cols=254  Identities=22%  Similarity=0.355  Sum_probs=196.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|...+.||+|+||.||++.+..+++.+|+|.+...     .....+|+.++.++. |+||+++++++..     ....+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence            577788999999999999999999999999988542     223456888898886 9999999998743     33478


Q ss_pred             EEEeeccccHHHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++|||+.+++.++..... .....+++..+..++.|++.||+|||+..+++||||||+||+++.++ .++|+|||++...
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            899999987766554322 22367899999999999999999999744999999999999999877 7999999999765


Q ss_pred             ccCCCccccccccccccchhccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ..........++..|+|||.+.+.  ..++.++|||||||++|+|++|+.||.....  ....+.+......        
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~--------  228 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP--------  228 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC--------
Confidence            444444445678899999999665  3588999999999999999999999976542  1122211111100        


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                              +..     .......++.++.+|+.+||+.||.+|||+++++.|
T Consensus       229 --------~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 --------PIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --------CcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    000     001123478999999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.7e-41  Score=302.02  Aligned_cols=254  Identities=23%  Similarity=0.347  Sum_probs=199.1

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeec
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  130 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  130 (354)
                      ...++|.+.+.||+|+||.||+|.+.     .++..+|+|.++...     ....+|+.+++++ +||||+++++++.  
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--  109 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT--  109 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe--
Confidence            34457999999999999999999863     345579999886432     2345799999999 7999999999873  


Q ss_pred             CCCCeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEE
Q 018514          131 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl  209 (354)
                         .....+++|||+. ++|.+.+....  ...+++.++..++.|++.||.|||++ +|+|+||||+||+++.++ .++|
T Consensus       110 ---~~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l  182 (302)
T cd05055         110 ---IGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGK-IVKI  182 (302)
T ss_pred             ---cCCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCC-eEEE
Confidence               3344899999998 47887776432  23489999999999999999999998 999999999999999776 7999


Q ss_pred             EeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 018514          210 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  285 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  285 (354)
                      +|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||........+....... 
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-  260 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-  260 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-
Confidence            99999976543221   11234567899999986655 8999999999999999998 999998766544443332210 


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                +....+...+..+.+++.+||..+|++|||+.++++.|..+
T Consensus       261 --------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 --------------------------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --------------------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                                      00011223678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-41  Score=304.45  Aligned_cols=246  Identities=28%  Similarity=0.480  Sum_probs=199.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||+|+||+||+|.+..+++.+|+|.+....       ....+|+++++.++|+||+++++.+     .+....
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            6999999999999999999999899999999886432       2345789999999999999999887     445568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+....  ...+++..++.++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            999999986 8877766432  35789999999999999999999998 999999999999999887 799999999865


Q ss_pred             cccCCC------------------------------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 018514          218 LVKGEP------------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  267 (354)
Q Consensus       218 ~~~~~~------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  267 (354)
                      ......                              .....|+..|+|||++.+.. ++.++||||||+++|+|++|..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCC
Confidence            432211                              11235788899999996554 79999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC----HH
Q 018514          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST----AF  343 (354)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt----a~  343 (354)
                      |.+.+....+..+....                 ..++          ....++..+.++|.+||..||++|||    ++
T Consensus       232 f~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         232 FKGSNRDETFSNILKKE-----------------VTFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCchHHHHHHHhcCC-----------------ccCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            98877665554443210                 0000          01126899999999999999999999    99


Q ss_pred             HHhhc
Q 018514          344 DAVGS  348 (354)
Q Consensus       344 e~l~~  348 (354)
                      +++.|
T Consensus       285 ~ll~~  289 (316)
T cd05574         285 EIKQH  289 (316)
T ss_pred             HHHcC
Confidence            99987

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-41  Score=296.40  Aligned_cols=244  Identities=26%  Similarity=0.396  Sum_probs=198.9

Q ss_pred             eEeeeccceEEEEEEEcCC---CceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||.||+|.+...   +..+++|.+....     ....+|++.++.++|+||+++++++.     ....++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence            4689999999999999765   8899999886542     34457999999999999999998873     345589999


Q ss_pred             eecc-ccHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          143 EYVP-ETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       143 e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ||+. ++|.+.+......     ...+++..++.++.|++.||+|||++ |++|+||||+||+++.++ .++|+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCC-cEEEccccccc
Confidence            9996 5888887765322     36789999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          217 VLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       217 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ......   ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...+..+....+...         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------  223 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---------  223 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence            764432   22344568889999998665 48999999999999999999 69999887655544443321         


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                         +....+..++.++.+++.+||+.||++|||+.+++++|+
T Consensus       224 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 -------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                               011123446899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.8e-41  Score=294.70  Aligned_cols=245  Identities=32%  Similarity=0.518  Sum_probs=199.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|+..+.||+|+||+||+|.+..++..|++|.+....         ....+|+.+++.++|+||+++++++     .+..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            4778899999999999999998889999999875422         2345799999999999999999877     3445


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++++||+++ +|.+.+...    ..+++..+..++.||+.||+|||+. |++|+||+|+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            58899999986 777777543    4588999999999999999999998 999999999999999887 7999999998


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .............++..|+|||.+.....++.++|+||||+++|+|++|..||...........+......         
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  220 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---------  220 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence            76644443345567889999999854444789999999999999999999999776644433333221000         


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                        ..++..+++.+.+++++||+.+|.+||++.+++.|
T Consensus       221 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         221 ------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                              01233478999999999999999999999999987

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-41  Score=304.31  Aligned_cols=251  Identities=21%  Similarity=0.278  Sum_probs=197.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCC-----CceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      .+|++.+.||+|+||.||+|.+..+     +..||+|++....     ....+|+.+++.++||||+++++.+     ..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence            3688999999999999999987543     5789999986432     2345788999999999999999987     33


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~  201 (354)
                      ....++++||+.+ +|.+++....            .....++...+..++.|++.||.|||++ ||+||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~  158 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVF  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEec
Confidence            3447899999985 7777775321            1124578888999999999999999998 999999999999999


Q ss_pred             CCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 018514          202 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (354)
Q Consensus       202 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  277 (354)
                      .++ .+||+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+..
T Consensus       159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            877 799999999876533221   11234467899999986555 8999999999999999998 88899877665555


Q ss_pred             HHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       278 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ..+......                            .++..++..+.+++.+||+.+|.+||++.+++..|..
T Consensus       237 ~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            444332100                            1223478999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.1e-41  Score=303.55  Aligned_cols=245  Identities=27%  Similarity=0.419  Sum_probs=197.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|+||+++++++     ....+.++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV   93 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEEE
Confidence            4799999999999999999999889999999988543    23345789999999999999999988     34456899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ ++.+.+..     ..+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++....
T Consensus        94 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~  166 (297)
T cd06656          94 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  166 (297)
T ss_pred             eecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEECcCccceEcc
Confidence            9999986 77776643     4578889999999999999999998 999999999999999877 79999999987654


Q ss_pred             cCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .... .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+... +.+           
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~-----------  233 (297)
T cd06656         167 PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP-----------  233 (297)
T ss_pred             CCccCcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCC-----------
Confidence            3322 22356788999999996544 789999999999999999999999765543322211110 000           


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    ....+..++..+.+++.+||+.||.+||++.++++|
T Consensus       234 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         234 --------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             --------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                          001123468899999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.4e-41  Score=297.43  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=201.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +|++.+.||.|+||+||+|.+..++..+|+|++..+     .....+|+++++.++|+|++++++.+     ......++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEEE
Confidence            699999999999999999999889999999988543     23455799999999999999998877     33455889


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||++.+ ++.+.+..... ...+++..++.++.|++.||+|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence            9999986 77777665321 24688999999999999999999998 999999999999999887 79999999987654


Q ss_pred             cCCCc-----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          220 KGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       220 ~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      .....     ....++..|+|||.+.....++.++|+||||+++|+|++|..||...+....+.++...   .+.     
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~-----  225 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPP-----  225 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCC-----
Confidence            43221     23467889999999876645899999999999999999999999877665544443331   000     


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                              ..+.       ......+++.+.+++.+||+.||++|||+.++++|
T Consensus       226 --------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 --------SLET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --------CcCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                    0000       00013478999999999999999999999999987

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=305.62  Aligned_cols=249  Identities=25%  Similarity=0.360  Sum_probs=206.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..|+.-++||+|+||.||-++-+.+|+-+|+|++.+.+       ....+|-.+|.++..+.||.+-.+|     +....
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd~  259 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKDA  259 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCCc
Confidence            45888999999999999999999999999999774332       2334688999999999999997777     44555


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +|+|+..|+| +|.-.|.+..  +..++++.++.++.+|+.||++||+. +||+|||||+|||+|+.| .|+|+|+|+|.
T Consensus       260 LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~G-hvRISDLGLAv  335 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHG-HVRISDLGLAV  335 (591)
T ss_pred             eEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCC-CeEeeccceEE
Confidence            9999999997 5554454433  35799999999999999999999999 999999999999999998 59999999999


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .+..+.+....+||.+|||||++.+.. |+...|+|||||++|||+.|+.||..........++.+....          
T Consensus       336 ei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----------  404 (591)
T KOG0986|consen  336 EIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----------  404 (591)
T ss_pred             ecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc----------
Confidence            998888888889999999999997776 999999999999999999999999775544333333332111          


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                     -...+++.+|++++++++.+|+.||.+|.-     +.++.+|
T Consensus       405 ---------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  405 ---------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             ---------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence                           122356779999999999999999999974     4455554

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3e-41  Score=296.76  Aligned_cols=247  Identities=28%  Similarity=0.423  Sum_probs=199.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      ++|++.+.||+|+||.||+|.+..++..+++|.+....  ....+|+++++.++||||+++++++.     ...+.++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEEEE
Confidence            46999999999999999999998889999999986543  44568999999999999999999884     345589999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+++ +|.+.+...   ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence            99996 777766532   35789999999999999999999998 999999999999999887 7999999998866443


Q ss_pred             C-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      . ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+...                 
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------------  214 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-----------------  214 (256)
T ss_pred             ccccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC-----------------
Confidence            3 222345788899999986654 899999999999999999999999876544332221110                 


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                             ....  ...+..++..+.++|.+||+.||.+|||+.++++|
T Consensus       215 -------~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         215 -------PPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -------CCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence                   0000  00123467899999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.6e-41  Score=296.30  Aligned_cols=244  Identities=27%  Similarity=0.452  Sum_probs=194.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      +|++.+.||+|+||.||+|.+ .+|+.+|+|.+....          ....+|+++++.++|+||+++.+++     .+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            488899999999999999986 578899999875321          2345799999999999999999987     344


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++++||+.+ +|.+.+...    .++++..+..++.|++.||+|||+. +|+|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCC-eEEeccchh
Confidence            668999999986 777777543    4678999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccC-------CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 018514          215 AKVLVKG-------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (354)
Q Consensus       215 a~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  287 (354)
                      +......       .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....+. 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  226 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-  226 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence            8754211       1112345788899999986554 789999999999999999999999776544433332221000 


Q ss_pred             CHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                               ...++..++.++.++|++||+.+|.+||++.+++.|
T Consensus       227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                                     011234578999999999999999999999999986

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.3e-41  Score=300.29  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=197.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .|++.+.||.|+||.||++.+..++..+++|.+....    ....+|+++++.++|||++++++++..     ....++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence            3788999999999999999999999999999885432    234568999999999999999998743     3458899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      +||+++ ++...+...   ..++++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~  155 (282)
T cd06643          81 IEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR  155 (282)
T ss_pred             EEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCC-CEEEccccccccccc
Confidence            999996 554444432   35689999999999999999999998 999999999999999887 799999999865432


Q ss_pred             CC-Cccccccccccccchhcc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          221 GE-PNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       221 ~~-~~~~~~g~~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .. ......+++.|+|||.+.    ....++.++|||||||++|+|++|.+||...+..+....+.......        
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  227 (282)
T cd06643         156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--------  227 (282)
T ss_pred             cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--------
Confidence            21 122346788999999984    22336789999999999999999999998776655555543321000        


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                        ...+..++..+.++|.+||+.||.+|||+.++++|-
T Consensus       228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         228 ------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                              001223678999999999999999999999999873

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.9e-41  Score=303.83  Aligned_cols=252  Identities=21%  Similarity=0.350  Sum_probs=195.7

Q ss_pred             ceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....     ....+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            47889999999999999998743     23568888875432     23457999999999999999998873     33


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYK--------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~--------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlk  194 (354)
                      ...++++||+.+ +|.+++.....                    ....++...++.++.|++.||.|||+. +++|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-Ceehhhhh
Confidence            447899999994 78777764321                    124578899999999999999999998 99999999


Q ss_pred             CCCeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 018514          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  270 (354)
Q Consensus       195 p~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~  270 (354)
                      |+||+++.++ .+||+|||++........   .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+
T Consensus       155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999877 899999999875533221   12234466899999986554 8999999999999999998 9999977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      ....+....+....                            ....+..++.++.+++.+||+.||.+||++.++++.|+
T Consensus       233 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~  284 (290)
T cd05045         233 IAPERLFNLLKTGY----------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE  284 (290)
T ss_pred             CCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            65444333221110                            00112347899999999999999999999999999988


Q ss_pred             cCC
Q 018514          351 SSF  353 (354)
Q Consensus       351 ~~~  353 (354)
                      +.+
T Consensus       285 ~~~  287 (290)
T cd05045         285 KMM  287 (290)
T ss_pred             HHH
Confidence            654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-43  Score=320.38  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=204.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh----hhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +.|.|+..||-|+||.||+|..+.++-.-|.|++.....    ...-|+++|..++||+||++++.|+..+.     ++|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEE
Confidence            469999999999999999999988887778888743322    22358999999999999999999865443     899


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc-
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-  219 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~-  219 (354)
                      +.|||+|+-.+.+.-.  ....+++.++..+++|++.||.|||++ +|||||||..|||++.+| .|+|+|||.+.... 
T Consensus       107 liEFC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEeecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecC-cEeeecccccccchh
Confidence            9999998655544432  247899999999999999999999999 999999999999999998 79999999875432 


Q ss_pred             cCCCccccccccccccchhcc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          220 KGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       220 ~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .....-++.|||+|||||+..    ....|+.++||||||++|.||.-+.+|....++...+..|.+.- +|..      
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-PPTL------  255 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTL------  255 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-CCcc------
Confidence            222345789999999999973    34559999999999999999999999999999888888876631 1111      


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 .....|        +..+.+||++||..||..||++.++++|
T Consensus       256 -----------lqPS~W--------s~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  256 -----------LQPSHW--------SRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             -----------cCcchh--------hhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                       011123        6889999999999999999999999998

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-41  Score=294.74  Aligned_cols=245  Identities=24%  Similarity=0.353  Sum_probs=198.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh---hhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|++.+.||.|+||.||+|..  .|+.||+|.+.....   ...+|+.+++.++|+||+++++++..     ....++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence            4699999999999999999987  578999999876543   44579999999999999999998743     3447899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+++ +|.+.+....  ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCC-CEEEccccccccccc
Confidence            999995 8888776542  23689999999999999999999998 999999999999999887 799999999976633


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      ...  ....+..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+...                
T Consensus       155 ~~~--~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------------  215 (256)
T cd05039         155 GQD--SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG----------------  215 (256)
T ss_pred             ccc--cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------------
Confidence            222  233456799999986554 7899999999999999997 99999776554433332211                


Q ss_pred             cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                  +....+..+++.+.++|.+||..+|++|||+.++++.|++
T Consensus       216 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         216 ------------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ------------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                        0001123468999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.8e-41  Score=300.15  Aligned_cols=262  Identities=26%  Similarity=0.366  Sum_probs=194.1

Q ss_pred             ce-EEEeEeeeccceEEEEEEE----cCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           66 SY-MAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        66 ~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      +| ++.+.||+|+||+||++..    ..++..||+|.+...     .....+|+++++.++||||+++++++..   .+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence            45 8999999999999988653    346788999988643     2234579999999999999999887643   233


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..++++|||+.+ +|.+.+..     ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~  153 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDR-LVKIGDFGL  153 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCC-cEEEeeccc
Confidence            457899999996 77776654     3589999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCH
Q 018514          215 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPTR  289 (354)
Q Consensus       215 a~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~  289 (354)
                      +.........    ....++..|+|||.+.+.. ++.++||||||+++|+|++|..||......  +...... .+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~  230 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV  230 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch
Confidence            9765433221    1223456799999986544 899999999999999999999998654321  1111110 000000


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ..+...            .........+..++..+.+++.+||+.||++|||++++++.|+.+
T Consensus       231 ~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         231 VRLIEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            000000            000011112345789999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-41  Score=295.47  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=200.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+...   .....+|+.+++.++|+||+++++++     ......++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceEE
Confidence            457999999999999999999975 5577999988643   23456799999999999999998876     33345799


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+.+ +|.+.+....  ...++...+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENL-VCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCC-CEEECccccceecc
Confidence            9999985 7887776532  34688999999999999999999998 999999999999999887 79999999987654


Q ss_pred             cCCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          220 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       220 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .....  ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.+.+....+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM----------  223 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            32111  1223456799999986554 8999999999999999998 99999887766655554332111          


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                        ..+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 ------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                              0122357899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.9e-41  Score=301.94  Aligned_cols=258  Identities=18%  Similarity=0.231  Sum_probs=199.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCC----------------ceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeec
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETG----------------EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  123 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~  123 (354)
                      .+|++.+.||+|+||.||+|.+...+                ..||+|.+....     ....+|+++++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            47999999999999999999876533                458999886432     234579999999999999999


Q ss_pred             ceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 018514          124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK-------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  195 (354)
Q Consensus       124 ~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp  195 (354)
                      ++++.     .....+++|||+.+ +|.+++.....       ....+++..++.++.|++.||+|||++ |++|+||||
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp  158 (296)
T cd05051          85 LGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLAT  158 (296)
T ss_pred             EEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccch
Confidence            98873     33458899999985 78877765431       123689999999999999999999998 999999999


Q ss_pred             CCeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 018514          196 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPG  270 (354)
Q Consensus       196 ~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~  270 (354)
                      +||+++.++ .++|+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999886 899999999876543321   12334567899999986554 8999999999999999998  6788877


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      .+..+.+............                     ......+..++.++.+++.+||+.||++|||+.++++.|.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         237 LTDQQVIENAGHFFRDDGR---------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cChHHHHHHHHhccccccc---------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            6655555444332111000                     0000112346789999999999999999999999999886


Q ss_pred             c
Q 018514          351 S  351 (354)
Q Consensus       351 ~  351 (354)
                      +
T Consensus       296 ~  296 (296)
T cd05051         296 R  296 (296)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.7e-41  Score=311.84  Aligned_cols=256  Identities=22%  Similarity=0.335  Sum_probs=199.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccch-----hhhHHHHHHHHHcC-CCCeeecceeeeecC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTT  131 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~  131 (354)
                      ...+|.+.+.||+|+||.||+|++.     .+++.||+|++....     ....+|++++.++. ||||+++++++.   
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~---  111 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT---  111 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc---
Confidence            3457999999999999999999864     345689999996442     23457999999997 999999999873   


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhh----------------------------------------------------
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYK----------------------------------------------------  158 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~----------------------------------------------------  158 (354)
                        .....++||||+.+ +|.+.+.....                                                    
T Consensus       112 --~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         112 --KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             --cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence              33458999999995 88888865321                                                    


Q ss_pred             ------------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 018514          159 ------------------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (354)
Q Consensus       159 ------------------------------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~  196 (354)
                                                                ....+++..+..++.||+.||+|||+. +++||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~  268 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAAR  268 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcc
Confidence                                                      112467778889999999999999998 9999999999


Q ss_pred             CeeeeCCCCcEEEEeccCceecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018514          197 NLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (354)
Q Consensus       197 Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  272 (354)
                      |||++.++ .+||+|||++.......   ......++..|+|||.+.+.. ++.++||||||+++|||++ |..||....
T Consensus       269 NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         269 NVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             eEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999876 79999999997643221   112345678899999996554 8999999999999999998 899997765


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ..+.........                           +....+..++.++.+++.+||..+|.+||++.+++..|+.+
T Consensus       347 ~~~~~~~~~~~~---------------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNEQFYNAIKRG---------------------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chHHHHHHHHcC---------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            544443332210                           00012234689999999999999999999999999999876


Q ss_pred             C
Q 018514          353 F  353 (354)
Q Consensus       353 ~  353 (354)
                      +
T Consensus       400 ~  400 (401)
T cd05107         400 L  400 (401)
T ss_pred             h
Confidence            5

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.9e-41  Score=296.07  Aligned_cols=245  Identities=26%  Similarity=0.431  Sum_probs=194.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|+..+.||+|+||.||+|.+..++..||+|++...         .....+|+.+++.++||||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence            699999999999999999999999999999987532         1234579999999999999999887643   2234


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++++||+++ +|.+.+...    ..++....+.++.|++.||+|||+. +|+||||||+||+++.++ .++|+|||++
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~-~~~l~dfg~~  153 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCCCc
Confidence            57899999985 777777643    4578899999999999999999998 999999999999999887 7999999998


Q ss_pred             eecccCC----CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          216 KVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       216 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .......    ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-------  225 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-------  225 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-------
Confidence            7543211    112245788899999996654 8899999999999999999999998765444333322110       


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                          ....++..+++.+.+++ +||..+|++||+++++++|
T Consensus       226 --------------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 --------------------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             --------------------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                                00112334678899999 6788899999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.6e-41  Score=303.84  Aligned_cols=253  Identities=21%  Similarity=0.338  Sum_probs=196.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcC-------CCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeec
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  130 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  130 (354)
                      .++|.+.+.||+|+||.||+|++..       ++..+|+|.+..+.     ....+|+++++.+ +||||+++++++   
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~---   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC---   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence            4579999999999999999998743       23469999886432     2344689999999 799999999987   


Q ss_pred             CCCCeeEEEEEEeeccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 018514          131 TEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~N  197 (354)
                        ......++||||+++ +|.+++.....            ....++...++.++.|++.||+|||++ |++||||||+|
T Consensus        94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~N  170 (307)
T cd05098          94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARN  170 (307)
T ss_pred             --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHh
Confidence              334458899999985 88888875432            123578889999999999999999998 99999999999


Q ss_pred             eeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 018514          198 LLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (354)
Q Consensus       198 ili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  273 (354)
                      |+++.++ .+||+|||.+........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+.
T Consensus       171 ill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         171 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             eEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            9999887 799999999875533211   11122346799999986654 8999999999999999998 8899976554


Q ss_pred             HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       274 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .+....+...                            +....+..++.++.+++.+||..+|++|||+.++++.|+.+
T Consensus       249 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         249 EELFKLLKEG----------------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHHHHHHcC----------------------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            3333322110                            00012234689999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.3e-40  Score=294.58  Aligned_cols=245  Identities=27%  Similarity=0.452  Sum_probs=194.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|++.+.||+|+||.||++.+..+|..||+|.+...         .....+|+.+++.++||||+++++++..   ....
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence            699999999999999999999999999999987422         1234569999999999999999987632   2234


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .++++|||+++ +|.+.+...    ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~Dfg~~  153 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVG-NVKLGDFGAS  153 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCC-CEEECcCccc
Confidence            57899999985 777776643    4578889999999999999999998 999999999999999887 7999999998


Q ss_pred             eecccCC----CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          216 KVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       216 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .......    ......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+......++..   .+.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~---  226 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT---  226 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence            7543211    122345788899999986654 89999999999999999999999977654444333221   110   


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                           ....+..++..+.++|++|+. +|++||++++++.|
T Consensus       227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                                 011233467899999999994 99999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.2e-41  Score=294.65  Aligned_cols=247  Identities=24%  Similarity=0.318  Sum_probs=196.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ++|++.+.||+|++|.||+|.+..+ ..+|+|.+....   ....+|+.+++.++|+|++++++++.     . ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence            4699999999999999999987554 469999876432   34457999999999999999987652     1 236799


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+.+ +|.+.+....  ...+++..+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            999985 8888876532  34578899999999999999999998 999999999999999887 799999999976533


Q ss_pred             CCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  ....++..|+|||...+.. ++.++||||||+++|+|++ |..||.+....+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-----------  222 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            3211  1234566799999986554 8999999999999999999 89999887665554443321100           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                       ..+..++..+.+++++||..||.+||+++++++.|++
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 -----------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                             1123468999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-41  Score=312.09  Aligned_cols=250  Identities=28%  Similarity=0.450  Sum_probs=211.9

Q ss_pred             CCCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        59 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ......+.|.+.+.||+|.|++|.+|++..++..||||.+.+..      +...+|+++|+.++|||||+++.+.     
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----  124 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----  124 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            44555668999999999999999999999999999999885532      3356899999999999999999988     


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                      .....+|+||||+.+ .+.+++..+    .+..+..++.++.|+++|++|||++ +|+|||||.+|||++.+. .+||+|
T Consensus       125 ~t~~~lylV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~m-nikIaD  198 (596)
T KOG0586|consen  125 ETEATLYLVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENM-NIKIAD  198 (596)
T ss_pred             eecceeEEEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhccccccc-ceeeec
Confidence            444459999999985 777777765    5666788999999999999999999 999999999999999988 699999


Q ss_pred             ccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       212 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ||++..+..+....+.+|++.|.|||++.+....++++|+||+|+++|-|+.|..||++.+-.+........        
T Consensus       199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--------  270 (596)
T KOG0586|consen  199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--------  270 (596)
T ss_pred             cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--------
Confidence            999999888877888999999999999998888899999999999999999999999876533222111110        


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                               .++            ++-.++.+..++|+++|..+|.+|++.+++.++
T Consensus       271 ---------k~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  271 ---------KYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ---------eec------------ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                     111            223378999999999999999999999999876

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.2e-41  Score=296.32  Aligned_cols=241  Identities=23%  Similarity=0.317  Sum_probs=190.5

Q ss_pred             EeeeccceEEEEEEE--cCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           72 VVGHGSFGVVFQAKC--LETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      .||+|+||.||+|.+  ..++..+|+|++....      ....+|+.+++.++||||+++++.+     .+ ...++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~-~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EA-ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cC-CCcEEEEe
Confidence            589999999999965  4567889999885432      2345789999999999999998865     22 23578999


Q ss_pred             eccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCC
Q 018514          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (354)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~  222 (354)
                      |+++ +|.+.+...    ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            9995 677777542    4688999999999999999999998 999999999999999877 79999999997654332


Q ss_pred             Cc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          223 PN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       223 ~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ..    ....++..|+|||.+.... ++.++|||||||++|||++ |..||...+..+....+.+..             
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-------------  215 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-------------  215 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            21    1222356899999985444 8899999999999999998 999998766554444332210             


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                     ....+..+++++.++|.+||+.||++||++.++...|++.+
T Consensus       216 ---------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~  256 (257)
T cd05116         216 ---------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY  256 (257)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence                           00122347899999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.5e-41  Score=299.15  Aligned_cols=248  Identities=21%  Similarity=0.316  Sum_probs=194.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCc----eEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|++.+.||+|+||+||+|++..+|.    .||+|.+...     .....+|..+++.+.||||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------   80 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT------   80 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC------
Confidence            469999999999999999999877776    4799987542     2234478889999999999999887732      


Q ss_pred             eEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...+++++|++ |++.+.+...   ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~-~~kL~dfG~  155 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPN-HVKITDFGL  155 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCC-cEEECCCCc
Confidence            12568999998 5877777643   25689999999999999999999999 999999999999998777 799999999


Q ss_pred             ceecccCCCcc---ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +..........   ...+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.......... .......++  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~--  231 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLP--  231 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC--
Confidence            98664332211   123456799999986554 8999999999999999998 899997665433322 222110000  


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                               .+...+.++.+++.+||..||++||++.+++..|..+
T Consensus       232 -------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         232 -------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             -------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                                     1123678999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.8e-41  Score=295.44  Aligned_cols=247  Identities=23%  Similarity=0.316  Sum_probs=196.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ++|++.+.||+|+||.||+|.+. .+..+|+|.+...   .....+|+.+++.++|+|++++++++.     . ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EPIYIV   78 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CCcEEE
Confidence            47999999999999999999865 5567999988643   234568999999999999999988651     1 226799


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+.+ +|.+.+....  ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05070          79 TEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence            999985 8887776432  34588999999999999999999998 999999999999999877 799999999976543


Q ss_pred             CCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  ....++..|+|||.+.+.. ++.++||||||+++|+|++ |.+||.+.+..+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-----------  222 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            2211  1223456799999986554 8999999999999999999 89999877665555444321100           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                       ..+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 -----------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                             1123468899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.6e-41  Score=295.15  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=198.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ++|++.++||+|+||.||+|.+ .+++.+|+|.+....   ....+|+.+++.++|+||+++++.+.      ....+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v   78 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIYII   78 (260)
T ss_pred             HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcEEE
Confidence            4799999999999999999985 467889999886533   34567999999999999999987652      1237899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+.+ +|.+.+....  ...++...+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETL-CCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence            999985 7887775432  35688899999999999999999998 999999999999999887 799999999976542


Q ss_pred             CCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  .....++..|+|||.+.... ++.++||||||+++|+|++ |++||.+.+..+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-----------  222 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----------
Confidence            221  11234567899999986554 7899999999999999998 99999877765554444321110           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                       ..+...+.++.+++.+||+.+|++|||++++++.|++
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 -----------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                             0123367899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-40  Score=296.76  Aligned_cols=255  Identities=26%  Similarity=0.415  Sum_probs=197.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +|+..+.||.|++|.||+|.+..+++.+|+|.+...     .....+|+++++.++||||+++++++..   .....+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEEE
Confidence            689999999999999999999889999999988643     2234579999999999999999988743   23345789


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ +|.+.+.........+++..+..++.||+.||+|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  156 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV  156 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence            9999985 77777765544556789999999999999999999998 999999999999999887 79999999987543


Q ss_pred             cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCHHHHhcc
Q 018514          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG----VDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       220 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .... ....++..|+|||.+.+.. ++.++|||||||++|+|++|..||.....    ..........  .....     
T Consensus       157 ~~~~-~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~-----  227 (287)
T cd06621         157 NSLA-GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--MPNPE-----  227 (287)
T ss_pred             cccc-ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc--CCchh-----
Confidence            3221 2345678899999986554 89999999999999999999999976522    1111111110  00000     


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                              .+...      ......++.+.++|.+||+.||++|||+.|+++|
T Consensus       228 --------~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         228 --------LKDEP------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             --------hccCC------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence                    00000      0001246789999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-40  Score=293.03  Aligned_cols=245  Identities=27%  Similarity=0.453  Sum_probs=200.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...      .....+|+.+++.++||||+++.+++     .+..+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            489999999999999999999989999999987532      12345799999999999999999987     4455689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +|+||+.+ +|.+.+....  ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999985 7777776432  24578899999999999999999998 999999999999999877 7999999999765


Q ss_pred             ccCCCc-cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...... ....+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+..+....+......           
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-----------  219 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-----------  219 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-----------
Confidence            433221 2345788899999986655 788999999999999999999999877665555444331100           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                       ..+..++.++.++|.+||+.+|.+||++.++++|
T Consensus       220 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 -----------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -----------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                             0123468999999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.9e-41  Score=295.96  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=197.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCc---eEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+|+..+.||+|+||.||+|.+..++.   .+|+|.+...     .....+|+++++.++|+|++++.+++     .+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence            469999999999999999999876554   6999988543     22345689999999999999999887     3344


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++||||+++ +|...+...   ...+++..+..++.|++.||+|||+. |++|+||||+||+++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~  154 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNL-ECKVSDFGLS  154 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCC-cEEECCCccc
Confidence            57899999996 776666542   25688999999999999999999998 999999999999999877 7999999998


Q ss_pred             eecccCCCcc----ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          216 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       216 ~~~~~~~~~~----~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      ..........    ....+..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+......+   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---  230 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---  230 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence            7654322111    112245699999986544 7999999999999999997 999998776655555543321110   


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                               .....+..+.+++.+||+.+|++||++.++++.|..+
T Consensus       231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                                     1123678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.1e-41  Score=296.44  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=196.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCc---eEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..|++.+.||+|+||.||+|.+..+++   .||+|.+...     .....+|+.+++.++||||+++.+++     .+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            369999999999999999999876664   5999988643     22345799999999999999998887     3444


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++||||+++ +|.+++...   ...++...++.++.|++.||+|||++ |++|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~-~~kl~dfg~~  153 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCC-cEEECCCccc
Confidence            57899999986 677776543   24688999999999999999999998 999999999999999877 7999999998


Q ss_pred             eecccCCCccc---cc---cccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          216 KVLVKGEPNIS---YI---CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       216 ~~~~~~~~~~~---~~---g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      ...........   ..   .+..|+|||.+.+.. ++.++|||||||++|||++ |..||...+..+....+....    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~----  228 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY----  228 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----
Confidence            76533221111   11   134699999986554 8999999999999999886 999998776555444432210    


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                    ..+          .+..++..+.+++.+||..+|++||++.+++..|+.+
T Consensus       229 --------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 --------------RLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --------------cCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                          000          1123678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.9e-41  Score=298.93  Aligned_cols=254  Identities=21%  Similarity=0.291  Sum_probs=196.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+....     ....+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----   78 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV-----   78 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            34589999999999999999997642     34579999875432     2234688999999999999999887     


Q ss_pred             CCeeEEEEEEeecc-ccHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC
Q 018514          133 KDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (354)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~  205 (354)
                      .+....++||||+. |+|.+.+......      ....+...+..++.|++.||.|||++ +|+||||||+||+++.++ 
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~-  156 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDF-  156 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCC-
Confidence            33345799999998 5888888653321      23456778899999999999999998 999999999999999877 


Q ss_pred             cEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 018514          206 QLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (354)
Q Consensus       206 ~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~  281 (354)
                      .++|+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            799999999875433221   11223466799999986554 8999999999999999998 789998766554433332


Q ss_pred             HHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .. +.                           ...+...++.+.+++.+||+.||++|||+.++++.|.+.
T Consensus       236 ~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         236 DG-GY---------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             cC-CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11 00                           001234678999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.1e-41  Score=307.58  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=195.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      .++|++.+.||+|+||+||+|.+.     .+++.||||.+....     ....+|+.++.++ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            347999999999999999999853     457889999986432     2344799999999 689999999876432  


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhh-----------------------------------------------------
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYK-----------------------------------------------------  158 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~-----------------------------------------------------  158 (354)
                        ...++++|||+++ +|.+.+.....                                                     
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              2347899999995 88777754211                                                     


Q ss_pred             ----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC---cc
Q 018514          159 ----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NI  225 (354)
Q Consensus       159 ----------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~  225 (354)
                                ....++...+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++........   ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcC
Confidence                      013467888899999999999999998 999999999999999877 799999999876532211   11


Q ss_pred             ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCC
Q 018514          226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  304 (354)
Q Consensus       226 ~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  304 (354)
                      ...++..|+|||.+.+.. ++.++||||||+++|+|++ |..||........+.........                  
T Consensus       240 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------  300 (343)
T cd05103         240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------  300 (343)
T ss_pred             CCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC------------------
Confidence            223456799999986554 8999999999999999997 99999765433332222111000                  


Q ss_pred             CCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       305 ~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                               ...+...++++.+++.+||+.||++|||+.+++++|+.++
T Consensus       301 ---------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         301 ---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                     0011235789999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.1e-41  Score=296.95  Aligned_cols=249  Identities=26%  Similarity=0.360  Sum_probs=197.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCc---eEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+...     .....+|+.+++.++||||+++++++     .+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            479999999999999999999865443   6999988543     23445799999999999999999887     3344


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      +.++||||+++ +|.+.+...   ...++...+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~-~~~l~dfg~~  153 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence            58899999985 777777643   24688999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       216 ~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      .........    ....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||...+..+....+.+...     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-----  227 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-----  227 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-----
Confidence            765433211    1122345799999996554 8999999999999999886 9999987765554444432110     


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                   .          ..+..+++.+.+++.+||+.+|.+||++.++++.|+..
T Consensus       228 -------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -------------L----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------------C----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                         0          01123688999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.7e-41  Score=295.56  Aligned_cols=243  Identities=28%  Similarity=0.443  Sum_probs=199.7

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+....       ....+|++++++++||||+++++++     .+..+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            4899999999999999999998899999999886432       3345799999999999999999887     555668


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++|+||+.+ +|...+...    .++++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||.+..
T Consensus        76 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            999999986 777776543    5788999999999999999999998 999999999999999887 799999999876


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCHHHHhcc
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..  ..+.....   .         
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~---------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---T---------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---c---------
Confidence            65443344566788899999996655 899999999999999999999999876642  22211111   0         


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH--HHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA--FDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta--~e~l~~  348 (354)
                                      ....++..++..+.++|.+||+.||.+||++  +|+++|
T Consensus       217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence                            0111334468999999999999999999999  888865

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=298.39  Aligned_cols=247  Identities=22%  Similarity=0.330  Sum_probs=190.7

Q ss_pred             eEeeeccceEEEEEEEcCCCc--eEEEEEcccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGE--AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||.||+|++..++.  .+++|.+...     .....+|+++++++ +||||+++++++     ......+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEE
Confidence            358999999999999887775  4688877632     12345799999999 799999999987     3344578999


Q ss_pred             eecc-ccHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEE
Q 018514          143 EYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (354)
Q Consensus       143 e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl  209 (354)
                      ||++ ++|.+++.....            ....+++..++.++.|++.||+|||++ |++||||||+||+++.++ .+||
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~-~~kl  153 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENY-VAKI  153 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCC-eEEE
Confidence            9998 588888865431            123578999999999999999999998 999999999999999887 7999


Q ss_pred             EeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      +|||++..............+..|+|||++.... ++.++|||||||++|+|++ |..||.+.+..+....+...     
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-----  227 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-----  227 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-----
Confidence            9999985332211112223356799999985544 8999999999999999997 99999776554443332110     


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                             +....+..++.++.+++.+||..||.+|||+.+++..|...|
T Consensus       228 -----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 -----------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -----------------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                                   000112336789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-41  Score=297.29  Aligned_cols=244  Identities=25%  Similarity=0.399  Sum_probs=190.4

Q ss_pred             EEEeEeeeccceEEEEEEEc----CCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           68 MAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        68 ~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++.+.||.|.||.||+|.+.    ..+..|+||.+...     .....+|++.+++++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46789999999999999987    34678999999542     2345579999999999999999998862221     7


Q ss_pred             EEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++|+||+. |+|.+.+....  ...++...+..|+.||+.||.|||++ +++|++|+++||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             cccccccccccccccccccc--cccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccc
Confidence            89999998 58998888752  35689999999999999999999998 999999999999999887 899999999987


Q ss_pred             cccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          218 LVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       218 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ......   .....+...|+|||.+.... ++.++||||||+++|||++ |+.||...+..+....+.+...        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------  223 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------  223 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence            632221   12334567899999996655 8999999999999999999 7899988876665555533210        


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                          ...+..++..+.+++.+||..||.+|||+.++++.|
T Consensus       224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                                112334789999999999999999999999999865

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.8e-42  Score=313.23  Aligned_cols=243  Identities=24%  Similarity=0.391  Sum_probs=199.6

Q ss_pred             EEEeEeeeccceEEEEEEEcCCCceEEEEEc------ccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        68 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~------~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +...+||+|+|-+||+|.|..+|..||.-.+      +...  +.+..|+.+|+.|+||||++++.+|.+...   .++.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            5667999999999999999999998885332      2222  456689999999999999999999976543   5678


Q ss_pred             EEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +|+|.+. |+|..+++++    +..+...++.|++||++||.|||++ ..|||||||.+||||+.+.+.|||+|+|+|+.
T Consensus       120 ~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            8999998 6888888776    5677889999999999999999986 26999999999999999888999999999987


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCCHHHHhccC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~  296 (354)
                      ....... ...|||.|||||++.  ..|+..+||||||+.|+||+|+..||..-...-++ .++..+  ..|..      
T Consensus       196 ~r~s~ak-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG--iKP~s------  264 (632)
T KOG0584|consen  196 LRKSHAK-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG--IKPAA------  264 (632)
T ss_pred             hhccccc-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC--CCHHH------
Confidence            6554433 378999999999984  45999999999999999999999999876555444 444332  22222      


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                         +.+--.+++++||.+||.. .++|+||.|+|.+
T Consensus       265 -------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  265 -------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             -------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                               1122368999999999999 9999999999986

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-40  Score=293.32  Aligned_cols=242  Identities=22%  Similarity=0.295  Sum_probs=190.3

Q ss_pred             EeeeccceEEEEEEEc--CCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEee
Q 018514           72 VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~  144 (354)
                      .||+|+||.||+|.+.  .++..||+|++....     ....+|+.+++.++||||+++++++     .. ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-----~~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EA-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----cC-CCeEEEEEe
Confidence            3899999999999875  345679999885432     2345799999999999999998875     11 247899999


Q ss_pred             ccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC
Q 018514          145 VPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (354)
Q Consensus       145 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~  223 (354)
                      +++ +|.+.+...   ...+++..++.++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++........
T Consensus        76 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            985 777766543   25689999999999999999999998 999999999999999877 799999999975533221


Q ss_pred             c----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          224 N----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       224 ~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .    ....++..|+|||.+.... ++.++|||||||++|+|++ |..||......+....+.+.. .            
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------------  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R------------  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C------------
Confidence            1    1122356799999986554 8999999999999999996 999998776655443332210 0            


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                     ..++...++++.+++.+||..||++||++.++.+.|...|
T Consensus       217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence                           0122346899999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.4e-41  Score=301.40  Aligned_cols=255  Identities=22%  Similarity=0.334  Sum_probs=198.6

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEc-------CCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeee
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  128 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~  128 (354)
                      ...++|.+.+.||+|+||.||+|++.       .++..+|+|.+....     ....+|+.+++.+ +||||+++++++ 
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-   90 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-   90 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE-
Confidence            34457999999999999999999753       234579999885431     2345799999999 899999999987 


Q ss_pred             ecCCCCeeEEEEEEeeccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 018514          129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  195 (354)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp  195 (354)
                          ......+++|||+.+ +|.+++.....            ....++...+..++.||+.||.|||++ |++||||||
T Consensus        91 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp  165 (304)
T cd05101          91 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAA  165 (304)
T ss_pred             ----ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-Ceeeccccc
Confidence                334457899999985 88888875432            124578888999999999999999998 999999999


Q ss_pred             CCeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 018514          196 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGE  271 (354)
Q Consensus       196 ~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~  271 (354)
                      +||+++.++ .+||+|||++........   .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.
T Consensus       166 ~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         166 RNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             ceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999877 799999999976543221   11233467799999996654 8999999999999999998 88999776


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       272 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      +..+....+.... .                           ...+..++..+.+++.+||..+|.+|||+.++++.|..
T Consensus       244 ~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         244 PVEELFKLLKEGH-R---------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             CHHHHHHHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            6544443332110 0                           00123468999999999999999999999999998865


Q ss_pred             C
Q 018514          352 S  352 (354)
Q Consensus       352 ~  352 (354)
                      +
T Consensus       296 ~  296 (304)
T cd05101         296 I  296 (304)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.7e-40  Score=292.03  Aligned_cols=248  Identities=27%  Similarity=0.462  Sum_probs=192.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      +......||+|+||.||+|.+..++..||+|.+...    .....+|+.+++.++|+||+++++++     ....+.++|
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv   83 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIF   83 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEE
Confidence            344456899999999999999889999999987543    23455799999999999999999987     344568899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~--~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||+.+ +|.+.+....   ..+  +...+..++.||+.||+|||+. ||+||||||+||+++.+...++|+|||.+...
T Consensus        84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          84 MEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999985 7877776532   234  7888899999999999999998 99999999999999874458999999998765


Q ss_pred             ccCCC-ccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKGEP-NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~~~-~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ..... .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||................            
T Consensus       160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~------------  227 (268)
T cd06624         160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF------------  227 (268)
T ss_pred             ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh------------
Confidence            33222 2234578899999998543 337889999999999999999999997544322111100000            


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    .....++..+++++.+++++||+.+|.+|||+.++++|
T Consensus       228 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 --------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                          00011334578999999999999999999999999987

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-40  Score=296.73  Aligned_cols=242  Identities=24%  Similarity=0.386  Sum_probs=196.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .|+..+.||.|+||.||+|.+..++..||+|.+....     ....+|+.+++.+.||||+++++++     .+..+.++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEEE
Confidence            5888899999999999999998889999999876432     2345799999999999999999988     34456899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ +|.+.+..     .++++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06640          80 IMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence            9999986 77776653     4688899999999999999999998 999999999999999877 79999999997654


Q ss_pred             cCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .... .....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+... .             
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~-------------  217 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-N-------------  217 (277)
T ss_pred             CCccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-C-------------
Confidence            3322 22345688899999986555 799999999999999999999999876544333222110 0             


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    ...+...++..+.+++.+||+.+|++||++.+++.|
T Consensus       218 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 --------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                          001223367899999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.8e-40  Score=299.66  Aligned_cols=253  Identities=22%  Similarity=0.337  Sum_probs=196.7

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcC-------CCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~  129 (354)
                      ..++|.+.+.||+|+||.||+|++..       ....+|+|.+....     ....+|+.+++.+ +||||+++++++  
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC--   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE--
Confidence            44589999999999999999998632       34568999876432     2234789999999 699999999987  


Q ss_pred             cCCCCeeEEEEEEeeccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 018514          130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (354)
Q Consensus       130 ~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~  196 (354)
                         .+...++++|||+.+ +|.+++.....            ....++...+..++.||+.||.|||++ |++||||||+
T Consensus        88 ---~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~  163 (314)
T cd05099          88 ---TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAAR  163 (314)
T ss_pred             ---ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-Ceeeccccce
Confidence               334458899999985 88888865421            124588889999999999999999998 9999999999


Q ss_pred             CeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018514          197 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (354)
Q Consensus       197 Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  272 (354)
                      ||+++.++ .+||+|||++........   .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+
T Consensus       164 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         164 NVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             eEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            99999887 799999999976533211   11222345799999986554 8999999999999999999 899997766


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ..+....+....                            ....+..++.++.+++.+||..||.+|||+.++++.|..
T Consensus       242 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~  292 (314)
T cd05099         242 VEELFKLLREGH----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK  292 (314)
T ss_pred             HHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            544444332210                            001223467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-40  Score=297.12  Aligned_cols=254  Identities=19%  Similarity=0.244  Sum_probs=198.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcC----CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLE----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      .++|.+.+.||+|+||.||+|.+..    ++..|++|.+....     ....+|+.+++.++|+||++++++++..    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            3579999999999999999999865    25789999886432     2345789999999999999999876432    


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEE
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYKMS----QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl  209 (354)
                      ....+++++|++ ++|..++.......    ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++ .+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCC-cEEE
Confidence            233678999998 58888776543221    5689999999999999999999998 999999999999999877 7999


Q ss_pred             EeccCceecccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 018514          210 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  285 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  285 (354)
                      +|||+++........   ....++..|+|||.+.+.. ++.++|||||||++|++++ |+.||...+..+....+.... 
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-  236 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-  236 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence            999999765332211   1233466799999986554 8999999999999999998 999998766544333222110 


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                       ..+          ....+++++.+++.+||+.||++|||+.++++.|+++
T Consensus       237 -----------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         237 -----------------RLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             -----------------CCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                             000          1123678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=299.44  Aligned_cols=257  Identities=20%  Similarity=0.259  Sum_probs=195.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCC--------------ceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecce
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETG--------------EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKH  125 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~  125 (354)
                      .+|++.+.||+|+||.||+|.+..++              ..||+|.+....     ....+|+++++.++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            47999999999999999999875432              358999886432     23457999999999999999999


Q ss_pred             eeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhh--------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 018514          126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK--------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (354)
Q Consensus       126 ~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~  196 (354)
                      ++     ......++||||+.+ +|.+.+.....        ....+++..++.++.|++.||+|||++ |++|+||||+
T Consensus        85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~  158 (295)
T cd05097          85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATR  158 (295)
T ss_pred             EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChh
Confidence            87     334458899999985 78777754321        112467888999999999999999998 9999999999


Q ss_pred             CeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q 018514          197 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPGE  271 (354)
Q Consensus       197 Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~  271 (354)
                      ||+++.++ .+||+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++  |..||...
T Consensus       159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999877 799999999876533221   11223466899999986655 8999999999999999998  66888876


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       272 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      +..+.+..+.+........            ..         ...+..+++.+.+++.+||..||.+|||+.++++.|.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~------------~~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         237 SDEQVIENTGEFFRNQGRQ------------IY---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ChHHHHHHHHHhhhhcccc------------cc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            6655544443321000000            00         0012236799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-40  Score=296.82  Aligned_cols=265  Identities=25%  Similarity=0.363  Sum_probs=194.1

Q ss_pred             ceEEEeEeeeccceEEEEEEE----cCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           66 SYMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      +|++.+.||+|+||.||+|..    ..++..||+|.+....    ....+|+++++.++||||+++.+++...   +...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~   81 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRN   81 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCCc
Confidence            699999999999999999974    4568899999986432    2345799999999999999998876432   3345


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++||||++ ++|.+++...   ...+++..++.++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++.
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~~  156 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESEN-RVKIGDFGLTK  156 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCC-eEEECCCcccc
Confidence            789999998 4888877643   24588999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCHHH
Q 018514          217 VLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-TPTREE  291 (354)
Q Consensus       217 ~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~  291 (354)
                      ........    ....++..|+|||.+.+.. ++.++||||||+++|||++|..++..... .....+..... ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHH
Confidence            65433221    1112344699999986554 89999999999999999998776643321 11110000000 000000


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      +......            ......+..++.++.+++.+||..+|++|||+.++++.|+.+
T Consensus       235 ~~~~~~~------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKN------------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhc------------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000000            000012234789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.4e-41  Score=297.87  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=196.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|.+.+.||+|+||.||++...     .++..+|+|.+...    .....+|+++++.++|+||+++++++     .+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence            36889999999999999999753     34667999987543    23456799999999999999998877     333


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~  203 (354)
                      ...+++|||+.+ +|.+++.....           ....+++..++.++.||+.||+|||+. |++||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCC
Confidence            457899999985 88877765421           113578899999999999999999998 99999999999999987


Q ss_pred             CCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 018514          204 THQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVE  279 (354)
Q Consensus       204 ~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  279 (354)
                      + .+||+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||......+....
T Consensus       159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            7 799999999875533221   12233467899999986555 8999999999999999998 9999987666554444


Q ss_pred             HHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      +.....                            ...+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus       237 ~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 ITQGRE----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHcCcc----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            322100                            0112347899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.8e-40  Score=290.51  Aligned_cols=247  Identities=28%  Similarity=0.460  Sum_probs=202.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||.|+||.||++++..+++.+|+|.+...      .....+|+++++.++|+||+++.+++.     +....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence            489999999999999999999999999999987542      123346899999999999999998873     335689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +|+||+++ +|...+.........+++..+..++.|++.||+|||+. |++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999985 88888877655557789999999999999999999998 999999999999999876 7999999999766


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+....+....              
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--------------  217 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            544 333456788999999996554 7889999999999999999999998776544333322210              


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                           ++.         .....+.++.+++.+||+.+|.+|||+.++++|-
T Consensus       218 -----~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         218 -----YPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             -----CCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence                 010         1124678999999999999999999999999873

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2e-40  Score=293.85  Aligned_cols=252  Identities=21%  Similarity=0.380  Sum_probs=200.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcC-CCceEEEEEcccch--------------hhhHHHHHHHHH-cCCCCeeecceeeee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK--------------RYKNRELQTMRL-LDHPNVVSLKHCFFS  129 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--------------~~~~~e~~~l~~-l~h~~iv~~~~~~~~  129 (354)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....              ....+|+.++.. ++||||+++++.+  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            38889999999999999999877 67889999874211              112357776654 7999999999987  


Q ss_pred             cCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEE
Q 018514          130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (354)
Q Consensus       130 ~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vk  208 (354)
                         .+..+.+++|||+.+ +|.+.+.........+++..++.++.|++.||.|||+..+++|+||+|+||+++.++ .++
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~  154 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT  154 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence               344568999999986 787777654444567999999999999999999999632899999999999999887 799


Q ss_pred             EEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      |+|||.+.............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+......+ 
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  232 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-  232 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence            99999998665443334556788999999997654 8999999999999999999999997766554444433311110 


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                                .....+++.+.+++.+||+.||++||++.|+.+++.+
T Consensus       233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                                      0112367899999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.5e-40  Score=298.77  Aligned_cols=245  Identities=29%  Similarity=0.486  Sum_probs=194.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +|.+.+.||+|+||.||++.+..+++.||+|.+....       ....+|+.+++.++||||+++++.+     ....++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            6999999999999999999999999999999885432       2334789999999999999999887     444568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.| +|.+.+...    ..+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            999999986 777777553    5689999999999999999999998 999999999999999877 799999998863


Q ss_pred             cccCC----------------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 018514          218 LVKGE----------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (354)
Q Consensus       218 ~~~~~----------------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  281 (354)
                      .....                ......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            11000                011234677899999986554 8999999999999999999999998776555444443


Q ss_pred             HHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC---HHHHhhc
Q 018514          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---AFDAVGS  348 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt---a~e~l~~  348 (354)
                      ......+                 .         ....++..+.++|.+||+.||++||+   +.++++|
T Consensus       230 ~~~~~~~-----------------~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SDDIEWP-----------------E---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hcccCCC-----------------C---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            3210000                 0         01136899999999999999999998   4555555

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.9e-40  Score=299.78  Aligned_cols=243  Identities=28%  Similarity=0.464  Sum_probs=196.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .|.+.+.||+|+||+||+|.+..+|+.||+|.+....       ....+|+++++.++||||+++.+++..     ....
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~~   90 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHTA   90 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCeE
Confidence            5999999999999999999998899999999885321       234579999999999999999998843     3347


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+.|++.+.+....   ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus        91 ~lv~e~~~g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~  165 (307)
T cd06607          91 WLVMEYCLGSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPG-TVKLADFGSASLV  165 (307)
T ss_pred             EEEHHhhCCCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCC-CEEEeecCcceec
Confidence            8999999998877775432   4689999999999999999999998 999999999999999887 7999999998754


Q ss_pred             ccCCCccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ...   ....+++.|+|||++.+  ...++.++||||||+++|+|++|..||.+.+.......+...  .+         
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~---------  231 (307)
T cd06607         166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS---------  231 (307)
T ss_pred             CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC---------
Confidence            322   23467888999998742  344788999999999999999999999876655443333211  00         


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                              +..        .....+..+.++|.+||..||.+||++.+++.|
T Consensus       232 --------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 --------PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --------CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                    000        011257899999999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-41  Score=303.23  Aligned_cols=247  Identities=25%  Similarity=0.417  Sum_probs=191.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..|+++++||+||.+.||++.. .+...+|+|++...      .....+|+..|.+|+ |.+|++++++-     -.+.+
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~  434 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY  434 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence            3699999999999999999985 45567888876432      233458999999995 89999999975     44677


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +||||||-+-+|...|....   ...+..+++.+..||+.|+.++|.+ ||||.||||.|+|+-.+  .+||+|||+|..
T Consensus       435 lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlVkG--~LKLIDFGIA~a  508 (677)
T KOG0596|consen  435 LYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLVKG--RLKLIDFGIANA  508 (677)
T ss_pred             EEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEEee--eEEeeeechhcc
Confidence            99999999889998888754   3344458999999999999999999 99999999999999743  699999999988


Q ss_pred             cccCCCc---cccccccccccchhccCCC----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 018514          218 LVKGEPN---ISYICSRYYRAPELIFGAT----------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  284 (354)
Q Consensus       218 ~~~~~~~---~~~~g~~~y~aPE~~~~~~----------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  284 (354)
                      +......   ...+||+.||+||.+....          ..++++||||||||||+|+-|++||.....  .+.++.. +
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~a-I  585 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHA-I  585 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHh-h
Confidence            7655433   3578999999999984211          256799999999999999999999954321  2222222 1


Q ss_pred             CCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..|.           .++.++.+..           ..++.++++.||.+||.+|||..++|+|
T Consensus       586 ~~P~-----------~~Iefp~~~~-----------~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  586 TDPN-----------HEIEFPDIPE-----------NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             cCCC-----------ccccccCCCC-----------chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            1111           1223333211           2349999999999999999999999998

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-40  Score=293.22  Aligned_cols=249  Identities=30%  Similarity=0.514  Sum_probs=196.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--------------hhhhHHHHHHHHHcCCCCeeecceeeeecC
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  131 (354)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+...              .+...+|+.+++.++|||++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            589999999999999999999889999999987431              11234689999999999999999877    


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEE
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                       ......++||||+.+ +|.+.+...    ..+++..++.++.|++.||.|||+. +++||||+|+||+++.++ .++|+
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCC-eEEEe
Confidence             344558899999985 777777653    5688999999999999999999998 999999999999999887 79999


Q ss_pred             eccCceecccCC---CccccccccccccchhccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 018514          211 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  286 (354)
Q Consensus       211 Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  286 (354)
                      |||++.......   ......++..|+|||.+.... .++.++|+||||+++|++++|..||...+.......+..... 
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  229 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-  229 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-
Confidence            999987543221   122345788899999986543 478899999999999999999999976554433332211000 


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                            ...+.......++..+.+++.+||.+||.+|||+.++++|
T Consensus       230 ----------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 ----------------------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ----------------------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                                  0000111223478999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.3e-41  Score=300.35  Aligned_cols=244  Identities=29%  Similarity=0.431  Sum_probs=195.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .|.....||+|+||.||++.+..++..||||.+....    ....+|+.+++.++|+||+++++.+.     ...+.++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence            4666778999999999999998899999999875422    23457999999999999999999873     34558999


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+++ ++.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||++.....
T Consensus        98 ~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~  170 (292)
T cd06658          98 MEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSK  170 (292)
T ss_pred             EeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEccCcchhhccc
Confidence            999986 56555532     4588999999999999999999998 999999999999999887 799999999865432


Q ss_pred             CCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          221 GEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       221 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      ... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+....+..+........           
T Consensus       171 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  238 (292)
T cd06658         171 EVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-----------  238 (292)
T ss_pred             ccccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-----------
Confidence            221 23356788999999986544 88999999999999999999999987766554444332211100           


Q ss_pred             cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     .....++..+.+++.+||..||++|||++++++|
T Consensus       239 ---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 ---------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                           0112367899999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.7e-40  Score=295.39  Aligned_cols=257  Identities=19%  Similarity=0.250  Sum_probs=188.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCC---CceEEEEEcccchhhhH---------------HHHHHHHHcCCCCeeeccee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKRYKN---------------RELQTMRLLDHPNVVSLKHC  126 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~---------------~e~~~l~~l~h~~iv~~~~~  126 (354)
                      .+|++.+.||+|+||+||+|.+..+   +..+|+|..........               .+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            3799999999999999999998777   66777776432221111               12334455689999999887


Q ss_pred             eeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCc
Q 018514          127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (354)
Q Consensus       127 ~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~  206 (354)
                      ..... ....+.+++++++..++.+.+...    ...++..++.++.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~-~  164 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNN-R  164 (294)
T ss_pred             eeEec-CCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-c
Confidence            54332 223456788998887776666542    3457788999999999999999998 999999999999999877 7


Q ss_pred             EEEEeccCceecccCC--------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 018514          207 LKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (354)
Q Consensus       207 vkl~Dfg~a~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  278 (354)
                      ++|+|||+|.......        ......||+.|+|||+..+.. ++.++|||||||++|||++|..||.+......+.
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999997653221        112346899999999986555 8999999999999999999999998764332222


Q ss_pred             HHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      ...+.      +.+......       .        ......++.+.++++.|++.+|++||++.++++.|+
T Consensus       244 ~~~~~------~~~~~~~~~-------~--------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKC------DFIKRLHEG-------K--------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHH------HHHHHhhhh-------h--------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            21110      000000000       0        001235789999999999999999999999998764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=309.55  Aligned_cols=241  Identities=30%  Similarity=0.429  Sum_probs=197.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ....|.+...+|.|+|+.|-.+.+..+++..++|++.+......+|+.++... +||||+++.+.+     .+..+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence            45679999999999999999999999999999999987766666788666555 799999999988     777779999


Q ss_pred             Eeecccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee-CCCCcEEEEeccCceecc
Q 018514          142 LEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       142 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~-~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||.+.|. +.+.+..     .+.....+..|+++|+.|+.|||++ |++||||||+|||++ ..+ .++|+|||.+....
T Consensus       395 ~e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  395 MELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELE  467 (612)
T ss_pred             ehhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCC-cEEEEEechhhhCc
Confidence            9999974 3333332     2333367778999999999999998 999999999999995 555 79999999997654


Q ss_pred             cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       220 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      ..  ..+.+-|..|.|||++. ...|++++||||||++||+|++|+.||......   .++...++.+..          
T Consensus       468 ~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~----------  531 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF----------  531 (612)
T ss_pred             hh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc----------
Confidence            33  23445688899999997 445999999999999999999999999876655   333333333222          


Q ss_pred             cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                       ...+|.++++||++||+.||.+|+++.+++.|
T Consensus       532 -----------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  532 -----------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             -----------------ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence                             23489999999999999999999999999887

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6e-40  Score=289.65  Aligned_cols=243  Identities=33%  Similarity=0.513  Sum_probs=199.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +|++.+.||+|++|.||+|++..+++.|++|++...     .....+|+..+..++|+|++++++++     ......++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence            589999999999999999999999999999988654     23455799999999999999999987     34456899


Q ss_pred             EEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ||||++ ++|.+.+...    ..+++..++.++.|++.||+|||+ . +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~  150 (264)
T cd06623          77 VLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKG-EVKIADFGISKVL  150 (264)
T ss_pred             EEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCC-CEEEccCccceec
Confidence            999999 5888777654    678999999999999999999999 8 999999999999999887 7999999999876


Q ss_pred             ccCCCcc-ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--H-HHHHHHHHHhCCCCHHHHhc
Q 018514          219 VKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--V-DQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       219 ~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~-~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.  . +....+..   ..       
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~-------  219 (264)
T cd06623         151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP-------  219 (264)
T ss_pred             ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC-------
Confidence            5443332 45678889999998655 489999999999999999999999977652  2 22222111   00       


Q ss_pred             cCCCCcccCCCCccCCCcccccCCC-CCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                               .+         .+... ++..+.++|.+||..+|++|||+.++++|
T Consensus       220 ---------~~---------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         220 ---------PP---------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ---------CC---------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                     00         01223 68999999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2e-40  Score=296.85  Aligned_cols=251  Identities=23%  Similarity=0.301  Sum_probs=196.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      ..+|++.+.||+|+||.||+|.+..     ++..+|+|.+....     ....+|+.+++.++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence            3479999999999999999998743     56789999886432     3355799999999999999999877     3


Q ss_pred             CeeEEEEEEeeccc-cHHHHHHhhhh------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 018514          134 DELYLNLVLEYVPE-TVHRVIKHHYK------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (354)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlk  194 (354)
                      +....+++|||+++ +|.+.+.....                  ....+++..++.++.|++.||+|||++ +++|||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~  157 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLA  157 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-Ceeccccc
Confidence            34457899999995 88888764321                  112467888999999999999999998 99999999


Q ss_pred             CCCeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 018514          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  270 (354)
Q Consensus       195 p~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~  270 (354)
                      |+||+++.++ .++|+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+
T Consensus       158 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         158 TRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             HhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999887 799999999876533221   11223456799999986554 8999999999999999997 8889977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      .+..+....+....                   ..         ..+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       236 ~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         236 MAHEEVIYYVRDGN-------------------VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCHHHHHHHHhcCC-------------------CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            66555443332210                   00         012346899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.9e-40  Score=290.67  Aligned_cols=246  Identities=28%  Similarity=0.433  Sum_probs=199.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|.+.+.||+|+||.||++.++.+|..+|+|.+...      .....+|+.+++.++|+||+++++.+     .+....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            488999999999999999999999999999988542      23445799999999999999999887     4455689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +|+||+.+ +|.+.+....  ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999985 8777776432  23578999999999999999999998 99999999999999987656799999998765


Q ss_pred             ccCCCc-cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...... ....|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            433222 2345788899999986554 8899999999999999999999998766555444332210             


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                            .         ......++..+.+++.+||..+|++|||+.+++.|
T Consensus       219 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 ------F---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ------C---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                  0         01123468899999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.6e-40  Score=297.43  Aligned_cols=257  Identities=19%  Similarity=0.259  Sum_probs=194.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcC----------------CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeec
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLE----------------TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  123 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~  123 (354)
                      .+|++.+.||+|+||.||++.+..                ++..+|+|.+....     ....+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            369999999999999999986532                23468999886432     234579999999999999999


Q ss_pred             ceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 018514          124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKM-------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  195 (354)
Q Consensus       124 ~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp  195 (354)
                      ++++.     .....+++|||+.+ +|.+.+......       ...+++..+..++.|++.||+|||+. |++|+||||
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp  158 (296)
T cd05095          85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLAT  158 (296)
T ss_pred             EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCh
Confidence            99873     33447899999985 888877654321       13477888999999999999999998 999999999


Q ss_pred             CCeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 018514          196 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPG  270 (354)
Q Consensus       196 ~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~  270 (354)
                      +||+++.++ .++|+|||++........   .....++..|+|||...+.. ++.++|||||||++|||++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999877 799999999976533321   11223356799999886555 8999999999999999998  7789977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      .+..+.+......+....           .....          ..+..+++.+.+++.+||+.||.+|||+.++++.|.
T Consensus       237 ~~~~~~~~~~~~~~~~~~-----------~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         237 LSDEQVIENTGEFFRDQG-----------RQVYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             cChHHHHHHHHHHHhhcc-----------ccccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            665554433222110000           00000          012236789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.3e-40  Score=295.18  Aligned_cols=247  Identities=20%  Similarity=0.318  Sum_probs=191.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCc----eEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|++.+.||+|+||+||+|.+..++.    .+++|.+....     .....|+..++.++||||+++++++.     + 
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~-   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----G-   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----C-
Confidence            469999999999999999999877776    47777774321     22345677888999999999998762     2 


Q ss_pred             eEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++++||+. |+|.+.+...   ...+++..+..++.||+.||+|||++ +++||||||+||+++.++ .+||+|||+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~-~~kl~Dfg~  155 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGV  155 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEEcCCcc
Confidence            22568899998 5888887653   25689999999999999999999998 999999999999999877 899999999


Q ss_pred             ceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +........   .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+...... .++......+.  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~--  231 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLA--  231 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCC--
Confidence            976543322   12234567899999996554 8999999999999999998 9999977654332 22222100000  


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                               .+...+.++.+++.+||..||++|||+.++++.|..
T Consensus       232 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         232 -------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence                                     112256789999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.9e-40  Score=289.95  Aligned_cols=242  Identities=25%  Similarity=0.338  Sum_probs=193.6

Q ss_pred             eEeeeccceEEEEEEEcC-CCc--eEEEEEcccchh-----hhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLE-TGE--AVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|++|.||+|.+.. .+.  .||+|.+.....     ...+|+.++++++||||+++++.+..      ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999865 333  589999865433     44579999999999999999888732      4588999


Q ss_pred             eecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+. ++|.+.+.....  ..+++..++.++.|++.||+|||++ |++|+||||+||+++.++ .+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9997 588888776432  4689999999999999999999998 999999999999999887 7999999999766442


Q ss_pred             CCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          222 EPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       222 ~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ...    ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+.....           
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------  218 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE-----------  218 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence            211    1234567899999986554 8999999999999999998 9999987766655554432100           


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                      ....+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus       219 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 ----------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                            00012246789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.7e-40  Score=289.29  Aligned_cols=246  Identities=20%  Similarity=0.336  Sum_probs=195.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|++.+.||.|+||.||++.+. ++..+|+|.+...   .....+|+++++.++|||++++++++     ......+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEE
Confidence            36999999999999999999875 4678999988643   23456799999999999999998887     334458899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+.+ +|.+.+...   ...+++..++.++.|++.+|+|||+. +++|+||||+||+++.++ .++|+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCC-eEEECCCcceeeccc
Confidence            999986 666666532   24578899999999999999999998 999999999999999777 799999999876533


Q ss_pred             CCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+...              
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------------  217 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG--------------  217 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC--------------
Confidence            2211  1223456799999986554 8899999999999999998 99999876655444443221              


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                    +....+...+..+.+++.+||+.+|.+|||+.+++++|.
T Consensus       218 --------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         218 --------------FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --------------CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                          000112235789999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.9e-41  Score=298.23  Aligned_cols=242  Identities=25%  Similarity=0.387  Sum_probs=194.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .|+..+.||+|+||.||+|.+..++..||+|.+....     ....+|+.+++.++||||+++++++     .+....++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence            4778889999999999999998889999999876332     2345799999999999999999988     34455899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ ++.+.+..     ..+++..++.++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06642          80 IMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCC-CEEEcccccccccc
Confidence            9999996 66665542     5688999999999999999999998 999999999999999887 79999999987654


Q ss_pred             cCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .... .....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||....+......+...               
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------  216 (277)
T cd06642         153 DTQIKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------  216 (277)
T ss_pred             CcchhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------
Confidence            3321 12345788899999996554 889999999999999999999999765543332221110               


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                   ....+...++..+.+++.+||+.+|.+|||+.+++.|
T Consensus       217 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 -------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                         0001223467899999999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.2e-40  Score=289.28  Aligned_cols=247  Identities=32%  Similarity=0.517  Sum_probs=203.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|.+.+.||.|+||.||++.+..++..+++|++...      .....+|+++++.++|+|++++.+.+.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence            489999999999999999999888999999998643      233457999999999999999998873     335688


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +|+||+++ +|.+.+.........+++..+..++.|++.||.+||+. |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999986 88888876544457899999999999999999999998 999999999999999877 7999999999765


Q ss_pred             ccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .... ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+..+.........             
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  219 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------  219 (258)
T ss_pred             ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence            4432 223356788899999986555 7899999999999999999999998766544444332211             


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                            .+         .++..++..+.+++.+||..+|++|||+.++++|
T Consensus       220 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 ------YP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ------CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  00         0122468999999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-40  Score=289.14  Aligned_cols=246  Identities=25%  Similarity=0.440  Sum_probs=196.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...         .....+|+++++.++|+||+++++++...   ...
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EEK   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CCC
Confidence            699999999999999999999999999999987421         12345799999999999999999886432   234


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++++||+++ +|.+.+...    ..+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~  153 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECccccc
Confidence            57899999985 777776542    4578899999999999999999998 999999999999999877 7999999999


Q ss_pred             eecccC----CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          216 KVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       216 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ......    .......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||........+.++..   .+.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~---  226 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT---  226 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC---
Confidence            754321    1112345788899999996654 78999999999999999999999987655444333221   111   


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                           ...++..++..+.+++++||+ +|..|||+.+++.|.
T Consensus       227 ---------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         227 ---------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             ---------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence                                 112345588999999999999 579999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=290.88  Aligned_cols=240  Identities=26%  Similarity=0.365  Sum_probs=190.0

Q ss_pred             eEeeeccceEEEEEEEcCCC---ceEEEEEcccchh-----hhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      ++||+|+||.||+|.+..++   ..+|+|.+.....     ...+|+.+++.+.|+||+++++++.      ....++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            46899999999999876554   7899998864432     3457899999999999999988652      12368999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+.+ +|.+.+...    ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            99985 788877653    3688999999999999999999998 999999999999999887 7999999998765433


Q ss_pred             CCcc----ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          222 EPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       222 ~~~~----~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ....    ...++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+....            
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~------------  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE------------  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC------------
Confidence            3211    112245799999986554 8999999999999999998 999998776544433332210            


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                      ....+..++..+.+++.+||..+|.+|||+.++++.|+.
T Consensus       216 ----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         216 ----------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             ----------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence                            001223468899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.1e-40  Score=294.05  Aligned_cols=241  Identities=26%  Similarity=0.366  Sum_probs=191.8

Q ss_pred             eeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        73 lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      ||+|+||+||+|.+..+|+.+|+|.+...       .....+|+++++.++||||+++++.+     ......|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            68999999999999999999999988532       12234699999999999999998887     3445689999999


Q ss_pred             cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCc
Q 018514          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (354)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~  224 (354)
                      ++ +|.+.+.....  ..+++..+..++.|++.||.|||+. |++||||+|+||+++.++ .++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            95 77777765432  4689999999999999999999998 999999999999999887 7999999998765443333


Q ss_pred             cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCC
Q 018514          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  304 (354)
Q Consensus       225 ~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  304 (354)
                      ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+......                  
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  212 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------  212 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence            4456788899999986655 899999999999999999999999765532221222111000                  


Q ss_pred             CCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       305 ~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                             ....++..+++.+.++|.+||+.||.+||     ++.+++.|
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence                   00112344689999999999999999999     88889876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.5e-40  Score=289.40  Aligned_cols=245  Identities=27%  Similarity=0.392  Sum_probs=196.1

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCC----ceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      +++.+.||.|+||.||++.+...+    ..||+|.+....     ....+|+.+++.++|+||+++++.+.     +...
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence            356789999999999999998766    889999986443     24457999999999999999999873     3345


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .+++|||+.+ ++.+.+.....  ..+++..+..++.|++.||++||+. |++|+||||+||+++.++ .++|+|||++.
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~-~~~l~dfg~~~  151 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENL-VVKISDFGLSR  151 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCC-eEEEcccCCce
Confidence            8899999985 78777765331  2289999999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCCCcc--ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          217 VLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       217 ~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      .........  ...+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||...+.......+.....        
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------  222 (258)
T smart00219      152 DLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------  222 (258)
T ss_pred             ecccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------
Confidence            665432211  1336788999999854 448999999999999999998 8899987665555544433110        


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                          ...+..++.++.+++.+||+.||++|||+.++++.|
T Consensus       223 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                                011223689999999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-40  Score=301.94  Aligned_cols=253  Identities=21%  Similarity=0.337  Sum_probs=196.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCC-------CceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeec
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  130 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  130 (354)
                      ..+|++.+.||+|+||.||+|.+...       +..+|+|.+....     ....+|+.+++++ +||||+++++++   
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---   87 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC---   87 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE---
Confidence            34799999999999999999986432       2368999876432     2345799999999 899999999987   


Q ss_pred             CCCCeeEEEEEEeeccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 018514          131 TEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~N  197 (354)
                        ......++++||+++ +|.+.+.....            ....++...+..++.|++.||+|||++ |++||||||+|
T Consensus        88 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~N  164 (334)
T cd05100          88 --TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARN  164 (334)
T ss_pred             --ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-Ceeccccccce
Confidence              334458899999985 88888765321            123577888999999999999999998 99999999999


Q ss_pred             eeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 018514          198 LLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (354)
Q Consensus       198 ili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  273 (354)
                      |+++.++ .+||+|||++........   .....++..|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+.
T Consensus       165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         165 VLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999887 799999999976543221   11223346799999996554 8899999999999999998 8899987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       274 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .+....+....                            ....+..++.++.+++.+||+.+|.+|||+.+++++|...
T Consensus       243 ~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         243 EELFKLLKEGH----------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             HHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            44443332210                            0011234678999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-40  Score=294.72  Aligned_cols=248  Identities=24%  Similarity=0.353  Sum_probs=196.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCc----eEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|++.+.||+|+||+||+|.++.+|.    .+|+|.+....     ....+|+.+++.++||||+++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            479999999999999999999876665    58999876442     234579999999999999999998743      


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||+.+ +|.+.+...   ...+++..+..++.|++.||+|||++ |++|+||||+||+++.++ .+||+|||.
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kL~dfg~  155 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCC-eEEECCCcc
Confidence            347899999985 787777653   24589999999999999999999998 999999999999999877 799999999


Q ss_pred             ceecccCCCccc---cccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~~~~~---~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +...........   ..++..|+|||.+.... ++.++|+||||+++||+++ |..||.+....+....+.... ..   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---  230 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RL---  230 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CC---
Confidence            976543322221   12356799999985544 7899999999999999998 999998766544333332210 00   


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                              ..+...+..+.+++.+||..||.+|||+.++++.|.++
T Consensus       231 ------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         231 ------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                                    01223578999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.8e-41  Score=294.80  Aligned_cols=238  Identities=19%  Similarity=0.273  Sum_probs=184.1

Q ss_pred             eEeeeccceEEEEEEEcCCCc-------eEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGE-------AVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +.||+|+||.||+|.+...+.       .+|+|.+....    ....+|+.+++.++|||++++++.+..     ....+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence            368999999999999865443       38888775432    234568899999999999999998743     23378


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCc-------EEEEe
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-------LKLCD  211 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~-------vkl~D  211 (354)
                      +||||+++ +|..++....   ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++..       ++++|
T Consensus        76 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999986 7777776532   3678899999999999999999998 99999999999999876532       79999


Q ss_pred             ccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       212 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      ||++.....   .....++..|+|||.+.+...++.++||||||+++|+|++|. +||...+...... ....       
T Consensus       152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-------  220 (258)
T cd05078         152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-------  220 (258)
T ss_pred             cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-------
Confidence            999865432   223457888999999976555789999999999999999984 6665544333221 1110       


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                            ...++...+.++.+++.+||+.||++|||++++++.|+
T Consensus       221 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ----------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                                  00122235688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-41  Score=321.43  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=208.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      +-+..+.||+|+||+||+|+...     ....||||.++..     ++.++||++++..++|||||+++|++     ..+
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~~  561 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC-----REG  561 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----ccC
Confidence            56778899999999999998642     2356999998754     34567999999999999999999999     444


Q ss_pred             eEEEEEEeecc-ccHHHHHHhhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC
Q 018514          136 LYLNLVLEYVP-ETVHRVIKHHYKM----------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (354)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~  204 (354)
                      ..++||+|||. |+|.++|......          ..+++..+.+.|+.||+.|++||-++ .+|||||...|+||..+.
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENL  640 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccce
Confidence            44899999999 7999999855421          23488899999999999999999998 999999999999999887


Q ss_pred             CcEEEEeccCceecccCCCcc---ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 018514          205 HQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (354)
Q Consensus       205 ~~vkl~Dfg~a~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  280 (354)
                       .|||+|||+++.....+...   ...-+..|||||.+...+ ++.++||||+||+|||+++ |..||.+..+.+.+..+
T Consensus       641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence             89999999998776544221   223467899999997655 9999999999999999997 99999999998888877


Q ss_pred             HHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      .+..-                            -.-+++.+.++.+||..||+.+|++||+.+||=..|+.
T Consensus       719 ~~g~l----------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  719 RAGQL----------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA  761 (774)
T ss_pred             HcCCc----------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence            66311                            01245689999999999999999999999999777654

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-40  Score=288.88  Aligned_cols=241  Identities=24%  Similarity=0.364  Sum_probs=190.1

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      +.||.|+||.||+|.+.. ++.||+|.+...     .....+|++++++++|+||+++++++     .+..+.++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence            468999999999999876 899999987643     23445799999999999999998887     3344588999999


Q ss_pred             cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCc
Q 018514          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (354)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~  224 (354)
                      .+ +|.+.+...   ...++...+..++.|++.+|+|||++ +++||||||+||+++.++ .++|+|||.+.........
T Consensus        75 ~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            75 777776543   24678889999999999999999998 999999999999999887 7999999998755322211


Q ss_pred             c---ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          225 I---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       225 ~---~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .   ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+....                
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~----------------  212 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY----------------  212 (251)
T ss_pred             eccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC----------------
Confidence            1   122355699999986554 8999999999999999999 889997766544333322110                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                  ....+..++..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       213 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         213 ------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             ------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence                        001123468899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.5e-40  Score=288.83  Aligned_cols=247  Identities=24%  Similarity=0.347  Sum_probs=196.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ++|++.+.||+|+||.||++.+. .+..+|+|.+....   ....+|+.+++.++|+||+++.+++..      ...+++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v   78 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII   78 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence            47999999999999999999864 45679999886532   344579999999999999999887632      346899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+++ +|.+.+....  ...++...+..++.|++.||.|||+. |++|+||||+||+++.++ .+||+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  154 (260)
T cd05073          79 TEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVIED  154 (260)
T ss_pred             EEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCCcceeeccC
Confidence            999984 8888876532  34578888999999999999999998 999999999999999887 799999999876543


Q ss_pred             CCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  ....++..|+|||.+.... ++.++|+|||||++|++++ |..||...+.......+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-----------  222 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-----------
Confidence            2211  1233456799999986544 8999999999999999998 99999877655544443221100           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                       ......+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       223 -----------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 -----------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -----------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                             0113468899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.6e-40  Score=290.75  Aligned_cols=251  Identities=22%  Similarity=0.293  Sum_probs=196.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      .+|++.+.||+|+||.||+|+++.     +...+++|.+....     ....+|++++++++|+||+++++.+     .+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            469999999999999999999754     34578999875432     2356799999999999999999877     44


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEE
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vk  208 (354)
                      ..+.++||||++ ++|.+++......     ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCC-cEE
Confidence            455799999998 4888887654321     12689999999999999999999998 999999999999999887 799


Q ss_pred             EEeccCceecccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 018514          209 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  285 (354)
Q Consensus       209 l~Dfg~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  285 (354)
                      ++|||++.......  ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+.... 
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~-  235 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-  235 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-
Confidence            99999986543221  112334567799999986554 7899999999999999998 889997665544333322110 


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                              ..|  ..+..++..+.+++.+||+.||++|||+.+++..|.
T Consensus       236 ------------------------~~~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 ------------------------LEL--PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ------------------------cCC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                                    001  112347899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.4e-40  Score=297.70  Aligned_cols=244  Identities=26%  Similarity=0.434  Sum_probs=195.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .|.....||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|||++++++++.     .....+++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEE
Confidence            355566899999999999999889999999987532    233457899999999999999999873     34458999


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      +||+++ ++...+..     ..+++..++.++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        97 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~  169 (297)
T cd06659          97 MEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK  169 (297)
T ss_pred             EecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCC-cEEEeechhHhhccc
Confidence            999996 66655433     4688999999999999999999998 999999999999999887 799999999865433


Q ss_pred             CC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       221 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      .. ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...+..+.+..+...   +.           
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-----------  234 (297)
T cd06659         170 DVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-----------  234 (297)
T ss_pred             ccccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-----------
Confidence            22 123456788999999996555 899999999999999999999999876655544433211   00           


Q ss_pred             cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                ..+.  ....++..+.++|.+||+.+|++||++.++++|
T Consensus       235 ----------~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         235 ----------PKLK--NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ----------CCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                      0000  112367899999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.9e-40  Score=293.85  Aligned_cols=260  Identities=23%  Similarity=0.386  Sum_probs=193.6

Q ss_pred             ceEEEeEeeeccceEEEEEEE----cCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .|++.+.||+|+||.||+|++    ..++..||+|.+....     ....+|+.+++.++|||++++.+++...   +..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence            478999999999999999984    3567889999986332     3445799999999999999998876432   234


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++||||++| +|.+.+...   ...+++..+..++.|++.||+|||++ |++||||||+||+++.++ .++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~-~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCC-CEEECCCccc
Confidence            57899999985 777777543   24578999999999999999999998 999999999999999877 7999999999


Q ss_pred             eecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH--
Q 018514          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR--  289 (354)
Q Consensus       216 ~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--  289 (354)
                      .........    ....++..|+|||.+.+.. ++.++||||||+++|+|+++..|+.....  ...   +..+....  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~---~~~~~~~~~~  230 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMT--LFL---KMIGPTHGQM  230 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccc--hhh---hhcccccccc
Confidence            765433221    1234566799999986554 88999999999999999998766533211  110   10010000  


Q ss_pred             --H-HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          290 --E-EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       290 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                        . ........             .....+..++..+.+|+.+||+.||.+|||+.++++.|+..
T Consensus       231 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         231 TVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence              0 00000000             00112234789999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.8e-40  Score=296.47  Aligned_cols=244  Identities=28%  Similarity=0.451  Sum_probs=198.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .|...+.||+|+||.||++++..++..+|+|.+....       ....+|+++++.++|||++++++++..     ....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence            3888999999999999999998899999999885321       234468999999999999999998743     3447


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+.|++.+.+...   ..++++..+..++.|++.||.|||++ |++||||+|+||+++.++ .++|+|||++...
T Consensus       101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence            899999999887776543   35689999999999999999999998 999999999999999877 7999999998654


Q ss_pred             ccCCCccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ..   .....+++.|+|||.+..  ...++.++|||||||++|+|++|..||...+.......+......+.        
T Consensus       176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  244 (317)
T cd06635         176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--------  244 (317)
T ss_pred             CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--------
Confidence            32   224467888999999742  33478899999999999999999999987665555554443211000        


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                         .....++.+.+++.+||+.+|.+||++.++++|.
T Consensus       245 -------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         245 -------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                               0123578999999999999999999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.7e-40  Score=292.22  Aligned_cols=239  Identities=26%  Similarity=0.378  Sum_probs=183.9

Q ss_pred             EeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHH---HcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMR---LLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .||+|+||.||++.+..+++.+|+|.+....       ....+|..+++   ...||||+.+++.+.     .....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence            4899999999999998899999999875431       11223433333   347999999988773     33458899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+.+ +|...+...    ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999996 666666542    5689999999999999999999998 999999999999999887 799999999875533


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .. .....|+..|+|||.+.+...++.++|||||||++|+|++|..||......... .+.....               
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---------------  212 (279)
T cd05633         150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---------------  212 (279)
T ss_pred             cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---------------
Confidence            22 233568999999999865555889999999999999999999999764322111 1111000               


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                .+...++..++.++.++|++||+.||++|+     |++++++|
T Consensus       213 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         213 ----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                      001113345789999999999999999999     69999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-40  Score=294.91  Aligned_cols=249  Identities=28%  Similarity=0.435  Sum_probs=194.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+|++.+.||+|+||+||++.+..+|+.+|+|++...     .....+|+++++.++||||+++++++     .+...++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEEE
Confidence            4699999999999999999999889999999987543     22345799999999999999999988     3445689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+++ +|...+..    .+.+++..+..++.|++.+|.|||+..+++||||||+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~  154 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGEL  154 (284)
T ss_pred             EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccch
Confidence            99999996 66665544    256899999999999999999999733899999999999999877 7999999998654


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-------HHHHHHHhCCCCHHH
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-------LVEIIKVLGTPTREE  291 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~~~~~~~~  291 (354)
                      .... .....++..|+|||++.+. .++.++|||||||++|+|++|..||........       +...........   
T Consensus       155 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  229 (284)
T cd06620         155 INSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---  229 (284)
T ss_pred             hhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence            3322 2245688999999998655 488999999999999999999999986543211       011111000000   


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                  .+.+        ....++.++.+++.+||+.||.+|||+.|++++
T Consensus       230 ------------~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         230 ------------PPRL--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             ------------CCCC--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                        0000        011267899999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.7e-40  Score=291.17  Aligned_cols=242  Identities=25%  Similarity=0.400  Sum_probs=195.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      -|++.+.||+|+||.||+|.+..+++.+|+|.+....     ....+|+.+++.++||||+++++++     .+....++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence            3888999999999999999998899999999875322     2345799999999999999999988     34455899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ ++...+..     ..++...+..++.|++.++.+||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCC-CEEEeecccceecc
Confidence            9999996 66666543     4688999999999999999999998 999999999999999887 79999999987654


Q ss_pred             cCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      .... .....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+... ..            
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------  218 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP------------  218 (277)
T ss_pred             cchhhhccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC------------
Confidence            3221 12345788899999986544 788999999999999999999999776544333332110 00            


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     ..+...++.++.+++.+||+.+|.+||++.+++.|
T Consensus       219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 ---------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                           01223468999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.3e-40  Score=291.35  Aligned_cols=248  Identities=27%  Similarity=0.368  Sum_probs=196.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCC---CceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+|.+.+.||.|+||.||+|.+...   ...+|+|......     +...+|+.+++.++||||+++++++..      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            3699999999999999999987543   3468999875432     234579999999999999999987632      2


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++||||+.+ +|.+.+...   ...+++..++.++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~~  154 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPD-CVKLGDFGLS  154 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCC-CeEEccCcee
Confidence            25799999985 788877653   24589999999999999999999998 999999999999999877 7999999998


Q ss_pred             eecccCCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          216 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       216 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      .........  ....++..|+|||.+.... ++.++||||||+++|+|++ |..||...+..+....+.+....      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------  227 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------  227 (270)
T ss_pred             eecccccceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------
Confidence            765433211  1222345799999985544 8999999999999999996 99999887765555443321000      


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                            ..+..++..+.+++.+|+..+|.+|||+.++++.|+..
T Consensus       228 ----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         228 ----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                                  12234789999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-39  Score=284.65  Aligned_cols=246  Identities=28%  Similarity=0.472  Sum_probs=200.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      +|.+.+.||+|++|.||++.+..+++.+++|++....    ....+|+++++.++|+|++++.+++.     .....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence            4888999999999999999998889999999986543    34567999999999999999999873     33458899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      +||+++ +|.+.+....   ..+++..+..++.|++.||.+||+. |++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence            999994 7777766532   5789999999999999999999998 999999999999999877 799999999987655


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+... ..+             
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-------------  215 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPP-------------  215 (253)
T ss_pred             cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCC-------------
Confidence            43334556788999999996655 789999999999999999999999876544444333221 000             


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                           ..   .    ....++..+.++|.+||+.||++|||+.++++|
T Consensus       216 -----~~---~----~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         216 -----GL---R----NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -----Cc---C----cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 00   0    011147899999999999999999999999987

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-40  Score=292.48  Aligned_cols=244  Identities=29%  Similarity=0.496  Sum_probs=194.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcC---CCCeeecceeeeecCCCCeeE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .|++.+.||+|+||.||+|.+..+++.+|+|.+...     .....+|+.+++.++   |||++++++++.     +...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            488889999999999999999999999999987532     223457888999886   999999999873     3445


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++||||+.+ +|.+.+..     ..+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence            8899999986 67666543     3688999999999999999999998 999999999999999877 79999999998


Q ss_pred             ecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ....... .....|+..|+|||.+.+...++.++|+||||+++|+|++|..||...........+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------  217 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------  217 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence            7644332 233467889999999876555789999999999999999999999765433322111000            


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                             ..+..        ....++.++.+++.+||+.||.+||++.+++.|
T Consensus       218 -------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 -------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                   00000        011267899999999999999999999999886

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.5e-40  Score=292.51  Aligned_cols=247  Identities=28%  Similarity=0.488  Sum_probs=195.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+....     ....+|+++++.++||||+++++.+.     .....++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEEE
Confidence            5888899999999999999999899999999875432     23457999999999999999998873     3456899


Q ss_pred             EEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||++ ++|.+.+....   ..+++..+..++.|++.||+|||+ . |++|+||||+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~  151 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRG-QIKLCDFGVSGQL  151 (265)
T ss_pred             EEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCC-CEEEeecccchhh
Confidence            999999 48887776543   678999999999999999999999 7 999999999999999877 7999999998765


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...... ...++..|+|||.+.+. .++.++||||||+++|+|++|..||...+. ........+......         
T Consensus       152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  220 (265)
T cd06605         152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---------  220 (265)
T ss_pred             HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC---------
Confidence            332222 26678889999998665 489999999999999999999999976421 111111111100000         


Q ss_pred             CCcccCCCCccCCCcccccCC-CCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~-~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                            .+.         .+. .++..+.++|.+||..||.+|||+.+++.|
T Consensus       221 ------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         221 ------PPR---------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ------CCC---------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                  000         111 168899999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.8e-40  Score=289.81  Aligned_cols=248  Identities=20%  Similarity=0.293  Sum_probs=186.6

Q ss_pred             EeeeccceEEEEEEEcC--CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEee
Q 018514           72 VVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~  144 (354)
                      .||+|+||.||+|....  ....+|+|.+....     ....+|+.+++.++||||+++++.+     ......++||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEEe
Confidence            58999999999997532  34568888775331     2345789999999999999999987     334458999999


Q ss_pred             ccc-cHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCC
Q 018514          145 VPE-TVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (354)
Q Consensus       145 ~~~-~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~  222 (354)
                      +.+ +|.+.+...... ....++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCC-cEEEeccccccccccch
Confidence            985 888888764322 23456778899999999999999998 999999999999999887 79999999986532221


Q ss_pred             C---ccccccccccccchhccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          223 P---NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       223 ~---~~~~~g~~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      .   .....++..|+|||++..      ...++.++|||||||++|+|++ |..||....+.+.+..+.......     
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-----  229 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK-----  229 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc-----
Confidence            1   122334667999999742      2346889999999999999999 789998776655555443321110     


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                 .+       ...+...++..+.+++..|+ .||.+|||++++++.|+
T Consensus       230 -----------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 -----------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             -----------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence                       00       01123347889999999998 59999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6e-40  Score=288.41  Aligned_cols=244  Identities=22%  Similarity=0.344  Sum_probs=195.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      .+|++.+.||+|+||.||++..  +++.+|+|.+..+.  ....+|+.+++.++|||++++++++..    +  ..+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~--~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH----N--GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC----C--CcEEEE
Confidence            4699999999999999999975  78889999886542  345579999999999999999887632    1  258999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+.+ +|.+.+....  ...+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence            99985 8888876542  24578899999999999999999998 999999999999999887 7999999998754322


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .  .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+.+..                
T Consensus       154 ~--~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------  214 (254)
T cd05083         154 V--DNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY----------------  214 (254)
T ss_pred             C--CCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC----------------
Confidence            1  1223456799999986554 8999999999999999997 999998766544433332210                


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                  .......++..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       215 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 ------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                        001123468999999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-39  Score=287.50  Aligned_cols=247  Identities=30%  Similarity=0.508  Sum_probs=195.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|.+.+.||+|+||.||+|.+..+++.+++|.+....      ....+|+.+++.++|+||+++++.+     .+....+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            4899999999999999999998899999999886432      2345799999999999999998876     3445588


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +|+||+.+ +|.+.+...    ..+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            99999985 777766542    4578889999999999999999998 999999999999999877 7999999998766


Q ss_pred             ccCCCcc-----ccccccccccchhccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          219 VKGEPNI-----SYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       219 ~~~~~~~-----~~~g~~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .......     ...++..|+|||.+.+..  .++.++||||||+++|+|++|..||...+........... +..+   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---  225 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP---  225 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence            4432211     245678899999986443  3788999999999999999999999765433322222111 0000   


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 .++          ....++..+.+++.+||+.+|.+|||+.+++.|
T Consensus       226 -----------~~~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         226 -----------PIP----------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             -----------CCC----------cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                       000          011358899999999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.1e-40  Score=291.73  Aligned_cols=237  Identities=17%  Similarity=0.228  Sum_probs=180.9

Q ss_pred             EeeeccceEEEEEEEcCC------------------------CceEEEEEcccch----hhhHHHHHHHHHcCCCCeeec
Q 018514           72 VVGHGSFGVVFQAKCLET------------------------GEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSL  123 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~  123 (354)
                      .||+|+||.||+|....+                        ...||+|.+....    ....+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            589999999999985322                        2358888885432    234467889999999999999


Q ss_pred             ceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC
Q 018514          124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (354)
Q Consensus       124 ~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~  202 (354)
                      ++++..     ....++||||+++ +|...+...   ...+++.++..++.||+.||+|||++ ||+||||||+||+++.
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEec
Confidence            998743     3347899999996 555555432   35688999999999999999999998 9999999999999975


Q ss_pred             CC------CcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCcHH
Q 018514          203 HT------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD  275 (354)
Q Consensus       203 ~~------~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~  275 (354)
                      .+      ..+|++|||++......   ....++..|+|||.+.+...++.++|||||||++|||+ +|..||......+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            43      13899999988643222   22356778999999876566899999999999999995 6999997765433


Q ss_pred             HHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      ... .....                             ..++...++.+.++|.+||+.+|++|||+.+++++|+
T Consensus       230 ~~~-~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KER-FYEKK-----------------------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHH-HHHhc-----------------------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            222 11100                             0011224678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.8e-40  Score=289.49  Aligned_cols=238  Identities=18%  Similarity=0.215  Sum_probs=179.6

Q ss_pred             eEeeeccceEEEEEEEcCC------------CceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           71 RVVGHGSFGVVFQAKCLET------------GEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~------------~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      +.||+|+||+||+|+....            ...+++|.+....    ....+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            3689999999999985322            2358889875432    234467889999999999999998733     


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC------cE
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------QL  207 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~------~v  207 (354)
                      ....++||||+++ ++..++...   ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.      .+
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCcee
Confidence            3346899999996 554444332   25689999999999999999999998 9999999999999976542      28


Q ss_pred             EEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCC
Q 018514          208 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT  286 (354)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~  286 (354)
                      +++|||++......   ....++..|+|||.+.....++.++|||||||++|+|+ +|..||......+.. .....   
T Consensus       152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---  224 (262)
T cd05077         152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---  224 (262)
T ss_pred             EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---
Confidence            99999998654322   23456788999999865556899999999999999998 588888764432221 11110   


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      .                .          ......+.++.++|.+||+.||.+||++.+++++++
T Consensus       225 ~----------------~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         225 Q----------------C----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             C----------------c----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0                0          001124578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1e-39  Score=293.50  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=194.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.++... .||||+++++++     ....
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~   87 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDS   87 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCC
Confidence            3457999999999999999999998889999999986431     1223466656555 599999999988     3444


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ..+++|||+++.+.+.+....   ..+++..+..++.|++.||+|||+..||+||||+|+||+++.++ .+||+|||++.
T Consensus        88 ~~~~v~e~~~~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~  163 (296)
T cd06618          88 DVFICMELMSTCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISG  163 (296)
T ss_pred             eEEEEeeccCcCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccch
Confidence            589999999887777665532   47899999999999999999999732999999999999999877 79999999987


Q ss_pred             ecccCCCccccccccccccchhccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHH
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  292 (354)
                      ............++..|+|||.+.+.   ..++.++||||||+++|+|++|+.||...... +.+..+...   .     
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~-----  235 (296)
T cd06618         164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---E-----  235 (296)
T ss_pred             hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---C-----
Confidence            66444333444577889999998543   23688999999999999999999999764332 222222111   0     


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 .+..   +    ....++.++.+++.+||+.||++|||+++++.|
T Consensus       236 -----------~~~~---~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         236 -----------PPSL---P----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -----------CCCC---C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                       0000   0    011367899999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1e-39  Score=288.26  Aligned_cols=237  Identities=30%  Similarity=0.476  Sum_probs=192.4

Q ss_pred             eeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        73 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      ||.|++|.||+|++..+++.+|+|++....       ....+|+.+++.++||||+++++.+     .+....++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            689999999999998889999999885421       2345789999999999999999987     3445589999999


Q ss_pred             cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCc
Q 018514          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (354)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~  224 (354)
                      .+ +|.+.+...    ..+++..+..++.||+.||+|||++ +++|+||+|+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            85 887777653    4588999999999999999999998 999999999999999887 7999999999876554333


Q ss_pred             cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCCHHHHhccCCCCccc
Q 018514          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF  302 (354)
Q Consensus       225 ~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  302 (354)
                      ....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....  ..+....+....                  
T Consensus       150 ~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  210 (262)
T cd05572         150 WTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN------------------  210 (262)
T ss_pred             ccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC------------------
Confidence            4456788999999986544 7899999999999999999999998765  333333322100                  


Q ss_pred             CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                               ....++...+.++.++|.+||+.||.+||+     ++|+++|
T Consensus       211 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         211 ---------GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             ---------CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence                     001122335789999999999999999999     9999986

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.9e-40  Score=293.82  Aligned_cols=246  Identities=26%  Similarity=0.406  Sum_probs=196.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .++|.+.+.||+|+||.||++.+..++..||+|.+...    .....+|+.+++.++|||++++++.+.     .....+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEE
Confidence            45899999999999999999998888999999987532    223457899999999999999999873     334588


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +|+||+.+ +|.+.+..     ..+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence            99999985 77776653     3578889999999999999999998 999999999999999877 7999999988655


Q ss_pred             ccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ..... .....+++.|+|||.+.... ++.++|+||||+++|++++|..||...+....+..+... +.           
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~-----------  232 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT-----------  232 (293)
T ss_pred             cccccccccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CC-----------
Confidence            33222 22346788899999986544 789999999999999999999999876543332221110 00           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    .....+..++..+.+++++||..+|++||++.+++.|
T Consensus       233 --------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 --------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                          0000123367899999999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.9e-40  Score=300.49  Aligned_cols=269  Identities=20%  Similarity=0.297  Sum_probs=191.8

Q ss_pred             eEeeec--cceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      ..||.|  +||+||+|++..+|+.||+|++....      ....+|+.+++.++||||++++++|     ....+.++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence            346666  99999999999999999999875322      3345788899999999999999988     3344589999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+.+ ++.+.+....  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence            99995 7777776543  24588999999999999999999998 999999999999999887 7999999865332211


Q ss_pred             CCc--------cccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH--
Q 018514          222 EPN--------ISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--  290 (354)
Q Consensus       222 ~~~--------~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  290 (354)
                      ...        ....++..|+|||++.+. ..++.++|||||||++|+|++|..||...................+..  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            110        012235569999998654 347899999999999999999999998876555544433321111100  


Q ss_pred             -------HHhccCCCCc----ccC-----CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 -------EIKCMNPNYT----EFK-----FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 -------~~~~~~~~~~----~~~-----~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                             ..........    +..     ........+.......++..+.+||++||+.||.+|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                   0000000000    000     000111112222234467899999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.4e-40  Score=289.92  Aligned_cols=245  Identities=22%  Similarity=0.353  Sum_probs=185.9

Q ss_pred             eEeeeccceEEEEEEEcC---CCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||+|+||.||+|.+..   .+..+|+|.+...     .....+|+.+++.++||||+++++.+...    ....+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            368999999999998653   3457999987432     12344688999999999999998865322    22367899


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+.+ +|.+++....   ...+...+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|||++......
T Consensus        77 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            99984 8887776432   3456777888999999999999998 999999999999999887 7999999998754322


Q ss_pred             C-----CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          222 E-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       222 ~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .     ......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||...+..+....+.... .         
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~---------  220 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-R---------  220 (262)
T ss_pred             cceeecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-C---------
Confidence            1     111234467899999986554 8999999999999999999 567776655444333221100 0         


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                        ...+..++..+.+++.+||..+|++||++.+++..|++.+
T Consensus       221 ------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         221 ------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                              0012236789999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.7e-39  Score=288.01  Aligned_cols=249  Identities=19%  Similarity=0.236  Sum_probs=186.1

Q ss_pred             eEeeeccceEEEEEEEcC--CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           71 RVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      +.||+|+||.||+|.+..  ++..+|+|.+....     ....+|+.+++.++||||+++++++     .+....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence            358999999999998643  45679999885432     2345699999999999999999887     33445789999


Q ss_pred             ecc-ccHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          144 YVP-ETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       144 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      |++ ++|.+.+..... .....+...++.++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            999 488887765432 123456778888999999999999998 999999999999999877 7999999998654322


Q ss_pred             CC---ccccccccccccchhccCCC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          222 EP---NISYICSRYYRAPELIFGAT------EYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       222 ~~---~~~~~g~~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ..   .....++..|+|||++.+..      .++.++||||||+++|+|++ |..||......+...........     
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----  228 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----  228 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence            11   12234677899999985321      25789999999999999996 99999876655443322211000     


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                 ..+       ...+....+..+.+++++|+ .+|++|||+++++..|+
T Consensus       229 -----------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         229 -----------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             -----------CCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                       000       00112236788999999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=283.06  Aligned_cols=247  Identities=26%  Similarity=0.428  Sum_probs=197.8

Q ss_pred             eEEE-eEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEE
Q 018514           67 YMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        67 y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      |++. +.||+|+|+.|--|....+|..+|||++.+.    +....+|++++.+. .|+||++++++|     +++..+|+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYL  153 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYL  153 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEE
Confidence            5553 6899999999999999999999999998543    34456899999988 499999999998     67777999


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC--cEEEEeccCcee
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKV  217 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~--~vkl~Dfg~a~~  217 (354)
                      |||-|.| +++..+..+    ..+++..+.++.++|+.||.|||++ ||.||||||+|||-.....  .||||||.+..-
T Consensus       154 VfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccc
Confidence            9999996 777777664    6799999999999999999999999 9999999999999854322  589999998754


Q ss_pred             cccCC--------Cccccccccccccchhcc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc------------
Q 018514          218 LVKGE--------PNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------------  273 (354)
Q Consensus       218 ~~~~~--------~~~~~~g~~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------------  273 (354)
                      .....        ...+.+|+..|||||+..    ....|+.+.|.||||+|+|-|+.|.+||.+.-.            
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            32211        223567888999999973    234589999999999999999999999987432            


Q ss_pred             ---HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          274 ---VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       274 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                         ...+..|....-..+.                    ..|.     .+|.+++++++.+|..|+..|.+|.+++.|
T Consensus       309 ~CQ~~LFesIQEGkYeFPd--------------------kdWa-----hIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPD--------------------KDWA-----HISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             HHHHHHHHHHhccCCcCCh--------------------hhhH-----HhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence               2233444433322222                    2232     379999999999999999999999999986

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.4e-39  Score=293.32  Aligned_cols=243  Identities=28%  Similarity=0.465  Sum_probs=197.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .|...+.||+|+||+||+|++..+|..|++|++....       ....+|+++++.++|||++++.+++.     +....
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   96 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTA   96 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence            4777888999999999999998899999999885321       23447899999999999999999884     34458


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+.+++.+.+...   ..++++..++.++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||++...
T Consensus        97 ~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~  171 (313)
T cd06633          97 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASKS  171 (313)
T ss_pred             EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCC-CEEEeecCCCccc
Confidence            899999999888777643   25688999999999999999999998 999999999999999877 7999999998643


Q ss_pred             ccCCCccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .   ......++..|+|||.+..  ...++.++|||||||++|+|++|..||...+.......+.... .          
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~----------  237 (313)
T cd06633         172 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-S----------  237 (313)
T ss_pred             C---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C----------
Confidence            2   2234567889999999842  2447889999999999999999999998876655555443210 0          


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                              +..        ....++..+.+++.+||+.+|.+||++.+++.|
T Consensus       238 --------~~~--------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 --------PTL--------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --------CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    000        112356889999999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-39  Score=285.75  Aligned_cols=240  Identities=23%  Similarity=0.360  Sum_probs=188.2

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      +.||+|+||.||+|... ++..+|+|.+....     ....+|+++++.++||||+++++.+.     .....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence            36899999999999854 67889999875432     23457999999999999999998873     334478999999


Q ss_pred             cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCc
Q 018514          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (354)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~  224 (354)
                      ++ +|.+.+...   ...+++..+..++.|++.+|.|||++ |++||||||+||+++.++ .+||+|||++.........
T Consensus        75 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            85 777766543   24578999999999999999999998 999999999999999877 7999999998754332211


Q ss_pred             c--ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcc
Q 018514          225 I--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (354)
Q Consensus       225 ~--~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .  ...++..|+|||.+.+.. ++.++||||||+++|++++ |..||...........+....                 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-----------------  211 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-----------------  211 (250)
T ss_pred             cCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            1  123356799999986544 8899999999999999998 999998766544433332210                 


Q ss_pred             cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                 ....+..++..+.+++.+||..+|++||++.++++.|.
T Consensus       212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                       00112346899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2e-39  Score=287.32  Aligned_cols=242  Identities=25%  Similarity=0.363  Sum_probs=187.9

Q ss_pred             ceEEEeEe--eeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           66 SYMAERVV--GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        66 ~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +|.+.+.+  |+|+||.||++.+..++..+|+|.+..... ...|+.....+ +||||+++++++.     .....++||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~-----~~~~~~iv~   88 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVT-----TLKGHVLIM   88 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEe-----cCCeeEEEE
Confidence            46666665  999999999999999999999998864321 11233333333 7999999999883     334689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+++ +|.+.+...    ..+++..++.++.|+++||.|||+. |++||||||+||+++.++..++|+|||++......
T Consensus        89 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         89 DYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            99985 888877653    3789999999999999999999998 99999999999999987657999999998765322


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                         ....++..|+|||++.+.. ++.++||||||+++|+|++|..||........ ...+......              
T Consensus       164 ---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  225 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK--------------  225 (267)
T ss_pred             ---ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------------
Confidence               2345788999999996655 89999999999999999999999975543221 1111111000              


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-HHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-AFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-a~e~l~~  348 (354)
                                  .....+.+++.+.++|.+||+.||.+||+ .+++++|
T Consensus       226 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 ------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                        00112347899999999999999999996 5999987

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.3e-40  Score=290.19  Aligned_cols=246  Identities=21%  Similarity=0.318  Sum_probs=191.1

Q ss_pred             eEeeeccceEEEEEEEcCCC------ceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETG------EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +.||+|+||.||+|++....      ..+|+|.+...     .....+|+.+++.++||||+++++++.     .....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence            36899999999999976433      67899987543     233457999999999999999998873     334478


Q ss_pred             EEEeeccc-cHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC----CcEEEEe
Q 018514          140 LVLEYVPE-TVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCD  211 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~----~~vkl~D  211 (354)
                      +||||+++ +|.+.+.....   ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999985 88888865432   224578889999999999999999998 999999999999998654    2699999


Q ss_pred             ccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 018514          212 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  287 (354)
Q Consensus       212 fg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  287 (354)
                      ||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+... .  
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~--  230 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G--  230 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C--
Confidence            999876533221   11234567899999996555 8999999999999999998 99999876655544333210 0  


Q ss_pred             CHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                               ....+..++..+.+++.+||..+|++||++.++++.|.+
T Consensus       231 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 -------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                                     001123468899999999999999999999999998763

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=313.45  Aligned_cols=207  Identities=28%  Similarity=0.417  Sum_probs=172.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEccc-----chhhhHHHHHHHHHcCCCCeeecceeeeecC-CCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTT-EKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~  139 (354)
                      .|...+.||+|+||.||+++++.+|+.||||.++.     +....-+|+++|++++|+|||++++.-.... ..-...-.
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            58888999999999999999999999999999865     3344558999999999999999977532111 00022356


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC---CCCcEEEEeccCc
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSA  215 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~---~~~~vkl~Dfg~a  215 (354)
                      +|||||.| +|...+.. ......+++..++.++.+++.||.|||++ ||+||||||.||++-.   .....||+|||.|
T Consensus        94 lvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            89999996 66666654 34456799999999999999999999999 9999999999998732   2235799999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  274 (354)
                      +.+.++....+.+||..|.+||++..+..|+..+|.|||||++|+++||..||......
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99988888889999999999999965566999999999999999999999999764433

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=286.95  Aligned_cols=238  Identities=33%  Similarity=0.512  Sum_probs=186.6

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccchh-------hhHHHHHH-HHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +.||.|+||.||+|.+..+|+.||+|.+.....       ....|..+ ....+|+|++++++++     ......++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            468999999999999988999999998864321       11233333 3445899999999988     3445689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+++ +|.+++...    ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99986 777776543    5689999999999999999999998 999999999999999877 799999999875432 


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (354)
                        .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+....                 
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  209 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-----------------  209 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-----------------
Confidence              22345788899999987655 8999999999999999999999998776655444433210                 


Q ss_pred             cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH---HHHhhc
Q 018514          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---FDAVGS  348 (354)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta---~e~l~~  348 (354)
                              ..|.......+++.+.+++.+||+.||++||++   +|++.|
T Consensus       210 --------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         210 --------INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             --------cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence                    011111223478999999999999999999966   566555

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.2e-39  Score=288.71  Aligned_cols=239  Identities=25%  Similarity=0.359  Sum_probs=184.6

Q ss_pred             EeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHH---HHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNREL---QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .||+|+||.||+|.+..+++.||+|.+....       .....|.   ..++...||||+++.+++     ......++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            4799999999999998899999999875421       1112233   344456899999998887     444568999


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+.| +|...+..    ...+++..++.++.|++.||+|||+. +++||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            999986 66555543    35789999999999999999999998 999999999999999887 799999999875533


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .. .....|+..|+|||.+.+...++.++||||+|+++|+|++|+.||.................               
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  213 (278)
T cd05606         150 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------  213 (278)
T ss_pred             cC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc---------------
Confidence            22 23456899999999997555588999999999999999999999976532211110000000               


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                 ....++..++..+.+++.+||..+|.+||     ++.++++|
T Consensus       214 -----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         214 -----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                       00112334689999999999999999999     99999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=286.13  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=203.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-----hhHHHHHH-HHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQT-MRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++.+-...||.|+||+|++..++.+|+..|||+++....     ....|.+. ++.-+.||||+++++.|...+     .
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c  138 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C  138 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence            345556789999999999999999999999999975432     23345554 444578999999999876443     6


Q ss_pred             EEEEeeccccHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ||.||.|+-++..+.+.... ....+++..+-.|....+.||.||.....|||||+||+|||++..| .|||||||++..
T Consensus       139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHh
Confidence            89999999888777765432 3467899999999999999999999877999999999999999988 799999999988


Q ss_pred             cccCCCccccccccccccchhccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhcc
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      +.++-..+...|-..|||||.+..... |+.++|+||||++|||+.||+.||.+.+. .+++.+++.  |.|+.-..   
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~---  292 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLF---  292 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecC---
Confidence            877777777788889999999966554 89999999999999999999999988654 344544443  22221100   


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                        ..-.-.++..+..+|..||.+|-++||...+++++
T Consensus       293 ------------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 ------------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ------------------cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                              00011378999999999999999999999999875

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.7e-39  Score=289.21  Aligned_cols=244  Identities=29%  Similarity=0.457  Sum_probs=195.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .|.-.+.||+|++|.||++.+..+++.+++|++....    ....+|+.+++.++|||++++++++.     ...+.+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence            4556679999999999999998899999999875322    23457899999999999999999873     34457899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      +||+.+ +|.+.+..     .+++...+..++.|++.||+|||++ |++||||+|+||+++.++ .++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCC-cEEEcccccchhhcc
Confidence            999986 77766654     4588899999999999999999998 999999999999999887 799999998865433


Q ss_pred             CCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          221 GEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       221 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      ... .....|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.... .+.           
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~-----------  234 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPK-----------  234 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCC-----------
Confidence            221 22346788999999986655 8999999999999999999999998766555544433210 000           


Q ss_pred             cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    ......++..+.+++.+||+.+|++|||+.++++|
T Consensus       235 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         235 --------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             --------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence                          00112367899999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=325.35  Aligned_cols=249  Identities=28%  Similarity=0.445  Sum_probs=209.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|.++++||+|+||.|.+++++.+++.||+|++.+.       ...+..|-.+|..-+.+=|+.+...|     .+.
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~  147 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE  147 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence            445799999999999999999999999999999988652       34456788899888899999998888     888


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .++|+||||++| +|..++...    .++++.++++|+..|+-||+.||+- |+|||||||+|||||..| .|||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~G-HikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSG-HIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccC-cEeeccchh
Confidence            999999999996 777777764    4799999999999999999999997 999999999999999999 599999999


Q ss_pred             ceecccCC--CccccccccccccchhccC---C-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          215 AKVLVKGE--PNISYICSRYYRAPELIFG---A-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       215 a~~~~~~~--~~~~~~g~~~y~aPE~~~~---~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      +-.+....  .....+|||.|.+||++..   + ..|++.+|+||+||++|||+.|..||...+-.+.+..|+..     
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-----  296 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-----  296 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-----
Confidence            97775333  2346789999999999942   2 45899999999999999999999999988877888777664     


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC---HHHHhhc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---AFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt---a~e~l~~  348 (354)
                                -..+.+|..          -.+|.++++||+++++ +|..|..   ++++..|
T Consensus       297 ----------k~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  297 ----------KESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             ----------hhhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence                      112233311          1289999999999984 7888888   8888877

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=332.63  Aligned_cols=248  Identities=28%  Similarity=0.462  Sum_probs=202.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+.+|.-...||.|.||.||-|.+..+|+..|+|-++-.      .....+|..++..++|||+|+++++=.     ++.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-----HRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-----HRE 1307 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee-----cHH
Confidence            445788888999999999999999999999999977422      223457999999999999999988652     223


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      -.+|.||||.| +|.+++.+.    .-.++...+.+..|++.|++|||++ |||||||||+||+++.+| .+|++|||.|
T Consensus      1308 kv~IFMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNG-LIKYGDFGSA 1381 (1509)
T ss_pred             HHHHHHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCC-cEEeecccce
Confidence            37899999996 777777663    4567778889999999999999999 999999999999999888 8999999999


Q ss_pred             eecccCCC-----ccccccccccccchhccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          216 KVLVKGEP-----NISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       216 ~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      ..+.+...     .....||+.|||||++.+..  ....++|||||||+..||+||+.||...+..-++.=-+.....| 
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P- 1460 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP- 1460 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC-
Confidence            88765532     23568999999999996533  35679999999999999999999998877655443333322222 


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                                .++.++|++-.+||.+||..||..|.++.|+++|
T Consensus      1461 --------------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 --------------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             --------------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                                      2445689999999999999999999999999987

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=290.65  Aligned_cols=238  Identities=29%  Similarity=0.452  Sum_probs=201.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhH-------HHHHHHHHc-CCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..+|..+.+||+|+||.|.+|..+.+.+.+|||+++++.-...       .|-++|... +-|.++++..||     ..-
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTm  422 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTM  422 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhh
Confidence            3479999999999999999999999999999999877643322       466666665 467888888888     334


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+|+||||+.| +|...+.+.    +.+.+..+..++.+|+-||-|||++ |||+||||.+||++|.++ .|||+|||+
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eG-HiKi~DFGm  496 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADFGM  496 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCC-ceEeeeccc
Confidence            448999999996 665555554    6688888999999999999999999 999999999999999999 599999999


Q ss_pred             ceec-ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          215 AKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       215 a~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ++.- ..+....+.+|||.|+|||++.-++ |+..+|+||+|++||||+.|.+||.+.++.+.++.|...          
T Consensus       497 cKEni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh----------  565 (683)
T KOG0696|consen  497 CKENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH----------  565 (683)
T ss_pred             ccccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----------
Confidence            9753 3344456789999999999997666 999999999999999999999999999999999998773          


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  342 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta  342 (354)
                                         ...+++.+|.++.++++.+|..+|.+|.-.
T Consensus       566 -------------------nvsyPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  566 -------------------NVSYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             -------------------cCcCcccccHHHHHHHHHHhhcCCccccCC
Confidence                               223677899999999999999999999743

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-39  Score=293.88  Aligned_cols=247  Identities=22%  Similarity=0.345  Sum_probs=192.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCc----eEEEEEcccchh-----hhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|+..+.||+|+||.||+|.+..+|.    .+|+|.+.....     ...+|+.+++.++||||+++++.+...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence            468999999999999999999887776    468887754321     345788999999999999999977321     


Q ss_pred             eEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                       ..+++++|++ |++.+.+...   ...+++..+..++.|++.||+|||++ ||+|+||||+||+++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~-~~kL~Dfg~  155 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPN-HVKITDFGL  155 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCC-ceEEccccc
Confidence             2468999998 5777776643   24688899999999999999999998 999999999999998777 799999999


Q ss_pred             ceecccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +.........   ....++..|+|||.+.+.. ++.++||||||+++|||++ |..||.+..... ...+......+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~---  230 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERL---  230 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCC---
Confidence            9865433221   1233466899999986554 8999999999999999997 899997655333 22222211000   


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                    +          .+...+..+.+++.+||..+|++||++.++++.|..
T Consensus       231 --------------~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         231 --------------P----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             --------------C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                          0          112357899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.3e-39  Score=285.59  Aligned_cols=246  Identities=24%  Similarity=0.456  Sum_probs=194.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEccc---------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|.+.+.||+|+||.||++.+..++..+++|..+.         ......+|+.+++.++||||+++++++.     +..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence            58999999999999999999987776666666532         1112346888999999999999998873     334


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++|+||+.+ ++.+.+.........+++..++.++.|++.||.|||+. |++|+||+|+||+++.+  .++|+|||++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~~--~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKNN--LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeecC--CEeecccCce
Confidence            47899999986 77777766555557799999999999999999999998 99999999999999753  5999999998


Q ss_pred             eecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          216 KVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       216 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+...   +.      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~~------  222 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG---PT------  222 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC---CC------
Confidence            76543322 22445788899999986544 788999999999999999999999765544433332211   00      


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                         ...+..++.++.++|.+||+.||++||++.++++|
T Consensus       223 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         223 -------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                               00123468899999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-39  Score=293.05  Aligned_cols=244  Identities=27%  Similarity=0.439  Sum_probs=196.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .|...+.||+|+||.||+|++..++..+|+|.+...       .....+|+++++.++|+|++++.+++..     ....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence            488889999999999999999989999999987532       1123468999999999999999998843     3457


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+.+++.+.+...   ...+++..++.++.|++.||.|||++ +++||||+|+||+++.++ .++|+|||++...
T Consensus        91 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence            899999999887776543   25688999999999999999999998 999999999999999877 7999999998765


Q ss_pred             ccCCCccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ...   ....+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+.....           
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----------  231 (308)
T cd06634         166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----------  231 (308)
T ss_pred             cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-----------
Confidence            332   23467889999999742  23478899999999999999999999977655444443322100           


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                              +.        .....++..+.++|++||..+|.+||++.+++.|.
T Consensus       232 --------~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 --------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --------CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                    00        01123678999999999999999999999999884

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-39  Score=287.99  Aligned_cols=256  Identities=21%  Similarity=0.328  Sum_probs=194.6

Q ss_pred             eEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe-e
Q 018514           67 YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE-L  136 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~-~  136 (354)
                      |.+.+.||+|+||.||+|.+.   .++..+|+|++..+.      ....+|+.+++.++||||+++++.+......+. .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            667889999999999999864   357889999886432      234478999999999999999987754332222 2


Q ss_pred             EEEEEEeeccc-cHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ..+++++|+.+ ++...+....  .....++...++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCC-CEEECccc
Confidence            34678899984 6666654322  1123578889999999999999999998 999999999999999877 79999999


Q ss_pred             CceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          214 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       214 ~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      ++........   .....+++.|++||.+.... ++.++|||||||++|+|++ |.+||.+.+..+....+... ..   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~---  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NR---  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-Cc---
Confidence            9876533221   12234467799999986554 7899999999999999999 88999776654433333221 00   


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                              ...+...+..+.+++.+||..+|.+|||+.+++..|+.++
T Consensus       234 ------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         234 ------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                                    0011236789999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=300.95  Aligned_cols=242  Identities=29%  Similarity=0.496  Sum_probs=202.8

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      .++||+|.||+||-|+++.+|+.||||++.+.      .....+|+.+|+.+.||.||.+.-.|     +....+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence            47899999999999999999999999988432      24456799999999999999986666     34444889999


Q ss_pred             eccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC--CCCcEEEEeccCceecccC
Q 018514          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~--~~~~vkl~Dfg~a~~~~~~  221 (354)
                      -+.|+.++.+....  .+++++.....++.||+.||.|||-+ +|+|+||||+|||+.+  ++.++||||||.|+.+.+.
T Consensus       644 Kl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  644 KLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            99998887776543  47899999999999999999999998 9999999999999954  4558999999999999887


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ....+.+|||.|.|||+++... |+..-|+||.|+|+|--++|..||....+. +++++.  .+.-              
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA--aFMy--------------  783 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA--AFMY--------------  783 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhHHhhcc--cccc--------------
Confidence            7777899999999999997766 999999999999999999999999765432 222221  0111              


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                             +..+|.     .+++++.+||..+|+..-++|.|.+..|.|
T Consensus       784 -------Pp~PW~-----eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  784 -------PPNPWS-----EISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             -------CCCchh-----hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence                   123443     479999999999999999999999998877

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1e-38  Score=280.47  Aligned_cols=247  Identities=32%  Similarity=0.495  Sum_probs=199.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|.+.+.||+|++|.||+|.+..++..|++|++....      ....+|+.++++++|+||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            4888999999999999999998899999999885443      34557999999999999999988874321   25688


Q ss_pred             EEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +++||+. ++|.+.+...    ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999996 4777777653    3789999999999999999999998 999999999999999877 7999999999877


Q ss_pred             ccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          219 VKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       219 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .....   .....++..|+|||.+.+.. .+.++||||||+++|+|++|..||...+....  .+.....          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc----------
Confidence            55543   34456788999999986555 89999999999999999999999987652111  1111000          


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    ......++..++..+.+++.+||+.||++||++.+++.|
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                          000111334468999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.2e-40  Score=322.22  Aligned_cols=255  Identities=30%  Similarity=0.452  Sum_probs=191.2

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC-----
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-----  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----  132 (354)
                      ...+|+..+.||+||||.||+|+++-+|+.||||++....     ....+|+.+|.+|.|||||+++..|.....     
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            4457889999999999999999999999999999996552     234589999999999999998877631000     


Q ss_pred             --------------------------------------------------------------------------------
Q 018514          133 --------------------------------------------------------------------------------  132 (354)
Q Consensus       133 --------------------------------------------------------------------------------  132 (354)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------C-------CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 018514          133 ----------------------K-------DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH  183 (354)
Q Consensus       133 ----------------------~-------~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH  183 (354)
                                            .       ...++||-||||+.++++.+-+......  ....++++++||+.||+|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence                                  0       0146899999999866665554332111  35678999999999999999


Q ss_pred             hcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc------------------cC-CCccccccccccccchhccCCC-
Q 018514          184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV------------------KG-EPNISYICSRYYRAPELIFGAT-  243 (354)
Q Consensus       184 ~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~------------------~~-~~~~~~~g~~~y~aPE~~~~~~-  243 (354)
                      +. |||||||||.|||+++++ .|||+|||+|+...                  .+ ...+..+||.-|+|||++.+.. 
T Consensus       715 ~~-giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  715 DQ-GIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             hC-ceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            99 999999999999999887 79999999998721                  00 1234678999999999996655 


Q ss_pred             -CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCH
Q 018514          244 -EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP  322 (354)
Q Consensus       244 -~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  322 (354)
                       .|+.|+|+||||+||+||+-   ||....+  - ..+...+..+.               +|.   .   ..|..+--+
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--R-a~iL~~LR~g~---------------iP~---~---~~f~~~~~~  845 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTSME--R-ASILTNLRKGS---------------IPE---P---ADFFDPEHP  845 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCchHH--H-HHHHHhcccCC---------------CCC---C---cccccccch
Confidence             59999999999999999984   4543222  1 22222211111               111   0   112222346


Q ss_pred             HHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          323 EAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       323 ~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .-..+|+.||+.||++||||.|+|.+
T Consensus       846 ~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  846 EEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHHHHHhcCCCccCCCHHHHhhc
Confidence            77899999999999999999999975

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.1e-39  Score=283.94  Aligned_cols=248  Identities=19%  Similarity=0.258  Sum_probs=186.0

Q ss_pred             EeeeccceEEEEEEEcCC--CceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEee
Q 018514           72 VVGHGSFGVVFQAKCLET--GEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~  144 (354)
                      .||+|+||.||++.....  ...+++|.+...     .....+|+.+++.++||||+++++.+.     +....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence            589999999999975433  234667765432     234457888999999999999999873     34458999999


Q ss_pred             ccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCC-
Q 018514          145 VPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-  222 (354)
Q Consensus       145 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~-  222 (354)
                      +.+ +|.+.+..........+...++.++.||+.||+|||+. +++||||||+||+++.++ .++|+|||++....... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence            995 88888876543345567778889999999999999998 999999999999999887 79999999986432211 


Q ss_pred             --CccccccccccccchhccCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          223 --PNISYICSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       223 --~~~~~~g~~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                        ......++..|+|||++...      ..++.++||||||+++|||++ |..||...+..+.+..+.+.....      
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------  228 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------  228 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence              12234578889999987421      225789999999999999997 578887777665555543321100      


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                       .+...+...+++.+.+++..|| .+|.+||++.++++.|.
T Consensus       229 -----------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 -----------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -----------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence                             0111122346789999999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-39  Score=280.69  Aligned_cols=243  Identities=35%  Similarity=0.571  Sum_probs=199.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +|++.+.||+|++|.||++++..+++.+++|.+....      ....+|++++++++|+|++++.+++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            4889999999999999999998899999999885443      23457999999999999999988873     345688


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++|||+.+ +|.+.+...    ..+++..+..++.|++.||.+||+. ||+||||+|+||+++.++ .++|+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999986 777766543    5789999999999999999999998 999999999999999876 7999999999876


Q ss_pred             ccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+....             
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  215 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-------------  215 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-------------
Confidence            54433 23456788899999986555 7899999999999999999999998766444333322110             


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     ...++..++..+.+++.+||..+|++|||+.+++.+
T Consensus       216 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         216 ---------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                           011234578999999999999999999999999976

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.9e-39  Score=292.08  Aligned_cols=270  Identities=20%  Similarity=0.286  Sum_probs=188.9

Q ss_pred             EEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        68 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+.+.+|.|  |.||++++..+++.||+|++...      .....+|+.+++.++|+||+++++++.     +....+++
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~   77 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVV   77 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEE
Confidence            333444444  55666666669999999998543      124557999999999999999999883     34458999


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+++ ++.+++....  ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||.+.....
T Consensus        78 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~  153 (314)
T cd08216          78 SPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIK  153 (314)
T ss_pred             EeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCC-ceEEecCccceeecc
Confidence            999995 7777776543  24688999999999999999999998 999999999999999877 799999998865532


Q ss_pred             CCC--------ccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH-
Q 018514          221 GEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-  290 (354)
Q Consensus       221 ~~~--------~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  290 (354)
                      ...        .....++..|+|||.+... ..++.++|||||||++|+|++|..||..........+........... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence            211        1223456789999998653 347889999999999999999999998766544433322211110000 


Q ss_pred             -HHhccCCCCccc---CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 -EIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 -~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       ............   .................++.++.+++.+||++||++|||++++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             000000000000   0000001111222233466789999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.6e-39  Score=287.22  Aligned_cols=249  Identities=29%  Similarity=0.455  Sum_probs=201.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ....|++.+.||+|++|.||+|.+..++..+++|++....   ....+|++.++.++|+|++++++++..     ....+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-----GDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEEE
Confidence            3346999999999999999999998889999999986543   345579999999999999999998843     34589


Q ss_pred             EEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +++||++ ++|.+.+....   ..++...+..++.|++.||+|||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDG-SVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCC-CEEECccchhhhh
Confidence            9999999 58888887643   4789999999999999999999998 999999999999999887 7999999988654


Q ss_pred             ccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+... ..+..        
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~--------  236 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPPL--------  236 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCC--------
Confidence            33221 12345678899999986554 899999999999999999999999876655444433221 00000        


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                       .....++..+.++|++||+.+|.+|||+.++++|
T Consensus       237 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 -----------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -----------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                             0112367899999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=302.03  Aligned_cols=248  Identities=24%  Similarity=0.354  Sum_probs=199.0

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCc---e-EEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGE---A-VAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      +-.+.++||+|+||.||+|+....+.   . ||+|..+..       .....+|.++|+.++|||||+++|+....    
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~----  233 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE----  233 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC----
Confidence            34455899999999999999865422   3 899988642       12334799999999999999999987433    


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                       ..+++|||+|.| +|.++|+...   ..++..+...++.+.++||+|||++ +++||||...|+|++.++ .+||+|||
T Consensus       234 -~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~-~vKISDFG  307 (474)
T KOG0194|consen  234 -EPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKG-VVKISDFG  307 (474)
T ss_pred             -CccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCC-eEEeCccc
Confidence             338999999996 8888888753   3689999999999999999999999 999999999999999877 68999999


Q ss_pred             CceecccCCCcc-ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          214 SAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       214 ~a~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      +++.-..-.... ...-+..|+|||.+... .|+.++|||||||++||+++ |..||.+....+....+....       
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~-------  379 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG-------  379 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC-------
Confidence            987542111111 11246779999999766 59999999999999999998 899999999888877774421       


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                          +....+...+.++..++.+|+..||++|||+.++.+.++.
T Consensus       380 --------------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~  419 (474)
T KOG0194|consen  380 --------------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEA  419 (474)
T ss_pred             --------------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence                                1112233467899999999999999999999999988764

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.8e-39  Score=286.36  Aligned_cols=242  Identities=31%  Similarity=0.554  Sum_probs=198.7

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      +|.+.+.||+|+||.||+|.+..+|..||+|++...       .....+|..++++++ ||||+++++++     .+...
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence            699999999999999999999999999999988542       123456889999998 99999999887     44556


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++||||+. ++|.+.+...    ..+++..++.++.|++.||.+||+. |++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            899999995 5888877653    4789999999999999999999998 999999999999999887 79999999987


Q ss_pred             ecccCCC---------------------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 018514          217 VLVKGEP---------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (354)
Q Consensus       217 ~~~~~~~---------------------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  275 (354)
                      .......                     .....++..|+|||.+.... ++.++|+||||++++++++|..||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            6543221                     12235678899999986554 7899999999999999999999998776544


Q ss_pred             HHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH----HHHhhc
Q 018514          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----FDAVGS  348 (354)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta----~e~l~~  348 (354)
                      .+..+....                             ..++..+++.+.++|.+||+.||.+|||+    ++++.|
T Consensus       230 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         230 TFQKILKLE-----------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHHHHhcC-----------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            444333210                             01233468999999999999999999999    999987

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.1e-39  Score=283.63  Aligned_cols=237  Identities=20%  Similarity=0.221  Sum_probs=183.7

Q ss_pred             eEeeeccceEEEEEEEcCCC----------ceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           71 RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ....+|+.+++.++||||+++++++..      ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence            46899999999999997666          347888765433   345578999999999999999998744      22


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC------cEEEE
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------QLKLC  210 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~------~vkl~  210 (354)
                      .++||||+.+ +|.+++....   ..++...+..++.||+.||+|||++ ||+||||||+||+++.++.      .+||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeC
Confidence            5899999995 7777666532   3688999999999999999999998 9999999999999987652      49999


Q ss_pred             eccCceecccCCCccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      |||++.....   .....++..|+|||.+.+. ..++.++||||||+++|+|++ |..||...+..+.......      
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~------  221 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD------  221 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc------
Confidence            9999976533   2234466779999998665 358999999999999999999 5788866543222111110      


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                              ....+......+.+++.+||..+|.+|||+.++++.|+
T Consensus       222 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 ------------------------QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------------------------CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                                    00011112379999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=318.64  Aligned_cols=251  Identities=20%  Similarity=0.328  Sum_probs=205.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCc-----eEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      .+-++.+.||+|+||.||.|......-     .||+|.+...     ...+.+|..+|+.++|||||+++++.+....  
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~--  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP--  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence            357888999999999999999764322     3899988654     2344579999999999999999999976333  


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEE
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                         .+|++|||.| +|..+|++...   ....++...+..++.||++|+.||+++ ++|||||...|+|++... .|||+
T Consensus       770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r-~VKIa  844 (1025)
T KOG1095|consen  770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERR-VVKIA  844 (1025)
T ss_pred             ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccC-cEEEc
Confidence               6899999995 89999987532   245688899999999999999999998 999999999999999886 89999


Q ss_pred             eccCceecccCCCcc---ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 018514          211 DFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  286 (354)
Q Consensus       211 Dfg~a~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  286 (354)
                      |||+|+.+.......   ...-+..|||||.+... .++.|+|||||||++||++| |..||.+.++.+.+....... +
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R  922 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R  922 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence            999999654433211   12335679999999764 49999999999999999998 999999988888776665532 1


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                                 -..+..++..+.++|..||+.+|++||+...+++.+..
T Consensus       923 ---------------------------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~  960 (1025)
T KOG1095|consen  923 ---------------------------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA  960 (1025)
T ss_pred             ---------------------------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence                                       11234589999999999999999999999999986643

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7e-39  Score=287.46  Aligned_cols=243  Identities=28%  Similarity=0.418  Sum_probs=193.4

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      |.....||+|+||.||++.+..+|+.||+|++...    .....+|+.+++.++|+|++++++.+.     ...+.+++|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEE
Confidence            44446799999999999999999999999987532    223457899999999999999999883     345689999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+++ ++.+.+..     ..+++..++.++.|++.||+|||+. |++|+||+|+||+++.++ .++|+|||++......
T Consensus        97 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~  169 (292)
T cd06657          97 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE  169 (292)
T ss_pred             ecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEcccccceecccc
Confidence            99997 55554432     4578899999999999999999998 999999999999999887 7999999998755432


Q ss_pred             C-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      . ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.+..+....+......              
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--------------  234 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP--------------  234 (292)
T ss_pred             cccccccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc--------------
Confidence            2 122356788999999986544 789999999999999999999999876655544433221100              


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                  .......++..+.+++.+||+.||.+||++.++++|
T Consensus       235 ------------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         235 ------------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             ------------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence                        000112368899999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=301.42  Aligned_cols=247  Identities=28%  Similarity=0.447  Sum_probs=201.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCC--C--ceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLET--G--EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~--~--~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..++.++||.|-||.||+|.....  |  -.||||..+.+     .+.+..|..+|+.++||||++++|++...      
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------  463 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------  463 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------
Confidence            345567899999999999987422  3  35889988653     34556799999999999999999988332      


Q ss_pred             EEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..|||||.++ |.|..++....   ..++...+..+++||+.||+|||+. ++|||||...|||+.+.. -|||+|||++
T Consensus       464 P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~-CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQ-CVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcc-eeeecccchh
Confidence            2799999999 78888888764   6789999999999999999999998 999999999999999887 6999999999


Q ss_pred             eecccCCCccccc--cccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          216 KVLVKGEPNISYI--CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       216 ~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      +.+..........  -+..|||||.+ +.+.++.++|||.|||.|||++. |..||.+-.+.+.+..+.++-+.      
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl------  611 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL------  611 (974)
T ss_pred             hhccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC------
Confidence            9875544322222  25679999999 56669999999999999999985 99999987766665555443111      


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                            ..++++++.+..|+.+||.+||.+||+..++...|++.
T Consensus       612 ----------------------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  612 ----------------------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             ----------------------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence                                  13456899999999999999999999999999887753

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.3e-40  Score=295.69  Aligned_cols=275  Identities=30%  Similarity=0.487  Sum_probs=224.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhh---HHHHHHHHHcC------CCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLD------HPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|.+....|+|-||+|.+|.+...|..||||++..+.-..   .+|+++|++|.      --|+++++..|     ...
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hk  506 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHK  506 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhc
Confidence            47999999999999999999999999999999998765443   47999999995      35788988888     677


Q ss_pred             eEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .++|||+|.+.-+|.+.++.... +-.+....++.+++|++-||..|... ||+|.||||+|||++.....+||||||.|
T Consensus       507 nHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  507 NHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             ceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCccc
Confidence            77999999999999999987653 46788889999999999999999987 99999999999999988888999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ...... ..+++..+.+|.|||++.+.+ |+...|+||.||+||||.||+..|++.++.+++.-.+...|..+...+...
T Consensus       585 ~~~~en-eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASEN-EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             cccccc-cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            876544 344566788899999999888 999999999999999999999999999999999999999999998776532


Q ss_pred             CCCCccc---------CCCCccCC-------------Cccccc------C---CCCCHHHHHHHHHhcCcCCCCCCCHHH
Q 018514          296 NPNYTEF---------KFPQIKAH-------------PWHKIF------Q---KRMPPEAVDLVSRLLQYSPNLRSTAFD  344 (354)
Q Consensus       296 ~~~~~~~---------~~~~~~~~-------------~~~~~~------~---~~~s~~l~~ll~~~l~~dp~~Rpta~e  344 (354)
                      .---..|         ....+...             .+...+      +   ..+-..|.+||.+||..||++|.|..+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence            2110011         00100000             000000      0   012246999999999999999999999


Q ss_pred             Hhhc
Q 018514          345 AVGS  348 (354)
Q Consensus       345 ~l~~  348 (354)
                      +|.|
T Consensus       743 AL~H  746 (752)
T KOG0670|consen  743 ALKH  746 (752)
T ss_pred             HhcC
Confidence            9998

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-38  Score=285.51  Aligned_cols=247  Identities=26%  Similarity=0.442  Sum_probs=193.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccch--------hhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 018514           66 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  133 (354)
                      +|++.+.||.|+||.||+|.+.   .+|..||+|++....        ....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4889999999999999999874   478899999886421        2345689999999 599999998887     4


Q ss_pred             CeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEec
Q 018514          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      .....++||||+.+ +|.+.+...    ..+++..+..++.|++.||.|||+. |++||||+|+||+++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCC-CEEEeeC
Confidence            44568899999996 777776542    5688999999999999999999998 999999999999999887 7999999


Q ss_pred             cCceecccCC--CccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          213 GSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       213 g~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      |++.......  ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+.......  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence            9987653322  12235578899999998643 236789999999999999999999997543322222222211000  


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                             ...++..+++.+.+++++||..||.+||     ++.+++.|
T Consensus       228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                                   0012334789999999999999999997     88998887

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.9e-39  Score=282.81  Aligned_cols=237  Identities=32%  Similarity=0.547  Sum_probs=190.2

Q ss_pred             eeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        73 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      ||.|+||.||++.+..+|+.+++|.+....       ....+|++++++++||||+++++.+     ......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999998889999999885432       2345788999999999999998877     4455689999999


Q ss_pred             cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCC--
Q 018514          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--  222 (354)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~--  222 (354)
                      .+ +|.+.+...    ..+++..+..++.||+.||+|||+. |++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            85 777777653    3689999999999999999999998 999999999999999887 79999999987543321  


Q ss_pred             -------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          223 -------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       223 -------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                             ......++..|+|||.+.... ++.++||||||+++|+|++|..||......+....+...  ..        
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------  218 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KI--------  218 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc--------
Confidence                   122345678899999986655 789999999999999999999999877655544443221  00        


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH---HHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---FDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta---~e~l~~  348 (354)
                             ..+.          ...++..+.+++.+||+.+|.+|||+   .++++|
T Consensus       219 -------~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         219 -------EWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             -------CCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence                   0000          01148999999999999999999999   666665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.4e-39  Score=285.83  Aligned_cols=264  Identities=25%  Similarity=0.363  Sum_probs=194.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEc----CCCceEEEEEcccchh-----hhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .|++.+.||+|+||.||+|.+.    .++..+|+|.+.....     ...+|+++++.++|+||+++++++..   .+..
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~   81 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR   81 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence            5888899999999999999864    3478899999865432     45679999999999999999887633   2345


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      +.+++|||+++ +|.+.+....   ..++...+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||.+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESED-LVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEcccccc
Confidence            58899999985 8887776532   3588999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-HhCCCCHH
Q 018514          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK-VLGTPTRE  290 (354)
Q Consensus       216 ~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~  290 (354)
                      .........    ....++..|+|||.+.+.. ++.++||||||+++|+|++|..||........  .+.. ..+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~  233 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFL--RMIGIAQGQMIVT  233 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhc--cccccccccccHH
Confidence            876432221    1223455699999986554 88999999999999999999998865322110  0000 00000000


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .+......  ....          ..+..++.++.+++.+||+.+|++|||+.++++.|+..
T Consensus       234 ~~~~~~~~--~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKE--GERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHc--CCcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00000000  0000          01223578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=297.96  Aligned_cols=245  Identities=26%  Similarity=0.405  Sum_probs=213.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .+.+.+..||-|+||.|-++..+.....+|+|++++..       +....|-.+|...+.|.||++|..|     .+..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence            35778889999999999999876665568999886432       2223588899999999999999988     88889


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +||+||-|-| .++..++.+    +.|...+++.++..++.|++|||++ |||+|||||+|.+++.+| -+||.|||+|+
T Consensus       495 vYmLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~G-y~KLVDFGFAK  568 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRG-YLKLVDFGFAK  568 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCC-ceEEeehhhHH
Confidence            9999999985 888888875    6789999999999999999999999 999999999999999998 69999999999


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .+..+....+++|||.|.|||++++.. .+.++|.||||+++|||++|.+||.+.++...+..|.+.+..          
T Consensus       569 ki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------  637 (732)
T KOG0614|consen  569 KIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------  637 (732)
T ss_pred             HhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------
Confidence            999999999999999999999998776 799999999999999999999999999999999888885321          


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                           +            .+++.++..+.+||+++...+|.+|.-     ..++-.|
T Consensus       638 -----i------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  638 -----I------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             -----h------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence                 1            145568999999999999999999986     4555544

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.6e-38  Score=311.05  Aligned_cols=141  Identities=26%  Similarity=0.440  Sum_probs=123.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .+|.+.+.||+|+||+||+|.+..+++.||||++....       ....+|+.+++.++||||++++.++     ....+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            47999999999999999999999899999999986432       3455789999999999999998877     34456


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +|+||||+.| +|..++...    ..+++..++.++.||+.||+|||.+ +|+||||||+|||++.++ .+||+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            8999999975 787777543    4688899999999999999999998 999999999999999887 79999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-41  Score=278.83  Aligned_cols=281  Identities=34%  Similarity=0.560  Sum_probs=219.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..+.+-.+-||.|+||.||-+.|..+|+.||+|++..-      .....+|+++|..++|.|++..++...-....--..
T Consensus        52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            33566678899999999999999999999999988542      234458999999999999999877542111110111


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +|+++|.+..+|...+-.    .+.++...+..+++||++||.|||+. +|.||||||.|.|++++. .+||||||+++.
T Consensus       132 iYV~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNC-vLKICDFGLARv  205 (449)
T KOG0664|consen  132 LYVLTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNC-ILKICDFGLART  205 (449)
T ss_pred             HHHHHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCc-eEEecccccccc
Confidence            567888888777666654    47788899999999999999999998 999999999999999998 899999999986


Q ss_pred             cccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          218 LVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       218 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .....  .....+.|.+|.|||.+.+.+.|+.+.||||.|||+.||+..+..|...++.+++..|...+|.|..+.++..
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            53332  2234566889999999999999999999999999999999999999999999999999999999999988654


Q ss_pred             CCCCcccCCCCc-cCCCccccc----CCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          296 NPNYTEFKFPQI-KAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       296 ~~~~~~~~~~~~-~~~~~~~~~----~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      .++...--.... +.......+    +..-..+...++..||.+||.+|.+..+++.|+.
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            433221111111 111111111    1223467889999999999999999999999864

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=275.61  Aligned_cols=235  Identities=34%  Similarity=0.534  Sum_probs=191.9

Q ss_pred             eeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        73 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      ||.|+||.||++.+..+++.+|+|.+....       ....+|+.+++.++|+||+++++.+     .+....+++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            689999999999998889999999886432       2445789999999999999999887     4556689999999


Q ss_pred             c-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC-CC
Q 018514          146 P-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  223 (354)
Q Consensus       146 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-~~  223 (354)
                      . ++|.+.+...    ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+...... ..
T Consensus        76 ~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            5 5887777653    4689999999999999999999998 999999999999999887 7999999999766443 22


Q ss_pred             ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccC
Q 018514          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  303 (354)
Q Consensus       224 ~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  303 (354)
                      .....++..|+|||...+.. .+.++|+||||+++|+|++|..||...+.......+...                 .  
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~--  209 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-----------------P--  209 (250)
T ss_pred             ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----------------C--
Confidence            33456788899999986554 788999999999999999999999776653333333220                 0  


Q ss_pred             CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH---HHHhhc
Q 018514          304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---FDAVGS  348 (354)
Q Consensus       304 ~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta---~e~l~~  348 (354)
                                ..++..++..+.+++++||..||++|||+   +++++|
T Consensus       210 ----------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         210 ----------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence                      01233468999999999999999999999   787776

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.9e-38  Score=281.41  Aligned_cols=250  Identities=28%  Similarity=0.440  Sum_probs=189.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccch--------hhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 018514           66 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  133 (354)
                      +|++.+.||+|++|.||++++.   .+++.||+|.+....        ....+|+.+++.+ .||||+++.+++     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            4889999999999999999864   457889999885321        2234789999999 599999998887     4


Q ss_pred             CeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEec
Q 018514          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      .....++||||+.+ +|.+.+..    ...+++..++.++.|++.+|.|||+. +++||||+|+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEG-HVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEEEC
Confidence            44558899999986 77666654    25688999999999999999999998 999999999999999887 7999999


Q ss_pred             cCceecccCCC--ccccccccccccchhccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          213 GSAKVLVKGEP--NISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       213 g~a~~~~~~~~--~~~~~g~~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      |++........  .....++..|+|||.+.+.. ..+.++||||||+++|+|++|..||...+.......+.+.....  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--  227 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--  227 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence            99876543322  12345788999999985433 36789999999999999999999996543222212221110000  


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                             ....+..++..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       228 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -----------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -----------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                                   001223478899999999999999999997666444443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-39  Score=281.78  Aligned_cols=260  Identities=22%  Similarity=0.271  Sum_probs=198.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-hhhHHHHHHHH--HcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMR--LLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      ..++.+.||+|.||.||+|.|  .|+.||||+|.... ....+|.++++  .|+|+||+.+++.-.... .....+++|+
T Consensus       212 qI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLvT  288 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLVT  288 (513)
T ss_pred             eeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEee
Confidence            589999999999999999999  78899999997543 34456777766  469999999988754433 4566799999


Q ss_pred             eecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-------~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      +|.+ |+|.++|..     ..++.....+++..+++||+|||..+       .|.|||||..|||+..++ .+.|+|+|+
T Consensus       289 dYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGL  362 (513)
T KOG2052|consen  289 DYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL  362 (513)
T ss_pred             ecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeecee
Confidence            9999 799999987     56889999999999999999999843       599999999999999998 899999999


Q ss_pred             ceecccCC-----CccccccccccccchhccCCCCC-----CCchhHHHHHHHHHHHHh----C------CCCCCCCCcH
Q 018514          215 AKVLVKGE-----PNISYICSRYYRAPELIFGATEY-----TAAIDIWSAGCVLAELLL----G------QPLFPGESGV  274 (354)
Q Consensus       215 a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~-----~~~~DiwslG~il~ell~----g------~~pf~~~~~~  274 (354)
                      |.......     .....+||..|||||++....+.     -..+||||||.++||++-    |      .+||.+-.+ 
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp-  441 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP-  441 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC-
Confidence            98775542     23467899999999999544321     136999999999999973    2      467765322 


Q ss_pred             HHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       275 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                   .+.....+.+..+.-++.......|...   ..-..+..+++.||..||.-|.||-.+.+.|..
T Consensus       442 -------------~DPs~eeMrkVVCv~~~RP~ipnrW~s~---~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  442 -------------SDPSFEEMRKVVCVQKLRPNIPNRWKSD---PALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             -------------CCCCHHHHhcceeecccCCCCCcccccC---HHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence                         1111222333333444444455566542   123467788999999999999999888776643

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=271.29  Aligned_cols=244  Identities=25%  Similarity=0.446  Sum_probs=195.1

Q ss_pred             CCCCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeee
Q 018514           58 NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (354)
Q Consensus        58 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~  129 (354)
                      ........+|.++++||+|+|++|.+++.+.+.+.+|+|++++.-       ...+-|-.+..+. +||.+|.+..||  
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--  320 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--  320 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--
Confidence            334445568999999999999999999999999999999986542       1222354555444 799999999998  


Q ss_pred             cCCCCeeEEEEEEeecccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEE
Q 018514          130 TTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (354)
Q Consensus       130 ~~~~~~~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vk  208 (354)
                         .....+++|.||.+|+ |.-.+.+    ...++++.++.+...|+.||.|||++ |||+||||.+|+|+|..+ .+|
T Consensus       321 ---qtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeg-hik  391 (593)
T KOG0695|consen  321 ---QTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEG-HIK  391 (593)
T ss_pred             ---cccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCC-cee
Confidence               5566699999999974 3333333    36799999999999999999999999 999999999999999999 599


Q ss_pred             EEeccCcee-cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CCcHHHHHHH
Q 018514          209 LCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-------ESGVDQLVEI  280 (354)
Q Consensus       209 l~Dfg~a~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-------~~~~~~~~~i  280 (354)
                      |+|+|.++. +.++....+++|||.|.|||++.+.. |+...|+|+||++|+||+.|+.||.-       .+..+.+.++
T Consensus       392 ltdygmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv  470 (593)
T KOG0695|consen  392 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV  470 (593)
T ss_pred             ecccchhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence            999999864 45566677899999999999998776 99999999999999999999999952       1223333333


Q ss_pred             HHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC
Q 018514          281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  341 (354)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt  341 (354)
                      +-.                            -+..+++.+|-.+..+++.-|.+||.+|..
T Consensus       471 ile----------------------------kqiriprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  471 ILE----------------------------KQIRIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             Hhh----------------------------hcccccceeehhhHHHHHHhhcCCcHHhcC
Confidence            221                            011245567888999999999999999974

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.2e-37  Score=300.53  Aligned_cols=276  Identities=21%  Similarity=0.258  Sum_probs=177.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCC----CceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLET----GEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  137 (354)
                      ..++|.+.+.||+|+||.||+|.+..+    +..||+|++...........+.++...+.++..+...+..... .....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            456899999999999999999999888    8999999875432211111112222233334433333322111 34455


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKM----------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~----------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili  200 (354)
                      +++|+||+++ +|.+++......                ........+..++.||+.||+|||++ +|+||||||+|||+
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~NILl  288 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQNIIF  288 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHHHEEE
Confidence            8899999995 777776542100                01122345678999999999999998 99999999999999


Q ss_pred             eCCCCcEEEEeccCceecccCC--CccccccccccccchhccCCC---------------------CCCCchhHHHHHHH
Q 018514          201 NPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---------------------EYTAAIDIWSAGCV  257 (354)
Q Consensus       201 ~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~---------------------~~~~~~DiwslG~i  257 (354)
                      +.+...+||+|||+|.....+.  ......+++.|+|||.+....                     .++.++|||||||+
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi  368 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI  368 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence            8754489999999997653322  223467899999999763221                     23456799999999


Q ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCC
Q 018514          258 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  337 (354)
Q Consensus       258 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~  337 (354)
                      +|||+++..++  .+....+..+....+.....+.......    ..+...   ......+.......+||++||++||+
T Consensus       369 L~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~----~~~~~~---~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        369 FLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPR----ASPDLR---RGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhccc----cchhhh---hhhhhccccchHHHHHHHHHccCCcc
Confidence            99999976554  3333344444433332222111111100    000000   00001122345677999999999999


Q ss_pred             CCCCHHHHhhc
Q 018514          338 LRSTAFDAVGS  348 (354)
Q Consensus       338 ~Rpta~e~l~~  348 (354)
                      +|||+.++|+|
T Consensus       440 kR~ta~e~L~H  450 (566)
T PLN03225        440 QRISAKAALAH  450 (566)
T ss_pred             cCCCHHHHhCC
Confidence            99999999998

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=290.36  Aligned_cols=250  Identities=21%  Similarity=0.343  Sum_probs=206.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +..+.++||.|.||.||.+.|+...-.||||.++.+.   ..+..|..+|+.++|||+|++++++.     ...-+|||+
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT-----~EpPFYIiT  342 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----HEPPFYIIT  342 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhc-----cCCCeEEEE
Confidence            4667789999999999999999888899999998763   45668999999999999999999983     344489999


Q ss_pred             eecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      |||. |+|+++|+....  ..++.-.+..++.||.+|++||..+ ++|||||...|+|+..+. .||++|||+++.+...
T Consensus       343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGD  418 (1157)
T ss_pred             ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccc-eEEeeccchhhhhcCC
Confidence            9998 799999987653  5567778889999999999999998 999999999999999775 8999999999977544


Q ss_pred             CCcc--ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          222 EPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       222 ~~~~--~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ....  ....+..|.|||.+.-. .++.++|||+|||+|||+.| |-.||++-+-.+.+..+.+.+              
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy--------------  483 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY--------------  483 (1157)
T ss_pred             ceecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc--------------
Confidence            3221  22235669999999544 48999999999999999998 999999877655555444432              


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                    +-+-++++++.+..|++.||+|.|.+||+..|+-+.|+..|
T Consensus       484 --------------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  484 --------------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             --------------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                          11224578999999999999999999999999988776543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=270.55  Aligned_cols=273  Identities=33%  Similarity=0.557  Sum_probs=221.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYL  138 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  138 (354)
                      +|.-...+|.|.- .|-.|.|.-.+++||+|+....      .....+|..++..+.|+||++++.+|.-... ..-...
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            6888889999998 7888888889999999988543      2334579999999999999999998754332 112237


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      |+|||++..++...+.      -.++-..+..+++|++.|+.|||+. ||+||||||+||++..+. .+||.|||+|...
T Consensus        97 y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   97 YLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDC-TLKILDFGLARTE  168 (369)
T ss_pred             HHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchh-heeeccchhhccc
Confidence            8999999999888777      3467778999999999999999998 999999999999999888 8999999999876


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ...-..+..+.|..|.|||++.+.. +...+||||+||++.||++|...|++.+..++..++...+|.|.+..+.++.+.
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             CcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            5554556778899999999998877 899999999999999999999999999999999999999999999877655432


Q ss_pred             Cccc----------CCC-CccCCCccccc--CCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEF----------KFP-QIKAHPWHKIF--QKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~----------~~~-~~~~~~~~~~~--~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...+          .+. ..+..-|....  ++.-+..+++++.+||..||++|.+++++|.|
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            2111          111 11111222222  12234679999999999999999999999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=254.85  Aligned_cols=218  Identities=22%  Similarity=0.403  Sum_probs=184.6

Q ss_pred             CCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHH-cCCCCeeecceeeeecCCC
Q 018514           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        60 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~  133 (354)
                      .....+...-+..||+|+||.|-+.++..+|...|+|.+....     ....+|+.+..+ ...|.+|.+++.++...+ 
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-
Confidence            4445556777788999999999999999999999999986432     222346665443 468999999998865444 


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                          .+|.||.|..++..+.++....++.+++..+-+|+..++.||.|||++..+||||+||+||||+.+| +||+||||
T Consensus       120 ----vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFG  194 (282)
T KOG0984|consen  120 ----VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFG  194 (282)
T ss_pred             ----EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccc
Confidence                8999999999999999999999999999999999999999999999998999999999999999998 89999999


Q ss_pred             CceecccCCCccccccccccccchhccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHH
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFG---ATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKV  283 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~  283 (354)
                      .+..+.++-..+...|...|||||.+..   ...|+.++||||||+++.||.+++.||.. .++.+++.+++..
T Consensus       195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            9998877766666778888999999843   33589999999999999999999999976 5666777777663

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.4e-38  Score=272.01  Aligned_cols=225  Identities=25%  Similarity=0.289  Sum_probs=177.5

Q ss_pred             ccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeeccc-cHHHHHH
Q 018514           76 GSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIK  154 (354)
Q Consensus        76 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~  154 (354)
                      |.+|.||+|++..+++.+|+|.+..... ..+|...+....||||+++++++     .+....++||||+.+ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH
Confidence            8999999999999999999999976543 23455556667899999999987     344568999999995 7877776


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCccccccccccc
Q 018514          155 HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR  234 (354)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~  234 (354)
                      ..    ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .++++|||.+......  .....++..|+
T Consensus        78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 KF----LNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             Hh----cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            53    4589999999999999999999998 999999999999999887 7999999987654332  22334567799


Q ss_pred             cchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCccc
Q 018514          235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  314 (354)
Q Consensus       235 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (354)
                      |||.+.+.. ++.++|+||+|+++|+|++|..||.......      .               ...            ..
T Consensus       150 aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~---------------~~~------------~~  195 (237)
T cd05576         150 APEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGI------N---------------THT------------TL  195 (237)
T ss_pred             CCcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhc------c---------------ccc------------cc
Confidence            999985544 7899999999999999999998874321100      0               000            00


Q ss_pred             ccCCCCCHHHHHHHHHhcCcCCCCCCCH-----HHHhhc
Q 018514          315 IFQKRMPPEAVDLVSRLLQYSPNLRSTA-----FDAVGS  348 (354)
Q Consensus       315 ~~~~~~s~~l~~ll~~~l~~dp~~Rpta-----~e~l~~  348 (354)
                      .++..+++.+.++|.+||+.||++||++     ++++.|
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence            1233478999999999999999999996     777765

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=284.99  Aligned_cols=256  Identities=20%  Similarity=0.265  Sum_probs=207.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ....+.++||+|-||.|.+|.- ..+..||+|+++.+.     ..+.+|+++|.+++||||+.+++++....     .++
T Consensus       538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chH
Confidence            4578899999999999999985 346899999997543     34558999999999999999999985433     288


Q ss_pred             EEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +|+||+. |+|.+++..+....  +.......|+.||++|++||.+. ++|||||.+.|+|++.++ ++||+|||.++.+
T Consensus       612 mI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~l  687 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEF-TIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcc-cEEecCccccccc
Confidence            9999999 78988888764322  34445667999999999999997 999999999999999998 7999999999987


Q ss_pred             ccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          219 VKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       219 ~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ..+...   ...+-+..|||||.+...+ ++.++|+|+||+++||+++  ...||....+.+...+....+..+...-+.
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence            666432   2344577899999997665 9999999999999999875  779998888777776665554443332111


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                           .-+.-++..+.++|.+||..|-.+||+.+++..+|.+.
T Consensus       767 ---------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 ---------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                                 01234789999999999999999999999999988764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=301.01  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=212.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCc---eEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .-.+.++||.|.||.|++|+.+..|+   .||||.++..     +..+..|..+|.+++||||+++.++..     ...-
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-----ks~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-----KSKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-----cCce
Confidence            36788999999999999999887664   5999999753     334557999999999999999999873     3334


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +.||+|||+ |+|..+|+.+.   +.|+..++..+++.|+.|+.||-+. |+|||||...|||++.+- .+|++|||+++
T Consensus       705 vMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnL-vCKVsDFGLSR  779 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNL-VCKVSDFGLSR  779 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc-Cchhhhhhhhheeeccce-EEEecccccee
Confidence            789999999 68999998765   6688889999999999999999987 999999999999999998 89999999999


Q ss_pred             ecccCCC-cccccc---ccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          217 VLVKGEP-NISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       217 ~~~~~~~-~~~~~g---~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .+.+..+ ..+..|   +..|.|||.+. .++++.++||||+|++|||.++ |..||...++.+.+..|.+.++-|++. 
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm-  857 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM-  857 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC-
Confidence            7755442 222222   56799999995 5559999999999999999886 999999999999999999977666653 


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                 .++..+.+|+..||++|-.+||+..+++..|+.+
T Consensus       858 ---------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  858 ---------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             ---------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence                                       3799999999999999999999999999998754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=293.98  Aligned_cols=259  Identities=26%  Similarity=0.398  Sum_probs=212.7

Q ss_pred             CCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCe
Q 018514           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        60 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+-..+-|++.+.||.|.+|.||+++.+.+++..|+|+...+   ....+.|.++|+.. .|||++.++++|.......+
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            344456799999999999999999999999999999987543   34455678888877 69999999999988777777


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+|+|||||+| +.-++.+...  +.++.+..+..|++.++.||.+||.+ .++|||||-.|||++.++ .|||+|||+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~-~VKLvDFGv  169 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENA-EVKLVDFGV  169 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccC-cEEEeeeee
Confidence            889999999996 6666666655  78899999999999999999999998 999999999999999998 799999999


Q ss_pred             ceecccC-CCccccccccccccchhccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKG-EPNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +..+... ....+.+|||+|||||++....    .|+..+|+||||++..||.-|.+|+-..-+...+..|..   .|++
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPP  246 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPP  246 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCc
Confidence            8765433 3445788999999999995433    367799999999999999999999977666555544422   2222


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..                  ..|     +.-++++.++|..||..|-.+||+..++|+|
T Consensus       247 kL------------------krp-----~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  247 KL------------------KRP-----KKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             cc------------------cch-----hhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            21                  111     1236899999999999999999999999988

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=289.71  Aligned_cols=244  Identities=24%  Similarity=0.354  Sum_probs=202.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCC-C--ceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLET-G--EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ...+.+.||+|.||.|++|.|... |  -.||||.++.+.     ..+.+|+.+|.+|+|+|++++|++..+.      -
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------P  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------h
Confidence            466778999999999999999643 3  358999987653     3456899999999999999999988542      1


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +.||||.+. |+|++.|..  .....|....+..++.||+.||.||.++ ++|||||...|+|+-... .|||+|||+.+
T Consensus       185 ~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllaspr-tVKI~DFGLmR  260 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPR-TVKICDFGLMR  260 (1039)
T ss_pred             hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccc-eeeeeccccee
Confidence            568999999 699988887  3347788999999999999999999999 999999999999998765 89999999999


Q ss_pred             ecccCCCcccccc----ccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          217 VLVKGEPNISYIC----SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       217 ~~~~~~~~~~~~g----~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .+..++..+...+    ...|+|||.+.... ++.++|||++||++|||++ |..||.+....+.+..|-+.-       
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-------  332 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-------  332 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-------
Confidence            8877766553322    45699999996554 9999999999999999998 889999999888777764320       


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 +++          -++.+++++.++++.||..+|++|||...+.+.
T Consensus       333 -----------rLp----------RPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  333 -----------RLP----------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             -----------cCC----------CCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                       000          134589999999999999999999999988643

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=278.53  Aligned_cols=259  Identities=26%  Similarity=0.404  Sum_probs=198.2

Q ss_pred             CCCccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-----------hhHHHHHHHHHcCCCCeeecceee
Q 018514           59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----------YKNRELQTMRLLDHPNVVSLKHCF  127 (354)
Q Consensus        59 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~e~~~l~~l~h~~iv~~~~~~  127 (354)
                      ..|...++|-++..||+|||+.||+|.|....+.||+|+-..+..           ..-+|.++-+.|+||.||++|++|
T Consensus       457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            345566789999999999999999999999999999997532221           122699999999999999999998


Q ss_pred             eecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCCeeeeCC--
Q 018514          128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-IGVCHRDIKPQNLLVNPH--  203 (354)
Q Consensus       128 ~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~~iiH~Dlkp~Nili~~~--  203 (354)
                      ....+    .+|.|+|||+| +|.-+++.+    +.+++..++.|+.||++||.||... ..|||-||||.|||+-..  
T Consensus       537 slDtd----sFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  537 SLDTD----SFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             eeccc----cceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc
Confidence            54333    37899999998 555455543    6789999999999999999999864 269999999999998533  


Q ss_pred             CCcEEEEeccCceecccCCCc--------cccccccccccchhccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 018514          204 THQLKLCDFGSAKVLVKGEPN--------ISYICSRYYRAPELIFG---ATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (354)
Q Consensus       204 ~~~vkl~Dfg~a~~~~~~~~~--------~~~~g~~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~  272 (354)
                      .+.|||+|||+++.+......        ....||.+|.+||.+.-   .+..+.++||||+|||+|.++.|+.||....
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            237999999999987554322        34678999999999842   3557889999999999999999999996644


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ....+.+....+             ...+..+|.          -..+++++++||++||.+--++|....++..+
T Consensus       689 sQQdILqeNTIl-------------kAtEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  689 SQQDILQENTIL-------------KATEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             hHHHHHhhhchh-------------cceeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            332222111100             001122221          12489999999999999999999998887654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=312.74  Aligned_cols=256  Identities=22%  Similarity=0.327  Sum_probs=187.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      .|...+.||+|+||.||+|++..++..||+|++........+|++.+++++||||+++++++..     ....++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCC
Confidence            4667789999999999999998899999999987655555678999999999999999998843     33478999999


Q ss_pred             cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH---NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ++ +|.+.+.       .+++..+..++.|++.||+|||   +. +|+||||||+||+++.++ ..++. ||....... 
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT-  834 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence            85 7777764       2778889999999999999999   66 999999999999999776 56654 665543321 


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                        .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||..... ...+.++.+.......  .       .
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~-------~  902 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH--L-------D  902 (968)
T ss_pred             --CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc--h-------h
Confidence              12336788999999986554 89999999999999999999999854221 1112222221100000  0       0


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .+.-+.... .+  ........++.+++.+||+.||++|||+.|+++.|+..
T Consensus       903 ~~~~~~~~~-~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        903 MWIDPSIRG-DV--SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             heeCccccC-CC--CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            000000000 00  00111234678899999999999999999999998753

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-36  Score=276.40  Aligned_cols=244  Identities=27%  Similarity=0.440  Sum_probs=191.6

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-------hhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      |..++.||-|+||.|.++.-..+...+|+|.+++..-       -.+.|-.||..-+++-||+++..|     .+..++|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnLY  705 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNLY  705 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCceE
Confidence            8889999999999999999888888999998865432       223588999999999999999988     7778899


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||+|++| ++-.+|-+-    +-|.+..++.++.++.+|+++.|+- |+|||||||+|||||.+| .|||+|||+|+-+
T Consensus       706 FVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdG-HIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCC-ceeeeeccccccc
Confidence            99999996 666665543    6789999999999999999999987 999999999999999999 5999999999643


Q ss_pred             c---------cCC----------------------------------CccccccccccccchhccCCCCCCCchhHHHHH
Q 018514          219 V---------KGE----------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAG  255 (354)
Q Consensus       219 ~---------~~~----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG  255 (354)
                      .         ++.                                  .....+||+.|+|||++.... |+..+|+||.|
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~g  858 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVG  858 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhh
Confidence            1         000                                  001356899999999996555 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcC
Q 018514          256 CVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  335 (354)
Q Consensus       256 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~d  335 (354)
                      ||||||+.|++||...++.+.-.+++++                     .    ......++.++|++..++|.++. -+
T Consensus       859 vil~em~~g~~pf~~~tp~~tq~kv~nw---------------------~----~~l~~~~~~~ls~e~~~li~kLc-~s  912 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQYKVINW---------------------R----NFLHIPYQGNLSKEALDLIQKLC-CS  912 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcceeeeeeh---------------------h----hccccccccccCHHHHHHHHHHh-cC
Confidence            9999999999999877765544433332                     0    01111234568999999998765 35


Q ss_pred             CCCCC---CHHHHhhc
Q 018514          336 PNLRS---TAFDAVGS  348 (354)
Q Consensus       336 p~~Rp---ta~e~l~~  348 (354)
                      +++|.   -++++..|
T Consensus       913 ad~RLGkng~d~vKaH  928 (1034)
T KOG0608|consen  913 ADSRLGKNGADQVKAH  928 (1034)
T ss_pred             hhhhhcccchhhhhcC
Confidence            56665   23444444

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.5e-36  Score=266.70  Aligned_cols=273  Identities=29%  Similarity=0.476  Sum_probs=211.7

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcC---CCceEEEEEccc--chhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQ--DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ....|.++++||.|.|++||++.+..   .++.||+|.+..  ......+|+++|..+ .+.||+++.+++     ....
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCC
Confidence            34469999999999999999999987   788999998853  345567899999998 589999999998     6666


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++|+||++. ...+++.       .++...++.+++.++.||.++|.+ |||||||||+|++.+.....-.|+|||+|
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhH
Confidence            68999999996 4444433       367889999999999999999999 99999999999999988778899999999


Q ss_pred             eecc-----------------c--C--------------------------CCccccccccccccchhccCCCCCCCchh
Q 018514          216 KVLV-----------------K--G--------------------------EPNISYICSRYYRAPELIFGATEYTAAID  250 (354)
Q Consensus       216 ~~~~-----------------~--~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~D  250 (354)
                      ....                 .  +                          .......||++|.|||++...+..++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7210                 0  0                          00123458999999999998888899999


Q ss_pred             HHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCCHHHHhccCCC------------------CcccCCCCccC--
Q 018514          251 IWSAGCVLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMNPN------------------YTEFKFPQIKA--  309 (354)
Q Consensus       251 iwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~--  309 (354)
                      |||.|+|+..+++++.||- ..++...+.+++..+|...-.....+...                  +.......+..  
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            9999999999999998874 45666777777777766554432221111                  11110011110  


Q ss_pred             --CCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          310 --HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       310 --~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        ..|.....+..+..+.+++.+||+.||.+|.||+++|.|
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence              124444455577899999999999999999999999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=286.90  Aligned_cols=245  Identities=30%  Similarity=0.438  Sum_probs=188.5

Q ss_pred             eEEEeEeeeccce-EEEEEEEcCCCceEEEEEcccchh-hhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           67 YMAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKR-YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        67 y~~~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~-~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      |.-.+.+|.|..| .||+|..  .|+.||||++..... ...+|+..|+.- +||||++++..     +.++.++||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEeh
Confidence            5556789999988 5899987  889999999876654 667999999888 59999997554     377888999999


Q ss_pred             eccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC---CC-CcEEEEeccCceecc
Q 018514          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HT-HQLKLCDFGSAKVLV  219 (354)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~---~~-~~vkl~Dfg~a~~~~  219 (354)
                      .|..+|.++++..............+..+.|+++||++||+. +||||||||.||||+.   ++ -.++|+|||+++.+.
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            999999999987411111112145677889999999999997 9999999999999976   22 368999999999886


Q ss_pred             cCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          220 KGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       220 ~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      .+...    ....||-+|+|||++.... -+.++|||||||++|+.++| ..||...-  +.-.+|....  ...     
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~--~~L-----  732 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGN--YTL-----  732 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCc--cce-----
Confidence            65433    3457899999999997776 47799999999999999985 89996432  2223332210  000     


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                         ..+......++.+||.+|+.+||..||+|.++|.|
T Consensus       733 -------------------~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  733 -------------------VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             -------------------eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                               00111112389999999999999999999999998

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=273.47  Aligned_cols=269  Identities=20%  Similarity=0.256  Sum_probs=179.9

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEc----------------CCCceEEEEEcccchh------------------hhHH
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCL----------------ETGEAVAIKKVLQDKR------------------YKNR  107 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~------------------~~~~  107 (354)
                      ...++|.+.++||+|+||+||+|.+.                ..++.||||++.....                  ....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            45668999999999999999999752                2346799999854321                  1123


Q ss_pred             HHHHHHHcCCCCe-----eecceeeeecCC---CCeeEEEEEEeeccc-cHHHHHHhhhh--------------------
Q 018514          108 ELQTMRLLDHPNV-----VSLKHCFFSTTE---KDELYLNLVLEYVPE-TVHRVIKHHYK--------------------  158 (354)
Q Consensus       108 e~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~iv~e~~~~-~l~~~l~~~~~--------------------  158 (354)
                      |+.++.+++|.++     +++++++.....   ......++||||+++ +|.+.+.....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6666777776654     556666543211   112347899999995 78777753211                    


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCccc--cccccccccc
Q 018514          159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--YICSRYYRAP  236 (354)
Q Consensus       159 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~g~~~y~aP  236 (354)
                      ....+++..++.++.|++.+|.|||+. +|+||||||+||+++.++ .+||+|||++.....+.....  ..+++.|+||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            012346678899999999999999998 999999999999999887 799999999976543322222  2347899999


Q ss_pred             hhccCCCC---------------------CCCchhHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          237 ELIFGATE---------------------YTAAIDIWSAGCVLAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       237 E~~~~~~~---------------------~~~~~DiwslG~il~ell~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      |.+.....                     ...+.||||+||++|+|++|.. ||.+......   ....... ....+..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~~~-~~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQYDN-DLNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhccc-hHHHHHh
Confidence            99853211                     1234799999999999999875 7654221111   0000000 0000110


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCC---CCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP---NLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp---~~Rpta~e~l~~  348 (354)
                      .            ....+.-......++..++|+.+||+.+|   .+|+|++|+|+|
T Consensus       456 ~------------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 Y------------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             h------------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0            00011111234478999999999999866   689999999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-34  Score=251.95  Aligned_cols=235  Identities=37%  Similarity=0.598  Sum_probs=188.9

Q ss_pred             cceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeeccc-cHH
Q 018514           77 SFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVH  150 (354)
Q Consensus        77 ~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~  150 (354)
                      +||.||+|.+..+|+.+|+|++...     .....+|++.+++++|+|++++.+++..     ....++++||+++ +|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            5899999999888999999998643     3455689999999999999999988733     3458899999997 888


Q ss_pred             HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCccccccc
Q 018514          151 RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS  230 (354)
Q Consensus       151 ~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~  230 (354)
                      ..+...    ..++...+..++.+++.++.+||+. +++|+||+|+||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKKR----GRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            777653    2388899999999999999999998 999999999999999887 7999999999877555444556678


Q ss_pred             cccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCC
Q 018514          231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  310 (354)
Q Consensus       231 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (354)
                      ..|+|||.+.+.. ++.++||||||+++++|++|..||..........+..........                     
T Consensus       150 ~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------  207 (244)
T smart00220      150 PEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP---------------------  207 (244)
T ss_pred             cCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------
Confidence            8899999986444 788999999999999999999999874444433333221000000                     


Q ss_pred             CcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          311 PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       311 ~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                          .....++.++.+++.+||..+|++||++.+++++
T Consensus       208 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      208 ----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             ----cccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence                0001167899999999999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-36  Score=265.36  Aligned_cols=269  Identities=23%  Similarity=0.297  Sum_probs=190.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-hhhhHHHHHHHH--HcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMR--LLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      ...+.+.+|+|+||.||+|+.  +++.||||++... .+....|-++.+  .++|+||+++++.-.... .+...+++|+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEe
Confidence            577788999999999999987  6789999999754 455556666655  468999999987643333 2244689999


Q ss_pred             eecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--------GVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--------~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      +|.+ |+|.++|+.     ..+++....+++..|++||+|||+.+        .|+|||||..|||+.+|. +..|+|||
T Consensus       288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFG  361 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFG  361 (534)
T ss_pred             eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccc
Confidence            9999 799999987     45899999999999999999999842        699999999999999998 89999999


Q ss_pred             CceecccCCC---ccccccccccccchhccCCCCCC-----CchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-HHh
Q 018514          214 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYT-----AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII-KVL  284 (354)
Q Consensus       214 ~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~-----~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~  284 (354)
                      +|..+..+..   ....+||..|||||++.+..++.     .+.||||+|.+||||++.-..+......+...-.. ...
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            9988765443   33578999999999997655444     47999999999999997643332111111000011 011


Q ss_pred             CCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                      ..|..+.+....-  .+...|.+ ...|...   .--..+.+.+..||..||+-|.||.=+-+.+
T Consensus       442 ~hPt~e~mq~~VV--~kK~RP~~-p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~  500 (534)
T KOG3653|consen  442 NHPTLEEMQELVV--RKKQRPKI-PDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERM  500 (534)
T ss_pred             CCCCHHHHHHHHH--hhccCCCC-hhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence            1122222211000  00001111 1123221   1346799999999999999999998666554

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-34  Score=277.49  Aligned_cols=251  Identities=24%  Similarity=0.391  Sum_probs=195.7

Q ss_pred             ceEEEeEeeeccceEEEEEEEcC-------CCceEEEEEcccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      +..+.+.||+|.||+|++|.-..       ....||||..+..     ......|+++|+.+ .|+||+.+++++..   
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---  373 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---  373 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence            34666799999999999997431       1456999988643     34455799999998 59999999998844   


Q ss_pred             CCeeEEEEEEeecc-ccHHHHHHhhh---hc-------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCee
Q 018514          133 KDELYLNLVLEYVP-ETVHRVIKHHY---KM-------S--QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (354)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~---~~-------~--~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nil  199 (354)
                        ...+++|+||+. |+|..++++..   ..       .  ..++...+..++.||+.|++||++. +++||||...|||
T Consensus       374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVL  450 (609)
T ss_pred             --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEE
Confidence              444889999999 79999998765   11       1  1388899999999999999999998 9999999999999


Q ss_pred             eeCCCCcEEEEeccCceecccCCCcc--ccc--cccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 018514          200 VNPHTHQLKLCDFGSAKVLVKGEPNI--SYI--CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGV  274 (354)
Q Consensus       200 i~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~--g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  274 (354)
                      +..+. .+||+|||+|+.........  ...  -+..|||||.+.. ..|+.++||||+|++|||+++ |..||.+-...
T Consensus       451 i~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  451 ITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             ecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99886 89999999998654433221  111  2456999999976 559999999999999999998 89999875422


Q ss_pred             HHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       275 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ..+.+..+....                           ...+..+++++.++++.||+.+|++||+..++.+.|+.
T Consensus       529 ~~l~~~l~~G~r---------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  529 EELLEFLKEGNR---------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             HHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            222322221100                           11234578999999999999999999999999998876

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-35  Score=264.17  Aligned_cols=198  Identities=29%  Similarity=0.447  Sum_probs=174.4

Q ss_pred             CccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhH------------HHHHHHHHcC---CCCeeecce
Q 018514           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------------RELQTMRLLD---HPNVVSLKH  125 (354)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------~e~~~l~~l~---h~~iv~~~~  125 (354)
                      +....+|...+.+|+|+||.|++|.++.+...|+||.+.+.+-...            -|+.+|..++   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            3445579999999999999999999999999999998876543221            4999999997   999999999


Q ss_pred             eeeecCCCCeeEEEEEEeeccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC
Q 018514          126 CFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (354)
Q Consensus       126 ~~~~~~~~~~~~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~  203 (354)
                      +|     ++..++|++||-.+.  +|.+++...    ..+++..+..|++|++.|+++||++ ||||||||-+||.++.+
T Consensus       637 fF-----Eddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  637 FF-----EDDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSN  706 (772)
T ss_pred             ee-----ecCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecC
Confidence            99     888889999999884  777777763    6799999999999999999999999 99999999999999999


Q ss_pred             CCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 018514          204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (354)
Q Consensus       204 ~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  270 (354)
                      | -+||+|||.|.... ..+.-.++||..|.|||++.+.+..+..-|||+||+++|.++....||.+
T Consensus       707 g-~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  707 G-FVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             C-eEEEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            8 79999999987543 44566789999999999998888788999999999999999999888864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=269.98  Aligned_cols=245  Identities=25%  Similarity=0.367  Sum_probs=195.4

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCc----eEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .+..++||+|+||+||+|.|...|+    +||+|++...     .....+|+-+|.+++|||+++++++.....      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            5556899999999999999987765    5788877543     233457899999999999999999873322      


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +-||++|++ |.|+++++.+.   ..+-.+..+.|..||++||.|||.+ +++||||...|||+..-. .+|++|||+++
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~-hvkitdfgla~  846 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPN-HVKITDFGLAK  846 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCC-eEEEEecchhh
Confidence            568999999 68999888764   7788889999999999999999999 999999999999999877 69999999998


Q ss_pred             ecccCCCcccccc---ccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          217 VLVKGEPNISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       217 ~~~~~~~~~~~~g---~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ............+   .+.|||-|.+... .|+.++|||||||++||++| |..|+.+....+.-..+.+.         
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g---------  916 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG---------  916 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc---------
Confidence            8765544433322   5569999988544 49999999999999999997 99999876643322222111         


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                             .....            +...+.++.-++.+||..|+..||+++++.+.+.+
T Consensus       917 -------eRLsq------------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  917 -------ERLSQ------------PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             -------ccCCC------------CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence                   01111            23478999999999999999999999999887654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.3e-33  Score=230.87  Aligned_cols=248  Identities=22%  Similarity=0.312  Sum_probs=182.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+.|.+.+.||+|.||.+-+|+++.+...+++|.+....   ..+.+|..---.| -|.||+.-++.-+..    ..+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT----SDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc----CceEE
Confidence            456999999999999999999999999999999887553   3444565543334 589999987765543    33678


Q ss_pred             EEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee-eCCCCcEEEEeccCcee
Q 018514          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili-~~~~~~vkl~Dfg~a~~  217 (354)
                      +++||++ |+|.+.+..     ..+-+....+++.|+++|+.|||++ ++||||||.+|||| +.+..+|||||||+.+.
T Consensus        99 F~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             EeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccc
Confidence            9999999 676665543     4577888999999999999999999 99999999999998 66666899999999875


Q ss_pred             cccCCCccccccccccccchhccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHH
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  292 (354)
                      ...-  ......+..|.+||.+....    ...+.+|+|.||+++|.++||++||+..... .-..+..++.+....   
T Consensus       173 ~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---  247 (378)
T KOG1345|consen  173 VGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---  247 (378)
T ss_pred             cCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---
Confidence            4221  11222355699999874322    3577899999999999999999999743221 112223222211111   


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHH
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA  345 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~  345 (354)
                                ..|         ...+.+++.+..+.++-|..+|++|-..-++
T Consensus       248 ----------~~P---------~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  248 ----------ALP---------KKFNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             ----------cCc---------hhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence                      001         1223478999999999999999999444333

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=8e-31  Score=222.47  Aligned_cols=207  Identities=35%  Similarity=0.609  Sum_probs=175.7

Q ss_pred             eeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeecc-
Q 018514           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-  146 (354)
Q Consensus        73 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-  146 (354)
                      ||+|.+|.||++.+..+++.+++|++....     ....+|+..++.++|++++++++++.     .....++++|++. 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence            689999999999998779999999997654     34678999999999999999988873     3355889999999 


Q ss_pred             ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC-CCCcEEEEeccCceecccCC-Cc
Q 018514          147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PN  224 (354)
Q Consensus       147 ~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~-~~~~vkl~Dfg~a~~~~~~~-~~  224 (354)
                      ++|...+....   ..++...+..++.+++.++.+||+. |++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            58887776532   4688999999999999999999998 9999999999999998 55 79999999997664432 12


Q ss_pred             cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCC
Q 018514          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  304 (354)
Q Consensus       225 ~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  304 (354)
                      ....+...|++||.+.....++.+.|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            3345677899999986553578999999999999998                                           


Q ss_pred             CCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       305 ~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                       ..+.+++.+|++.||++||++.++++++
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             3677999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-33  Score=258.58  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=199.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ..++|.+..++|+|.||.||+++++.+++..|+|+++..    ....++|+-+++..+||||+.+++.+...     .-+
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~-----dkl   87 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----DKL   87 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh-----cCc
Confidence            345799999999999999999999999999999998643    34456789999999999999999998443     338


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +|.||||+|+-++.+.   ....++++.++....+..+.||+|||+. |-+|||||-.||++++.+ .+|+.|||.+..+
T Consensus        88 wicMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~g-DvklaDfgvsaqi  162 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEG-DVKLADFGVSAQI  162 (829)
T ss_pred             EEEEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccC-ceeecccCchhhh
Confidence            9999999974333333   3358899999999999999999999998 999999999999999888 7999999988654


Q ss_pred             ccC-CCccccccccccccchhcc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          219 VKG-EPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       219 ~~~-~~~~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ... .....+.||++|||||+..  ....|...+|||++|+...|+---.+|.....+...+..+-+....|+.-     
T Consensus       163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l-----  237 (829)
T KOG0576|consen  163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL-----  237 (829)
T ss_pred             hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc-----
Confidence            322 2334678999999999962  23348999999999999999987777765555555554444322221110     


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                 -....|        ++.+.+|++.+|..+|.+|||++-+|.|
T Consensus       238 -----------kDk~kw--------s~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  238 -----------KDKTKW--------SEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             -----------cCCccc--------hHHHHHHHHHHhcCCCccCCChhhheec
Confidence                       012233        6889999999999999999999999886

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.4e-30  Score=220.86  Aligned_cols=201  Identities=34%  Similarity=0.579  Sum_probs=166.8

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...     .....+|++.++.++|+|++++++++.     .....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence            56788999999999999999888899999998653     345567999999999999999988773     33457899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      +||+.+ +|.+.+....   ..+++..+..++.+++.++.+||+. +++|+||+|.||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~  150 (225)
T smart00221       76 MEYCEGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDG-LVKLADFGLARFIHR  150 (225)
T ss_pred             EeccCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeCceeeEecC
Confidence            999997 8888776532   1178899999999999999999998 999999999999999886 799999999987655


Q ss_pred             CC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCcHHHH
Q 018514          221 GE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQL  277 (354)
Q Consensus       221 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~  277 (354)
                      ..  ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .++...+
T Consensus       151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~  210 (225)
T smart00221      151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLL  210 (225)
T ss_pred             cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHH
Confidence            43  233456778899999984334477899999999999999999999977 4544333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-31  Score=228.57  Aligned_cols=252  Identities=19%  Similarity=0.235  Sum_probs=194.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCC-----ceEEEEEcccchhh-----hHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQDKRY-----KNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~-----~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      .++++.-.+-+|.||.||.|.|+...     +.|.+|.++.....     ...|-..+..+.|||++++.++....    
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~----  359 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED----  359 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec----
Confidence            46888889999999999999887543     34556666544322     22466667777899999998876542    


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhh----hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEE
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHY----KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl  209 (354)
                      ....++++.+++ |+|..++....    ...+.++..++..++.|++.|++|||++ |+||.||...|.+||+.- +|||
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~L-qVkl  437 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQL-QVKL  437 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-Ccccchhhhhcceehhhe-eEEe
Confidence            222456788888 78888887332    2235677788889999999999999999 999999999999999876 8999


Q ss_pred             EeccCceecccCCCcc---ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 018514          210 CDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  285 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  285 (354)
                      +|=.+++.+.++..+.   ....+..||+||.+.+.. |+..+|+||||++||||+| |+.||-.-++.++..-+..+. 
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-  515 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-  515 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-
Confidence            9999998776554321   122356799999996655 9999999999999999998 999998887766655444321 


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                       ++.          -+-+++.++..++.-||..+|++||+.+|++..|.+
T Consensus       516 -----------------Rla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  516 -----------------RLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             -----------------eec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                             111          123589999999999999999999999999988764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3.6e-30  Score=259.97  Aligned_cols=200  Identities=18%  Similarity=0.195  Sum_probs=141.0

Q ss_pred             HcCC-CCeeecceeeeecCC--CCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 018514          114 LLDH-PNVVSLKHCFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (354)
Q Consensus       114 ~l~h-~~iv~~~~~~~~~~~--~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH  190 (354)
                      .++| +||+.+++.|.....  ....+++.++||++++|.+.+...   ...+++..++.+++||+.||+|||++ ||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ-GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            4455 577777776522221  122357788999999999988643   35689999999999999999999998 9999


Q ss_pred             cCCCCCCeeeeCCC------------------CcEEEEeccCceecccCC-----------------Ccccccccccccc
Q 018514          191 RDIKPQNLLVNPHT------------------HQLKLCDFGSAKVLVKGE-----------------PNISYICSRYYRA  235 (354)
Q Consensus       191 ~Dlkp~Nili~~~~------------------~~vkl~Dfg~a~~~~~~~-----------------~~~~~~g~~~y~a  235 (354)
                      |||||+||||+..+                  ..+|++|||+++......                 ......||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996432                  246667777665321100                 0012357888999


Q ss_pred             chhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccc
Q 018514          236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  315 (354)
Q Consensus       236 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (354)
                      ||++.+.. ++.++|||||||+||||++|.+|+....  ..+..+..... ++ ..                        
T Consensus       184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~~-~~------------------------  234 (793)
T PLN00181        184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-PP-QI------------------------  234 (793)
T ss_pred             hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-Ch-hh------------------------
Confidence            99997665 8999999999999999999988875322  12222211110 00 00                        


Q ss_pred             cCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          316 FQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       316 ~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        ....+...+++.+||++||.+||++.|+++|
T Consensus       235 --~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        235 --LLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             --hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence              0013567789999999999999999999987

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=5.6e-29  Score=204.16  Aligned_cols=205  Identities=25%  Similarity=0.344  Sum_probs=168.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh--hhHHHHHHHHHcCC-CCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--YKNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ++|+++++||+|+||.+|+|....+|+.||||+-+....  ....|.++.+.|++ ..|+.+.++.     .+..+..+|
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlV   89 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLV   89 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceee
Confidence            479999999999999999999999999999998765533  34578999999975 5566666655     566678899


Q ss_pred             EeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC--CCCcEEEEeccCceecc
Q 018514          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~--~~~~vkl~Dfg~a~~~~  219 (354)
                      |+.++.+|.+++.-.   +..++..+++.++-|++.-++|+|.+ +++||||||+|+|+.-  ..+++.|+|||+|+.+.
T Consensus        90 MdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            999999998887654   36789999999999999999999998 9999999999999843  34479999999998765


Q ss_pred             cCCC--------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 018514          220 KGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (354)
Q Consensus       220 ~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  279 (354)
                      +...        .....||..|.+-....+.. .+...|+-|+|.++.++.-|..||++.......++
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            4322        23567899999987775554 68899999999999999999999998665444333

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=8.5e-29  Score=205.30  Aligned_cols=164  Identities=21%  Similarity=0.224  Sum_probs=123.6

Q ss_pred             ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCccc
Q 018514          147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS  226 (354)
Q Consensus       147 ~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~  226 (354)
                      |+|.+.+...   ..++++..++.++.|++.||.|||++ +      ||+||+++.++ .+|+  ||++......    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence            5677777653   35699999999999999999999998 7      99999999887 6888  9998765332    2


Q ss_pred             cccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhccCCCCcccCCC
Q 018514          227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFP  305 (354)
Q Consensus       227 ~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  305 (354)
                      ..||+.|||||++.+.. ++.++|||||||++|||++|..||....... .+..+..........               
T Consensus        64 ~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  127 (176)
T smart00750       64 SRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---------------  127 (176)
T ss_pred             CCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------------
Confidence            36789999999997655 8999999999999999999999997654332 222222211110000               


Q ss_pred             CccCCCcccccCCCCCH--HHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          306 QIKAHPWHKIFQKRMPP--EAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       306 ~~~~~~~~~~~~~~~s~--~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                      .       ......++.  .+.+++.+||..||.+|||+.++++|+.
T Consensus       128 ~-------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      128 D-------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             c-------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence            0       000011233  7999999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-28  Score=208.68  Aligned_cols=200  Identities=24%  Similarity=0.338  Sum_probs=168.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ..|++.++||+|.||.++.|++.-++++||||.-...  ......|.+..+.|. .+.|+.++.+-     ....+..+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhh
Confidence            4799999999999999999999999999999976433  333456888888885 68888875432     566677899


Q ss_pred             EeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee----CCCCcEEEEeccCcee
Q 018514          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKV  217 (354)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~----~~~~~vkl~Dfg~a~~  217 (354)
                      +|.++.+|.+++.-.   ...|+..++..++.||+.-++++|++ .+|.|||||+|+||.    .+.+.|.++|||+|+.
T Consensus       103 idLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  103 IDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            999999999888754   47899999999999999999999999 999999999999994    3444799999999987


Q ss_pred             cccCCC--------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH
Q 018514          218 LVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (354)
Q Consensus       218 ~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  274 (354)
                      +.+...        .....||..||+-...++.. .+...|+-|||-+++++|-|..||.+....
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            755432        34577999999998887766 799999999999999999999999986543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-27  Score=215.99  Aligned_cols=254  Identities=20%  Similarity=0.213  Sum_probs=193.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCC-ceEEEEEcccch----hhhHHHHHHHHHcCC----CCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDK----RYKNRELQTMRLLDH----PNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~----~~~~~e~~~l~~l~h----~~iv~~~~~~~~~~~~~~~  136 (354)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|......    .....|..++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999987664 578888775431    145679999988873    57777766542    3455


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC----CcEEEEec
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCDF  212 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~----~~vkl~Df  212 (354)
                      +.+|||+.++.+|.++.....  .+.++..++..++.|++.+|.+||+. |++||||||+|+++....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999998776554  57899999999999999999999998 999999999999997543    47999999


Q ss_pred             cCce--ecccC--------CC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 018514          213 GSAK--VLVKG--------EP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (354)
Q Consensus       213 g~a~--~~~~~--------~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  281 (354)
                      |+++  .....        +. .....||..|+++.+..+.. .+.+.|+||++.++.+++.|..||.+...........
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  32111        11 22456999999999986665 7999999999999999999999997766443333333


Q ss_pred             HHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      +........               .         +....+.++..++..+-..+...+|....+...|..
T Consensus       251 ~~~~~~~~~---------------~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~  296 (322)
T KOG1164|consen  251 KDPRKLLTD---------------R---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD  296 (322)
T ss_pred             HHhhhhccc---------------c---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence            221100000               0         112245778888888888999999999888777543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.3e-26  Score=208.57  Aligned_cols=160  Identities=21%  Similarity=0.312  Sum_probs=121.1

Q ss_pred             CccccceEEEeEeeeccceEEEEEEEcC-CCceEEEEEcccc---------hhhhHHHHHHHHHcCCCCeeecceeeeec
Q 018514           61 PKQTISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFST  130 (354)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  130 (354)
                      +...+.|.+.+.||+|+||+||+|.+.. +++.+|||++...         .....+|+++|+.++|+|+++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3445679999999999999999999876 6777899986422         23456899999999999998533211   


Q ss_pred             CCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC-CCCCeeeeCCCCcEEE
Q 018514          131 TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI-KPQNLLVNPHTHQLKL  209 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dl-kp~Nili~~~~~~vkl  209 (354)
                         +  ..++||||+.|..+....       ...   ...++.|++.+|.|||++ ||+|||| ||+|||++.++ .+||
T Consensus        91 ---~--~~~LVmE~~~G~~L~~~~-------~~~---~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~-~ikL  153 (365)
T PRK09188         91 ---G--KDGLVRGWTEGVPLHLAR-------PHG---DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDG-EAAV  153 (365)
T ss_pred             ---C--CcEEEEEccCCCCHHHhC-------ccc---hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCC-CEEE
Confidence               1  268999999974333221       111   145788999999999998 9999999 99999998776 7999


Q ss_pred             EeccCceecccCCCc---------cccccccccccchhcc
Q 018514          210 CDFGSAKVLVKGEPN---------ISYICSRYYRAPELIF  240 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~~---------~~~~g~~~y~aPE~~~  240 (354)
                      +|||+|.........         ....+++.|+|||.+.
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            999999866443211         2345677899999884

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=9.5e-24  Score=191.15  Aligned_cols=252  Identities=35%  Similarity=0.508  Sum_probs=189.2

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCC-CeeecceeeeecCCCCeeEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHP-NVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~  138 (354)
                      |.+.+.||.|+||.||++.+.   ..+++|.+...       .....+|..+++.+.|+ +++++...+     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            788899999999999999986   67889987543       23345788999999988 799998887     222337


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++++++.+ .+...+...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+..++++|||.+..
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            899999997 555344432111 3688999999999999999999998 9999999999999998764599999999975


Q ss_pred             cccCC-------CccccccccccccchhccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhC
Q 018514          218 LVKGE-------PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLG  285 (354)
Q Consensus       218 ~~~~~-------~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~  285 (354)
                      .....       ......|+..|+|||.+.+.  ..+....|+||+|++++++++|..||.....   ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            54432       23566789999999999763  4589999999999999999999999877664   333333333222


Q ss_pred             CC-CHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          286 TP-TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       286 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+ ...              .      ............+.+++.+++..+|..|.+..+...+
T Consensus       232 ~~~~~~--------------~------~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 TPSLAS--------------P------LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             Cccccc--------------c------cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            21 000              0      0000001123689999999999999999999887664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.9e-26  Score=222.36  Aligned_cols=250  Identities=25%  Similarity=0.362  Sum_probs=182.1

Q ss_pred             EEEeEeeeccceEEEEEEEcCCCceEEEEEccc----chhh------hHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----DKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        68 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ...+.+|.|++|.|+.+......+.++.|.++.    ....      ...|+.+-..+.|+|++.....+.....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            456789999999999888877776666665531    1110      1235555567899999887665533222     


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ..-.||||+++|..++...    ..+....+..++.|++.|+.|||+. ||.|||+||+|++++.++ .+||+|||.+..
T Consensus       396 ~~~~mE~~~~Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g-~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENG-ILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccHHHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCC-ceEEeecCccee
Confidence            2234999999888887763    4678888999999999999999998 999999999999999988 899999999876


Q ss_pred             cccCCC-----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          218 LVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       218 ~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ......     ....+|+..|+|||++.+........||||.|+++..|++|+.||......+....             
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------------  536 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------------  536 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-------------
Confidence            543322     34567899999999997777556689999999999999999999976443322110             


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        .+.....+.....   .+  .+...++.+-+.+|.+||++||.+|.|++++++.
T Consensus       537 --~~~~~~~~~~~~~---~~--~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  537 --TNNYSDQRNIFEG---PN--RLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             --hhccccccccccC---hH--HHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence              0000000111110   00  1223478899999999999999999999999863

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.2e-25  Score=194.17  Aligned_cols=201  Identities=24%  Similarity=0.355  Sum_probs=146.9

Q ss_pred             CCCCeeecceeeeecCC----------------------CCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHH
Q 018514          116 DHPNVVSLKHCFFSTTE----------------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY  173 (354)
Q Consensus       116 ~h~~iv~~~~~~~~~~~----------------------~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~  173 (354)
                      +|||||++...|.+...                      .....+|+||..+..+|..++-.     ...+....+.++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            69999999888754322                      22345899999999998888875     4567778889999


Q ss_pred             HHHHHHHHHHhcCCceecCCCCCCeeee---CCCCcEEEEeccCceecccCC-------CccccccccccccchhccCCC
Q 018514          174 QICRALAYIHNTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGE-------PNISYICSRYYRAPELIFGAT  243 (354)
Q Consensus       174 qi~~~l~~LH~~~~iiH~Dlkp~Nili~---~~~~~vkl~Dfg~a~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~  243 (354)
                      |+++|+.|||.+ ||.|||+|.+|||+.   +....+.|+|||++-.-..-.       ......|...-||||+....+
T Consensus       349 QlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999999 999999999999983   233368999999885432211       112345677899999985433


Q ss_pred             CC-----CCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCC
Q 018514          244 EY-----TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK  318 (354)
Q Consensus       244 ~~-----~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (354)
                      ..     -.++|.|+.|.+.||+++...||.+......-..                  .+.+-..|.         +++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r------------------~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR------------------TYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh------------------hhhhhhCCC---------Ccc
Confidence            21     2379999999999999999999987332111000                  011112222         345


Q ss_pred             CCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          319 RMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       319 ~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                      .+++.+++++..+|+.||++|+++.-+..-|
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence            6899999999999999999999987665443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=1.2e-24  Score=189.32  Aligned_cols=237  Identities=24%  Similarity=0.326  Sum_probs=145.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhH-------HHHHHHHHcC----------CCCeeecceee-
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLD----------HPNVVSLKHCF-  127 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~e~~~l~~l~----------h~~iv~~~~~~-  127 (354)
                      .+...+.||.|+++.||.+++..+|+.+|+|++........       +|.-....+.          |-.++-..+.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            47788999999999999999999999999998854332222       2221111111          11111111111 


Q ss_pred             -------eecCC-CCee---EEEEEEeeccccHHHHHHhhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 018514          128 -------FSTTE-KDEL---YLNLVLEYVPETVHRVIKHHYKMSQR---MPLIYVKLYFYQICRALAYIHNTIGVCHRDI  193 (354)
Q Consensus       128 -------~~~~~-~~~~---~~~iv~e~~~~~l~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dl  193 (354)
                             +.... ....   ..+++|+-+.++|..++..-......   +.......+..|+++.+++||+. |++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEeccc
Confidence                   11111 1111   24678888888888776543222222   23333455668999999999999 9999999


Q ss_pred             CCCCeeeeCCCCcEEEEeccCceecccCCCccccccccccccchhccCC-------CCCCCchhHHHHHHHHHHHHhCCC
Q 018514          194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTAAIDIWSAGCVLAELLLGQP  266 (354)
Q Consensus       194 kp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~ell~g~~  266 (354)
                      +|+|++++.+| .+.|+||+...........  ...+..|.+||.....       ..++.+.|.|+||+++|.|.+|..
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999998 7999999987755332221  3445779999987332       237889999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCC
Q 018514          267 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR  339 (354)
Q Consensus       267 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~R  339 (354)
                      ||..........                            .   .|.. . .++++.++.||..+|++||.+|
T Consensus       249 Pf~~~~~~~~~~----------------------------~---~f~~-C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPE----------------------------W---DFSR-C-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSG----------------------------G---GGTT-S-S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccccc----------------------------c---cchh-c-CCcCHHHHHHHHHHccCCcccC
Confidence            997543211000                            0   1111 1 1578999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=2.7e-24  Score=208.66  Aligned_cols=241  Identities=30%  Similarity=0.403  Sum_probs=170.0

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhH---HHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKN---RELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      +|...+.||++.|=+|.+|++. .|. |+||++....     ....   +|++ ...+++||.+++....     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            5888899999999999999974 454 9999884332     1112   3444 5667999999975432     23334


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .|||-+|...+|.+.+..+    .-+...+.+.|+.||++||.-+|+. ||+|||||.+||||++=+ -+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWN-W~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWN-WLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeec-hhhhhcccccCC
Confidence            5778888888888777643    3456667888999999999999998 999999999999999776 599999986543


Q ss_pred             cccCCCc---cc-----cccccccccchhccCC----------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 018514          218 LVKGEPN---IS-----YICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (354)
Q Consensus       218 ~~~~~~~---~~-----~~g~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  278 (354)
                      ..-.+.+   ..     ...-.+|.|||.+...          +..+++.||||+||++.||++ |++||.    ..++.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHH
Confidence            2211111   11     1113459999998431          125678999999999999998 899994    22333


Q ss_pred             HHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .........+...+.                        +--+..++.+|..|++.||++|.+|++.|+.
T Consensus       246 aYr~~~~~~~e~~Le------------------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGNADDPEQLLE------------------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccCccCHHHHHH------------------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            332221111111111                        1124689999999999999999999999975

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.5e-23  Score=175.25  Aligned_cols=134  Identities=16%  Similarity=0.244  Sum_probs=102.5

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccchh------------------------------hhHHHHHHHHHcCCCC
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN  119 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------------------~~~~e~~~l~~l~h~~  119 (354)
                      ...||+|+||+||+|.+. +|+.||+|+++....                              ...+|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999986 899999999854311                              1124889999998877


Q ss_pred             eeecceeeeecCCCCeeEEEEEEeecccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCceecCCCCCC
Q 018514          120 VVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI-HNTIGVCHRDIKPQN  197 (354)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~L-H~~~~iiH~Dlkp~N  197 (354)
                      +.......  .  .+   .+|||||++|+ +......    ...++...+..++.|++.+|.++ |+. ||+||||||+|
T Consensus        81 v~~p~~~~--~--~~---~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~N  148 (190)
T cd05147          81 IPCPEPIL--L--KS---HVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYN  148 (190)
T ss_pred             CCCCcEEE--e--cC---CEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHH
Confidence            64332211  1  11   37999999974 3222221    25688999999999999999999 688 99999999999


Q ss_pred             eeeeCCCCcEEEEeccCceec
Q 018514          198 LLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       198 ili~~~~~~vkl~Dfg~a~~~  218 (354)
                      |+++. + .++|+|||+|...
T Consensus       149 Ili~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEEC-C-cEEEEEccccccC
Confidence            99984 4 6999999999744

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=2.4e-23  Score=176.06  Aligned_cols=170  Identities=14%  Similarity=0.144  Sum_probs=125.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhh---------hHHHHHHHHHcCCCCeeecceeeeec
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRY---------KNRELQTMRLLDHPNVVSLKHCFFST  130 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~---------~~~e~~~l~~l~h~~iv~~~~~~~~~  130 (354)
                      .++|++.++||.|+||.||++.+  ++..+|+|.+...    ...         .++|+..+.++.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            45799999999999999999765  4668999998532    111         35788899999999999998876543


Q ss_pred             CCC---CeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCc
Q 018514          131 TEK---DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (354)
Q Consensus       131 ~~~---~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~  206 (354)
                      ...   .....+++|||++| +|.+..        .+++    ....+++.+|..||+. |++|||+||+||++++++  
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g--  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG--  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC--
Confidence            211   12347899999998 554431        1232    2456999999999999 999999999999999776  


Q ss_pred             EEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHH
Q 018514          207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  262 (354)
Q Consensus       207 vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  262 (354)
                      ++|+|||.........            |-+.+.-...++.++|+||||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~------------a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRK------------AKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchh------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence            9999999886442211            1111222333678999999999987654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=9.9e-24  Score=176.39  Aligned_cols=243  Identities=16%  Similarity=0.223  Sum_probs=182.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEccc------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +..+..+|.....|..|+++|.  |..+++|++..      ..+.+..|.-.|+.+.||||+.+++.+     .....+.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCce
Confidence            4566778999999999999994  44566676532      234556788899999999999999988     5556689


Q ss_pred             EEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceec-CCCCCCeeeeCCCCcEEE--EeccCc
Q 018514          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR-DIKPQNLLVNPHTHQLKL--CDFGSA  215 (354)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~-Dlkp~Nili~~~~~~vkl--~Dfg~a  215 (354)
                      ++..||+ |+|+..+....  +--.+..++.+++.++++|++|||+.-.++-| -|....++||++- +.+|  +|--++
T Consensus       264 ~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfs  340 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFS  340 (448)
T ss_pred             EeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceee
Confidence            9999999 68888887643  23456678889999999999999985345544 5888899998875 4444  332222


Q ss_pred             eecccCCCccccccccccccchhccCCCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEY--TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~--~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      .      ........|.||+||.+...+..  -.++|+|||++++|||.|...||...++.+.-.+|.-.          
T Consensus       341 f------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale----------  404 (448)
T KOG0195|consen  341 F------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE----------  404 (448)
T ss_pred             e------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc----------
Confidence            2      11233457889999999655432  34799999999999999999999988876654443221          


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                       ..+..++.+++..+..|++-|+..||.+||..+.++-.|+.
T Consensus       405 -----------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  405 -----------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             -----------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence                             12233567799999999999999999999999988776653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=2.7e-23  Score=201.44  Aligned_cols=210  Identities=27%  Similarity=0.500  Sum_probs=154.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      ..+|..++.+..|+||.||.++++.+.+.+|+| +.++.-..++   ++.....|.+|                      
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfvv----------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFVV----------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCccee----------------------
Confidence            346999999999999999999999999999994 4433222221   22222222222                      


Q ss_pred             eccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCC-
Q 018514          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-  222 (354)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~-  222 (354)
                         |+-...++.    .++++.        +++.+++|||+. ||+|||+||+|.+|+.-+ .+|++|||+++...... 
T Consensus       136 ---gDc~tllk~----~g~lPv--------dmvla~Eylh~y-givhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKN----IGPLPV--------DMVLAVEYLHSY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhccc----CCCCcc--------hhhHHhHhhccC-CeecCCCCCCcceeeecc-cccccchhhhhhhhhhcc
Confidence               322222322    234443        337789999998 999999999999999888 69999999986532111 


Q ss_pred             ---------------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 018514          223 ---------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (354)
Q Consensus       223 ---------------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  287 (354)
                                     .....+|||.|.|||++..+. |+..+|+|++|+|+||.+.|..||.+.++.+.+...+...   
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~---  274 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD---  274 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh---
Confidence                           012357899999999997665 9999999999999999999999999999988888776632   


Q ss_pred             CHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH
Q 018514          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF  343 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~  343 (354)
                                    +.+++        . ...++++++++|.++|+.+|..|.-..
T Consensus       275 --------------i~wpE--------~-dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  275 --------------IEWPE--------E-DEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             --------------ccccc--------c-CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence                          12221        1 234789999999999999999998433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.8e-24  Score=197.89  Aligned_cols=230  Identities=28%  Similarity=0.405  Sum_probs=178.4

Q ss_pred             EeeeccceEEEEEEEc---CCCceEEEEEcccc------hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEEEE
Q 018514           72 VVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|.|.||.|++++-.   ..|..+|+|+.++.      ......|-.++...+ ||.++++..+|.     .+..++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq-----t~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ-----TDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec-----cccchhHh
Confidence            3789999999987632   34667888876432      122335777888886 999999988873     33347889


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      +++..| .+...+..    ...+.+...+.+...++-+++++|+. +|+|||+|++||+++.+| .+++.|||+++....
T Consensus        76 ld~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~G-hi~~tdfglske~v~  149 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVK  149 (612)
T ss_pred             hhhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccC-ccccCCchhhhHhHh
Confidence            999987 44433332    45678888889999999999999998 999999999999999999 599999999987655


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ....   +||..|||||++.   .....+|.||+|+++++|+||..||..    +....|.+....              
T Consensus       150 ~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~--------------  205 (612)
T KOG0603|consen  150 EKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE--------------  205 (612)
T ss_pred             hhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC--------------
Confidence            5433   8999999999996   267899999999999999999999977    555555553211              


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH--HHHhhccCc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA--FDAVGSFDS  351 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta--~e~l~~l~~  351 (354)
                                     +++.++..+++++..++..+|..|.-+  ..+.+..+.
T Consensus       206 ---------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h  243 (612)
T KOG0603|consen  206 ---------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH  243 (612)
T ss_pred             ---------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence                           233468999999999999999999966  455554443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.3e-22  Score=165.64  Aligned_cols=182  Identities=17%  Similarity=0.120  Sum_probs=132.7

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh--------hhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      +.+...|++|+||+||.+..  .+.+++.+.+.....        ...+|+++|+++. |+++++++++.     .    
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----
Confidence            34567899999999998875  677888776654322        4568999999995 47788886641     1    


Q ss_pred             EEEEEeecccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC-CCCCeeeeCCCCcEEEEeccCc
Q 018514          138 LNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI-KPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       138 ~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dl-kp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++|+|+.|. |...+.          .. ...++.|++.+|.++|++ ||+|||| ||+|||++.++ .++|+|||+|
T Consensus        73 ~~lvmeyI~G~~L~~~~~----------~~-~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g-~i~LIDFG~A  139 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPP----------RG-DLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDG-SPAVIDFQLA  139 (218)
T ss_pred             EEEEEeeecCccHHhhhh----------hh-hHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCC-CEEEEECCCc
Confidence            58999999984 432211          01 134678999999999999 9999999 79999999877 7999999999


Q ss_pred             eecccCCCc--------------cccccccccccchhccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 018514          216 KVLVKGEPN--------------ISYICSRYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGES  272 (354)
Q Consensus       216 ~~~~~~~~~--------------~~~~g~~~y~aPE~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~  272 (354)
                      ........-              .....++.|+.|+...-....+ ...+.++.|+-+|.++|+..|+.+.+
T Consensus       140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            855433210              0122467788887653222223 56788899999999999998876543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.9e-22  Score=167.99  Aligned_cols=134  Identities=17%  Similarity=0.254  Sum_probs=104.3

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccch------------------------------hhhHHHHHHHHHcCCCC
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------------------------RYKNRELQTMRLLDHPN  119 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------------------~~~~~e~~~l~~l~h~~  119 (354)
                      .+.||+|++|+||+|.+. +|+.||||+++...                              ....+|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999976 89999999886431                              01246888999999998


Q ss_pred             eeecceeeeecCCCCeeEEEEEEeecccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCC
Q 018514          120 VVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQN  197 (354)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~iiH~Dlkp~N  197 (354)
                      +.....+...   .    .++||||++|. +......    ...++...+..++.|++.++.++|. . ||+||||||+|
T Consensus        81 i~~p~~~~~~---~----~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~N  148 (190)
T cd05145          81 VPVPEPILLK---K----NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYN  148 (190)
T ss_pred             CCCceEEEec---C----CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhh
Confidence            7543332211   1    37999999975 3222111    2457788899999999999999999 8 99999999999


Q ss_pred             eeeeCCCCcEEEEeccCceec
Q 018514          198 LLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       198 ili~~~~~~vkl~Dfg~a~~~  218 (354)
                      |+++ ++ .++|+|||++...
T Consensus       149 Ill~-~~-~~~liDFG~a~~~  167 (190)
T cd05145         149 ILYH-DG-KPYIIDVSQAVEL  167 (190)
T ss_pred             EEEE-CC-CEEEEEcccceec
Confidence            9998 55 7999999999765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=5.9e-21  Score=188.30  Aligned_cols=193  Identities=25%  Similarity=0.387  Sum_probs=146.1

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhH-HHHHHHHHcC---CCCeeecceeeeecCCCCeeE
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-RELQTMRLLD---HPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .....|.|.+.||.|+||+||+|.... |+.||+|+-+....... -=.+++.+|+   -+.|..+..++...   +.  
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~---~~--  768 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQ---NA--  768 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccC---Cc--
Confidence            344579999999999999999999865 99999998754432111 0123444444   23344443333222   22  


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee------CCCCcEEEE
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN------PHTHQLKLC  210 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~------~~~~~vkl~  210 (354)
                      -++|+||.+ |+|++++.    ..+.+++..+..+..||++.+++||.. +|||+||||+|++|.      .+..-++|+
T Consensus       769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEE
Confidence            367999999 79988887    357788999999999999999999998 999999999999982      233359999


Q ss_pred             eccCceec---ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 018514          211 DFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  266 (354)
Q Consensus       211 Dfg~a~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  266 (354)
                      |||.+-.+   .++.......+|-.+-.+|+..|.+ ++.++|.|.|+.+++-||+|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence            99998654   3333444566788899999997666 9999999999999999999963

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=8.2e-20  Score=154.10  Aligned_cols=134  Identities=18%  Similarity=0.242  Sum_probs=100.6

Q ss_pred             EEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHc-----CCCCeeecceeeeecCCCCeeE-E
Q 018514           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLL-----DHPNVVSLKHCFFSTTEKDELY-L  138 (354)
Q Consensus        69 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~-~  138 (354)
                      -.+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     .||||+++++++.+..  +..+ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~   80 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVY   80 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEE
Confidence            346899999999995  6666655 69987643    34456899999999     6799999999875532  2233 4


Q ss_pred             EEEEeecc---ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCceecCCCCCCeeeeCC---CCcEEEEe
Q 018514          139 NLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL-AYIHNTIGVCHRDIKPQNLLVNPH---THQLKLCD  211 (354)
Q Consensus       139 ~iv~e~~~---~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l-~~LH~~~~iiH~Dlkp~Nili~~~---~~~vkl~D  211 (354)
                      .+|+||++   ++|.+++++     ..+++.  ..++.|++.++ +|||++ +|+||||||+||+++..   ...++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            47899955   588888865     235554  35577888777 999999 99999999999999742   22799999


Q ss_pred             ccCc
Q 018514          212 FGSA  215 (354)
Q Consensus       212 fg~a  215 (354)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5444

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=4.7e-20  Score=159.27  Aligned_cols=138  Identities=14%  Similarity=0.161  Sum_probs=104.1

Q ss_pred             ceEEEeEeeeccceEEEEEE-EcCCCceEEEEEcccch----------------------------hhhHHHHHHHHHcC
Q 018514           66 SYMAERVVGHGSFGVVFQAK-CLETGEAVAIKKVLQDK----------------------------RYKNRELQTMRLLD  116 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~----------------------------~~~~~e~~~l~~l~  116 (354)
                      -|.+.+.||+|+||.||+|. +..+|+.||+|++....                            ....+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 66789999999885321                            11346999999997


Q ss_pred             CCCeeecceeeeecCCCCeeEEEEEEeecccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-ceecCCC
Q 018514          117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-VCHRDIK  194 (354)
Q Consensus       117 h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~-iiH~Dlk  194 (354)
                      +.. +.+...+.. . .    .++||||++|. +......    ...+....+..++.|++.++.+||+. | ++|||||
T Consensus       109 ~~~-i~~p~~~~~-~-~----~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dik  176 (237)
T smart00090      109 EAG-VPVPKPIAW-R-R----NVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLS  176 (237)
T ss_pred             hcC-CCCCeeeEe-c-C----ceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCC
Confidence            532 222222211 1 1    47999999984 3332211    23456667789999999999999998 9 9999999


Q ss_pred             CCCeeeeCCCCcEEEEeccCcee
Q 018514          195 PQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       195 p~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      |+||+++ ++ .++|+|||.+..
T Consensus       177 p~NIli~-~~-~i~LiDFg~a~~  197 (237)
T smart00090      177 EYNILVH-DG-KVVIIDVSQSVE  197 (237)
T ss_pred             hhhEEEE-CC-CEEEEEChhhhc
Confidence            9999999 55 799999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=2.4e-20  Score=169.74  Aligned_cols=173  Identities=29%  Similarity=0.479  Sum_probs=128.3

Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ..++||.|++|.. +|.+.+.+.. .....+......++.|+..|++|   + +.+|+|+||.||++..+. ++||.|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~-q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDD-QLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccch-hhhhhhhh
Confidence            4468999999995 7777776433 34556777889999999999999   6 999999999999998777 89999999


Q ss_pred             CceecccCC-------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 018514          214 SAKVLVKGE-------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  285 (354)
Q Consensus       214 ~a~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  285 (354)
                      +........       ..+...||..||+||.+.+.. |+.++||||||++++|++. =...|      +.....     
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~-----  469 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQF------ERIATL-----  469 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHH------HHHHhh-----
Confidence            998765554       455678999999999997666 9999999999999999997 22222      111110     


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHH
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA  345 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~  345 (354)
                                    .+++-..++...|.      -.+.-..|+.+|+.+.|.+||++.+.
T Consensus       470 --------------~d~r~g~ip~~~~~------d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 --------------TDIRDGIIPPEFLQ------DYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             --------------hhhhcCCCChHHhh------cCcHHHHHHHHhcCCCcccCchHHHH
Confidence                          11111111111111      13566799999999999999966554

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=2.5e-19  Score=165.80  Aligned_cols=208  Identities=25%  Similarity=0.363  Sum_probs=152.1

Q ss_pred             HHHcCCCCeeecceeeeecCCCCeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc-e
Q 018514          112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV-C  189 (354)
Q Consensus       112 l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~i-i  189 (354)
                      |+.+.|.|+.++++..+..     ...++|.+||. |+|.+.+...   ...++......++++|+.||+|||+. .| .
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS-PIGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC-ccee
Confidence            3568999999999988654     44889999999 6888888763   36678888889999999999999987 55 9


Q ss_pred             ecCCCCCCeeeeCCCCcEEEEeccCceecccC---CCccccccccccccchhccCCC---C---CCCchhHHHHHHHHHH
Q 018514          190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGAT---E---YTAAIDIWSAGCVLAE  260 (354)
Q Consensus       190 H~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~---~---~~~~~DiwslG~il~e  260 (354)
                      |+.+++.|.++|... .+||+|||+.......   .......-..-|.|||.+....   .   .+.+.||||+|++++|
T Consensus        72 hg~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            999999999999887 8999999998765320   1111112244599999996531   1   4667999999999999


Q ss_pred             HHhCCCCCCCCCc----HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCC
Q 018514          261 LLLGQPLFPGESG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  336 (354)
Q Consensus       261 ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp  336 (354)
                      +++...||.....    .+.+..+.+....+...               .+    |..   ..+++++..+++.||..+|
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP---------------~i----~~~---~e~~~~l~~l~~~cw~e~P  208 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRP---------------SI----ELL---NELPPELLLLVARCWEEIP  208 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHhcCCCCcCc---------------ch----hhh---hhcchHHHHHHHHhcccCh
Confidence            9999999976322    12233322201111111               11    000   0356689999999999999


Q ss_pred             CCCCCHHHHhhccCc
Q 018514          337 NLRSTAFDAVGSFDS  351 (354)
Q Consensus       337 ~~Rpta~e~l~~l~~  351 (354)
                      ..||+++++-..+..
T Consensus       209 ~~rPs~~~i~~~~~~  223 (484)
T KOG1023|consen  209 EKRPSIEQIRSKLLT  223 (484)
T ss_pred             hhCccHHHHHhhhhh
Confidence            999999998766544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=2.9e-18  Score=146.28  Aligned_cols=129  Identities=19%  Similarity=0.320  Sum_probs=101.5

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch------------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +.||+|++|.||+|.+  .|..+++|+.....            ....+|+.++..+.|++++....++...     ...
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence            5789999999999987  77789999754211            2244689999999999887665554322     225


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++|||++| +|.+.+....       . ....++.+++.+|.++|+. |++|+|++|.||+++ ++ .++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            789999987 7766664321       1 6778899999999999998 999999999999999 44 799999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=2.1e-18  Score=145.70  Aligned_cols=132  Identities=17%  Similarity=0.178  Sum_probs=99.4

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch--------------------------hhhHHHHHHHHHcCCCC
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------------------RYKNRELQTMRLLDHPN  119 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------------~~~~~e~~~l~~l~h~~  119 (354)
                      .|.+.+.||+|+||.||++.+ .+|+.||||++....                          ....+|..++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            388889999999999999986 479999999864321                          11346788888887774


Q ss_pred             --eeecceeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 018514          120 --VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (354)
Q Consensus       120 --iv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~N  197 (354)
                        ++..++.         ...++||||++|.....+..         ......++.+++.++.++|.. ||+||||||+|
T Consensus        95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~N  155 (198)
T cd05144          95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKH-GIIHGDLSEFN  155 (198)
T ss_pred             CCCCceeec---------CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHC-CCCcCCCCccc
Confidence              3333221         12478999999843222211         023567888999999999998 99999999999


Q ss_pred             eeeeCCCCcEEEEeccCceec
Q 018514          198 LLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       198 ili~~~~~~vkl~Dfg~a~~~  218 (354)
                      |+++.++ .++|+|||.+...
T Consensus       156 ill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         156 ILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             EEEcCCC-cEEEEECCccccC
Confidence            9999876 8999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=1.1e-17  Score=141.41  Aligned_cols=125  Identities=20%  Similarity=0.335  Sum_probs=94.4

Q ss_pred             EeeeccceEEEEEEEcCCCceEEEEEcccch------------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .||+|+||.||++.+  +|..+++|......            ....+|++++..+.|+++.....++...     ...+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence            379999999999985  67789999854211            2234699999999888754443333221     1257


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +||||++| ++.+.+....    .       .++.|++.+|.+||+. |++|+|++|.||+++ ++ .++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            89999987 6665544311    0       6788999999999998 999999999999999 54 799999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=1.3e-17  Score=161.39  Aligned_cols=130  Identities=18%  Similarity=0.291  Sum_probs=98.8

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcc-c----c-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-Q----D-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~----~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      .|...+.||+|+||+||++.+..  ..+++|+.. .    .       .....+|+++++.++|++++....+....   
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~---  408 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP---  408 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC---
Confidence            46778999999999999998743  344444321 1    0       12345799999999999988765544322   


Q ss_pred             CeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEec
Q 018514          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                        ...++||||++| +|.+.+.            ....++.|++.+|.+||+. |++||||||+||+++ ++ .++|+||
T Consensus       409 --~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl~-~~-~~~liDF  471 (535)
T PRK09605        409 --EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIVR-DD-RLYLIDF  471 (535)
T ss_pred             --CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEEE-CC-cEEEEeC
Confidence              225799999987 6666554            2457889999999999998 999999999999995 44 6999999


Q ss_pred             cCcee
Q 018514          213 GSAKV  217 (354)
Q Consensus       213 g~a~~  217 (354)
                      |++..
T Consensus       472 Gla~~  476 (535)
T PRK09605        472 GLGKY  476 (535)
T ss_pred             ccccc
Confidence            99964

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=5.6e-17  Score=135.68  Aligned_cols=130  Identities=20%  Similarity=0.227  Sum_probs=91.1

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccchhhh----------------------------HHHHHHHHHcCCCC--
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK----------------------------NRELQTMRLLDHPN--  119 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~e~~~l~~l~h~~--  119 (354)
                      .+.||+|+||+||+|.+. +|+.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999975 78999999875432100                            23444555554332  


Q ss_pred             eeecceeeeecCCCCeeEEEEEEeecccc-HH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCC
Q 018514          120 VVSLKHCFFSTTEKDELYLNLVLEYVPET-VH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQ  196 (354)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~-~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~iiH~Dlkp~  196 (354)
                      +++.+.+.         ..++||||++++ +. ..+....     .. ..++.++.+++.++.++|. . ||+|+||||+
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~  144 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA-GLVHGDLSEY  144 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc-CcCcCCCChh
Confidence            33332211         147999999972 11 1122111     01 5678899999999999999 7 9999999999


Q ss_pred             CeeeeCCCCcEEEEeccCceec
Q 018514          197 NLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       197 Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ||+++ ++ .++|+|||.+...
T Consensus       145 Nili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         145 NILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             hEEEE-CC-cEEEEECcccccc
Confidence            99999 55 7999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.4e-16  Score=147.85  Aligned_cols=243  Identities=26%  Similarity=0.286  Sum_probs=185.1

Q ss_pred             cceEEEeEeee--ccceEEEEEEE--cCCCceEEEEEccc------chhhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 018514           65 ISYMAERVVGH--GSFGVVFQAKC--LETGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        65 ~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~------~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  133 (354)
                      ..+.+...+|.  |.+|.||.+.+  ..++..+|+|.-..      ......+|+...+.+ .|+|.++....+     .
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e  188 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E  188 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence            35778889999  99999999998  88899999997422      223334677666666 489999866666     5


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhcCCceecCCCCCCeeeeCCCCcEEE
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~----~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl  209 (354)
                      +...+++-+|+|+.++..+.....   .-++...++..+.++..    ||.++|+. +++|-|+||+||++..+...+++
T Consensus       189 ~~~~lfiqtE~~~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  189 GSGILFIQTELCGESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cCCcceeeeccccchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeec
Confidence            666689999999988777666532   44677788888888888    99999999 99999999999999988447999


Q ss_pred             EeccCceecccCCCcc------ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHH
Q 018514          210 CDFGSAKVLVKGEPNI------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE--SGVDQLVEII  281 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~~~------~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~  281 (354)
                      +|||+...+..+....      ...+...|++||...+-  ++...|+|++|.++.+..+|..++...  +.-.+     
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----  337 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----  337 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----
Confidence            9999998876654221      22567789999998433  799999999999999999887655432  11111     


Q ss_pred             HHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                               .+......++-.+.+.++...+..|++.+|..|++++.+.++
T Consensus       338 -------------------------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  338 -------------------------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             -------------------------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                                     111112223444567788889999999999999999998876

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=6.2e-16  Score=133.87  Aligned_cols=133  Identities=17%  Similarity=0.271  Sum_probs=97.4

Q ss_pred             eEee-eccceEEEEEEEcCCCceEEEEEcccc-----------------hhhhHHHHHHHHHcCCCCe--eecceeeeec
Q 018514           71 RVVG-HGSFGVVFQAKCLETGEAVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNV--VSLKHCFFST  130 (354)
Q Consensus        71 ~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~  130 (354)
                      ..|| .|+.|+||.+..  .+..++||.+...                 .....+|++++..+.|+++  +..++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4687 899999999986  4778999977421                 1223569999999998875  5555443221


Q ss_pred             CCCCeeEEEEEEeeccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEE
Q 018514          131 TEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vk  208 (354)
                      . ......++|||+++|  +|...+..     ..+++..    +.|++.+|.+||+. ||+||||||+|||++.++ .++
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~-~v~  182 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHDA-GVYHADLNAHNILLDPDG-KFW  182 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCC-CEE
Confidence            1 111123599999996  66666543     3445443    56899999999999 999999999999999876 799


Q ss_pred             EEeccCcee
Q 018514          209 LCDFGSAKV  217 (354)
Q Consensus       209 l~Dfg~a~~  217 (354)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=3e-18  Score=165.69  Aligned_cols=251  Identities=25%  Similarity=0.319  Sum_probs=182.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCC-CceEEEEEcccch------hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .|.+.+.||+|.|+.|-.+....+ ...+|.|.+....      .....|..+-+.+. |+|++.+++..     .+..+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence            588999999999999998876333 3456666554332      11224777777776 99999998877     56666


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++++|..| ++...+..  ......+...+..++.|+..++.|+| .. ++.|+|+||+|.+++..+..+++.|||+|
T Consensus        96 ~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             cccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchhh
Confidence            8899999776 44444421  11124566678889999999999999 77 99999999999999877646999999999


Q ss_pred             eeccc-CC---Ccccccc-ccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          216 KVLVK-GE---PNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       216 ~~~~~-~~---~~~~~~g-~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      ..+.. ..   .....+| ++.|+|||...+.....+..|+||+|+++.-+++|..|+.........             
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------------  239 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------------  239 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-------------
Confidence            87755 22   1234567 999999999977566789999999999999999999998654432200             


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                ...+.... ..........++....+++.+++..+|..|.+.+++...
T Consensus       240 ----------~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  240 ----------YSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             ----------ceeecccc-cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                      00000000 000011224578999999999999999999999887543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=3.1e-16  Score=125.97  Aligned_cols=131  Identities=19%  Similarity=0.243  Sum_probs=101.8

Q ss_pred             EEeEeeeccceEEEEEEEcCCCceEEEEEcccch--hhhHHHHHHHHHcCC--CCeeecceeeeecCCCCeeEEEEEEee
Q 018514           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDELYLNLVLEY  144 (354)
Q Consensus        69 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~iv~e~  144 (354)
                      +.+.||.|.++.||++.+.  +..+++|......  ....+|..+++.++|  .++++++..+     ......+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence            3578999999999999973  4789999886654  356689999999976  4788876655     222457899999


Q ss_pred             ccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--CCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT--IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       145 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +.|.....+          +......++.+++.+++.||..  .+++|+|++|+||+++..+ .++++|||.+..
T Consensus        75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            987422111          4455667889999999999984  1699999999999999865 799999998863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=3.3e-15  Score=128.80  Aligned_cols=207  Identities=18%  Similarity=0.173  Sum_probs=147.5

Q ss_pred             HHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-
Q 018514          109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-  186 (354)
Q Consensus       109 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-  186 (354)
                      +..|-++.|.|||++..++.+....+.....++.||+. |++..+|++.......+......+|+.||++||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            45566778999999988886666556777889999999 6999999988888888999999999999999999999842 


Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCceeccc-----CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHH
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~el  261 (354)
                      .|+|+++..+-|++..++ .||++--.-......     ........+-++|.|||.=.. .+.+..+|||++|....+|
T Consensus       198 piihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             ccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHH
Confidence            699999999999999777 677653222111100     011122345677999987532 2357789999999999999


Q ss_pred             HhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC
Q 018514          262 LLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  340 (354)
Q Consensus       262 l~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp  340 (354)
                      ..|..- -.+.+....-..+.+.+                                ...-...-++++.+|++..|+.||
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i--------------------------------~~len~lqr~~i~kcl~~eP~~rp  323 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVI--------------------------------IGLENGLQRGSITKCLEGEPNGRP  323 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhhe--------------------------------eeccCccccCcCcccccCCCCCCc
Confidence            887643 22222222112221110                                000122334678999999999999


Q ss_pred             CHHHHhhcc
Q 018514          341 TAFDAVGSF  349 (354)
Q Consensus       341 ta~e~l~~l  349 (354)
                      +|.+++.|.
T Consensus       324 ~ar~llfHp  332 (458)
T KOG1266|consen  324 DARLLLFHP  332 (458)
T ss_pred             chhhhhcCc
Confidence            999999884

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.48  E-value=4.5e-13  Score=111.17  Aligned_cols=131  Identities=17%  Similarity=0.242  Sum_probs=93.8

Q ss_pred             eEeeeccceEEEEEEEcC------CCceEEEEEccc--------------c------------hhh----hHHHHHHHHH
Q 018514           71 RVVGHGSFGVVFQAKCLE------TGEAVAIKKVLQ--------------D------------KRY----KNRELQTMRL  114 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~--------------~------------~~~----~~~e~~~l~~  114 (354)
                      ..||.|.-+.||.|....      .+..+|||+++.              +            ...    .++|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543      247899997621              0            001    1268999998


Q ss_pred             cCC--CCeeecceeeeecCCCCeeEEEEEEeecccc-HH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCce
Q 018514          115 LDH--PNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYI-HNTIGVC  189 (354)
Q Consensus       115 l~h--~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~-~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~L-H~~~~ii  189 (354)
                      +..  -++++.+++.     .    .++||||++++ +. ..++.     ..++...+..+..|++.+|..| |+. |++
T Consensus        83 l~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~-glV  147 (197)
T cd05146          83 MQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC-NLV  147 (197)
T ss_pred             HHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC-Cee
Confidence            853  4555555431     2    47899999863 21 12221     2345556777889999999999 887 999


Q ss_pred             ecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       190 H~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      |+||++.||+++. + .+.|+|||.+...
T Consensus       148 HGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         148 HADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             cCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            9999999999984 3 6999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.7e-13  Score=111.40  Aligned_cols=123  Identities=15%  Similarity=0.225  Sum_probs=89.7

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeee-cceeeeecCCCCeeEEEEEEeec
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVS-LKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      .+.|+.|.++.||+++.  .+..+++|......   ....+|+.+++.+.+.++++ ++...     .+.  .++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence            45688999999999986  47789999876543   33567999999987655543 33321     111  36899999


Q ss_pred             ccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc-----eecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          146 PET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV-----CHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       146 ~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~i-----iH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +|. +...         ..   ....++.+++.+|+.||+. ++     +|+|++|.||+++ ++ .++++|||.+.
T Consensus        74 ~G~~l~~~---------~~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          74 EGSELLTE---------DF---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             CCCccccc---------cc---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            984 2211         00   1234567999999999987 75     9999999999999 44 69999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.47  E-value=5.1e-13  Score=125.55  Aligned_cols=136  Identities=20%  Similarity=0.256  Sum_probs=89.9

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccchh--------------------------------------------hhH
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------------------------------------------YKN  106 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------------------------~~~  106 (354)
                      +.||+|++|+||+|+. .+|+.||||+.+....                                            ...
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999986 4789999998743210                                            011


Q ss_pred             HHHHHHHHc----CCCCeeecceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHH-HHH
Q 018514          107 RELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR-ALA  180 (354)
Q Consensus       107 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~-~l~  180 (354)
                      +|...+.++    +|.+-+.+...+....    ...++||||++| ++.+......   ....   ...++.+++. .+.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~  271 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLN  271 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHH
Confidence            244444444    2333344434432211    125799999997 5555443211   1122   2345555555 467


Q ss_pred             HHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       181 ~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      .+|.. |++|+|++|.||+++.++ +++++|||++..+.
T Consensus       272 ql~~~-g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       272 QVLRD-GFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             HHHhC-CceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            88988 999999999999998877 79999999998664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.47  E-value=1.8e-12  Score=121.99  Aligned_cols=180  Identities=23%  Similarity=0.296  Sum_probs=127.4

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh----hhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      |.+ ...+-++.+..-.|..+.++.+|.|..+.....    ...+-++.|+.++||||+++++.+     ....++|+|+
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEe
Confidence            666 444444444322456677888888887754332    345678889999999999999987     4455689999


Q ss_pred             eeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCC
Q 018514          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (354)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~  222 (354)
                      |-+.. |...++..       ....+...++||+.||.|||+.++++|++|.-+.|+++..| ..||++|.++.......
T Consensus        89 ErV~P-l~~~lk~l-------~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~  159 (690)
T KOG1243|consen   89 ERVRP-LETVLKEL-------GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFN  159 (690)
T ss_pred             ecccc-HHHHHHHh-------HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCC
Confidence            99875 33344432       25566778899999999999766999999999999999998 79999999886543322


Q ss_pred             C-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhC
Q 018514          223 P-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  264 (354)
Q Consensus       223 ~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  264 (354)
                      . .....---.|..|+.....   .-..|.|-|||++++++.|
T Consensus       160 ~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  160 APAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            1 1111111225566654221   1357999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=3e-13  Score=128.73  Aligned_cols=142  Identities=20%  Similarity=0.262  Sum_probs=90.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhh-----------------------------------------
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-----------------------------------------  104 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------------------------------------  104 (354)
                      .|.. +-||+|++|+||+|+.+.+|+.||||+.+.....                                         
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4666 7899999999999998877999999988533100                                         


Q ss_pred             ---hHHHHHHHHHc----CCCCeeecceeeeecCCCCeeEEEEEEeeccc-cHHHH--HHhhhhcCCCCCHHHHHHHHHH
Q 018514          105 ---KNRELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRV--IKHHYKMSQRMPLIYVKLYFYQ  174 (354)
Q Consensus       105 ---~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~--l~~~~~~~~~~~~~~~~~~~~q  174 (354)
                         ..+|...+.++    .+.+.+.+...+.+-    ....++||||+.| .+.+.  +.........+.+..+..++.|
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence               01233333333    244444444444221    1225799999998 55442  2211100112344444455555


Q ss_pred             HHHHHHHHHhcCCceecCCCCCCeeeeCCC---CcEEEEeccCceeccc
Q 018514          175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHT---HQLKLCDFGSAKVLVK  220 (354)
Q Consensus       175 i~~~l~~LH~~~~iiH~Dlkp~Nili~~~~---~~vkl~Dfg~a~~~~~  220 (354)
                      ++       .. |++|+|+||.||+++.++   ++++++|||++..+..
T Consensus       276 if-------~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VF-------RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            54       46 999999999999998765   3799999999987644

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.42  E-value=3.7e-12  Score=101.88  Aligned_cols=139  Identities=19%  Similarity=0.279  Sum_probs=100.3

Q ss_pred             EEeEeeeccceEEEEEEEcCCCceEEEEEcccc------------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        69 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ....+-+|+-+.|+++.+  .|+...||.-...            .....+|.+.|.++.--.|.--.-+|.+...    
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence            467889999999999987  7888888854211            2334478999888753333222222222221    


Q ss_pred             EEEEEEeeccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcE--EEEec
Q 018514          137 YLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDF  212 (354)
Q Consensus       137 ~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~v--kl~Df  212 (354)
                       -.|+|||++|  ++.+++.....  ..........++++|-..+.-||.+ +|||+||..+||++.+++.++  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEee
Confidence             3689999998  77777776542  2333334478889999999999999 999999999999998777665  89999


Q ss_pred             cCcee
Q 018514          213 GSAKV  217 (354)
Q Consensus       213 g~a~~  217 (354)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.38  E-value=3.7e-11  Score=110.06  Aligned_cols=216  Identities=20%  Similarity=0.258  Sum_probs=158.2

Q ss_pred             cceEEEEEEEcCCCceEEEEEcccchh----hhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeeccc--cHH
Q 018514           77 SFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVH  150 (354)
Q Consensus        77 ~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~--~l~  150 (354)
                      .-.+.|++....+|..|++|++.-++.    ....-+++.+++.|.|+|++..+|.... -++..+++|++|+++  +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence            345889999999999999999832221    2234688999999999999999987443 456778999999995  666


Q ss_pred             HHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          151 RVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       151 ~~l~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +.......           .+...++..+|.++.|+..||.++|+. |+..+-|.|.+|+++.+. +|+|+..|......
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKM-RIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcc-eEEEecccceeeec
Confidence            65443221           234578899999999999999999998 999999999999999876 79999998887654


Q ss_pred             cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCcHHH-HHHHHHHhCCCCHHHHhccCC
Q 018514          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQ-LVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       220 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...           .  |.+.    -..+-|.=.||.++..|.||..- +......+. +..|                 
T Consensus       445 ~d~-----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-----------------  490 (655)
T KOG3741|consen  445 EDP-----------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-----------------  490 (655)
T ss_pred             CCC-----------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------------
Confidence            332           0  1121    12357999999999999999643 212222222 2222                 


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                                         ...++.++++++.-+...++++ -+..+++.++
T Consensus       491 -------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  491 -------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             -------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                               1236788888888888888887 6777877664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=5.5e-13  Score=124.13  Aligned_cols=244  Identities=20%  Similarity=0.170  Sum_probs=168.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEEc-CCCceEEEEEcccchh------hhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDKR------YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~------~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|.++..||.|.|+.|+.+..+ .++..+++|.......      ....|+-+...+ .|.+++.+...|....   
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r---  339 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR---  339 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc---
Confidence            4457999999999999999998765 5677899987654322      222466555555 5888888877774332   


Q ss_pred             eeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                        ..++-.|||.+.....-.   .....+.+...+.+..|++.++.++|+. .++|+|+||+||++..++...++.|||.
T Consensus       340 --~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  340 --QGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             --cccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhcccccc
Confidence              256889999863222222   1224566777888999999999999998 9999999999999987644689999999


Q ss_pred             ceecccCCCccccccccccc-cchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          215 AKVLVKGEPNISYICSRYYR-APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~-aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ++.+.-  ..........++ .+|.+.....+..+.|++|||..+.+.++|.+.-...+...   .+...          
T Consensus       414 ~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~----------  478 (524)
T KOG0601|consen  414 WTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSG----------  478 (524)
T ss_pred             ccccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecc----------
Confidence            864211  111222233444 36666666668999999999999999999875433222111   01000          


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                               ..+.          ....+.+++.+.+.++..++..||.+.++..+.
T Consensus       479 ---------~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  479 ---------DTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             ---------cccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence                     0000          112347889999999999999999999987764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.35  E-value=2.4e-13  Score=133.11  Aligned_cols=242  Identities=23%  Similarity=0.267  Sum_probs=172.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhh-------hHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+.+.+.+-+.+|.++.++.+.-..+|...++|+.......       ...+-.++-...+|.++.....+     .-..
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs  877 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS  877 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence            34578888999999999999988777866666654332211       11122222223456665543322     2333


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..+++++|+++ ++...+...    ...+...++.++..+..++++||.. .+.|+|++|.|.++..++ ..+++|||..
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~g-h~~l~~~~t~  951 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDG-HRPLTDFGTL  951 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccC-CcccCccccc
Confidence            37889999985 665555543    3566667778888899999999987 799999999999999888 5899999843


Q ss_pred             eeccc---------------------C-----------CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh
Q 018514          216 KVLVK---------------------G-----------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  263 (354)
Q Consensus       216 ~~~~~---------------------~-----------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  263 (354)
                      ....-                     .           .......+|+.|.+||.+.+.. .+..+|+|+.|+++++.++
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhc
Confidence            22100                     0           0112346799999999997766 7889999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH
Q 018514          264 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF  343 (354)
Q Consensus       264 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~  343 (354)
                      |.+||......+.+.+|.+....                 ++.         -+...+.++++++..++..+|.+|..+.
T Consensus      1031 g~pp~na~tpq~~f~ni~~~~~~-----------------~p~---------g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENILNRDIP-----------------WPE---------GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhhhhhccccCCCC-----------------CCC---------CccccChhhhhhhhhhhccCchhccCcc
Confidence            99999988887777666553111                 111         1233689999999999999999999876

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.31  E-value=1.1e-10  Score=104.51  Aligned_cols=264  Identities=16%  Similarity=0.209  Sum_probs=163.6

Q ss_pred             EEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-hhHHHHHHHHHc-CCCCeee----cceeeeecCCCCeeEEEEEE
Q 018514           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-YKNRELQTMRLL-DHPNVVS----LKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        69 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~e~~~l~~l-~h~~iv~----~~~~~~~~~~~~~~~~~iv~  142 (354)
                      ..+-||+|+-+.+|-.-.  - ...+.|++..... ...+.+..|... .||-+-.    -... .... .......+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e--~-~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~-L~G~-~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--V-RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQAT-LHGG-RRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecch--h-hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHH-hhCC-CccceeEEec
Confidence            456799999999996542  2 2345577754322 222233333332 4553322    0010 1111 2222367788


Q ss_pred             eeccc--cHHHHHH--hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          143 EYVPE--TVHRVIK--HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       143 e~~~~--~l~~~l~--~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +.+.|  ....++.  .+.+......+..+.+.++.++.+.+.||+. |.+-+|+.++|+|+++++ .|.|+|=..-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDS-KVVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCc-eEEEEcccceeec
Confidence            88875  3333332  1222234567889999999999999999999 999999999999999887 7999986554444


Q ss_pred             ccCCCccccccccccccchhcc----CCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          219 VKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      .++......+|...|.+||...    ..-..+...|.|-||+++++++.| +.||.+-....       .-+.|.+..+.
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-------~ap~p~E~~Ia  240 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-------DAPNPLETDIA  240 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC-------CCCCcchhhhh
Confidence            5556666778899999999863    112257789999999999999986 89997632100       00111111111


Q ss_pred             ccC----CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCc--CCCCCCCHHHHhhccCc
Q 018514          294 CMN----PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY--SPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       294 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~--dp~~Rpta~e~l~~l~~  351 (354)
                      ...    +.-.....+.....+|.     -+++.++.+..+|+..  +++-|||++..+.-|.+
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~-----~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLS-----MLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChh-----hcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            000    00001112222233332     3789999999999965  47799999988776543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=3.6e-11  Score=96.68  Aligned_cols=123  Identities=15%  Similarity=0.331  Sum_probs=85.4

Q ss_pred             EeeeccceEEEEEEEcCCCceEEEEEcccc------------hhhhHHHHHHHHHcCCCC--eeecceeeeecCCCCeeE
Q 018514           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~  137 (354)
                      .+++|+-+.+|.+.+  -|..+++|.-...            .....+|..++.+++--.  .+.++++  +..     .
T Consensus         3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~-----~   73 (204)
T COG3642           3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPD-----N   73 (204)
T ss_pred             hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCC-----C
Confidence            578899999999976  4555677743211            122346999988885433  3333332  221     1


Q ss_pred             EEEEEeeccccHHH-HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~~l~~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ..|+|||++|.+.. .+...           ...+++.+-.-+.-||.. ||+|+||.++||++..++  +.++|||++.
T Consensus        74 ~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~--i~~IDfGLg~  139 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR--IYFIDFGLGE  139 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc--EEEEECCccc
Confidence            46899999995433 55432           134566777778889998 999999999999998654  9999999996


Q ss_pred             e
Q 018514          217 V  217 (354)
Q Consensus       217 ~  217 (354)
                      .
T Consensus       140 ~  140 (204)
T COG3642         140 F  140 (204)
T ss_pred             c
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.19  E-value=1.5e-10  Score=95.70  Aligned_cols=121  Identities=22%  Similarity=0.304  Sum_probs=77.1

Q ss_pred             EEEEEEEcCCCceEEEEEcccc------------------------------hhhhHHHHHHHHHcCCC--Ceeecceee
Q 018514           80 VVFQAKCLETGEAVAIKKVLQD------------------------------KRYKNRELQTMRLLDHP--NVVSLKHCF  127 (354)
Q Consensus        80 ~V~~~~~~~~~~~vavK~~~~~------------------------------~~~~~~e~~~l~~l~h~--~iv~~~~~~  127 (354)
                      .||.|.. .+|..+|+|..+..                              .....+|.+.|.++...  ++++.+.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3888885 56789999976321                              01223699999999765  456655432


Q ss_pred             eecCCCCeeEEEEEEeecc--ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHH-HHhcCCceecCCCCCCeeeeCCC
Q 018514          128 FSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY-IHNTIGVCHRDIKPQNLLVNPHT  204 (354)
Q Consensus       128 ~~~~~~~~~~~~iv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~-LH~~~~iiH~Dlkp~Nili~~~~  204 (354)
                           .    .+|||||++  |.....+....     ++......++.+++..+.. +|+. ||+|+||.+.||+++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-
Confidence                 2    368999999  64333333321     1123355677788886665 5777 99999999999999976 


Q ss_pred             CcEEEEeccCceec
Q 018514          205 HQLKLCDFGSAKVL  218 (354)
Q Consensus       205 ~~vkl~Dfg~a~~~  218 (354)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             5999999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=2.9e-11  Score=114.46  Aligned_cols=147  Identities=21%  Similarity=0.340  Sum_probs=103.1

Q ss_pred             HHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCc--------cc--cccccccccchhccCCC
Q 018514          174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--------IS--YICSRYYRAPELIFGAT  243 (354)
Q Consensus       174 qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~--------~~--~~g~~~y~aPE~~~~~~  243 (354)
                      +.+.|+.|+|...++||++|.|++|.++..+ ..||+.|+.+....++...        ..  ..-...|.|||.+.+ .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            3448999999988999999999999999888 7999999988765442110        01  112456999999966 4


Q ss_pred             CCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCH
Q 018514          244 EYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP  322 (354)
Q Consensus       244 ~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  322 (354)
                      ..+.++|+||+|+++|.+.. |+..+...+.... .......                    .+..    ...+..++++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~~--------------------~~~~----~~~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRNL--------------------LNAG----AFGYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhhcc--------------------cccc----cccccccCcH
Confidence            47899999999999999984 5555543322111 1111100                    0000    0112356899


Q ss_pred             HHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          323 EAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       323 ~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                      ++.+-|.+++..++..||++.+++.
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhc
Confidence            9999999999999999997776654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.14  E-value=1.7e-09  Score=94.77  Aligned_cols=132  Identities=12%  Similarity=0.105  Sum_probs=88.7

Q ss_pred             EEEEEEcCCCceEEEEEcccc---------------hhhhHHHHHHHHHcCCCCeee--cceeeeecCCCCeeEEEEEEe
Q 018514           81 VFQAKCLETGEAVAIKKVLQD---------------KRYKNRELQTMRLLDHPNVVS--LKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        81 V~~~~~~~~~~~vavK~~~~~---------------~~~~~~e~~~l~~l~h~~iv~--~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      |+++..  .|+.+.||.....               .....+|+..+.++..-+|..  .+++...........-++|+|
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            555544  5667777755211               113568999888885433333  333332211111223568999


Q ss_pred             eccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC------CCCcEEEEeccCc
Q 018514          144 YVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP------HTHQLKLCDFGSA  215 (354)
Q Consensus       144 ~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~------~~~~vkl~Dfg~a  215 (354)
                      ++++  ++.+++....  ..+.+......++.+++..+.-||.. ||+|+|+++.|||++.      +...+.|+||+.+
T Consensus       116 ~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        116 DLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             eCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            9997  5777765332  23456667788999999999999999 9999999999999975      2347999999988


Q ss_pred             ee
Q 018514          216 KV  217 (354)
Q Consensus       216 ~~  217 (354)
                      ..
T Consensus       193 ~~  194 (268)
T PRK15123        193 QI  194 (268)
T ss_pred             cc
Confidence            53

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.13  E-value=5.3e-10  Score=95.82  Aligned_cols=138  Identities=16%  Similarity=0.179  Sum_probs=90.7

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCC--eeecceeeeecCCCCeeEEEEEEe
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      +.|+.|..+.||++... +|..+++|.....     .....+|.++++.+.+.+  +++++......  ......++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence            56899999999999863 3578999987653     234568999999997633  45554433111  11123579999


Q ss_pred             ecccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 018514          144 YVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-------------------------------------  185 (354)
Q Consensus       144 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-------------------------------------  185 (354)
                      |++|. +...+..     ..++......++.+++.+|..||+.                                     
T Consensus        81 ~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          81 RVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            99974 3222110     2344445555555666666655531                                     


Q ss_pred             ------------------CCceecCCCCCCeeeeCC-CCcEEEEeccCce
Q 018514          186 ------------------IGVCHRDIKPQNLLVNPH-THQLKLCDFGSAK  216 (354)
Q Consensus       186 ------------------~~iiH~Dlkp~Nili~~~-~~~vkl~Dfg~a~  216 (354)
                                        ..++|+|++|.||+++.+ ...+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                              257999999999999873 2268999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.03  E-value=1.9e-09  Score=91.97  Aligned_cols=130  Identities=19%  Similarity=0.205  Sum_probs=93.5

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcc----------c----------------chhhhHHHHHHHHHcCCC--
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----------Q----------------DKRYKNRELQTMRLLDHP--  118 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----------~----------------~~~~~~~e~~~l~~l~h~--  118 (354)
                      +.+...||-|.-|.||.|.+ ..|.++|||.=+          .                .+...++|.++|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            66778999999999999996 478899999321          0                112235799999998644  


Q ss_pred             CeeecceeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 018514          119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  198 (354)
Q Consensus       119 ~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Ni  198 (354)
                      .+++.++.         +..++||||+.|-.+.-+        +++......++..|+.-+..+-.. ||||+|+.+-||
T Consensus       172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~~-GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIAW---------NRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYRR-GIVHGDLSEFNI  233 (304)
T ss_pred             CCCCcccc---------ccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHHc-CccccCCchheE
Confidence            66665442         225789999998422111        123344555666677766666666 999999999999


Q ss_pred             eeeCCCCcEEEEeccCce
Q 018514          199 LVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       199 li~~~~~~vkl~Dfg~a~  216 (354)
                      ++++++ .+.++||-.+.
T Consensus       234 lV~~dg-~~~vIDwPQ~v  250 (304)
T COG0478         234 LVTEDG-DIVVIDWPQAV  250 (304)
T ss_pred             EEecCC-CEEEEeCcccc
Confidence            999987 69999997664

>PRK09902 hypothetical protein; Provisional

Probab=98.95  E-value=4e-08  Score=81.94  Aligned_cols=138  Identities=12%  Similarity=0.100  Sum_probs=97.0

Q ss_pred             eeccceEEEEEEEcCCCceEEEEEcc----------cchhhhHHHHHHHHHcCCCC--eeecceeeeecCCCCeeEEEEE
Q 018514           74 GHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        74 g~G~~g~V~~~~~~~~~~~vavK~~~----------~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      |.||.|.|++...  .|..+-+|...          .....+.+|+..|++|..-+  +++.. ++-.......-.-+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            5688888888775  44467788653          12344568999999885333  44443 2211222334446789


Q ss_pred             Eeeccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC-cEEEEeccCcee
Q 018514          142 LEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  217 (354)
Q Consensus       142 ~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~-~vkl~Dfg~a~~  217 (354)
                      +|-++|  +|.+.+....  ..+.+......++.+++..++-||+. |+.|+|+.+.||+++.++. .++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            999984  7777765432  13456677788999999999999998 9999999999999985551 499999987754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=2.7e-08  Score=84.27  Aligned_cols=108  Identities=18%  Similarity=0.297  Sum_probs=77.9

Q ss_pred             hhHHHHHHHHHcCCCC--eeecceeeeecCCCCeeEEEEEEeeccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH
Q 018514          104 YKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL  179 (354)
Q Consensus       104 ~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l  179 (354)
                      ...+|...+..|....  .++.+++........ ..-++|+|++++  +|.+++....    ..+......++.+++..+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI  131 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence            4557888888775433  333344333222222 345789999997  5777666532    255566788999999999


Q ss_pred             HHHHhcCCceecCCCCCCeeeeCCC--CcEEEEeccCcee
Q 018514          180 AYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  217 (354)
Q Consensus       180 ~~LH~~~~iiH~Dlkp~Nili~~~~--~~vkl~Dfg~a~~  217 (354)
                      +-||.. ||+|+|+++.|||++.+.  ..+.|+||+.+..
T Consensus       132 ~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999 999999999999998764  3699999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.91  E-value=2.2e-08  Score=84.67  Aligned_cols=133  Identities=16%  Similarity=0.203  Sum_probs=92.2

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch----------------------------hhhHHHHHHHHHcC--CCCe
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------------------------RYKNRELQTMRLLD--HPNV  120 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------------~~~~~e~~~l~~l~--h~~i  120 (354)
                      ..|++|.-+.||+|.. .++..+|+|+++...                            ....+|+..|+++.  +-.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3788888999999984 568899999874321                            11125888888884  3444


Q ss_pred             eecceeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee
Q 018514          121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (354)
Q Consensus       121 v~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili  200 (354)
                      ++-+.+.     .    ..+||||++..-   ........-++....+..+..+++..+.-|-...++||+||+.-|||+
T Consensus       133 P~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~  200 (268)
T COG1718         133 PEPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV  200 (268)
T ss_pred             CCceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence            5554443     2    468999998530   000000012233336777888999999988873499999999999999


Q ss_pred             eCCCCcEEEEeccCceec
Q 018514          201 NPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       201 ~~~~~~vkl~Dfg~a~~~  218 (354)
                      . ++ .+.++|||.|...
T Consensus       201 ~-~~-~p~iID~~QaV~~  216 (268)
T COG1718         201 H-DG-EPYIIDVSQAVTI  216 (268)
T ss_pred             E-CC-eEEEEECcccccc
Confidence            9 44 6999999998754

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.81  E-value=1.7e-07  Score=78.58  Aligned_cols=136  Identities=15%  Similarity=0.200  Sum_probs=87.2

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhH-------------HHHHHHHHcCC---CCeeecceee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------RELQTMRLLDH---PNVVSLKHCF  127 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------~e~~~l~~l~h---~~iv~~~~~~  127 (354)
                      ..+|.+.+++-......|.+..-  +|..+.+|..+......+             +++..+..++.   -....++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            34688999998888877777764  778899998765432222             23343444422   2222222222


Q ss_pred             eecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCc
Q 018514          128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (354)
Q Consensus       128 ~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~  206 (354)
                      ......-....+++|||++| .+.+...        +++    .+...+..++.-||+. |+.|+|..|.|++++.++  
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~~--  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNNG--  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc-CCccCCCCcCcEEEECCc--
Confidence            22222233446789999998 4332211        222    2345677889999998 999999999999999654  


Q ss_pred             EEEEeccCce
Q 018514          207 LKLCDFGSAK  216 (354)
Q Consensus       207 vkl~Dfg~a~  216 (354)
                      ++++||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999998664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.75  E-value=3.2e-08  Score=94.02  Aligned_cols=138  Identities=20%  Similarity=0.239  Sum_probs=84.6

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccchhh--------------------------------------------hH
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY--------------------------------------------KN  106 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------------------------------~~  106 (354)
                      +-|+.++-|+||+|+.. +|+.||||+.+.+...                                            ..
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            56899999999999964 5999999986432100                                            01


Q ss_pred             HHHHHHHHc----CCCCeeecceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 018514          107 RELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY  181 (354)
Q Consensus       107 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~  181 (354)
                      +|...+.++    +...-+.+...|.+-+.+    ..++|||+.| .+.+......   ..++...+.....++.-  ..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~--~q  280 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFL--RQ  280 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHH--HH
Confidence            344444444    333334444555332222    5799999998 4444422211   23442222222222211  12


Q ss_pred             HHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       182 LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      +-.. |+.|.|..|.||+++.++ ++.+.|||+.....+
T Consensus       281 ~~~d-gffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRD-GFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhc-CccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence            2224 999999999999999997 799999999987644

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.54  E-value=2.3e-08  Score=94.31  Aligned_cols=186  Identities=18%  Similarity=0.125  Sum_probs=131.5

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCC-eeecceeeeecCCCCeeEEEEEEeec
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPN-VVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      |...+.+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++.+     ..+.+.+++++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhhh
Confidence            555677899999999999875554433 5555444 33345889999999999 44433332     5677789999999


Q ss_pred             ccc--HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC
Q 018514          146 PET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (354)
Q Consensus       146 ~~~--l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~  223 (354)
                      +++  .......   ..-.+.+.+...+.+.-+++++++|+. -=+|+|    ||+..+.  ..+..||+....+.....
T Consensus       317 s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~  386 (829)
T KOG0576|consen  317 STGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMK  386 (829)
T ss_pred             cCCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc-cccCcc----ccccccc--ccccccccCCcccCcccc
Confidence            864  1111000   011223334455666678899999986 568888    8888764  589999999887766555


Q ss_pred             ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 018514          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (354)
Q Consensus       224 ~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  270 (354)
                      .....+++.++|||+..... +....|.|++|.-..+|.-|-+|-..
T Consensus       387 ~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCC
Confidence            66778999999999986666 78899999999877777777777544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.50  E-value=2.4e-06  Score=73.62  Aligned_cols=74  Identities=19%  Similarity=0.181  Sum_probs=49.4

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCC--eeecceeeeecCCCCeeEEEEEEeec
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....  +++++.....  .......+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~--~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTS--DEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE--TEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeeccc--ccccccceEEEEEe
Confidence            4679999999999998743  58999988655  344557888888885433  4444442211  12223368899999


Q ss_pred             cc
Q 018514          146 PE  147 (354)
Q Consensus       146 ~~  147 (354)
                      +|
T Consensus        78 ~g   79 (239)
T PF01636_consen   78 PG   79 (239)
T ss_dssp             SS
T ss_pred             cc
Confidence            97

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.42  E-value=1.2e-06  Score=88.17  Aligned_cols=200  Identities=18%  Similarity=0.255  Sum_probs=133.2

Q ss_pred             hHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 018514          105 KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH  183 (354)
Q Consensus       105 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH  183 (354)
                      .+-|+..+....|+|++.++.+-+.....+ ..+.+..++|.+ ++...+.+.    ...+...++.+..++..||+++|
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHH
Confidence            345777888899999999877664433322 112234566665 555555543    67889999999999999999999


Q ss_pred             hcCCceecCCCCC---CeeeeCCCCcEEEE--eccCceecccCCCccccccccccccchhccCCCCCCC--chhHHHHHH
Q 018514          184 NTIGVCHRDIKPQ---NLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA--AIDIWSAGC  256 (354)
Q Consensus       184 ~~~~iiH~Dlkp~---Nili~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~--~~DiwslG~  256 (354)
                      +. ...|.-+..+   +.-.+.++ .+.++  ||+.+..............+..+.+||...... +..  ..|+|++|.
T Consensus       304 ~~-~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  304 SL-SLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGL  380 (1351)
T ss_pred             Hh-ccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHH
Confidence            97 6666555444   33344444 46666  888887766555555555667788888874332 333  479999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCC
Q 018514          257 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  336 (354)
Q Consensus       257 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp  336 (354)
                      ....+..|..+-.....   ...+                                   ..........+++.+|+.-++
T Consensus       381 l~~~~~~~~~i~~~~~~---~~~~-----------------------------------l~~~~~~~~~d~~~~~~~~~~  422 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV---PVSL-----------------------------------LDVLSTSELLDALPKCLDEDS  422 (1351)
T ss_pred             HHhhhhhcCcccccccc---hhhh-----------------------------------hccccchhhhhhhhhhcchhh
Confidence            99999887543211100   0000                                   000112278889999999999


Q ss_pred             CCCCCHHHHhhccC
Q 018514          337 NLRSTAFDAVGSFD  350 (354)
Q Consensus       337 ~~Rpta~e~l~~l~  350 (354)
                      ++|+++.+++.|..
T Consensus       423 ~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  423 EERLSALELLTHPF  436 (1351)
T ss_pred             hhccchhhhhhchh
Confidence            99999999998853

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.39  E-value=5.1e-06  Score=71.34  Aligned_cols=69  Identities=16%  Similarity=0.111  Sum_probs=45.6

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch--hhhHHHHHHHHHcCCCCe--eecceeeeecCCCCeeEEEEEEeecc
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNV--VSLKHCFFSTTEKDELYLNLVLEYVP  146 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~iv~e~~~  146 (354)
                      ..||+|..+.||+.    .|..+++|......  ....+|.++++.+..-.+  ++.+++.     .+.....+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            56899999999974    24467889876432  345689999988864333  3333332     22222578999999


Q ss_pred             cc
Q 018514          147 ET  148 (354)
Q Consensus       147 ~~  148 (354)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            83

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.38  E-value=6e-06  Score=78.51  Aligned_cols=137  Identities=20%  Similarity=0.255  Sum_probs=84.5

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccchh-----------------------------------------hhHHHH
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----------------------------------------YKNREL  109 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------------------------------~~~~e~  109 (354)
                      +-||.-+.|+||+|+.+ +|+.||||+....-+                                         .+.+|.
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            56899999999999965 599999997632210                                         001233


Q ss_pred             HHHH----HcCCCC---eeecceeeeecCCCCeeEEEEEEeeccc---cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH
Q 018514          110 QTMR----LLDHPN---VVSLKHCFFSTTEKDELYLNLVLEYVPE---TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL  179 (354)
Q Consensus       110 ~~l~----~l~h~~---iv~~~~~~~~~~~~~~~~~~iv~e~~~~---~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l  179 (354)
                      +...    .++|-+   -|.+..++.+-..    ...++||||+|   +-.+.++.     ..++...+..-+.+...-+
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~~q  316 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYLEQ  316 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHHHH
Confidence            3332    234555   2233344433222    26799999997   22334443     3455554444333333333


Q ss_pred             HHHHhcCCceecCCCCCCeeeeC---CCCcEEEEeccCceeccc
Q 018514          180 AYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       180 ~~LH~~~~iiH~Dlkp~Nili~~---~~~~vkl~Dfg~a~~~~~  220 (354)
                      -+.  . |++|+|=.|.||++.+   .+..+.+-|||+......
T Consensus       317 If~--~-GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  317 IFK--T-GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHh--c-CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            232  4 9999999999999984   345899999999876543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.33  E-value=3.2e-06  Score=67.91  Aligned_cols=128  Identities=17%  Similarity=0.263  Sum_probs=85.2

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEee
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~  144 (354)
                      -+..+.|++|.+|.||++.+  .|..+|+|+-+.+  +...+.|.++|..++..++-+-+-.+  .  .    ..+.|||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y--g--~----~~i~me~   93 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY--G--E----DFIRMEY   93 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe--c--h----hhhhhhh
Confidence            34567899999999999998  6678999988655  34567899999999877665532211  1  1    2456999


Q ss_pred             ccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCC-CCCeeeeCCCCcEEEEeccCcee
Q 018514          145 VPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK-PQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       145 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlk-p~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +.| .|...-..       .+...    +..++..---|-.. ||-|+.|. |..+++..+. .+.|+||..|+.
T Consensus        94 i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~~-GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLDRL-GIEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhc-------ccHHH----HHHHHHHHHHHHHh-ccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            998 54433221       01122    23455553334444 99999986 5555555454 699999999873

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.28  E-value=3e-05  Score=64.39  Aligned_cols=126  Identities=26%  Similarity=0.349  Sum_probs=89.8

Q ss_pred             cceEEEeEeeeccc-eEEEEEEEcCCCceEEEEEccc-----------c--------------hhhhHHHHHHHHHcC--
Q 018514           65 ISYMAERVVGHGSF-GVVFQAKCLETGEAVAIKKVLQ-----------D--------------KRYKNRELQTMRLLD--  116 (354)
Q Consensus        65 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vavK~~~~-----------~--------------~~~~~~e~~~l~~l~--  116 (354)
                      .+++.++.||.|.- |.||+++.  .|..+|+|.+..           .              ...+..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57999999999999 99999987  788999998321           0              012235777766664  


Q ss_pred             -CCCe--eecceeeeecC-------------CCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 018514          117 -HPNV--VSLKHCFFSTT-------------EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA  180 (354)
Q Consensus       117 -h~~i--v~~~~~~~~~~-------------~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~  180 (354)
                       +.++  +++++++.-..             ........||.||....-            .+....    +.+|.+-+.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence             4455  88888774432             122334678999887642            122222    457888888


Q ss_pred             HHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       181 ~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+|.. ||+-+|+++.|..   +   -+|+|||.+
T Consensus       179 ~~~k~-gI~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL-GIVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             HHHHC-CeeeccCcccccc---C---CEEEecccC
Confidence            99998 9999999999985   2   389999965

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.23  E-value=9.4e-06  Score=72.63  Aligned_cols=137  Identities=17%  Similarity=0.234  Sum_probs=97.5

Q ss_pred             EEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------------------------------hhhhHHHHHHHHHcCC
Q 018514           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------------------------KRYKNRELQTMRLLDH  117 (354)
Q Consensus        68 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------------------------~~~~~~e~~~l~~l~h  117 (354)
                      .+..+|..|.-+.||.|. ..+|..+|||+++..                              .-..++|++.|++|..
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            455789999999999998 568888999987321                              0122468999999976


Q ss_pred             CCeeecceeeeecCCCCeeEEEEEEeecccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 018514          118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (354)
Q Consensus       118 ~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~  196 (354)
                      ..|+--.-... .      ...+||+++++. ...-    ....-.++...+..+-.|++.-+.-|...+++||.||.--
T Consensus       226 aGIP~PePIlL-k------~hVLVM~FlGrdgw~aP----kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEf  294 (520)
T KOG2270|consen  226 AGIPCPEPILL-K------NHVLVMEFLGRDGWAAP----KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEF  294 (520)
T ss_pred             cCCCCCCceee-e------cceEeeeeccCCCCcCc----ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhh
Confidence            66433211111 1      136899999852 1111    1112456777788888899999998887779999999999


Q ss_pred             CeeeeCCCCcEEEEeccCceec
Q 018514          197 NLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       197 Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      |+|+..+  .+.++|.+.+...
T Consensus       295 N~LyhdG--~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  295 NLLYHDG--KLYIIDVSQSVEH  314 (520)
T ss_pred             hheEECC--EEEEEEccccccC
Confidence            9999854  6999999887643

>PLN02876 acyl-CoA dehydrogenase

Probab=98.10  E-value=5.6e-05  Score=77.35  Aligned_cols=77  Identities=19%  Similarity=0.217  Sum_probs=49.8

Q ss_pred             EeEeeeccceEEEEEEEcCCC--ceEEEEEcccc-----hhhhHHHHHHHHHcC-CCCe--eecceeeeecCCCCeeEEE
Q 018514           70 ERVVGHGSFGVVFQAKCLETG--EAVAIKKVLQD-----KRYKNRELQTMRLLD-HPNV--VSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~~-----~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~~  139 (354)
                      .+.++.|.+..+|+......+  ..+++|+....     .....+|.++++.+. |.++  ++++..+.+..  .....+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCCce
Confidence            467889999999998764332  46788876432     234668999999995 6664  45444332211  112356


Q ss_pred             EEEeecccc
Q 018514          140 LVLEYVPET  148 (354)
Q Consensus       140 iv~e~~~~~  148 (354)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            899999874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.10  E-value=4.1e-05  Score=66.69  Aligned_cols=68  Identities=19%  Similarity=0.149  Sum_probs=41.9

Q ss_pred             eeeccc-eEEEEEEEcCCCceEEEEEcccc-hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEEEEEeeccc
Q 018514           73 VGHGSF-GVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE  147 (354)
Q Consensus        73 lg~G~~-g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~  147 (354)
                      |..|.. +.||++..  .+..+.+|..... .....+|+++++.+. +--+++++++..     .....++||++++|
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEEeeCC
Confidence            344444 78999975  3467888877543 123457898888884 333444444331     11235789999987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.03  E-value=0.00014  Score=60.90  Aligned_cols=123  Identities=20%  Similarity=0.324  Sum_probs=81.9

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccch--------------------hhhHHHHHHHHHcC------CCCeeecc
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------------RYKNRELQTMRLLD------HPNVVSLK  124 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------~~~~~e~~~l~~l~------h~~iv~~~  124 (354)
                      ..||+|+.-.||.--   .....+||+.....                    ....+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            468999999999543   34457888876544                    33346777666665      78899998


Q ss_pred             eeeeecCCCCeeEEEEEEeecc-------ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 018514          125 HCFFSTTEKDELYLNLVLEYVP-------ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (354)
Q Consensus       125 ~~~~~~~~~~~~~~~iv~e~~~-------~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~N  197 (354)
                      |...+..+     ..+|+|.+.       .+|.+++.+     ..++. .+..   .+-.-..+|-++ +|+.+|++|.|
T Consensus        84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~---~L~~f~~~l~~~-~Iv~~dl~~~N  148 (199)
T PF10707_consen   84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQ---ALDEFKRYLLDH-HIVIRDLNPHN  148 (199)
T ss_pred             EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHH---HHHHHHHHHHHc-CCeecCCCccc
Confidence            87644333     567777754       256666643     44555 3333   344445567777 89999999999


Q ss_pred             eeeeCC--CC-cEEEEe
Q 018514          198 LLVNPH--TH-QLKLCD  211 (354)
Q Consensus       198 ili~~~--~~-~vkl~D  211 (354)
                      |++...  +. .+.|+|
T Consensus       149 Iv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  149 IVVQRRDSGEFRLVLID  165 (199)
T ss_pred             EEEEecCCCceEEEEEe
Confidence            999533  22 577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.93  E-value=0.0002  Score=61.96  Aligned_cols=69  Identities=20%  Similarity=0.327  Sum_probs=44.1

Q ss_pred             EeEeeeccceEEEEEEEcC-CCceEEEEEcccchh---hhHHHHHHHHHcCCCCe-eecceeeeecCCCCeeEEEEEEee
Q 018514           70 ERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLNLVLEY  144 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~---~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~iv~e~  144 (354)
                      .+.|..|-...+|++.... .++.+++|+......   ...+|+.+++.+....+ +++++.+     .+    .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence            3567788888999997532 256788997754322   23478889988854333 3333222     11    379999


Q ss_pred             ccc
Q 018514          145 VPE  147 (354)
Q Consensus       145 ~~~  147 (354)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            886

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.86  E-value=0.00016  Score=62.67  Aligned_cols=29  Identities=34%  Similarity=0.441  Sum_probs=24.3

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++|+|+.|.||+++.+. ..-|+||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGR-LSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence            589999999999998653 45699999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.86  E-value=0.00011  Score=64.39  Aligned_cols=132  Identities=18%  Similarity=0.254  Sum_probs=72.9

Q ss_pred             eeeccceEEEEEEEcCCCceEEEEEcccchh----hhHHHHHHHHHcCCCCee-ecceeeeecCCCCeeEEEEEEeeccc
Q 018514           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVV-SLKHCFFSTTEKDELYLNLVLEYVPE  147 (354)
Q Consensus        73 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~iv~e~~~~  147 (354)
                      +..|-...+|+...  ++..+++|.......    ...+|..+++.+....+. +++...     .    -++||||++|
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            45677778898873  566788887643322    246789999988644333 232221     1    2579999987


Q ss_pred             c-HH--------------HHHHhhhh---cCCCCCHH-HHHHHHHHH---------HHHHHHHHh-------cCCceecC
Q 018514          148 T-VH--------------RVIKHHYK---MSQRMPLI-YVKLYFYQI---------CRALAYIHN-------TIGVCHRD  192 (354)
Q Consensus       148 ~-l~--------------~~l~~~~~---~~~~~~~~-~~~~~~~qi---------~~~l~~LH~-------~~~iiH~D  192 (354)
                      . +.              ..+.+...   ...+++.. .+..+..++         ...+..+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            3 21              11111111   11122211 111221111         111222211       11489999


Q ss_pred             CCCCCeeeeCCCCcEEEEeccCcee
Q 018514          193 IKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       193 lkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +.|.||+++.++  +.|+||+.+..
T Consensus       153 l~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC--CEEEeccccCc
Confidence            999999998765  78999998853

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.75  E-value=0.0001  Score=61.27  Aligned_cols=101  Identities=22%  Similarity=0.172  Sum_probs=75.7

Q ss_pred             HHHHHHHHHcCC-CCeeecceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 018514          106 NRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH  183 (354)
Q Consensus       106 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH  183 (354)
                      ..|.-+++.+++ +++++++|++     .    ..++.||.+. ++... ..........++..+.+++.+++..+.+|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            358888999976 6999998887     2    2568999984 43321 000001134678899999999999999998


Q ss_pred             h---cCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          184 N---TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       184 ~---~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      .   . .+.-.|++|+|+-++.++ ++|++|...+...
T Consensus        77 ~~~~~-~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~  112 (188)
T PF12260_consen   77 HGPLG-FFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE  112 (188)
T ss_pred             cCCCC-cEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence            7   4 478889999999999877 7999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.70  E-value=0.00076  Score=62.58  Aligned_cols=71  Identities=21%  Similarity=0.302  Sum_probs=47.0

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcc-----------cchhhhHHHHHHHHHcC---CCCeeecceeeeecCCCCe
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----------QDKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-----------~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+.||.|.+..||++.....++.++||.-.           ........|.+.|+.+.   -.++++++++.     .  
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~--  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E--  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--
Confidence            367899999999999975333589999742           12233456788887763   24566665542     2  


Q ss_pred             eEEEEEEeeccc
Q 018514          136 LYLNLVLEYVPE  147 (354)
Q Consensus       136 ~~~~iv~e~~~~  147 (354)
                      ...++||||+++
T Consensus       104 ~~~~lVME~L~~  115 (401)
T PRK09550        104 ELAVTVMEDLSD  115 (401)
T ss_pred             CCCEEEEecCCC
Confidence            124689999875

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.70  E-value=4.8e-05  Score=67.13  Aligned_cols=128  Identities=17%  Similarity=0.222  Sum_probs=86.7

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcc----------cch----------------hhhHHHHHHHHHcC-CCC
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDK----------------RYKNRELQTMRLLD-HPN  119 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----------~~~----------------~~~~~e~~~l~~l~-h~~  119 (354)
                      +.+.++||-|.-+.+|.+-+ ..|.+.++|.=+          ..+                -...+|+..|+.|. |..
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            77889999999999999986 568888888421          111                11236888888874 322


Q ss_pred             -eeecceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 018514          120 -VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (354)
Q Consensus       120 -iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~N  197 (354)
                       +++.+++         ...++|||++.| .+... .+      -.+   +..+...+..-+--|-++ |+||+|..-=|
T Consensus       173 pVPkpiD~---------~RH~Vvmelv~g~Pl~~v-~~------v~d---~~~ly~~lm~~Iv~la~~-GlIHgDFNEFN  232 (465)
T KOG2268|consen  173 PVPKPIDH---------NRHCVVMELVDGYPLRQV-RH------VED---PPTLYDDLMGLIVRLANH-GLIHGDFNEFN  232 (465)
T ss_pred             CCCCcccc---------cceeeHHHhhcccceeee-ee------cCC---hHHHHHHHHHHHHHHHHc-Cceecccchhe
Confidence             3333322         225789999987 33221 11      111   233445566666778888 99999999999


Q ss_pred             eeeeCCCCcEEEEeccCce
Q 018514          198 LLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       198 ili~~~~~~vkl~Dfg~a~  216 (354)
                      |+++.++ .++++||-.+.
T Consensus       233 imv~dd~-~i~vIDFPQmv  250 (465)
T KOG2268|consen  233 IMVKDDD-KIVVIDFPQMV  250 (465)
T ss_pred             eEEecCC-CEEEeechHhh
Confidence            9999777 79999997553

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.62  E-value=0.00012  Score=68.43  Aligned_cols=163  Identities=19%  Similarity=0.250  Sum_probs=102.3

Q ss_pred             HHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 018514          108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG  187 (354)
Q Consensus       108 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~  187 (354)
                      ....++.+.|+|..+++++...    ......+|+|+++.++.+.+..+.     +...       ++.       .+ +
T Consensus        32 r~~~lktl~~~~l~~yl~~~r~----~~~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~~-~   87 (725)
T KOG1093|consen   32 RFQYLKSLQHDNLCQYLDFSRG----KHERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------AH-G   87 (725)
T ss_pred             hhHHHHhhcCccceeeEeeecC----ccceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------cc-c
Confidence            4667888999999998775422    122278899999999998887643     1100       111       22 3


Q ss_pred             ceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 018514          188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  267 (354)
Q Consensus       188 iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  267 (354)
                      +.|-     |        .++.+| -++..               |  |-.      ..+|+||||+|.++.++..|...
T Consensus        88 ~~~~-----~--------~~~~td-~~~t~---------------~--~~~------~~pKsdVwsl~~i~~el~L~~~l  130 (725)
T KOG1093|consen   88 VLHL-----N--------IIYITD-HFLTK---------------Y--PSP------IGPKSDVWSLGFIILELYLGISL  130 (725)
T ss_pred             ccee-----h--------hhhccc-ccccc---------------C--CCC------CCcchhhhhHHHHHHHHHHhhHH
Confidence            3331     1        233444 11100               1  110      12599999999999999999988


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                      +......+...-+.+..-.+........                 ...+...++..+..++++|+...|..||...++.+
T Consensus       131 ~~~~~~s~~l~~i~k~~~~d~~~~~~a~-----------------e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  131 EAELTESEYLEILLKYYTDDQELLSTAM-----------------EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHHHHHHHHHHHHHHhccCchhHHHHHH-----------------HHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            8777777776666665433332211100                 00223346788999999999999999998887766


Q ss_pred             c
Q 018514          348 S  348 (354)
Q Consensus       348 ~  348 (354)
                      +
T Consensus       194 ~  194 (725)
T KOG1093|consen  194 R  194 (725)
T ss_pred             C
Confidence            4

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.60  E-value=0.00076  Score=60.91  Aligned_cols=144  Identities=14%  Similarity=0.043  Sum_probs=76.4

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCC--eeecceeeeec-CCCCeeEEEEEEee
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFST-TEKDELYLNLVLEY  144 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~iv~e~  144 (354)
                      .+.++.|....+|++..  ++..+++|+....  ......|.+++..|....  +++++...... ........+++++|
T Consensus        27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            45677777788999874  3335788877542  234456778887774322  33332211000 00112335789999


Q ss_pred             ccccH-----H-------HHHH---hhhhc-CCC----CCHHH-----HH----------HHHHHHHHHHHHHHh-----
Q 018514          145 VPETV-----H-------RVIK---HHYKM-SQR----MPLIY-----VK----------LYFYQICRALAYIHN-----  184 (354)
Q Consensus       145 ~~~~l-----~-------~~l~---~~~~~-~~~----~~~~~-----~~----------~~~~qi~~~l~~LH~-----  184 (354)
                      ++|..     .       ..+.   ..... ...    .....     ..          .....+...++++..     
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            88621     0       1111   10000 000    00000     00          001123334555532     


Q ss_pred             -cCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          185 -TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       185 -~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                       ..+++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence             13899999999999999775 56899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.57  E-value=0.0008  Score=60.34  Aligned_cols=143  Identities=12%  Similarity=0.023  Sum_probs=77.2

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEccc-chhhhHHHHHHHHHcCCCC--eeecceeeeecC--CCCeeEEEEEEee
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTT--EKDELYLNLVLEY  144 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~--~~~~~~~~iv~e~  144 (354)
                      .+.+..|....+|++..  ++..+++|+... .......|+++++.+.+..  +++++... ...  .......++|+++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADR-DGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCC-CCcEeeeeCCceEEEEEe
Confidence            45677788789999864  445789998764 3344557888888885433  33332210 000  0111235789999


Q ss_pred             ccccHH------------HHHHh---hhh-cCCC----CCHHHHHH------------HHHHHHHHHHHHHh------cC
Q 018514          145 VPETVH------------RVIKH---HYK-MSQR----MPLIYVKL------------YFYQICRALAYIHN------TI  186 (354)
Q Consensus       145 ~~~~l~------------~~l~~---~~~-~~~~----~~~~~~~~------------~~~qi~~~l~~LH~------~~  186 (354)
                      ++|...            ..+.+   ... ....    ........            ....+..++.++.+      ..
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            986211            11110   000 0000    00010000            11112233444432      12


Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            799999999999999765 56899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.55  E-value=0.0017  Score=58.95  Aligned_cols=29  Identities=31%  Similarity=0.327  Sum_probs=25.0

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ++||+|+.|.||+++.+. ..-|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            899999999999998554 45799999885

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.52  E-value=0.0018  Score=58.30  Aligned_cols=68  Identities=19%  Similarity=0.261  Sum_probs=42.0

Q ss_pred             eEeeeccceEEEEEEEcC------CCceEEEEEcccch---hhhHHHHHHHHHcCCCCee-ecceeeeecCCCCeeEEEE
Q 018514           71 RVVGHGSFGVVFQAKCLE------TGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVV-SLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~i  140 (354)
                      +.|..|-...+|++....      .++.+++|+.....   ....+|.++++.+....+. +++..+     .+    .+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~----~~   74 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF-----PN----GR   74 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe-----CC----Cc
Confidence            456666677888887532      25789999876532   2346788888888543333 333332     11    24


Q ss_pred             EEeeccc
Q 018514          141 VLEYVPE  147 (354)
Q Consensus       141 v~e~~~~  147 (354)
                      |++|++|
T Consensus        75 v~e~i~G   81 (302)
T cd05156          75 IEEFIPS   81 (302)
T ss_pred             hhheeCC
Confidence            7888776

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10593 hypothetical protein; Provisional

Probab=97.49  E-value=0.0019  Score=57.89  Aligned_cols=75  Identities=8%  Similarity=0.026  Sum_probs=49.7

Q ss_pred             EEeEeeeccceEEEEEEEcCCCceEEEEEccc--chhhhHHHHHHHHHcCC---CCeeecceeeeecCCCCeeEEEEEEe
Q 018514           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQTMRLLDH---PNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        69 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      -.+.||.|..+.||+... .++ .+.+|..+.  ......+|.+.|+.+..   -.++++++.+....  ....-++|||
T Consensus        18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEEe
Confidence            356799999999999874 233 467777554  23467789999998854   34566665442211  1222578999


Q ss_pred             eccc
Q 018514          144 YVPE  147 (354)
Q Consensus       144 ~~~~  147 (354)
                      +++|
T Consensus        94 ~i~G   97 (297)
T PRK10593         94 RLRG   97 (297)
T ss_pred             ccCC
Confidence            9886

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.34  E-value=8e-05  Score=77.50  Aligned_cols=156  Identities=15%  Similarity=0.023  Sum_probs=110.8

Q ss_pred             HHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 018514          108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI  186 (354)
Q Consensus       108 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  186 (354)
                      |...++...|+++...+.-.   ........+.+++|+. |.+.+.+-........+....+.....+.+.+..-+|+.-
T Consensus      1279 e~de~~~~~h~~~~~~p~rI---~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRI---PPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccC---CCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            44455667899887764433   2223333577899988 5777777766655556665555555555466666666542


Q ss_pred             C----ceecCCCCCCeeeeCCCCcEEEEeccCceecccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHH
Q 018514          187 G----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (354)
Q Consensus       187 ~----iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~el  261 (354)
                      +    .+|++||+-|.+|..+. .++++++|+.+...+.. ......+++.|++|+.... -.++.++|+|..|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence            3    58999999999999887 79999999998432222 2334567888999998743 3478889999999999999


Q ss_pred             HhCCCCC
Q 018514          262 LLGQPLF  268 (354)
Q Consensus       262 l~g~~pf  268 (354)
                      ..|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            9998877

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.33  E-value=0.0029  Score=57.74  Aligned_cols=30  Identities=27%  Similarity=0.435  Sum_probs=25.9

Q ss_pred             ceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       188 iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++|+|+.+.||+++++++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999986544799999998853

>PLN02236 choline kinase

Probab=97.31  E-value=0.0038  Score=57.25  Aligned_cols=31  Identities=26%  Similarity=0.645  Sum_probs=26.5

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .++|+|+++.||+++.+...+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999986544799999998853

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.26  E-value=0.0059  Score=55.12  Aligned_cols=28  Identities=29%  Similarity=0.631  Sum_probs=24.7

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++|+|+.+.||+++. + .+.|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            7899999999999987 4 58999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.23  E-value=0.0042  Score=56.62  Aligned_cols=69  Identities=22%  Similarity=0.194  Sum_probs=42.4

Q ss_pred             EeeeccceEEEEEEEcCCCceEEEEEccc-----------chhhhHHHHHHHHHcC--CC-CeeecceeeeecCCCCeeE
Q 018514           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----------DKRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~~  137 (354)
                      .||.|....||++.+...++.|+||.-..           .......|.+.|+...  -| .+++++++-       ...
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------ccc
Confidence            47889999999999743336799996421           1122345777776653  24 445554421       222


Q ss_pred             EEEEEeeccc
Q 018514          138 LNLVLEYVPE  147 (354)
Q Consensus       138 ~~iv~e~~~~  147 (354)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            4589999863

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.10  E-value=0.0028  Score=57.17  Aligned_cols=106  Identities=16%  Similarity=0.243  Sum_probs=72.6

Q ss_pred             CCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEec
Q 018514          133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      .+..|.|++|++.++++...        .--...++..++.+.+..++-+..+...-|||+.-.||+|+ +| +|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            56778899999988764432        12345567788899999988888777899999999999999 66 7999999


Q ss_pred             cCceecccCCCccccccccccccchhccCCCCCCCchhHHHH
Q 018514          213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSA  254 (354)
Q Consensus       213 g~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Diwsl  254 (354)
                      -+++.-..+..-.    ....--|-.+.|.  -+.+.+||-+
T Consensus       366 klsRl~~~q~~is----y~rldhp~lF~G~--dd~QFeIYrl  401 (488)
T COG5072         366 KLSRLSYSQGIIS----YNRLDHPDLFNGV--DDYQFEIYRL  401 (488)
T ss_pred             eeeecccCCceee----ccccCchhhhcCc--cceeeeHHHH
Confidence            9998543322111    1112223334332  3666777764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.09  E-value=0.0057  Score=54.27  Aligned_cols=30  Identities=27%  Similarity=0.496  Sum_probs=24.9

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++|+|++|.||+++.++...-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            489999999999999755335699999885

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.88  E-value=0.0094  Score=55.04  Aligned_cols=71  Identities=17%  Similarity=0.167  Sum_probs=45.1

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcc----------cchhhhHHHHHHHHHcC--CC-CeeecceeeeecCCCCee
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----------~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~  136 (354)
                      .+.||.|.-..||++.+...++.|+||.-.          ....+...|.+.|+...  -| ++++++++-       ..
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence            567899999999999974335679999642          11233345778887663  34 455554421       22


Q ss_pred             EEEEEEeeccc
Q 018514          137 YLNLVLEYVPE  147 (354)
Q Consensus       137 ~~~iv~e~~~~  147 (354)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            24579999863

>PTZ00384 choline kinase; Provisional

Probab=96.83  E-value=0.032  Score=51.88  Aligned_cols=29  Identities=28%  Similarity=0.344  Sum_probs=24.5

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ..+|.|+-+.||+.+.+  .+.++||..|..
T Consensus       228 VfCHNDL~~gNIL~~~~--~l~lID~EYA~~  256 (383)
T PTZ00384        228 LFCHNDLFFTNILDFNQ--GIYFIDFDFAGF  256 (383)
T ss_pred             eeeeccCCcccEEecCC--CEEEEEeccccC
Confidence            68999999999998654  599999987753

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.80  E-value=0.023  Score=51.01  Aligned_cols=30  Identities=27%  Similarity=0.513  Sum_probs=26.9

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .++|+|+.+.|+++++++ .+=+.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            489999999999999888 489999999874

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.72  E-value=0.033  Score=51.81  Aligned_cols=69  Identities=19%  Similarity=0.243  Sum_probs=45.4

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcc-----------cchhhhHHHHHHHHHcC---CCCeeecceeeeecCCCCe
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----------QDKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-----------~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+.||.|....||++.+  .+..++||.-.           ........|.+.|+.+.   -.++++++++.     ++.
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM  109 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence            56789999999999986  34568899654           12233345677776654   24666666644     222


Q ss_pred             eEEEEEEeeccc
Q 018514          136 LYLNLVLEYVPE  147 (354)
Q Consensus       136 ~~~~iv~e~~~~  147 (354)
                        -+++||++++
T Consensus       110 --~vlvME~L~~  119 (418)
T PLN02756        110 --ALIGMRYLEP  119 (418)
T ss_pred             --CEEEEeecCC
Confidence              4678999965

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.62  E-value=0.038  Score=49.91  Aligned_cols=29  Identities=14%  Similarity=0.192  Sum_probs=26.1

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++|+|+.++||++++++ .+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence            799999999999998776 68999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.06  E-value=0.051  Score=48.41  Aligned_cols=73  Identities=15%  Similarity=0.154  Sum_probs=42.6

Q ss_pred             EEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-hhhhHHHHHHHHHcC---CCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        68 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      +-.+.++.|....+|+..  .+++.+.||+-... ......|.+-|+.|.   --.+++++++....   +.  -++|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~---~~--~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD---DD--AFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S---SC--CEEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec---CC--ceEEEE
Confidence            345678989999999987  47778999977633 345677888888884   33455555543221   11  378999


Q ss_pred             eccc
Q 018514          144 YVPE  147 (354)
Q Consensus       144 ~~~~  147 (354)
                      |++.
T Consensus        93 ~l~~   96 (288)
T PF03881_consen   93 FLEM   96 (288)
T ss_dssp             ----
T ss_pred             eecC
Confidence            9873

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=95.63  E-value=0.047  Score=51.28  Aligned_cols=30  Identities=17%  Similarity=0.302  Sum_probs=24.0

Q ss_pred             ceecCCCCCCeeeeCCCC----cEEEEeccCcee
Q 018514          188 VCHRDIKPQNLLVNPHTH----QLKLCDFGSAKV  217 (354)
Q Consensus       188 iiH~Dlkp~Nili~~~~~----~vkl~Dfg~a~~  217 (354)
                      ++|+||...|||.+.++.    -..|+||-.+..
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~  303 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR  303 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence            799999999999987553    356889877654

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.55  E-value=0.27  Score=44.74  Aligned_cols=27  Identities=26%  Similarity=0.351  Sum_probs=23.4

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ++||+|+.+.||+++ +  .+.|+||+-+.
T Consensus       197 ~liHgD~h~~NvL~~-d--~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D--GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-C--CcEEEeCCCCC
Confidence            789999999999995 3  37899999875

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.31  E-value=0.031  Score=49.91  Aligned_cols=132  Identities=19%  Similarity=0.252  Sum_probs=88.2

Q ss_pred             EEEeEeeeccceEEEEEEEc--C--------CCceEEEEEcccch-------------------------h-----hhHH
Q 018514           68 MAERVVGHGSFGVVFQAKCL--E--------TGEAVAIKKVLQDK-------------------------R-----YKNR  107 (354)
Q Consensus        68 ~~~~~lg~G~~g~V~~~~~~--~--------~~~~vavK~~~~~~-------------------------~-----~~~~  107 (354)
                      .+..+|..|.-+.|+.|.--  .        ....+|||+++..-                         +     ..++
T Consensus       255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk  334 (531)
T KOG2269|consen  255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK  334 (531)
T ss_pred             hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence            34567888999999888320  0        12358888763210                         0     1124


Q ss_pred             HHHHHHHcC-----CCCeeecceeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 018514          108 ELQTMRLLD-----HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI  182 (354)
Q Consensus       108 e~~~l~~l~-----h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~L  182 (354)
                      |...|.+++     .|-+|.+..            ..+||-|++..   .+.......-.++....+..-.|+..++.-|
T Consensus       335 EmhNL~RMq~~GlpcP~vV~lkk------------hvLVMsFiGd~---~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~l  399 (531)
T KOG2269|consen  335 EMHNLSRMQKHGLPCPQVVKLKK------------HVLVMSFIGDQ---GLAAPKLKNVELTDDERRNAYDQVQSIMCRL  399 (531)
T ss_pred             HHHHHHHHHhcCCCCCceeeeec------------ceEEEEeecCC---CCCCccccccccChHHHHHHHHHHHHHHHHH
Confidence            666666653     566666532            35799998842   1111112234578888888888999999988


Q ss_pred             HhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       183 H~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ...+-+||.|+.--|+|...+  .+.++|..-+.
T Consensus       400 Y~Ec~LVHADlSEyN~Lw~~g--Kvw~IDVsQsv  431 (531)
T KOG2269|consen  400 YKECLLVHADLSEYNLLWTPG--KVWVIDVSQSV  431 (531)
T ss_pred             HHhhheeecchhhhhheecCC--ceEEEechhcc
Confidence            766689999999999999975  69999987664

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.73  E-value=0.1  Score=48.22  Aligned_cols=59  Identities=29%  Similarity=0.295  Sum_probs=39.8

Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~  201 (354)
                      ..++-+|..| ++..+++.     ...++....+++.-.++|+.-+----+++|.|+.|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            4567777777 77777765     33445555666655666665443322899999999999984

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.43  E-value=0.075  Score=47.58  Aligned_cols=39  Identities=31%  Similarity=0.451  Sum_probs=26.8

Q ss_pred             HHHHHHHHHHHHHHHHHHHh---cCCceecCCCCCCeeeeCC
Q 018514          165 LIYVKLYFYQICRALAYIHN---TIGVCHRDIKPQNLLVNPH  203 (354)
Q Consensus       165 ~~~~~~~~~qi~~~l~~LH~---~~~iiH~Dlkp~Nili~~~  203 (354)
                      .+-++.++.||+--.-.+-.   ..+.+|.||||+|||+-+.
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            44577778888765433322   1269999999999998443

>PTZ00296 choline kinase; Provisional

Probab=94.29  E-value=0.9  Score=43.18  Aligned_cols=70  Identities=13%  Similarity=0.144  Sum_probs=43.1

Q ss_pred             EEeEeeeccceEEEEEEEcCC--------CceEEEEEcccchh---hhHHHHHHHHHcCCCCee-ecceeeeecCCCCee
Q 018514           69 AERVVGHGSFGVVFQAKCLET--------GEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVV-SLKHCFFSTTEKDEL  136 (354)
Q Consensus        69 ~~~~lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~---~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~  136 (354)
                      -.+.|..|-.-.+|++.....        ++.|.+|+.-....   ...+|..+++.+...+|- ++++.+     .+  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~g--  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-----SG--  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-----CC--
Confidence            456677777788999875421        46788998754332   234688888887644443 333433     21  


Q ss_pred             EEEEEEeeccc
Q 018514          137 YLNLVLEYVPE  147 (354)
Q Consensus       137 ~~~iv~e~~~~  147 (354)
                        +.|.+|++|
T Consensus       182 --g~I~efi~g  190 (442)
T PTZ00296        182 --GRIEEWLYG  190 (442)
T ss_pred             --CEEEEeeCC
Confidence              347888875

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.15  E-value=0.046  Score=45.14  Aligned_cols=29  Identities=28%  Similarity=0.350  Sum_probs=24.9

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      -.+|+|+.|.||++++++  ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            369999999999998665  89999998863

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	354
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-125
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-125
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-125
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-125
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-125
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-124
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-124
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-124
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-123
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-123
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-123
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-123
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-123
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-122
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-122
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-122
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-122
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-121
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-121
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-121
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-119
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-116
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-84
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-78
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-41
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-41
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-41
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-41
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-40
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-40
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-40
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-40
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-40
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-40
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-40
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-39
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-39
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-39
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-39
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-39
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-39
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-39
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-39
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-39
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-39
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-39
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-39
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-39
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-39
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-39
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-39
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-39
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-39
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-39
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-39
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-39
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-39
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-39
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-39
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-39
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-39
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-39
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-39
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-39
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-39
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-39
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-39
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-39
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-39
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-39
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-39
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-39
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-39
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-39
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-39
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-38
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-38
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-38
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-38
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-38
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-38
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-38
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-38
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-38
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-38
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-38
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-38
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-38
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-38
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-38
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-38
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-38
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-38
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-38
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-38
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-37
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-36
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-36
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-36
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-36
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-36
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-36
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-35
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-35
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-35
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-35
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-35
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-35
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-35
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-35
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-35
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-35
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-35
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-35
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-35
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-35
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-35
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-35
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-35
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-35
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-35
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-35
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-35
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-35
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-35
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-35
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-35
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-35
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-35
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-35
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-35
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-35
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-35
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-35
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-35
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-35
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-35
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-34
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-34
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-34
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-34
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-34
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-34
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-34
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-34
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-34
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-34
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-34
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-34
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-34
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-34
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-34
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-34
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-34
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-34
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-34
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-34
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-34
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-34
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-34
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-34
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-34
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-34
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-33
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-33
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-33
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-33
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-31
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-31
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-31
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-31
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-31
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-30
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-30
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-30
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-30
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-30
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-30
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-29
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-29
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-29
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-29
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-29
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-29
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-29
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-29
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-29
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-29
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-29
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-29
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-29
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-29
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-29
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-29
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-29
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-29
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-28
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-28
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-28
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-28
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-28
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-28
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-27
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-27
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-27
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-27
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-27
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-27
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-27
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-27
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-27
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-27
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		8e-27
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		9e-27
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		9e-27
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-27
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-26
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-26
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-26
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-26
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-26
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-26
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-26
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-26
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-26
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-26
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-26
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-26
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-26
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		7e-26
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		7e-26
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		7e-26
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-26
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		7e-26
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		8e-26
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-26
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-26
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		8e-26
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-26
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-26
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-25
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-25
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-25
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-25
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-25
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-25
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-24
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-24
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-24
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-24
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-24
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-24
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-24
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-23
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-23
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-22
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-22
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-20
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-20
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-20
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-20
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-20
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-20
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-20
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-20
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-20
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-20
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-20
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-20
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-20
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-19
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-19
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-19
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-19
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-19
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-19
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-19
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-19
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-19
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-19
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-19
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-19
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-19
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-19
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-19
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-19
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-18
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-18
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-18
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-18
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-18
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-17
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-16
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-16
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-16
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-16
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-16
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-16
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-16
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-16
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-16
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-16
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-16
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-16
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-16
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-16
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-16
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-16
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-16
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-16
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-16
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-16
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-16
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-16
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-16
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-16
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-16
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-16
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-16
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-16
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-16
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-15
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-14
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-14
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-14
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-14
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-14
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-14
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-14
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-14
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-14
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-14
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-14
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-14
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-14
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-14
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-13
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-13
3soa_A	444	Full-Length Human Camkii Length = 444		1e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-13
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		9e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-12
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-12
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-11
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-11
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-10
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-10
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-10
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-10
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-10
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-10
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		7e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-05
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-05
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		4e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		7e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		9e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		9e-04

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  444 bits (1141), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 211/329 (64%), Positives = 261/329 (79%), Gaps = 13/329 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 22  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 70
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 71  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 130
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 131 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 189
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 190 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 249
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 250 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 309
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 310 RTPPEAIALCSRLLEYTPTARLTPLEACA 338

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  444 bits (1141), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 211/327 (64%), Positives = 261/327 (79%), Gaps = 13/327 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 65  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 113
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 114 VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 173
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 174 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 232
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 233 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 292
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 293 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 352
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           R PPEA+ L SRLL+Y+P  R T  +A
Sbjct: 353 RTPPEAIALCSRLLEYTPTARLTPLEA 379

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  444 bits (1141), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 211/327 (64%), Positives = 261/327 (79%), Gaps = 13/327 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 24  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 72
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 73  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 132
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 133 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 191
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 192 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 251
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 252 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 311
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           R PPEA+ L SRLL+Y+P  R T  +A
Sbjct: 312 RTPPEAIALCSRLLEYTPTARLTPLEA 338

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  444 bits (1141), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 211/329 (64%), Positives = 261/329 (79%), Gaps = 13/329 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 20  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACA 336

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  444 bits (1141), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 211/329 (64%), Positives = 261/329 (79%), Gaps = 13/329 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 14  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 62
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 63  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 122
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 123 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 181
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 182 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 241
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 242 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 301
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 302 RTPPEAIALCSRLLEYTPTARLTPLEACA 330

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  441 bits (1134), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 207/309 (66%), Positives = 256/309 (82%), Gaps = 4/309 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 339 RSTAFDAVG 347
           R T  +A  
Sbjct: 307 RLTPLEACA 315

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  441 bits (1133), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 210/329 (63%), Positives = 260/329 (79%), Gaps = 13/329 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 20  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACA 336

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  440 bits (1131), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 207/299 (69%), Positives = 252/299 (84%), Gaps = 3/299 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 11  VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 69
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 70  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 129
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 130 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 188
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 248
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 249 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 307

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  438 bits (1127), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 206/309 (66%), Positives = 255/309 (82%), Gaps = 4/309 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 339 RSTAFDAVG 347
           R T  +A  
Sbjct: 306 RLTPLEACA 314

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  438 bits (1126), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 207/299 (69%), Positives = 252/299 (84%), Gaps = 3/299 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  438 bits (1126), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 206/309 (66%), Positives = 255/309 (82%), Gaps = 4/309 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 339 RSTAFDAVG 347
           R T  +A  
Sbjct: 302 RLTPLEACA 310

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  438 bits (1126), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 206/309 (66%), Positives = 255/309 (82%), Gaps = 4/309 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 339 RSTAFDAVG 347
           R T  +A  
Sbjct: 313 RLTPLEACA 321

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  438 bits (1126), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 206/309 (66%), Positives = 255/309 (82%), Gaps = 4/309 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 339 RSTAFDAVG 347
           R T  +A  
Sbjct: 306 RLTPLEACA 314

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  435 bits (1119), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 206/299 (68%), Positives = 251/299 (83%), Gaps = 3/299 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  435 bits (1119), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 206/299 (68%), Positives = 251/299 (83%), Gaps = 3/299 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 7   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 65
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 66  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 125
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 126 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 184
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 185 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 244
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 245 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 303

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  435 bits (1119), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 206/299 (68%), Positives = 251/299 (83%), Gaps = 3/299 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  435 bits (1119), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 206/299 (68%), Positives = 251/299 (83%), Gaps = 3/299 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 10  VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 68
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 69  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 128
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 129 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 187
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 188 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 247
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 248 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 306

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  432 bits (1111), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 205/299 (68%), Positives = 250/299 (83%), Gaps = 3/299 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  432 bits (1111), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 205/299 (68%), Positives = 250/299 (83%), Gaps = 3/299 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK D +YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  431 bits (1108), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 204/299 (68%), Positives = 249/299 (83%), Gaps = 3/299 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           RE+I+ MNPNYTEF FPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 244 REQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  425 bits (1092), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 202/299 (67%), Positives = 247/299 (82%), Gaps = 3/299 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVP TV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           RE+I+ MNPNYTEF FPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A  
Sbjct: 244 REQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  415 bits (1067), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 197/299 (65%), Positives = 247/299 (82%), Gaps = 4/299 (1%)
Query: 49  IIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE 108
           I V    GK G+ ++ I+Y   +V+G+GSFGVVFQAK +E+ E VAIKKVLQDKR+KNRE
Sbjct: 25  IKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
           LQ MR++ HPNVV LK  F+S  +K DE++LNLVLEYVPETV+R  +H+ K+ Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           +KLY YQ+ R+LAYIH +IG+CHRDIKPQNLL++P +  LKL DFGSAK+L+ GEPN+S 
Sbjct: 143 IKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           ICSRYYRAPELIFGAT YT  IDIWS GCV+AEL+ GQPLFPGESG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           +RE+IK MNPNY E KFPQI+ HP+ K+F+ R PP+A+DL+SRLL+Y+P+ R TA +A+
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  308 bits (788), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 143/314 (45%), Positives = 211/314 (67%), Gaps = 34/314 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH N++ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 127 FFSTTEKD---------------------------------ELYLNLVLEYVPETVHRVI 153
           F++T +++                                   YLN+++EYVP+T+H+V+
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 154 KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 213
           K   +  + +P+  + +Y YQ+ RA+ +IH ++G+CHRDIKPQNLLVN   + LKLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
           SAK L+  EP+++ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+PLF GE+ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 333
           +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +  P  A+DL+ ++L+
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 334 YSPNLRSTAFDAVG 347
           Y P+LR   ++A+ 
Sbjct: 308 YEPDLRINPYEAMA 321

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  288 bits (738), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 139/294 (47%), Positives = 200/294 (68%), Gaps = 9/294 (3%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---LLDHP 118
           K+   +  ER+ G G+FG V   K   TG +VAIKKV+QD R++NRELQ M+   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 119 NVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           N+V L+  F++  E+D  ++YLN+V+EYVP+T+HR  +++Y+     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 177 RALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           R++  +H  ++ VCHRDIKP N+LVN     LKLCDFGSAK L   EPN++YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PELIFG   YT A+DIWS GC+ AE++LG+P+F G++   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 296 NPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           NP++T+      K  PW  +F     +   EA DL+S LLQY P  R   ++A+
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 160/291 (54%), Gaps = 25/291 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     VG G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           VSL     S     E  L LV E++ + + +V+  +    Q      +K+Y YQ+ R +A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDS---QIKIYLYQLLRGVA 133
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           + H    + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+
Sbjct: 134 HCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD 189
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 296
           ++ G+ +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +  
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249
Query: 297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            P + +  F   +  PW  I       E +DL+S +L + PN R +A DA+
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAM 299

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 160/291 (54%), Gaps = 25/291 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     VG G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           VSL     S     E  L LV E++ + + +V+  +    Q      +K+Y YQ+ R +A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDS---QIKIYLYQLLRGVA 133
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           + H    + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+
Sbjct: 134 HCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD 189
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 296
           ++ G+ +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +  
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249
Query: 297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            P + +  F   +  PW  I       E +DL+S +L + PN R +A DA+
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAM 299

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 105/289 (36%), Positives = 156/289 (53%), Gaps = 31/289 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 123
           +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F   +      ++LV +++   +  +IK +   S  +   ++K Y     + L Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 240
               + HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CMNPN 298
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT E+    C  P+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 299 YTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           Y  FK FP I   P H IF      + +DL+  L  ++P  R TA  A+
Sbjct: 246 YVTFKSFPGI---PLHHIFSA-AGDDLLDLIQGLFLFNPCARITATQAL 290

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 98/294 (33%), Positives = 169/294 (57%), Gaps = 22/294 (7%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y   + +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H NV+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            ++    ++T +    + +V + +   +++++K     SQ++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLK-----SQQLSNDHICYFLYQILRGLKY 159
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPE 237
           IH+   V HRD+KP NLL+N  T  LK+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IHSA-NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 295
           ++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 296 --NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
               NY +   P      W K+F K    +A+DL+ R+L ++PN R T  +A+ 
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALA 329

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 108/309 (34%), Positives = 169/309 (54%), Gaps = 36/309 (11%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------REL 109
           G  G P+   ++     +G G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIY 167
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           +K Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 228 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + L
Sbjct: 168 THEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 285 GTPTREEIKCMN--PNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNL 338
           GTP       +   P+Y    FP+     W  + F K +PP   +   L+S++L Y PN 
Sbjct: 228 GTPDEVVWPGVTSMPDYKP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 281
Query: 339 RSTAFDAVG 347
           R +A  A+ 
Sbjct: 282 RISAKAALA 290

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 108/309 (34%), Positives = 169/309 (54%), Gaps = 36/309 (11%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------REL 109
           G  G P+   ++     +G G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIY 167
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           +K Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 228 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + L
Sbjct: 168 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 285 GTPTREEIKCMN--PNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNL 338
           GTP       +   P+Y    FP+     W  + F K +PP   +   L+S++L Y PN 
Sbjct: 228 GTPDEVVWPGVTSMPDYKP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 281
Query: 339 RSTAFDAVG 347
           R +A  A+ 
Sbjct: 282 RISAKAALA 290

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 97/327 (29%), Positives = 173/327 (52%), Gaps = 57/327 (17%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTM-RLLDHPN 119
           Y   + +G G++G+V+++    TGE VA+KK+        D +   RE+  +  L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V+L +   +  ++D   + LV +Y+   +H VI+     +  +  ++ +   YQ+ + +
Sbjct: 71  IVNLLNVLRADNDRD---VYLVFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIKVI 122
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------------------- 220
            Y+H+  G+ HRD+KP N+L+N   H +K+ DFG ++  V                    
Sbjct: 123 KYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 221 --GEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
              +P ++ Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG S ++QL
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
Query: 278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH-------------PWHKIFQKRMPP-- 322
             II V+  P+ E+++ +   + +     +K                W  +  K  P   
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 323 ---EAVDLVSRLLQYSPNLRSTAFDAV 346
              EA+DL+ +LLQ++PN R +A DA+
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDAL 327

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 106/292 (36%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E VH+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 99/290 (34%), Positives = 160/290 (55%), Gaps = 22/290 (7%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
            +G+G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 126 CFFSTTEKDEL-YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               T    E   + +VL+ +   +H++I      SQ + L +V+ + YQ+ R L Y+H+
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 239
              V HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 177 A-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +    
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 294
Query: 300 TEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                   P  +  PW  ++      +A+ L+ R+L++ P+ R +A  A+
Sbjct: 295 VRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAAL 343

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 104/290 (35%), Positives = 163/290 (56%), Gaps = 32/290 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E+V + + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEHVDQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 302 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 286

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 99/290 (34%), Positives = 160/290 (55%), Gaps = 22/290 (7%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
            +G+G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 126 CFFSTTEKDEL-YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               T    E   + +VL+ +   +H++I      SQ + L +V+ + YQ+ R L Y+H+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 239
              V HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 178 A-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +    
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 295
Query: 300 TEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                   P  +  PW  ++      +A+ L+ R+L++ P+ R +A  A+
Sbjct: 296 VRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAAL 344

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 284

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 284

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 240 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 285

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 241 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 286

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 240 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 285

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 126 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 181
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 242 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 241 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 286

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 284

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 126 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 181
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 242 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 287

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 241 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 286

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + L++ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 284

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/292 (35%), Positives = 163/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 240 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 285

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 97/301 (32%), Positives = 172/301 (57%), Gaps = 28/301 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRY----KNRELQTMRLLDHPNV 120
            +  + ++G G++GVV  A    TGE VAIKK+   DK        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------ISYIC 229
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +      EP       + ++ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 288
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 289 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA +A
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 346 V 346
           +
Sbjct: 304 L 304

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 97/301 (32%), Positives = 171/301 (56%), Gaps = 28/301 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRY----KNRELQTMRLLDHPNV 120
            +  + ++G G++GVV  A    TGE VAIKK+   DK        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----------YIC 229
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +   + S           Y+ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 288
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 289 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA +A
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 346 V 346
           +
Sbjct: 304 L 304

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 94/283 (33%), Positives = 161/283 (56%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + LV   +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 321

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 103/290 (35%), Positives = 161/290 (55%), Gaps = 32/290 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   +   +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 73  IHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 124
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 302 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 242 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 285

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 301

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/292 (35%), Positives = 162/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/292 (35%), Positives = 162/292 (55%), Gaps = 36/292 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 102/290 (35%), Positives = 162/290 (55%), Gaps = 32/290 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 72  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 123
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 302 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 241 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 284

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 102/290 (35%), Positives = 162/290 (55%), Gaps = 32/290 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 302 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 286

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 103/290 (35%), Positives = 161/290 (55%), Gaps = 32/290 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   +   +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 302 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTAFDAVG 347
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A+ 
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 286

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 160/282 (56%), Gaps = 26/282 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC---MNP 297
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C   +  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                  P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 303

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 263 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKR 303

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 263 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKR 303

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 321

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 152
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 269 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 309

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 301

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 301

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 299

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 266 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 306

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 150
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 267 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 307

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 141
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 258 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 298

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/278 (34%), Positives = 153/278 (55%), Gaps = 21/278 (7%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 125
           +VG GS+G+V + +  +TG  VAIKK L+       K+   RE++ ++ L H N+V+L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
                 +K   YL  V E+V    H ++         +    V+ Y +QI   + + H+ 
Sbjct: 92  V---CKKKKRWYL--VFEFVD---HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATE 244
             + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +
Sbjct: 144 -NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEF 302
           Y  A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG   P  +E+   NP +   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 303 KFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           + P+IK   P  + + K +    +DL  + L   P+ R
Sbjct: 262 RLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKR 298

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAI+K+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 161/283 (56%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P +E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 299

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 161/283 (56%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----CQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 96/301 (31%), Positives = 170/301 (56%), Gaps = 28/301 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRY----KNRELQTMRLLDHPNV 120
            +  + ++G G++GVV  A    TGE VAIKK+   DK        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----------YIC 229
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +   + S            + 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 288
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 289 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA +A
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 346 V 346
           +
Sbjct: 304 L 304

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 97/289 (33%), Positives = 157/289 (54%), Gaps = 34/289 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNP 297
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA  A+
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 160/280 (57%), Gaps = 22/280 (7%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGAT 243
           V HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 299
            YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 268 L-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 160/280 (57%), Gaps = 22/280 (7%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGAT 243
           V HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 299
            YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 269 L-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 306

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 160/283 (56%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 301

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 157/289 (54%), Gaps = 34/289 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNP 297
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA  A+
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 157/289 (54%), Gaps = 34/289 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNP 297
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA  A+
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 95/245 (38%), Positives = 142/245 (57%), Gaps = 25/245 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 126
           +G GS+GVVF+ +  +TG+ VAIKK L+       K+   RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNT 185
           F     + +  L+LV EY   TV     H     QR +P   VK   +Q  +A+ + H  
Sbjct: 71  F-----RRKRRLHLVFEYCDHTV----LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
               HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G 
Sbjct: 122 -NCIHRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGD 177
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYT 300
           T+Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K LG   P  +++   N  ++
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 301 EFKFP 305
             K P
Sbjct: 238 GVKIP 242

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 96/287 (33%), Positives = 154/287 (53%), Gaps = 20/287 (6%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 125 HCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F  +T+ +D   + LV   +   ++ ++K     SQ +   +V+   YQ+ R L YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----SQALSDEHVQFLVYQLLRGLKYIH 148
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +  G+ HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 149 SA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 302
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 303 --KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
               P +       IF +   P A+DL+ R+L    + R +A +A+ 
Sbjct: 265 IQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALA 310

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 159/283 (56%), Gaps = 28/283 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+ DFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            NY     P     PW+++F      +A+DL+ ++L ++P+ R
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 301

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/292 (32%), Positives = 156/292 (53%), Gaps = 23/292 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 119
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 120 VVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+ L   F   +     Y   LV+ ++   + +++   +   +      ++   YQ+ + 
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEK------IQYLVYQMLKG 156
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 237
           L YIH+  GV HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 157 LKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 211
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +N 
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271
Query: 298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
              +      PQ     + ++F  R  P+A DL+ ++L+   + R TA  A+
Sbjct: 272 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQAL 322

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 156/291 (53%), Gaps = 23/291 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  V++ K   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L       TEK    L LV EY+ + + + +         + +  VKL+ +Q+ R LA
Sbjct: 63  VTLHDIIH--TEKS---LTLVFEYLDKDLKQYLD---DCGNIINMHNVKLFLFQLLRGLA 114
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 295
           ++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           N  +  + +P+ +A         R+  +  DL+++LLQ+    R +A DA+
Sbjct: 231 NEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  147 bits (372), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 153/287 (53%), Gaps = 20/287 (6%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 125 HCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F  +T+ +D   + LV   +   ++ ++K      Q +   +V+   YQ+ R L YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKYIH 148
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +  G+ HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 149 SA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 302
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 303 --KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
               P +       IF +   P A+DL+ R+L    + R +A +A+ 
Sbjct: 265 IQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALA 310

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 94/292 (32%), Positives = 156/292 (53%), Gaps = 23/292 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 119
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 120 VVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+ L   F   +     Y   LV+ ++   + +++   +   +      ++   YQ+ + 
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK------IQYLVYQMLKG 138
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 237
           L YIH+  GV HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 139 LKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 193
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +N 
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
              +      PQ     + ++F  R  P+A DL+ ++L+   + R TA  A+
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQAL 304

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 100/289 (34%), Positives = 156/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++  A
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNA 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 152/287 (52%), Gaps = 20/287 (6%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 125 HCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F  +T+ +D   + LV   +   ++ ++K      Q +   +V+   YQ+ R L YIH
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKYIH 140
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +  G+ HRD+KP N+ VN    +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 141 SA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 196
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 302
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 303 --KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
               P +       IF +   P A+DL+ R+L    + R +A +A+ 
Sbjct: 257 IQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALA 302

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 156/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K     SQ++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----SQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN  + +LK+ DFG  +     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 156/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 264 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 310

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 156/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 306

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 217
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 278 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 324

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 99/290 (34%), Positives = 152/290 (52%), Gaps = 34/290 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +     L LV E+  + +    K+    +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 303 KFPQIKAHPWHKIFQK------RMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           K P  K +P +           ++     DL+  LL+ +P  R +A +A+
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 108 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 160
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 161 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 216
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 276
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 277 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 323

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 99/290 (34%), Positives = 151/290 (52%), Gaps = 34/290 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +     L LV E+  + +    K+    +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
            Y+ +ID+WSAGC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 303 KFPQIKAHPWHKIFQK------RMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           K P  K +P +           ++     DL+  LL+ +P  R +A +A+
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 264 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 310

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 99  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 151
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 152 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 267
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 268 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 314

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 254 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 300

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 100 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 152
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 153 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 208
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 268
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 269 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 315

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 309

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 311

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 311

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 311

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 306

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 217
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 278 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 324

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 270 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 316

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 270 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 316

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 270 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 316

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 309

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 108 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 160
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 161 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 216
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 276
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 277 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 323

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 306

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 309

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 264 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 310

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 100 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 152
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 153 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 208
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 268
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 269 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 315

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 112 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 164
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 165 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 220
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 280
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 281 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 327

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 112 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 164
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 165 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNW 220
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 280
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 281 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 327

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 311

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 309

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 88  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 140
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 141 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 196
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 256
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 257 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 303

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 86  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 138
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 139 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 194
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 254
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 255 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 301

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 96/286 (33%), Positives = 147/286 (51%), Gaps = 22/286 (7%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 126
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 127 FFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F      D+     LV+ ++   + +++KH      R     ++   YQ+ + L YIH  
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR-----IQFLVYQMLKGLRYIH-A 146
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            G+ HRD+KP NL VN    +LK+ DFG A+           + +R+YRAPE+I     Y
Sbjct: 147 AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--ADSEMXGXVVTRWYRAPEVILNWMRY 203
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 301
           T  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ +      NY +
Sbjct: 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263
Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
              P+++   +  I      P AV+L+ ++L      R TA +A+ 
Sbjct: 264 -GLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALA 307

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 306

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 87  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 139
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 140 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 195
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 255
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 256 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 302

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 254 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 300

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 86  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 138
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 139 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 194
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 254
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 255 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 301

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 264 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 310

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 152/287 (52%), Gaps = 24/287 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  +  +++G  +A+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 126 CFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F   T  +E   + LV   +   ++ ++K      Q++   +V+   YQI R L YIH+
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 172
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 173 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 300
           Y   +DIWS GC++AELL G+ LFPG   ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
               PQ+    +  +F     P AVDL+ ++L    + R TA +A+ 
Sbjct: 289 N-SLPQMPKRNFADVFIG-ANPLAVDLLEKMLVLDTDKRITASEALA 333

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 254 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 300

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 155/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D+G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 154/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K       ++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CAKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 254 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 300

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 100/311 (32%), Positives = 164/311 (52%), Gaps = 48/311 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVV- 121
           YM  + +G G  G+VF A   +  + VAIKK++    Q  ++  RE++ +R LDH N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 122 ----------SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 169
                      L     S TE + +Y+  V EY+   +  V+       ++ PL+  + +
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVL-------EQGPLLEEHAR 123
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 227
           L+ YQ+ R L YIH+   V HRD+KP NL +N     LK+ DFG A+++   +P+ S+  
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKG 179
Query: 228 -----ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL---VE 279
                + +++YR+P L+     YT AID+W+AGC+ AE+L G+ LF G   ++Q+   +E
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP---EAVDLVSRLLQYSP 336
            I V+    R+E+  + P Y      +      HK   + +P    EAVD + ++L +SP
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEP-----HKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 337 NLRSTAFDAVG 347
             R TA +A+ 
Sbjct: 295 MDRLTAEEALS 305

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 154/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNW 217
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 278 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 324

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 154/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DF  A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 154/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+  FG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 154/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 154/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 154/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 154/289 (53%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA  A+ 
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALA 304

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 155/293 (52%), Gaps = 32/293 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G+G++  V++     TG  VA+K+V  D          RE+  M+ L H N+V L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +  +     L LV E++   + + +         + + L  VK + +Q+ + LA+ H  
Sbjct: 73  HTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
             + HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP+++ G+
Sbjct: 128 -KILHRDLKPQNLLINKRG-QLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y+ +IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++GTP     + + P+ T+ 
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN----ESLWPSVTKL 239
Query: 303 -KF-PQIKAHPWHKIFQKRMP-------PEAVDLVSRLLQYSPNLRSTAFDAV 346
            K+ P I+  P   + Q   P          +D +  LLQ +P++R +A  A+
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 96/302 (31%), Positives = 154/302 (50%), Gaps = 19/302 (6%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 113
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 114 -------LLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    +    +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
             +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            P  E+    +       F    A P  K F   +     DL+ + L ++P  R +A+ A
Sbjct: 237 LPGEEDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 346 VG 347
           + 
Sbjct: 295 LS 296

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 30/294 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------------LQDKRYKNRELQTMRL 114
           Y  +R +  GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 115 LDH---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 169
           L+H   PN++ L+  F    E     L LV E +   + +VI       QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 290 EEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           E++   +     +Y       + A  W  +      P A+DL++++L+++P  R
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRR 308

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 30/294 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------------LQDKRYKNRELQTMRL 114
           Y  +R +  GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 115 LDH---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 169
           L+H   PN++ L+  F    E     L LV E +   + +VI       QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 290 EEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           E++   +     +Y       + A  W  +      P A+DL++++L+++P  R
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRR 308

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 96/302 (31%), Positives = 154/302 (50%), Gaps = 19/302 (6%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 113
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 114 -------LLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    +    +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
             +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            P  E+    +       F    A P  K F   +     DL+ + L ++P  R +A+ A
Sbjct: 237 LPGEEDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 346 VG 347
           + 
Sbjct: 295 LS 296

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 96/301 (31%), Positives = 154/301 (51%), Gaps = 19/301 (6%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 113
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 114 -------LLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    +    +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
             +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            P  E+    +       F    A P  K F   +     DL+ + L ++P  R +A+ A
Sbjct: 237 LPGEEDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 346 V 346
           +
Sbjct: 295 L 295

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 XGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 254 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 343 FDAV 346
            DA+
Sbjct: 313 DDAL 316

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 XGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 254 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 343 FDAV 346
            DA+
Sbjct: 313 DDAL 316

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 129
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 XGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 247 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 343 FDAV 346
            DA+
Sbjct: 306 DDAL 309

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/301 (31%), Positives = 154/301 (51%), Gaps = 31/301 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTAFDA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  DA
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 346 V 346
           +
Sbjct: 316 L 316

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 152/289 (52%), Gaps = 28/289 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G V++A    T E VAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                      L+L+ EY    + + +  +  +S R+    +K + YQ+   + + H+  
Sbjct: 102 IHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRV----IKSFLYQLINGVNFCHSR- 151
Query: 187 GVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
              HRD+KPQNLL++      T  LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 297
            G+  Y+ ++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +   P
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A +A+
Sbjct: 270 DWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 94/301 (31%), Positives = 154/301 (51%), Gaps = 31/301 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTAFDA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  DA
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 346 V 346
           +
Sbjct: 316 L 316

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 174
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 175 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 233 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 292 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 343 FDAV 346
            DA+
Sbjct: 351 DDAL 354

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 95/303 (31%), Positives = 158/303 (52%), Gaps = 35/303 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y A +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 198 LGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 298 -NYTEF--KFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTAF 343
            NY E   K+P IK   + ++F   + P           +A DL+S++L   P+ R +  
Sbjct: 257 RNYVENRPKYPGIK---FEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVD 313
Query: 344 DAV 346
           +A+
Sbjct: 314 EAL 316

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 174
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 175 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 233 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 292 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 343 FDAV 346
            DA+
Sbjct: 351 DDAL 354

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 137
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 138 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 255 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 313
Query: 343 FDAV 346
            DA+
Sbjct: 314 DDAL 317

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 137
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 138 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 255 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 313
Query: 343 FDAV 346
            DA+
Sbjct: 314 DDAL 317

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 254 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 343 FDAV 346
            DA+
Sbjct: 313 DDAL 316

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 254 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 343 FDAV 346
            DA+
Sbjct: 313 DDAL 316

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 135
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 136 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 193
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 194 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 252
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 253 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 311
Query: 343 FDAV 346
            DA+
Sbjct: 312 DDAL 315

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 155/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 130
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 131 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 189 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 248 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 306
Query: 343 FDAV 346
            DA+
Sbjct: 307 DDAL 310

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 129
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 247 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 343 FDAV 346
            DA+
Sbjct: 306 DDAL 309

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 130
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 131 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 189 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 248 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 306
Query: 343 FDAV 346
            DA+
Sbjct: 307 DDAL 310

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 148/294 (50%), Gaps = 25/294 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTMR-LLDHPNVVSL 123
            Y   R +G G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 244 EYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMN 296
            Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ ++
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LD 266
Query: 297 PNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 267 PRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 155/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 154/301 (51%), Gaps = 31/301 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 137
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 138 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 196 LGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTAFDA 345
            NY E + P      + ++F   + P           +A DL+S++L   P+ R +  +A
Sbjct: 255 RNYVENR-PAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 346 V 346
           +
Sbjct: 314 L 314

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 138
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+        + ++ +RYYRAP
Sbjct: 139 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAP 196
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 197 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 255
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 256 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 314
Query: 343 FDAV 346
            +A+
Sbjct: 315 DEAL 318

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 153/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 137
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 138 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 255 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313
Query: 343 FDAV 346
            +A+
Sbjct: 314 DEAL 317

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 153/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 142/260 (54%), Gaps = 20/260 (7%)
Query: 61  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 117
           P   ++Y  E  +V+G GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 118 -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 231
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 292 IKCMNPNYTEFKFPQIKAHP 311
            K ++ +     F   K +P
Sbjct: 321 -KLLDASKRAKNFVSXKGYP 339

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 142/260 (54%), Gaps = 20/260 (7%)
Query: 61  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 117
           P   ++Y  E  +V+G GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 118 -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 231
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 292 IKCMNPNYTEFKFPQIKAHP 311
            K ++ +     F   K +P
Sbjct: 321 -KLLDASKRAKNFVSXKGYP 339

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 148/296 (50%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E VA+K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N+L++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 146/304 (48%), Gaps = 33/304 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L+  
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 FDAV 346
            +A+
Sbjct: 310 LEAM 313

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 153/301 (50%), Gaps = 31/301 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 133
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTAFDA 345
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  +A
Sbjct: 251 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 346 V 346
           +
Sbjct: 310 L 310

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 153/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 141
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 142 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 199
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 200 EVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 258
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 259 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 317
Query: 343 FDAV 346
            +A+
Sbjct: 318 DEAL 321

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 33/304 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 47  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 106
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 107 PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 157
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 158 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 216
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 217 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 270
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 271 AYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 330
Query: 343 FDAV 346
            +A+
Sbjct: 331 LEAM 334

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 152/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 103/347 (29%), Positives = 164/347 (47%), Gaps = 77/347 (22%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 119
           +Y+ + ++G GS+G V+ A    T + VAIKKV      L D +   RE+  +  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 120 VVSLKHCFF--STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L          + DELY+  VLE     + ++ K    +++     ++K   Y +  
Sbjct: 87  IIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLL 140
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNI----------- 225
              +IH + G+ HRD+KP N L+N     +K+CDFG A+ +  + + NI           
Sbjct: 141 GENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 226 -----------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQ-------- 265
                      S++ +R+YRAPELI     YT +IDIWS GC+ AELL + Q        
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 266 --PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMN-PNYTEFKFP 305
             PLFPG                 +S  DQL  I  ++GTPT +++K +N P   ++   
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY--- 315
Query: 306 QIKAHPWHK-IFQKRMPP----EAVDLVSRLLQYSPNLRSTAFDAVG 347
            IK  P  K I  K+  P    + ++L+  +L+++PN R T   A+ 
Sbjct: 316 -IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 140/287 (48%), Gaps = 24/287 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 119
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           VV L     ++    E+ + LV E+V + +   +         +P   +K    Q  R L
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRGL 125
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H    + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE++
Sbjct: 126 DFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL 183
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
             +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    + + 
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSL 241
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
               FP     P   +  + M      L+  +L ++P+ R +AF A+
Sbjct: 242 PRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRAL 287

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 140/287 (48%), Gaps = 24/287 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 119
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           VV L     ++    E+ + LV E+V + +   +         +P   +K    Q  R L
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRGL 125
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H    + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE++
Sbjct: 126 DFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL 183
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
             +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    + + 
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSL 241
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
               FP     P   +  + M      L+  +L ++P+ R +AF A+
Sbjct: 242 PRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRAL 287

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 33/304 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 86
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 250
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 343 FDAV 346
            +A+
Sbjct: 311 LEAM 314

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 33/304 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 FDAV 346
            +A+
Sbjct: 310 LEAM 313

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 33/304 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 FDAV 346
            +A+
Sbjct: 310 LEAM 313

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 33/304 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 FDAV 346
            +A+
Sbjct: 310 LEAM 313

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 33/304 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 28  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 87
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 88  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 138
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 139 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 197
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 251
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 252 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 311
Query: 343 FDAV 346
            +A+
Sbjct: 312 LEAM 315

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 139/260 (53%), Gaps = 20/260 (7%)
Query: 61  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 117
           P   ++Y  E  +V+G G FG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 118 -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 231
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +     I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSR 263
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P +  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ-- 320
Query: 292 IKCMNPNYTEFKFPQIKAHP 311
            K ++ +     F   K +P
Sbjct: 321 -KLLDASKRAKNFVSXKGYP 339

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 140/287 (48%), Gaps = 24/287 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 119
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           VV L     ++    E+ + LV E+V + +   +         +P   +K    Q  R L
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRGL 125
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H    + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE++
Sbjct: 126 DFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVL 183
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
             +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    + + 
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSL 241
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
               FP     P   +  + M      L+  +L ++P+ R +AF A+
Sbjct: 242 PRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRAL 287

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 33/304 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 86
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 250
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 343 FDAV 346
            +A+
Sbjct: 311 LEAM 314

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 33/304 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 FDAV 346
            +A+
Sbjct: 310 LEAM 313

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 33/304 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 FDAV 346
            +A+
Sbjct: 310 LEAM 313

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 130/242 (53%), Gaps = 22/242 (9%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 117 HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 158
Query: 168 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 286 TP 287
            P
Sbjct: 276 IP 277

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 140/290 (48%), Gaps = 27/290 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------RELQTMRLLD--- 116
           +G G++G V++A+   +G  VA+K V    R  N             RE+  +R L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           HPNVV L     ++    E+ + LV E+V + +   +         +P   +K    Q  
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFL 130
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           R L ++H    + HRD+KP+N+LV      +KL DFG A++          + + +YRAP
Sbjct: 131 RGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    +
Sbjct: 189 EVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RD 246
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            +     FP     P   +  + M      L+  +L ++P+ R +AF A+
Sbjct: 247 VSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRAL 295

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 130/242 (53%), Gaps = 22/242 (9%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 117 HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 158
Query: 168 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY 216
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 286 TP 287
            P
Sbjct: 276 IP 277

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 130/242 (53%), Gaps = 22/242 (9%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 28  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 117 HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 139
Query: 168 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 197
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 198 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 286 TP 287
            P
Sbjct: 257 IP 258

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 152/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP    +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRNYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLRQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 43  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 100
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 101 TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 151
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 152 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 210
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 211 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 269
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 270 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 94
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 95  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 145
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 146 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 263
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 264 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 93
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 94  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 144
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 145 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 262
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 263 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 94
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 95  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 145
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 146 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 263
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 264 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 88/304 (28%), Positives = 152/304 (50%), Gaps = 37/304 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 FDAV 346
            +A+
Sbjct: 313 DEAL 316

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 147/296 (49%), Gaps = 29/296 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA +A+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 24/220 (10%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV EY+  T  +      ++ Q +    ++ Y Y++ +AL Y H+  G+ HRD+KP N++
Sbjct: 112 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 164
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 165 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 310
            ++   +P F G+   DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 225 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 280
Query: 311 PWHKIFQKR----MPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            W           + PEA+DL+ +LL+Y    R TA +A+
Sbjct: 281 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAM 320

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 24/220 (10%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV EY+  T  +      ++ Q +    ++ Y Y++ +AL Y H+  G+ HRD+KP N++
Sbjct: 117 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 169
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 170 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 310
            ++   +P F G+   DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 230 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 285
Query: 311 PWHKIFQKR----MPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            W           + PEA+DL+ +LL+Y    R TA +A+
Sbjct: 286 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAM 325

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 98/349 (28%), Positives = 153/349 (43%), Gaps = 78/349 (22%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 119
           +Y  + ++G GS+G V+ A      + VAIKKV      L D +   RE+  +  L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 120 VVSLKHCFF--STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L          + DELY+  VLE     + ++ K    ++++    +VK   Y +  
Sbjct: 89  IIRLHDLIIPEDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLLL 142
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI------------ 225
              +IH + G+ HRD+KP N L+N     +K+CDFG A+  +  + +I            
Sbjct: 143 GEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKDIHIVNDLEEKEEN 199
Query: 226 ---------------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ----- 265
                          S++ +R+YRAPELI     YT +IDIWS GC+ AELL        
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 266 ------PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMNPN---- 298
                 PLFPG                 +S  DQL  I  V+GTP  E++KC+       
Sbjct: 260 NPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIK 319
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
           Y +  FP        K +   +  E +DL+  +L+++   R T   A+ 
Sbjct: 320 YIKL-FPTRDGIDLSKKYSS-ISKEGIDLLESMLRFNAQKRITIDKALS 366

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 113/221 (51%), Gaps = 28/221 (12%)
Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQ 161
           RE+  +R L HPNV+SL+  F S  ++    + L+ +Y    +  +IK H      K   
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 162 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL 218
           ++P   VK   YQI   + Y+H    V HRD+KP N+LV    P   ++K+ D G A++ 
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 219 ---VKGEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF------ 268
              +K   ++   + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F      
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 269 ---PGESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFK 303
                    DQL  I  V+G P     E+IK M  + T  K
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMK 283

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 153/345 (44%), Gaps = 79/345 (22%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNV 120
           Y    ++G GS+G V +A        VAIKK+L+      D +   RE+  +  L+H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 121 VS-LKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  L        EK DELY+  VLE       ++ +    +++    +++K   Y +   
Sbjct: 115 VKVLDIVIPKDVEKFDELYV--VLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVG 168
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS------------ 226
           + Y+H+  G+ HRD+KP N LVN     +K+CDFG A+ +   E   S            
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 227 ----------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL------- 263
                           ++ +R+YRAPELI     YT AID+WS GC+ AELL        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 264 ----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNY 299
                 PLFPG S                      DQL  I  +LGTP+ E+I+ +    
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 300 TEFKFPQIKAHPWHKIFQKRMP---PEAVDLVSRLLQYSPNLRST 341
            + ++ +I          +R P    +A+ L+ R+L ++PN R T
Sbjct: 347 AK-RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 146/297 (49%), Gaps = 32/297 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 127 FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 297 PNYTEF-KFPQIKAHPWHKIFQKRMP-----PEAVDLVSRLLQYSPNLRSTAFDAVG 347
            NY  + K   +K     +  + R+      P A+DL+ +LL   P  R  + DA+ 
Sbjct: 259 -NYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 145/299 (48%), Gaps = 38/299 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 127 FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    + 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE----VW 254
Query: 297 PNYTEF----KFPQIKAHPWHKIFQKRMP-----PEAVDLVSRLLQYSPNLRSTAFDAV 346
           PN   +    K   +K     +  + R+      P A+DL+ +LL   P  R  + DA+
Sbjct: 255 PNVDNYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 145/300 (48%), Gaps = 38/300 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 127 FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKASIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    + 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE----VW 254
Query: 297 PNYTEF----KFPQIKAHPWHKIFQKRMP-----PEAVDLVSRLLQYSPNLRSTAFDAVG 347
           PN   +    K   +K     +  + R+      P A+DL+ +LL   P  R  + DA+ 
Sbjct: 255 PNVDNYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 146/297 (49%), Gaps = 32/297 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 127 FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 85  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 139
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 140 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    ++
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 297 PNYTEF-KFPQIKAHPWHKIFQKRMP-----PEAVDLVSRLLQYSPNLRSTAFDAVG 347
            NY  + K   +K     +  + R+      P A+DL+ +LL   P  R  + DA+ 
Sbjct: 258 -NYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 133/291 (45%), Gaps = 49/291 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 111 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 160
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 161 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 219
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 220 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 264
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A DA+
Sbjct: 265 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDAL 303

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 133/291 (45%), Gaps = 49/291 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 112 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 161
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 162 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 220
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 221 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 265
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A DA+
Sbjct: 266 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDAL 304

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 133/291 (45%), Gaps = 49/291 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A DA+
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDAL 280

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 133/291 (45%), Gaps = 49/291 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 94  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 143
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 144 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 203 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 247
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A DA+
Sbjct: 248 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDAL 286

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 129/291 (44%), Gaps = 49/291 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +  L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 88  IXKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIA 196
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
              YT F+ PQ     W     K++   A DL+ + L Y P+ R +A DA+
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKXLTYVPSXRISARDAL 280

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 118
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+     F    E     LN+VLE      + R+IKH  K  + +P   V  YF Q+C 
Sbjct: 93  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 236
           AL ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 148 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 237 ELIFGATEYTAAIDIWSAGCVLAEL-LLGQPLFPGESGVDQLVEIIKVLGTPT------R 289
           E I     Y    DIWS GC+L E+  L  P +  +  +  L + I+    P        
Sbjct: 206 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264
Query: 290 EEIK-----CMNPN 298
           EE++     C+NP+
Sbjct: 265 EELRQLVNMCINPD 278

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 93/322 (28%), Positives = 146/322 (45%), Gaps = 44/322 (13%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 119 N--------VVSLKHCF-----FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MP 164
           N         +   H       F+    + +++ +V E + E +  +IK   K   R +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIP 129
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 219
           LIYVK    Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------ 273
             E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 274 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FQKRM 320
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 321 PPEAVDLVSRLLQYSPNLRSTA 342
             E  D +S +LQ  P  R+ A
Sbjct: 307 AKEISDFLSPMLQLDPRKRADA 328

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 93/322 (28%), Positives = 146/322 (45%), Gaps = 44/322 (13%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 119 N--------VVSLKHCF-----FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MP 164
           N         +   H       F+    + +++ +V E + E +  +IK   K   R +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIP 129
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 219
           LIYVK    Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------ 273
             E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 274 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FQKRM 320
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 321 PPEAVDLVSRLLQYSPNLRSTA 342
             E  D +S +LQ  P  R+ A
Sbjct: 307 AKEISDFLSPMLQLDPRKRADA 328

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 75  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 125
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 126 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 74  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 124
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 125 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 65  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 115
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 116 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 173
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 69  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 119
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 120 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 137/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 150
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 151 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 207
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 250
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 251 ----EYDFPE-------KFF-----PKARDLVEKLL 270

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 137/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 146
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 147 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 203
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 204 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 246
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 247 ----EYDFPE-------KFF-----PKARDLVEKLL 266

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 135/276 (48%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             CF    + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 103 YFCF---QDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 154
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 155 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 211
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 212 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 254
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 255 ----EYDFPE-------KFF-----PKARDLVEKLL 274

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 115/228 (50%), Gaps = 17/228 (7%)
Query: 55  GGKN-GQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---- 107
           GG++   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 2   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60
Query: 108 -ELQTMRLLDHPNVVSLKHC--FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP 164
            E+Q M+ L+HPNVVS +           ++L L L +EY      R   + ++    + 
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGE 222
              ++     I  AL Y+H    + HRD+KP+N+++ P   +L  K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFP 269
               ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 179 LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 115/228 (50%), Gaps = 17/228 (7%)
Query: 55  GGKN-GQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---- 107
           GG++   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 3   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 61
Query: 108 -ELQTMRLLDHPNVVSLKHC--FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP 164
            E+Q M+ L+HPNVVS +           ++L L L +EY      R   + ++    + 
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLK 120
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGE 222
              ++     I  AL Y+H    + HRD+KP+N+++ P   +L  K+ D G AK L +GE
Sbjct: 121 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 179
Query: 223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFP 269
               ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 180 LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 137/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL- 204
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLL 267

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 138/283 (48%), Gaps = 72/283 (25%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNL-------VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
              +F+  + ++LY  L       +L+Y+     R I    +   R        Y  +I 
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGCLLKYI-----RKIGSFDETCTR-------FYTAEIV 142
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYY 233
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y
Sbjct: 143 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 234 RAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTR 289
            +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+      
Sbjct: 201 VSPELL---TEKSASKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------ 249
Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                      E+ FP+       K F     P+A DLV +LL
Sbjct: 250 -----------EYDFPE-------KFF-----PKARDLVEKLL 269

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSAXKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLL 269

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLL 269

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLL 267

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLL 269

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLL 267

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 150
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 151 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 207
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 250
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 251 ----EYDFPE-------KFF-----PKARDLVEKLL 270

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLL 269

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 58/276 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
               E+ FP+       K F     P+A DLV +LL
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLL 269

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 60/277 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 71
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 72  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 123
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 124 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 181
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCM 295
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+            
Sbjct: 182 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------ 224
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                E+ FP+       K F     P+A DLV +LL
Sbjct: 225 -----EYDFPE-------KFF-----PKARDLVEKLL 244

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 60/277 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 94  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 145
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 146 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 203
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCM 295
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+            
Sbjct: 204 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------ 246
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                E+ FP+       K F     P+A DLV +LL
Sbjct: 247 -----EYDFPE-------KFF-----PKARDLVEKLL 266

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 60/277 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 73  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 125 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 182
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCM 295
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+            
Sbjct: 183 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------ 225
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                E+ FP+       K F     P+A DLV +LL
Sbjct: 226 -----EYDFPE-------KFF-----PKARDLVEKLL 245

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 60/277 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 78
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 79  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 130
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 131 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCM 295
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+            
Sbjct: 189 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------ 231
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                E+ FP+       K F     P+A DLV +LL
Sbjct: 232 -----EYDFPE-------KFF-----PKARDLVEKLL 251

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 60/277 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 74
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 75  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 127 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 184
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCM 295
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+            
Sbjct: 185 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------ 227
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                E+ FP+       K F     P+A DLV +LL
Sbjct: 228 -----EYDFPE-------KFF-----PKARDLVEKLL 247

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 60/277 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 73
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 74  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 126 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 183
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCM 295
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+            
Sbjct: 184 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------ 226
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                E+ FP+       K F     P+A DLV +LL
Sbjct: 227 -----EYDFPE-------KFF-----PKARDLVEKLL 246

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 120 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 171
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 244 E--YTAAIDIWSAGCVLAELLLGQP 266
           E  Y   +D+WS G    EL   +P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 38/279 (13%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 127
           V+G G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
                 +  ++ + +E VP      +        +     +  Y  QI   L Y+H+   
Sbjct: 89  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 142
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELI-FGATEY 245
           + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
             A DIWS GC + E+  G+P F                        +   P    FK  
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVG 239
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
             K HP      + M  EA   + +  +  P+ R+ A D
Sbjct: 240 MFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACAND 275

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 93/298 (31%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 58  NGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTMR 113
           +G  +  +S  +  E  +G G+  +V++ K   T +  A+K  K   DK+    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLY 171
            L HPN++ LK  F + TE     ++LVLE V   E   R+++  Y  S+R     VK  
Sbjct: 104 RLSHPNIIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEKGY-YSERDAADAVK-- 155
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQ-LKLCDFGSAKVLVKGEPNISYIC 229
             QI  A+AY+H   G+ HRD+KP+NLL   P     LK+ DFG +K+ V+ +  +  +C
Sbjct: 156 --QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC 211
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
            +  Y APE++ G   Y   +D+WS G +   LL G   F  E G DQ +          
Sbjct: 212 GTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------F 260
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           R  + C      E+ F      PW       +   A DLV +L+   P  R T F A+
Sbjct: 261 RRILNC------EYYF----ISPWW----DEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 134/277 (48%), Gaps = 60/277 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF     A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCM 295
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+            
Sbjct: 205 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------ 247
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                E+ FP+       K F     P+A DLV +LL
Sbjct: 248 -----EYDFPE-------KFF-----PKARDLVEKLL 267

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 124/280 (44%), Gaps = 46/280 (16%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 124
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y    D+WSAG +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
             PQ     W  I       +A DL+ ++L + P+LR TA
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITA 271

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 38/279 (13%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 127
           V+G G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
                 +  ++ + +E VP      +        +     +  Y  QI   L Y+H+   
Sbjct: 75  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 128
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELI-FGATEY 245
           + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
             A DIWS GC + E+  G+P F                        +   P    FK  
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVG 225
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
             K HP      + M  EA   + +  +  P+ R+ A D
Sbjct: 226 MFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACAND 261

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 132
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187
Query: 244 E--YTAAIDIWSAGCVLAELLLGQP 266
           E  Y   +D+WS G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 120/227 (52%), Gaps = 29/227 (12%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 101 ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 152
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 153 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 209
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 210 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 252

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 131/287 (45%), Gaps = 44/287 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   F   T   ++YL + L    E   RV+ K  ++ S    ++        +  A+AY
Sbjct: 71  LYETFEDNT---DIYLVMELCTGGELFERVVHKRVFRESDAARIM------KDVLSAVAY 121
Query: 182 IHNTIGVCHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            H  + V HRD+KP+N   L +     LKL DFG A     G+   + + + YY +P+++
Sbjct: 122 CHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G   Y    D WSAG ++  LL G P F   +  + +++I +  GT             
Sbjct: 181 EGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT------------- 223
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
             F FP+     W  +      P+A  L+ RLL  SP  R T+  A+
Sbjct: 224 --FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 131/287 (45%), Gaps = 44/287 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   F   T   ++YL + L    E   RV+ K  ++ S    ++        +  A+AY
Sbjct: 88  LYETFEDNT---DIYLVMELCTGGELFERVVHKRVFRESDAARIM------KDVLSAVAY 138
Query: 182 IHNTIGVCHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            H  + V HRD+KP+N   L +     LKL DFG A     G+   + + + YY +P+++
Sbjct: 139 CHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G   Y    D WSAG ++  LL G P F   +  + +++I +  GT             
Sbjct: 198 EGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT------------- 240
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
             F FP+     W  +      P+A  L+ RLL  SP  R T+  A+
Sbjct: 241 --FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 277

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 124/280 (44%), Gaps = 46/280 (16%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 124
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y    D+WSAG +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
             PQ     W  I       +A DL+ ++L + P+LR TA
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITA 271

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 124/280 (44%), Gaps = 46/280 (16%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 124
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y    D+WSAG +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
             PQ     W  I       +A DL+ ++L + P+LR TA
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITA 271

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y  ++ +G G+F  V  A+ + TG  VA+K +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E  E  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 74  PNIVKL----FEVIET-EKTLYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 123
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 124 VSAVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAA 181
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 139/313 (44%), Gaps = 44/313 (14%)
Query: 48  HIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKR 103
           H IVT    K G      +     ++G G FG V + +   TG  +A K +    ++DK 
Sbjct: 75  HRIVT---AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 104 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQ 161
               E+  M  LDH N++ L   F S  +     + LV+EYV   E   R+I   Y +++
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKND-----IVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 162 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVK 220
              ++++K    QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+    
Sbjct: 187 LDTILFMK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
            E       +  + APE++      +   D+WS G +   LL G   F G++  + L  I
Sbjct: 242 REKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300
Query: 281 IKVLGTPTREEIKCMNPNYTEF--------KFPQIKA-----HPW---HKIF-------Q 317
           +        EE + ++    EF        K  +I A     HPW   HK+        +
Sbjct: 301 LACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360
Query: 318 KRMPPEAVDLVSR 330
           K    +A D V++
Sbjct: 361 KNRGSDAQDFVTK 373

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 144/299 (48%), Gaps = 56/299 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           +  Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  +A+
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEAL 273

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 144/299 (48%), Gaps = 56/299 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           +  Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  +A+
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEAL 273

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 144/299 (48%), Gaps = 56/299 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           +  Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  +A+
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEAL 273

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 144/299 (48%), Gaps = 56/299 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 120
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 177
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           +  Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 227
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  +A+
Sbjct: 228 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEAL 272

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+   +   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F  +T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-KVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  D    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 140/297 (47%), Gaps = 52/297 (17%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 127
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSR 231
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 232 YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
            Y APE++   G   Y  A+D WS G +L   L G P F        L           +
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 235
Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  +A+
Sbjct: 236 DQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEAL 279

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 142 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 199 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 240
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 241 TFPDF------------VTEGARDLISRLLKHNPSQR 265

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQR 253

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 110/227 (48%), Gaps = 25/227 (11%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------R 107
           G + QP    +Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        R
Sbjct: 4   GSDEQP-HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFR 60
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
           E++ M++L+HPN+V L    F   E ++  L L++EY    E    ++ H      RM  
Sbjct: 61  EVRIMKILNHPNIVKL----FEVIETEKT-LYLIMEYASGGEVFDYLVAHG-----RMKE 110
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              +  F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    
Sbjct: 111 KEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLD 168
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           ++  S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 169 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 151 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQR 274

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------- 106
           G K+    +   Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMP 164
           RE+Q ++L  HP+++ L     + T+       +V+EYV   E    + KH      R+ 
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVE 109
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
            +  +  F QI  A+ Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE  
Sbjct: 110 EMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFL 167
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            +   S  Y APE+I G       +DIWS G +L  LL G   F  E
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 128
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 227
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNPSQR 252

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 129/304 (42%), Gaps = 59/304 (19%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----------------E 108
           SY   R +G G++G V   K        AIK + + +  K R                 E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLI 166
           +  ++ LDHPN++ L   F     +D+ Y  LV E+    E   ++I  H K  +     
Sbjct: 97  ISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAAN 150
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN 224
            +K    QI   + Y+H    + HRDIKP+N+L+        +K+ DFG +    K    
Sbjct: 151 IMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              + + YY APE++    +Y    D+WS G ++  LL G P F G++  D + ++ K  
Sbjct: 206 RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-- 261
Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                         Y +F       + W     K +  EA +L+  +L Y  N R TA +
Sbjct: 262 -----------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 345 AVGS 348
           A+ S
Sbjct: 299 ALNS 302

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 123
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 124 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 181 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 222
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 223 TFPDF------------VTEGARDLISRLLKHNPSQR 247

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H +   +       +  F QI
Sbjct: 66  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGWMKEKE-----ARAKFRQI 115
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 116 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 173
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 23/227 (10%)
Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------- 106
           G K+    +   Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMP 164
           RE+Q ++L  HP+++ L     + T+       +V+EYV   E    + KH      R+ 
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVE 109
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
            +  +  F QI  A+ Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE  
Sbjct: 110 EMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFL 167
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
                S  Y APE+I G       +DIWS G +L  LL G   F  E
Sbjct: 168 RDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQR 253

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQR 249

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 140/297 (47%), Gaps = 52/297 (17%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 260
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSR 231
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 232 YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
            Y APE++   G   Y  A+D WS G +L   L G P F        L           +
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 368
Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  +A+
Sbjct: 369 DQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEAL 412

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 140/297 (47%), Gaps = 52/297 (17%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 246
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSR 231
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 232 YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
            Y APE++   G   Y  A+D WS G +L   L G P F        L           +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  +A+
Sbjct: 355 DQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEAL 398

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G     +  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 182
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQR 249

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 X-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQR 253

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 151 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQR 274

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 127 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 183
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQR 250

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 135/286 (47%), Gaps = 46/286 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVV 121
           ++ +R +G G+FG V   +   +G    IK + +D+          E++ ++ LDHPN++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +   F     +D   + +V+E     E + R++    +  + +   YV     Q+  AL
Sbjct: 84  KIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNAL 137
Query: 180 AYIHNTIGVCHRDIKPQNLL---VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           AY H+   V H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y AP
Sbjct: 138 AYFHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+     + T   DIWSAG V+  LL G   F G S    L E+        +++     
Sbjct: 196 EVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKE 241
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           PNY       ++  P        + P+AVDL+ ++L   P  R +A
Sbjct: 242 PNYA------VECRP--------LTPQAVDLLKQMLTKDPERRPSA 273

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 122 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 178
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 179 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 220
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 221 TFPDF------------VTEGARDLISRLLKHNPSQR 245

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 128/284 (45%), Gaps = 64/284 (22%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-------SAKVLVKGEPNISYICSRYYRA 235
           H+   V HRDIKP+NLL+     +LK+ DFG       S +  + G  +        Y  
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLP 175
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V            
Sbjct: 176 PEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                EF FP              +   A DL+SRLL+++P+ R
Sbjct: 223 -----EFTFPDF------------VTEGARDLISRLLKHNPSQR 249

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           Y+    +G GSFG V  A   +T + VA+K + +    K+       RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L     + T+     + +V+EY    +   I    +M++       + +F QI  A+
Sbjct: 71  IIKLYDVITTPTD-----IVMVIEYAGGELFDYIVEKKRMTEDEG----RRFFQQIICAI 121
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            Y H    + HRD+KP+NLL++ + + +K+ DFG + ++  G    +   S  Y APE+I
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            G       +D+WS G VL  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G 
Sbjct: 127 HSK-RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 183
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQR 250

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L L++EY    E    ++ H      RM     +  F QI
Sbjct: 74  PNIVKL----FEVIETEKT-LYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQI 123
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 124 VSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P   V++ ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQR 253

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 114/214 (53%), Gaps = 25/214 (11%)
Query: 70  ERV--VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNV 120
           ER+  +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +
Sbjct: 19  ERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYI 76
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V     F+S  E     +++ +E++   ++ +V+K     ++R+P   +      + R L
Sbjct: 77  VGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGL 127
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           AY+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE +
Sbjct: 128 AYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERL 185
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
            G T Y+   DIWS G  L EL +G+ P+ P ++
Sbjct: 186 QG-THYSVQSDIWSMGLSLVELAVGRYPIPPPDA 218

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 20/216 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DH 117
            ++  +++G GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           P +  +  C F T E     L  V+EY+       + +H +   +  L     Y  +I  
Sbjct: 78  PFLTHM-FCTFQTKEN----LFFVMEYLNGGD---LMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 236
            L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C +  Y AP
Sbjct: 130 GLQFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           E++ G  +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 188 EILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P   V++ ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            FP              +   A DL+SRLL+++P+ R
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQR 253

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 127/279 (45%), Gaps = 50/279 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   +  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            FP              +   A DL+SRLL+++ + R T
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLT 254

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 134/293 (45%), Gaps = 46/293 (15%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTMRLLDH 117
           ++T  +M   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H
Sbjct: 8   RKTFIFM--EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N+V+L+  + STT     YL + L    E   R+++      +   L+       Q+  
Sbjct: 66  ENIVTLEDIYESTTH---YYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS 117
Query: 178 ALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           A+ Y+H   G+ HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C +  Y 
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE +     Y+ A+D WS G +   LL G P F  E+   +L E IK            
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK------------ 220
Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
               Y EF+ P          F   +   A D +  LL+  PN R T   A+ 
Sbjct: 221 --EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALS 261

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 112/220 (50%), Gaps = 21/220 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           RV+G GSFG V  A+  ETG+  A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  C F T ++    L  V+E+V       +  H + S+R      + Y  +I  AL ++
Sbjct: 89  L-FCCFQTPDR----LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I  
Sbjct: 141 HDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQ 197
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              Y  A+D W+ G +L E+L G   F  E+  D L E I
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 236

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 127/279 (45%), Gaps = 50/279 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   +  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            FP              +   A DL+SRLL+++ + R T
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLT 254

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY+P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGG---DMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY+P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGG---DMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 124/283 (43%), Gaps = 47/283 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 129 STTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
               +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L ++H   
Sbjct: 224 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 274
Query: 187 GVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--AT 243
              H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            YT   D+WS G +   LL G   F GE+  + L              +K  + N  +  
Sbjct: 335 YYT---DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSA 379
Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           F  I               +  D + +LL   PN R T   A+
Sbjct: 380 FSGISE-------------DGKDFIRKLLLADPNTRMTIHQAL 409

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 137/290 (47%), Gaps = 40/290 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           R +G GSFG V   +  +T +  A+K     K ++    +N  +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            + F     +DE  + +V++ +   +   +++H + +       VKL+  ++  AL Y+ 
Sbjct: 81  WYSF-----QDEEDMFMVVDLL---LGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-- 241
           N   + HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+     
Sbjct: 133 NQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP--------TREEI- 292
              Y+ A+D WS G    ELL G+  +   S      EI+    T         ++E + 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQEMVS 249
Query: 293 ---KCMNPN----YTEF----KFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
              K + PN    +++      FP +    W  +FQKR+ P  +    RL
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRL 299

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 95/336 (28%), Positives = 140/336 (41%), Gaps = 90/336 (26%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD 116
           Y  +  +G GS+GVV  A   +T    AIK + ++K          R K  E++ M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYV------------------------------- 145
           HPN+  L   +     +DE Y+ LV+E                                 
Sbjct: 87  HPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 146 -PETVHRVIK---HHYKMS----QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN 197
            PE     I    H ++ S    QR  LI       QI  AL Y+HN  G+CHRDIKP+N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLI--SNIMRQIFSALHYLHNQ-GICHRDIKPEN 198
Query: 198 LLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE-YTAAID 250
            L + + + ++KL DFG +K   K      Y  +      Y+ APE++    E Y    D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 251 IWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 310
            WSAG +L  LL+G   FPG +  D + +++        +++   NPNY           
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN---------- 301
Query: 311 PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                    + P A DL+S LL  + + R  A  A+
Sbjct: 302 --------VLSPLARDLLSNLLNRNVDERFDAMRAL 329

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 124/283 (43%), Gaps = 47/283 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 129 STTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
               +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L ++H   
Sbjct: 118 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 168
Query: 187 GVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--AT 243
              H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            YT   D+WS G +   LL G   F GE+  + L              +K  + N  +  
Sbjct: 229 YYT---DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSA 273
Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           F  I               +  D + +LL   PN R T   A+
Sbjct: 274 FSGISE-------------DGKDFIRKLLLADPNTRMTIHQAL 303

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 113/221 (51%), Gaps = 25/221 (11%)
Query: 59  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 111
           G P++   Y+A  + +G GS G+V  A    TG+ VA+KK+  D R + R      E+  
Sbjct: 41  GDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVI 95
Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           MR   H NVV +   + S    DEL++  V+E++       I  H +M++      +   
Sbjct: 96  MRDYHHDNVVDM---YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATV 146
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
              + RAL+Y+HN  GV HRDIK  ++L+     ++KL DFG    + K  P    +  +
Sbjct: 147 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGT 204
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            Y+ APE+I     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 205 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 244

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 27/268 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G G++GVV + + + +G+ +A+K++   +   N + Q   L+D    +    C F+ T 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 133 KDELY----LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
              L+    + + +E +  ++ +  K      Q +P   +      I +AL ++H+ + V
Sbjct: 116 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---FGATEY 245
            HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I        Y
Sbjct: 176 IHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-------------EI 292
           +   DIWS G  + EL + +  FP +S      ++ +V+  P+ +               
Sbjct: 235 SVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS 292
Query: 293 KCMNPNYTEF-KFPQIKAHPWHKIFQKR 319
           +C+  N  E   +P++  HP+  + + +
Sbjct: 293 QCLKKNSKERPTYPELMQHPFFTLHESK 320

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 121
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 287
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 20/211 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +++G GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +  C F T E     L  V+EY+       + +H +   +  L     Y  +I   L ++
Sbjct: 84  M-FCTFQTKEN----LFFVMEYLNGGD---LMYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C +  Y APE++ G
Sbjct: 136 HSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
             +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 194 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 114/219 (52%), Gaps = 24/219 (10%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCG 201
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 202 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 86  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 134
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++       
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 247 AAIDIWSAGCVLAELLLG 264
              D+WS G  L  +L+G
Sbjct: 195 KVADVWSCGVTLYVMLVG 212

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 247 AAIDIWSAGCVLAELLLG 264
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 121
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 287
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 121
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 91  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 141 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 287
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 199 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 39/277 (14%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +   T E VA+K + +         RE+   R L HPN+V  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +++EY    E   R+       + R      + +F Q+   ++Y H ++ 
Sbjct: 88  PT-----HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCH-SMQ 136
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           +CHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYD 195
Query: 247 AAI-DIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT------PTREEIKC---- 294
             I D+WS G  L  +L+G  P    E   D    I ++L          R   +C    
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255
Query: 295 -----MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD 326
                 +P  T    P+IK H W   F K +P + ++
Sbjct: 256 SRIFVADPA-TRISIPEIKTHSW---FLKNLPADLMN 288

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 23/212 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVD 275
           Y+   DIWS G  L E+ +G+ P+ P ++  D
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKED 211

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 134 AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 185 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 241
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L E+ +G+ P+ P ++
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 270

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 136/296 (45%), Gaps = 48/296 (16%)
Query: 62  KQTISYMAERV--VGHGSFGVVF--QAKCLETGEAVAIKKVLQDKRYKN----RELQTMR 113
           K  +S M +RV  +G G++G V   + K      A+ I +        N     E+  ++
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLE-YVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           LLDHPN++ L + FF    +D+    LV+E Y    +   I H  K ++    + +K   
Sbjct: 92  LLDHPNIMKL-YDFF----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK--- 143
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICS 230
            Q+   + Y+H    + HRD+KP+NLL+        +K+ DFG + V    +     + +
Sbjct: 144 -QVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            YY APE++    +Y    D+WS G +L  LL G P F G++  DQ  EI++        
Sbjct: 202 AYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR-------- 247
Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
             K     YT F  P+     W     K +   A DL+ ++LQ+    R +A  A+
Sbjct: 248 --KVEKGKYT-FDSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQAL 290

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 90
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 91  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 142 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 198
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           Y+   DIWS G  L E+ +G+      SG   + E++
Sbjct: 199 YSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 29/211 (13%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHP 118
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH---HYKMSQRMPLIYVKLYFY 173
           +++ L     + ++     + +V+EYV   E    + K+     K S+R+        F 
Sbjct: 77  HIIKLYQVISTPSD-----IFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQ 123
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QI   + Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y
Sbjct: 124 QILSGVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNY 181
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            APE+I G       +DIWS+G +L  LL G
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 114/219 (52%), Gaps = 24/219 (10%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 19  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 79  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 130
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   
Sbjct: 131 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCG 186
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTM 112
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFSEPHARFYA 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR- 231
            QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 115/242 (47%), Gaps = 39/242 (16%)
Query: 72  VVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
            +G G+FG V +  C++    G  VA+K V    RY       +++L+H N       F 
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 129 STTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                +      ++ +V E +  + +  IK +  +  R+   +++   YQIC+++ ++H+
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHS 136
Query: 185 TIGVCHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEP 223
              + H D+KP+N+L                     +NP    +K+ DFGSA      E 
Sbjct: 137 N-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           + + + +R+YRAPE+I  A  ++   D+WS GC+L E  LG  +FP     + L  + ++
Sbjct: 191 HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 284 LG 285
           LG
Sbjct: 250 LG 251

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTM 112
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFSEPHARFYA 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR- 231
            QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    R +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           +  + ++ P +V L+  F     KD   L +VLEY P      +  H +   R    + +
Sbjct: 94  RIQQAVNFPFLVKLEFSF-----KDNSNLYMVLEYAPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 127/269 (47%), Gaps = 29/269 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G G++GVV + + + +G+ +A+K++   +   N + Q   L+D    +    C F+ T 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 133 KDELY----LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
              L+    + + +E +  ++ +  K      Q +P   +      I +AL ++H+ + V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGATE 244
            HRD+KP N+L+N    Q+K+CDFG +  LV     +I   C + Y APE I        
Sbjct: 132 IHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGC-KPYMAPERINPELNQKG 189
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-------------E 291
           Y+   DIWS G  + EL + +  FP +S      ++ +V+  P+ +              
Sbjct: 190 YSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 292 IKCMNPNYTEF-KFPQIKAHPWHKIFQKR 319
            +C+  N  E   +P++  HP+  + + +
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFTLHESK 276

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 98
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 99  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 150 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 206
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFP 269
           Y+   DIWS G  L E+ +G+ P+ P
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTM 112
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFXEPHARFYA 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR- 231
            QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/323 (25%), Positives = 138/323 (42%), Gaps = 61/323 (18%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL---------- 115
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 116 -DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
            D P +V + + F  T +K    L+L+              HY +SQ        + FY 
Sbjct: 249 GDCPFIVCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEADMRFYA 298
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            +I   L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV---- 283
           Y APE++     Y ++ D +S GC+L +LL G   F       +  +D++   + V    
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 284 -------------LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVS 329
                        L       + C+     E K  P  ++  W  +F ++ PP  +    
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI---- 471
Query: 330 RLLQYSPNLRSTAFDA--VGSFD 350
                 P     A DA  +GSFD
Sbjct: 472 -----PPRGEVNAADAFDIGSFD 489

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/323 (25%), Positives = 138/323 (42%), Gaps = 61/323 (18%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL---------- 115
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 116 -DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
            D P +V + + F  T +K    L+L+              HY +SQ        + FY 
Sbjct: 248 GDCPFIVCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEADMRFYA 297
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            +I   L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  
Sbjct: 298 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 354
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV---- 283
           Y APE++     Y ++ D +S GC+L +LL G   F       +  +D++   + V    
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 414
Query: 284 -------------LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVS 329
                        L       + C+     E K  P  ++  W  +F ++ PP  +    
Sbjct: 415 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI---- 470
Query: 330 RLLQYSPNLRSTAFDA--VGSFD 350
                 P     A DA  +GSFD
Sbjct: 471 -----PPRGEVNAADAFDIGSFD 488

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L E+ +G+ P+ P ++
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L E+ +G+ P+ P ++
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 28/205 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSL 123
           R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D   + ++++Y+   E    + K     SQR P    K Y  ++C AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-IC-SRYYRAPELI 239
           +H+   + +RD+KP+N+L++ + H +K+ DFG AK +    P+++Y +C +  Y APE++
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV 175
Query: 240 FGATEYTAAIDIWSAGCVLAELLLG 264
                Y  +ID WS G ++ E+L G
Sbjct: 176 -STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/323 (25%), Positives = 138/323 (42%), Gaps = 61/323 (18%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL---------- 115
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 116 -DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
            D P +V + + F  T +K    L+L+              HY +SQ        + FY 
Sbjct: 249 GDCPFIVCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEADMRFYA 298
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            +I   L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV---- 283
           Y APE++     Y ++ D +S GC+L +LL G   F       +  +D++   + V    
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 284 -------------LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVS 329
                        L       + C+     E K  P  ++  W  +F ++ PP  +    
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI---- 471
Query: 330 RLLQYSPNLRSTAFDA--VGSFD 350
                 P     A DA  +GSFD
Sbjct: 472 -----PPRGEVNAADAFDIGSFD 489

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/323 (25%), Positives = 138/323 (42%), Gaps = 61/323 (18%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL---------- 115
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 116 -DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
            D P +V + + F  T +K    L+L+              HY +SQ        + FY 
Sbjct: 249 GDCPFIVCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEADMRFYA 298
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            +I   L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV---- 283
           Y APE++     Y ++ D +S GC+L +LL G   F       +  +D++   + V    
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 284 -------------LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVS 329
                        L       + C+     E K  P  ++  W  +F ++ PP  +    
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI---- 471
Query: 330 RLLQYSPNLRSTAFDA--VGSFD 350
                 P     A DA  +GSFD
Sbjct: 472 -----PPRGEVNAADAFDIGSFD 489

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFP 269
           Y+   DIWS G  L E+ +G+   P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIP 204

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFP 269
           Y+   DIWS G  L E+ +G+   P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIP 204

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 119/255 (46%), Gaps = 46/255 (18%)
Query: 53  TIGGKNGQPK-----QTISY-----MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK 102
           ++GG +G+ +     QT+          RV+  G F  V++A+ + +G   A+K++L ++
Sbjct: 6   SLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE 65
Query: 103 RYKNR----ELQTMRLLD-HPNVVSLKHCFFSTTEKDE-----LYLNLVLEYVPETVHRV 152
             KNR    E+  M+ L  HPN+V    C  ++  K+E         L+ E     +   
Sbjct: 66  EEKNRAIIQEVCFMKKLSGHPNIVQF--CSAASIGKEESDTGQAEFLLLTELCKGQLVEF 123
Query: 153 IKHHYKMSQRMPLI--YVKLYFYQICRALAYIHNTI-GVCHRDIKPQNLLVNPHTHQLKL 209
           +K   KM  R PL    V   FYQ CRA+ ++H     + HRD+K +NLL++ +   +KL
Sbjct: 124 LK---KMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKL 179
Query: 210 CDFGSAKVLVKGEPNISYICSR--------------YYRAPELI--FGATEYTAAIDIWS 253
           CDFGSA   +   P+ S+   R               YR PE+I  +         DIW+
Sbjct: 180 CDFGSATT-ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA 238
Query: 254 AGCVLAELLLGQPLF 268
            GC+L  L   Q  F
Sbjct: 239 LGCILYLLCFRQHPF 253

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFXEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/317 (24%), Positives = 142/317 (44%), Gaps = 59/317 (18%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIK--------KVLQDKRYKNRELQTMRLLDHPN 119
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +V L + F +  +     L L+LEY+   E   ++ +    M           Y  +I  
Sbjct: 83  IVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMEDT-----ACFYLAEISM 132
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAP 236
           AL ++H   G+ +RD+KP+N+++N H   +KL DFG  K  +  G    ++  +  Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-------LGTPTR 289
           E++   + +  A+D WS G ++ ++L G P F GE+    + +I+K        L    R
Sbjct: 191 EILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249
Query: 290 EEIKCMNPNYTEFKF-------PQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSP 336
           + +K +       +         +++AHP      W ++  +++ P           + P
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEP----------PFKP 299
Query: 337 NLRSTAFDAVGSFDSSF 353
            L+S   + V  FDS F
Sbjct: 300 LLQSE--EDVSQFDSKF 314

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 41/290 (14%)
Query: 53  TIGGKNGQPKQTISYMAERV---------VGHGSFGVVFQAKCLETGEAVAIK----KVL 99
           ++  +NG+   +    AE +         +G G+F  V  A+   TG+  A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 100 QDKRYK-NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 158
           + K      E+  +R + H N+V+L+  + S    + LYL + L    E   R+++  + 
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESP---NHLYLVMQLVSGGELFDRIVEKGFY 117
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL--CDFGSAK 216
             +    +       Q+  A+ Y+H  +G+ HRD+KP+NLL      + K+   DFG +K
Sbjct: 118 TEKDASTL-----IRQVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK 171
Query: 217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 276
           +  KG+   +   +  Y APE +     Y+ A+D WS G +   LL G P F  E+    
Sbjct: 172 MEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKL 230
Query: 277 LVEIIKV---LGTPTREEIKC-----------MNPNYTEFKFPQIKAHPW 312
             +I+K      +P  ++I              +PN   +   Q   HPW
Sbjct: 231 FEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPN-KRYTCEQAARHPW 279

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 48/290 (16%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 112
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE   +   + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPS 286

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++  ++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV EY    E    ++ H     +       +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVXEYASGGEVFDYLVAHGRXKEKE-----ARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 114 RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 165
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 166 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 220
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 221 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/317 (24%), Positives = 139/317 (43%), Gaps = 59/317 (18%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIK--------KVLQDKRYKNRELQTMRLLDHPN 119
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +V L + F +  +     L L+LEY+   E   ++ +    M           Y  +I  
Sbjct: 83  IVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMEDT-----ACFYLAEISM 132
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAP 236
           AL ++H   G+ +RD+KP+N+++N H   +KL DFG  K  +         C    Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-------LGTPTR 289
           E++   + +  A+D WS G ++ ++L G P F GE+    + +I+K        L    R
Sbjct: 191 EILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249
Query: 290 EEIKCMNPNYTEFKF-------PQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSP 336
           + +K +       +         +++AHP      W ++  +++ P           + P
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEP----------PFKP 299
Query: 337 NLRSTAFDAVGSFDSSF 353
            L+S   + V  FDS F
Sbjct: 300 LLQSE--EDVSQFDSKF 314

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 48/290 (16%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 112
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPS 286

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 138 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 192
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 193 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 114/242 (47%), Gaps = 39/242 (16%)
Query: 72  VVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
            +G G+FG V +  C++    G  VA+K V    RY       +++L+H N       F 
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 129 STTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                +      ++ +V E +  + +  IK +  +  R+   +++   YQIC+++ ++H+
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHS 136
Query: 185 TIGVCHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEP 223
              + H D+KP+N+L                     +NP    +K+ DFGSA      E 
Sbjct: 137 N-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           + + +  R+YRAPE+I  A  ++   D+WS GC+L E  LG  +FP     + L  + ++
Sbjct: 191 HSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 284 LG 285
           LG
Sbjct: 250 LG 251

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N+L++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNS 172
Query: 225 I----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           +    + I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 48/290 (16%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 112
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 21  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 80
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 81  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 132
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 133 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 191 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 227
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +
Sbjct: 228 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPS 270

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 138 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 192
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 193 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 48/290 (16%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 112
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPS 286

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 128/284 (45%), Gaps = 47/284 (16%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLD-HPNVVSL 123
           + ++ +G GSF +  +    ++ +A A+K +   KR +    +E+  ++L + HPN+V L
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F      D+L+  LV+E +   E   R+ K  +        I  KL       A+++
Sbjct: 72  HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL-----VSAVSH 121
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
           +H+ +GV HRD+KP+NLL       L  K+ DFG A++       +   C + +Y APEL
Sbjct: 122 MHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM 295
           +     Y  + D+WS G +L  +L GQ  F            VEI+K +           
Sbjct: 181 L-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--------- 230
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                +F F   +   W  + Q     EA DL+  LL   PN R
Sbjct: 231 ----GDFSF---EGEAWKNVSQ-----EAKDLIQGLLTVDPNKR 262

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/326 (24%), Positives = 144/326 (44%), Gaps = 70/326 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 86  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 138 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 281
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 196 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMS 254
Query: 282 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPPEAVDL 327
                     L    +E + C+     +  F  I+ HP      W  + QK++ P     
Sbjct: 255 VKAASVLKSFLNKDPKERLGCL----PQTGFADIQGHPFFRNVDWDMMEQKQVVP----- 305
Query: 328 VSRLLQYSPNLRSTAFDAVGSFDSSF 353
                 + PN+ S  F  + +FDS F
Sbjct: 306 -----PFKPNI-SGEF-GLDNFDSQF 324

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+C FG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 247 AAIDIWSAGCVLAELLLG 264
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 117/266 (43%), Gaps = 30/266 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK    K L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMN 296
                Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I    
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 297 PNY----------TEFKFPQIKAHPW 312
            ++            F   Q   HPW
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 133/284 (46%), Gaps = 50/284 (17%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIK-----KVLQDKRYKNRELQTMRLLDH----P 118
           +V+G G++G VF  + +   +TG+  A+K      ++Q  +         ++L+H    P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +V+L + F + T+     L+L+L+Y+       +  H    +R     V++Y  +I  A
Sbjct: 120 FLVTLHYAFQTETK-----LHLILDYINGGE---LFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAP 236
           L ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C    Y AP
Sbjct: 172 LEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 237 ELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           +++ G  + +  A+D WS G ++ ELL G   F  +   +   EI       +R  +K  
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKSE 282
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            P      +PQ             M   A DL+ RLL   P  R
Sbjct: 283 PP------YPQ------------EMSALAKDLIQRLLMKDPKKR 308

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 122
           R +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            K   +S   ++   L L++E++P    R  ++  K  +R+  I +  Y  QIC+ + Y+
Sbjct: 79  YKGVCYSAGRRN---LKLIMEFLPYGSLR--EYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRA 235
             T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ A
Sbjct: 134 -GTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYA 188
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE +   ++++ A D+WS G VL EL 
Sbjct: 189 PESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/326 (24%), Positives = 144/326 (44%), Gaps = 70/326 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 75  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 127 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 281
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 185 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 282 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPPEAVDL 327
                     L    +E + C    + +  F  I+ HP      W  + QK++ P     
Sbjct: 244 VKAASVLKSFLNKDPKERLGC----HPQTGFADIQGHPFFRNVDWDMMEQKQVVPP---- 295
Query: 328 VSRLLQYSPNLRSTAFDAVGSFDSSF 353
                 + PN+ S  F  + +FDS F
Sbjct: 296 ------FKPNI-SGEF-GLDNFDSQF 313

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 162
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 163 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 218
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 219 SL-TESKFSVASDVWSFGVVLYELF 242

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/326 (25%), Positives = 143/326 (43%), Gaps = 70/326 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVA---IKKVLQDKRYKNRELQTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A   +KK L +       +QT + +     +HP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 118 LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  L  G+   ++  +  Y APE++ G
Sbjct: 170 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 281
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 228 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286
Query: 282 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPPEAVDL 327
                     L    +E + C    + +  F  I+ HP      W  + QK++ P     
Sbjct: 287 VKAASVLKSFLNKDPKERLGC----HPQTGFADIQGHPFFRNVDWDMMEQKQVVP----- 337
Query: 328 VSRLLQYSPNLRSTAFDAVGSFDSSF 353
                 + PN+ S  F  + +FDS F
Sbjct: 338 -----PFKPNI-SGEF-GLDNFDSQF 356

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 172
Query: 225 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 85  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 139 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 194
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 195 SL-TESKFSVASDVWSFGVVLYELF 218

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/326 (24%), Positives = 144/326 (44%), Gaps = 70/326 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 71  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 123 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 281
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 181 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 239
Query: 282 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPPEAVDL 327
                     L    +E + C    + +  F  I+ HP      W  + QK++ P     
Sbjct: 240 VKAASVLKSFLNKDPKERLGC----HPQTGFADIQGHPFFRNVDWDMMEQKQVVPP---- 291
Query: 328 VSRLLQYSPNLRSTAFDAVGSFDSSF 353
                 + PN+ S  F  + +FDS F
Sbjct: 292 ------FKPNI-SGEF-GLDNFDSQF 309

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYV       +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 84  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 137
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 138 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 193
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 194 SL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 172
Query: 225 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 83  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 136
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 137 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 192
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 193 SL-TESKFSVASDVWSFGVVLYELF 216

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 20/224 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y+  + +G GSFG     K  E G    IK++       +++    RE+  +  + HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  +  F    E   LY+  V++Y    +   R+      + Q   ++    +F QIC A
Sbjct: 86  VQYRESF---EENGSLYI--VMDYCEGGDLFKRINAQKGVLFQEDQILD---WFVQICLA 137
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPE 237
           L ++H+   + HRDIK QN+ +      ++L DFG A+VL    E   + I + YY +PE
Sbjct: 138 LKHVHDR-KILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            I     Y    DIW+ GCVL EL   +  F   S  + +++II
Sbjct: 196 -ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 134
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 135 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 190
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 191 SL-TESKFSVASDVWSFGVVLYELF 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 172
Query: 225 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 131
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 82  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 135
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 136 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 191
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 192 SL-TESKFSVASDVWSFGVVLYELF 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 131
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 131
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 149
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 76  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 129
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 130 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 185
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 186 SL-TESKFSVASDVWSFGVVLYELF 209

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 22/201 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 74
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 75  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T 
Sbjct: 126 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-TH 182
Query: 245 YTAAIDIWSAGCVLAELLLGQ 265
           Y+   DIWS G  L E+ +G+
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGR 203

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 217 YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 266
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 245
           GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y+ APELI     Y
Sbjct: 267 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 324
Query: 246 TAAIDIWSAGCVLAELLLGQPLF 268
              +DIWS G ++ E++ G+P +
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 149
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 77  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 130
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 131 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 186
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 187 SL-TESKFSVASDVWSFGVVLYELF 210

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 172
Query: 225 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 18  GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 77
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 78  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 135
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 136 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 189
Query: 225 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 59  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 111
           G P+   SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 16  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 70
Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 71  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 121
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  +
Sbjct: 122 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 179
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVV 121
           +V+G GSFG VF  + +   ++G   A+K +      ++D+     E   +  ++HP VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++   L
Sbjct: 94  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 144 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 287
           +     ++ + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 202 V-NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 94
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 95  YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 144
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 245
           GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y+ APELI     Y
Sbjct: 145 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 202
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGE 271
              +DIWS G ++ E++ G+P +  E
Sbjct: 203 GPEVDIWSLGIMVIEMVDGEPPYFNE 228

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 96
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 97  YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 146
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 245
           GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y+ APELI     Y
Sbjct: 147 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 204
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGE 271
              +DIWS G ++ E++ G+P +  E
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEPPYFNE 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 28/206 (13%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 125 HCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +S   ++   L L++EY+P  ++   ++ H   ++R+  I +  Y  QIC+ + Y+ 
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQAH---AERIDHIKLLQYTSQICKGMEYL- 133
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAP 236
            T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ AP
Sbjct: 134 GTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAP 189
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E +   ++++ A D+WS G VL EL 
Sbjct: 190 ESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 140 YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 189
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 245
           GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y+ APELI     Y
Sbjct: 190 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 247
Query: 246 TAAIDIWSAGCVLAELLLGQPLF 268
              +DIWS G ++ E++ G+P +
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 130 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 180
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 228
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 181 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 234
Query: 229 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 235 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 185
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 228
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 186 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 239
Query: 229 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 240 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            + F      D   + L+LE+ P   +++ ++ H +  ++    +++    ++  AL Y 
Sbjct: 81  YNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 131
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H    V HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 132 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
           T +   +D+W AG +  E L+G P F   S  +    I+ V                 + 
Sbjct: 189 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 230
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           KFP              +   + DL+S+LL+Y P  R
Sbjct: 231 KFPPF------------LSDGSKDLISKLLRYHPPQR 255

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 131/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 45/289 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTMRLLDHPN 119
           Y   + +G G++G V   K   TG   AIK + +              E+  ++ LDHPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L   F    +K   YL + +    E    +I     + Q+   +   +   Q+    
Sbjct: 66  IMKLYEFF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGT 117
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE
Sbjct: 118 TYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++    +Y    D+WS G +L  LL G P F G++  DQ     ++L    + +     P
Sbjct: 177 VL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGKFSFDPP 227
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           ++T+                  +  EA  LV  +L Y P+ R +A +A+
Sbjct: 228 DWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEAL 258

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 185
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 228
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 186 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 239
Query: 229 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 240 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 23/228 (10%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   + +  A+K + +       D  +   E   M   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L  C F    +D+ YL +V+EY+P      +  +Y + ++    + K Y  ++  A
Sbjct: 136 WVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYTAEVVLA 186
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNI-SYICSRYYRAP 236
           L  IH ++G+ HRD+KP N+L++ H H LKL DFG+  K+   G  +  + + +  Y +P
Sbjct: 187 LDAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYISP 244
Query: 237 ELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           E++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+C FG +K  V        + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDG 195
Query: 247 AAIDIWSAGCVLAELLLG 264
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 59  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 111
           G P+   SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 20  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 74
Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 75  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 125
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  +
Sbjct: 126 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 183
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 184 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 223

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 30/266 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK + ++     +     E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMN 296
                Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I    
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 297 PNY----------TEFKFPQIKAHPW 312
            ++            F   Q   HPW
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 30/266 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMN 296
                Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I    
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 297 PNY----------TEFKFPQIKAHPW 312
            ++            F   Q   HPW
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 47/295 (15%)
Query: 63  QTISYMAERV--VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTMR 113
           Q +S   +RV  +G G++G V   K   TG   AIK + +              E+  ++
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            LDHPN++ L   F    +K   YL + +    E    +I     + Q+   +   +   
Sbjct: 77  QLDHPNIMKLYEFF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMK 128
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSR 231
           Q+     Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + + 
Sbjct: 129 QVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTA 187
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           YY APE++    +Y    D+WS G +L  LL G P F G++  DQ     ++L    + +
Sbjct: 188 YYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGK 238
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                P++T+                  +  EA  LV  +L Y P+ R +A +A+
Sbjct: 239 FSFDPPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEAL 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 30/266 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMN 296
                Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I    
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 297 PNY----------TEFKFPQIKAHPW 312
            ++            F   Q   HPW
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 130/290 (44%), Gaps = 50/290 (17%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKRYKNRELQTMRLLDHPNVV 121
           YM    +G G FG+V   +C+ET       A  +K    D+    +E+  + +  H N++
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L   F S  E     L ++ E++   +   R+    +++++R  + YV    +Q+C AL
Sbjct: 65  HLHESFESMEE-----LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 180 AYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
            ++H+   + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +      + A D+WS G ++  LL G   F  E+   Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 299 YT--EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           YT  E  F +I               EA+D V RLL      R TA +A+
Sbjct: 220 YTFDEEAFKEI-------------SIEAMDFVDRLLVKERKSRMTASEAL 256

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 50/277 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            + F      D   + L+LE+ P   +++ ++ H +  ++    +++    ++  AL Y 
Sbjct: 80  YNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 130
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H    V HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 131 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
           T +   +D+W AG +  E L+G P F   S  +    I+ V                 + 
Sbjct: 188 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 229
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           KFP              +   + DL+S+LL+Y P  R
Sbjct: 230 KFPPF------------LSDGSKDLISKLLRYHPPQR 254

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 258

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 47/283 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEA-VAIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHC 126
           +G G+FGVV   +C+E     V + K +      DK     E+  M  L HP +++L   
Sbjct: 59  LGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 127 FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           F     +D+  + L+LE++   E   R+    YKMS+   + Y++    Q C  L ++H 
Sbjct: 117 F-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHE 167
Query: 185 TIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
              + H DIKP+N++        +K+ DFG A  L   E       +  + APE++    
Sbjct: 168 H-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DRE 225
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
                 D+W+ G +   LL G   F GE  ++ L            + +K  +  + E  
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDA 273
Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           F  +              PEA D +  LLQ  P  R T  DA+
Sbjct: 274 FSSVS-------------PEAKDFIKNLLQKEPRKRLTVHDAL 303

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 121/255 (47%), Gaps = 29/255 (11%)
Query: 42  NGTEAGHIIVTTIGGKNGQPK-QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ 100
           +G + G++   TIGG+  Q +   +  + E  +G G+ G V++ +  +TG  +A+K++  
Sbjct: 6   SGKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM-- 58
Query: 101 DKRYKNRELQTMRLLDHPNVVSLKH-------CFFSTTEKDELYLNLVLEYVPETVHRVI 153
            +R  N+E +  R+L   +VV   H       CF +     ++++   +E +     ++ 
Sbjct: 59  -RRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLK 114
Query: 154 KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 213
           K   +M   +P   +      I +AL Y+    GV HRD+KP N+L++    Q+KLCDFG
Sbjct: 115 K---RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFG 170
Query: 214 SAKVLVKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFP 269
            +  LV  +          Y APE I        +Y    D+WS G  L EL  GQ  FP
Sbjct: 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FP 228
Query: 270 GESGVDQLVEIIKVL 284
            ++       + KVL
Sbjct: 229 YKNCKTDFEVLTKVL 243

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 125
           +G G    V+ A+       VAIK +    R K        RE+     L H N+VS+  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 126 CFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                 E+D+ Y  LV+EY+   T+   I+ H  +S    + +      QI   + + H+
Sbjct: 77  --IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN----QILDGIKHAHD 129
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIF 240
            + + HRDIKPQN+L++ +   LK+ DFG AK L   E +++     + +  Y +PE   
Sbjct: 130 -MRIVHRDIKPQNILIDSNK-TLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAK 185
Query: 241 G-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           G AT+     DI+S G VL E+L+G+P F GE+ V
Sbjct: 186 GEATD--ECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 258

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 258

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 258

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 131/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 258

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 131/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 67
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 68  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 120 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 216
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 256

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 131/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 131/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 131/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 128/284 (45%), Gaps = 48/284 (16%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           ++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 131/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 258

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 128/284 (45%), Gaps = 48/284 (16%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           ++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 124
           V+G GSFG V  A    T E  AIK + +D   ++ +++        + LLD P  ++  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T ++    L  V+EYV       + +H +   +        Y  +I   L ++H 
Sbjct: 86  HSCFQTVDR----LYFVMEYVNGGD---LMYHIQQVGKFKEPQAVFYAAEISIGLFFLHK 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I    
Sbjct: 139 R-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-AYQ 195
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 79  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 132
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HR++  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 133 TKRYIHRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWYAPE 188
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 189 SL-TESKFSVASDVWSFGVVLYELF 212

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 134/301 (44%), Gaps = 40/301 (13%)
Query: 51  VTTIGGKNGQPKQTISYMAERV-----VGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKR 103
           + + G     P+Q   + AE +     +G G++G V +     +G+ +A+K++    D++
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 104 YKNRELQ----TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK- 158
            + + L      MR  D P +V      F   +       + +E +  +  +  K+ Y  
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-----CWICMELMSTSFDKFYKYVYSV 117
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
           +   +P   +        +AL ++   + + HRDIKP N+L++  +  +KLCDFG +  L
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQL 176
Query: 219 VKGEPNISYICSRYYRAPELIFGATE---YTAAIDIWSAGCVLAELLLGQPLFPGESGV- 274
           V           R Y APE I  +     Y    D+WS G  L EL  G+  +P  + V 
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
Query: 275 DQLVEIIKVLGTP---TREEIKCMNPNYTEF-------------KFPQIKAHPWHKIFQK 318
           DQL +++K  G P   +  E +  +P++  F             K+ ++  HP+  ++++
Sbjct: 237 DQLTQVVK--GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294
Query: 319 R 319
           R
Sbjct: 295 R 295

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 146/304 (48%), Gaps = 64/304 (21%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 123 LKHCFFSTTEKDELYL-----NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
             +C  S T    LY+     NL L+ + E+ + V   + K+ +    I +     QI  
Sbjct: 92  Y-YC--SETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISL---LRQIAS 144
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 145 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 226 SYIC-----SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
                    +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 262
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
            II+  G  + +E+KC++                     + +  EA DL+S+++ + P  
Sbjct: 263 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 300
Query: 339 RSTA 342
           R TA
Sbjct: 301 RPTA 304

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 146/304 (48%), Gaps = 64/304 (21%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 123 LKHCFFSTTEKDELYL-----NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
             +C  S T    LY+     NL L+ + E+ + V   + K+ +    I +     QI  
Sbjct: 92  Y-YC--SETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISL---LRQIAS 144
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 145 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 226 SYIC-----SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
                    +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 262
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
            II+  G  + +E+KC++                     + +  EA DL+S+++ + P  
Sbjct: 263 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 300
Query: 339 RSTA 342
           R TA
Sbjct: 301 RPTA 304

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 109/214 (50%), Gaps = 37/214 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           V+G G FG   +    ETGE + +K+++    + +R   +E++ MR L+HPNV+     F
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 128 FSTTEKDELYLNLVLEYVP-ETVHRVIK---HHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                KD+  LN + EY+   T+  +IK     Y  SQR+       +   I   +AY+H
Sbjct: 73  IGVLYKDK-RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS------FAKDIASGMAYLH 125
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEP-------------NISYI 228
            ++ + HRD+   N LV  + + + + DFG A+++V  K +P               + +
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
            + Y+ APE+I G + Y   +D++S G VL E++
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 20/205 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 128 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y APE+I  + 
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-SK 234
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLF 268
            Y  A+D W+ G ++ E+  G P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  +  E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYAH-AMQ 135
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           V HRD+K +N L++     +LK+ DFG +K  V      S + +  Y APE++       
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDG 195
Query: 247 AAIDIWSAGCVLAELLLG 264
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 129/285 (45%), Gaps = 48/285 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           +G G+F VV +   +  G+  A K +       +D +   RE +  RLL HPN+V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 88
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             S +E+   YL   L    E    ++ + +Y  +     I       QI  A+ + H  
Sbjct: 89  --SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCHQ- 139
Query: 186 IGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFG 241
           +GV HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +  
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLR 197
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y   +D+W+ G +L  LL+G P F  E    +L + IK                   
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GA 240
Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           + FP  +   W  +      PEA DL++++L  +P+ R TA +A+
Sbjct: 241 YDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEAL 277

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 128 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 179
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 233
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 129/287 (44%), Gaps = 43/287 (14%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH 117
           QP++    + +  +G GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D 
Sbjct: 26  QPEEVFDVLEK--LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS 83
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           P+VV     +F  T+     L +V+EY    +V  +I+   K      +  +        
Sbjct: 84  PHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI---LQSTL 135
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRYYRA 235
           + L Y+H    + HRDIK  N+L+N   H  KL DFG A  L       +  I + ++ A
Sbjct: 136 KGLEYLHFMRKI-HRDIKAGNILLNTEGHA-KLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE+I     Y    DIWS G    E+  G+P +   + +  +  I  +   PT       
Sbjct: 194 PEVI-QEIGYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMI---PT------- 239
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           NP  T F+ P++    W   F         D V + L  SP  R+TA
Sbjct: 240 NPPPT-FRKPEL----WSDNF--------TDFVKQCLVKSPEQRATA 273

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 108 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 213
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 20/205 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SK 213
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLF 268
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 48/284 (16%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+    +L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVK--- 69
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           ++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 258

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 130/287 (45%), Gaps = 54/287 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 20/205 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SK 213
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLF 268
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 130/287 (45%), Gaps = 54/287 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 122 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 177
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 217
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 218 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 258

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 127/278 (45%), Gaps = 33/278 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   VA+K + + +  K        RE++    L HPN++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F+     D   + L+LEY P  E    + K      QR   I       ++  AL Y
Sbjct: 89  YNYFY-----DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATI-----MEELADALMY 138
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H    V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G
Sbjct: 139 CHGK-KVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-----LGTPTREE---IK 293
              +   +D+W  G +  ELL+G P F   S  +    I+KV        PT  +    K
Sbjct: 196 RM-HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISK 254
Query: 294 CMNPNYTE-FKFPQIKAHPWHKIFQKR-MPPEAVDLVS 329
            +  N +E     Q+ AHPW +   +R +PP A+  V+
Sbjct: 255 LLRHNPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA 292

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 45/288 (15%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 122
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           LK  +      D  Y+ +V E +   E + ++++  +  S+R          + I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELMKGGELLDKILRQKF-FSERE----ASAVLFTITKTVE 130
Query: 181 YIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + 
Sbjct: 131 YLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE +     Y AA DIWS G +L  +L G   F      D   EI+  +G+        
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSG------- 238
Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                   KF  +    W+ +        A DLVS++L   P+ R TA
Sbjct: 239 --------KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTA 272

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 94  EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 146 -SLDLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 200 KGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 50/285 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G+ G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           +++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 102 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 154 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 208 KGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 20/219 (9%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------LLDHPNVVSLK 124
           ++G GSF  V++A+ + TG  VAIK + +   YK   +Q ++        L HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + F     +D  Y+ LVLE      ++R +K+  K          + + +QI   + Y+H
Sbjct: 78  NYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE---ARHFMHQIITGMLYLH 129
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGA 242
           +  G+ HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE I   
Sbjct: 130 SH-GILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           + +    D+WS GC+   LL+G+P F  ++  + L +++
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 29/269 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G G++GVV + + + +G+  A+K++   +   N + Q   L D         C F+ T 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI---RATVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 133 KDELY----LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
              L+    + +  E    ++ +  K      Q +P   +      I +AL ++H+ + V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGATE 244
            HRD+KP N+L+N    Q+K CDFG +  LV     +I   C + Y APE I        
Sbjct: 159 IHRDVKPSNVLIN-ALGQVKXCDFGISGYLVDDVAKDIDAGC-KPYXAPERINPELNQKG 216
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-------------E 291
           Y+   DIWS G    EL + +  FP +S      ++ +V+  P+ +              
Sbjct: 217 YSVKSDIWSLGITXIELAILR--FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 274
Query: 292 IKCMNPNYTEF-KFPQIKAHPWHKIFQKR 319
            +C+  N  E   +P++  HP+  + + +
Sbjct: 275 SQCLKKNSKERPTYPELXQHPFFTLHESK 303

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVV--SLKHCF- 127
           +V+G GSFG V  A+  +  E     KVLQ K    ++ +   ++   NV+  ++KH F 
Sbjct: 44  KVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFL 101
Query: 128 ----FSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
               FS    D+LY   VL+Y+   E  + + +    +  R      + Y  +I  AL Y
Sbjct: 102 VGLHFSFQTADKLYF--VLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALGY 154
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE + 
Sbjct: 155 LH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VL 211
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y   +D W  G VL E+L G P F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 130/287 (45%), Gaps = 54/287 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE------------------ 216
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 43/284 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +    +   +YL   L    E + ++++  +  S+R          + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKF-FSERE----ASFVLHTIGKTVEYLHSQ 140
Query: 186 IGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
            GV HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 240 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
                Y    DIWS G +L  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
               KF  +    W+ + +      A DLVS++L   P+ R TA
Sbjct: 244 ----KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTA 277

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIII-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 48/294 (16%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 117
           T  Y     +G G+F VV +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
           PN+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 63  PNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 113
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 232
            ++ + H   G+ HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  
Sbjct: 114 ESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK          
Sbjct: 172 YLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA--------- 220
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                    + FP  +   W  +      PEA DL++++L  +P  R TA +A+
Sbjct: 221 -------GAYDFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEAL 259

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ ++  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 130/287 (45%), Gaps = 54/287 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 43/284 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +    +   +YL   L    E + ++++  +  S+R          + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKF-FSERE----ASFVLHTIGKTVEYLHSQ 140
Query: 186 IGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
            GV HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 240 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
                Y    DIWS G +L  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
               KF  +    W+ + +      A DLVS++L   P+ R TA
Sbjct: 244 ----KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTA 277

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 130/287 (45%), Gaps = 54/287 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T  D
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARITIPD 257

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 85/334 (25%), Positives = 145/334 (43%), Gaps = 68/334 (20%)
Query: 24  NDMKIRDDKEME---ATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAE----RVVGHG 76
           + +K ++++EM+    +  D +G E   + +        +PK  ++ M E    +++G G
Sbjct: 111 DGLKKQEEEEMDFRSGSPSDNSGAEEMEVSL-------AKPKHRVT-MNEFEYLKLLGKG 162
Query: 77  SFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           +FG V   K   TG          E +  K  +     +NR LQ  R   HP + +LK+ 
Sbjct: 163 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYS 219
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           F  T ++    L  V+EY        +  H    +       + Y  +I  AL Y+H+  
Sbjct: 220 F-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 271
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 245
            V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    +Y
Sbjct: 272 NVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDY 329
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
             A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+            
Sbjct: 330 GRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------------ 370
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                     F + + PEA  L+S LL+  P  R
Sbjct: 371 ----------FPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 122/282 (43%), Gaps = 57/282 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 72  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 121
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE
Sbjct: 122 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 180
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 228
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L+S LL+  P  R
Sbjct: 229 ------------------FPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 122/282 (43%), Gaps = 57/282 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 70
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 71  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 120
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE
Sbjct: 121 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 179
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 180 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 227
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L+S LL+  P  R
Sbjct: 228 ------------------FPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 122/282 (43%), Gaps = 57/282 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 72
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 73  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 122
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE
Sbjct: 123 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 181
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 182 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 229
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L+S LL+  P  R
Sbjct: 230 ------------------FPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 48/294 (16%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 117
           T  Y     +G G+F VV +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
           PN+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 63  PNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 113
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 232
            ++ + H   G+ HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  
Sbjct: 114 ESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK          
Sbjct: 172 YLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA--------- 220
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                    + FP  +   W  +      PEA DL++++L  +P  R TA +A+
Sbjct: 221 -------GAYDFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEAL 259

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 32/223 (14%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKN--RELQTMRLLDHPNVV 121
           E ++G G FG V++A     G+ VA+K    D      +  +N  +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 122 SLKHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L+          E  L LV+E+     ++RV+       +R+P   +  +  QI R + 
Sbjct: 70  ALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 181 YIHN--TIGVCHRDIKPQNLLV-------NPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
           Y+H+   + + HRD+K  N+L+       +     LK+ DFG A+   +    +S   + 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAY 178
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
            + APE+I  A+ ++   D+WS G +L ELL G+  F G  G+
Sbjct: 179 AWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 53/280 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 210
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I  AL 
Sbjct: 211 TALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 239
           Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-V 320
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+      
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------ 367
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                           F + + PEA  L+S LL+  P  R
Sbjct: 368 ----------------FPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 95/217 (43%), Gaps = 22/217 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
           Y+  + +G G F  V   + L  G   A+K++L    QD+    RE    RL +HPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 123 L-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L  +C      K E +L L   +   T+   I+        +    +      ICR L  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPF-FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS---AKVLVKGEPNISYI-------CSR 231
           IH   G  HRD+KP N+L+     Q  L D GS   A + V+G      +       C+ 
Sbjct: 150 IHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 232 YYRAPELIFGATEYTA---AIDIWSAGCVLAELLLGQ 265
            YRAPEL F    +       D+WS GCVL  ++ G+
Sbjct: 208 SYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP +I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPAIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 125/288 (43%), Gaps = 45/288 (15%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 122
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           LK  +      D  Y+ +V E     E + ++++  +  S+R          + I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELXKGGELLDKILRQKF-FSERE----ASAVLFTITKTVE 130
Query: 181 YIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + 
Sbjct: 131 YLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE +     Y AA DIWS G +L   L G   F      D   EI+  +G+        
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSG------- 238
Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                   KF  +    W+ +        A DLVS+ L   P+ R TA
Sbjct: 239 --------KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTA 272

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 141/308 (45%), Gaps = 68/308 (22%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY-----FYQICR 177
                +  +E  + +L + LE     +  +++      + + L   K Y       QI  
Sbjct: 74  -----YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 126
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+ + 
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 226 SYIC-----SRYYRAPELIFGAT------EYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
                    +  +RAPEL+  +         T +IDI+S GCV    +L +   P     
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKY 244
Query: 275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 334
            +   II+  G  + +E+KC++                     + +  EA DL+S+++ +
Sbjct: 245 SRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDH 282
Query: 335 SPNLRSTA 342
            P  R TA
Sbjct: 283 DPLKRPTA 290

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 48/285 (16%)
Query: 73  VGHGSFGVVFQA-KCLETGEAVAI-----KKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           +G G+F VV +  K L   E  A+     K   +D +   RE +  RLL HPN+V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 77
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             S +E+   YL   L    E    ++ + +Y  +     I       QI  A+ + H  
Sbjct: 78  --SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCHQ- 128
Query: 186 IGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFG 241
           +GV HR++KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +  
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLR 186
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y   +D+W+ G +L  LL+G P F  E    +L + IK                   
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GA 229
Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           + FP  +   W  +      PEA DL++++L  +P+ R TA +A+
Sbjct: 230 YDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEAL 266

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   DHP +V L   +
Sbjct: 19  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +   +     L +++E+ P      I          P I V     Q+  AL ++H+   
Sbjct: 78  YHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK-R 129
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI----FGA 242
           + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 130 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 243 TEYTAAIDIWSAGCVLAELLLGQP 266
           T Y    DIWS G  L E+   +P
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEP 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   DHP +V L   +
Sbjct: 27  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +   +     L +++E+ P      I          P I V     Q+  AL ++H+   
Sbjct: 86  YHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK-R 137
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI----FGA 242
           + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 138 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 243 TEYTAAIDIWSAGCVLAELLLGQP 266
           T Y    DIWS G  L E+   +P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEP 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 129
           ++G G FG VF+AK    G+   IK+V  +     RE++ +  LDH N+V    C+    
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 130 ----TTEKDELY-----LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
               T+ K+        L + +E+  + T+ + I+   +  +++  +     F QI + +
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGV 135
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y +PE I
Sbjct: 136 DYIHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 240 FGATEYTAAIDIWSAGCVLAELL 262
             + +Y   +D+++ G +LAELL
Sbjct: 194 -SSQDYGKEVDLYALGLILAELL 215

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C      APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEALAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 140/308 (45%), Gaps = 68/308 (22%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY-----FYQICR 177
                +  +E  + +L + LE     +  +++      + + L   K Y       QI  
Sbjct: 74  -----YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 126
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 226 SYIC-----SRYYRAPELIFGAT------EYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
                    +  +RAPEL+  +         T +IDI+S GCV    +L +   P     
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKY 244
Query: 275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 334
            +   II+  G  + +E+KC++                     + +  EA DL+S+++ +
Sbjct: 245 SRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDH 282
Query: 335 SPNLRSTA 342
            P  R TA
Sbjct: 283 DPLKRPTA 290

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 129/279 (46%), Gaps = 35/279 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLET--GEAVAIKKVLQDKRYKN------RELQTMRLLDHP 118
           Y+   ++G GS+G V +    ET    AV I K  + +R  N      +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           NV+ L    ++  EK ++Y+  V+EY    +  ++       +R P+     YF Q+   
Sbjct: 67  NVIQLVDVLYNE-EKQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGYFCQLIDG 121
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRA 235
           L Y+H+  G+ H+DIKP NLL+      LK+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 236 PELIFGATEYTA-AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV--------LGT 286
           PE+  G   ++   +DIWSAG  L  +  G   F G++ + +L E I           G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 287 PTREEIKCM---NPNYTEFKFPQIKAHPWHKIFQKRMPP 322
           P  + +K M    P    F   QI+ H W   F+K+ PP
Sbjct: 239 PLSDLLKGMLEYEPA-KRFSIRQIRQHSW---FRKKHPP 273

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 28/253 (11%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 290 EEIKCMNPNYTEF 302
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 117
           T  Y     +G G+F VV +   L TG   A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
            N+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 63  SNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 113
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 232
            A+ + H  +GV HRD+KP+NLL+        +KL DFG A + V+G+      +  +  
Sbjct: 114 EAVLHCHQ-MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y +PE +     Y   +DIW+ G +L  LL+G P F  E    +L + IK          
Sbjct: 172 YLSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA--------- 220
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                    + FP  +   W  +      PEA +L++++L  +P  R TA +A+
Sbjct: 221 -------GAYDFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITAHEAL 259

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 120/253 (47%), Gaps = 28/253 (11%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVG 178
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 290 EEIKCMNPNYTEF 302
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 120/253 (47%), Gaps = 28/253 (11%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 178
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 290 EEIKCMNPNYTEF 302
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 120/253 (47%), Gaps = 28/253 (11%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 121
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 179
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 237
Query: 290 EEIKCMNPNYTEF 302
           +  + ++  + +F
Sbjct: 238 QNPEKLSAIFRDF 250

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 129
           ++G G FG VF+AK    G+   I++V  +     RE++ +  LDH N+V    C+    
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 78
Query: 130 ---TTEKDELYLNLVLEYVPETVHRVIKHHYK---------------------MSQRMPL 165
               T  D L  +   +Y PE      +   K                       +++  
Sbjct: 79  YDPETSDDSLESS---DYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
           +     F QI + + YIH+   + HRD+KP N+ +   T Q+K+ DFG    L       
Sbjct: 136 VLALELFEQITKGVDYIHSK-KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRT 193
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               +  Y +PE I  + +Y   +D+++ G +LAELL
Sbjct: 194 RSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY----VKLYFYQICR 177
           S    + S   KDEL+L + L     +V  +IKH     +    +     +     ++  
Sbjct: 72  SY---YTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNISYICSR 231
            L Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ + 
Sbjct: 128 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            + APE++     Y    DIWS G    EL  G
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY----VKLYFYQICR 177
           S    + S   KDEL+L + L     +V  +IKH     +    +     +     ++  
Sbjct: 77  SY---YTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNISYICSR 231
            L Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ + 
Sbjct: 133 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            + APE++     Y    DIWS G    EL  G
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-- 185
            +        + LV+EY        + H  +        +   +  Q  + +AY+H+   
Sbjct: 72  LNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F  + Y
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNY 181
Query: 246 TAAIDIWSAGCVLAELL 262
           +   D++S G +L E++
Sbjct: 182 SEKCDVFSWGIILWEVI 198

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +    E     L +++E++       I    ++++      +      + +ALAY+H   
Sbjct: 111 YLVGEE-----LWVLMEFLQGGALTDIVSQVRLNEEQ----IATVCEAVLQALAYLHAQ- 160
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 245
           GV HRDIK  ++L+     ++KL DFG    + K  P    +  + Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
              +DIWS G ++ E++ G+P +  +S V  +
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM----- 112
           N   K + +Y  +  +G G+F VV +     TG   A K ++  K+   R+ Q +     
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREAR 80
Query: 113 --RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVK 169
             R L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I   
Sbjct: 81  ICRKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 135
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 227
               QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +
Sbjct: 136 ----QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
             +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E
Sbjct: 191 AGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 116/277 (41%), Gaps = 48/277 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K  + + M       R L H +VV   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 88  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 141 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 197
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 231
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            +IK + +     K + P A  L+ ++LQ  P  R T
Sbjct: 232 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 265

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 28/253 (11%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 121
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HR+IK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 237
Query: 290 EEIKCMNPNYTEF 302
           +  + ++  + +F
Sbjct: 238 QNPEKLSAIFRDF 250

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 117/277 (42%), Gaps = 48/277 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 84  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 137 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            +IK + +     K + P A  L+ ++LQ  P  R T
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 261

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-- 185
            +        + LV+EY        + H  +        +   +  Q  + +AY+H+   
Sbjct: 71  LNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F  + Y
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNY 180
Query: 246 TAAIDIWSAGCVLAELL 262
           +   D++S G +L E++
Sbjct: 181 SEKCDVFSWGIILWEVI 197

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 117/277 (42%), Gaps = 48/277 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 84  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 137 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            +IK + +     K + P A  L+ ++LQ  P  R T
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 261

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 52/303 (17%)
Query: 13  TVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERV 72
           + GVD   E +    ++  K    +V D    + GH+ V  IG           ++ ER 
Sbjct: 8   SSGVDLGTENLYFQSMQSSKRSSRSVED---DKEGHL-VCRIG----------DWLQERY 53
Query: 73  -----VGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 124
                +G G+FG V   +CL+       VA+K +    +Y+      + +L        +
Sbjct: 54  EIVGNLGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKE 111
Query: 125 HCFFSTTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + F      D      ++ +  E + +     +K +    Q  PL +V+   YQ+C AL 
Sbjct: 112 NKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALR 169
Query: 181 YIHNTIGVCHRDIKPQNLLV---------NPHTH---------QLKLCDFGSAKVLVKGE 222
           ++H    + H D+KP+N+L          N H            +++ DFGSA      E
Sbjct: 170 FLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHE 226
Query: 223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            + + + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K
Sbjct: 227 HHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 285
Query: 283 VLG 285
           +LG
Sbjct: 286 ILG 288

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 122
           IS+  + V+GHG+ G +      +  + VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                +  TEKD  +  + +E    T+   ++   K    + L  + L   Q    LA++
Sbjct: 83  -----YFCTEKDRQFQYIAIELCAATLQEYVEQ--KDFAHLGLEPITL-LQQTTSGLAHL 134
Query: 183 HNTIGVCHRDIKPQNLLVN-PHTH---QLKLCDFGSAKVLVKGEPNISYIC----SRYYR 234
           H ++ + HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  + 
Sbjct: 135 H-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 235 APELIFGATEY--TAAIDIWSAGCVL 258
           APE++    +   T  +DI+SAGCV 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVF 219

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 115/277 (41%), Gaps = 48/277 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K  + + M       R L H +VV   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 108 GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 161 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 217
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 251
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            +IK + +     K + P A  L+ ++LQ  P  R T
Sbjct: 252 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 285

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 33/238 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 27  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 130 TTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
               D      ++ +  E + +     +K      Q  PL +V+   YQ+C AL ++H  
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN 142
Query: 186 IGVCHRDIKPQNLLV---------NPHTH---------QLKLCDFGSAKVLVKGEPNISY 227
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 143 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 199
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K+LG
Sbjct: 200 VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 256

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 33/238 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 36  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 93
Query: 130 TTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
               D      ++ +  E + +     +K      Q  PL +V+   YQ+C AL ++H  
Sbjct: 94  VLMSDWFNFHGHMCIAFELLGKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN 151
Query: 186 IGVCHRDIKPQNLLV---------NPHTH---------QLKLCDFGSAKVLVKGEPNISY 227
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 152 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 208
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K+LG
Sbjct: 209 VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 265

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 115/277 (41%), Gaps = 48/277 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K  + + M       R L H +VV   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 106 GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 159 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 215
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 249
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            +IK + +     K + P A  L+ ++LQ  P  R T
Sbjct: 250 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 283

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 48/277 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 82  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 135 -RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 191
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 225
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            +IK + +     K + P A  L+ ++LQ  P  R T
Sbjct: 226 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 259

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 246
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 247 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 127
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 128 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 185
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 245
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 246 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 35  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 94  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 147
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 148 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 205
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 265
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 114
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 62  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 112
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 231
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 102 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 155
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 156 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 213
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 274 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 114
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 60
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 61  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 111
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 231
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 112 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 170
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E 
Sbjct: 171 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 210

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 258
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 114
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 62  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 112
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 231
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTM 112
           QP    ++   RV+G G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLY 171
             ++   VVSL + + +   KD L L L L    +       H Y M Q   P      Y
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKF----HIYHMGQAGFPEARAVFY 291
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + + 
Sbjct: 292 AAEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE++     YT + D W+ GC+L E++ GQ  F       Q  + IK      REE
Sbjct: 350 GYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REE 396
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           ++ +           +K  P  + + +R  P+A  L S+LL   P  R
Sbjct: 397 VERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAER 431

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 116/269 (43%), Gaps = 50/269 (18%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKC-LETG--EAVAIKKVLQDKR--YKNRELQTMRLL 115
           P+ +  +  E  +G G+F  V+ A   L+ G  E +A+K ++          ELQ + + 
Sbjct: 17  PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVA 76
Query: 116 D-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
               NV+ +K+CF     +   ++ + + Y+       I +     +      V+ Y   
Sbjct: 77  GGQDNVMGVKYCF-----RKNDHVVIAMPYLEHESFLDILNSLSFQE------VREYMLN 125
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----------VLVKGEP- 223
           + +AL  IH   G+ HRD+KP N L N    +  L DFG A+            V+ E  
Sbjct: 126 LFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184
Query: 224 ------NISYIC-SRY-----------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
                 N   IC SR            +RAPE++      T AID+WSAG +   LL G+
Sbjct: 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244
Query: 266 -PLFPGESGVDQLVEIIKVLGTPTREEIK 293
            P +     +  L +I+ + G  +RE I+
Sbjct: 245 YPFYKASDDLTALAQIMTIRG--SRETIQ 271

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +  K C     EK    L LV+EYVP    R     Y     + L  + L+  QIC  +A
Sbjct: 79  IKYKGCCEDQGEKS---LQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMA 131
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-------YY 233
           Y+H+   + HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++
Sbjct: 132 YLHSQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFW 186
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELL 262
            APE +     Y A+ D+WS G  L ELL
Sbjct: 187 YAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 44/249 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 124
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 125 HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             +          T  K +  L + +EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 225
            AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 226 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 282 KVLGTPTRE 290
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 44/249 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 124
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 125 HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             +          T  K +  L + +EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 225
            AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 226 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 282 KVLGTPTRE 290
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTM 112
           QP    ++   RV+G G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLY 171
             ++   VVSL + + +   KD L L L L    +       H Y M Q   P      Y
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKF----HIYHMGQAGFPEARAVFY 291
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + + 
Sbjct: 292 AAEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE++     YT + D W+ GC+L E++ GQ  F       Q  + IK      REE
Sbjct: 350 GYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REE 396
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           ++ +           +K  P  + + +R  P+A  L S+LL   P  R
Sbjct: 397 VERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAER 431

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 246
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 247 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 102 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 155
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 156 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 213
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 274 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 127
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 128 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 185
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 245
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 246 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 48  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 107 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 160
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 161 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 218
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 219 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 278
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 279 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 309

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
             +  +R Y  PE I     +  +  +WS G +L +++ G
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 129/299 (43%), Gaps = 58/299 (19%)
Query: 64  TISYMAERVVGHGSFGVV-----------FQAKCLETGEAVAIKKVLQDKRYKNRELQTM 112
           T  Y     +G G+F VV           + AK + T +  A     +D +   RE +  
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-----RDHQKLEREARIC 84
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLY 171
           RLL HPN+V L     S +E+   YL   L    E    ++ + +Y  +     I+    
Sbjct: 85  RLLKHPNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH---- 137
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISY 227
             QI  ++ +IH    + HRD+KP+NLL+        +KL DFG A + V+GE      +
Sbjct: 138 --QILESVNHIHQH-DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGF 193
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
             +  Y +PE +     Y   +DIW+ G +L  LL+G P F  E    +L + IK     
Sbjct: 194 AGTPGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA---- 247
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                         + FP  +   W  +      PEA +L++++L  +P  R TA  A+
Sbjct: 248 ------------GAYDFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITADQAL 286

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +  K C     EK    L LV+EYVP    R     Y     + L  + L+  QIC  +A
Sbjct: 79  IKYKGCCEDQGEKS---LQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMA 131
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-------YY 233
           Y+H    + HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++
Sbjct: 132 YLHAQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFW 186
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELL 262
            APE +     Y A+ D+WS G  L ELL
Sbjct: 187 YAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 37  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +  K C     +     L LV+EYVP    R     Y     + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMA 148
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYY 233
           Y+H    + HRD+  +N+L++ +   +K+ DFG AK + +G       E   S +   ++
Sbjct: 149 YLHAQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FW 203
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELL 262
            APE +     Y A+ D+WS G  L ELL
Sbjct: 204 YAPECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 58/282 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L++ LL+  P  R
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 58/282 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 72
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 73  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 122
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 123 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 228
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L++ LL+  P  R
Sbjct: 229 ------------------FPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 78  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 132
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 133 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 188 SL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +     +   L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 75  GVSYGPGRPE---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 129
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 130 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPE 184
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 185 SL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 91  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 145
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 146 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 200
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 201 SL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 79  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 133
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 134 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 188
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 189 SL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 58/282 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L++ LL+  P  R
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 131/298 (43%), Gaps = 46/298 (15%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTM-RLLDHPNVVS 122
           +   ++G G++  V  A  L+ G+  A+K + +   +      RE++T+ +   + N++ 
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   F     +D+    LV E +   ++   I+     ++R     V+     +  AL +
Sbjct: 76  LIEFF-----EDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVR----DVAAALDF 126
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDF--GSAKVLVKG-----EPNISYIC-SR 231
           +H T G+ HRD+KP+N+L         +K+CDF  GS   L         P ++  C S 
Sbjct: 127 LH-TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 232 YYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVL 284
            Y APE++      AT Y    D+WS G VL  +L G P F G  G D      E+ +V 
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVC 245
Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                E I+       +++FP      W  I       EA DL+S+LL      R +A
Sbjct: 246 QNKLFESIQ-----EGKYEFPD---KDWAHI-----SSEAKDLISKLLVRDAKQRLSA 290

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 58/282 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L++ LL+  P  R
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 58/282 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L++ LL+  P  R
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K      TE     + L++E++P    +  + K+  K++ +  L Y      QIC+ +
Sbjct: 87  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGM 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRA 235
            Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ A
Sbjct: 140 DYLGSRQYV-HRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 197
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE +  +  Y A+ D+WS G  L ELL
Sbjct: 198 PECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 1   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 59
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 60  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 113
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 114 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 171
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 232 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 58/282 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 70
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 71  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 120
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 121 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 179 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 226
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L++ LL+  P  R
Sbjct: 227 ------------------FPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 58/282 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                             F + + PEA  L++ LL+  P  R
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 124
           V+G GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T ++    L  V+EYV       + +H +   R    +   Y  +I   L ++ +
Sbjct: 87  HSCFQTMDR----LYFVMEYVNGGD---LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE+I    
Sbjct: 140 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 196
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 233

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 130/294 (44%), Gaps = 58/294 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 122
           V+G G+F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 123 LKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHH---YKMSQRMPLIYVKLYFYQICR 177
           L   + S        L +V E++   +    ++K     +  S+ +   Y++    QI  
Sbjct: 91  LLETYSSDG-----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----QILE 141
Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRY 232
           AL Y H+   + HRD+KP+N+L+    ++  +KL DFG A  L  GE  +     + + +
Sbjct: 142 ALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPH 198
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           + APE++     Y   +D+W  G +L  LL G   F G    ++L E I       + + 
Sbjct: 199 FMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGKY 249
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           K MNP              W  I +      A DLV R+L   P  R T ++A+
Sbjct: 250 K-MNPR------------QWSHISES-----AKDLVRRMLMLDPAERITVYEAL 285

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K      TE     + L++E++P    +  + K+  K++ +  L Y      QIC+ +
Sbjct: 75  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGM 127
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRA 235
            Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ A
Sbjct: 128 DYLGSRQYV-HRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 185
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE +  +  Y A+ D+WS G  L ELL
Sbjct: 186 PECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 22/260 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 293
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +  +  I+ 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRW 237
Query: 294 CMNPNYTEF-KFPQIKAHPW 312
           C+    ++   F +I+ HPW
Sbjct: 238 CLALRPSDRPTFEEIQNHPW 257

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 124
           V+G GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +H +   R    +   Y  +I   L ++ +
Sbjct: 408 HSCFQTM--DRLYF--VMEYVNGGD---LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE+I    
Sbjct: 461 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 517
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 22/260 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 67
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 68  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 123 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 293
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +  +  I+ 
Sbjct: 181 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 240
Query: 294 CMNPNYTEF-KFPQIKAHPW 312
           C+    ++   F +I+ HPW
Sbjct: 241 CLALRPSDRPTFEEIQNHPW 260

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 113/277 (40%), Gaps = 48/277 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-------DHPNVVSL 123
           +V+G G+F  V   K  +TG+  A+K + +    K  E+   R         D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F     +DE YL LV+EY       ++    K  +R+P    + Y  +I  A+  +H
Sbjct: 127 HFAF-----QDENYLYLVMEYY--VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGE-PNISYICSRYYRAPELIFG 241
             +G  HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++  
Sbjct: 180 R-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 242 ATEYTAAI------DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
                         D W+ G    E+  GQ  F  +S  +   +I+              
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV-------------- 283
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                       K H    +  + +P EA D + RLL
Sbjct: 284 ----------HYKEHLSLPLVDEGVPEEARDFIQRLL 310

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 22/260 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 293
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +  +  I+ 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 237
Query: 294 CMNPNYTEF-KFPQIKAHPW 312
           C+    ++   F +I+ HPW
Sbjct: 238 CLALRPSDRPTFEEIQNHPW 257

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 24  KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 83  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 136
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 137 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 194
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 254
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
               +  I+ C+    ++   F +I+ HPW
Sbjct: 255 SXECQHLIRWCLALRPSDRPTFEEIQNHPW 284

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 116/261 (44%), Gaps = 32/261 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +      E  L +++E+        +    ++ + +    +++   Q   AL Y+H+   
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDN-K 155
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 244
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 245 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK----VLGTPTREEI------ 292
             Y    D+WS G  L E+   +P     + +  L++I K     L  P+R         
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 293 -KCMNPNY-TEFKFPQIKAHP 311
            KC+  N    +   Q+  HP
Sbjct: 275 KKCLEKNVDARWTTSQLLQHP 295

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +      E  L +++E+        +    ++ + +    +++   Q   AL Y+H+   
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDN-K 155
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 244
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 245 --YTAAIDIWSAGCVLAELLLGQP 266
             Y    D+WS G  L E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---------------- 207
           P+  V+   +Q+C+A+ ++H+   + H D+KP+N+L     ++L                
Sbjct: 135 PIHQVRHMAFQLCQAVKFLHDN-KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKST 193
Query: 208 --KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
             ++ DFGSA      E + + + +R+YRAPE+I     ++   D+WS GC++ E  +G 
Sbjct: 194 AVRVVDFGSATF--DHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGF 250
Query: 266 PLFPGESGVDQLVEIIKVLG-TPTREEIKC------------MNPNYTEFKFPQIKAHPW 312
            LF      + L  + ++LG  P+R   K              + N +  ++ +    P 
Sbjct: 251 TLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPL 310
Query: 313 HKIFQKRMPP--EAVDLVSRLLQYSPNLRSTAFDAV 346
            +          +  DL+  +L+Y P  R T  +A+
Sbjct: 311 RRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEAL 346

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTM-RLLDHPNVVSLKH 125
           +GHGS+G VF+ +  E G   A+K+ +      +D+  K  E+ +  ++  HP  V L+ 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +    E   LYL   L         + +H       +P   V  Y      ALA++H+ 
Sbjct: 125 AW---EEGGILYLQTEL-----CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFG--------SAKVLVKGEPNISYICSRYYRAPE 237
            G+ H D+KP N+ + P   + KL DFG         A  + +G+P         Y APE
Sbjct: 177 -GLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPE 226
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           L+ G+  Y  A D++S G  + E+     L  G  G  QL
Sbjct: 227 LLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  K C     EK    + LV+EYVP    R  + +H   ++Q +      L+  QIC  
Sbjct: 74  VKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 124
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------- 231
           +AY+H    + HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       
Sbjct: 125 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 179
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 180 FWYAPECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  K C     EK    + LV+EYVP    R  + +H   ++Q +      L+  QIC  
Sbjct: 73  VKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------- 231
           +AY+H    + HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       
Sbjct: 124 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 178
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 179 FWYAPECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 118/260 (45%), Gaps = 22/260 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 293
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + +    +  I+ 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRW 237
Query: 294 CMNPNYTEF-KFPQIKAHPW 312
           C+    ++   F +I+ HPW
Sbjct: 238 CLALRPSDRPTFEEIQNHPW 257

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           VG GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 135
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L Y+H T  + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 190
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 249
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +DIWS+ C++  +L G
Sbjct: 250 DAKVDIWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           VG GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 119
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L Y+H T  + H 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 174
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 233
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +DIWS+ C++  +L G
Sbjct: 234 DAKVDIWSSCCMMLHMLNG 252

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 122/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 1   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 59
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
              VV LK                E+ + ++ L+LE +   + +   I     + + +  
Sbjct: 60  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILERMEPVQDLFDFITERGALQEEL-- 115
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 116 --ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 171
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 232 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +++  R +G G+FG V   + ++  +  A+K V   K+Y         +L       + +
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 126 CFFSTTEKDELYLN---LVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
                     +Y +   L+ E +  +++ +I +++Y       +  +KLY  +I +AL Y
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNY 152
Query: 182 IHNTIGVCHRDIKPQNLLVN-PHTHQ-----------------------LKLCDFGSAKV 217
           +   + + H D+KP+N+L++ P+  +                       +KL DFG A  
Sbjct: 153 LRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
             K + + S I +R YRAPE+I     +  + D+WS GCVLAEL  G  LF     ++ L
Sbjct: 212 --KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 114
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 174 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYI 228
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L   E     ++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDEDFAKEFV 177
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+     L +++EY+       +     + +      +     +I + L Y+H+   
Sbjct: 95  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQ----IATILREILKGLDYLHSEKK 145
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 246
           + HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 146 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 202
Query: 247 AAIDIWSAGCVLAELLLGQP 266
           +  DIWS G    EL  G+P
Sbjct: 203 SKADIWSLGITAIELARGEP 222

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 32/261 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +      E  L +++E+        +    ++ + +    +++   Q   AL Y+H+   
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDN-K 155
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 244
           + HRD+K  N+L       +KL DFG SAK     +    +I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 245 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK----VLGTPTREEI------ 292
             Y    D+WS G  L E+   +P     + +  L++I K     L  P+R         
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 293 -KCMNPNY-TEFKFPQIKAHP 311
            KC+  N    +   Q+  HP
Sbjct: 275 KKCLEKNVDARWTTSQLLQHP 295

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 133
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L Y+H T  + H 
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 188
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 247
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +DIWS+ C++  +L G
Sbjct: 248 DAKVDIWSSCCMMLHMLNG 266

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 130/290 (44%), Gaps = 45/290 (15%)
Query: 65  ISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDKRYKNRELQTMR-LLDHPNVVS 122
           +S +  R V H + G  F  K +E T E ++ +++ + +    RE   +R +  HP++++
Sbjct: 106 VSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + S++     ++ LV + + +  +   +     +S++      +     +  A+++
Sbjct: 165 LIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEK----ETRSIMRSLLEAVSF 215
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE       +  Y APE++  
Sbjct: 216 LHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273
Query: 242 ATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           + +     Y   +D+W+ G +L  LL G P F     +  L  I              M 
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--------------ME 319
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
             Y +F  P+     W             DL+SRLLQ  P  R TA  A+
Sbjct: 320 GQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTAEQAL 358

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           +E+  ++ LDHPNVV L        E D LY+  V E V +     +     +S+     
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNE-DHLYM--VFELVNQGPVMEVPTLKPLSEDQ--- 138
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
             + YF  + + + Y+H    + HRDIKP NLLV    H +K+ DFG +      +  +S
Sbjct: 139 -ARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDALLS 195
Query: 227 -YICSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGV--------- 274
             + +  + APE +    +  +  A+D+W+ G  L   + GQ  F  E  +         
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQ 255
Query: 275 -----DQ--LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 312
                DQ  + E +K L T   ++    NP  +    P+IK HPW
Sbjct: 256 ALEFPDQPDIAEDLKDLITRMLDK----NPE-SRIVVPEIKLHPW 295

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---------QTMRLLDHPNVVSL 123
           +G G FGVVF+AK        AIK++    R  NREL         + +  L+HP +V  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 124 KHCFF--STTEK-----DELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
            + +   +TTEK      ++YL + ++    E +   +     + +R   + + + F QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI-FLQI 127
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNISY- 227
             A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +Y 
Sbjct: 128 AEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 228 -----ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
                + ++ Y +PE I G + Y+  +DI+S G +L ELL
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 75  LKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 180
Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y +  DIWS G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 89/340 (26%), Positives = 136/340 (40%), Gaps = 84/340 (24%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGK-NGQPKQTISYMAERVVGHGSF 78
           PE+  ++   DD E E    D N    G   +  IG   NG+      Y   R +G G F
Sbjct: 1   PEQEEEILGSDDDEQE----DPNDYCKGGYHLVKIGDLFNGR------YHVIRKLGWGHF 50
Query: 79  GVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHPN---VVSLKHCF 127
             V+ +  ++  + VA+K V   + Y    L  +RLL        + PN   VV L   F
Sbjct: 51  STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110
Query: 128 FSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
              +  +  ++ +V E +   + + +IK +Y   Q +PL  VK    Q+ + L Y+H   
Sbjct: 111 -KISGVNGTHICMVFEVLGHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKC 166
Query: 187 GVCHRDIKPQNL------------------------------------------LVNP-- 202
            + H DIKP+N+                                          LVNP  
Sbjct: 167 RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLE 226
Query: 203 ----HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
                  ++K+ D G+A  + K       I +R YR+ E++ G+  Y    DIWS  C+ 
Sbjct: 227 PKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMA 283
Query: 259 AELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI 292
            EL  G  LF   SG       D +  II++LG   R+ I
Sbjct: 284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 23/210 (10%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 127
           +VG+G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 128 FSTTE---KDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    D+L+  LV+E+    +V  +IK+       +   ++     +I R L+++H
Sbjct: 91  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH 146
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 240
               V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 147 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 203
Query: 241 ----GATEYTAAIDIWSAGCVLAELLLGQP 266
                AT Y    D+WS G    E+  G P
Sbjct: 204 DENPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 90  LKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 139 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 195
Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y +  DIWS G    EL  G+P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 204 YSFQVARGMEFLSSRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 286
           R    + APE IF    Y+   D+WS G +L E+  LG   +PG       V++ +   +
Sbjct: 262 RLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDFCS 313
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
             RE ++   P Y+  +  QI    WH+  ++R  P   +LV +L
Sbjct: 314 RLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELVEKL 356

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 22/225 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-------DHPNVVSL 123
           +V+G G+FG V   K     +  A+K + + +  K  E    R         D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            + F     +D+  L LV++Y       ++    K   R+P    + Y  ++  A+  +H
Sbjct: 140 HYAF-----QDDNNLYLVMDYY--VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI-- 239
             +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 193 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 240 --FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
              G   Y    D WS G  + E+L G+  F  ES V+   +I+ 
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 229 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 176 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 234
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 235 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 275

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 131 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 189
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 190 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 230

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 75  LKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 180
Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y +  DIWS G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 130 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 188
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 189 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 229

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 132 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 190
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 191 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 231

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 130
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 153
Query: 131 TE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 +DE +L LV++Y       ++    K   ++P    + Y  ++  A+  IH  +
Sbjct: 154 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 210
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 240
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 211 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           G  +Y    D WS G  + E+L G+  F  ES V+   +I+ 
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 311

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 154
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ +++K    + +   L Y+     Q    L Y+H+   + H 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 209
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++       LCDFG A  L       S +   Y      + APE++ G +  
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-C 268
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +D+WS+ C++  +L G
Sbjct: 269 DAKVDVWSSCCMMLHMLNG 287

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 125 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 183
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 184 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 224

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 124 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 182
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 117/287 (40%), Gaps = 71/287 (24%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHP 118
           Y   R +G G F  V+    ++    VA+K V   + Y    L  ++LL          P
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDP 92
Query: 119 N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQ 174
           N   VV L    F  +  + +++ +V E +   + + +IK +Y   Q +P+  VK    Q
Sbjct: 93  NKDMVVQLID-DFKISGMNGIHVCMVFEVLGHHLLKWIIKSNY---QGLPVRCVKSIIRQ 148
Query: 175 ICRALAYIHNTIGVCHRDIKPQN------------------------------------- 197
           + + L Y+H+   + H DIKP+N                                     
Sbjct: 149 VLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAP 208
Query: 198 ---LLVNP------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAA 248
              LLVNP         ++K+ D G+A  + K       I +R YR+ E++ GA  Y+  
Sbjct: 209 AADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQYRSIEVLIGAG-YSTP 265
Query: 249 IDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTR 289
            DIWS  C+  EL  G  LF   SG       D +  II++LG+  R
Sbjct: 266 ADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPR 312

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM 112
            G+  Q  S M+   +G G+FG V+ A   E  + V +K     KVL+D   ++ +L  +
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 113 RL-------LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRM 163
            L       ++H N++ +   F     +++ +  LV+E       +   I  H ++ +  
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-- 129
Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
           PL      F Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+ 
Sbjct: 130 PL--ASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKL 185
Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             ++  +  Y APE++ G       +++WS G  L  L+  +  F
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 140 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 198
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 199 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 239

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD---------- 116
           Y    ++G G FG VF    L     VAIK +      +NR L    L D          
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI-----PRNRVLGWSPLSDSVTCPLEVAL 87
Query: 117 ---------HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
                    HP V+ L   F    E  E ++ LVLE  P     +  +   ++++ PL  
Sbjct: 88  LWKVGAGGGHPGVIRLLDWF----ETQEGFM-LVLER-PLPAQDLFDY---ITEKGPLGE 138
Query: 168 --VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F Q+  A+ + H+  GV HRDIK +N+L++      KL DFGS   L+  EP  
Sbjct: 139 GPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYT 196
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
            +  +R Y  PE I     +     +WS G +L +++ G 
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 130
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 137
Query: 131 TE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 +DE +L LV++Y       ++    K   ++P    + Y  ++  A+  IH  +
Sbjct: 138 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 194
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 240
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 195 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           G  +Y    D WS G  + E+L G+  F  ES V+   +I+ 
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 114
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 174 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 228
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFV 177
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 123/271 (45%), Gaps = 39/271 (14%)
Query: 89  TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-E 147
             + ++IK    D  +KN ELQ +  + +   ++   C    T  DE+Y+  + EY+  +
Sbjct: 77  NNDKISIKSKYDD--FKN-ELQIITDIKNEYCLT---CEGIITNYDEVYI--IYEYMEND 128
Query: 148 TVHRVIKHHYKMSQR----MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH 203
           ++ +  ++ + + +     +P+  +K     +  + +YIHN   +CHRD+KP N+L++ +
Sbjct: 129 SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188
Query: 204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAA-IDIWSAGCVLAELL 262
             ++KL DFG ++ +V  +   S   +  +  PE     + Y  A +DIWS G  L  + 
Sbjct: 189 G-RVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
Query: 263 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR--- 319
                F  +     LVE+   + T   E             +P  + H  + +  K+   
Sbjct: 247 YNVVPFSLKIS---LVELFNNIRTKNIE-------------YPLDRNHFLYPLTNKKSTC 290
Query: 320 ----MPPEAVDLVSRLLQYSPNLRSTAFDAV 346
               +  E +D +   L+ +P  R T+ DA+
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 289
           R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 290 EEIK-CMNPNYTEF-KFPQIKAHPW 312
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 114
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 174 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 228
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFV 177
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK             + Y
Sbjct: 124 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPY 182
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 111/249 (44%), Gaps = 44/249 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 124
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVXLLASLNHQYVVRYY 68
Query: 125 HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             +          T  K +  L +  EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 225
            AL+YIH+  G+ HR++KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 226 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNIL 238
Query: 282 KVLGTPTRE 290
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 135
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ +++K    + +   L Y+     Q    L Y+H+   + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 190
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++       LCDFG A  L         +   Y      + APE++ G +  
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-C 249
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +D+WS+ C++  +L G
Sbjct: 250 DAKVDVWSSCCMMLHMLNG 268

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 456 L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG V++     T E VAIK +       +     +E+  +   D P +      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
             +T+     L +++EY+             + +  PL   Y+     +I + L Y+H+ 
Sbjct: 87  LKSTK-----LWIIMEYLGGG------SALDLLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++     +KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 136 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 192
Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y    DIWS G    EL  G+P
Sbjct: 193 YDFKADIWSLGITAIELAKGEP 214

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 118/292 (40%), Gaps = 73/292 (25%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHP 118
           Y   R +G G F  V+ +  ++  + VA+K V   + Y    L  +RLL        + P
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 119 N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQ 174
           N   VV L   F   +  +  ++ +V E +   + + +IK +Y   Q +PL  VK    Q
Sbjct: 83  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSNY---QGLPLPCVKKIIQQ 138
Query: 175 ICRALAYIHNTIGVCHRDIKPQNL------------------------------------ 198
           + + L Y+H    + H DIKP+N+                                    
Sbjct: 139 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 198
Query: 199 ------LVNP------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
                 LVNP         ++K+ D G+A  + K       I +R YR+ E++ G+  Y 
Sbjct: 199 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YN 255
Query: 247 AAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI 292
              DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I
Sbjct: 256 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 307

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 28/225 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L      TT + ++   L++E+ P     TV     + Y + +   LI ++     +  
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVG 123
Query: 178 ALAYIHNTIGVCHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYR 234
            + ++    G+ HR+IKP N++  +      + KL DFG+A+ L   E  +S   +  Y 
Sbjct: 124 GMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 235 APELIFGAT-------EYTAAIDIWSAGCVLAELLLGQ-PLFPGE 271
            P++   A        +Y A +D+WS G        G  P  P E
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D WS G +   LL G P F    G+
Sbjct: 229 YVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL 269

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 126/312 (40%), Gaps = 76/312 (24%)
Query: 66  SYMAERVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 113
           +Y  + ++G G   VV     +  C E   AV I  V     +   E+Q +R        
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 114 ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 160
               +  HPN++ LK  +         F   +K EL+     +Y+ E V         +S
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKV--------TLS 122
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           ++     ++     IC AL    + + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 123 EKETRKIMRALLEVIC-AL----HKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 176
Query: 221 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           GE   S   +  Y APE+I  +       Y   +D+WS G ++  LL G P F     + 
Sbjct: 177 GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
            L  I              M+ NY +F  P+     W             DLVSR L   
Sbjct: 237 MLRMI--------------MSGNY-QFGSPE-----WDD-----YSDTVKDLVSRFLVVQ 271
Query: 336 PNLRSTAFDAVG 347
           P  R TA +A+ 
Sbjct: 272 PQKRYTAEEALA 283

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 62/116 (53%), Gaps = 17/116 (14%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---KLCDFG-SAKVLVKGE------PN 224
           +  AL ++HN  G+ HRD+KP+N+L   H +Q+   K+CDFG  + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 225 ISYIC-SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           +   C S  Y APE++   +E    Y    D+WS G +L  LL G P F G  G D
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 104 L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 155
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 156 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 210
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 211 SI-NFRRFTSASDVWMFGVCMWEILM 235

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 79  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 130
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 131 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 185
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 186 SI-NFRRFTSASDVWMFGVCMWEILM 210

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 79  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 129
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 188
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 81  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 132
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 133 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 188 SI-NFRRFTSASDVWMFGVCMWEILM 212

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 72  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 122
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 123 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 182 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 93  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 143
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 144 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 203 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 247

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN- 184
            F         L++V EY+   +++R++ H     +++         Y + + + Y+HN 
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPEL 238
              + HRD+K  NLLV+   + +K+CDFG +++         ++ S+       + APE+
Sbjct: 157 NPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWMAPEV 210
Query: 239 IFGATEYTAAIDIWSAGCVLAEL-LLGQP 266
           +        + D++S G +L EL  L QP
Sbjct: 211 LRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 78  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 130 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 184
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 185 SI-NFRRFTSASDVWMFGVCMWEILM 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 73  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 125 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 179
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 180 SI-NFRRFTSASDVWMFGVCMWEILM 204

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 28/226 (12%)
Query: 59  GQPKQTIS---YMAERVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE---- 108
           G P+  I+    +  R++G G FG V++       GE   VA+K   +D    N+E    
Sbjct: 15  GSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 109 -LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
               M+ LDHP++V L        E++  ++ + L    E  H + ++       + ++ 
Sbjct: 75  EAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLT 126
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           + LY  QIC+A+AY+  +I   HRDI  +N+LV      +KL DFG ++  ++ E     
Sbjct: 127 LVLYSLQICKAMAYLE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKA 183
Query: 228 ICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLF 268
             +R    + +PE I     +T A D+W     + E+L    QP F
Sbjct: 184 SVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 456 L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 71  RVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 122
           R++G G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L        E++  ++ + L    E  H + ++       + ++ + LY  QIC+A+AY+
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYL 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 239
             +I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +PE I
Sbjct: 130 E-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI 186
Query: 240 FGATEYTAAIDIWSAGCVLAELLL--GQPLF 268
                +T A D+W     + E+L    QP F
Sbjct: 187 -NFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 71  RVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 122
           R++G G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L        E++  ++ + L    E  H + ++       + ++ + LY  QIC+A+AY+
Sbjct: 74  L----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYL 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 239
             +I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +PE I
Sbjct: 126 E-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI 182
Query: 240 FGATEYTAAIDIWSAGCVLAELLL--GQPLFPGES 272
                +T A D+W     + E+L    QP F  E+
Sbjct: 183 -NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN- 184
            F         L++V EY+   +++R++ H     +++         Y + + + Y+HN 
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPEL 238
              + HR++K  NLLV+   + +K+CDFG +++        +++ S+       + APE+
Sbjct: 157 NPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWMAPEV 210
Query: 239 IFGATEYTAAIDIWSAGCVLAEL-LLGQP 266
           +        + D++S G +L EL  L QP
Sbjct: 211 LRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L      TT + ++   L++E+ P     TV     + Y + +   LI ++     +  
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVG 123
Query: 178 ALAYIHNTIGVCHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYR 234
            + ++    G+ HR+IKP N++  +      + KL DFG+A+ L   E  +    +  Y 
Sbjct: 124 GMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYL 182
Query: 235 APELIFGAT-------EYTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
            P++   A        +Y A +D+WS G        G  P  P E 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 122/312 (39%), Gaps = 76/312 (24%)
Query: 66  SYMAERVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 113
           +Y  + ++G G   VV     +  C E   AV I  V     +   E+Q +R        
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 114 ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 160
               +  HPN++ LK  +         F   +K EL+     +Y+ E V    K   K+ 
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEKETRKIM 117
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           + +  +   L+              + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 118 RALLEVICALH-------------KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 163
Query: 221 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           GE       +  Y APE+I  +       Y   +D+WS G ++  LL G P F     + 
Sbjct: 164 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 223
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
            L  I              M+ NY +F  P+   +               DLVSR L   
Sbjct: 224 MLRMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQ 258
Query: 336 PNLRSTAFDAVG 347
           P  R TA +A+ 
Sbjct: 259 PQKRYTAEEALA 270

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ERV+G G FG V   +    G+   AVAIK +      K R     E   M   DHPNVV
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+             + +V+E++    +   ++ H     +  +I +      I   + 
Sbjct: 108 HLEGVVTRGKP-----VMIVIEFMENGALDAFLRKH---DGQFTVIQLVGMLRGIAAGMR 159
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + A
Sbjct: 160 YLAD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTA 216
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 217 PEAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 125/312 (40%), Gaps = 76/312 (24%)
Query: 66  SYMAERVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 113
           +Y  + ++G G   VV     +  C E   AV I  V     +   E+Q +R        
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 114 ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 160
               +  HPN++ LK  +         F   +K EL+     +Y+ E V         +S
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKV--------TLS 122
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           ++     ++     IC AL    + + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 123 EKETRKIMRALLEVIC-AL----HKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 176
Query: 221 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           GE       +  Y APE+I  +       Y   +D+WS G ++  LL G P F     + 
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
            L  I              M+ NY +F  P+     W             DLVSR L   
Sbjct: 237 MLRMI--------------MSGNY-QFGSPE-----WDD-----YSDTVKDLVSRFLVVQ 271
Query: 336 PNLRSTAFDAVG 347
           P  R TA +A+ 
Sbjct: 272 PQKRYTAEEALA 283

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKV-----LQDKRYKNRELQTM 112
           P + +   ++RV+G G FGVV+  + ++  +     AIK +     +Q      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R L+HPNV++L            + L       P   H  +    +  QR P +   + F
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLL-------PYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ R + Y+     V HRD+  +N +++  +  +K+ DFG A+ ++  E   S    R
Sbjct: 130 GLQVARGMEYLAEQKFV-HRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHR 186
Query: 232 YYRAPELIFGATE------YTAAIDIWSAGCVLAELL 262
           + R P + + A E      +T   D+WS G +L ELL
Sbjct: 187 HARLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 58/294 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 122
           V+G G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 123 LKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHH---YKMSQRMPLIYVKLYFYQICR 177
           L      T   D + L +V E++   +    ++K     +  S+ +   Y++    QI  
Sbjct: 93  L----LETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----QILE 143
Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRY 232
           AL Y H+   + HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + +
Sbjct: 144 ALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPH 200
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           + APE++     Y   +D+W  G +L  LL G   F G    ++L E I       + + 
Sbjct: 201 FMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGKY 251
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           K MNP              W  I +      A DLV R+L   P  R T ++A+
Sbjct: 252 K-MNPRQ------------WSHISES-----AKDLVRRMLMLDPAERITVYEAL 287

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 26/176 (14%)
Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           HP++V + +    T    +    +V+EYV  +++ R         Q++P+     Y  +I
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR------SKGQKLPVAEAIAYLLEI 191
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICS 230
             AL+Y+H +IG+ + D+KP+N+++     QLKL D G+   +     + G P       
Sbjct: 192 LPALSYLH-SIGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINSFGYLYGTPG------ 242
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
             ++APE++   T  T A DI++ G  LA L L  P   G   VD L E   VL T
Sbjct: 243 --FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLKT 293

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ERV+G G FG V   +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   +K   K   +  +I +      I   + 
Sbjct: 87  HLEGVVTKSKP-----VMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMK 138
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 139 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 195
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 196 PEAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 33/209 (15%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL--------VKGEPNISYICSRYYR 234
            +   V HRDI  +N+LV+ +   +KL DFG ++ +         KG+  I ++      
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKGKLPIKWM------ 179
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLL 263
           APE I     +T+A D+W  G  + E+L+
Sbjct: 180 APESI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 58/294 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 122
           V+G G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 123 LKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHH---YKMSQRMPLIYVKLYFYQICR 177
           L      T   D + L +V E++   +    ++K     +  S+ +   Y++    QI  
Sbjct: 91  L----LETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----QILE 141
Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRY 232
           AL Y H+   + HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + +
Sbjct: 142 ALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPH 198
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           + APE++     Y   +D+W  G +L  LL G   F G    ++L E I       + + 
Sbjct: 199 FMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGKY 249
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           K MNP              W  I +      A DLV R+L   P  R T ++A+
Sbjct: 250 K-MNPR------------QWSHISES-----AKDLVRRMLMLDPAERITVYEAL 285

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 73  VGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRY-KNRELQT-MRLLDH-------- 117
           +G G+FG V +A         T   VA+K + +   + ++R L + +++L H        
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 118 -----------PNVVSLKHCFFSTTEKDELYL----NLVLEYVPETVHRVIKHHYKMSQR 162
                      P +V ++ C F        YL    N  + Y PE +++           
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKPEDLYKDF--------- 144
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 40/222 (18%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYK----------NRELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 174
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 175 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 229
           I   + Y+ N    + HRD++  N+ +        +C    DFG+++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLL 187
Query: 230 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 268
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 61/116 (52%), Gaps = 17/116 (14%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---KLCDFG-SAKVLVKGE------PN 224
           +  AL ++HN  G+ HRD+KP+N+L   H +Q+   K+CDF   + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 225 ISYIC-SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           +   C S  Y APE++   +E    Y    D+WS G +L  LL G P F G  G D
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 98  RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 149
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 150 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 206
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 207 PEAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 81  RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 132
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 133 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 189
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 190 PEAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 116/286 (40%), Gaps = 46/286 (16%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 120
           +  + +G G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           ++L   + +T+E     + L+LEY    E     +    +M     +I +     QI   
Sbjct: 92  INLHEVYENTSE-----IILILEYAAGGEIFSLCLPELAEMVSENDVIRL---IKQILEG 143
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           + Y+H    + H D+KPQN+L++       +K+ DFG ++ +         + +  Y AP
Sbjct: 144 VYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E I      T A D+W+ G +   LL     F GE   +  + I +V            N
Sbjct: 203 E-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------------N 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
            +Y+E  F  +                A D +  LL  +P  R TA
Sbjct: 250 VDYSEETFSSVSQL-------------ATDFIQSLLVKNPEKRPTA 282

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 108 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 159
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 160 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 216
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 217 PEAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+             + ++ EY+            K   R  +I +      I   + Y
Sbjct: 94  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + +   V HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 147 LSDMSAV-HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G V+ E++
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMEN--GSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 162
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYK----------NRELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 174
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 175 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 229
           I   + Y+ N    + HRD++  N+ +        +C    DFG ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 230 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 268
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D   V      +
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              ++     L +++EY+       +       +      +     +I + L Y+H+   
Sbjct: 91  LKGSK-----LWIIMEYLGGGSALDLLRAGPFDE----FQIATMLKEILKGLDYLHSEKK 141
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 246
           + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 142 I-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 198
Query: 247 AAIDIWSAGCVLAELLLGQP 266
           +  DIWS G    EL  G+P
Sbjct: 199 SKADIWSLGITAIELAKGEP 218

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC-SR 231
           I  A+ ++H+   + HRD+KP+NLL         LKL DFG AK   +    +   C + 
Sbjct: 118 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 174
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
           YY APE + G  +Y  + D+WS G ++  LL G P F   +G
Sbjct: 175 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 215

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 254
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 255 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 306
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 307 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 362

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC-SR 231
           I  A+ ++H+   + HRD+KP+NLL         LKL DFG AK   +    +   C + 
Sbjct: 137 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 193
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
           YY APE + G  +Y  + D+WS G ++  LL G P F   +G
Sbjct: 194 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 245
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 246 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 297
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 298 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 353

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 193
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 252
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 253 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 304
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 305 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 360

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 193
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKN--------RELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + HPN+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 81  RLEGVV--TKSKPVMIVTEXME--NGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 133
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G VL E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 247
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 299
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 300 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 129/286 (45%), Gaps = 39/286 (13%)
Query: 73  VGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRY-KNRELQT-MRLL----DHPNVV 121
           +G G+FG V +A         T   VA+K + +   + ++R L + +++L     H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 122 SLKHCFFSTTEKDELYLNLVLE---------YVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +L         K    L +++E         Y+    +  + +       + L ++  Y 
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +R 
Sbjct: 151 FQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 233 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 288
              + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +      
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRL 260
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 202
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMEN--GSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 162
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 190 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 286
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 248 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 299
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 204
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 256
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 257 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 312

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 193
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 193
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 202
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 129/289 (44%), Gaps = 36/289 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+        +  L + +V EY+   ++   ++ H      M L+ +      +   + 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +Y  +       + A
Sbjct: 166 YLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWTA 222
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           PE I   T +++A D+WS G V+ E+L  G+  +   +  D +  +         E  + 
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRL 273
Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQYSPNLRSTA 342
             P        Q+    WHK   +R    + V ++  L++   +LR+TA
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+             + ++ EY+            K   R  +I +      I   + Y
Sbjct: 79  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 132 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G V+ E++
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+             + ++ EY+            K   R  +I +      I   + Y
Sbjct: 73  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 126 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G V+ E++
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 121
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      ++      L LV +Y+P    +  V +H   +  ++ L     +  QI + +
Sbjct: 97  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 146
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+    G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A 
Sbjct: 147 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 237 ELI-FGATEYTAAIDIWSAGCVLAELL 262
           E I FG  +YT   D+WS G  + EL+
Sbjct: 205 ESIHFG--KYTHQSDVWSYGVTVWELM 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 121
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      ++      L LV +Y+P    +  V +H   +  ++ L     +  QI + +
Sbjct: 79  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 128
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+    G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A 
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 237 ELI-FGATEYTAAIDIWSAGCVLAELL 262
           E I FG  +YT   D+WS G  + EL+
Sbjct: 187 ESIHFG--KYTHQSDVWSYGVTVWELM 211

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+ E V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILIGELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYK----------NRELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 174
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 175 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 229
           I   + Y+ N    + HRD++  N+ +        +C    DF  ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH---SVSGLL 187
Query: 230 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 268
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L     S T      + LV + +P        H +K +    L+    +  QI + + Y
Sbjct: 104 RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--WCVQIAKGMMY 155
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 238
           +     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E 
Sbjct: 156 LEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 239 IFGATEYTAAIDIWSAGCVLAELL 262
           I    ++T   D+WS G  + EL+
Sbjct: 214 IH-YRKFTHQSDVWSYGVTIWELM 236

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L     S T      + LV + +P        H +K +    L+    +  QI + + Y
Sbjct: 81  RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--WCVQIAKGMMY 132
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 238
           +     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E 
Sbjct: 133 LEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 239 IFGATEYTAAIDIWSAGCVLAELLL--GQP 266
           I    ++T   D+WS G  + EL+   G+P
Sbjct: 191 IH-YRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 20  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 184
            F   + K +L +  V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 72  LFMGYSTKPQLAI--VTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF- 240
              + HRD+K  N+ ++   + +K+ DFG A V  +   +  +     S  + APE+I  
Sbjct: 127 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGXLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 84  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 133
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 134 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 192 ESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 106 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 154
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 155 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 213 LESILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 81  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 87  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 135
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 136 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 194 LESILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+ DFG A+ + K    +    +
Sbjct: 149 YSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 286
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXR 258
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 259 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 91  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 139
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 140 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 198 LESILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 184
            F   + K +L +  V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 84  LFMGYSTKPQLAI--VTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF- 240
              + HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I  
Sbjct: 139 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 128/289 (44%), Gaps = 36/289 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+        +  L + +V EY+   ++   ++ H      M L+ +      +   + 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +   +       + A
Sbjct: 166 YLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIRWTA 222
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           PE I   T +++A D+WS G V+ E+L  G+  +   +  D +  +         E  + 
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRL 273
Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQYSPNLRSTA 342
             P        Q+    WHK   +R    + V ++  L++   +LR+TA
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL------ 123
           +G G FG V++    +    VA+K + +D        +E   M+ + HPN+V L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F+  TE    Y NL L+Y+ E   + +         + L+Y+     QI  A+ Y+ 
Sbjct: 79  EPPFYIITEF-MTYGNL-LDYLRECNRQEV-------SAVVLLYMAT---QISSAMEYLE 126
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 240
                 HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + APE + 
Sbjct: 127 KK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESL- 182
Query: 241 GATEYTAAIDIWSAGCVLAEL-LLGQPLFPG 270
              +++   D+W+ G +L E+   G   +PG
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 17/195 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 125
           +G GSF  V++    ET   VA  + LQD++    E Q        ++ L HPN+V    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN- 184
            + ST  K +  + LV E       +     +K+ +   +  ++ +  QI + L ++H  
Sbjct: 93  SWESTV-KGKKCIVLVTELXTSGTLKTYLKRFKVXK---IKVLRSWCRQILKGLQFLHTR 148
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
           T  + HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE      +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EEK 205
Query: 245 YTAAIDIWSAG-CVL 258
           Y  ++D+++ G C L
Sbjct: 206 YDESVDVYAFGXCXL 220

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQ 110
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +  K +       E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 167
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 226
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 75  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 124 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 182 LESILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQ 110
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +  K +       E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 167
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 226
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQ 110
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +  K +       E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 167
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 226
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   + + R       N+E+      M  +D+P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 115 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 163
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 164 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 222 LESILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +T      + ++ E++   ++   ++ +     +  +I +      I   + 
Sbjct: 98  HLEGVVTKSTP-----VMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMK 149
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 234
           Y+ + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 150 YLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 208 APEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQ 110
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +  K +       E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 167
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 226
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 114/243 (46%), Gaps = 41/243 (16%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIK-KVLQDKRYKNR------ELQ 110
           P++ + +   +V+G G+FG V  A      +TG ++ +  K+L++K   +       EL+
Sbjct: 43  PRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 111 TM-RLLDHPNVVSLKHCFFSTTEKDELYLNL-------VLEYVPETVHRVIKHH--YKMS 160
            M +L  H N+V+L     + T    +YL         +L Y+     +  +    Y+  
Sbjct: 101 MMTQLGSHENIVNL---LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 161 QRMP-------LIYVKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 211
           +R+        L +  L  + YQ+ + + ++     V HRD+  +N+LV  H   +K+CD
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV-HRDLAARNVLVT-HGKVVKICD 215
Query: 212 FGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPL 267
           FG A+ ++     +    +R    + APE +F    YT   D+WS G +L E+  LG   
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP 274
Query: 268 FPG 270
           +PG
Sbjct: 275 YPG 277

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 85
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 184
             +ST  +    L +V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 86  MGYSTAPQ----LAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF- 240
              + HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I  
Sbjct: 139 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI   
Sbjct: 78  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAEG 126
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 127 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 185 LESILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------TMRLLDHPN 119
           ++  + ++G G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGR-LADGXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI--CR 177
           ++ L+    + TE+  +Y  +    V   +        +   + PL + K     +   R
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLRE------RPESQPPLDWPKRQRIALGSAR 142
Query: 178 ALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY--Y 233
            LAY+H+     + HRD+K  N+L++     + + DFG AK++   + ++         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 124
           +G G FGVV++     T   VA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYI 182
              FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELI 239
           H    + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 124
           +G G FGVV++     T   VA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYI 182
              FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELI 239
           H    + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------TMRLLDHPN 119
           ++  + ++G G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGR-LADGTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI--CR 177
           ++ L+    + TE+  +Y  +    V   +        +   + PL + K     +   R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLRE------RPESQPPLDWPKRQRIALGSAR 150
Query: 178 ALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY--Y 233
            LAY+H+     + HRD+K  N+L++     + + DFG AK++   + ++         +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHP 118
           ++ I+ + E  +G G FGVV   K  +    VA+K + +    ++   +E QTM  L HP
Sbjct: 7   REEITLLKE--LGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            +V     F+    K E  + +V EY+    +   ++ H K  +   L+ +    Y +C 
Sbjct: 64  KLVK----FYGVCSK-EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM---CYDVCE 115
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YR 234
            +A++ +   + HRD+  +N LV+     +K+ DFG  + ++  +  +S + +++   + 
Sbjct: 116 GMAFLESHQFI-HRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWS 172
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE +F   +Y++  D+W+ G ++ E+ 
Sbjct: 173 APE-VFHYFKYSSKSDVWAFGILMWEVF 199

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 124
           +G G FGVV++     T   VA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYI 182
              FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++
Sbjct: 90  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELI 239
           H    + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 144 HENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
            G  E T   DI+S G VL E++ G P
Sbjct: 202 RG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA-----VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 119
           ++V+G G FG V++   L+T        VAIK +      K R     E   M    H N
Sbjct: 49  QKVIGAGEFGEVYKG-MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L+             + ++ EY+      + K   +      ++ +      I   +
Sbjct: 108 IIRLEGVISKYKP-----MMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYR 234
            Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 161 KYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT 217
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 218 APEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 122
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 123 --LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
             L  C  ST +       LV + +P     ++ H  +   R+    +  +  QI + ++
Sbjct: 83  RLLGICLTSTVQ-------LVTQLMPYGC--LLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 237
           Y+ + + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E
Sbjct: 134 YLED-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            I     +T   D+WS G  + EL+
Sbjct: 192 SIL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 65  ISYMA-ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLL 115
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           +HPN++ L+     T     + L   +E    ++  R+    + + Q + ++        
Sbjct: 73  EHPNIIRLEGVV--TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR------G 124
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 231
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S    
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               + APE I    ++T+A D WS G V+ E++
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 88  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 137
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 138 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 196 ESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 103/266 (38%), Gaps = 81/266 (30%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---------QTMRLLDHPNVV 121
           + +G G FGVVF+AK        AIK++    R  NREL         + +  L+HP +V
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 122 SLKHCFFST------TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------- 168
              + +  T       E DE++L       P +    +       +RM            
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 169 -----KLYFY---QICR-------------------------------ALAYIHNTIGVC 189
                K+Y Y   Q+CR                               A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186
Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNISY------ICSRYYRAP 236
           HRD+KP N+        +K+ DFG    + + E       P  +Y      + ++ Y +P
Sbjct: 187 HRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSP 245
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I G   Y+  +DI+S G +L ELL
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELL 270

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 45/227 (19%)
Query: 63  QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRELQTMRL--LDHPN 119
           Q++      V   G FG V++A+ L   E VA+K   +QDK+    E +   L  + H N
Sbjct: 22  QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHEN 79
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC--- 176
           ++      F   EK    +++ L  +          H K S    L    + + ++C   
Sbjct: 80  ILQ-----FIGAEKRGTSVDVDLWLI-------TAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 177 ----RALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKG 221
               R LAY+H  I          + HRDIK +N+L+    + L  C  DFG A     G
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAG 184
Query: 222 EP---NISYICSRYYRAPELIFGATEYTA----AIDIWSAGCVLAEL 261
           +        + +R Y APE++ GA  +       ID+++ G VL EL
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNVVS 122
           M    +G GSFG V++ K      AV I KV+     Q + ++N E+  +R   H N++ 
Sbjct: 39  MLSTRIGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL- 95
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
               F     KD L   +V ++   +   + KH +    +  +  +     Q  + + Y+
Sbjct: 96  ---LFMGYMTKDNL--AIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISY-ICSRYYRAPELI 239
           H    + HRD+K  N+ ++     +K+ DFG A V  +  G   +     S  + APE+I
Sbjct: 149 HAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206
Query: 240 F--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
                  ++   D++S G VL EL+ G+  +   +  DQ++ ++
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 38/229 (16%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 120 VVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
           +V+L              ++C +         LN +    P  +       +   +++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
             +  +  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 166 RDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 223
Query: 226 SYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 224 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +T      + ++ E++   ++   ++ +     +  +I +      I   + 
Sbjct: 72  HLEGVVTKSTP-----VMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMK 123
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 234
           Y+ + +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 124 YLAD-MNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 182 APEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 152 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 43  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 95  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 150
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 60/244 (24%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDKRYK-----NRELQ 110
           P+  I Y+  R +G G+FG VFQA+       E    VA+K + ++          RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 111 TMRLLDHPNVVSL--------KHC----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 158
            M   D+PN+V L          C    + +  + +E   ++    V    H  +    +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 159 MSQRMP--------LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 210
           +S   P        L   +    Q+   +AY+     V HRD+  +N LV      +K+ 
Sbjct: 163 VSSPGPPPLSCAEQLCIAR----QVAAGMAYLSERKFV-HRDLATRNCLVG-ENMVVKIA 216
Query: 211 DFGSAKVLVKGEPNISYICSRYYRA------------PELIFGATEYTAAIDIWSAGCVL 258
           DFG ++ +   +         YY+A            PE IF    YT   D+W+ G VL
Sbjct: 217 DFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVL 266
Query: 259 AELL 262
            E+ 
Sbjct: 267 WEIF 270

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 129 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 129 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 18  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 70  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 125
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 126 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 46/102 (45%), Gaps = 25/102 (24%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK    GE          
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE---------- 173
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
                      +Y  + D+WS G ++  LL G P F    G+
Sbjct: 174 -----------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 65  ISYMA-ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLL 115
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           +HPN++ L+     T     + L   +E    ++  R+    + + Q + ++        
Sbjct: 75  EHPNIIRLEGVV--TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR------G 126
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 231
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S    
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               + APE I    ++T+A D WS G V+ E++
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLKH 125
           G G FGVV++     T   VA+KK+         + K+  ++E++      H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYIH 183
             FS+   D   L LV  Y P     ++     +    PL +  +    Q     + ++H
Sbjct: 87  LGFSSDGDD---LCLVYVYXPNG--SLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH 141
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 240
               + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + 
Sbjct: 142 ENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR 199
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQP 266
           G  E T   DI+S G VL E++ G P
Sbjct: 200 G--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
           +V+L     + T    + +  + EY     +   + R  +         PL    L  + 
Sbjct: 104 IVNL---LGACTHGGPVLV--ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R 
Sbjct: 159 SQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 233 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
              + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 217 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 152 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
           +V+L     + T    + +  + EY     +   + R  +         PL    L  + 
Sbjct: 112 IVNL---LGACTHGGPVLV--ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R 
Sbjct: 167 SQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 233 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
              + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 225 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 120 VVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
           +V+L              ++C +     D L        V ET       +  +S R  L
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYG----DLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            +      Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 168 HFSS----QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 226 SYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/84 (38%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 190 HRDIKPQNLLVNPHTHQLKLCDFG--SAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
           HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T 
Sbjct: 157 HRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHATY 214
Query: 248 AIDIWSAGCVLAELLLGQPLFPGE 271
             DI++  CVL E L G P + G+
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGD 238

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 36  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 88  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 144 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             +ST  +    L +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 70  MGYSTAPQ----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 42/230 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 120 VVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
           +V+L              ++C +          + VLE  P          + ++     
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA---------FAIANSTAS 162
Query: 166 IYVKLYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               L+F  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     
Sbjct: 163 TRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNY 220
Query: 225 ISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 221 IVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/291 (22%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 82
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 83  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 135
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + F  Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ ++  E +  +
Sbjct: 136 LIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMLDKEFDSVH 193
Query: 228 ------ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
                 +  ++     L     ++T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 194 NKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 251
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 252 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 80
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 81  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 133
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + F  Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    +
Sbjct: 134 LIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEXXSVH 191
Query: 228 ------ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
                 +  ++     L     ++T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 192 NKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 249
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 250 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/311 (20%), Positives = 114/311 (36%), Gaps = 54/311 (17%)
Query: 72  VVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 123
           V+G G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F +    +EL++             +  H       + + Y+      + +AL YIH
Sbjct: 76  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 184 NTIGVCHRDIKPQNLLVNPH--------THQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 130 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII-------------- 281
             L      Y A  DI+S G    EL  G   F        L+E +              
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 282 --KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
             ++  +P+R        + +    P  +    P   +HP+H+ F     P     V + 
Sbjct: 249 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTFS----PHFHHFVEQC 301
Query: 332 LQYSPNLRSTA 342
           LQ +P+ R +A
Sbjct: 302 LQRNPDARPSA 312

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 45  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 103
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 104 KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 156
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 157 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 210
Query: 232 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 211 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 269
Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 270 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 309

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/311 (20%), Positives = 114/311 (36%), Gaps = 54/311 (17%)
Query: 72  VVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 123
           V+G G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F +    +EL++             +  H       + + Y+      + +AL YIH
Sbjct: 92  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 184 NTIGVCHRDIKPQNLLVNPH--------THQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII-------------- 281
             L      Y A  DI+S G    EL  G   F        L+E +              
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 282 --KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
             ++  +P+R        + +    P  +    P   +HP+H+ F     P     V + 
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTFS----PHFHHFVEQC 317
Query: 332 LQYSPNLRSTA 342
           LQ +P+ R +A
Sbjct: 318 LQRNPDARPSA 328

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 19  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 73
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 74  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 126
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----- 222
            + F  Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 127 LIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVH 184
Query: 223 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
               + +  ++     L     ++T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 185 NKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 242
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 243 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 283

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 82  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 134
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----- 222
            + F  Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 135 LIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVH 192
Query: 223 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
               + +  ++     L     ++T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 193 NKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 251 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 24  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 79  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 131
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----- 222
            + F  Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 132 LIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVH 189
Query: 223 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
               + +  ++     L     ++T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 190 NKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 248 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 288

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 129
           VG G +G V++   L  GE+VA+K      +   ++  E+    LL H N++        
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDM- 72
Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--- 186
           T+      L L+  Y     H  +    +     P + ++L     C  LA++H  I   
Sbjct: 73  TSRNSSTQLWLITHY---HEHGSLYDFLQRQTLEPHLALRLAVSAAC-GLAHLHVEIFGT 128
Query: 187 ----GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPE 237
                + HRD K +N+LV  +  Q  + D G A +  +G       N   + ++ Y APE
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNL-QCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 238 LI--------FGATEYTAAIDIWSAGCVLAEL 261
           ++        F + ++T   DIW+ G VL E+
Sbjct: 188 VLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 79
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 80  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 132
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----- 222
            + F  Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 133 LIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVH 190
Query: 223 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
               + +  ++     L     ++T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 191 NKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 248
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 249 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL----QTMRLL 115
           +P+    +   R +G GSFG ++    ++T E VAIK  L++ + K+ +L    +  R+L
Sbjct: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRIL 59
Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
                +     F    E D  Y  LV++ +  ++  +       S+++ L  V +   Q+
Sbjct: 60  QGGTGIPNVRWF--GVEGD--YNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
Query: 176 CRALAYIHNTIGVCHRDIKPQNLL--VNPHTHQLKLCDFGSAK 216
              + ++H+     HRDIKP N L  +    +Q+ + DFG AK
Sbjct: 113 INRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 46  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 100
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 101 GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 153
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----- 222
            + F  Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 154 LIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVH 211
Query: 223 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
               + +  ++     L     ++T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 212 NKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 269
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 270 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 310

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 86  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 141 GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 193
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + F  Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 194 LIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE--FDS 249
Query: 228 ICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
           + ++      + + A E      +T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 310 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 350

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 50/293 (17%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 22  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 77  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 129
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + F  Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y
Sbjct: 130 LIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----Y 183
Query: 228 ICSRYYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV 278
                    +L             ++T   D+WS G +L EL+  G P +P  +  D  V
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
            ++        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 244 YLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 286

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 50/293 (17%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 80
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 81  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 133
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + F  Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y
Sbjct: 134 LIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----Y 187
Query: 228 ICSRYYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV 278
                    +L             ++T   D+WS G +L EL+  G P +P  +  D  V
Sbjct: 188 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 247
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
            ++        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 248 YLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 82  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 134
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----- 222
            + F  Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 135 LIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVH 192
Query: 223 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
               + +  ++     L     ++T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 193 NKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 251 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 32  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 86
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 87  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 139
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + F  Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 140 LIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE--FDS 195
Query: 228 ICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
           + ++      + + A E      +T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 196 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 255
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 256 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 296

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+K  +Y  +V+E V             +      + VK     +  A A +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTF-----LRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 188 VC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE-LIFG 241
            C  HRD+  +N LV    + LK+ DFG ++    G    S    +    + APE L +G
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 242 ATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 272
              Y++  D+WS G +L E   LG   +P  S
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 82
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 83  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 135
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + F  Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 136 LIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE--FDS 191
Query: 228 ICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
           + ++      + + A E      +T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 192 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 251
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 252 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 133
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 134 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 189
Query: 235 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 190 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 49/238 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTM-RLLDHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 120 VVSL--------------KHC-------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 158
           +V+L              ++C       F     +  L  +L     PE + +       
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK------- 149
Query: 159 MSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 216
                PL    L  +  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+
Sbjct: 150 -EDGRPLELRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLAR 206
Query: 217 VLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            ++     I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 207 DIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 82  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 134
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + F  Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E     
Sbjct: 135 LIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE--FDS 190
Query: 228 ICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
           + ++      + + A E      +T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 191 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 251 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 127
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 128 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 183
Query: 235 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 184 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 79
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 80  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 132
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + F  Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +
Sbjct: 133 LIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVH 190
Query: 228 ------ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
                 +  ++     L     ++T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 191 NKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 248
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 249 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------------E 108
           P   I +  E V+G G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
              M+   HPNV+SL         + E    +VL Y+    H  +++  +     P +  
Sbjct: 82  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 134
Query: 169 KLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + F  Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +
Sbjct: 135 LIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVH 192
Query: 228 ------ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 280
                 +  ++     L     ++T   D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 193 NKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +        +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 251 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 29/214 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+K  +Y  +V+E V             +      + VK     +  A A +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTF-----LRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 188 VC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 244
            C  HRD+  +N LV    + LK+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 245 -----YTAAIDIWSAGCVLAELL-LGQPLFPGES 272
                Y++  D+WS G +L E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 179
Query: 235 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 180 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 127
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 128 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 183
Query: 235 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 184 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 179
Query: 235 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 180 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 133
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYR 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +      R     + 
Sbjct: 134 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 192 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 33/175 (18%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---KRMPPEAVDL 327
           Q++  I  L          ++PN+ E +FP I       + +   KR P + + +
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 33/175 (18%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---KRMPPEAVDL 327
           Q++  I  L          ++PN+ E +FP I       + +   KR P + + +
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYR 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +      R     + 
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 182 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MSLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 33/175 (18%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---KRMPPEAVDL 327
           Q++  I  L          ++PN+ E +FP I       + +   KR P + + +
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSL-KHC 126
           ++GHG FG V++   L  G  VA+K+      Q       E++T+    HP++VSL   C
Sbjct: 46  LIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----RALAYI 182
                E++E+ L  + +Y+       +K H   S    +        +IC    R L Y+
Sbjct: 105 ----DERNEMIL--IYKYMENGN---LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------VLVKGEPNISYICSR 231
           H T  + HRD+K  N+L++      K+ DFG +K            +VKG   + YI   
Sbjct: 156 H-TRAIIHRDVKSINILLD-ENFVPKITDFGISKKGTELGQTHLXXVVKG--TLGYIDPE 211
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           Y+    L       T   D++S G VL E+L
Sbjct: 212 YFIKGRL-------TEKSDVYSFGVVLFEVL 235

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSL-KHC 126
           ++GHG FG V++   L  G  VA+K+      Q       E++T+    HP++VSL   C
Sbjct: 46  LIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----RALAYI 182
                E++E+ L  + +Y+       +K H   S    +        +IC    R L Y+
Sbjct: 105 ----DERNEMIL--IYKYMENGN---LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------VLVKGEPNISYICSR 231
           H T  + HRD+K  N+L++      K+ DFG +K            +VKG   + YI   
Sbjct: 156 H-TRAIIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLXXVVKG--TLGYIDPE 211
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           Y+    L       T   D++S G VL E+L
Sbjct: 212 YFIKGRL-------TEKSDVYSFGVVLFEVL 235

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 33/175 (18%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---KRMPPEAVDL 327
           Q++  I  L          ++PN+ E +FP I       + +   KR P + + +
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 75/175 (42%), Gaps = 33/175 (18%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---KRMPPEAVDL 327
           Q+ ++  ++           +PN+ E +FP I       + +   KR P + + +
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G  +  AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 169
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 90  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 170 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
           L+F   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 145 LHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 200
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 201 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 235

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G  +  AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 169
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 80  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 170 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
           L+F   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 135 LHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 190
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 191 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 225

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 75/175 (42%), Gaps = 33/175 (18%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 166
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+   P +  ++
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 224
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---KRMPPEAVDL 327
           Q+ ++  ++           +PN+ E +FP I       + +   KR P + + +
Sbjct: 225 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISI 267

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 33/175 (18%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 224
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---KRMPPEAVDL 327
           Q++  I  L          ++PN+ E +FP I       + +   KR P + + +
Sbjct: 225 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISI 271

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 74/175 (42%), Gaps = 33/175 (18%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +      +   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDXXXVVKD 186
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---KRMPPEAVDL 327
           Q+ ++  ++           +PN+ E +FP I       + +   KR P + + +
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 20/180 (11%)
Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRE 108
           G    + + T  +     +G G FG VF+      G   AIK+  +      D++   RE
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 109 LQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLI 166
           +    +L  H +VV     +FS   +D+ ++ +  EY    ++   I  +Y++       
Sbjct: 61  VYAHAVLGQHSHVVR----YFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEA 115
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 220
            +K    Q+ R L YIH ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 116 ELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 8/152 (5%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y   R +G GSFG ++    + +GE VAIK      ++    +++         V +   
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSI 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
            +   E D  Y  +V+E +  ++  +       S++  L  V L   Q+   + YIH+  
Sbjct: 71  KWCGAEGD--YNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK- 124
Query: 187 GVCHRDIKPQNLL--VNPHTHQLKLCDFGSAK 216
              HRD+KP N L  +    + + + DFG AK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G  +  AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 169
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 87  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 170 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
           L+F   + R + Y+     + HR++  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 142 LHFAADVARGMDYLSQKQFI-HRNLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 197
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 198 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 232

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 20/162 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSLKH 125
           +G G FG VF+      G   AIK+  +      D++   RE+    +L  H +VV    
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR--- 73
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            +FS   +D+ ++ +  EY    ++   I  +Y++        +K    Q+ R L YIH 
Sbjct: 74  -YFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH- 130
Query: 185 TIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 220
           ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 131 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 24/164 (14%)
Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSL 123
           +G G FG VF  KC++   G   AIK+  +      D++   RE+    +L  H +VV  
Sbjct: 15  IGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 71
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              +FS   +D+ ++ +  EY    ++   I  +Y++        +K    Q+ R L YI
Sbjct: 72  ---YFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 183 HNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 220
           H ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 128 H-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 170

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 20/162 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSLKH 125
           +G G FG VF+      G   AIK+  +      D++   RE+    +L  H +VV    
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR--- 73
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            +FS   +D+ ++ +  EY    ++   I  +Y++        +K    Q+ R L YIH 
Sbjct: 74  -YFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH- 130
Query: 185 TIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 220
           ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 131 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	354
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-93
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-92
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-92
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-90
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-90
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-89
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-89
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-88
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-88
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-88
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-88
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-87
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-86
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-86
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-86
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-85
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-84
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-84
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-82
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-82
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-82
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-82
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-81
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-80
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-80
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-80
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-75
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-58
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-58
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-58
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-56
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-56
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-55
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-55
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-54
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-54
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-54
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-54
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-54
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-53
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-53
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-52
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-52
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-52
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-52
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-52
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-52
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-52
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-52
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-51
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-51
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-51
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-51
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-51
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-50
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-50
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-49
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-49
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-49
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-49
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-49
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-49
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-49
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-49
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-49
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-49
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-49
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-48
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-48
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-48
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-48
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-48
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-48
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-47
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-47
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-47
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-47
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-47
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-47
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-46
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-46
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-46
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-46
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-46
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-46
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-45
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-45
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-45
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-45
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-44
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-44
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-44
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-43
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-43
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-43
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-43
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-42
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-42
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-42
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-42
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-42
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-41
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-41
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-41
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-41
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-41
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-40
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-40
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-40
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-40
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-39
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-37
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-37
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-37
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-37
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-37
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-36
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-35
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-35
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-35
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-35
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-35
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-34
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-34
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-34
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-34
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-34
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-33
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-33
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-33
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-33
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-33
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-33
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-32
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-32
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-32
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-32
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-32
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-31
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-30
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-30
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-30
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-30
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-28
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-27
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-27
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-19
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-16
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  561 bits (1448), Expect = 0.0
 Identities = 211/338 (62%), Positives = 264/338 (78%), Gaps = 13/338 (3%)

Query: 9   ASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYM 68
           +   +    + P     MK+  DK         +G++   ++ T   G+     Q +SY 
Sbjct: 9   SFAESCKPVQQPSAFGSMKVSRDK---------DGSKVTTVVATP--GQGPDRPQEVSYT 57

Query: 69  AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
             +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+
Sbjct: 58  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117

Query: 129 STTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFG 176

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
           +CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT+
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 236

Query: 248 AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 307
           +ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQI
Sbjct: 237 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 296

Query: 308 KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           KAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A
Sbjct: 297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  554 bits (1430), Expect = 0.0
 Identities = 198/316 (62%), Positives = 251/316 (79%), Gaps = 4/316 (1%)

Query: 31  DKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG 90
           +  +    ++        I V    GK G+ ++ I+Y   +V+G+GSFGVVFQAK +E+ 
Sbjct: 7   NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 91  EAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETV 149
           E VAIKKVLQDKR+KNRELQ MR++ HPNVV LK  F+S  +K DE++LNLVLEYVPETV
Sbjct: 66  E-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124

Query: 150 HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
           +R  +H+ K+ Q MP++ +KLY YQ+ R+LAYIH +IG+CHRDIKPQNLL++P +  LKL
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKL 183

Query: 210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP 269
            DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YT  IDIWS GCV+AEL+ GQPLFP
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243

Query: 270 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS 329
           GESG+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+ HP+ K+F+ R PP+A+DL+S
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303

Query: 330 RLLQYSPNLRSTAFDA 345
           RLL+Y+P+ R TA +A
Sbjct: 304 RLLEYTPSARLTAIEA 319

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  535 bits (1381), Expect = 0.0
 Identities = 139/310 (44%), Positives = 201/310 (64%), Gaps = 11/310 (3%)

Query: 47  GHIIVTTIGGKNGQP--KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY 104
           G ++         +   K+   +  ER+ G G+FG V   K   TG +VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 105 KNRELQTMRLL---DHPNVVSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKM 159
           +NRELQ M+ L    HPN+V L+  F++  E+   ++YLN+V+EYVP+T+HR  +++Y+ 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 160 SQRMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
               P I +K++ +Q+ R++  +H  ++ VCHRDIKP N+LVN     LKLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
              EPN++YICSRYYRAPELIFG   YT A+DIWS GC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYS 335
           EI++VLG P+RE ++ +NP++T+      K  PW  +F     +   EA DL+S LLQY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 336 PNLRSTAFDA 345
           P  R   ++A
Sbjct: 303 PEERMKPYEA 312

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  515 bits (1329), Expect = 0.0
 Identities = 145/320 (45%), Positives = 212/320 (66%), Gaps = 34/320 (10%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           G    +  Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 119 NVVSLKHCFFSTTEK---------------------------------DELYLNLVLEYV 145
           N++ L   F++T ++                                    YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 146 PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH 205
           P+T+H+V+K   +  + +P+  + +Y YQ+ RA+ +IH ++G+CHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDN 179

Query: 206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
            LKLCDFGSAK L+  EP+++YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 266 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAV 325
           PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 326 DLVSRLLQYSPNLRSTAFDA 345
           DL+ ++L+Y P+LR   ++A
Sbjct: 300 DLLEQILRYEPDLRINPYEA 319

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  278 bits (714), Expect = 9e-93
 Identities = 97/283 (34%), Positives = 147/283 (51%), Gaps = 21/283 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G GS+GVVF+ +  +TG+ VAIKK L+ +          RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           F     K  L+L  V EY   TV   +    +  + +P   VK   +Q  +A+ + H   
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 245
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 303
              +D+W+ GCV AELL G PL+PG+S VDQL  I K LG       +    N  ++  K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 304 FPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            P  +   P    F   +   A+ L+   L   P  R T    
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQL 282

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  278 bits (713), Expect = 1e-92
 Identities = 90/302 (29%), Positives = 150/302 (49%), Gaps = 34/302 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQD----KR-YKNRELQTMRLLDHPNV 120
           YM  + +G G  G+VF A   +  + VAIKK+ L D    K     RE++ +R LDH N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 121 VSLKHCF-----------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           V +                S TE + +Y+  V EY+   +  V++        +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 226
           L+ YQ+ R L YIH +  V HRD+KP NL +N     LK+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 227 -YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
             + +++YR+P L+     YT AID+W+AGC+ AE+L G+ LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 286 TPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF 343
               E+ + +      +          P  ++    +  EAVD + ++L +SP  R TA 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301

Query: 344 DA 345
           +A
Sbjct: 302 EA 303

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  278 bits (714), Expect = 1e-92
 Identities = 93/283 (32%), Positives = 151/283 (53%), Gaps = 21/283 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           VG GS+G+V + +  +TG  VAIKK L+    K       RE++ ++ L H N+V+L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                +K   YL  V E+V  T+   ++        +    V+ Y +QI   + + H+  
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 245
            + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 303
             A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG       E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 304 FPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            P+IK   P  + +  ++    +DL  + L   P+ R    + 
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAEL 304

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  272 bits (698), Expect = 6e-90
 Identities = 103/288 (35%), Positives = 149/288 (51%), Gaps = 31/288 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 123
           +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F     K  + L  V +++   +  +IK     S  +   ++K Y     + L Y+H
Sbjct: 78  LDAF---GHKSNISL--VFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 240
               + HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNP 297
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           +Y    F      P H IF      + +DL+  L  ++P  R TA  A
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQA 289

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  273 bits (699), Expect = 7e-90
 Identities = 86/302 (28%), Positives = 144/302 (47%), Gaps = 34/302 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------------RELQT 111
           Y  +R +  GS+G V        G  VAIK+V                       RE++ 
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 112 MRLLDHPNVVSLKHCF--FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IY 167
           +    HPN++ L+  F  F      +LYL  V E +   + +VI       QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           ++ + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           +  R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 288 TREEIKCM-NP---NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF 343
             E++    +P   +Y       + A  W  +      P A+DL++++L+++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312

Query: 344 DA 345
            A
Sbjct: 313 QA 314

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  269 bits (689), Expect = 8e-89
 Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 25/292 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMR-LLDHPNVVSL 123
           Y   R +G G +  VF+A  +   E V +K +  ++ K+ K RE++ +  L   PN+++L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 124 KHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                    +       V E+V  T   ++        Q +    ++ Y Y+I +AL Y 
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 146

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+   
Sbjct: 147 H-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205

Query: 243 TEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNY 299
             Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +   K      
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 300 TEFK--FPQIKAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             F     +     W +      Q  + PEA+D + +LL+Y    R TA +A
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  269 bits (691), Expect = 8e-89
 Identities = 95/303 (31%), Positives = 164/303 (54%), Gaps = 36/303 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQD-KR-YKNRELQTMRLLDHPN 119
           +  + ++G G++GVV  A    TGE VAIKK+          R    RE++ ++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 120 VVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++++ +     + ++  E+Y+  + E +   +HRVI      +Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLR 123

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----------- 226
           A+  +H    V HRD+KP NLL+N     LK+CDFG A+++ +   + S           
Sbjct: 124 AVKVLH-GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           ++ +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 287 PTREEI--KCMNPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           P  +       +P   E+    P   A P  K+F + + P+ +DL+ R+L + P  R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300

Query: 343 FDA 345
            +A
Sbjct: 301 KEA 303

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  268 bits (687), Expect = 2e-88
 Identities = 92/295 (31%), Positives = 154/295 (52%), Gaps = 33/295 (11%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLD 116
           +Y+    +G G++  V++ K   T   VA+K++    R ++         RE+  ++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           H N+V+L         +  L L  V EY+ + + + +         + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLL 110

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYY 233
           R LAY H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--- 290
           R P+++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            I      +  + +P+ +A         R+  +  DL+++LLQ+    R +A DA
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDA 279

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  269 bits (689), Expect = 3e-88
 Identities = 93/295 (31%), Positives = 162/295 (54%), Gaps = 28/295 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQD----KR-YKNRELQTMRLLDHPN 119
           Y     +G G++G+V  A        VAIKK+   +     +R    RE++ +    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 120 VVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ +     + T +   ++Y+  V + +   +++++K     +Q +   ++  + YQI R
Sbjct: 87  IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLK-----TQHLSNDHICYFLYQILR 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYY 233
            L YIH +  V HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+Y
Sbjct: 140 GLKYIH-SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ 
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 294 CM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           C+ N     +    P     PW+++F      +A+DL+ ++L ++P+ R     A
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 311

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  266 bits (682), Expect = 9e-88
 Identities = 85/289 (29%), Positives = 151/289 (52%), Gaps = 30/289 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G V++A    T E VAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                    L+L  + EY    + + +  +  +S R+    +K + YQ+   + + H+  
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDKNPDVSMRV----IKSFLYQLINGVNFCHSR- 151

Query: 187 GVCHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
              HRD+KPQNLL++         LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 296
            G+  Y+ ++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           P++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A +A
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  265 bits (680), Expect = 1e-87
 Identities = 99/285 (34%), Positives = 158/285 (55%), Gaps = 27/285 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           VG G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 +  L L  V E++ + + +V+         +    +K+Y YQ+ R +A+ H   
Sbjct: 88  I---HSERCLTL--VFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 300
           +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           +  F   +  PW  I       E +DL+S +L + PN R +A DA
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDA 298

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  264 bits (677), Expect = 2e-86
 Identities = 92/292 (31%), Positives = 152/292 (52%), Gaps = 26/292 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   + VG G++G V  A    TG  VAIKK+          +   REL+ ++ + H NV
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 121 VSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           + L   F    +  +  + YL  V+ ++   + +++K      +++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 236
            L YIH   G+ HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIH-AAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 295
           E+I     YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ + 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 296 NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           +     +    P+++   +  I      P AV+L+ ++L      R TA +A
Sbjct: 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEA 305

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  260 bits (668), Expect = 4e-86
 Identities = 96/285 (33%), Positives = 153/285 (53%), Gaps = 28/285 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 K  L L  V E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  I---HTKKRLVL--VFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 300
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           +  F   +  PW     K +    +DL+S++L+  PN R TA  A
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQA 278

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  263 bits (673), Expect = 4e-86
 Identities = 96/294 (32%), Positives = 154/294 (52%), Gaps = 31/294 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQD----KR-YKNRELQTMRLLDHP 118
           Y++   VG G++G V  A    +GE VAIKK+    Q     KR Y  REL  ++ + H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 119 NVVSLKHCFFSTTEKD---ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           NV+ L   F   +      + YL  V+ ++   + +++        +     ++   YQ+
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMG------LKFSEEKIQYLVYQM 135

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYR 234
            + L YIH+  GV HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YR
Sbjct: 136 LKGLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYR 190

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE+I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ 
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250

Query: 295 M-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           + +     +    PQ     + ++F  R  P+A DL+ ++L+   + R TA  A
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQA 303

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  257 bits (659), Expect = 8e-85
 Identities = 94/286 (32%), Positives = 148/286 (51%), Gaps = 28/286 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                   +L L  V E+  + + +        +  +    VK + +Q+ + L + H+  
Sbjct: 70  L---HSDKKLTL--VFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 299
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             +            +   ++     DL+  LL+ +P  R +A +A
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEA 280

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  259 bits (664), Expect = 1e-84
 Identities = 97/294 (32%), Positives = 154/294 (52%), Gaps = 30/294 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y     VG G++G V  A   +TG  VA+KK+ +        KR Y  REL+ ++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 119 NVVSLKHCFFSTTEKD---ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           NV+ L   F      +   ++YL  V   +   ++ ++K      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYR 234
            R L YIH+   + HRD+KP NL VN    +LK+ DFG A+        ++ Y+ +R+YR
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 295 M-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           + + +   +     Q+    +  +F     P AVDL+ ++L    + R TA  A
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQA 309

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  257 bits (658), Expect = 3e-84
 Identities = 88/294 (29%), Positives = 150/294 (51%), Gaps = 36/294 (12%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 123
           +G+G++  V++     TG  VA+K+V    +  +         RE+  M+ L H N+V L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH--YKMSQRMPLIYVKLYFYQICRALAY 181
                    +++L L  V E++   + + +         + + L  VK + +Q+ + LA+
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 238
            H    + HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 295
           + G+  Y+ +IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++GTP       +  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 296 NPNYTEFKFPQIKAHPWHKIFQK----RMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            P Y      Q       ++ Q      +    +D +  LLQ +P++R +A  A
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  252 bits (645), Expect = 2e-82
 Identities = 81/291 (27%), Positives = 136/291 (46%), Gaps = 31/291 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RE---LQTMRLLDHPNV 120
           +G G++G V++A+   +G  VA+K V                 RE   L+ +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L     ++    E+ + LV E+V + +   +         +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLD 134

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           ++H    + HRD+KP+N+LV      +KL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 298 NYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                    FP     P   +    M      L+  +L ++P+ R +AF A
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRA 294

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  252 bits (647), Expect = 3e-82
 Identities = 84/291 (28%), Positives = 137/291 (47%), Gaps = 24/291 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK-- 124
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 125 -HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                S   + +  + LV ++     H +      +  +  L  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV--LVKGEPNISY---ICSRYYRAPEL 238
               + HRD+K  N+L+      LKL DFG A+   L K      Y   + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 295
           + G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    +   
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259

Query: 296 NPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTAFDA 345
              Y + +  + +        +     P A+DL+ +LL   P  R  + DA
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  253 bits (649), Expect = 5e-82
 Identities = 95/328 (28%), Positives = 168/328 (51%), Gaps = 61/328 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL---QD----KR-YKNRELQTMRLL-DH 117
           Y   + +G G++G+V+++    TGE VA+KK+    Q+    +R +  RE+  +  L  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N+V+L +   +  ++D +YL  V +Y+   +H VI+     +  +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----------- 226
            + Y+H + G+ HRD+KP N+L+N   H +K+ DFG ++  V      +           
Sbjct: 121 VIKYLH-SGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 227 -----------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 276 QLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMP----------- 321
           QL  II V+  P+ E+++ + +P          +                          
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 322 ----PEAVDLVSRLLQYSPNLRSTAFDA 345
                EA+DL+ +LLQ++PN R +A DA
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDA 326

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  252 bits (646), Expect = 9e-82
 Identities = 92/305 (30%), Positives = 151/305 (49%), Gaps = 41/305 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQD----KR-YKNRELQTMRLLDHP 118
           Y   + +G G+ G+V  A        VAIKK+    Q+    KR Y  REL  M+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 119 NVVSLKHCF---FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFY 173
           N++ L + F    S  E  ++Y+  V+E +   + +VI        +M L    +    Y
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVI--------QMELDHERMSYLLY 134

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           Q+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYY
Sbjct: 135 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K
Sbjct: 193 RAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251

Query: 294 CMNPNYTEF--KFPQIKAHPWHKIFQKRMP-----------PEAVDLVSRLLQYSPNLRS 340
            + P    +    P+   + + K+F   +             +A DL+S++L    + R 
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311

Query: 341 TAFDA 345
           +  +A
Sbjct: 312 SVDEA 316

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  255 bits (652), Expect = 1e-81
 Identities = 92/303 (30%), Positives = 149/303 (49%), Gaps = 37/303 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y   + +G G+ G+V  A        VAIKK+ +        KR Y  REL  M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 119 NVVSLKHCF---FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           N++SL + F    +  E  ++YL  V+E +   + +VI+        +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQ------MELDHERMSYLLYQM 173

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
              + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 296 NPNYTEF--KFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQYSPNLRSTA 342
            P    +    P+     + K+F            K    +A DL+S++L   P  R + 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 343 FDA 345
            DA
Sbjct: 351 DDA 353

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  252 bits (644), Expect = 2e-80
 Identities = 98/351 (27%), Positives = 151/351 (43%), Gaps = 83/351 (23%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y    ++G GS+G V +A        VAIKK+L+        KR    RE+  +  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 119 NVVSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           +VV +         +  DELY  +VLE       ++ +        +  +++K   Y + 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLL 166

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------- 226
             + Y+H + G+ HRD+KP N LVN     +K+CDFG A+ +   E   S          
Sbjct: 167 VGVKYVH-SAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 227 ------------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL----- 263
                             ++ +R+YRAPELI     YT AID+WS GC+ AELL      
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 264 ------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM-N 296
                   PLFPG S                      DQL  I  +LGTP+ E+I+ +  
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344

Query: 297 PNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            +   +   FP+ +     + F      +A+ L+ R+L ++PN R T  + 
Sbjct: 345 EDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINEC 394

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  250 bits (641), Expect = 2e-80
 Identities = 95/343 (27%), Positives = 150/343 (43%), Gaps = 75/343 (21%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQD-KR-YKNRELQTMRLLDHP 118
           Y+ + ++G GS+G V+ A    T + VAIKKV      L D KR    RE+  +  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 119 NVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            ++ L             ELY+  VLE     + ++ K    +++     ++K   Y + 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTE----EHIKTILYNLL 139

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------- 226
               +IH   G+ HRD+KP N L+N     +K+CDFG A+ +   +              
Sbjct: 140 LGENFIH-ESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 227 -------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-------- 265
                        ++ +R+YRAPELI     YT +IDIWS GC+ AELL           
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 266 ---PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 302
              PLFPG S                   DQL  I  ++GTPT +++K +  P   ++  
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            FP  K     + +   +  + ++L+  +L+++PN R T   A
Sbjct: 318 LFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQA 359

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  247 bits (632), Expect = 3e-80
 Identities = 88/290 (30%), Positives = 142/290 (48%), Gaps = 31/290 (10%)

Query: 73  VGHGSFGVVFQAK-CLETGEAVAIKKVLQDKRYKN-------RE---LQTMRLLDHPNVV 121
           +G G++G VF+A+     G  VA+K+V      +        RE   L+ +   +HPNVV
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L      +    E  L LV E+V + +   +         +P   +K   +Q+ R L +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDF 135

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 238
           +H+   V HRD+KPQN+LV   + Q+KL DFG A++       ++    + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-MALTSVVVTLWYRAPEV 190

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+     P 
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245

Query: 299 YTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                   F    A P  K     +     DL+ + L ++P  R +A+ A
Sbjct: 246 DVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSA 294

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  237 bits (606), Expect = 2e-75
 Identities = 89/309 (28%), Positives = 143/309 (46%), Gaps = 42/309 (13%)

Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++AK  +    +  A+K++       +  RE+  +R L HPNV+SL+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHH-----YKMSQRMPLIYVKLYFYQICRALAYIH 183
           S  ++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 184 NTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEPNISY------ICSRYYR 234
               V HRD+KP N+LV    P   ++K+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---------GVDQLVEIIKVLG 285
           APEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 286 TPTRE---------EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 336
            P  +         E   +  ++    +       + +  + +   +A  L+ +LL   P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 337 NLRSTAFDA 345
             R T+  A
Sbjct: 323 IKRITSEQA 331

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  194 bits (494), Expect = 2e-58
 Identities = 88/322 (27%), Positives = 145/322 (45%), Gaps = 57/322 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL------DH 117
           Y   +V+G GSFG V +A   +  + VA+K V  +KR+      E++ +  L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 118 PNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
            NV+ +   F         + N   +  E +   ++ +IK +    Q   L  V+ + + 
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHS 208

Query: 175 ICRALAYIHNTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           I + L  +H    + H D+KP+N LL       +K+ DFGS+      +   +YI SR+Y
Sbjct: 209 ILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P+++ + 
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 294 -----------CMNPNYTEFKF---------------PQIKAHPWHKIFQKRMPPEA--- 324
                         P Y                     +++  P  + +   +       
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 325 -VDLVSRLLQYSPNLRSTAFDA 345
            +D + + L++ P +R T   A
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQA 406

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  190 bits (485), Expect = 2e-58
 Identities = 70/312 (22%), Positives = 108/312 (34%), Gaps = 56/312 (17%)

Query: 51  VTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKN 106
           +  I  K+        Y+  + +G G F  V   + L  G   A+K++L    QD+    
Sbjct: 23  MVIIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74

Query: 107 RELQTMRLLDHPNVVSLKHCFF-STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMP 164
           RE    RL +HPN++ L          K E +  L+L +    T+   I+        + 
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--- 221
              +      ICR L  IH   G  HRD+KP N+L+     Q  L D GS          
Sbjct: 133 EDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEG 190

Query: 222 -------EPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
                  +   +  C+  YRAPEL             D+WS GCVL  ++ G+  +    
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                V +  V                 +   PQ            R       L++ ++
Sbjct: 251 QKGDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMM 284

Query: 333 QYSPNLRSTAFD 344
              P+ R     
Sbjct: 285 TVDPHQRPHIPL 296

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  188 bits (480), Expect = 9e-58
 Identities = 67/292 (22%), Positives = 106/292 (36%), Gaps = 65/292 (22%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL----DHP 118
           S+     +GHGS+G VF+ +  E G   A+K+     +  + + R+L  +        HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             V L+  +    E   LY  L  E    ++ +  +        +P   V  Y      A
Sbjct: 118 CCVRLEQAWE---EGGILY--LQTELCGPSLQQHCE---AWGASLPEAQVWGYLRDTLLA 169

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           LA++H+  G+ H D+KP N+ + P     KL DFG    L              Y APEL
Sbjct: 170 LAHLHSQ-GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     Y  A D++S G  + E+     L  G                            
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHG---------------------------- 257

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPP--------EAVDLVSRLLQYSPNLRSTA 342
                        W ++ Q  +PP        E   ++  +L+  P LR+TA
Sbjct: 258 ----------GEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATA 299

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  186 bits (474), Expect = 5e-56
 Identities = 89/328 (27%), Positives = 144/328 (43%), Gaps = 62/328 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL------DH 117
           Y  + ++G GSFG V +A      E VAIK +   K + N    E++ + L+        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 118 PNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +V LK  F         + N   LV E +   ++ ++++     + + L   + +  Q
Sbjct: 116 YYIVHLKRHFM--------FRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQ 165

Query: 175 ICRALAYIH-NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           +C AL ++    + + H D+KP+N LL NP    +K+ DFGS+     G+    YI SR+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRF 223

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG P    +
Sbjct: 224 YRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282

Query: 293 K-----------CMNPNYTEFKFPQIKAH---PWHKIFQ-----KRMPPEA--------- 324
                         +  +   K    K     P  +        +   P           
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342

Query: 325 -------VDLVSRLLQYSPNLRSTAFDA 345
                   DL+ R+L Y P  R   + A
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYA 370

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  184 bits (469), Expect = 5e-56
 Identities = 61/297 (20%), Positives = 109/297 (36%), Gaps = 60/297 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHPN- 119
           Y   + +G G    VFQ    E  +  AIK V      ++   +   E+  +  L   + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 120 -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 89  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 235
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 236 PELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           PE I             ++ +   D+WS GC+L  +  G+  F         +  I    
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 252

Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                    ++PN+ E +FP I               +  D++   L+  P  R + 
Sbjct: 253 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISI 287

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  182 bits (465), Expect = 5e-55
 Identities = 61/297 (20%), Positives = 108/297 (36%), Gaps = 60/297 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPN- 119
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 120 -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 70  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 235
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 236 PELIFG----------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           PE I             ++ +   D+WS GC+L  +  G+  F         +  I    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233

Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                    ++PN+ E +FP I               +  D++   L+  P  R + 
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISI 268

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  184 bits (468), Expect = 5e-55
 Identities = 61/297 (20%), Positives = 108/297 (36%), Gaps = 60/297 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPN- 119
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 120 -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 235
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 236 PELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           PE I             ++ +   D+WS GC+L  +  G+  F         +  I    
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 280

Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                    ++PN+ E +FP I               +  D++   L+  P  R + 
Sbjct: 281 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISI 315

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  182 bits (464), Expect = 1e-54
 Identities = 81/316 (25%), Positives = 137/316 (43%), Gaps = 42/316 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL-----DHP 118
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 119 NVVSLKHC-----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           + +   H       F+    + +++ +V E + E +  +IK +    + +PLIYVK    
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISK 138

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEPNISYI 228
           Q+   L Y+H   G+ H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIK 282
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 283 VLGTPTREEI-------KCMNPNYTEFKFPQIKAHPWHKIFQKRMP------PEAVDLVS 329
           +LG      +          N         ++K  P   +  ++         E  D +S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315

Query: 330 RLLQYSPNLRSTAFDA 345
            +LQ  P  R+ A   
Sbjct: 316 PMLQLDPRKRADAGGL 331

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  179 bits (457), Expect = 1e-54
 Identities = 69/290 (23%), Positives = 111/290 (38%), Gaps = 45/290 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V          ++    L +V+EY     +  VI    K  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 180 AYIH----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
              H        V HRD+KP N+ ++     +KL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +PE +     Y    DIWS GC+L EL    P F   S   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                 E KF +I               E  ++++R+L      R +  +
Sbjct: 230 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEE 264

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  181 bits (460), Expect = 1e-54
 Identities = 56/295 (18%), Positives = 110/295 (37%), Gaps = 27/295 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      TT      L  ++E+ P       + +     +  +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125

Query: 180 AYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
            ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 237 ELIFGAT-------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK--VLGTP 287
           ++   A        +Y A +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           +               +      P      + +      +++ +L+         
Sbjct: 245 SGAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  182 bits (464), Expect = 5e-54
 Identities = 65/295 (22%), Positives = 122/295 (41%), Gaps = 51/295 (17%)

Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 122
           IS+  + V+GHG+ G +   + +     VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
                   TEKD  +  + +E    T+   + +  +      P+  ++    Q    LA+
Sbjct: 83  YFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133

Query: 182 IHNTIGVCHRDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEPNISY---IC-SRYY 233
           +H+ + + HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  +
Sbjct: 134 LHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 234 RAPELIFGATE--YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 290
            APE++    +   T  +DI+SAGCV   ++  G   F                G   + 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQR 236

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           +   +               P            A +L+ +++   P  R +A   
Sbjct: 237 QANILLGAC-SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRPSAKHV 281

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  180 bits (459), Expect = 5e-54
 Identities = 75/331 (22%), Positives = 137/331 (41%), Gaps = 66/331 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL-----DHP 118
           ++  R +G G+FG V   + ++  +  A+K V   K+Y      E   ++ +     ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 119 NVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           N+V     F        +Y +   L+ E +  +++ +I  +        +  +KLY  +I
Sbjct: 97  NIVKYHGKF--------MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEI 146

Query: 176 CRALAYIHNTIGVCHRDIKPQN-LLVNPHTH-----------------------QLKLCD 211
            +AL Y+   + + H D+KP+N LL +P+                          +KL D
Sbjct: 147 LKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           FG A    K + + S I +R YRAPE+I     +  + D+WS GCVLAEL  G  LF   
Sbjct: 206 FGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 272 SGVDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQIKAHPWHKIFQKRMPP 322
             ++ L  +  ++    +  +         K +N +  +  +P+  +        K+  P
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 323 EA--------VDLVSRLLQYSPNLRSTAFDA 345
                      D +  +LQ  P LR +  + 
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAEL 353

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  177 bits (452), Expect = 1e-53
 Identities = 81/296 (27%), Positives = 122/296 (41%), Gaps = 60/296 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPN 119
           +  E+ +G G F  V++A CL  G  VA+KKV        + +    +E+  ++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+     F    E +EL   +VLE      + R+IKH  K  + +P   V  YF Q+C A
Sbjct: 94  VIKYYASFI---EDNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYIC 229
           L ++H+   V HRDIKP N+ +   T  +KL D G  +           + G P      
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP------ 200

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPT 288
             YY +PE I     Y    DIWS GC+L E+   Q  F G+   +  L + I+      
Sbjct: 201 --YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                       +  +P +               E   LV+  +   P  R     
Sbjct: 252 ------------QCDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDVTY 287

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  179 bits (456), Expect = 3e-53
 Identities = 56/295 (18%), Positives = 110/295 (37%), Gaps = 27/295 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      TT      L  ++E+ P       + +     +  +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125

Query: 180 AYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
            ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 237 ELIFGAT-------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK--VLGTP 287
           ++   A        +Y A +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           +               +      P      + +      +++ +L+         
Sbjct: 245 SGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  180 bits (458), Expect = 1e-52
 Identities = 70/290 (24%), Positives = 120/290 (41%), Gaps = 50/290 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 120
           Y   + +G G++G V   +   T    AIK +               E+  ++LLDHPN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           + L   F     +D+    LV+E     E    +I    +  ++        +   Q+  
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKF--NEV----DAAVIIKQVLS 147

Query: 178 ALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+N LL +      +K+ DFG + V    +     + + YY A
Sbjct: 148 GVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++    +Y    D+WS G +L  LL G P F G++  DQ  EI+         +++  
Sbjct: 207 PEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEKG 252

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
              +            W  +        A DL+ ++LQ+    R +A  A
Sbjct: 253 KYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQA 289

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  179 bits (457), Expect = 1e-52
 Identities = 80/291 (27%), Positives = 130/291 (44%), Gaps = 51/291 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K +    ++ K  K    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQIC 176
           ++ L   F     +D+ Y  LV E     E    +I    +  S+            Q+ 
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRF--SEV----DAARIIRQVL 136

Query: 177 RALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYR 234
             + Y+H    + HRD+KP+N LL +      +++ DFG +      +     I + YY 
Sbjct: 137 SGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++ G   Y    D+WS G +L  LL G P F G +  +   +I+        ++++ 
Sbjct: 196 APEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEK 241

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
               +            W K+        A DL+ ++L Y P++R +A DA
Sbjct: 242 GKYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDA 279

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  176 bits (449), Expect = 1e-52
 Identities = 71/325 (21%), Positives = 123/325 (37%), Gaps = 60/325 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKN---RELQTMRLL------D 116
           Y     +G G+FG V +      G   VA+K +    +Y+     E+  ++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 117 HPNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
               V +   F         +     +  E + +     +K +    Q  PL +V+   Y
Sbjct: 81  KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENNF--QPYPLPHVRHMAY 130

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVN------------------PHTHQLKLCDFGSA 215
           Q+C AL ++H    + H D+KP+N+L                         +++ DFGSA
Sbjct: 131 QLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
                 E + + + +R+YR PE+I     +    D+WS GC+L E   G  LF      +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246

Query: 276 QLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKAHPWHKIFQKRMPPEA-- 324
            LV + K+LG      I               + E            K  +  M  ++  
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306

Query: 325 ----VDLVSRLLQYSPNLRSTAFDA 345
                DL+ R+L++ P  R T  +A
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEA 331

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  177 bits (451), Expect = 3e-52
 Identities = 72/308 (23%), Positives = 131/308 (42%), Gaps = 60/308 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMR-LLDHPNVVSLK 124
            ++E+++G+GS G V   +    G  VA+K++L D       E++ +    DHPNV+   
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY---VKLYFYQICRALAY 181
                 +E  + +L + LE     +  +++      + + L           QI   +A+
Sbjct: 76  C-----SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGE----PNI 225
           +H+ + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     N+
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 226 SYIC-SRYYRAPELIFGATE------YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 277
           +    +  +RAPEL+  +         T +IDI+S GCV   +L  G+  F  +    + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247

Query: 278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 337
             II+                   F   ++K      +       EA DL+S+++ + P 
Sbjct: 248 SNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPL 285

Query: 338 LRSTAFDA 345
            R TA   
Sbjct: 286 KRPTAMKV 293

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  175 bits (445), Expect = 3e-52
 Identities = 75/328 (22%), Positives = 126/328 (38%), Gaps = 66/328 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKN---RELQTMRLL------D 116
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q +  L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 117 HPNVVSLKHCF------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 170
               V +   F          E   L L+          +  IK +        L +++ 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFEL--LGLST---------YDFIKENGF--LPFRLDHIRK 122

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVN------------------PHTHQLKLCDF 212
             YQIC+++ ++H+   + H D+KP+N+L                         +K+ DF
Sbjct: 123 MAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           GSA      E + + + +R+YRAPE+I     ++   D+WS GC+L E  LG  +FP   
Sbjct: 182 GSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238

Query: 273 GVDQLVEIIKVLGTPTREEI-KCMNPNY-TEFKFPQIKAHPWHKIFQKRMPP-------- 322
             + L  + ++LG   +  I K     Y    +    +     +   +   P        
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298

Query: 323 -----EAVDLVSRLLQYSPNLRSTAFDA 345
                   DL+ ++L+Y P  R T  +A
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREA 326

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  173 bits (441), Expect = 5e-52
 Identities = 71/306 (23%), Positives = 116/306 (37%), Gaps = 59/306 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 123
           +    V+G G+FG V +A+        AIKK+   +   +    E+  +  L+H  VV  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 124 KHCF--------FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
              +          T  K +  L + +EY    T++ +I       QR         F Q
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---EYWRLFRQ 124

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 231
           I  AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK + +    +         
Sbjct: 125 ILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 232 ------------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                        Y A E++ G   Y   ID++S G +  E++   P   G       V 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236

Query: 280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           I+K L +                +FP     P    F          ++  L+ + PN R
Sbjct: 237 ILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKR 275

Query: 340 STAFDA 345
             A   
Sbjct: 276 PGARTL 281

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  175 bits (445), Expect = 5e-52
 Identities = 74/306 (24%), Positives = 119/306 (38%), Gaps = 47/306 (15%)

Query: 48  HIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQ 100
           H       G      Q++  Y+  + +G GSFG     K  E G    IK++       +
Sbjct: 6   HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65

Query: 101 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKM 159
           ++    RE+  +  + HPN+V  +  F    E   LY  +V++Y     + + I      
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRINAQKG- 119

Query: 160 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 219
                   +  +F QIC AL ++H+   + HRDIK QN+ +      ++L DFG A+VL 
Sbjct: 120 -VLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLN 176

Query: 220 KGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
                      + YY +PE+      Y    DIW+ GCVL EL   +  F   S +  LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234

Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
             I             ++ +Y                       +   LVS+L + +P  
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267

Query: 339 RSTAFD 344
           R +   
Sbjct: 268 RPSVNS 273

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  177 bits (452), Expect = 9e-52
 Identities = 74/290 (25%), Positives = 123/290 (42%), Gaps = 50/290 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 120
           Y    ++G GSFG V + K   T +  A+K +       +D     RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           + L         +D     +V E     E    +IK   +  S+            Q+  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF--SEH----DAARIIKQVFS 132

Query: 178 ALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+N LL +      +K+ DFG +    +       I + YY A
Sbjct: 133 GITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WSAG +L  LL G P F G++  +   +I+        + ++  
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVETG 237

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
              +            W  I       +A DL+ ++L + P+LR TA   
Sbjct: 238 KYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQC 274

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  172 bits (438), Expect = 1e-51
 Identities = 61/290 (21%), Positives = 109/290 (37%), Gaps = 50/290 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           +    ++G G FG VF+AK    G+   IK+V  +     RE++ +  LDH N+V    C
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 127 FFSTTEKDEL-----------YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           +       E             L + +E+  + T+ + I+   +  +++  +     F Q
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQ 130

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I + + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y 
Sbjct: 131 ITKGVDYIHSK-KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +PE I    +Y   +D+++ G +LAELL                ++              
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------------ 233

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                               I       +   L+ +LL   P  R    +
Sbjct: 234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSE 264

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  177 bits (452), Expect = 1e-51
 Identities = 77/301 (25%), Positives = 125/301 (41%), Gaps = 61/301 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------------REL 109
           Y   R +G G++G V   K        AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLI 166
             ++ LDHPN++ L   F     +D+ Y  LV E+    E   ++I    +   +     
Sbjct: 98  SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKF--DEC---- 146

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPN 224
                  QI   + Y+H    + HRDIKP+N LL N ++   +K+ DFG +    K    
Sbjct: 147 DAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205

Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              + + YY APE++    +Y    D+WS G ++  LL G P F G++  DQ  +II   
Sbjct: 206 RDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII--- 256

Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                ++++     +          + W  I       EA +L+  +L Y  N R TA +
Sbjct: 257 -----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEE 298

Query: 345 A 345
           A
Sbjct: 299 A 299

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  174 bits (441), Expect = 2e-51
 Identities = 41/313 (13%), Positives = 80/313 (25%), Gaps = 56/313 (17%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHP 118
                  +  G   VVF  + +E  E  A+K                +        L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 119 NVVSLKHCFFSTTEKDELYLN---------------------LVLEYVP---ETVHRVIK 154
           +    +         D + +                      L++       E +   + 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 155 HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS 214
             Y       ++ + +   Q+ R  A + +  G+ H    P NL + P    L L D  +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGR-LMLGDVSA 240

Query: 215 AKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
              +  G    +      Y   E +      +T A++ W  G  +  +      F   + 
Sbjct: 241 LWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 333
             +       L  P  +                             +P     L+ R L 
Sbjct: 299 GIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLN 338

Query: 334 YSPNLRSTAFDAV 346
           +    R    +A+
Sbjct: 339 FDRRRRLLPLEAM 351

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  170 bits (433), Expect = 7e-51
 Identities = 73/280 (26%), Positives = 125/280 (44%), Gaps = 42/280 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
            V+G G++G+V+  + L     +AIK++  +D RY      E+   + L H N+V     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHN 184
            +  +  +  ++ + +E VP  ++  +++  +  +      I    Y  QI   L Y+H+
Sbjct: 84  -YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 243
              + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I    
Sbjct: 141 N-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 244 E-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y  A DIWS GC + E+  G+P F       +L E    +                 F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------F 236

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           K    K HP      + M  EA   + +  +  P+ R+ A
Sbjct: 237 KVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACA 273

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  170 bits (432), Expect = 7e-51
 Identities = 70/301 (23%), Positives = 132/301 (43%), Gaps = 66/301 (21%)

Query: 59  GQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQ 110
               + I  +    ++G GSF  V++A+ + TG  VAIK + +   YK         E++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVK 169
               L HP+++ L + F      + +Y  LVLE      ++R +K+  K          +
Sbjct: 64  IHCQLKHPSILELYNYFED---SNYVY--LVLEMCHNGEMNRYLKNRVK---PFSENEAR 115

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE------ 222
            + +QI   + Y+H+  G+ HRD+   NLL+  +   +K+ DFG + ++ +  E      
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC 173

Query: 223 --PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
             PN        Y +PE+    + +    D+WS GC+   LL+G+P F  ++  + L ++
Sbjct: 174 GTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224

Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 340
           +                   +++ P      +       +  EA DL+ +LL+ +P  R 
Sbjct: 225 VLA-----------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRL 255

Query: 341 T 341
           +
Sbjct: 256 S 256

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  169 bits (430), Expect = 1e-50
 Identities = 82/298 (27%), Positives = 125/298 (41%), Gaps = 50/298 (16%)

Query: 59  GQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTM 112
           G  K  I+  Y  E  +G GS+G V  A    T    A K      ++D     +E++ M
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVK 169
           + LDHPN++ L   F     +D   + LV+E     E   RV+    +   +        
Sbjct: 61  KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVF--RES----DAA 109

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 227
                +  A+AY H  + V HRD+KP+N L    +    LKL DFG A     G+   + 
Sbjct: 110 RIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168

Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           + + YY +P+++ G   Y    D WSAG ++  LL G P F   +  + +++I +     
Sbjct: 169 VGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG---- 222

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                         F FP      W  +      P+A  L+ RLL  SP  R T+  A
Sbjct: 223 -------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 259

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  167 bits (426), Expect = 8e-50
 Identities = 73/298 (24%), Positives = 115/298 (38%), Gaps = 66/298 (22%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN---RELQTMR 113
           P+    Y+  R +G G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 172
            L H +VV     F      D ++  +VLE     ++  + K      + +     + Y 
Sbjct: 71  SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRR----KALTEPEARYYL 121

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------P 223
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE        P
Sbjct: 122 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 179

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           N        Y APE++     ++  +D+WS GC++  LL+G+P F      +  + I K 
Sbjct: 180 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230

Query: 284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
                            E+  P              + P A  L+ ++LQ  P  R T
Sbjct: 231 -----------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPT 259

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  167 bits (424), Expect = 1e-49
 Identities = 76/312 (24%), Positives = 129/312 (41%), Gaps = 52/312 (16%)

Query: 48  HIIVTTIGGKNGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQ 100
           H    + G +N   + TI   ++ +R +G G+FG V   +   +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 101 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYK 158
                  E++ ++ LDHPN++ +   F     +D   + +V+E     E + R++    +
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117

Query: 159 M---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFG 213
               S+     YV     Q+  ALAY H+   V H+D+KP+N+L    +    +K+ DFG
Sbjct: 118 GKALSEG----YVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFG 172

Query: 214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
            A++    E + +   +  Y APE+     + T   DIWSAG V+  LL G   F G S 
Sbjct: 173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230

Query: 274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 333
            +   +                     E  +               + P+AVDL+ ++L 
Sbjct: 231 EEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQMLT 264

Query: 334 YSPNLRSTAFDA 345
             P  R +A   
Sbjct: 265 KDPERRPSAAQV 276

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  168 bits (427), Expect = 1e-49
 Identities = 83/332 (25%), Positives = 128/332 (38%), Gaps = 84/332 (25%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL---------QDKRYKNRELQTMRLLDH 117
           Y  +  +G GS+GVV  A   +T    AIK +          +D      E++ M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL----- 170
           PN+  L   +     +DE Y+ LV+E       + ++       + +  +  VK      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 171 ------------------------------YFYQICRALAYIHNTIGVCHRDIKPQN-LL 199
                                            QI  AL Y+HN  G+CHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLF 201

Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE-YTAAIDIWS 253
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 254 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 313
           AG +L  LL+G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 314 KIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            +      P A DL+S LL  + + R  A  A
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRA 328

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  166 bits (422), Expect = 2e-49
 Identities = 74/285 (25%), Positives = 118/285 (41%), Gaps = 66/285 (23%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K     ++ +        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F      D   + L+LEY P       + K       +        Y  ++  AL+Y
Sbjct: 75  YGYF-----HDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSY 124

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNISYICSRYYR 234
            H+   V HRDIKP+NLL+      LK+ DFG +            G  +        Y 
Sbjct: 125 CHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YL 174

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
            PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V           
Sbjct: 175 PPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------- 222

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                 EF FP      +       +   A DL+SRLL+++P+ R
Sbjct: 223 ------EFTFP-----DF-------VTEGARDLISRLLKHNPSQR 249

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  170 bits (432), Expect = 2e-49
 Identities = 77/298 (25%), Positives = 136/298 (45%), Gaps = 56/298 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------------RELQTMRL 114
           Y+  + +G G+ G V  A   +T + VAI+ + + K                 E++ ++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 172
           L+HP ++ +K+ F    + ++ Y+  VLE +   E   +V+ +  ++ +       KLYF
Sbjct: 197 LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNK-RLKEAT----CKLYF 245

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC- 229
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 246 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303

Query: 230 SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           +  Y APE++       Y  A+D WS G +L   L G P F        L + I   G  
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                        ++ F       W ++       +A+DLV +LL   P  R T  +A
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 397

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  167 bits (424), Expect = 2e-49
 Identities = 64/304 (21%), Positives = 113/304 (37%), Gaps = 60/304 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNVV 121
           +   + +G G FGVVF+AK        AIK++        +    RE++ +  L+HP +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 122 SLKHCFF-------STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 173
              + +              ++YL + ++    E +   +       +          F 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFL 125

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 231
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 232 -----------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
                       Y +PE I G   Y+  +DI+S G +L ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 340
           ++                    KFP +              P    +V  +L  SP  R 
Sbjct: 240 VR------------------NLKFPPLFTQ---------KYPCEYVMVQDMLSPSPMERP 272

Query: 341 TAFD 344
            A +
Sbjct: 273 EAIN 276

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  168 bits (427), Expect = 2e-49
 Identities = 56/300 (18%), Positives = 113/300 (37%), Gaps = 47/300 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN----------------REL 109
           R +  G F  +   +  +  +  A+K      + + + +                   EL
Sbjct: 37  RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMP 164
           Q +  + +   ++      +    DE+Y+  + EY+      +            +  +P
Sbjct: 95  QIITDIKNEYCLTC-EGIITN--YDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +K     +  + +YIHN   +CHRD+KP N+L++ +   +KL DFG ++ +V  +  
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206

Query: 225 ISYIC-SRYYRAPELIFGATEY-TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           I     +  +  PE     + Y  A +DIWS G  L  +      F  +  + +L   I+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                  + I+   P      F     +         +  E +D +   L+ +P  R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  165 bits (421), Expect = 3e-49
 Identities = 55/314 (17%), Positives = 97/314 (30%), Gaps = 90/314 (28%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL----DHPN 119
           +     +G G FG VF+      G   AIK+    L     +   L+ +        H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           VV     +    E D + +    EY    ++   I  +Y++        +K    Q+ R 
Sbjct: 73  VVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPH------------------THQLKLCDFGSAKVL-- 218
           L YIH+   + H DIKP N+ ++                        K+ D G    +  
Sbjct: 128 LRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 219 ---VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
               +G+          + A E++     +    DI++    +      +PL        
Sbjct: 187 PQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----- 233

Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP-------EAVDLV 328
                                               WH+I Q R+P        E  +L+
Sbjct: 234 ---------------------------------GDQWHEIRQGRLPRIPQVLSQEFTELL 260

Query: 329 SRLLQYSPNLRSTA 342
             ++   P  R +A
Sbjct: 261 KVMIHPDPERRPSA 274

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  167 bits (425), Expect = 3e-49
 Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 59/303 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMR-LLDHPNVV 121
               RV+  G F  V++A+ + +G   A+K++L    +  R   +E+  M+ L  HPN+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 122 SLKHCFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
                     E        +L L+ E     +   +K   +    +    V   FYQ CR
Sbjct: 90  QFCSAASIGKEESDTGQAEFL-LLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCR 147

Query: 178 ALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------------EP 223
           A+ ++H     + HRD+K +NLL++     +KLCDFGSA  +                E 
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 224 NISYICSRYYRAPELI--FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            I+   +  YR PE+I  +         DIW+ GC+L  L   Q  F   +         
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA--------- 257

Query: 282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
                    +++ +N  Y+                          L+  +LQ +P  R +
Sbjct: 258 ---------KLRIVNGKYSIPPHD-------------TQYTVFHSLIRAMLQVNPEERLS 295

Query: 342 AFD 344
             +
Sbjct: 296 IAE 298

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  167 bits (425), Expect = 3e-49
 Identities = 76/298 (25%), Positives = 116/298 (38%), Gaps = 66/298 (22%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN---RELQTMR 113
           P+    Y+  R +G G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 172
            L H +VV     F      D ++  +VLE     ++  + K      + +     + Y 
Sbjct: 97  SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRR----KALTEPEARYYL 147

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------P 223
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE        P
Sbjct: 148 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 205

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           N        Y APE++     ++  +D+WS GC++  LL+G+P F        L E    
Sbjct: 206 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKE---- 248

Query: 284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
               T   IK       E+  P              + P A  L+ ++LQ  P  R T
Sbjct: 249 ----TYLRIKK-----NEYSIP-----KH-------INPVAASLIQKMLQTDPTARPT 285

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  166 bits (423), Expect = 4e-49
 Identities = 69/286 (24%), Positives = 124/286 (43%), Gaps = 44/286 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVA---IKKVLQDKRYKNRELQTMRLLDHPNVVSL 123
           YM    +G G FG+V +     + +      +K    D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +    L ++ E++   +   R+    +++++R  + YV     Q+C AL +
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH----QVCEALQF 117

Query: 182 IHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
           +H+   + H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y APE +
Sbjct: 118 LHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                 + A D+WS G ++  LL G   F  E+  +Q  +II        E I      +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTF 222

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            E  F +I               EA+D V RLL      R TA +A
Sbjct: 223 DEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEA 255

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  168 bits (427), Expect = 5e-49
 Identities = 74/286 (25%), Positives = 115/286 (40%), Gaps = 43/286 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG     K        DK     E+  M  L HP +++
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   F     +D+  + L+LE++   E   R+    YKMS+   + Y++    Q C  L 
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLK 163

Query: 181 YIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           ++H    + H DIKP+N++        +K+ DFG A  L   E       +  + APE I
Sbjct: 164 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                     D+W+ G +   LL G   F GE  ++ L  + +                 
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            +++F       +  +      PEA D +  LLQ  P  R T  DA
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDA 302

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  171 bits (434), Expect = 1e-48
 Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 43/286 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG   A K V      DK    +E+QTM +L HP +V+
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   F     +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L 
Sbjct: 219 LHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 181 YIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           ++H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+ 
Sbjct: 270 HMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G        D+WS G +   LL G   F GE+  +            T   +K  + N 
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            +  F  I               +  D + +LL   PN R T   A
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQA 408

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  164 bits (417), Expect = 1e-48
 Identities = 74/290 (25%), Positives = 120/290 (41%), Gaps = 50/290 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y    ++G GSFG V + K   T +  A+K + +            RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           + L         +D     +V E     E    +IK   +  S+            Q+  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF--SEHD----AARIIKQVFS 132

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+N+L+        +K+ DFG +    +       I + YY A
Sbjct: 133 GITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WSAG +L  LL G P F G++  D L  +               
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------- 236

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                ++ F       W  I       +A DL+ ++L + P+LR TA   
Sbjct: 237 ----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQC 274

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  164 bits (418), Expect = 2e-48
 Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 56/298 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN--------RELQTMRL 114
           Y+  + +G G+ G V  A   +T + VAIK    +       +          E++ ++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 172
           L+HP ++ +K+ F    + ++ Y+  VLE +   E   +V+ +  ++ +       KLYF
Sbjct: 72  LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNK-RLKEA----TCKLYF 120

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC- 229
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 121 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 178

Query: 230 SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           +  Y APE++       Y  A+D WS G +L   L G P F        L + I   G  
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 235

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                        ++ F       W ++       +A+DLV +LL   P  R T  +A
Sbjct: 236 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  164 bits (418), Expect = 3e-48
 Identities = 64/307 (20%), Positives = 117/307 (38%), Gaps = 48/307 (15%)

Query: 45  EAGHIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDK 102
             G ++   +   + + ++ +     +  VG GSFG V + K  +TG   A+KKV L+  
Sbjct: 37  NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV- 95

Query: 103 RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQ 161
            ++  EL     L  P +V L         ++  ++N+ +E +   ++ ++IK    + +
Sbjct: 96  -FRVEELVACAGLSSPRIVPLYGA-----VREGPWVNIFMELLEGGSLGQLIKQMGCLPE 149

Query: 162 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 221
                    Y  Q    L Y+H    + H D+K  N+L++    +  LCDFG A  L   
Sbjct: 150 D----RALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

Query: 222 EPNISYICSR------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
               S +          + APE++ G     A +DIWS+ C++  +L G   +       
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
             ++I      P                  +I              P     +   L+  
Sbjct: 264 LCLKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKE 297

Query: 336 PNLRSTA 342
           P  R++A
Sbjct: 298 PVHRASA 304

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  163 bits (414), Expect = 4e-48
 Identities = 74/290 (25%), Positives = 118/290 (40%), Gaps = 66/290 (22%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K     ++ ++       RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +  +Y  L+LE+ P  E    + KH      R        +  ++  AL Y
Sbjct: 80  YNYFHD---RKRIY--LMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHY 129

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNISYICSRYYR 234
            H    V HRDIKP+NLL+      LK+ DFG +            G  +        Y 
Sbjct: 130 CHER-KVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YL 179

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
            PE+I G   +   +D+W AG +  E L+G P F   S  +    I+ V           
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                 + KFP     P+       +   + DL+S+LL+Y P  R     
Sbjct: 228 ------DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKG 259

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  163 bits (414), Expect = 5e-48
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 50/289 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 122
           ++   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H N+V+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRAL 179
           L+  +         Y  LV++ V   E   R++ +  Y  +++       L   Q+  A+
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVY--TEKDA----SLVIQQVLSAV 119

Query: 180 AYIHNTIGVCHRDIKPQNLLV-NPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 236
            Y+H   G+ HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y AP
Sbjct: 120 KYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAP 176

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E +     Y+ A+D WS G +   LL G P F  E+      +I +              
Sbjct: 177 E-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------- 222

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                ++F    +  W  I        A D +  LL+  PN R T   A
Sbjct: 223 ----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKA 259

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  170 bits (431), Expect = 1e-47
 Identities = 77/303 (25%), Positives = 124/303 (40%), Gaps = 26/303 (8%)

Query: 55  GGKNGQPKQTIS---YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----- 106
           GG       T +   +  +  +G G FG V +    +TGE VAIK+  Q+   KN     
Sbjct: 1   GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60

Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN-LVLEYVP--ETVHRVIKHHYKMSQRM 163
            E+Q M+ L+HPNVVS +       +     L  L +EY    +    + +        +
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGL 118

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKG 221
               ++     I  AL Y+H    + HRD+KP+N+++ P   +   K+ D G AK L +G
Sbjct: 119 KEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177

Query: 222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           E    ++ +  Y APEL+    +YT  +D WS G +  E + G   F       Q    +
Sbjct: 178 ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

Query: 282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH--KIFQKRMPPEAVDLVSRLLQYSPNLR 339
           +     + E I   +      KF  +   P H   I       +    +  +L +    R
Sbjct: 237 R---EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG----KLERWLQCMLMWHQRQR 289

Query: 340 STA 342
            T 
Sbjct: 290 GTD 292

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  163 bits (415), Expect = 2e-47
 Identities = 73/299 (24%), Positives = 127/299 (42%), Gaps = 43/299 (14%)

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNREL 109
           +  K G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIY 167
             M  LDH N++ L   F     + +  + LV+EYV   E   R+I   Y +++   +++
Sbjct: 138 SVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           +K    QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+     E    
Sbjct: 193 MK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
              +  + APE +      +   D+WS G +   LL G   F G++  + L  I+     
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--- 303

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                          +         +  I       EA + +S+LL    + R +A +A
Sbjct: 304 --------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  162 bits (412), Expect = 3e-47
 Identities = 77/311 (24%), Positives = 129/311 (41%), Gaps = 47/311 (15%)

Query: 44  TEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR 103
           T   H IV  +   + Q      Y  +  +G GS+ V  +     T    A+K + + KR
Sbjct: 3   TVGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60

Query: 104 YKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKM 159
               E++ + R   HPN+++LK  +      D  Y+ +V E +   E + ++++   +  
Sbjct: 61  DPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFF-- 113

Query: 160 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAK 216
           S+R          + I + + Y+H   GV HRD+KP N+L    + +   +++CDFG AK
Sbjct: 114 SERE----ASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 217 VLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
            L      +   C +  + APE +     Y AA DIWS G +L  +L G   F       
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227

Query: 276 QLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 334
               + ++  G               +F         W+ +        A DLVS++L  
Sbjct: 228 PEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHV 264

Query: 335 SPNLRSTAFDA 345
            P+ R TA   
Sbjct: 265 DPHQRLTAALV 275

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  163 bits (415), Expect = 4e-47
 Identities = 73/285 (25%), Positives = 118/285 (41%), Gaps = 35/285 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
            +  +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             +         L +V+E +   E   R+  +     ++R            I  A+ Y+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER----EASEIMKSIGEAIQYL 177

Query: 183 HNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           H+ I + HRD+KP+NLL  +   +  LKL DFG AK         +   + YY APE + 
Sbjct: 178 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           G  +Y  + D+WS G ++  LL G P F    G+     +           I+       
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MG 282

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           +++FP      W ++       E   L+  LL+  P  R T  + 
Sbjct: 283 QYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEF 319

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  160 bits (408), Expect = 8e-47
 Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 38/283 (13%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 128
           ++V+G G  G V +     TG+  A+K +L D     +E+    +    P++V +    +
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91

Query: 129 STTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
                 +  L +++E +   E   R+  +     ++R            I  A+ ++H+ 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----AAEIMRDIGTAIQFLHS- 146

Query: 186 IGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
             + HRD+KP+NLL  +      LKL DFG AK   +    +   C + YY APE + G 
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGP 203

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
            +Y  + D+WS G ++  LL G P F   +G      + +         I+       ++
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-----QY 250

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            FP      W ++       +A  L+  LL+  P  R T    
Sbjct: 251 GFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQF 285

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  159 bits (404), Expect = 9e-47
 Identities = 57/286 (19%), Positives = 112/286 (39%), Gaps = 56/286 (19%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 125
            +G GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH- 183
            + ST +  +  + LV E +   T+   +K      + M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAP 236
            T  + HRD+K  N+ +   T  +K+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+     +Y  ++D+++ G  + E+   +  +       Q+                   
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------------- 238

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                ++       P    F K   PE  +++   ++ + + R + 
Sbjct: 239 -----YRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSI 277

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  160 bits (408), Expect = 1e-46
 Identities = 83/298 (27%), Positives = 130/298 (43%), Gaps = 48/298 (16%)

Query: 58  NGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMR 113
           +G  +  +S  +  E  +G G+  +V++ K   T +  A+K + +    K    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKL 170
            L HPN++ LK  F     +    ++LVLE V   E   R+++  +Y  S+R        
Sbjct: 104 RLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYY--SERD----AAD 152

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYI 228
              QI  A+AY+H   G+ HRD+KP+NLL   P     LK+ DFG +K++      +  +
Sbjct: 153 AVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTV 210

Query: 229 C-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           C +  Y APE I     Y   +D+WS G +   LL G   F  E G   +   I      
Sbjct: 211 CGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----- 264

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                 C      E+ F    +  W ++        A DLV +L+   P  R T F A
Sbjct: 265 -----NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQA 303

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  158 bits (403), Expect = 2e-46
 Identities = 67/296 (22%), Positives = 111/296 (37%), Gaps = 56/296 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F +V + +   TG+  A K          +    +    RE+  +R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           HPN+++L   F     +++  + L+LE V   E    +  K     ++         +  
Sbjct: 67  HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESL--TEDE----ATQFLK 115

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
           QI   + Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G      I  
Sbjct: 116 QILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFG 173

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           +  + APE I          D+WS G +   LL G   F GE+  + L  I  V      
Sbjct: 174 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV------ 226

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                       + F       +           A D + RLL   P  R T   +
Sbjct: 227 -----------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQS 263

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  159 bits (405), Expect = 2e-46
 Identities = 71/287 (24%), Positives = 131/287 (45%), Gaps = 39/287 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTMRLLD-HPNVVSLK 124
            + ++ +G GSF +  +    ++ +A A+K + +       +E+  ++L + HPN+V L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
             F      D+L+  LV+E +   E   R+  K H+  S+            ++  A+++
Sbjct: 73  EVF-----HDQLHTFLVMELLNGGELFERIKKKKHF--SETE----ASYIMRKLVSAVSH 121

Query: 182 IHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
           +H+ +GV HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE 
Sbjct: 122 MHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE- 179

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     Y  + D+WS G +L  +L GQ  F            ++++     ++IK     
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG--- 231

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             +F F       W  +       EA DL+  LL   PN R      
Sbjct: 232 --DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGL 268

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  161 bits (410), Expect = 4e-46
 Identities = 73/291 (25%), Positives = 118/291 (40%), Gaps = 50/291 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G+F VV +   +  G+  A   +   K          RE +  RLL HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           V L          +E +  L+ + V   E    ++   +Y  S+            QI  
Sbjct: 73  VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYY--SEAD----ASHCIQQILE 121

Query: 178 ALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           A+ + H  +GV HR++KP+NLL  +      +KL DFG A  +   +        +  Y 
Sbjct: 122 AVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +PE +     Y   +D+W+ G +L  LL+G P F  E       +I              
Sbjct: 181 SPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA------------ 227

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                  + FP   +  W  +      PEA DL++++L  +P+ R TA +A
Sbjct: 228 -----GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEA 265

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  156 bits (398), Expect = 7e-46
 Identities = 75/291 (25%), Positives = 116/291 (39%), Gaps = 51/291 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y  +  +G G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICR 177
           V L         ++E +  LV + V   E    ++ +  Y  S+            QI  
Sbjct: 68  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFY--SEAD----ASHCIQQILE 116

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E        +  Y 
Sbjct: 117 SIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYL 174

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +PE +     Y+  +DIW+ G +L  LL+G P F  E       +I              
Sbjct: 175 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                  + +P   +  W  +      PEA  L+  +L  +P  R TA  A
Sbjct: 223 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQA 259

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  158 bits (401), Expect = 8e-46
 Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 54/295 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F VV + +   TG   A K          +    +    RE+  ++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           HPNV++L   +     +++  + L+LE V   E    + +    +++         +  Q
Sbjct: 73  HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKES-LTEEE----ATEFLKQ 122

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
           I   + Y+H+ + + H D+KP+N+++   N    ++K+ DFG A  +  G      I  +
Sbjct: 123 ILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGT 180

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
             + APE I          D+WS G +   LL G   F G++  + L  +  V       
Sbjct: 181 PEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV------- 232

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                      ++F       +           A D + RLL   P  R T  D+
Sbjct: 233 ----------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDS 269

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  158 bits (402), Expect = 1e-45
 Identities = 75/297 (25%), Positives = 113/297 (38%), Gaps = 56/297 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDH 117
           Y    V+G G F VV +    ETG+  A+K V   K   +         RE     +L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIY----VKLY 171
           P++V L   +       +  L +V E++   +    ++K           +Y       Y
Sbjct: 86  PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHY 135

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC 229
             QI  AL Y H+   + HRD+KP   LL +   +  +KL  FG A  L +         
Sbjct: 136 MRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
            + ++ APE +     Y   +D+W  G +L  LL G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                       ++K        W  I        A DLV R+L   P  R T ++A
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEA 284

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  156 bits (397), Expect = 2e-45
 Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 43/283 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN---RELQTMRLLDHP 118
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           NV+ L    ++  ++  +Y+  V+EY      E +  V +       R P+     YF Q
Sbjct: 67  NVIQLVDVLYNEEKQK-MYM--VMEYCVCGMQEMLDSVPEK------RFPVCQAHGYFCQ 117

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SR 231
           +   L Y+H+  G+ H+DIKP NLL+      LK+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLHS-QGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 232 YYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV------- 283
            ++ PE+  G   ++   +DIWSAG  L  +  G   F G++ + +L E I         
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPG 234

Query: 284 -LGTPTREEIKCM---NPNYTEFKFPQIKAHPWHKIFQKRMPP 322
             G P  + +K M    P    F   QI+ H W   F+K+ PP
Sbjct: 235 DCGPPLSDLLKGMLEYEPA-KRFSIRQIRQHSW---FRKKHPP 273

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  158 bits (401), Expect = 2e-45
 Identities = 79/320 (24%), Positives = 125/320 (39%), Gaps = 58/320 (18%)

Query: 46  AGHIIVTTIGGKNGQPKQTIS---------YMAERVVGHGSFGVVFQAKCLETGEAVAIK 96
             H+   T G + G+  + +          Y  +  +G G+F VV +     TG   A K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60

Query: 97  KVLQDKRYKN------RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ET 148
            +   K          RE +  R L HPN+V L         ++E +  LV + V   E 
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGEL 115

Query: 149 VHRVIKH-HYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV--NPHTH 205
              ++    Y  S+            QI  ++AY H+  G+ HR++KP+NLL+       
Sbjct: 116 FEDIVAREFY--SEAD----ASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGA 168

Query: 206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
            +KL DFG A  +   E    +  +  Y +PE +     Y+  +DIW+ G +L  LL+G 
Sbjct: 169 AVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGY 227

Query: 266 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAV 325
           P F  E       +I                     + +P   +  W  +      PEA 
Sbjct: 228 PPFWDEDQHRLYAQIKAG-----------------AYDYP---SPEWDTV-----TPEAK 262

Query: 326 DLVSRLLQYSPNLRSTAFDA 345
            L+  +L  +P  R TA  A
Sbjct: 263 SLIDSMLTVNPKKRITADQA 282

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  156 bits (397), Expect = 3e-45
 Identities = 65/296 (21%), Positives = 106/296 (35%), Gaps = 56/296 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           H NV++L   +     ++   + L+LE V   E    +  K     S+         +  
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL--SEEE----ATSFIK 122

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
           QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I  
Sbjct: 123 QILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFG 180

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           +  + APE I          D+WS G +   LL G   F G++  + L  I  V      
Sbjct: 181 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV------ 233

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                       + F       +           A D + +LL      R T  +A
Sbjct: 234 -----------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEA 270

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  155 bits (395), Expect = 1e-44
 Identities = 65/296 (21%), Positives = 108/296 (36%), Gaps = 56/296 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           HPN+++L   +     ++   + L+LE V   E    +  K     S+         +  
Sbjct: 74  HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL--SEEE----ATSFIK 122

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
           QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I  
Sbjct: 123 QILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFG 180

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           +  + APE I          D+WS G +   LL G   F G++  + L  I  V      
Sbjct: 181 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV------ 233

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                       + F       + +         A D + +LL      R T  +A
Sbjct: 234 -----------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEA 270

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  155 bits (394), Expect = 2e-44
 Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 46/284 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           Y   + +G G+FGV    +   T E VA+K       + +     RE+   R L HPN+V
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K    +      L   +++EY    E   R+         R      + +F Q+   +
Sbjct: 80  RFKEVILT---PTHLA--IIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGV 129

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +Y H+ + +CHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 239 IFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +    EY     D+WS G  L  +L+G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
              ++  P             R+ PE   L+SR+    P  R +
Sbjct: 238 ---KYSIPD----------DIRISPECCHLISRIFVADPATRIS 268

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  153 bits (388), Expect = 4e-44
 Identities = 68/302 (22%), Positives = 121/302 (40%), Gaps = 62/302 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK------------KVLQDKRYK-NRELQTMR 113
           Y  + ++G G   VV +     T +  A+K            + +Q+ R    +E+  +R
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 114 LLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVK 169
            +  HPN++ LK  +     +   +  LV + +   E    + +      S++      +
Sbjct: 79  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTL--SEK----ETR 127

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
                +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE  +  +C
Sbjct: 128 KIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LREVC 184

Query: 230 -SRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
            +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I+  
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244

Query: 284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF 343
                             ++F    +  W             DLVSR L   P  R TA 
Sbjct: 245 -----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAE 279

Query: 344 DA 345
           +A
Sbjct: 280 EA 281

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  150 bits (380), Expect = 3e-43
 Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 50/286 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
                     E +  Y  L LEY    E   R+          MP    + +F+Q+   +
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 236
            Y+H  IG+ HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 237 ELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           EL+    E+ A  +D+WS G VL  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
                          PW K     +    + L+ ++L  +P+ R T
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARIT 255

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  150 bits (382), Expect = 3e-43
 Identities = 75/301 (24%), Positives = 121/301 (40%), Gaps = 50/301 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTM-RLLDHPNVVSLK 124
           E V+G G+   V     L T +  A+K    +    +    RE++ + +   H NV+ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICRALAY 181
             F     ++E    LV E +     +  + K  H+  ++        +    +  AL +
Sbjct: 78  EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHF--NEL----EASVVVQDVASALDF 126

Query: 182 IHNTIGVCHRDIKPQNLL-VNP-HTHQLKLCDFGSAKVLVKGE-------PNISYIC-SR 231
           +HN  G+ HRD+KP+N+L  +P     +K+CDF     +           P +   C S 
Sbjct: 127 LHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 232 YYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
            Y APE++      A+ Y    D+WS G +L  LL G P F G  G D   +  +     
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 288 TR---EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                E I+       +++FP      W  I        A DL+S+LL      R +A  
Sbjct: 246 QNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRLSAAQ 292

Query: 345 A 345
            
Sbjct: 293 V 293

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  151 bits (384), Expect = 5e-43
 Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 61/301 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----------KVLQDKRYK-NRELQTMRL 114
           Y  + V+G G   VV +     TG   A+K           + L++ R    RE   +R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 115 L-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKL 170
           +  HP++++L   +     +   ++ LV + +   E    + +      S++      + 
Sbjct: 156 VAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVAL--SEK----ETRS 204

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
               +  A++++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +C 
Sbjct: 205 IMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LRELCG 261

Query: 230 SRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
           +  Y APE++  + +     Y   +D+W+ G +L  LL G P F     +  L  I++  
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG- 320

Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                           +++F    +  W             DL+SRLLQ  P  R TA  
Sbjct: 321 ----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAEQ 356

Query: 345 A 345
           A
Sbjct: 357 A 357

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  150 bits (380), Expect = 8e-43
 Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 50/286 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
                     E +  Y  L LEY    E   R+          MP    + +F+Q+   +
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 236
            Y+H  IG+ HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 237 ELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           EL+    E+ A  +D+WS G VL  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
                          PW K     +    + L+ ++L  +P+ R T
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARIT 255

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  150 bits (380), Expect = 1e-42
 Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 50/291 (17%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 120
           +  + +G G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICR 177
           ++L   +     ++   + L+LEY    E     + +    +S+      V     QI  
Sbjct: 92  INLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND----VIRLIKQILE 142

Query: 178 ALAYIHNTIGVCHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
            + Y+H    + H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y 
Sbjct: 143 GVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL 200

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE I      T A D+W+ G +   LL     F GE   +  + I +V           
Sbjct: 201 APE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV----------- 248

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                    +       +  +        A D +  LL  +P  R TA   
Sbjct: 249 ------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEIC 285

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  148 bits (376), Expect = 2e-42
 Identities = 67/285 (23%), Positives = 109/285 (38%), Gaps = 56/285 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
            +  +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             +         L +V+E +   E   R+  +     ++R            I  A+ Y+
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE----ASEIMKSIGEAIQYL 133

Query: 183 HNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           H+ I + HRD+KP+NLL  +   +  LKL DFG AK                        
Sbjct: 134 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE------------------- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
              +Y  + D+WS G ++  LL G P F    G+     +           I+       
Sbjct: 174 ---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MG 217

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           +++FP      W ++       E   L+  LL+  P  R T  + 
Sbjct: 218 QYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEF 254

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  147 bits (374), Expect = 2e-42
 Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 39/289 (13%)

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------R 107
           G K+    +   Y+    +G G+FG V   +   TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
           E+Q ++L  HP+++ L     +     + ++  V+EYV   E    + KH      R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVIST---PTDFFM--VMEYVSGGELFDYICKH-----GRVEE 110

Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
           +  +  F QI  A+ Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 226 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV- 283
              C S  Y APE+I G       +DIWS G +L  LL G   F  E  V  L + I+  
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGG 226

Query: 284 -------LGTPTREEIKCM---NPNYTEFKFPQIKAHPWHKIFQKRMPP 322
                  L       +  M   +P         I+ H W   F++ +P 
Sbjct: 227 VFYIPEYLNRSVATLLMHMLQVDPL-KRATIKDIREHEW---FKQDLPS 271

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  148 bits (376), Expect = 2e-42
 Identities = 74/322 (22%), Positives = 119/322 (36%), Gaps = 73/322 (22%)

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--- 106
            G +G   Q   Y  +  +G GS+GVV  A         A+K     K+++   +     
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 107 ----------------------RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY 144
                                 +E+  ++ LDHPNVV L         +D LY+  V E 
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119

Query: 145 VP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP 202
           V     V  V        + +     + YF  + + + Y+H    + HRDIKP NLLV  
Sbjct: 120 VNQGP-VMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG- 171

Query: 203 HTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT-EYT-AAIDIWSAGCVLA 259
               +K+ DFG +      +  +S    +  + APE +      ++  A+D+W+ G  L 
Sbjct: 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

Query: 260 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR 319
             + GQ  F  E  +  L   IK                    +FP     P        
Sbjct: 232 CFVFGQCPFMDER-IMCLHSKIK----------------SQALEFPD---QPD------- 264

Query: 320 MPPEAVDLVSRLLQYSPNLRST 341
           +  +  DL++R+L  +P  R  
Sbjct: 265 IAEDLKDLITRMLDKNPESRIV 286

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  150 bits (380), Expect = 2e-42
 Identities = 47/329 (14%), Positives = 97/329 (29%), Gaps = 84/329 (25%)

Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRL 114
           ++  + +   V+G        +A   ETGE+  +      +R  +        E+  +RL
Sbjct: 70  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129

Query: 115 L-------------------------DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 149
           L                             ++ ++            +L   ++   +T 
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189

Query: 150 HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
             V+  H    + +          Q+ R LA +H+  G+ H  ++P +++++     + L
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGG-VFL 247

Query: 210 CDFGSAKVLVKGEPNISYICSRYYRAPELI----------FGATEYTAAIDIWSAGCVLA 259
             F      V+    +    SR +  PEL              T  T + D W+ G V+ 
Sbjct: 248 TGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 260 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ-- 317
            +         ++ +                                        IF+  
Sbjct: 305 WIWCADLPITKDAALG-----------------------------------GSEWIFRSC 329

Query: 318 KRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           K +P     L+   L+Y    R     A+
Sbjct: 330 KNIPQPVRALLEGFLRYPKEDRLLPLQAM 358

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  146 bits (371), Expect = 2e-41
 Identities = 79/280 (28%), Positives = 120/280 (42%), Gaps = 44/280 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHP 118
           Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           N+V L       TEK    L L++EY    E    ++ H      RM     +  F QI 
Sbjct: 75  NIVKLFEVI--ETEKT---LYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIV 124

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
            A+ Y H    + HRD+K +NLL++     +K+ DFG +     G   +   C +  Y A
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181

Query: 236 PELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV--------LGT 286
           PEL  G  +Y    +D+WS G +L  L+ G   F G++ + +L E +          + T
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVLRGKYRIPFYMST 239

Query: 287 PTREEIKCM---NPNYTEFKFPQIKAHPWHKIFQKRMPPE 323
                +K     NP        QI    W          +
Sbjct: 240 DCENLLKRFLVLNPI-KRGTLEQIMKDRW---INAGHEED 275

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  145 bits (369), Expect = 3e-41
 Identities = 66/293 (22%), Positives = 118/293 (40%), Gaps = 40/293 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-----RELQTMRLLD 116
           Y    ++G G FG V+    +     VAIK     ++       N      E+  ++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 117 H--PNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLY 171
                V+ L   +F     D   L  +LE      +    + +        +     + +
Sbjct: 105 SGFSGVIRLLD-WFER--PDSFVL--ILERPEPVQDLFDFITER-----GALQEELARSF 154

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
           F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS  +L       +    +
Sbjct: 155 FWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGT 211

Query: 231 RYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPT 288
           R Y  PE I     Y      +WS G +L +++ G   F  +  + +  V   + + +  
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 270

Query: 289 REEIKCM---NPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPN 337
           +  I+      P+     F +I+ HPW    Q   +P E  ++    L   P+
Sbjct: 271 QHLIRWCLALRPS-DRPTFEEIQNHPW---MQDVLLPQETAEIHLHSLSPGPS 319

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  147 bits (373), Expect = 4e-41
 Identities = 53/347 (15%), Positives = 103/347 (29%), Gaps = 89/347 (25%)

Query: 50  IVTTIGGKNGQPKQTISYMAER--------VVGHGSFGVVFQAKCLETGEAVAIKKVLQD 101
           +V+T     GQP +  S + ER        V+G        +A   ETGE+  +      
Sbjct: 55  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114

Query: 102 KRYKN-------RELQTMRLL-------------------------DHPNVVSLKHCFFS 129
           +R  +        E+  +RLL                             ++ ++     
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174

Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
                  +L   ++   +T   V+  H    + +          Q+ R LA +H+  G+ 
Sbjct: 175 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLV 233

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY----YRAPELIFGA--- 242
           H  ++P +++++     + L  F        G   +S I   +      A  ++      
Sbjct: 234 HTYLRPVDIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHH 290

Query: 243 -TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
            T  T A D W+ G  +  +         ++ +                           
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------------ 326

Query: 302 FKFPQIKAHPWHKIFQ--KRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                        IF+  K +P     L+   L+Y    R     A+
Sbjct: 327 -----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  144 bits (365), Expect = 9e-41
 Identities = 74/287 (25%), Positives = 117/287 (40%), Gaps = 66/287 (22%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++    Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D+  L   L Y    E     +  + +          + Y  +I  AL Y
Sbjct: 96  YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------YICSRY 232
           +H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+    
Sbjct: 146 LHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
             +PEL+        + D+W+ GC++ +L+ G P F   +    + + I           
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII---------- 245

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                   E+ FP            ++  P+A DLV +LL      R
Sbjct: 246 ------KLEYDFP------------EKFFPKARDLVEKLLVLDATKR 274

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  144 bits (365), Expect = 2e-40
 Identities = 72/311 (23%), Positives = 127/311 (40%), Gaps = 34/311 (10%)

Query: 53  TIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--R 107
           T   K G+ K    +     +G G+ GVVF+     +G  +A K +   ++        R
Sbjct: 22  TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLI 166
           ELQ +   + P +V     F+S  E     +++ +E++   ++ +V     K + R+P  
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQV----LKKAGRIPEQ 131

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
            +      + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           ++ +R Y +PE + G   Y+   DIWS G  L E+ +G+   P     +  +     +  
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---------------KRMPPEAVDLVSRL 331
              E                + + P   IF+                    E  D V++ 
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308

Query: 332 LQYSPNLRSTA 342
           L  +P  R+  
Sbjct: 309 LIKNPAERADL 319

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  143 bits (362), Expect = 3e-40
 Identities = 71/294 (24%), Positives = 112/294 (38%), Gaps = 68/294 (23%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-----RELQTMRLLD 116
           Y    ++G G FG VF    L     VAIK     +VL      +      E+  +  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 117 ----HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV---IKHHYKMSQRMPLIYVK 169
               HP V+ L   +F T  ++   L  VLE  P     +   I     + +       +
Sbjct: 93  AGGGHPGVIRL-LDWFET--QEGFML--VLER-PLPAQDLFDYITEKGPLGEGP----SR 142

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            +F Q+  A+ + H+  GV HRDIK +N+L++      KL DFGS  +L       +   
Sbjct: 143 CFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFD 199

Query: 230 -SRYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
            +R Y  PE I    +Y A    +WS G +L +++ G   F  +       EI++     
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---- 248

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
                        E  FP              + P+   L+ R L   P+ R +
Sbjct: 249 -------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPS 277

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  143 bits (362), Expect = 5e-40
 Identities = 72/276 (26%), Positives = 125/276 (45%), Gaps = 38/276 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 119
           Y+    +G GSFG V  A   +T + VA+K      + +   +    RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           ++ L     +     ++ +  V+EY   E    +++      +RM     + +F QI  A
Sbjct: 71  IIKLYDVITT---PTDIVM--VIEYAGGELFDYIVEK-----KRMTEDEGRRFFQQIICA 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           + Y H    + HRD+KP+NLL++ +   +K+ DFG + ++  G   +   C S  Y APE
Sbjct: 121 IEYCHR-HKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPE 177

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV--------LGTPTR 289
           +I G       +D+WS G VL  +L+G+  F  E  +  L + +          L    +
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVNSCVYVMPDFLSPGAQ 236

Query: 290 EEIKCM---NPNYTEFKFPQIKAHPWHKIFQKRMPP 322
             I+ M   +P        +I+  PW   F   +P 
Sbjct: 237 SLIRRMIVADPM-QRITIQEIRRDPW---FNVNLPD 268

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  143 bits (361), Expect = 8e-40
 Identities = 43/296 (14%), Positives = 97/296 (32%), Gaps = 38/296 (12%)

Query: 66  SYMAERVVGHGSFGVVFQAKC-----LETGEAVAIK----KVLQDKRYKNRELQTMRLLD 116
                 ++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
               +           ++   L  V E       ++ +  +     + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----------LKLCDFGSA---KVLVKG 221
           +   +  +H+   + H DIKP N ++     +          L L D G +   K+  KG
Sbjct: 181 MLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-PGESGVDQLVEI 280
               +   +  ++  E++     +   ID +     +  +L G  +    E G  +   +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 281 IKVL-GTPTREEI--KCMNPNYTEFKFPQIKA--HPWHKIFQKRMPPEAVDLVSRL 331
            + L       E     +N        P +        K+FQ+    +   L +RL
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIP-DCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRL 353

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  144 bits (364), Expect = 3e-39
 Identities = 78/289 (26%), Positives = 124/289 (42%), Gaps = 40/289 (13%)

Query: 56  GKNGQPKQTI-SYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--R 107
            +    +  I  Y+    +G G+FG V   K   TG  VA+K     K+          R
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
           E+Q ++L  HP+++ L     +     ++++  V+EYV   E    + K+      R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVIST---PSDIFM--VMEYVSGGELFDYICKN-----GRLDE 115

Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              +  F QI   + Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 116 KESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 172

Query: 226 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV- 283
              C S  Y APE+I G       +DIWS+G +L  LL G   F  +  V  L + I   
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICDG 231

Query: 284 -------LGTPTREEIKCM---NPNYTEFKFPQIKAHPWHKIFQKRMPP 322
                  L       +K M   +P         I+ H W   F++ +P 
Sbjct: 232 IFYTPQYLNPSVISLLKHMLQVDPM-KRATIKDIREHEW---FKQDLPK 276

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  135 bits (342), Expect = 1e-37
 Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 41/280 (14%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQ-TMRLLDHPNVVSLKH 125
            +G G++GVV + + + +G+ +A+K++   +  +  K    +L  +MR +D P  V+   
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             F   +     + + +E +  ++ +  K      Q +P   +      I +AL ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG---A 242
           + V HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y+   DIWS G  + EL + +  +       Q ++ + V                   
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
             PQ+ A  +          E VD  S+ L+ +   R T 
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTY 261

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  136 bits (344), Expect = 2e-37
 Identities = 68/292 (23%), Positives = 114/292 (39%), Gaps = 66/292 (22%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-------RELQTMRL 114
           Y     +G G+FG V+ A   E  + V +K     KVL+D   ++        E+  +  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLY 171
           ++H N++ +    F    +      LV+E      +    + +H      R+        
Sbjct: 86  VEHANIIKVLD-IFEN--QGFFQ--LVMEKHGSGLDLFAFIDRH-----PRLDEPLASYI 135

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
           F Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+      C +
Sbjct: 136 FRQLVSAVGYLRLK-DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192

Query: 231 RYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
             Y APE++ G   Y    +++WS G  L  L+  +  F       +L E ++       
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
                          P              +  E + LVS LLQ  P  R+T
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTT 268

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  137 bits (347), Expect = 2e-37
 Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 53/282 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           R +G GSFG V   +  +T +  A+K     K ++    R   +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +DE  + +V++ +   +     +++H + +       VKL+  ++  AL Y
Sbjct: 81  WYSF-----QDEEDMFMVVDLLLGGD-----LRYHLQQNVHFKEETVKLFICELVMALDY 130

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF- 240
           + N   + HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQN-QRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188

Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNP 297
                Y+ A+D WS G    ELL G+  +   S     ++V   +               
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
             T   +P                 E V L+ +LL+ +P+ R
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQR 262

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  140 bits (353), Expect = 7e-37
 Identities = 67/282 (23%), Positives = 115/282 (40%), Gaps = 53/282 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----------LQTMRLLDHPN 119
           R++G G FG V+  +  +TG+  A+K  L  KR K ++           L  +   D P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +V + + F +    D+L    +L+ +   +     + +H           ++ Y  +I  
Sbjct: 254 IVCMSYAFHT---PDKLSF--ILDLMNGGD-----LHYHLSQHGVFSEADMRFYAAEIIL 303

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ + + +  Y APE
Sbjct: 304 GLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++     Y ++ D +S GC+L +LL G   F      D             + EI     
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                                   PE   L+  LLQ   N R
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRR 436

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  134 bits (340), Expect = 3e-36
 Identities = 71/292 (24%), Positives = 110/292 (37%), Gaps = 65/292 (22%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKK-----VLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +V+G G+F  V   K  +TG+  A+K      +L+         E   +   D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +DE YL LV+EY    + +        K  +R+P    + Y  +I  A+  
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--------YICSRYY 233
           +H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+     
Sbjct: 178 VHR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230

Query: 234 RAPELI------FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
            +PE++       G   Y    D W+ G    E+  GQ  F  +S   +    I      
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------ 282

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                  ++        P            + +P EA D + RLL   P  R
Sbjct: 283 -------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETR 316

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  133 bits (337), Expect = 1e-35
 Identities = 67/278 (24%), Positives = 112/278 (40%), Gaps = 50/278 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           +V+G G+FG V   K     +  A+K     ++L+         E   +   D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +D+  L LV++Y    + +        K   R+P    + Y  ++  A+  
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELI 239
           +H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++
Sbjct: 191 VHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 240 ----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
                G   Y    D WS G  + E+L G+  F  ES + +    I             M
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------M 294

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 333
           N     F+FP              +   A DL+ RL+ 
Sbjct: 295 NHK-ERFQFPT---------QVTDVSENAKDLIRRLIC 322

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  131 bits (331), Expect = 1e-35
 Identities = 69/348 (19%), Positives = 116/348 (33%), Gaps = 103/348 (29%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G FGVVF+AK        AIK++    R        RE++ +  L+HP +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------------- 168
              + +  T  +        +    E+    +     M      I               
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 169 -------KLY--------------------------------FYQICRALAYIHNTIGVC 189
                   LY                                F QI  A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-KGLM 186

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------------VKGEPNISYICSRYYRAP 236
           HRD+KP N+        +K+ DFG    +                  +   + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E I G   Y+  +DI+S G +L ELL     F  +    +++  ++              
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR-------------- 287

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                 KFP         +F ++ P E   +V  +L  SP  R  A D
Sbjct: 288 ----NLKFP--------LLFTQKYPQEH-MMVQDMLSPSPTERPEATD 322

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  130 bits (330), Expect = 1e-35
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--N 184
                     + LV+EY    +++ V+ H  +        +   +  Q  + +AY+H   
Sbjct: 70  --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP NLL+      LK+CDFG+A          +   S  + APE+  G + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
           Y+   D++S G +L E++  +  F    G    + 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  134 bits (339), Expect = 2e-35
 Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 46/280 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           RV+G G FG VF  +   TG+  A K  L  KR K R        E + +  +    +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L + F +   K +L L  V+  +   +  +  I +  + +          Y  QI   L 
Sbjct: 250 LAYAFET---KTDLCL--VMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
           ++H    + +RD+KP+N+L++   + +++ D G A  L  G+        +  + APEL+
Sbjct: 304 HLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G  EY  ++D ++ G  L E++  +  F       +  E+         + +      Y
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------QRVLEQAVTY 412

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            +                    P + D    LLQ  P  R
Sbjct: 413 PDK-----------------FSPASKDFCEALLQKDPEKR 435

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  132 bits (334), Expect = 3e-35
 Identities = 78/327 (23%), Positives = 135/327 (41%), Gaps = 58/327 (17%)

Query: 27  KIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAK 85
            ++     E     G+ ++        +     + + T++ +   +++G G+FG V   K
Sbjct: 109 GLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVK 168

Query: 86  CLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNVVSLKHCFFSTTEKDE 135
              TG   A+K      ++           NR LQ  R   HP + +LK+ F +    D 
Sbjct: 169 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYSFQT---HDR 222

Query: 136 LYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI 193
           L    V+EY    E     +  H    +       + Y  +I  AL Y+H+   V +RD+
Sbjct: 223 LCF--VMEYANGGE-----LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275

Query: 194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIW 252
           K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++    +Y  A+D W
Sbjct: 276 KLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWW 333

Query: 253 SAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 312
             G V+ E++ G+  F  +   ++L E+I                   E +FP       
Sbjct: 334 GLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------MEEIRFP------- 369

Query: 313 HKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                + + PEA  L+S LL+  P  R
Sbjct: 370 -----RTLGPEAKSLLSGLLKKDPKQR 391

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  133 bits (337), Expect = 6e-35
 Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 53/282 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           RV+G G FG V   +   TG+  A K  L+ KR K R        E Q +  ++   VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPET-----VHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           L + + +   KD L L  VL  +        ++ + +  +  ++         Y  +IC 
Sbjct: 249 LAYAYET---KDALCL--VLTLMNGGDLKFHIYHMGQAGFPEAR------AVFYAAEICC 297

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE
Sbjct: 298 GLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++     YT + D W+ GC+L E++ GQ  F       +  E+ ++        +K +  
Sbjct: 356 VVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------VKEVPE 406

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            Y+E                    P+A  L S+LL   P  R
Sbjct: 407 EYSER-----------------FSPQARSLCSQLLCKDPAER 431

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  129 bits (326), Expect = 1e-34
 Identities = 58/311 (18%), Positives = 110/311 (35%), Gaps = 44/311 (14%)

Query: 67  YMAERVVGHG--SFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHP 118
           Y    V+G G      V  A+   TGE V ++++      ++       EL   +L +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           N+V  +  F +    +EL+  +V  ++   +   +I  H+     M  + +      + +
Sbjct: 87  NIVPYRATFIA---DNELW--VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLK 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--------KVLVKGEPNISYIC 229
           AL YIH+  G  HR +K  ++L++    ++ L    S         +  V  +     + 
Sbjct: 140 ALDYIHHM-GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 230 SRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQP----------LF-------PGE 271
              + +PE++      Y A  DI+S G    EL  G            L        P  
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                +      +          ++ + T               + +   P     V + 
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 332 LQYSPNLRSTA 342
           LQ +P+ R +A
Sbjct: 318 LQRNPDARPSA 328

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  127 bits (322), Expect = 2e-34
 Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 46/282 (16%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 125
            +G G+ G V++ +  +TG  +A+K++      +  K    +L   ++  D P +V    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F + T+     + + +E +     ++ K   +M   +P   +      I +AL Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI----FG 241
            GV HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I      
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 300
             +Y    D+WS G  L EL  GQ  +       + L ++++    P             
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
               P +  H            +    V   L      R   
Sbjct: 248 ----PLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKY 278

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  127 bits (322), Expect = 2e-34
 Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 39/281 (13%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 125
            +G G++G V +     +G+ +A+K++   + +K  K    +L   MR  D P +V    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHN 184
             F   +       + +E +  +  +  K+ Y +    +P   +        +AL ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
            + + HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 245 ---YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y    D+WS G  L EL  G+  +P  + V   +  + V G P              
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-------------- 247

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
              PQ+      + F     P  ++ V+  L    + R   
Sbjct: 248 ---PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKY 280

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  127 bits (321), Expect = 6e-34
 Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 65/284 (22%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K   +   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +  F     KD   L +V+EYV   E     +  H +   R    + + Y  QI     Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRA 235
           +H+ + + +RD+KP+NLL++   + +++ DFG AK +        G P           A
Sbjct: 157 LHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALA 206

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE+I     Y  A+D W+ G ++ E+  G P F  +    Q+ E I          +   
Sbjct: 207 PEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG- 253

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                + +FP                 +  DL+  LLQ     R
Sbjct: 254 -----KVRFP------------SHFSSDLKDLLRNLLQVDLTKR 280

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  125 bits (316), Expect = 8e-34
 Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 32/225 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK ++                  RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
           N+V L                +V+E+VP   ++  +    + +   + L  +      I 
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM----LDIA 132

Query: 177 RALAYIHN-TIGVCHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNISYICSR 231
             + Y+ N    + HRD++  N+ +           K+ DFG ++           + + 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNF 190

Query: 232 YYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
            + APE I    E YT   D +S   +L  +L G+  F   S   
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  127 bits (322), Expect = 1e-33
 Identities = 73/282 (25%), Positives = 117/282 (41%), Gaps = 64/282 (22%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           +V+G G+FG V   +   T +  A+K     ++++     +   E   M   + P VV L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +D+ YL +V+EY+P  + V+ +  +       +P  + + Y  ++  AL  
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDA 183

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--------YICSRYY 233
           IH+ +G  HRD+KP N+L++   H LKL DFG+   + K              YI     
Sbjct: 184 IHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236

Query: 234 RAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            +PE++    G   Y    D WS G  L E+L+G   F  +S    LV            
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS-------- 283

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
             K MN       FP              +  EA +L+   L
Sbjct: 284 --KIMNHK-NSLTFPD---DND-------ISKEAKNLICAFL 312

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  126 bits (318), Expect = 1e-33
 Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 52/279 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           +++G G+FG V   +   TG   A+K      ++      +   E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           K+ F  T ++  L    V+EY    E     +  H    +       + Y  +I  AL Y
Sbjct: 71  KYAF-QTHDR--LCF--VMEYANGGE-----LFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIF 240
           +H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++ 
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
              +Y  A+D W  G V+ E++ G+  F  +   ++L E+I                   
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------ME 220

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           E +FP            + + PEA  L++ LL+  P  R
Sbjct: 221 EIRFP------------RTLSPEAKSLLAGLLKKDPKQR 247

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  124 bits (313), Expect = 4e-33
 Identities = 71/284 (25%), Positives = 121/284 (42%), Gaps = 65/284 (22%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           R +G GSFG V   +    G   A+K      V++ K   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D   + ++++Y+   E     +    + SQR P    K Y  ++C AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGE-----LFSLLRKSQRFPNPVAKFYAAEVCLALEY 121

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRA 235
           +H+   + +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y A
Sbjct: 122 LHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIA 171

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++     Y  +ID WS G ++ E+L G   F   +   +  E I              
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL------------- 216

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                E +FP                 +  DL+SRL+    + R
Sbjct: 217 ---NAELRFP------------PFFNEDVKDLLSRLITRDLSQR 245

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  123 bits (312), Expect = 6e-33
 Identities = 70/281 (24%), Positives = 122/281 (43%), Gaps = 54/281 (19%)

Query: 71  RVVGHGSFGVVFQAK---CLETGEAVAIKKVLQDKRYKNRELQTM---RLL---DHPNVV 121
           +V+G GSFG VF  K     +  +  A+K + +        ++T     +L   +HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L + F  T  K  LYL  +L+++   +     +              VK Y  ++  AL
Sbjct: 90  KLHYAF-QTEGK--LYL--ILDFLRGGD-----LFTRLSKEVMFTEEDVKFYLAELALAL 139

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
            ++H+ +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE+
Sbjct: 140 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     +T + D WS G ++ E+L G   F G+    + + +I                 
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
             +   PQ             + PEA  L+  L + +P  R
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANR 268

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (323), Expect = 7e-33
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 37/221 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQD-------KRYKNRELQTMRLLDHP 118
           Y  +  + HG  G ++ A      G  V +K  L               E Q +  + HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139

Query: 119 NVVSLKHCFFSTTEKDELYLN-LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           ++V +   F   T++    +  +V+EYV  +++ R         Q++P+     Y  +I 
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICSR 231
            AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +     + G P        
Sbjct: 193 PALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYLYGTP-------- 241

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            ++APE++      T A DI++ G  LA L L  P   G  
Sbjct: 242 GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  123 bits (312), Expect = 8e-33
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 60/285 (21%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQ----DKRYKNRELQTM---RLL---DH 117
           RV+G G +G VFQ + +    TG+  A+K VL+     +  K+    T     +L    H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTA-HTKAERNILEEVKH 80

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           P +V L + F  T  K  LYL  +LEY+   E     +    +            Y  +I
Sbjct: 81  PFIVDLIYAF-QTGGK--LYL--ILEYLSGGE-----LFMQLEREGIFMEDTACFYLAEI 130

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YR 234
             AL ++H   G+ +RD+KP+N+++N   H +KL DFG  K  +         C    Y 
Sbjct: 131 SMALGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYM 188

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++   + +  A+D WS G ++ ++L G P F GE+   + ++ I             
Sbjct: 189 APEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL------------ 234

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                 +   P              +  EA DL+ +LL+ +   R
Sbjct: 235 ----KCKLNLP------------PYLTQEARDLLKKLLKRNAASR 263

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  124 bits (313), Expect = 9e-33
 Identities = 76/282 (26%), Positives = 121/282 (42%), Gaps = 57/282 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 120
           RV+G GSFG V  A+  ETG+  A+K      +LQD   +      R L   R  +HP +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L  C F T ++  L+   V+E+V   +     +  H + S+R      + Y  +I  A
Sbjct: 87  TQLFCC-FQTPDR--LF--FVMEFVNGGD-----LMFHIQKSRRFDEARARFYAAEIISA 136

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 237
           L ++H+  G+ +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE
Sbjct: 137 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++     Y  A+D W+ G +L E+L G   F  E+  D L E I                
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL--------------- 237

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
              E  +P              +  +A  ++   +  +P +R
Sbjct: 238 -NDEVVYP------------TWLHEDATGILKSFMTKNPTMR 266

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  123 bits (311), Expect = 1e-32
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 61/284 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 118
           +++G GSFG VF A+  +T +  AIK      VL D   +     TM   R+L    +HP
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLAWEHP 78

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +  +   F  T E   L+   V+EY+   +     + +H +   +  L     Y  +I 
Sbjct: 79  FLTHMFCTF-QTKEN--LFF--VMEYLNGGD-----LMYHIQSCHKFDLSRATFYAAEII 128

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRA 235
             L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y A
Sbjct: 129 LGLQFLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIA 186

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G  +Y  ++D WS G +L E+L+GQ  F G+   ++L   I+             
Sbjct: 187 PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR------------- 231

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                   +P            + +  EA DL+ +L    P  R
Sbjct: 232 ---MDNPFYP------------RWLEKEAKDLLVKLFVREPEKR 260

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  122 bits (308), Expect = 1e-32
 Identities = 76/294 (25%), Positives = 118/294 (40%), Gaps = 46/294 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR--- 177
           S    F     KDEL+  LV++ +   +V  +IKH     +    +  +     I R   
Sbjct: 77  SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 178 -ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR---- 231
             L Y+H   G  HRD+K  N+L+      +++ DFG SA +   G+   +    R    
Sbjct: 132 EGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187

Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
               + APE++     Y    DIWS G    EL  G   +     +  L+  ++      
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                  N        P ++     K   K+       ++S  LQ  P  R TA
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA 282

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  122 bits (309), Expect = 1e-32
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYK---NRELQTMRLLDHP 118
           Y   R+VG G  G V++A+       VA+K ++      D  ++    RE +T   L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +VV +        E D     + +  +    +  +++    ++    +  V+    QI  
Sbjct: 95  HVVPI----HDFGEIDGQLY-VDMRLINGVDLAAMLRRQGPLAPPRAVAIVR----QIGS 145

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYY 233
           AL   H   G  HRD+KP+N+LV+       L DFG A      +  +    + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            APE    +   T   DI++  CVL E L G P + G+ 
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  124 bits (312), Expect = 2e-32
 Identities = 75/358 (20%), Positives = 133/358 (37%), Gaps = 84/358 (23%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLL-----DHP 118
           Y   R +G G F  V+ +  ++  + VA+K V   + Y      E++ ++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 119 N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           N   VV L   F  +      ++ +V E +   + + I       Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLV----------------------------------- 200
            + L Y+H    + H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 201 -------------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
                        N    ++K+ D G+A  +   +     I +R YR+ E++ G+  Y  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 248 AIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KC 294
             DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I       + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMP------PEAVDLVSRLLQYSPNLRSTAFDAV 346
                      ++K     ++  ++            D +  +L+  P  R+TA + +
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  123 bits (311), Expect = 2e-32
 Identities = 72/281 (25%), Positives = 114/281 (40%), Gaps = 55/281 (19%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQ-TM-------RLLDHPNVV 121
           +V+G GSFG V  A+        A+ KVLQ     K +E +  M       + + HP +V
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAV-KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L    F T +K  LY   VL+Y+   E     + +H +  +       + Y  +I  AL
Sbjct: 103 GLHFS-FQTADK--LY--FVLDYINGGE-----LFYHLQRERCFLEPRARFYAAEIASAL 152

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            Y+H+ + + +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE+
Sbjct: 153 GYLHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     Y   +D W  G VL E+L G P F   +   ++ + I                 
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
               +                +   A  L+  LLQ     R
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKR 281

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  121 bits (307), Expect = 5e-32
 Identities = 73/282 (25%), Positives = 113/282 (40%), Gaps = 57/282 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 120
            V+G GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L  C F T ++  LY   V+EYV   +     + +H +   R    +   Y  +I   
Sbjct: 84  TQLHSC-FQTMDR--LY--FVMEYVNGGD-----LMYHIQQVGRFKEPHAVFYAAEIAIG 133

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 237
           L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE
Sbjct: 134 LFFLQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I                
Sbjct: 192 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM--------------- 234

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                 +P            K M  EAV +   L+   P  R
Sbjct: 235 -EHNVAYP------------KSMSKEAVAICKGLMTKHPGKR 263

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  120 bits (302), Expect = 5e-32
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHPNVV 121
           E ++G G FG V++A  +  G+ VA+K    D             +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 122 SLK-HCFFSTTEKDELYLNLVLEYVPE-TVHRVI-KHHYKMSQRMPLIYVKLYFYQICRA 178
           +L+  C     ++  L L  V+E+     ++RV+          +          QI R 
Sbjct: 70  ALRGVC----LKEPNLCL--VMEFARGGPLNRVLSGKRIPPDILVNWAV------QIARG 117

Query: 179 LAYIH--NTIGVCHRDIKPQNLLVN-------PHTHQLKLCDFGSAKVLVKGEPNISYIC 229
           + Y+H    + + HRD+K  N+L+             LK+ DFG A+   +    +S   
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAG 176

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
           +  + APE+I  +  ++   D+WS G +L ELL G+  F G
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  120 bits (303), Expect = 6e-32
 Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 30/222 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDH 117
           Y     +G G    V+ A+       VAIK  +           KR++ RE+     L H
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFE-REVHNSSQLSH 70

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            N+VS+        E+D+ Y  LV+EY+   T+   I+ H  +S    + +      QI 
Sbjct: 71  QNIVSM----IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN----QIL 121

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRY 232
             + + H+   + HRDIKPQN+L++     LK+ DFG AK L   E +++     + +  
Sbjct: 122 DGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQ 177

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y +PE   G        DI+S G VL E+L+G+P F GE+ V
Sbjct: 178 YFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  120 bits (304), Expect = 6e-32
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNR---ELQTMRLLDHP 118
           Y    ++G G    V  A+ L     VA+K VL     +D  +  R   E Q    L+HP
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHP 72

Query: 119 NVVSLKHCFFSTTEKDELYLN---LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
            +V++    + T E +        +V+EYV   T+  ++     M+ +  +  +      
Sbjct: 73  AIVAV----YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA----D 124

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICS 230
            C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++     I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
             Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 183 AQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  121 bits (306), Expect = 9e-32
 Identities = 77/286 (26%), Positives = 130/286 (45%), Gaps = 54/286 (18%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNREL--QTM---RLL----DHP 118
           +V+G G++G VF  + +   +TG+  A+K + +    +  +    T    ++L      P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V+L + F  T  K  L+L  +L+Y+   E     +  H    +R     V++Y  +I 
Sbjct: 120 FLVTLHYAF-QTETK--LHL--ILDYINGGE-----LFTHLSQRERFTEHEVQIYVGEIV 169

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-IC-SRYYR 234
            AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C +  Y 
Sbjct: 170 LALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 235 APELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           AP+++ G    +  A+D WS G ++ ELL G   F  +   +   EI           I 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL 279

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                 +E  +PQ             M   A DL+ RLL   P  R
Sbjct: 280 -----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKR 308

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  120 bits (304), Expect = 1e-31
 Identities = 65/284 (22%), Positives = 117/284 (41%), Gaps = 52/284 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 118
           RV+G GS+  V   +  +T    A+K      V  D+              +     +HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID----WVQTEKHVFEQASNHP 70

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V L  C F T  +  L+   V+EYV   +     +  H +  +++P  + + Y  +I 
Sbjct: 71  FLVGLHSC-FQTESR--LF--FVIEYVNGGD-----LMFHMQRQRKLPEEHARFYSAEIS 120

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
            AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 121 LALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G  +Y  ++D W+ G ++ E++ G+  F      D   +        T + +   
Sbjct: 179 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 227

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                   F  I          + +  +A  ++   L   P  R
Sbjct: 228 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  117 bits (296), Expect = 1e-30
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
           +  +G GSFG V +A+    G  VA+K +++   +        RE+  M+ L HPN+V  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 124 K-HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                   T+   L   +V EY+   +++R++ H     +++         Y + + + Y
Sbjct: 100 MGAV----TQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNY 152

Query: 182 IHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELI 239
           +HN    + HR++K  NLLV+   + +K+CDFG +++      +  S   +  + APE++
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
                     D++S G +L EL   Q  +  
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  118 bits (297), Expect = 1e-30
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 22/209 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           +   R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +  + C+     +   +  LV+EY   +   +++ H K    +  + +    +   + L
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 240 FGATE--YTAAIDIWSAGCVLAELLLGQP 266
               E  Y   +D+WS G    EL   +P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKP 251

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  117 bits (294), Expect = 2e-30
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKN--RELQTMRLLDHPNVVSLKH 125
             V+G G FG   +    ETGE + +K++++  ++  +   +E++ MR L+HPNV+    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAYIH 183
                 +   L    + EY+   T+  +IK    M  + P    ++ F   I   +AY+H
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIK---SMDSQYPWS-QRVSFAKDIASGMAYLH 125

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------------ 231
           + + + HRD+   N LV      + + DFG A+++V  +     + S             
Sbjct: 126 S-MNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
              Y+ APE+I G   Y   +D++S G VL E++      P 
Sbjct: 184 GNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  118 bits (298), Expect = 2e-30
 Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 52/284 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 118
           RV+G GS+  V   +  +T    A++      V  D+              +     +HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID----WVQTEKHVFEQASNHP 113

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V L  C F T  +  L+   V+EYV   +     +  H +  +++P  + + Y  +I 
Sbjct: 114 FLVGLHSC-FQTESR--LF--FVIEYVNGGD-----LMFHMQRQRKLPEEHARFYSAEIS 163

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
            AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 164 LALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G  +Y  ++D W+ G ++ E++ G+  F      D   +        T + +   
Sbjct: 222 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 270

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                   F  I          + +  +A  ++   L   P  R
Sbjct: 271 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 304

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  117 bits (295), Expect = 2e-30
 Identities = 44/216 (20%), Positives = 84/216 (38%), Gaps = 34/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 125
            + +G G +G V+  K    GE VA+K     ++    RE  +    L+ H N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 183
               T    +LYL  + +Y    +++  +K         + L Y           L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 184 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 231
             I        + HRD+K +N+LV  +     + D G A   +     +    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 232 YYRAPELIFGAT-----EYTAAIDIWSAGCVLAELL 262
            Y  PE++  +      +     D++S G +L E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  115 bits (290), Expect = 5e-30
 Identities = 47/216 (21%), Positives = 87/216 (40%), Gaps = 34/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 125
              VG G +G V++      GE VA+K    +D++   RE  L    +L H N++  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 183
              S     +L+L  +  Y    +++  ++         + +         I   LA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRI------VLSIASGLAHLH 122

Query: 184 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 231
             I        + HRD+K +N+LV  +     + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 232 YYRAPELI-----FGATEYTAAIDIWSAGCVLAELL 262
            Y APE++         +    +DIW+ G VL E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  120 bits (301), Expect = 5e-30
 Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 57/282 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 120
            V+G GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 404

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L  CF  T ++  LY   V+EYV   +     + +H +   R    +   Y  +I   
Sbjct: 405 TQLHSCF-QTMDR--LYF--VMEYVNGGD-----LMYHIQQVGRFKEPHAVFYAAEIAIG 454

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE
Sbjct: 455 LFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I                
Sbjct: 513 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM--------------- 555

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                 +P            K M  EAV +   L+   P  R
Sbjct: 556 -EHNVAYP------------KSMSKEAVAICKGLMTKHPGKR 584

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (288), Expect = 9e-30
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 20/207 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +     +G GSFG VF+     T + VAIK +  ++         +E+  +   D P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                +   T+     L +++EY+   +   +++        +    +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLD 133

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 239
           Y+H+     HRDIK  N+L++    ++KL DFG + ++        +++ + ++ APE+I
Sbjct: 134 YLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
             +  Y +  DIWS G    EL  G+P
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP 217

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  113 bits (285), Expect = 2e-29
 Identities = 28/211 (13%), Positives = 74/211 (35%), Gaps = 22/211 (10%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 123
              +     G +++ +    G  + +K +          R  N E   +R+  HPNV+ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                        +  L+  ++P  +++ V+  H   +  +       +   + R +A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 183 HN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           H     +    +  ++++++      ++                  + +  + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPEALQK 182

Query: 242 --ATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
                   + D+WS   +L EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  113 bits (285), Expect = 3e-29
 Identities = 71/293 (24%), Positives = 124/293 (42%), Gaps = 47/293 (16%)

Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMR 113
            G PK+   Y     +G G+ G V+ A  + TG+ VAI+++       K     E+  MR
Sbjct: 15  VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 172
              +PN+V+    +      DEL+  +V+EY+   ++  V+         M    +    
Sbjct: 73  ENKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTET-----CMDEGQIAAVC 122

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSR 231
            +  +AL ++H+   V HRDIK  N+L+      +KL DFG    +   +    + + + 
Sbjct: 123 RECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP  + 
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN 238

Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                                  IF+        D ++R L+     R +A +
Sbjct: 239 -----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKE 266

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (281), Expect = 1e-28
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 20/210 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
           +     +G G+FG V++AK  ETG   A K +     ++      E++ +   DHP +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   ++   +     L +++E+ P   V  ++    +    +    +++   Q+  AL +
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNF 132

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 240
           +H+   + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++ 
Sbjct: 133 LHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 241 GAT----EYTAAIDIWSAGCVLAELLLGQP 266
             T     Y    DIWS G  L E+   +P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (282), Expect = 2e-28
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 34/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 125
           +  +G G FG V++ K    GE VA+K    +++R   RE  +    +L H N++  +  
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 183
                    +L+L  V +Y    ++   +  +   +   + L             LA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156

Query: 184 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 231
             I        + HRD+K +N+LV  +     + D G A         I    +     +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 232 YYRAPELIFGAT-----EYTAAIDIWSAGCVLAELL 262
            Y APE++  +      E     DI++ G V  E+ 
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  111 bits (280), Expect = 2e-28
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 15/204 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 124
           +     +G GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D P+VV   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             +F  T+     L +V+EY    +V  +I+     ++ +    +        + L Y+H
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLH 142

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 242
                 HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I   
Sbjct: 143 FM-RKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 243 TEYTAAIDIWSAGCVLAELLLGQP 266
             Y    DIWS G    E+  G+P
Sbjct: 201 -GYNCVADIWSLGITAIEMAEGKP 223

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  110 bits (277), Expect = 3e-28
 Identities = 48/224 (21%), Positives = 96/224 (42%), Gaps = 26/224 (11%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   +   +L +  V ++    +++  +        +  +  +     Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
           H    + HRD+K  N+ ++   + +K+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 H-AKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 240 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
                  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  110 bits (278), Expect = 3e-28
 Identities = 67/284 (23%), Positives = 123/284 (43%), Gaps = 45/284 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
             +   +G GS G+V  A+   +G  VA+K +     Q +     E+  MR   H NVV 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +   +      +EL+  +++E++    +  ++        R+    +      + +ALAY
Sbjct: 107 MYKSYLV---GEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAY 156

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 240
           +H   GV HRDIK  ++L+     ++KL DFG  A++        S + + Y+ APE+I 
Sbjct: 157 LHAQ-GVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
             + Y   +DIWS G ++ E++ G+P +  +S V  +  +      P  +          
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN--------- 263

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
                   +H    + +        D + R+L   P  R+TA +
Sbjct: 264 --------SHKVSPVLR--------DFLERMLVRDPQERATAQE 291

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (278), Expect = 5e-28
 Identities = 67/287 (23%), Positives = 121/287 (42%), Gaps = 42/287 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMR-LLDHPNVVS 122
           +    +VG+G++G V++ + ++TG+  AIK +     ++    +E+  ++    H N+ +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 123 LKHCFF-STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               F        +  L LV+E+    +V  +IK+       +   ++     +I R L+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLS 143

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 239
           ++H    V HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I
Sbjct: 144 HLHQH-KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 240 ----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
                    Y    D+WS G    E+  G P       +  L  I +             
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------------- 248

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           NP       P++K+  W K FQ          +   L  + + R   
Sbjct: 249 NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPAT 281

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  109 bits (274), Expect = 1e-27
 Identities = 56/255 (21%), Positives = 104/255 (40%), Gaps = 39/255 (15%)

Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNV 120
           ++      V   G FG V++A+     E VA+K    QDK+    E  + ++  + H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 121 VS-LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICR 177
           +  +      T+   +L+L  +  +  + ++   +K +    ++   +         + R
Sbjct: 81  LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132

Query: 178 ALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
            LAY+H  I          + HRDIK +N+L+  +     + DFG A      E   S  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAG 188

Query: 229 CSRY------YRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
            +        Y APE++ GA     +    ID+++ G VL EL        G      L 
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 279 EIIKVLGTPTREEIK 293
              ++   P+ E+++
Sbjct: 249 FEEEIGQHPSLEDMQ 263

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  108 bits (271), Expect = 4e-27
 Identities = 41/228 (17%), Positives = 85/228 (37%), Gaps = 47/228 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
             ++G G FG V+  +       VAI+ +  ++  ++      RE+   R   H NVV  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 124 K-HCFFSTTEKDELYLNLVLEYVPE-TVHRVI---KHHYKMSQRMPLIYVKLYFYQICRA 178
              C         L   ++       T++ V+   K    +++   +        +I + 
Sbjct: 95  MGAC----MSPPHLA--IITSLCKGRTLYSVVRDAKIVLDVNKTRQIA------QEIVKG 142

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------ 232
           + Y+H   G+ H+D+K +N+  +     + + DFG     + G         +       
Sbjct: 143 MGYLH-AKGILHKDLKSKNVFYDNGK--VVITDFGLFS--ISGVLQAGRREDKLRIQNGW 197

Query: 233 --YRAPELIFGATE--------YTAAIDIWSAGCVLAELLLGQPLFPG 270
             + APE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  104 bits (261), Expect = 9e-26
 Identities = 55/253 (21%), Positives = 102/253 (40%), Gaps = 37/253 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHC 126
             ++G G +G V++         VA+K     +++    E    R+  ++H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
               T    +   LV+EY P  ++ + +  H         +      + + R LAY+H  
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130

Query: 186 I--------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---------PNISYI 228
           +         + HRD+  +N+LV        + DFG +  L               IS +
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 229 CSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVD-QLVEI 280
            +  Y APE++ GA            +D+++ G +  E+ +    LFPGES  + Q+   
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 281 IKVLGTPTREEIK 293
            +V   PT E+++
Sbjct: 250 TEVGNHPTFEDMQ 262

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 95.6 bits (238), Expect = 8e-23
 Identities = 35/284 (12%), Positives = 63/284 (22%), Gaps = 70/284 (24%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNR---ELQTMRLLDHPN 119
           Y      G       +QA        VA+  V                    +  +D P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  +              L +V E++   ++  V             +        +  A
Sbjct: 93  VARV----LDVVHTRAGGL-VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAA 141

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
               H   GV      P  + V+     + L                             
Sbjct: 142 ADAAHRA-GVALSIDHPSRVRVSI-DGDVVLAYPA-------------------TMPDA- 179

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
                      DI   G  L  LL+ +   P       L    +        E   ++ +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD 231

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                                +P +   + +R +Q    +RS +
Sbjct: 232 ---------------------IPFQISAVAARSVQGDGGIRSAS 254

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 52/238 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L            +   L+ + +P    +  V +H       +   Y+  +  QI + 
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKG 129

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                    A E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 44/235 (18%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            R +G G FG V           TGE VA+K +  D   ++     +E+  +R L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +  K C     +     L LV+EYVP      ++  Y     + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLR-DYLPRHSIGLAQLLLFAQQICEGMA 148

Query: 181 YIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           Y+H  + I   HRD+  +N+L++ +   +K+ DFG AK + +G          YYR    
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196

Query: 235 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEI 280
                   APE +     +  A D+WS G  L ELL          +   +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 88.1 bits (219), Expect = 4e-20
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 46/218 (21%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            + +G G+FG V   +       TGE VA+KK LQ    ++     RE++ ++ L H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  K             L L++EY+P       + KH  ++     L Y      QIC+ 
Sbjct: 74  VKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT----SQICKG 126

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         +++  
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDKE--------FFKVK 174

Query: 235 ----------APELIFGATEYTAAIDIWSAGCVLAELL 262
                     APE +   ++++ A D+WS G VL EL 
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 44/217 (20%)

Query: 70  ERVVGHGSFGVVFQAKCL----ETGEAVAIK--KVLQDKRYKN--RELQTMRLLDHPNVV 121
            + +G G+FG V   +       TGE VA+K  +   ++  ++  RE++ ++ L H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K             L L++EY+P       + KH  ++     L Y      QIC+ +
Sbjct: 106 KYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT----SQICKGM 158

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         YY+   
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206

Query: 235 ---------APELIFGATEYTAAIDIWSAGCVLAELL 262
                    APE +   ++++ A D+WS G VL EL 
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 49/233 (21%), Positives = 88/233 (37%), Gaps = 40/233 (17%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
            R++G G FG V +A+  +       VA+K +  D    +      RE   M+  DHP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 121 VSLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL--YFYQIC 176
             L      S  +       ++L ++    +H  +           L    L  +   I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
             + Y+ ++    HRD+  +N ++      + + DFG ++ +  G+         YYR  
Sbjct: 148 CGMEYL-SSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGD---------YYRQG 196

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     A E L      YT   D+W+ G  + E++  GQ  + G    +
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 43/217 (19%)

Query: 70  ERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            R +G G FG V   +       TGE VA+K +  +    +     +E++ +R L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V  K      TE     + L++E++P  ++   +  +     ++ L     Y  QIC+ +
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGM 139

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     +   HRD+  +N+LV    HQ+K+ DFG  K +   +         YY    
Sbjct: 140 DYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKD 187

Query: 235 ---------APELIFGATEYTAAIDIWSAGCVLAELL 262
                    APE +  +  +  A D+WS G  L ELL
Sbjct: 188 DRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 46/218 (21%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
              +G G+FG V   +       TG  VA+K  LQ           RE+Q ++ L    +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  +   +    +  L   LV+EY+P       + +H  ++     L+Y      QIC+ 
Sbjct: 87  VKYRGVSYGPGRQS-LR--LVMEYLPSGCLRDFLQRHRARLDASRLLLYS----SQICKG 139

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   +         YY   
Sbjct: 140 MEYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVR 187

Query: 235 ----------APELIFGATEYTAAIDIWSAGCVLAELL 262
                     APE +     ++   D+WS G VL EL 
Sbjct: 188 EPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 46/234 (19%), Positives = 87/234 (37%), Gaps = 43/234 (18%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
            +++G G FG V +    +       VA+K +  D   +        E   M+   HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL--YFYQICR 177
           + L       + +      ++L ++    +H  + +    +    +    L  +   I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + Y+   N +   HRD+  +N ++      + + DFG +K +  G+         YYR 
Sbjct: 159 GMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YYRQ 205

Query: 235 -----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                      A E L      YT+  D+W+ G  + E+   G   +PG    +
Sbjct: 206 GRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 33/226 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
               T +   Y  ++ E++    +  +  + +   R  +  V L     QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N I   HR++  +N LV    H +K+ DFG ++++        Y      +      AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E +     ++   D+W+ G +L E+   G   +PG       +L+E
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 55/224 (24%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT----MRLLDHPNVVSL-K 124
           + ++GHG FG V++   L  G  VA+K+   +      E +T    +    HP++VSL  
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 125 HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMS--QRMPLIYVKLYFYQIC- 176
            C     E++E+ L  + +Y+        ++        MS  QR+          +IC 
Sbjct: 103 FC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EICI 146

Query: 177 ---RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 232
              R L Y+H    + HRD+K  N+L++ +    K+ DFG +K   + +   +++ +   
Sbjct: 147 GAARGLHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLSTVVK 202

Query: 233 ----YRAPELIFGATEY------TAAIDIWSAGCVLAELLLGQP 266
               Y  P       EY      T   D++S G VL E+L  + 
Sbjct: 203 GTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 53/228 (23%), Positives = 84/228 (36%), Gaps = 45/228 (19%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 124
              +G G+FG VF  +       VA+K   +      +     E + ++   HPN+V L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 125 H--CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAY 181
              C    T+K  +Y  +V+E V            +       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------- 234
           + +     HRD+  +N LV    + LK+ DFG ++    G          Y         
Sbjct: 229 LES-KCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLRQV 277

Query: 235 -----APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                APE L +G   Y++  D+WS G +L E   LG   +P  S   
Sbjct: 278 PVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 47/232 (20%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGEA--VAIKKV---LQDKRYKN---RELQTMRLLDHPN 119
           + ++ +G G+FG V +           VA+K +     D   K+    E   M+ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V +        E +     LV+E         +  + + ++ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+   N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+   
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                    APE + +   ++++  D+WS G ++ E    GQ  + G  G +
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 45/235 (19%), Positives = 78/235 (33%), Gaps = 50/235 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA-------VAIKKVLQDKRYKN----RELQTMRLLDHP 118
              +G G+F  +F+    E G+        V +K + +  R  +         M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 119 NVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQIC 176
           ++V     C       DE    LV E+V       +  + K ++    I  KL    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 177 RALAYI--HNTIGVCHRDIKPQNLLVNPHTHQL-------KLCDFGSAKVLVKGEPNISY 227
            A+ ++  +  I   H ++  +N+L+     +        KL D G +  ++  +     
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175

Query: 228 ICSRYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 +       PE I        A D WS G  L E+   G           
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 48/236 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             L            +   L+ + +P   +   ++ H      +   Y+  +  QI + +
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y    
Sbjct: 131 NYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEG 178

Query: 235 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                   A E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 179 GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 84.2 bits (208), Expect = 5e-18
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 35/226 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
            ++   ++ +Y  +V EY+       +    K      L   +L     QI   +AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 382 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 433

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E       +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 434 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 83.6 bits (207), Expect = 6e-18
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 37/215 (17%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
            + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI--H 183
               EK  LY  +V EY+       +  + +   R  L    L  +   +C A+ Y+  +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------APE 237
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356

Query: 238 -LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            L     +++   D+WS G +L E+   G+  +P 
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 81.9 bits (203), Expect = 6e-18
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 33/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
               T +   Y  ++ E++    +  +  + +   R  +  V L     QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N I   HRD+  +N LV  + H +K+ DFG ++++        Y      +      AP
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 181

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           E L +   +++   D+W+ G +L E+   G   +PG
Sbjct: 182 ESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.4 bits (204), Expect = 6e-18
 Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 38/231 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            +V+G G FG V +   +  GE+    V IK +      ++       +  +  LDH ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L            L   LV +Y+P  ++   ++ H      +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGM 128

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+  H  +   HR++  +N+L+     Q+++ DFG A +L   +     +     +   
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPI 181

Query: 235 ---APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
              A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 35/226 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
            ++   ++ +Y  +V EY+       +    K      L   +L     QI   +AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 299 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 350

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E       +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 81.5 bits (202), Expect = 6e-18
 Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 37/220 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
            + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI--H 183
               EK  LY  +V EY+       +  + +   R  L    L  +   +C A+ Y+  +
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------APE 237
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184

Query: 238 -LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
            L     +++   D+WS G +L E+   G+  +P     D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 83.8 bits (207), Expect = 7e-18
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 47/232 (20%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L        + + L   LV+E      +H+ +       + +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGM 449

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+   N +   HR++  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                    APE + F   ++++  D+WS G  + E L  GQ  +    G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 57/252 (22%), Positives = 93/252 (36%), Gaps = 56/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLDHP 118
            + +G G+FG V +A        +    VA+K +     L ++     EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRMPL 165
           N+V+L       T        ++ EY                 +             + L
Sbjct: 88  NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 166 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
               L    YQ+ + +A++  +    HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDS- 199

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                    Y             APE IF    YT   D+WS G  L EL  LG   +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 271 ESGVDQLVEIIK 282
                +  ++IK
Sbjct: 251 MPVDSKFYKMIK 262

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E+ +G G FG V+ A   +  + VA+K +            E   M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
             +   K+ +Y  ++ E++       +    K  +       KL  +  QI   +A+I  
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 234
            N I   HRD++  N+LV+      K+ DFG A+V+   E         Y          
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349

Query: 235 ---APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
              APE + FG   +T   D+WS G +L E++  G+  +PG S  +  + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 56/238 (23%), Positives = 96/238 (40%), Gaps = 49/238 (20%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L        + + L   LV+E      +H+ +    +      +       +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAE---LLHQVSMGM 123

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+   N +   HRD+  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                    APE + F   ++++  D+WS G  + E L  GQ  +    G +    +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 49/242 (20%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTM 112
           P + +   ++RV+G G FGVV+  + ++  +     AIK    + + +      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R L+HPNV++L         +   +  ++L Y+    H  +    +  QR P +   + F
Sbjct: 77  RGLNHPNVLALIGI--MLPPEGLPH--VLLPYMC---HGDLLQFIRSPQRNPTVKDLISF 129

Query: 173 -YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
             Q+ R + Y+     +   HRD+  +N +++  +  +K+ DFG A+ ++  E       
Sbjct: 130 GLQVARGMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE------- 178

Query: 230 SRYYR--------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 273
             YY               A E L      +T   D+WS G +L ELL  G P +     
Sbjct: 179 --YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

Query: 274 VD 275
            D
Sbjct: 235 FD 236

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 51/229 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 125
            + +G G FG+V     L   + VAIK + +    +     E + M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 126 CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C     E+  +   LV E++         R  +  +       L+        +C  +AY
Sbjct: 72  C----LEQAPIC--LVTEFMEHGCLSDYLRTQRGLFAAET---LLG---MCLDVCEGMAY 119

Query: 182 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
           +     I   HRD+  +N LV  +   +K+ DFG  + ++  +         Y       
Sbjct: 120 LEEACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTK 166

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 +PE   F    Y++  D+WS G ++ E+   G+  +   S  +
Sbjct: 167 FPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 56/261 (21%), Positives = 102/261 (39%), Gaps = 63/261 (24%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKV----LQDKRYKNRELQT 111
            ++ I     R +G G+FG VF A+C           VA+K +    L  ++   RE + 
Sbjct: 13  KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMS 160
           +  L H ++V          + D L   +V EY+                 ++       
Sbjct: 71  LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 161 QRMPLIYVKLYF--YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 216
            +  L   ++     QI   + Y+   + +   HRD+  +N LV  +   +K+ DFG ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSR 181

Query: 217 VLVKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL- 262
            +   +         YYR             PE +++   ++T   D+WS G +L E+  
Sbjct: 182 DVYSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFT 230

Query: 263 LG-QPLFPGESGVDQLVEIIK 282
            G QP +   S   +++E I 
Sbjct: 231 YGKQP-WFQLS-NTEVIECIT 249

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 78.8 bits (195), Expect = 5e-17
 Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 53/235 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 125
            + +G G FGVV   K     + VA+K + +    ++   +E QTM  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 126 CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    +++  +Y  +V EY+         R      + SQ   L+      Y +C  +A+
Sbjct: 72  C----SKEYPIY--IVTEYISNGCLLNYLRSHGKGLEPSQ---LLE---MCYDVCEGMAF 119

Query: 182 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
           +  H  I   HRD+  +N LV+     +K+ DFG  + ++  +         Y       
Sbjct: 120 LESHQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTK 166

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
                 APE   +   +Y++  D+W+ G ++ E+  LG+  +   +   V   V 
Sbjct: 167 FPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 79.6 bits (197), Expect = 6e-17
 Identities = 57/249 (22%), Positives = 100/249 (40%), Gaps = 53/249 (21%)

Query: 71  RVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLD-HPN 119
           + +G G+FG V +A         T   VA+K +       + R    EL+ +  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRMPLI 166
           VV+L      T     L   +++E+               E V   +         + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           ++  Y +Q+ + + ++  +    HRD+  +N+L++   + +K+CDFG A+ + K      
Sbjct: 149 HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP---- 202

Query: 227 YICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 273
                 Y             APE IF    YT   D+WS G +L E+  LG   +PG   
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 274 VDQLVEIIK 282
            ++    +K
Sbjct: 257 DEEFCRRLK 265

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 79.6 bits (197), Expect = 6e-17
 Identities = 52/243 (21%), Positives = 95/243 (39%), Gaps = 50/243 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGE-----AVAIKKV-----LQDKRYKNRELQTMRLLDHPNV 120
           R +G GSFG+V++       +      VAIK V     ++++     E   M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           V L       ++       +++E +            R    +  +     L  +     
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           +I   +AY+ N     HRD+  +N +V      +K+ DFG  + + + +         YY
Sbjct: 146 EIADGMAYL-NANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETD---------YY 194

Query: 234 R------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 279
           R            +PE L  G   +T   D+WS G VL E+  L +  + G S  +Q++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251

Query: 280 IIK 282
            + 
Sbjct: 252 FVM 254

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 78.8 bits (195), Expect = 6e-17
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
              +G G FG V+        + VA+K + Q     +    E   M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
            ++   ++ +Y  ++ EY+    +  +    K    + L   KL     QI   +A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 234
            N I   HRD++  N+LV+      K+ DFG A+++   E         Y          
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174

Query: 235 ---APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
              APE + +G   +T   D+WS G +L E++  G+  +PG +   V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 79.5 bits (195), Expect = 7e-17
 Identities = 49/314 (15%), Positives = 89/314 (28%), Gaps = 69/314 (21%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----------RELQTMRLL----- 115
           +G G FG VFQ         VAIK + ++     N            E+   + L     
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 116 ----DHPNVVSLKHCFFSTTEKDELYLNLVLEY---------------------VPETVH 150
                    + L            L L     Y                     V E   
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 151 RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 210
             I      ++   L   K   +Q+  +LA    ++   HRD+   N+L+   + + KL 
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK-KLH 204

Query: 211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
              + K                     L     +YT +        V  ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 271 ESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKAHPWHKIFQ--KRMP 321
           +   D   +I +++           +P       +Y   K  +             K++ 
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309

Query: 322 PEAVDLVSRLLQYS 335
            +  +    +L +S
Sbjct: 310 RKIQEFHRTMLNFS 323

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 55/236 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 121
             V+G G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH----HYKMSQRMPLIYVKL--YFYQI 175
           SL         +      +VL Y+        KH    ++  ++        L  +  Q+
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYM--------KHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + + Y+ +     HRD+  +N +++     +K+ DFG A+ +   E         YY  
Sbjct: 138 AKGMKYLAS-KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSV 186

Query: 235 -------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                        A E L     ++T   D+WS G +L EL+  G P +P  +  D
Sbjct: 187 HNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 56/239 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
            R +G G FG V Q   +       AVAIK          R     E  TMR  DHP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L         ++ ++  +++E        +  +V K    ++    LI    Y YQ+  
Sbjct: 455 KL----IGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLAS---LIL---YAYQLST 502

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
           ALAY+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+ 
Sbjct: 503 ALAYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKA 549

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
                     APE + F    +T+A D+W  G  + E+L  G   F G     V   +E
Sbjct: 550 SKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 54/233 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
            R++G G FG V++            VA+K   +D    N+     E   M+ LDHP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L        E++  +  +++E  P           K+  K+     L+    Y  QIC+
Sbjct: 77  KL----IGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLT---LVL---YSLQICK 124

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
           A+AY+   N +   HRDI  +N+LV      +KL DFG ++ +   +         YY+ 
Sbjct: 125 AMAYLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKA 171

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     +PE + F    +T A D+W     + E+L  G+  F      D
Sbjct: 172 SVTRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 56/240 (23%), Positives = 90/240 (37%), Gaps = 54/240 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
              +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L    +       +   +V E  P    + R+ KH         L  +  Y  Q+  
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAE 132

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + Y+     I   HRD+  +NLL+      +K+ DFG  + L + +         +Y  
Sbjct: 133 GMGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVM 180

Query: 235 -----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                      APE L      ++ A D W  G  L E+   GQ  + G +G      ++
Sbjct: 181 QEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 54/233 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
            R +G G FG V Q   +       AVAIK          R     E  TMR  DHP++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L         ++ ++  +++E        +  +V K+   ++    LI    Y YQ+  
Sbjct: 80  KL----IGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLAS---LIL---YAYQLST 127

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
           ALAY+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+ 
Sbjct: 128 ALAYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKA 174

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     APE + F    +T+A D+W  G  + E+L  G   F G    D
Sbjct: 175 SKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 43/229 (18%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 122 SLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L+       T+   +   +V EY+   ++   ++ H      + L+        I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYMENGSLDSFLRKHDAQFTVIQLVG---MLRGIASGM 160

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
            Y+ + +G  HRD+  +N+L+N +    K+ DFG  +VL              Y      
Sbjct: 161 KYL-SDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRGGK 211

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 +PE + +   ++T+A D+WS G VL E++  G+  +   S  D
Sbjct: 212 IPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 55/249 (22%), Positives = 96/249 (38%), Gaps = 56/249 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKV----LQDKRYKNRELQTMRLLDHPNV 120
           +  +G G+FG VF A+C           VA+K +       ++   RE + + +L H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP----------ETVHRVIKHHYKMSQRMPLIYVKL 170
           V         TE   L   +V EY+                 +    +     PL   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 171 YF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
                Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +   +      
Sbjct: 161 LAVASQVAAGMVYL-AGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD------ 212

Query: 229 CSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGESG 273
              YYR             PE +++   ++T   D+WS G VL E+   G QP +   S 
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265

Query: 274 VDQLVEIIK 282
             + ++ I 
Sbjct: 266 NTEAIDCIT 274

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 54/238 (22%), Positives = 93/238 (39%), Gaps = 51/238 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 122 SLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L+       T        +V EY+   ++   ++ H      M L+        +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGM 164

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     +   HRD+  +N+LV+ +    K+ DFG ++VL                   
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTT 212

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                    APE + F    +++A D+WS G V+ E+L  G+  +   +  D    VE
Sbjct: 213 GGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 76.5 bits (189), Expect = 4e-16
 Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 51/229 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 125
            + +G G FGVV   K     + VAIK + +    ++    E + M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 126 CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    T++  ++  ++ EY+         R ++H ++  Q   L+        +C A+ Y
Sbjct: 88  C----TKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQ---LLE---MCKDVCEAMEY 135

Query: 182 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
           +     +   HRD+  +N LVN     +K+ DFG ++ ++  E         Y       
Sbjct: 136 LESKQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSK 182

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                  PE L++   ++++  DIW+ G ++ E+  LG+  +   +  +
Sbjct: 183 FPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 76.6 bits (189), Expect = 4e-16
 Identities = 47/223 (21%), Positives = 87/223 (39%), Gaps = 43/223 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 123
           Y   R +G GSFGV+F+   L   + VAIK   +         E +T +LL     + ++
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            +       ++ L+  LV++ +  ++  ++       ++  +  V +   Q+   +  IH
Sbjct: 72  YYFG-----QEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 184 NTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YR 234
               + +RDIKP N L+    + + + + + DFG  K          Y          YR
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYR 173

Query: 235 APELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
             + + G   Y  +I            D+ + G V    L G 
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 76.5 bits (189), Expect = 7e-16
 Identities = 51/222 (22%), Positives = 98/222 (44%), Gaps = 50/222 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 124
           + ++G G FG V++ + L  G  VA+K++ +++          E++ + +  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 125 -HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKM--SQRMPLIYVKLYFYQIC 176
             C        E  L  V  Y+        +    +    +   +R           +I 
Sbjct: 94  GFC----MTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQ----------RIA 137

Query: 177 ----RALAYIHNTIGVC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
               R LAY+H+       HRD+K  N+L++    +  + DFG AK++   +   +++ +
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTT 193

Query: 231 RY-----YRAPE-LIFG-ATEYTAAIDIWSAGCVLAELLLGQ 265
                  + APE L  G ++E T   D++  G +L EL+ GQ
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 76.7 bits (189), Expect = 8e-16
 Identities = 50/233 (21%), Positives = 90/233 (38%), Gaps = 49/233 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 121
             V+G G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH----HYKMSQRMPLIYVKL--YFYQI 175
           SL         +      +VL Y+        KH    ++  ++        L  +  Q+
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYM--------KHGDLRNFIRNETHNPTVKDLIGFGLQV 201

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + + ++  +    HRD+  +N +++     +K+ DFG A+ +   E +        +  
Sbjct: 202 AKGMKFL-ASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNK 253

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     A E L     ++T   D+WS G +L EL+  G P +P  +  D
Sbjct: 254 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 58/268 (21%), Positives = 100/268 (37%), Gaps = 68/268 (25%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQ 110
           P+  I Y+  R +G G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-------------------ETVHR 151
            M   D+PN+V L            + L  + EY+                         
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 152 VIKHHYKMSQRMPLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
             +         PL   +      Q+   +AY+ +     HRD+  +N LV  +   +K+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLATRNCLVGEN-MVVKI 215

Query: 210 CDFGSAKVLVKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGC 256
            DFG ++ +   +         YY+             PE + +    YT   D+W+ G 
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264

Query: 257 VLAELL-LG-QPLFPGESGVDQLVEIIK 282
           VL E+   G QP + G +  ++++  ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 53/245 (21%), Positives = 94/245 (38%), Gaps = 52/245 (21%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            R +GHG+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYF--Y 173
           +V        + +    +  +++E +      +  R  +   + SQ   L  + L     
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 147

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSR 231
            I     Y+       HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 148 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197

Query: 232 YYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 277
           YYR             PE  + G   +T+  D WS G +L E+  LG   +P +S   ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254

Query: 278 VEIIK 282
           +E + 
Sbjct: 255 LEFVT 259

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 54/245 (22%), Positives = 94/245 (38%), Gaps = 52/245 (21%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            R +GHG+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYF--Y 173
           +V        + +    +  ++LE +      +  R  +   + SQ   L  + L     
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 188

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSR 231
            I     Y+       HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 189 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238

Query: 232 YYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 277
           YYR             PE  + G   +T+  D WS G +L E+  LG   +P +S   ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295

Query: 278 VEIIK 282
           +E + 
Sbjct: 296 LEFVT 300

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 45/223 (20%), Positives = 81/223 (36%), Gaps = 43/223 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTMRLLDH-PNVVSL 123
           +   + +G G+FG +   K L T E VAIK   +       + E +  + L     +  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            +           Y  +VLE +  ++  +        +   L  V +   Q+   + Y+H
Sbjct: 71  YYFG-----PCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 184 NTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YR 234
           +   + +RD+KP+N L+    N     + + DF  AK          YI         YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172

Query: 235 APELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
             + + G   Y  +I            D+ + G +    L G 
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 49/232 (21%), Positives = 91/232 (39%), Gaps = 48/232 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           ++V+G G FG V++     +       VAIK +      K R     E   M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 121 VSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRA 178
           + L+       ++   +   ++ EY+    +  +    +       +   +     I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+   N +   HRD+  +N+LVN +    K+ DFG ++VL              Y   
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP-------EATYTTS 208

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                    APE + +    +T+A D+WS G V+ E++  G+  +   S  +
Sbjct: 209 GGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 55/258 (21%), Positives = 100/258 (38%), Gaps = 64/258 (24%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            + +G G FG V +A             VA+K +       + R    E   ++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVK--- 169
           V+ L       ++   L   L++EY             R +   Y  S            
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 170 ----------LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
                     + F +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDV 200

Query: 219 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LG- 264
            + +          Y             A E +F    YT   D+WS G +L E++ LG 
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250

Query: 265 QPLFPGESGVDQLVEIIK 282
            P +PG    ++L  ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 41/221 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 123
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     + ++
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C       +  Y  +V+E +  ++  +       S++  L  V L   Q+   + YIH
Sbjct: 71  RWCG-----AEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 184 NTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           +     HRD+KP N L+      + + + DFG AK          Y  +R      YR  
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------KYRDARTHQHIPYREN 172

Query: 237 ELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
           + + G   Y A+I            D+ S G VL    LG 
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 57/251 (22%), Positives = 93/251 (37%), Gaps = 58/251 (23%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
              +G   FG V++         E  +AVAIK +        +     E      L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPLIYV 168
           VV L       T+   L   ++  Y                  V       + +  L   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 169 KLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
                  QI   + Y+ ++  V H+D+  +N+LV      +K+ D G  + +   +    
Sbjct: 129 DFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD---- 182

Query: 227 YICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGE 271
                YY+            APE +++G  +++   DIWS G VL E+   G QP + G 
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCGY 234

Query: 272 SGVDQLVEIIK 282
           S    +VE+I+
Sbjct: 235 S-NQDVVEMIR 244

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 59/251 (23%), Positives = 96/251 (38%), Gaps = 58/251 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKV-----LQDKRYKNRELQTM-RLLDHP 118
            + +G G+FG V +A     G+      VA+K +       +K     EL+ M  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP---------ETVHRVIKHHYKMSQRMPLIYVK 169
           N+V+L       T    +   ++ EY                +                 
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 170 L-YF-YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
           L +F  Q+ + +A++   N I   HRD+  +N+L+    H  K+ DFG A+ ++      
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS--- 218

Query: 226 SYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGE 271
                  Y             APE IF    YT   D+WS G +L E+  LG  P +PG 
Sbjct: 219 ------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGI 270

Query: 272 SGVDQLVEIIK 282
               +  +++K
Sbjct: 271 LVNSKFYKLVK 281

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 57/258 (22%), Positives = 100/258 (38%), Gaps = 63/258 (24%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLDHP 118
            +V+G G+FG V  A             VA+K +       ++     EL+ M +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP-----------------ETVHRVIKHHYKMSQ 161
           N+V+L       T    +YL  + EY                   + +    +   +  +
Sbjct: 110 NIVNLLGA---CTLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 162 RMPLIYVK--LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            + ++  +  L F YQ+ + + ++       HRD+  +N+LV      +K+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDI 222

Query: 219 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAEL--LLG 264
           +             Y             APE +F    YT   D+WS G +L E+  L  
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272

Query: 265 QPLFPGESGVDQLVEIIK 282
            P +PG        ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLL-DHPNVVSL 123
           +   R +G GSFG ++    ++T E VAIK      ++     E +  R+L     + ++
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +         +  Y  LV++ +  ++  +       S+++ L  V +   Q+   + ++H
Sbjct: 69  RWFG-----VEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 184 NTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 236
           +     HRDIKP N L+      +Q+ + DFG AK          Y  +       YR  
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYREN 170

Query: 237 ELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
           + + G   Y A++            D+ S G VL   L G 
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 58/252 (23%), Positives = 103/252 (40%), Gaps = 57/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 116
            + +G G+FG V  A+ +            VA+K +      +D      E++ M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPL 165
           H N+++L       T+   LY  +++EY                     ++   +    L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 166 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
               L    YQ+ R + Y+  +    HRD+  +N+LV    + +K+ DFG A+ +   + 
Sbjct: 189 SSKDLVSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHID- 245

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                   YY+            APE +F    YT   D+WS G +L E+  LG   +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 271 ESGVDQLVEIIK 282
              V++L +++K
Sbjct: 297 VP-VEELFKLLK 307

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.5 bits (181), Expect = 8e-15
 Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 57/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 116
            + +G G FG V  A+ +       +    VA+K +      +D      E++ M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRM 163
           H N+++L       T+   LY  +++EY              P  +      +    ++M
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
               +    YQ+ R + Y+  +    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 201 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 257

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 271 ESGVDQLVEIIK 282
              V++L +++K
Sbjct: 309 IP-VEELFKLLK 319

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 56/252 (22%), Positives = 105/252 (41%), Gaps = 57/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 116
            + +G G+FG V  A+ +       +    VA+K +      +D      E++ M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-----------TVHRVIKHHYKMSQRMPL 165
           H N+++L       T+   LY  +++EY  +                  +         +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 166 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            +  L    YQ+ R + Y+  +    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 211

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

Query: 271 ESGVDQLVEIIK 282
              V++L +++K
Sbjct: 263 IP-VEELFKLLK 273

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 40/250 (16%), Positives = 81/250 (32%), Gaps = 49/250 (19%)

Query: 46  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK 105
            G ++    G +         ++  + +G G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 106 N---RELQTMRLLDHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYVPET 148
                EL+  + +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 149 VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQL 207
           + ++   +    +      V     ++   L YIH      H DIK  NLL+   +  Q+
Sbjct: 138 LQKISGQNGTFKKST----VLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192

Query: 208 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWSAG 255
            L D+G +        +  Y         +   G  E+  ++            D+   G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247

Query: 256 CVLAELLLGQ 265
             +   L G+
Sbjct: 248 YCMLRWLCGK 257

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 46/218 (21%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK----NRELQT----MRLLDHPNVVSL 123
            +G G FGVV++   +     VA+KK+            ++       M    H N+V L
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 124 K-HCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----R 177
                   ++ D+L L  V  Y+P  ++         +    PL +      +I      
Sbjct: 96  LGFS----SDGDDLCL--VYVYMPNGSLLD---RLSCLDGTPPLSWHMRC--KIAQGAAN 144

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 231
            + ++H      HRDIK  N+L+           K+ DFG A+   K     + + SR  
Sbjct: 145 GINFLHEN-HHIHRDIKSANILLDEAFTA-----KISDFGLARASEKFA--QTVMTSRIV 196

Query: 232 --Y-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
               Y APE + G  E T   DI+S G VL E++ G P
Sbjct: 197 GTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 60/238 (25%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA--VAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPLIYVKL 170
           +L         +  LYL   +EY P             +          S    L   +L
Sbjct: 90  NLLGA---CEHRGYLYL--AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 171 -YF-YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
            +F   + R + Y+     I   HRD+  +N+LV  + +  K+ DFG ++          
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191

Query: 227 YICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                 Y             A E L +    YT   D+WS G +L E++ LG   + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 38/252 (15%), Positives = 80/252 (31%), Gaps = 50/252 (19%)

Query: 46  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG--------EAVAIKK 97
            G ++    G +         +  +      + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 98  VLQDKRYKNRELQTMRLLDHPNVVSLK-----------HCFFSTTEKDELYLNLVLEYVP 146
             +D R  N +    R      V   K            C      +D+    LVL  + 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTH 205
            ++   +    K    +    V     ++  AL ++H      H ++  +N+ V+P    
Sbjct: 142 RSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQS 198

Query: 206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWS 253
           Q+ L  +G A        +++Y             G  E+  ++            D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253

Query: 254 AGCVLAELLLGQ 265
            G  + + L G 
Sbjct: 254 LGYCMLKWLYGF 265

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 43/252 (17%), Positives = 77/252 (30%), Gaps = 50/252 (19%)

Query: 46  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQA-----KCLETGEAVAIKKVLQ 100
            G II                +     +G G FG ++ A     + + +     +K    
Sbjct: 25  VGEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS 75

Query: 101 DKRYKNRELQTMRLLDHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYVP 146
           D      EL+  +    P  +                        +  + Y  ++++   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTH 205
             + ++ + + K   R     V     +I   L YIH      H DIK  NLL+N  +  
Sbjct: 136 SDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191

Query: 206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWS 253
           Q+ L D+G A        + +Y             G  E+  +I            D+  
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246

Query: 254 AGCVLAELLLGQ 265
            G  + + L G 
Sbjct: 247 LGYCMIQWLTGH 258

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 25/123 (20%)

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           +Q+ + + ++  +    HRD+  +N+L++   + +K+CDFG A+ + K            
Sbjct: 200 FQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP---------D 248

Query: 233 YR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 279
           Y             APE IF    YT   D+WS G +L E+  LG   +PG    ++   
Sbjct: 249 YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307

Query: 280 IIK 282
            +K
Sbjct: 308 RLK 310

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 27/147 (18%), Positives = 52/147 (35%), Gaps = 23/147 (15%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLD-HP 118
            + +G G+FG V +A         T   VA+K +       + R    EL+ +  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           NVV+L      T     L   +++E+        +  +   S+R   +  K    +  + 
Sbjct: 87  NVVNLLGA--CTKPGGPLM--VIVEFCK---FGNLSTYL-RSKRNEFVPYKTKGARFRQG 138

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTH 205
             Y+         D+K +   +     
Sbjct: 139 KDYVGA----IPVDLKRRLDSITSSQS 161

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 3e-04
 Identities = 24/139 (17%), Positives = 44/139 (31%), Gaps = 30/139 (21%)

Query: 108 ELQTMRLLD---HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-- 162
           +L    L++     + +S+   +     K E    L         HR I  HY + +   
Sbjct: 410 KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL---------HRSIVDHYNIPKTFD 460

Query: 163 ---MPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
              +   Y+  YFY     + + H   I    R    + + ++    + K+    +A   
Sbjct: 461 SDDLIPPYLDQYFYSH---IGH-HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516

Query: 219 VKGEPNI--------SYIC 229
                N          YIC
Sbjct: 517 SGSILNTLQQLKFYKPYIC 535

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.0 bits (95), Expect = 5e-04
 Identities = 38/343 (11%), Positives = 89/343 (25%), Gaps = 106/343 (30%)

Query: 96  KKVLQDKRYK------NRELQTMRLLD-------------------------------HP 118
           K +L  +         +    T+RL                                   
Sbjct: 43  KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRM----PLIYVKLY--- 171
              S+    +   ++D LY N    +    V R ++ + K+ Q +    P   V +    
Sbjct: 103 RQPSMMTRMYI-EQRDRLY-NDNQVFAKYNVSR-LQPYLKLRQALLELRPAKNVLIDGVL 159

Query: 172 -------FYQICRALAYIHN--------TIGVCHRD---IKPQNLLVNPHTHQLKLCDFG 213
                     +C +               +  C+     ++    L+    +Q+   ++ 
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL----YQID-PNWT 214

Query: 214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI----DIWSAGCVLAELLLGQPLFP 269
           S         NI             +  +  Y   +    ++ +A    A        F 
Sbjct: 215 S---RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA--------FN 263

Query: 270 GESGVDQLV-----EIIKVLGTPTREEIKC--MNPNYTEFKFPQIKAHPWHKIFQKRMPP 322
               +  L+     ++   L   T   I     +   T  +   +    +     + +P 
Sbjct: 264 LSCKI--LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK-YLDCRPQDLPR 320

Query: 323 EAVD-------LVSRLLQYSP----NLRSTAFDAVGSFDSSFL 354
           E +        +++  ++       N +    D + +   S L
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL 363

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	354
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.8
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.69
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.48
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.42
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.32
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.32
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.3
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.23
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.86
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.78
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.59
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.55
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.54
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.54
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.48
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.41
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.4
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.39
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.17
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.85
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.45
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.41
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.51

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.2e-62  Score=429.66  Aligned_cols=245  Identities=29%  Similarity=0.456  Sum_probs=199.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...       .....+|+++++.++||||++++++|     .+..
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence            35799999999999999999999999999999998532       23456899999999999999999998     4455


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .+|+|||||+|+|.+.+...    .++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        87 ~~~ivmEy~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~-~vkl~DFGla~  160 (275)
T 3hyh_A           87 EIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHL-NVKIADFGLSN  160 (275)
T ss_dssp             EEEEEEECCCEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred             EEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCC-CEEEeecCCCe
Confidence            68999999999999888763    6799999999999999999999999 999999999999999887 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .........+.+||+.|||||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.....           
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-----------  229 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-----------  229 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            776655556788999999999998777567899999999999999999999998877766666654210           


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                        .+++.+|+++.+||.+||+.||++|||++|+++|
T Consensus       230 ------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          230 ------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                              1234579999999999999999999999999987

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.5e-61  Score=433.70  Aligned_cols=245  Identities=28%  Similarity=0.410  Sum_probs=210.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..|++.++||+|+||+||+|+++.+|+.||||++...    .+...+|+.+|+.++|||||+++++|.+     ...+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998532    3445689999999999999999999843     445899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      |||||+| +|.+++.+     .++++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|....
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence            9999996 78777754     4699999999999999999999999 999999999999999888 79999999998765


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ... .....+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..+........          
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~----------  290 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL----------  290 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred             CCCCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence            443 345678999999999996555 89999999999999999999999999888777777655321110          


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      .....+|+++.+||.+||+.||++|||+.|+|+|
T Consensus       291 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          291 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             ----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                            0123479999999999999999999999999998

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.7e-61  Score=429.55  Aligned_cols=243  Identities=31%  Similarity=0.521  Sum_probs=211.0

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...       .....+|+++|+.++|||||+++++|     .+..
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            35799999999999999999999999999999998643       23456899999999999999999998     4556


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ++|||||||.| +|.+.+...    +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g-~vKl~DFGla  179 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTA  179 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCC-CEEEEEcCCc
Confidence            69999999995 898888764    5799999999999999999999999 999999999999999888 7999999999


Q ss_pred             eecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          216 KVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       216 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      +......   ...+.+||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+.+|.+.-        
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--------  250 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--------  250 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Confidence            8764332   234568999999999997665 8999999999999999999999999988888777776631        


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                               +            .++..+|+++++||++||+.||++|||++|++.
T Consensus       251 ---------~------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          251 ---------Y------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             ---------C------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             ---------C------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence                     1            123458999999999999999999999998643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.3e-61  Score=436.87  Aligned_cols=247  Identities=28%  Similarity=0.422  Sum_probs=206.2

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...      .....+|+++|+.++|||||+++++|.     +...
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGS   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence            35799999999999999999999999999999998543      234568999999999999999999984     4445


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +|||||||+| +|.+.+....  ...+++..++.|+.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~  173 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIAR  173 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTC-CEEECSTTEES
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-CEEEcccccce
Confidence            8999999985 9998887543  35689999999999999999999999 999999999999999888 79999999998


Q ss_pred             ecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ....... ....+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.++......         
T Consensus       174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------  243 (350)
T 4b9d_A          174 VLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---------  243 (350)
T ss_dssp             CCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---------
T ss_pred             eecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---------
Confidence            7644322 23567999999999997665 899999999999999999999999998888888777663111         


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                         .++..+|+++.+||.+||+.||++|||+.|+|+|
T Consensus       244 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          244 -------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                               0223479999999999999999999999999987

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.8e-61  Score=431.89  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=210.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      ...|++.++||+|+||+||+|+++.+|+.||||++..+. ...+|+.+++.++|||||+++++|.     +..++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEe
Confidence            346999999999999999999999999999999997543 3357999999999999999999983     4455899999


Q ss_pred             eccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCC
Q 018514          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (354)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~  222 (354)
                      ||+| +|.+++...    +++++..++.++.||+.||+|||++ |||||||||+|||++.++..+||+|||+|+......
T Consensus       131 y~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9995 899888764    5799999999999999999999999 999999999999999887569999999998764432


Q ss_pred             C------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          223 P------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       223 ~------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .      ....+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+...  .++.       
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~-------  275 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPPI-------  275 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCGG-------
T ss_pred             cccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCCc-------
Confidence            1      12357999999999997765 899999999999999999999999987776666666552  1110       


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                       ..++..+|+++.+||.+||+.||.+|||+.|++++|..
T Consensus       276 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          276 -----------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             -----------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                             12345689999999999999999999999999988754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-59  Score=435.30  Aligned_cols=245  Identities=28%  Similarity=0.410  Sum_probs=210.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.++|||||+++++|..     ...+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998532    3445689999999999999999999844     345899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      |||||.| +|.+++..     ..+++..++.++.||+.||+|||++ |||||||||+||||+.++ .+||+|||+|....
T Consensus       226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence            9999996 78777754     4699999999999999999999999 999999999999999888 79999999998765


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ... .....+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..+........          
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~----------  367 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL----------  367 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------
T ss_pred             CCCccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence            443 345678999999999996655 89999999999999999999999999888877777655311100          


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      .....+|+++.+||.+||+.||.+|||+.|+|+|
T Consensus       368 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          368 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             ----------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                            1123479999999999999999999999999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-59  Score=415.99  Aligned_cols=247  Identities=22%  Similarity=0.341  Sum_probs=204.9

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      |++.++||+|+||+||+|.+..++..||+|++...      ...+.+|+++++.++|||||+++++|.... .+..++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            47888999999999999999999999999998543      234568999999999999999999875433 34667899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~--iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      |||||+| +|.+.+...    ..+++..++.|+.||+.||+|||++ |  |+||||||+|||++...+.+||+|||+|+.
T Consensus       107 vmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            9999995 888888764    5799999999999999999999998 8  999999999999985333799999999975


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      . ........+||+.|||||++.+ . |+.++|||||||++|||+||+.||.+.+....+...+.....|          
T Consensus       182 ~-~~~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~----------  248 (290)
T 3fpq_A          182 K-RASFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------  248 (290)
T ss_dssp             C-CTTSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred             C-CCCccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC----------
Confidence            4 3334456789999999999854 3 8999999999999999999999998776655544433311111          


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      ..++...++++.+||.+||+.||++|||+.|+|+|
T Consensus       249 ----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          249 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                            11234478999999999999999999999999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-59  Score=434.27  Aligned_cols=277  Identities=35%  Similarity=0.630  Sum_probs=228.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecC-CCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTT-EKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  137 (354)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....      ....+|+++|+.++|||||++++++.... ..+...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            47999999999999999999999999999999985432      23457999999999999999999875432 133456


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +|||||||+|+|.+.+..    .+++++..++.+++||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+.
T Consensus       134 ~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCC-CEEEeecceeee
Confidence            899999999999888865    36799999999999999999999999 999999999999999888 799999999986


Q ss_pred             cccC-----CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          218 LVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       218 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ....     ......+||+.|||||++.+...++.++||||+||++|||++|++||.+.+..+++..|....+.|+...+
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            5332     22345789999999999988777899999999999999999999999999999999999999999987754


Q ss_pred             hccCCCCcc---cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .........   ..++.....+|...+ ..+++++.+||++||++||.+||||.|+|+|
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            332211100   112333334444433 3589999999999999999999999999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.5e-59  Score=414.55  Aligned_cols=243  Identities=27%  Similarity=0.412  Sum_probs=202.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|++.+.||+|+||+||+|++.   .+++.||||++...      .....+|+++|++++|||||+++++|.     +.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence            47999999999999999999974   46788999998532      234567999999999999999999984     34


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+|||||||+| +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGl  172 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGL  172 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence            458999999995 898888764    5799999999999999999999999 999999999999999888 799999999


Q ss_pred             ceecccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          215 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       215 a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      |+..... ....+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+.+...        
T Consensus       173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------  243 (304)
T 3ubd_A          173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--------  243 (304)
T ss_dssp             EEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred             ceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC--------
Confidence            9865433 3345678999999999997665 89999999999999999999999999888888777765210        


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH-----HHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----FDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta-----~e~l~~  348 (354)
                                           .++..+|+++.+||++||+.||++||||     +|+++|
T Consensus       244 ---------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 ---------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                                 1234589999999999999999999984     789887

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.2e-58  Score=410.35  Aligned_cols=252  Identities=22%  Similarity=0.320  Sum_probs=207.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ..+|.+.+.||+|+||+||+|++.     .++..||||++...    .+.+.+|+++|++++|||||++++++..     
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----
Confidence            357999999999999999999875     35788999998643    2345689999999999999999999843     


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhh---------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHY---------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~  204 (354)
                      ...++||||||+ |+|.+++....         .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCC
Confidence            334899999999 59999987643         2345799999999999999999999999 999999999999999887


Q ss_pred             CcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 018514          205 HQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (354)
Q Consensus       205 ~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  280 (354)
                       .+||+|||+|+.......   .....||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus       166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             799999999976544322   12346899999999997665 8999999999999999998 99999998887777766


Q ss_pred             HHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      .+....                            ..+..+|+++.+|+.+||+.||++|||+.++++.|++
T Consensus       244 ~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          244 TQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             HHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            553111                            1234578999999999999999999999999888764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-57  Score=411.07  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=203.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ..+|.+.++||+|+||+||+|++.     .++..||||++...    .+.+.+|+++|++++|||||++++++.     +
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~  114 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----E  114 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            347999999999999999999875     35788999998643    234568999999999999999999984     3


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~  202 (354)
                      ...++||||||+ |+|.+++.....           ...++++..+..|+.||+.||+|||++ +||||||||+|||++.
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEET
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECC
Confidence            344899999999 589888876432           235699999999999999999999998 9999999999999998


Q ss_pred             CCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 018514          203 HTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (354)
Q Consensus       203 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  278 (354)
                      ++ .+||+|||+|+.......   .....||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+.
T Consensus       194 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          194 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TT-EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            87 899999999986543322   23457899999999997665 8999999999999999999 999999988877776


Q ss_pred             HHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      .+.+....                            ..+..+++++.+|+.+||+.||++|||+.|++++|+.
T Consensus       272 ~i~~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~  316 (329)
T 4aoj_A          272 CITQGREL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA  316 (329)
T ss_dssp             HHHHTCCC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHcCCCC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            66553111                            1234578999999999999999999999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-57  Score=406.95  Aligned_cols=252  Identities=22%  Similarity=0.276  Sum_probs=208.1

Q ss_pred             ccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      ..++++.++||+|+||+||+|++.     .+++.||||++...     .+.+.+|+.++++++|||||++++++..    
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----  100 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK----  100 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----
Confidence            346899999999999999999864     35788999998543     2446689999999999999999999843    


Q ss_pred             CeeEEEEEEeecc-ccHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee
Q 018514          134 DELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (354)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili  200 (354)
                       ...++||||||+ |+|.+++.....            ....+++..+..++.||+.||+|||++ +||||||||+|||+
T Consensus       101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl  178 (308)
T 4gt4_A          101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLV  178 (308)
T ss_dssp             -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEE
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEE
Confidence             333789999999 599998865421            235689999999999999999999999 99999999999999


Q ss_pred             eCCCCcEEEEeccCceecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 018514          201 NPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  276 (354)
Q Consensus       201 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  276 (354)
                      +.++ .+||+|||+|+......   ......||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+..+.
T Consensus       179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9887 79999999998664332   223467899999999997665 9999999999999999998 8999999887766


Q ss_pred             HHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          277 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      +..+......                            ..+..+++++.+|+.+||+.||++|||+.|++++|+.
T Consensus       257 ~~~i~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          257 VEMIRNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            6655432111                            1234578999999999999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-56  Score=411.06  Aligned_cols=275  Identities=27%  Similarity=0.430  Sum_probs=211.1

Q ss_pred             CccccceEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccch--hhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 018514           61 PKQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  134 (354)
                      |...++|++.+.||+|+||+||+|+++   .+++.||+|++....  ....+|+++|+.+ .||||++++++|     .+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~~   91 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF-----RK   91 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----EE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE-----EE
Confidence            344567999999999999999999875   457889999885443  3455899999998 699999999998     34


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ..++|+|||||+| +|.+.+       +.+++..++.+++||+.||+|||++ ||+||||||+|||++.+.+.+||+|||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            4568999999985 777766       2489999999999999999999999 999999999999999875589999999


Q ss_pred             CceecccCC-----------------------------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhC
Q 018514          214 SAKVLVKGE-----------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  264 (354)
Q Consensus       214 ~a~~~~~~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  264 (354)
                      +|+......                             .....+||+.|||||++.+...|+.++||||+||++|||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            997653321                             112357999999999998877799999999999999999999


Q ss_pred             CCCCC-CCCcHHHHHHHHHHhCCCCHHHHhccCCCC---------------------cccCCC----CccCCCcccccCC
Q 018514          265 QPLFP-GESGVDQLVEIIKVLGTPTREEIKCMNPNY---------------------TEFKFP----QIKAHPWHKIFQK  318 (354)
Q Consensus       265 ~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------------------~~~~~~----~~~~~~~~~~~~~  318 (354)
                      +.||. +.++.+++..|....|.+............                     .+...+    .............
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            99985 456678888888887765443322111000                     000000    0001111112234


Q ss_pred             CCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          319 RMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       319 ~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+|+++.+||++||++||++|+||+|+|+|
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            589999999999999999999999999998

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.7e-57  Score=401.30  Aligned_cols=250  Identities=21%  Similarity=0.298  Sum_probs=200.1

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..++++.++||+|+||+||+|++..   .||||+++..      .+.+.+|+.++++++|||||++++++..    +  .
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--N  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--e
Confidence            3578999999999999999998642   5999988532      2345689999999999999999997621    1  2


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ++||||||++ +|.+.+...   ..++++..+..|+.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~-~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTE-EEEECCCSSCB
T ss_pred             EEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCC-cEEEeeccCce
Confidence            6899999995 888888653   35799999999999999999999998 999999999999999887 89999999997


Q ss_pred             ecccCC---CccccccccccccchhccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          217 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       217 ~~~~~~---~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ......   .....+||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+..+......++   
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p---  257 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP---  257 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC---
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence            654322   23356899999999999643  3489999999999999999999999998877766665554311111   


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                    ..      ..++..+++++.+|+.+||+.||++|||+.|++++|+
T Consensus       258 --------------~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le  296 (307)
T 3omv_A          258 --------------DL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE  296 (307)
T ss_dssp             --------------CS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred             --------------Cc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence                          00      1123457899999999999999999999999998875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-55  Score=413.99  Aligned_cols=286  Identities=71%  Similarity=1.197  Sum_probs=260.5

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeEEEE
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYLNL  140 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~i  140 (354)
                      ....+|++.+.||+|+||+||+|++..+|+.||||++..+.....+|+++++.++||||++++++|..... .+..++++
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            34557999999999999999999999999999999998777777789999999999999999998865443 45677889


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      ||||+++++...+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||+++....
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            999999999888877666668899999999999999999999998 9999999999999997765789999999987766


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ........||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+..+.+.++.+.++.+..+.+......+.
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66666778999999999997766699999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+.++.+...+|...+...+++++.+||.+||++||.+|||+.|+++|
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            999999999999999988999999999999999999999999999987

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3e-56  Score=398.19  Aligned_cols=250  Identities=24%  Similarity=0.415  Sum_probs=188.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC-------
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-------  132 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------  132 (354)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....     ....+|+++|+.++|||||+++++|.....       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            47999999999999999999999999999999985422     334589999999999999999999865442       


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                      ....++|||||||.| +|.+.+..... ....+...++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCC-cEEEcc
Confidence            234568999999985 88888875432 23356677899999999999999999 999999999999999888 799999


Q ss_pred             ccCceecccCCC-------------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 018514          212 FGSAKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (354)
Q Consensus       212 fg~a~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  278 (354)
                      ||+|+.......             ....+||+.|||||++.+.. |+.++|||||||++|||++   ||.+..  +...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~--~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQM--ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence            999987643321             12357999999999997655 8999999999999999996   775432  2222


Q ss_pred             HHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+........+..                         ....++.+.+||++||+.||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~p~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 TLTDVRNLKFPPL-------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHTTCCCHH-------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhcCCCCCC-------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            2222111111110                         11246788999999999999999999999997

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-55  Score=406.93  Aligned_cols=284  Identities=51%  Similarity=0.999  Sum_probs=256.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCC-----------
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-----------  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----------  132 (354)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++..+.....+|+.+++.++||||++++++|.....           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            357999999999999999999999999999999998877777799999999999999999998866443           


Q ss_pred             ----------------------CCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 018514          133 ----------------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (354)
Q Consensus       133 ----------------------~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH  190 (354)
                                            .+..++++||||++++|.+.+.........+++..++.++.||+.||+|||++ ||+|
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-gi~H  164 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICH  164 (383)
T ss_dssp             ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEEC
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-cCcc
Confidence                                  34556899999999999999887766678899999999999999999999998 9999


Q ss_pred             cCCCCCCeeeeCCCCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 018514          191 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (354)
Q Consensus       191 ~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  270 (354)
                      |||||+||+++.+.+.+||+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||.+
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            99999999998544489999999999876666667778999999999997777789999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+..+.+..+.+..+.|..+.+...+..+....++......|...++..+++++.+||.+||++||.+|||+.|+++|
T Consensus       245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-56  Score=405.91  Aligned_cols=255  Identities=22%  Similarity=0.341  Sum_probs=208.0

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCC-----ceEEEEEcccc-----hhhhHHHHHHHHHcCC-CCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQD-----KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-----~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~  132 (354)
                      .++|++.+.||+|+||+||+|.+...+     +.||||.+...     ...+.+|+++|++++| ||||++++++.... 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-
Confidence            457999999999999999999986543     57999988643     2345579999999976 89999999874322 


Q ss_pred             CCeeEEEEEEeecc-ccHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCee
Q 018514          133 KDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (354)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nil  199 (354)
                         ..++||||||+ |+|.++++.....            ...+++..+..++.||+.||+|||++ +||||||||+|||
T Consensus       142 ---~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NIL  217 (353)
T 4ase_A          142 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  217 (353)
T ss_dssp             ---SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEE
T ss_pred             ---CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCcccee
Confidence               23789999999 5999998764321            34589999999999999999999999 9999999999999


Q ss_pred             eeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 018514          200 VNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (354)
Q Consensus       200 i~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  275 (354)
                      ++.++ .+||+|||+|+.......   .....||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+..+
T Consensus       218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99887 799999999987644332   22456899999999997665 9999999999999999998 999999876555


Q ss_pred             HHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .+..++.....+                           ..+..+++++.++|.+||+.||++|||+.++++||+++
T Consensus       296 ~~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          296 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            555444421111                           12344789999999999999999999999999998764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.6e-54  Score=402.09  Aligned_cols=284  Identities=68%  Similarity=1.159  Sum_probs=257.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeEEEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLV  141 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~iv  141 (354)
                      ...+|++.+.||+|+||+||+|++..+++ +|+|++..+.....+|+++++.++||||+++++++..... .+..++++|
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            34579999999999999999999876665 9999887777777789999999999999999999876654 566778999


Q ss_pred             EeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      |||+++++...+.........+++..++.++.||+.||+|||++ ||+||||||+|||++...+.+||+|||++.....+
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            99999998888877666678899999999999999999999998 99999999999999943348999999999887666


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+......+..
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  275 (394)
T 4e7w_A          196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME  275 (394)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred             CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence            66677889999999999977767999999999999999999999999999999999999999999999999988888888


Q ss_pred             cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..++.....+|...+...+++++.+||.+||++||.+|||+.|+++|
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            88999888999988888999999999999999999999999999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-54  Score=420.87  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=215.2

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++...    .....+|+.+|+.++||||++++++|     .+...+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            46899999999999999999999999999999988543    23456899999999999999999998     4556699


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC-CCcEEEEeccCcee
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  217 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~-~~~vkl~Dfg~a~~  217 (354)
                      ||||||.| +|.+.+...   ...+++..++.+++||+.||.|||++ ||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus       231 iv~E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEeecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999985 888877543   25799999999999999999999999 99999999999999864 23799999999998


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      +.........+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+.+....++.        
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------  377 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------  377 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS--------
T ss_pred             ccCCCceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc--------
Confidence            87666666778999999999997665 899999999999999999999999999888888777653222111        


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                       .....+|+++++||++||+.||.+|||+.|+|+|
T Consensus       378 -----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          378 -----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                             1224589999999999999999999999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.9e-54  Score=417.72  Aligned_cols=247  Identities=25%  Similarity=0.368  Sum_probs=204.3

Q ss_pred             CccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHH---HHHHHHHcCCCCeeecceeeeec
Q 018514           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFST  130 (354)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~---e~~~l~~l~h~~iv~~~~~~~~~  130 (354)
                      +...++|++.+.||+|+||+||+|+++.+|+.||||++....       ....+   ++.+++.++|||||+++++|   
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f---  261 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF---  261 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence            445568999999999999999999999999999999985432       11222   45566677999999999998   


Q ss_pred             CCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEE
Q 018514          131 TEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl  209 (354)
                        .+..++|||||||.| +|...+...    ..+++..++.|+.||+.||+|||++ |||||||||+||||+.++ .+||
T Consensus       262 --~~~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G-~vKL  333 (689)
T 3v5w_A          262 --HTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRI  333 (689)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTS-CEEE
T ss_pred             --EECCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCC-CEEe
Confidence              555669999999995 888888764    6799999999999999999999999 999999999999999988 6999


Q ss_pred             EeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCC
Q 018514          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGT  286 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~  286 (354)
                      +|||+|...... ...+.+||+.|||||++.....|+.++|||||||++|||++|.+||.+.+...   ....+...   
T Consensus       334 ~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---  409 (689)
T 3v5w_A          334 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---  409 (689)
T ss_dssp             CCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---
T ss_pred             cccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---
Confidence            999999876544 34467899999999999765569999999999999999999999997643322   22222110   


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                                ...++..+|+++++||.+||+.||.+|++     |+|+++|
T Consensus       410 --------------------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          410 --------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             --------------------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             --------------------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                                      01134458999999999999999999998     7999988

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.6e-54  Score=386.27  Aligned_cols=257  Identities=19%  Similarity=0.240  Sum_probs=191.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-h--hHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-Y--KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~--~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|.+.++||+|+||+||+|++  +|+.||||++..... .  .++|+..+..++|||||++++++.... .....++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence            3699999999999999999998  689999999865432 2  234566667889999999999886543 233468999


Q ss_pred             Eeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-------IGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-------~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ||||+ |+|.+.+..     .++++..+..++.|++.||+|||++       .+|+||||||+|||++.++ .+||+|||
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG  153 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence            99999 588888865     4689999999999999999999964       2899999999999999888 79999999


Q ss_pred             CceecccCCCc-----cccccccccccchhccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCc----------
Q 018514          214 SAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFPGESG----------  273 (354)
Q Consensus       214 ~a~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~----------  273 (354)
                      +|+........     ...+||+.|||||++.+..     .++.++|||||||++|||+||.+||.....          
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876544322     2357999999999996542     257799999999999999999877643221          


Q ss_pred             ----HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhcc
Q 018514          274 ----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSF  349 (354)
Q Consensus       274 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l  349 (354)
                          .+.+.......+                 ..+.++. .|   .....+..+.+|+.+||+.||++|||+.|+++.|
T Consensus       234 ~~~~~~~~~~~~~~~~-----------------~rp~~p~-~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L  292 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQK-----------------LRPNIPN-RW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTL  292 (303)
T ss_dssp             SSCCHHHHHHHHTTSC-----------------CCCCCCG-GG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred             ccchHHHHHHHHhccc-----------------CCCCCCc-cc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence                111111110000                 0000000 00   0011345789999999999999999999999988


Q ss_pred             Cc
Q 018514          350 DS  351 (354)
Q Consensus       350 ~~  351 (354)
                      +.
T Consensus       293 ~~  294 (303)
T 3hmm_A          293 SQ  294 (303)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3e-51  Score=366.38  Aligned_cols=274  Identities=33%  Similarity=0.536  Sum_probs=223.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++.     +...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence            47999999999999999999999999999999985332      33457999999999999999999884     34458


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+++++...+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence            999999999888877653   36799999999999999999999999 999999999999999887 7999999999876


Q ss_pred             ccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ... .......||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+....
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            433 2334567899999999997776689999999999999999987766 67777778889999988888877654433


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ........+..............+++++.+||++||+.||++|||++|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            2221112222222222223345689999999999999999999999999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2e-51  Score=389.82  Aligned_cols=276  Identities=31%  Similarity=0.542  Sum_probs=220.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  136 (354)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .+..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            35799999999999999999999999999999998643      2334579999999999999999998854332 2345


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .+|+||||+++++...+.      ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~-~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCCC-
T ss_pred             eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCC-CEEEEEEEeee
Confidence            689999999998877764      3489999999999999999999999 999999999999999888 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+....
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             ecCCCcccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            776655556678999999999997765 8999999999999999999999999999999999999999999988765543


Q ss_pred             CCCccc--CCCCccCCCcccccCCC-----------CCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEF--KFPQIKAHPWHKIFQKR-----------MPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~--~~~~~~~~~~~~~~~~~-----------~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....+  ..+......|...++..           .++++.+||++||++||++|||++|+|+|
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            211111  01111111222222211           25789999999999999999999999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.1e-51  Score=368.24  Aligned_cols=274  Identities=35%  Similarity=0.646  Sum_probs=223.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..++|++.+.||+|+||+||+|++. +|+.||+|++....      ....+|+++++.++||||+++++++     .+..
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   92 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER   92 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence            3457999999999999999999985 58999999986432      2345799999999999999999988     4445


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ++++||||+++++.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        93 ~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~  167 (311)
T 3niz_A           93 CLTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLAR  167 (311)
T ss_dssp             CEEEEEECCSEEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCC-CEEEccCcCce
Confidence            58999999999988888754   35689999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ...... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+...
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            764332 2334578999999999977666899999999999999999999999999988999999999888877655433


Q ss_pred             CCC--CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...  +............|.. +...+++++.+||++||++||.+|||+.|+++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hccchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            211  0111122222233332 334588999999999999999999999999997

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.6e-51  Score=369.81  Aligned_cols=247  Identities=28%  Similarity=0.432  Sum_probs=211.6

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+++++.++||||+++++++     ...
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~   86 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETE   86 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence            34568999999999999999999999999999999985432      2345799999999999999999988     344


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+++||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~  160 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADM-NIKIADFGF  160 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCC-CEEEeeccC
Confidence            558999999975 888887654    5699999999999999999999999 999999999999999887 799999999


Q ss_pred             ceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      +.....+.......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....         
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------  231 (328)
T 3fe3_A          161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---------  231 (328)
T ss_dssp             CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            98765555556678999999999998776556899999999999999999999998887666666554211         


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                          .++..+++++.++|++||+.||.+|||+.|+++|
T Consensus       232 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 --------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                                1223478999999999999999999999999998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9.5e-51  Score=365.88  Aligned_cols=278  Identities=30%  Similarity=0.523  Sum_probs=228.1

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---------hhhHHHHHHHHHc---CCCCeeecceeeeecC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLL---DHPNVVSLKHCFFSTT  131 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~  131 (354)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++....         ....+|+.+++.+   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            457999999999999999999999999999999986322         2345677777666   4999999999987766


Q ss_pred             CCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          132 EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                      ......+++||||+.++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEEee
Confidence            56666789999999999999887643  23489999999999999999999999 999999999999999887 799999


Q ss_pred             ccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       212 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            99998766555556678899999999997665 89999999999999999999999999999999999999988887765


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +...... ....++......+ ......+++.+.+||.+||++||.+|||+.|+|+|
T Consensus       243 ~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          243 WPRDVSL-PRGAFPPRGPRPV-QSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             SCSSCSS-CGGGSCCCCCCCH-HHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccchhhc-cccccCCCCCCcH-HHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            4332111 1111221111111 22334689999999999999999999999999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-50  Score=373.45  Aligned_cols=285  Identities=46%  Similarity=0.874  Sum_probs=235.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh---hhHHHHHHHHHcCCCCeeecceeeeecCC--CCeeE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTE--KDELY  137 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~  137 (354)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++..+..   ...+++..++.++||||+++++++.....  ....+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            34579999999999999999999999999999998865433   33456777788899999999999866443  44567


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      +++||||+++++...+.........+++..++.++.|++.||.|||  ++ ||+||||||+|||++...+.+||+|||++
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            8899999999988888776666778999999999999999999999  88 99999999999999973348999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .............||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+.+.++.++.+.+...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            87766666666788999999999977666899999999999999999999999999999999999999999999998888


Q ss_pred             CCCCcccCCCCccCCCcccccCC---CCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~---~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...............+|...++.   ..++++.+||.+||++||.+|||+.|+|+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            77766666666666666655543   367899999999999999999999999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1e-50  Score=362.21  Aligned_cols=272  Identities=34%  Similarity=0.621  Sum_probs=217.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++|++.+.||+|+||+||+|++ .+|+.||+|++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence            4799999999999999999998 678999999985432      334579999999999999999998843     3448


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||++++|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        76 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence            999999999988888753   25789999999999999999999999 999999999999999887 7999999999765


Q ss_pred             ccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            322 2233457899999999997766689999999999999999999999999998889999988888776654432211


Q ss_pred             CC-cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NY-TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .. .+-.++.....+|. .+...+++++.+||.+||+.||++|||+.|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             STTCCTTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCccHH-HHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00 00011111222232 2345689999999999999999999999999997

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.2e-50  Score=369.70  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=213.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----------hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ..+.|++.+.||+|+||+||+|++..+|+.||+|++....          ....+|+.+++.++||||+++++++     
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----   84 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----   84 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence            4457999999999999999999999999999999985432          3456899999999999999999988     


Q ss_pred             CCeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC---cEE
Q 018514          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  208 (354)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~---~vk  208 (354)
                      .+...+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.   .+|
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEE
Confidence            44456899999997 588887754    35799999999999999999999998 9999999999999987653   699


Q ss_pred             EEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      |+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus       160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD  238 (361)
T ss_dssp             ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EEecCCceEcCCCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            99999998876655556678999999999996555 89999999999999999999999999888777777665432222


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..                         +...+++.+.+||.+||+.||.+|||+.|+++|
T Consensus       239 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          239 EE-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ch-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            22                         223478999999999999999999999999987

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.8e-51  Score=378.57  Aligned_cols=275  Identities=33%  Similarity=0.643  Sum_probs=214.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++...      .....+|+.+++.+. ||||+++++++...   +..
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence            45799999999999999999999999999999988432      233457999999997 99999999987542   333


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .+|+||||++++|...+..     ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+|+
T Consensus        85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  157 (388)
T 3oz6_A           85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAEC-HVKVADFGLSR  157 (388)
T ss_dssp             CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCC-CEEecCCcccc
Confidence            4889999999999888875     4689999999999999999999999 999999999999999888 79999999997


Q ss_pred             ecccC----------------------CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH
Q 018514          217 VLVKG----------------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (354)
Q Consensus       217 ~~~~~----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  274 (354)
                      .....                      ......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                      11234578999999999987666999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhccCCCCcccCCC------CccCCCcccc------------cCCCCCHHHHHHHHHhcCcCC
Q 018514          275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFP------QIKAHPWHKI------------FQKRMPPEAVDLVSRLLQYSP  336 (354)
Q Consensus       275 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~------------~~~~~s~~l~~ll~~~l~~dp  336 (354)
                      +++..+...++.|..+.+......+...-..      ......+...            ....+++++.+||++||++||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            9999999999999988765443221110000      0000011111            112578999999999999999


Q ss_pred             CCCCCHHHHhhc
Q 018514          337 NLRSTAFDAVGS  348 (354)
Q Consensus       337 ~~Rpta~e~l~~  348 (354)
                      .+|||+.|+|+|
T Consensus       318 ~~R~t~~e~l~H  329 (388)
T 3oz6_A          318 NKRISANDALKH  329 (388)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             ccCCCHHHHhCC
Confidence            999999999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.3e-50  Score=363.87  Aligned_cols=277  Identities=31%  Similarity=0.527  Sum_probs=211.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+|++.+.||+|+||+||+|.+..+|+.||+|++....     ....+|+.+++.++||||+++++++     .+...++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence            47999999999999999999999999999999885432     3455899999999999999999988     4445689


Q ss_pred             EEEeeccccHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          140 LVLEYVPETVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +||||++++|.+.+.....  ....+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  157 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRG-QLKLGDFGLARA  157 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence            9999999999998876542  224589999999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       218 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ..... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+....
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            64332 23355789999999999776668999999999999999999999999999999999999988887765543321


Q ss_pred             CCCcc-cCCCCccCCC----cccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTE-FKFPQIKAHP----WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~-~~~~~~~~~~----~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..... ..........    +.......++.++.+||.+||+.||.+|||+.|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            11000 0000000111    1112234588999999999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-50  Score=381.94  Aligned_cols=278  Identities=33%  Similarity=0.547  Sum_probs=211.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...      .....+|+.+|+.++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            35799999999999999999999999999999988542      233457999999999999999999886554444566


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +|+||||++++|...+..    ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+++.
T Consensus       132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~-~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCC-CEeecccccchh
Confidence            899999999999888865    36799999999999999999999999 999999999999999888 799999999986


Q ss_pred             cccCC----------------------------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh------
Q 018514          218 LVKGE----------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL------  263 (354)
Q Consensus       218 ~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~------  263 (354)
                      .....                            .....+||+.|+|||++.....++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            53221                            12345789999999987666669999999999999999998      


Q ss_pred             -----CCCCCCCCC--------------------cHHHHHHHHHHhCCCCHHHHhccCCCCcc---cCCCCccCCCcccc
Q 018514          264 -----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKI  315 (354)
Q Consensus       264 -----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  315 (354)
                           |.++|.+.+                    ..+++..+...++.+..+.+.........   ..++......+...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 777787654                    35778889999999998876544321100   01111122222222


Q ss_pred             cCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          316 FQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       316 ~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       ....++++.+||++||++||.+|||++|+|+|
T Consensus       366 -~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          366 -FPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             -STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -CCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence             23479999999999999999999999999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-50  Score=363.06  Aligned_cols=250  Identities=25%  Similarity=0.390  Sum_probs=213.0

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .++|++.+.||+|+||+||+|.+..+++.+|+|.+....   ....+|+.+++.++||||+++++++.     +...+++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEEE
Confidence            357999999999999999999999999999999886432   34468999999999999999999883     3345899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC-CCcEEEEeccCceec
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  218 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~-~~~vkl~Dfg~a~~~  218 (354)
                      ||||+.| +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+ ...+||+|||++...
T Consensus        79 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           79 IFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            9999986 888777542   25689999999999999999999999 99999999999999862 337999999999887


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..+.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+......++...       
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------  226 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------  226 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred             CCCCccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh-------
Confidence            6655555678899999999996654 79999999999999999999999999888877777776543333322       


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                        ...++.++.++|.+||+.||.+|||+.|+|+|
T Consensus       227 ------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                              13478999999999999999999999999987

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.2e-51  Score=370.03  Aligned_cols=246  Identities=28%  Similarity=0.440  Sum_probs=206.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++.     ..
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~   81 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TP   81 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence            456899999999999999999999999999999998543       224568999999999999999999883     34


Q ss_pred             eEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ...++||||++|++.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        82 ~~~~lv~E~~~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~DFG~s  155 (336)
T 3h4j_B           82 TDIVMVIEYAGGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNL-NVKIADFGLS  155 (336)
T ss_dssp             SEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTC-CEEECCSSCT
T ss_pred             CEEEEEEECCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCC-CEEEEEeccc
Confidence            458999999999998888764    5699999999999999999999999 999999999999999887 7999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .....+.......||+.|+|||++.+....+.++|||||||++|+|++|..||.+........                 
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-----------------  218 (336)
T 3h4j_B          156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-----------------  218 (336)
T ss_dssp             BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----------------
T ss_pred             eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----------------
Confidence            877666555677899999999999776645789999999999999999999997643211100                 


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                .+..  ....++..+++++.++|++||+.||.+|||+.|+++|
T Consensus       219 ----------~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          219 ----------KVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             ----------CCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             ----------HHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                      0000  0112344579999999999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-49  Score=375.13  Aligned_cols=278  Identities=32%  Similarity=0.528  Sum_probs=220.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            35799999999999999999999999999999998642      234458999999999999999999885543333355


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +|+||||++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~-~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCC-CEEEccCCCccc
Confidence            899999999999888865    35699999999999999999999999 999999999999999887 799999999987


Q ss_pred             cccCCC-----------------------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-----------
Q 018514          218 LVKGEP-----------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-----------  263 (354)
Q Consensus       218 ~~~~~~-----------------------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-----------  263 (354)
                      ......                       ....+||+.|+|||++.....++.++|||||||++|||++           
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            643321                       2456789999999997666669999999999999999998           


Q ss_pred             CCCCCCCCC-----------------cHHHHHHHHHHhCCCCHHHHhccCCCCccc---CCCCccCCCcccccCCCCCHH
Q 018514          264 GQPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPE  323 (354)
Q Consensus       264 g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~  323 (354)
                      |.++|.+.+                 ..+++..+...+|.|+.+.+..........   ..+......+... ...++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~  337 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK-YPSISDD  337 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH-STTSCHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH-CCCCCHH
Confidence            455555543                 367889999999999988765433210000   0111111122222 2358999


Q ss_pred             HHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          324 AVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       324 l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +.+||++||++||.+|||++|+|+|
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcC
Confidence            9999999999999999999999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-50  Score=365.61  Aligned_cols=273  Identities=33%  Similarity=0.613  Sum_probs=218.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-----hhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ++|++.+.||+|+||+||+|++..+++.||+|++.....     ...+|+.+++.++||||+++++++.     +....+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence            469999999999999999999999999999999864332     2236999999999999999999883     334488


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+++++.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence            99999999998888764   35689999999999999999999998 999999999999999887 79999999997654


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+......
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            322 2234577999999999977666899999999999999999999999999999999999999998887655432211


Q ss_pred             --CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 --YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        +..+..+......+ ......+++++.+||.+||++||.+|||+.|+|+|
T Consensus       232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEAL-LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHHHTCCCCCCCCCH-HHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccchhh-hhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence              11111121111111 11234578999999999999999999999999997

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-49  Score=365.19  Aligned_cols=274  Identities=34%  Similarity=0.593  Sum_probs=220.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  137 (354)
                      .+|++.+.||+|+||+||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .+...
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4799999999999999999999999999999998432      2234579999999999999999998854321 12234


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++||||++++|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  177 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  177 (367)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence            689999998898888875     5689999999999999999999999 999999999999999887 799999999986


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+..+.++.+.+.....
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            543  234567899999999998756699999999999999999999999999999999999999999999887654432


Q ss_pred             CCcc---cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ....   ...+......|.. +...+++.+.+||.+||+.||.+|||+.++|+|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            1100   0122222333333 234579999999999999999999999999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3e-49  Score=364.42  Aligned_cols=276  Identities=32%  Similarity=0.608  Sum_probs=229.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+++++.++||||+++++++...........+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            47999999999999999999999999999999986322     3345799999999999999999988655444445689


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+.++|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus       107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  179 (364)
T ss_dssp             EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCC-CEEEEeCcceEecC
Confidence            9999999999888865     4699999999999999999999999 999999999999999887 79999999998764


Q ss_pred             cCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          220 KGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       220 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ....    .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+.+.
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            3322    234578999999999876666899999999999999999999999999999999999999999998876543


Q ss_pred             CCCCc---ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYT---EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~---~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....   ....+.....+|.. +...+++++.+||.+||++||.+|||+.|+|+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHHHhcCCccCCCHHH-hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            32100   00112222223332 234578999999999999999999999999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.9e-50  Score=364.09  Aligned_cols=277  Identities=29%  Similarity=0.551  Sum_probs=219.7

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++.     +.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HN  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ET
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cC
Confidence            34568999999999999999999999999999999986432      23457999999999999999999884     33


Q ss_pred             eEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC----CcEEEEe
Q 018514          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCD  211 (354)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~----~~vkl~D  211 (354)
                      ..+++||||+.++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++    ..+||+|
T Consensus       106 ~~~~lv~e~~~~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          106 HRLHLIFEYAENDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             TEEEEEEECCSEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             CEEEEEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECc
Confidence            458999999999999888764    5689999999999999999999999 999999999999995332    2599999


Q ss_pred             ccCceecccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          212 FGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       212 fg~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      ||++...... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+...
T Consensus       181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            9999765432 223345679999999999776668999999999999999999999999999999999999988888766


Q ss_pred             HHhccCCCC-cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 EIKCMNPNY-TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+....... ....++......+...+...+++++.+||.+||++||.+|||+.|+|+|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            543221100 0112233333334444455588999999999999999999999999997

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.5e-49  Score=362.11  Aligned_cols=253  Identities=28%  Similarity=0.376  Sum_probs=208.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++...         .....+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----   97 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----   97 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence            345799999999999999999999999999999998532         2345689999999999999999998843    


Q ss_pred             CeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--CcEEEE
Q 018514          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLC  210 (354)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--~~vkl~  210 (354)
                       ...+++||||+.| +|.+.+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++  ..+||+
T Consensus        98 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           98 -DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             -TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             -CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEe
Confidence             3458999999995 88888876655556799999999999999999999999 999999999999997654  249999


Q ss_pred             eccCceecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          211 DFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       211 Dfg~a~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      |||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. ......+.........
T Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP  253 (351)
T ss_dssp             CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH
T ss_pred             cCcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc
Confidence            9999987654332 33567899999999996655 8999999999999999999999998743 3444444443222221


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..                         ...+++++.+||.+||+.||.+|||+.++++|
T Consensus       254 ~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          254 RQ-------------------------WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cc-------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11                         13478999999999999999999999999987

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.7e-49  Score=354.69  Aligned_cols=246  Identities=25%  Similarity=0.390  Sum_probs=207.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ..+|++.+.||+|+||+||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++..     ...++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence            35799999999999999999999999999999988533    2345679999999999999999998843     33489


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|.+.+..     ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCC-CEEEeeCCCceec
Confidence            99999975 88887765     4689999999999999999999999 999999999999999887 7999999999876


Q ss_pred             ccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+........         
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------  236 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---------  236 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------
T ss_pred             CCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            4433 234567899999999997665 89999999999999999999999998887766665544311110         


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                       ..+..+++.+.++|.+||+.||.+|||+.|+++|
T Consensus       237 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 -----------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             -----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                             1123478999999999999999999999999997

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-49  Score=358.53  Aligned_cols=250  Identities=24%  Similarity=0.373  Sum_probs=211.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----------hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...          .....+|+.+++.++||||+++++++     
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   83 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----   83 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            445799999999999999999999999999999988542          23456899999999999999999988     


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC---cEE
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  208 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~---~vk  208 (354)
                      .+....++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.   .+|
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEE
Confidence            344558999999975 88887754    35799999999999999999999998 9999999999999986652   699


Q ss_pred             EEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      |+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  237 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence            99999998776555555678999999999996554 89999999999999999999999998887777766655322222


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..                         +...++..+.+||++||+.||.+|||+.++++|
T Consensus       238 ~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          238 DE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            21                         223478999999999999999999999999997

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-50  Score=365.21  Aligned_cols=274  Identities=34%  Similarity=0.588  Sum_probs=221.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++....         ....+|+.+++.++||||+++++++.     +
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----H   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----C
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----e
Confidence            347999999999999999999999999999999986421         23457999999999999999999883     3


Q ss_pred             eeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ....++||||+.+++...+...   ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  158 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGL  158 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred             CCceEEEEEcCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence            3447899999999988877653   25688889999999999999999999 999999999999999887 799999999


Q ss_pred             ceecccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          215 AKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       215 a~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      +....... ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            97654322 23456789999999999766668999999999999999999999999999999999999998888877655


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..........+......++.. +...++.++.+||++||+.||.+|||+.|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            443322222222222222222 234578999999999999999999999999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.2e-49  Score=364.70  Aligned_cols=250  Identities=29%  Similarity=0.432  Sum_probs=210.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     .+..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            3457999999999999999999999999999999985432      3445799999999999999999988     4455


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--CcEEEEecc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFG  213 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--~~vkl~Dfg  213 (354)
                      ..++||||+.| +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++  ..+||+|||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecC
Confidence            68999999986 887777642    5689999999999999999999999 999999999999997653  259999999


Q ss_pred             CceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ++.............||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+.......+.    
T Consensus       177 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----  251 (362)
T 2bdw_A          177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----  251 (362)
T ss_dssp             TCBCCTTCCSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----
T ss_pred             cceEecCCcccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc----
Confidence            998776555555678999999999996654 899999999999999999999999988877777666553221111    


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      ..|     ..+++++.+||.+||+.||.+|||+.++|+|
T Consensus       252 ----------------~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          252 ----------------PEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----------------TGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----------------ccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                            111     3478999999999999999999999999988

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.2e-49  Score=358.41  Aligned_cols=244  Identities=25%  Similarity=0.397  Sum_probs=207.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++     .+..
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence            357999999999999999999999999999999986432       2345799999999999999999988     4445


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++||||+.| +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG~a  152 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCC-CEEEeeccch
Confidence            68999999986 887777653    5789999999999999999999998 999999999999999888 7999999999


Q ss_pred             eeccc-CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          216 KVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       216 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ..... +.......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+....          
T Consensus       153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  221 (337)
T 1o6l_A          153 KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------  221 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             hhcccCCCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------
Confidence            76432 33345678999999999996654 8999999999999999999999998877766666554420          


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                             .            .++..+++++.++|.+||+.||.+||     +++++++|
T Consensus       222 -------~------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 -------I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------C------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                   0            12345799999999999999999999     99999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=364.49  Aligned_cols=244  Identities=27%  Similarity=0.453  Sum_probs=203.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++....       ....+|..+++.+ +||||+++++++     .+.
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence            457999999999999999999999999999999986532       2334788899988 799999999988     444


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+|+||||+.| +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g-~ikL~DFG~  170 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFGM  170 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCC-CEEEccccc
Confidence            568999999986 888777654    5699999999999999999999999 999999999999999888 799999999


Q ss_pred             ceeccc-CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          215 AKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       215 a~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      +..... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....        
T Consensus       171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------  241 (353)
T 3txo_A          171 CKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--------  241 (353)
T ss_dssp             CBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred             eeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            975332 23344668999999999996555 89999999999999999999999999888877777765210        


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH------HHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------FDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta------~e~l~~  348 (354)
                                           .++..+++++.++|++||+.||.+||++      .++++|
T Consensus       242 ---------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          242 ---------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                                 1233478999999999999999999999      888887

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.5e-49  Score=369.95  Aligned_cols=275  Identities=31%  Similarity=0.509  Sum_probs=226.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHc------CCCCeeecceeeeecCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL------DHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~  133 (354)
                      ...+|++.+.||+|+||+||+|.+..+++.||||++....   ....+|+.+++.+      .|+||+++++++..    
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~----  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF----  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence            3457999999999999999999999999999999997653   2344688888877      57799999998843    


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC-cEEEEec
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDF  212 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~-~vkl~Df  212 (354)
                       ...+++||||+.++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++. .+||+||
T Consensus       171 -~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          171 -RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             -TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             -CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeec
Confidence             34589999999999999887643  24589999999999999999999999 9999999999999998762 2999999


Q ss_pred             cCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       213 g~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      |++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++...+
T Consensus       247 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          247 GSSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             TTCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            99976432  334567899999999997665 899999999999999999999999999999999999999999998876


Q ss_pred             hccCCCCcccC------------------------------CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH
Q 018514          293 KCMNPNYTEFK------------------------------FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  342 (354)
Q Consensus       293 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta  342 (354)
                      .........+.                              ........|...+....++.+.+||++||++||++|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence            53321100000                              001123345555556678999999999999999999999


Q ss_pred             HHHhhc
Q 018514          343 FDAVGS  348 (354)
Q Consensus       343 ~e~l~~  348 (354)
                      .|+|+|
T Consensus       404 ~e~L~H  409 (429)
T 3kvw_A          404 GQALRH  409 (429)
T ss_dssp             HHHHTS
T ss_pred             HHHhCC
Confidence            999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=352.09  Aligned_cols=274  Identities=34%  Similarity=0.582  Sum_probs=214.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++.     +....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence            47999999999999999999999999999999885432      23457999999999999999999884     33458


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+++++...+...   ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHS-VIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence            899999998644444332   36689999999999999999999999 999999999999999887 7999999999876


Q ss_pred             ccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC-
Q 018514          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  296 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  296 (354)
                      .... ......||+.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+.+.++........... 
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            4332 23456789999999999876668999999999999999999999999999999999888888887765433221 


Q ss_pred             -CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       ..+.....+..............+++.+.+||++||+.||.+|||++++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             1111222222111111111224588999999999999999999999999988

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=370.50  Aligned_cols=250  Identities=27%  Similarity=0.374  Sum_probs=208.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..++|++.+.||+|+||+||+|.+..+|+.+|+|++...      .....+|+.+++.++||||+++++++     .+..
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence            456899999999999999999999999999999988543      23456899999999999999999988     4455


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC--CCcEEEEecc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFG  213 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~--~~~vkl~Dfg  213 (354)
                      ..++||||+.| +|.+.+...    ..+++..+..++.||+.||+|||++ ||+||||||+|||++.+  +..+||+|||
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            68999999986 887877653    5699999999999999999999999 99999999999999842  2379999999


Q ss_pred             CceecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          214 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       214 ~a~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+.......+..  
T Consensus       159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--  235 (444)
T 3soa_A          159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP--  235 (444)
T ss_dssp             SCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred             eeEEecCCCceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc--
Confidence            9976644332 34567999999999996654 8999999999999999999999999988877777776642221111  


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                             ....+++++.+||.+||+.||.+|||+.|+|+|
T Consensus       236 -----------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          236 -----------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -----------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                                   113478999999999999999999999999998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.2e-49  Score=364.28  Aligned_cols=276  Identities=30%  Similarity=0.540  Sum_probs=210.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  136 (354)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++...      .....+|+.+++.++||||+++++++..... .+..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            34799999999999999999999999999999998542      1234579999999999999999998754321 2234


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ..++||||+++++.+.+.      ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       104 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCCCC--
T ss_pred             ceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEEEeeccc
Confidence            689999999999888775      3588999999999999999999999 999999999999999887 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+..+.+..+.
T Consensus       176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          176 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             --------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             ccccccccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            765544445678899999999997655 8999999999999999999999999999999999999998988877665432


Q ss_pred             CCCccc--CCCCccCCCcccccC-----------CCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEF--KFPQIKAHPWHKIFQ-----------KRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~--~~~~~~~~~~~~~~~-----------~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....+  ..+......+...++           ...+.++.+||++||+.||.+|||++|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            211000  001111111111111           1125789999999999999999999999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.5e-49  Score=364.89  Aligned_cols=274  Identities=34%  Similarity=0.567  Sum_probs=209.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  137 (354)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .+...
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4799999999999999999999999999999998542      2334579999999999999999998754321 12244


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .++|+||++++|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence            789999998888887764     5699999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+.++.|..+.+.....
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            533  234567899999999997756689999999999999999999999999999999999999999999887654432


Q ss_pred             CCcc---cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ....   ...+......|... ....++.+.+||++||++||.+|||+.++|+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHH-TTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHhccCCCCCCCHHHH-CCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            1100   01122222333332 23578999999999999999999999999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.7e-48  Score=359.06  Aligned_cols=277  Identities=30%  Similarity=0.568  Sum_probs=219.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---------------hhhHHHHHHHHHcCCCCeeecceeeee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSLKHCFFS  129 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~~~~~~~  129 (354)
                      ++|++.+.||+|+||.||+|.+. +|..||||++....               ....+|+.+++.++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            47999999999999999999975 48999999884321               344589999999999999999999877


Q ss_pred             cCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEE
Q 018514          130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (354)
Q Consensus       130 ~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl  209 (354)
                      ........+++||||+.+++.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||
T Consensus       101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl  175 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMRTDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNN-DITI  175 (362)
T ss_dssp             CCTTTCCEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEE
T ss_pred             ccCCCcceEEEEEccCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCC-CEEE
Confidence            666666778999999999998888753   35799999999999999999999999 999999999999999887 7999


Q ss_pred             EeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999986655555556788999999999977566899999999999999999999999999999999999999999887


Q ss_pred             HHHhccCCC----CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          290 EEIKCMNPN----YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .........    +............|.. ....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            755322110    0000111222233332 334578999999999999999999999999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-48  Score=357.69  Aligned_cols=281  Identities=28%  Similarity=0.480  Sum_probs=221.2

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC---C
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---K  133 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~  133 (354)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++.....   .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            4568999999999999999999999999999999885432      234579999999999999999998855321   1


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ....+++||||+.+++...+....   ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCceEEEEEeccCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-CEEEccch
Confidence            144588999999999888876543   5699999999999999999999999 999999999999999887 79999999


Q ss_pred             CceecccC-----CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          214 SAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       214 ~a~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      ++......     .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99865422     1223457899999999997766689999999999999999999999999999999999999888877


Q ss_pred             HHHHhccCCCC--cccCCCCccCCCccccc-CCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          289 REEIKCMNPNY--TEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...+.......  ................+ ....++.+.+||.+||+.||.+|||+.|+|+|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            66543321110  00000000000000000 00136889999999999999999999999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-48  Score=350.75  Aligned_cols=242  Identities=26%  Similarity=0.449  Sum_probs=208.1

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..+|++.+.||+|+||+||+|++..+|+.||+|++....       ....+|..+++.++||||+++++++     .+..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence            457999999999999999999999999999999986432       2345799999999999999999988     4445


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++||||+.| +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~Dfg~a  153 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFA  153 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCC-CEEEeecCcc
Confidence            68999999985 888888753    5689999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.....          
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------  220 (318)
T 1fot_A          154 KYVPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL----------  220 (318)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC----------
T ss_pred             eecCC--ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence            86533  234567999999999996655 89999999999999999999999998887777776655210          


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                         .++..+++++.++|++||+.||++||     +++++++|
T Consensus       221 -------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 -------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                               12345789999999999999999999     89999987

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2e-48  Score=361.08  Aligned_cols=245  Identities=25%  Similarity=0.451  Sum_probs=201.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|++.+.||+|+||+||+|+++.+++.||+|++....       ....+|..+++++ +||||++++++|     .+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~  124 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT  124 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EE
Confidence            4468999999999999999999999999999999986432       2345788888877 899999999988     44


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+++||||+.| +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~DFG  198 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDYG  198 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCC-CEEEeecc
Confidence            5568999999986 887777653    5799999999999999999999999 999999999999999888 79999999


Q ss_pred             Cceec-ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------HHHH-HHHHHH
Q 018514          214 SAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--------VDQL-VEIIKV  283 (354)
Q Consensus       214 ~a~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~-~~i~~~  283 (354)
                      ++... .........+||+.|+|||++.+.. ++.++|||||||++|||++|..||.....        ...+ ..+...
T Consensus       199 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~  277 (396)
T 4dc2_A          199 MCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  277 (396)
T ss_dssp             TCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred             eeeecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence            99763 3334455678999999999997655 89999999999999999999999964321        1112 222110


Q ss_pred             hCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH------HHHhhc
Q 018514          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------FDAVGS  348 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta------~e~l~~  348 (354)
                                                   ...++..+++++.+||++||+.||.+||++      .++++|
T Consensus       278 -----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          278 -----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             -----------------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             -----------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                                         011334589999999999999999999995      688877

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=360.06  Aligned_cols=247  Identities=27%  Similarity=0.412  Sum_probs=205.0

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||++++++|     .+
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~   86 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QD   86 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            34568999999999999999999999999999999985432       3345799999999999999999988     34


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+++||||+.| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG  160 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHG-HVHITDFN  160 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCC-CEEEeccc
Confidence            4558999999975 77777765    35799999999999999999999999 999999999999999888 79999999


Q ss_pred             CceecccCCCccccccccccccchhccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCC
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGTPT  288 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~  288 (354)
                      ++.............||+.|+|||++.+.  ..++.++|||||||++|+|++|..||...+..   .....+....    
T Consensus       161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----  236 (384)
T 4fr4_A          161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV----  236 (384)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC----
T ss_pred             eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc----
Confidence            99887666666678899999999998642  34789999999999999999999999754322   2222221110    


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-HHHHhhc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-AFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-a~e~l~~  348 (354)
                                               ..++..+++.+.+||.+||+.||.+||+ ++++++|
T Consensus       237 -------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          237 -------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             -------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             -------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                                     0123457899999999999999999998 8888876

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-48  Score=354.83  Aligned_cols=277  Identities=32%  Similarity=0.597  Sum_probs=221.3

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++.     +.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   96 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KK   96 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cC
Confidence            34568999999999999999999999999999999885332      22457999999999999999999883     34


Q ss_pred             eEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ...++||||+++++...+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~  171 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGFA  171 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             CEEEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCC-cEEEEeCCCc
Confidence            458999999998655554332   35799999999999999999999999 999999999999999887 7999999999


Q ss_pred             eecccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          216 KVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       216 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ...... .......||+.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.........
T Consensus       172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            765432 2233457899999999997765689999999999999999999999999999999999998888877664432


Q ss_pred             c--CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 M--NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .  ...+.....+..............+++.+.+||.+||+.||.+|||+.|+|+|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            2  22233333444433333333345689999999999999999999999999987

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7e-49  Score=361.34  Aligned_cols=253  Identities=26%  Similarity=0.425  Sum_probs=193.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....   ....+|+.+++.++||||+++++++.     +...++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence            3457999999999999999999999999999999986532   34568999999999999999999884     344589


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC-cEEEEeccCcee
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  217 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~-~vkl~Dfg~a~~  217 (354)
                      +||||+.+ +|.+.+...    .++++..++.++.||+.||+|||++ ||+||||||+||+++.++. .+||+|||++..
T Consensus        93 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           93 IIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            99999975 888877653    5699999999999999999999998 9999999999999986652 499999999975


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+...+....         
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~---------  238 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK---------  238 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC---------
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC---------
Confidence            54444455677999999999997766444559999999999999999999987654333333322211000         


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                          ...+          ....+++++.+||.+||+.||.+|||+.|+++|
T Consensus       239 ----~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 ----YSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ----CCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ----CCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                0000          112478999999999999999999999999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.5e-48  Score=356.32  Aligned_cols=245  Identities=27%  Similarity=0.455  Sum_probs=206.3

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|++.+.||+|+||+||+|+++.+|+.||+|++....       ....+|..+++.+ +||||+++++++     .+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~   89 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT   89 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence            3457999999999999999999999999999999986532       2344688888876 999999999988     44


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+++||||+.| +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG  163 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFG  163 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCC-CEEEeECh
Confidence            4568999999985 888887753    5689999999999999999999999 999999999999999888 79999999


Q ss_pred             Cceeccc-CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          214 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       214 ~a~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ++..... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....        
T Consensus       164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  234 (345)
T 1xjd_A          164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------  234 (345)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             hhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            9975432 22344668999999999997655 8999999999999999999999999888777666664421        


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH-HHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF-DAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~-e~l~~  348 (354)
                                           ..++..+++++.++|.+||+.||++||++. ++++|
T Consensus       235 ---------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          235 ---------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                                 012334789999999999999999999998 88776

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.1e-48  Score=343.34  Aligned_cols=249  Identities=29%  Similarity=0.411  Sum_probs=209.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     .+...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence            457999999999999999999999999999999985432      3345799999999999999999988     44455


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--CcEEEEeccC
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGS  214 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--~~vkl~Dfg~  214 (354)
                      .++||||+.+ +|.+.+...    ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++  ..+||+|||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            7899999986 777777653    5689999999999999999999998 999999999999997654  2499999999


Q ss_pred             ceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      +.............||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+.......+.......+..    
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T 3kk8_A          155 AIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP----  229 (284)
T ss_dssp             CEECCSSCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----
T ss_pred             eEEcccCccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch----
Confidence            98776655555678899999999997655 8999999999999999999999999888777666665532211111    


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                           ....+++++.++|.+||+.||.+|||+.++++|
T Consensus       230 ---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          230 ---------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ---------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ---------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                                 113478999999999999999999999999997

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.7e-48  Score=354.77  Aligned_cols=243  Identities=27%  Similarity=0.410  Sum_probs=208.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++     .+.
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~  113 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN  113 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            4568999999999999999999999999999999985432       2345799999999999999999988     445


Q ss_pred             eEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+++||||+. ++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DFg~  187 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFGF  187 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCC-CEEEccccc
Confidence            56899999997 4888888764    5689999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      +......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.....         
T Consensus       188 a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------  255 (350)
T 1rdq_E          188 AKRVKGR--TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------  255 (350)
T ss_dssp             CEECSSC--BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             ceeccCC--cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            9866432  34568999999999997655 89999999999999999999999998887777766655210         


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                          .++..+++++.++|.+||+.||.+||+     ++++++|
T Consensus       256 --------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 --------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --------------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                                123457899999999999999999998     9999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=357.89  Aligned_cols=277  Identities=19%  Similarity=0.297  Sum_probs=210.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+|++.+.||+|+||+||+|++..+|+.||||++....     ....+|+++++.++||||+++++++...   +....+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceEE
Confidence            47999999999999999999999999999999986432     3345899999999999999999987442   233478


Q ss_pred             EEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee----eCCCCcEEEEeccC
Q 018514          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGS  214 (354)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili----~~~~~~vkl~Dfg~  214 (354)
                      +||||+. ++|.+.+..... ...+++..++.++.||+.||+|||++ ||+||||||+||++    +.++ .+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCE-EEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCc-eEEEccCCC
Confidence            9999998 588888876432 34489999999999999999999999 99999999999998    5554 699999999


Q ss_pred             ceecccCCCccccccccccccchhccC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHH
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG----VDQLVEIIKV  283 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~  283 (354)
                      +.............||+.|+|||++..       ...++.++|||||||++|+|++|..||.....    .+.+..+...
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            988766655566789999999999852       34489999999999999999999999975432    3344444443


Q ss_pred             hCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ........+.........+  ..  ..+....+...++..+.++|++||+.||++|||++|+++|.++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDW--SG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEE--ES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CCcccchhhhcccCCcccc--Cc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            2211111111111110000  00  0000112233456789999999999999999999999999765

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-48  Score=361.70  Aligned_cols=251  Identities=27%  Similarity=0.394  Sum_probs=209.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++     .+...+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~  123 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEM  123 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEE
Confidence            345799999999999999999999999999999998643    23456899999999999999999988     344558


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC-CCcEEEEeccCce
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAK  216 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~-~~~vkl~Dfg~a~  216 (354)
                      ++||||+.+ +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+ ...+||+|||++.
T Consensus       124 ~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccce
Confidence            999999985 877766543   24689999999999999999999998 99999999999999753 3379999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.......         
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------  269 (387)
T 1kob_A          200 KLNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF---------  269 (387)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred             ecCCCcceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence            776555555668999999999996654 8999999999999999999999999888777666665421110         


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      .......+++++.+||.+||+.||.+|||+.++++|
T Consensus       270 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 ----------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ----------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                            011123478999999999999999999999999998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.2e-47  Score=346.47  Aligned_cols=281  Identities=32%  Similarity=0.526  Sum_probs=226.7

Q ss_pred             CccccceEEEeEeeeccceEEEEEEEc-CCCceEEEEEcccch------hhhHHHHHHHHHc---CCCCeeecceeeeec
Q 018514           61 PKQTISYMAERVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFST  130 (354)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~  130 (354)
                      .....+|++.+.||+|+||+||+|++. .+|+.||+|++....      ....+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            344568999999999999999999985 678899999885432      2344677777766   899999999988654


Q ss_pred             CCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEE
Q 018514          131 TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                      ........++||||+.++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~-~~kl~  162 (326)
T 1blx_A           87 RTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLA  162 (326)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEEC
T ss_pred             ccCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCC-CEEEe
Confidence            444677789999999999999887643  24589999999999999999999999 999999999999999887 79999


Q ss_pred             eccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      |||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+....+.+...
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            999998765444445567899999999996655 8999999999999999999999999999999999999988888776


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+....... ...+...... ....+...++..+.+||.+||+.||.+|||+.++++|
T Consensus       242 ~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          242 DWPRDVALP-RQAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GSCTTCSSC-GGGSCCCCCC-CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCccccccc-hhhhcccCcc-hhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            554321110 0011111111 1123445689999999999999999999999999987

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=349.74  Aligned_cols=250  Identities=27%  Similarity=0.394  Sum_probs=200.6

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------------------------------hhhHHHHHH
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------------------------RYKNRELQT  111 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------------------~~~~~e~~~  111 (354)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++....                              ....+|+++
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            34568999999999999999999999999999999985432                              234579999


Q ss_pred             HHHcCCCCeeecceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 018514          112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (354)
Q Consensus       112 l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH  190 (354)
                      ++.++||||+++++++..   .....+++||||+++ +|.+.+     ....+++..++.++.||+.||+|||++ ||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH  160 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIH  160 (298)
T ss_dssp             HHTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            999999999999998743   224568999999986 544322     235799999999999999999999999 9999


Q ss_pred             cCCCCCCeeeeCCCCcEEEEeccCceecccCCC-ccccccccccccchhccCCCC--CCCchhHHHHHHHHHHHHhCCCC
Q 018514          191 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPL  267 (354)
Q Consensus       191 ~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~p  267 (354)
                      |||||+||+++.++ .+||+|||++........ .....||+.|+|||++.+...  ++.++|||||||++|+|++|..|
T Consensus       161 ~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          161 RDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            99999999999887 799999999987644322 234578999999999965442  37789999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                      |...+.......+.....                 ..+          ....+++++.++|.+||+.||++|||+.|+++
T Consensus       240 f~~~~~~~~~~~~~~~~~-----------------~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          240 FMDERIMCLHSKIKSQAL-----------------EFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCCSSHHHHHHHHHHCCC-----------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCccHHHHHHHHhcccC-----------------CCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            987765554444433110                 000          11347899999999999999999999999998


Q ss_pred             c
Q 018514          348 S  348 (354)
Q Consensus       348 ~  348 (354)
                      |
T Consensus       293 h  293 (298)
T 2zv2_A          293 H  293 (298)
T ss_dssp             C
T ss_pred             C
Confidence            7

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-48  Score=357.29  Aligned_cols=250  Identities=28%  Similarity=0.423  Sum_probs=204.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ..++|++.+.||+|+||+||+|.++.+|+.||+|++........+|++++.++ +||||+++++++     .+..++++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEE
Confidence            34579999999999999999999999999999999987766677899999888 799999999988     445568999


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC---cEEEEeccCcee
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKLCDFGSAKV  217 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~---~vkl~Dfg~a~~  217 (354)
                      |||+.| +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||+..+.+   .+||+|||++..
T Consensus        95 ~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           95 TELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             ECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999985 888877653    5689999999999999999999999 9999999999999854322   499999999987


Q ss_pred             cccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHHhCCCCHHHHh
Q 018514          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE---SGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       218 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.   +..+.+..+....         
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~---------  239 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK---------  239 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC---------
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC---------
Confidence            64432 334567899999999996544 789999999999999999999999763   2233333333210         


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                              +..        ...++..+++++.+||++||+.||.+|||+.++++|
T Consensus       240 --------~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          240 --------FSL--------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             --------CCC--------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             --------ccc--------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    000        011224589999999999999999999999999987

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-48  Score=344.59  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=203.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..++|++.+.||+|+||+||+|.+..++..+|+|++....     ....+|+++++.++||||+++++++     .+...
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence            4457999999999999999999999999999999986543     3456899999999999999999988     34455


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC--CCcEEEEeccC
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGS  214 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~--~~~vkl~Dfg~  214 (354)
                      .++||||+.+ +|.+.+.........+++..++.++.||+.||+|||++ ||+||||||+||+++.+  ...+||+|||+
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            8999999985 88888877666668899999999999999999999998 99999999999999432  23799999999


Q ss_pred             ceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      +.............||+.|+|||++. . .++.++||||||+++|+|++|..||.+.+..+....+........      
T Consensus       174 a~~~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------  245 (285)
T 3is5_A          174 AELFKSDEHSTNAAGTALYMAPEVFK-R-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA------  245 (285)
T ss_dssp             CCC----------CTTGGGCCHHHHT-T-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred             ceecCCcccCcCcccccCcCChHHhc-c-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc------
Confidence            98765555555677899999999984 3 378999999999999999999999988776555444333110000      


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                          .....+++++.++|.+||+.||++|||+.|+++|
T Consensus       246 --------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          246 --------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             --------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             --------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                0112368999999999999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.7e-48  Score=356.49  Aligned_cols=274  Identities=24%  Similarity=0.419  Sum_probs=218.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcC-----CCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----HPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~~  135 (354)
                      .++|++.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.+.     ||||+++++++..     .
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-----~  108 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-----Y  108 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-----T
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-----C
Confidence            457999999999999999999999999999999986432   33457999999986     9999999998843     3


Q ss_pred             eEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC-------------
Q 018514          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-------------  202 (354)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~-------------  202 (354)
                      ...++||||++++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.             
T Consensus       109 ~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          109 DHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             CeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcc
Confidence            4589999999889999888643  24589999999999999999999998 9999999999999974             


Q ss_pred             -----------CCCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 018514          203 -----------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (354)
Q Consensus       203 -----------~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  271 (354)
                                 ....+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                       133799999999986433  334567899999999997665 899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhccCCCCcc---------cCCCCccCC--------CcccccCCCCCHHHHHHHHHhcCc
Q 018514          272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTE---------FKFPQIKAH--------PWHKIFQKRMPPEAVDLVSRLLQY  334 (354)
Q Consensus       272 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~--------~~~~~~~~~~s~~l~~ll~~~l~~  334 (354)
                      +..+.+..+....+.++.............         ..++.....        .....+....++.+.+||.+||++
T Consensus       263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  342 (360)
T 3llt_A          263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI  342 (360)
T ss_dssp             SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred             cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence            999999999998888887665432211100         000100000        000011122357889999999999


Q ss_pred             CCCCCCCHHHHhhc
Q 018514          335 SPNLRSTAFDAVGS  348 (354)
Q Consensus       335 dp~~Rpta~e~l~~  348 (354)
                      ||.+|||+.|+|+|
T Consensus       343 dP~~Rpta~elL~h  356 (360)
T 3llt_A          343 DPTLRPSPAELLKH  356 (360)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999987

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.3e-47  Score=340.08  Aligned_cols=247  Identities=30%  Similarity=0.456  Sum_probs=211.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .++|++.+.||+|+||+||+|.+..++..+|+|++...    .....+|+++++.++||||+++++++     .+....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence            45799999999999999999999999999999998543    34556899999999999999999988     3445589


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee---eCCCCcEEEEeccCc
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA  215 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili---~~~~~~vkl~Dfg~a  215 (354)
                      +||||+.+ +|.+.+...    ..+++..++.++.|++.||+|||++ ||+||||||+||++   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~  156 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA  156 (277)
T ss_dssp             EEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence            99999985 887777653    5689999999999999999999999 99999999999999   5555 7999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .............||+.|+|||.+.+.  ++.++||||||+++|+|++|..||...+..+....+.......+...+   
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW---  231 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred             eeccCccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---
Confidence            877666555667899999999998543  799999999999999999999999988887777777664333333221   


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                            ..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       232 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          232 ----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                  2378999999999999999999999999987

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-48  Score=363.94  Aligned_cols=249  Identities=27%  Similarity=0.448  Sum_probs=208.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...+|++.+.||+|+||+||+|+++.+++.||+|++...       .....+|..+++.++||||++++++|     .+.
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            345799999999999999999999999999999998542       22345799999999999999999988     455


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .++|+||||++| +|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCC-CEEEeccce
Confidence            568999999975 88887754     4689999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecccCCC--ccccccccccccchhccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKGEP--NISYICSRYYRAPELIFGATE---YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +........  ....+||+.|+|||++.+...   ++.++|||||||++|||++|..||.+.+.......+......   
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---  291 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---  291 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc---
Confidence            987644322  235679999999999965432   678999999999999999999999998887777777653110   


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCC--CCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~--Rpta~e~l~~  348 (354)
                                  ..++.          ...+++++.+||++||+.+|.+  |++++|+++|
T Consensus       292 ------------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          292 ------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ------------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ------------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                        00110          1247899999999999999988  9999999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-48  Score=368.89  Aligned_cols=246  Identities=29%  Similarity=0.432  Sum_probs=210.7

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|.+.+.||+|+||+||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++.     ..
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~   88 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TP   88 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence            4467999999999999999999999999999999986432       24568999999999999999999883     34


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~-~vkL~DFG~  162 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFGL  162 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCC-CeEEEeccc
Confidence            458999999975 88777754    35799999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      +.....+.......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....         
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------  233 (476)
T 2y94_A          163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---------  233 (476)
T ss_dssp             CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---------
T ss_pred             hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---------
Confidence            98776655555678999999999997766557899999999999999999999998877766666544210         


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                          ..+..+++++.+||++||+.||.+|||+.++++|
T Consensus       234 --------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 --------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                                0123478999999999999999999999999987

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.5e-48  Score=346.95  Aligned_cols=255  Identities=27%  Similarity=0.371  Sum_probs=204.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||.||+|++..++..||+|.+...       .....+|+.+++.++||||+++++++     .+.
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~   83 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EED   83 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECS
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeC
Confidence            345799999999999999999999999999999987432       13445799999999999999999987     445


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||+.| +|.+.+...    .++++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~  157 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNK-TLKIFDFGI  157 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCSS
T ss_pred             CeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEEeCCC
Confidence            568999999986 888888754    5789999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          215 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       215 a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      +.......  ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+.............. .    
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~----  231 (294)
T 4eqm_A          158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP-N----  231 (294)
T ss_dssp             STTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC-C----
T ss_pred             ccccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC-C----
Confidence            97654332  223456899999999997665 899999999999999999999999887766554443332111 1    


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-CHHHHhhccCcCC
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-TAFDAVGSFDSSF  353 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-ta~e~l~~l~~~~  353 (354)
                                         ........+++.+.++|.+||+.||.+|| +++++++.|+..+
T Consensus       232 -------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          232 -------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             -------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             -------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence                               11123345789999999999999999999 8888888776653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.3e-48  Score=355.23  Aligned_cols=244  Identities=27%  Similarity=0.408  Sum_probs=206.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..+|++.+.||+|+||+||+|++..+|+.||+|++....       ....+|..+++.+ +||||+++++++     .+.
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcC
Confidence            457999999999999999999999999999999986432       2344688888877 799999999988     444


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+|+||||+.| +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG~  167 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFGM  167 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCC-cEEEEeCCc
Confidence            568999999985 888887754    5699999999999999999999999 999999999999999888 799999999


Q ss_pred             ceecc-cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          215 AKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       215 a~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      +.... ........+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....+....         
T Consensus       168 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------  237 (353)
T 2i0e_A          168 CKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------  237 (353)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             ccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------
Confidence            97643 233344678999999999996655 8999999999999999999999999888777777665521         


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                          ..++..+++++.+||++||+.||.+||+     +.++++|
T Consensus       238 --------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          238 --------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                                0123457999999999999999999994     6899887

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.1e-48  Score=351.92  Aligned_cols=245  Identities=25%  Similarity=0.454  Sum_probs=200.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|++.+.||+|+||.||+|+++.+++.||+|++....       ....+|..+++.+ +||||+++++++     .+
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~   81 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT   81 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----Ee
Confidence            4468999999999999999999999999999999986432       2345789999887 899999999988     44


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+++||||+.| +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        82 ~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DFG  155 (345)
T 3a8x_A           82 ESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDYG  155 (345)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCGG
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEEecc
Confidence            4568999999985 888777653    5699999999999999999999998 999999999999999888 79999999


Q ss_pred             Cceecc-cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------HH-HHHHHHHH
Q 018514          214 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--------VD-QLVEIIKV  283 (354)
Q Consensus       214 ~a~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~-~~~~i~~~  283 (354)
                      ++.... .........||+.|+|||++.+.. ++.++|||||||++|||++|..||.....        .. ....+...
T Consensus       156 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~  234 (345)
T 3a8x_A          156 MCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  234 (345)
T ss_dssp             GCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred             ccccccCCCCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence            997533 233345668999999999997655 89999999999999999999999975321        11 11222110


Q ss_pred             hCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH------HHHhhc
Q 018514          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------FDAVGS  348 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta------~e~l~~  348 (354)
                                                   ...++..++.++.++|++||+.||.+||++      .++++|
T Consensus       235 -----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          235 -----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -----------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -----------------------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                                         001334578999999999999999999996      788887

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.6e-48  Score=348.64  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=211.7

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----------hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++...          .....+|+.+++.++||||+++++++     
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   84 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----   84 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----
Confidence            445799999999999999999999999999999988543          23456899999999999999999988     


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC---cEE
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  208 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~---~vk  208 (354)
                      .+....++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.   .+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEE
Confidence            344558999999975 88888865    35689999999999999999999999 9999999999999987763   699


Q ss_pred             EEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      |+|||++.............||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+.......+
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  238 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD  238 (321)
T ss_dssp             ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EccCccceecCccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence            99999998776655555677999999999996554 89999999999999999999999998887777666654322222


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..                         +...++..+.++|.+||+.||.+|||+.++++|
T Consensus       239 ~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          239 EE-------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HH-------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             hh-------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11                         223478999999999999999999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.5e-48  Score=350.29  Aligned_cols=253  Identities=21%  Similarity=0.324  Sum_probs=198.5

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ....+|++.+.||+|+||+||+|++  +|..||+|++....      ....+|++++++++||||+++++++.     +.
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~  106 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QP  106 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----ST
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence            3456899999999999999999987  68899999985432      23457999999999999999999883     33


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeeeCCCCcEEEEec
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~--iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      ..+++||||+.+ +|.+.+..... ...+++..++.++.||+.||+|||++ |  |+||||||+||+++.++ .+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~-~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY-TVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTC-CEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCC-cEEECCC
Confidence            347899999986 88888875321 13489999999999999999999998 9  99999999999999887 7999999


Q ss_pred             cCceecccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          213 GSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       213 g~a~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      |++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+......     
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-----  257 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-----  257 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----
Confidence            9997543332 233567899999999997655 899999999999999999999999888766655544331111     


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                            ..++..+++.+.++|.+||+.||.+|||+.++++.|+.+
T Consensus       258 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          258 ----------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                                  113345889999999999999999999999999988654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.6e-47  Score=367.40  Aligned_cols=249  Identities=29%  Similarity=0.460  Sum_probs=210.7

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----------------hhhhHHHHHHHHHcCCCCeeecce
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNVVSLKH  125 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~e~~~l~~l~h~~iv~~~~  125 (354)
                      ...+|++.+.||+|+||+||+|++..+++.||+|++...                 .....+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            345799999999999999999999999999999998542                 223457999999999999999999


Q ss_pred             eeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC
Q 018514          126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (354)
Q Consensus       126 ~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~  204 (354)
                      ++     .+..++++|||||.| +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++
T Consensus       114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          114 VF-----EDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKN  183 (504)
T ss_dssp             EE-----ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTT
T ss_pred             EE-----EcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCC
Confidence            98     455568999999985 888877653    5699999999999999999999998 999999999999998765


Q ss_pred             C--cEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 018514          205 H--QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (354)
Q Consensus       205 ~--~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  282 (354)
                      .  .+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            3  599999999988766655566789999999999853  389999999999999999999999999888887777766


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .........                         ...+++++.+||++||++||.+|||+.|+|+|
T Consensus       262 ~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          262 GKYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            432222221                         13478999999999999999999999999987

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.3e-48  Score=352.62  Aligned_cols=248  Identities=28%  Similarity=0.366  Sum_probs=201.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++     .+....
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence            457999999999999999999999999999999985332     3456899999999999999999987     444568


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  154 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  154 (323)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCC-CEEEEEeeccce
Confidence            999999986 76666543    35699999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          218 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       218 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      .....   ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+..............        
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------  226 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------  226 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--------
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--------
Confidence            53322   2235678999999999977665588999999999999999999999876544332222111000        


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                   ...     ....+++.+.+||.+||+.||.+|||+.|+++|
T Consensus       227 -------------~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 -------------YLN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -------------TST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -------------cCC-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                         000     113478999999999999999999999999987

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.4e-48  Score=357.52  Aligned_cols=278  Identities=21%  Similarity=0.312  Sum_probs=204.4

Q ss_pred             ccccceEEEeEeeec--cceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           62 KQTISYMAERVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      ...++|++.+.||+|  +||+||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----   97 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----   97 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----
Confidence            345689999999999  99999999999999999999986432      334579999999999999999999843    


Q ss_pred             CeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEec
Q 018514          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                       ...+++||||+.+ +|.+++....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~df  172 (389)
T 3gni_B           98 -DNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGL  172 (389)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCG
T ss_pred             -CCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEccc
Confidence             3458999999985 8888877543  35689999999999999999999999 999999999999999887 7999999


Q ss_pred             cCceecccCC--------CccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 018514          213 GSAKVLVKGE--------PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (354)
Q Consensus       213 g~a~~~~~~~--------~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  283 (354)
                      |.+.......        ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            9886543221        12234688999999999763 45899999999999999999999999887766665544432


Q ss_pred             hCCCCHHHHh--------c---------cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHh
Q 018514          284 LGTPTREEIK--------C---------MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV  346 (354)
Q Consensus       284 ~~~~~~~~~~--------~---------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l  346 (354)
                      ..........        .         .....................++..+++++.+||++||++||++|||+.|+|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            1111000000        0         0000000000000000111224456899999999999999999999999999


Q ss_pred             hc
Q 018514          347 GS  348 (354)
Q Consensus       347 ~~  348 (354)
                      +|
T Consensus       333 ~h  334 (389)
T 3gni_B          333 NH  334 (389)
T ss_dssp             TS
T ss_pred             cC
Confidence            88

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.2e-48  Score=367.96  Aligned_cols=250  Identities=28%  Similarity=0.437  Sum_probs=208.4

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ....+|++.+.||+|+||+||+|++..+++.||||++...      .....+|+.+++.++||||+++++++     .+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~   93 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS   93 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcC
Confidence            3456899999999999999999999999999999998432      23456899999999999999999988     445


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC--CCcEEEEec
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDF  212 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~--~~~vkl~Df  212 (354)
                      ..+++|||||.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++..  ...+||+||
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            568999999985 887777654    5689999999999999999999999 99999999999999643  226999999


Q ss_pred             cCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       213 g~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      |++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+..........  
T Consensus       169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  244 (486)
T 3mwu_A          169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP--  244 (486)
T ss_dssp             SCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG--
T ss_pred             CcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc--
Confidence            99987655555556789999999999964  38999999999999999999999999988877777766532211111  


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                             ....+|+++.+||++||+.||.+|||+.++|+|
T Consensus       245 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          245 -----------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -----------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -----------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                                   113478999999999999999999999999998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.1e-48  Score=354.05  Aligned_cols=250  Identities=28%  Similarity=0.410  Sum_probs=191.5

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++...  .....+|+.+++.++||||+++++++.     +....+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEE
Confidence            3456799999999999999999999999999999998654  234557999999999999999999883     344589


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC---CCCcEEEEeccCc
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSA  215 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~---~~~~vkl~Dfg~a  215 (354)
                      +||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+|||++
T Consensus       125 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a  198 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDA-PLKIADFGLS  198 (349)
T ss_dssp             EEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTC-CEEECCCC--
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCC-CEEEccCccc
Confidence            99999985 88777764    35689999999999999999999998 9999999999999974   44 7999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  294 (354)
                      .............||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ +..+......        
T Consensus       199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~--------  269 (349)
T 2w4o_A          199 KIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY--------  269 (349)
T ss_dssp             --------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC--------
T ss_pred             cccCcccccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc--------
Confidence            8765544445667899999999997655 89999999999999999999999987665543 3333221100        


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                       +...+...++.++.+||++||+.||++|||+.++++|
T Consensus       270 -----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 -----------------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -----------------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----------------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             0011223578999999999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.2e-48  Score=356.03  Aligned_cols=273  Identities=33%  Similarity=0.588  Sum_probs=218.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC-CeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~  137 (354)
                      .+|.+.+.||+|+||+||+|.+..+|+.||+|++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4799999999999999999999999999999998643      23345799999999999999999988543321 1122


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++||||+.++|.+.+.      ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       122 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~  193 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH  193 (371)
T ss_dssp             CEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred             EEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence            48999999998776653      4589999999999999999999999 999999999999999887 799999999976


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.......
T Consensus       194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            533  234567899999999997756689999999999999999999999999999999999999999998876654332


Q ss_pred             CCccc---CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....   ..+......+. .+...+++.+.+||++||+.||.+|||+.|+|+|
T Consensus       272 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            11100   01111111221 2234579999999999999999999999999998

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.1e-48  Score=357.53  Aligned_cols=246  Identities=26%  Similarity=0.376  Sum_probs=200.9

Q ss_pred             EEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        68 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      ...+.||+|+||.||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++     .+...+++|||
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E  166 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVME  166 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEe
Confidence            3467899999999999999999999999998653    34456899999999999999999988     34445899999


Q ss_pred             eccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC-CCCcEEEEeccCceecccC
Q 018514          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~-~~~~vkl~Dfg~a~~~~~~  221 (354)
                      |+++ +|.+.+....   ..+++..++.++.||+.||+|||++ ||+||||||+|||++. +...+||+|||++......
T Consensus       167 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          167 YVDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             CCTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             CCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            9985 8877776532   4689999999999999999999998 9999999999999942 3337999999999877665


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.........            
T Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------------  309 (373)
T 2x4f_A          243 EKLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED------------  309 (373)
T ss_dssp             CBCCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS------------
T ss_pred             cccccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh------------
Confidence            5555667999999999996554 899999999999999999999999998888777777664211111            


Q ss_pred             cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                   .....+++++.+||.+||+.||.+|||+.++++|
T Consensus       310 -------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          310 -------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             -------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                         1123478999999999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.6e-48  Score=349.45  Aligned_cols=274  Identities=29%  Similarity=0.506  Sum_probs=213.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|++... .....+|+.+++.++ ||||+++++++...   .....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEE
Confidence            35799999999999999999999999999999998643 445678999999997 99999999987432   23457899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+.+ +|...+.       .+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||++.....
T Consensus       112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999996 5555442       388999999999999999999998 9999999999999997776899999999987766


Q ss_pred             CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCHHHHhc-cCCC
Q 018514          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEIKC-MNPN  298 (354)
Q Consensus       221 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~-~~~~  298 (354)
                      ........+++.|+|||++.+...++.++|||||||++|+|++|..||.. .+..+.+..+....+.+....... ....
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            65556678899999999997756689999999999999999999999854 455566666666655443322111 0000


Q ss_pred             Ccc---cCCCCccCCCcccc----cCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTE---FKFPQIKAHPWHKI----FQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~---~~~~~~~~~~~~~~----~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...   ..........|...    ....+++++.+||.+||++||.+|||++|+|+|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000   00001111222221    223479999999999999999999999999998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.9e-48  Score=343.21  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=193.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh------hhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++.....      ...++...++.++||||+++++++..     ..
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EG   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cC
Confidence            34589999999999999999999999999999999864321      12234445777899999999998843     33


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ..++||||+++++.+.+.........+++..++.++.||+.||+|||++.||+||||||+||+++.++ .+||+|||++.
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  158 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISG  158 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC----
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcc
Confidence            37899999999998888876666788999999999999999999999844999999999999999887 79999999998


Q ss_pred             ecccCCCccccccccccccchhc---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHH
Q 018514          217 VLVKGEPNISYICSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ............||+.|+|||++   .....++.++|||||||++|+|++|..||.... ....+.........      
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  232 (290)
T 3fme_A          159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP------  232 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC------
T ss_pred             cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC------
Confidence            76555555556789999999997   244458899999999999999999999998643 33333333331100      


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                   .        .....+++++.++|.+||+.||.+|||+.++++|
T Consensus       233 -------------~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          233 -------------Q--------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             -------------C--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -------------C--------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                         0        0113478999999999999999999999999987

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-47  Score=351.62  Aligned_cols=244  Identities=27%  Similarity=0.435  Sum_probs=205.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..|++.+.||+|+||+||+|++..+|+.||||++....       ....+|+++++.++||||+++++++..     ...
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence            46999999999999999999999999999999985321       234579999999999999999998843     335


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .++||||+.|++.+.+...   ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence            8899999999988887654   36799999999999999999999999 999999999999999887 899999999976


Q ss_pred             cccCCCccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          218 LVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ...   .....||+.|+|||++.+  ...++.++|||||||++|+|++|..||.+.+....+..+......         
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~---------  271 (348)
T 1u5q_A          204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------  271 (348)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------
T ss_pred             cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------
Confidence            533   234578999999999853  344899999999999999999999999888776666655442110         


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                .        .....+++.+.++|.+||+.||++|||+.++++|
T Consensus       272 ----------~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 ----------A--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ----------C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ----------C--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                      0        0123468999999999999999999999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-47  Score=346.91  Aligned_cols=245  Identities=27%  Similarity=0.430  Sum_probs=199.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccch--------hhhHHHHHHHHHcCCCCeeecceeeeecC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  131 (354)
                      ...+|++.+.||+|+||.||+|++.   .+|+.||+|++....        ....+|+.+++.++||||+++++++.   
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---   91 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ---   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE---
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE---
Confidence            3457999999999999999999985   678999999986431        23457999999999999999999883   


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEE
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                        ....+++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+
T Consensus        92 --~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~  163 (327)
T 3a62_A           92 --TGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQG-HVKLT  163 (327)
T ss_dssp             --CSSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTS-CEEEC
T ss_pred             --cCCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCC-cEEEE
Confidence              33448999999985 888877653    5689999999999999999999999 999999999999999887 79999


Q ss_pred             eccCceecccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          211 DFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       211 Dfg~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      |||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+.+...    
T Consensus       164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----  238 (327)
T 3a62_A          164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL----  238 (327)
T ss_dssp             CCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----
T ss_pred             eCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC----
Confidence            99998754322 2234567899999999996655 89999999999999999999999998887777766655211    


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                               .++..+++++.++|.+||+.||.+||     ++.++++|
T Consensus       239 -------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 -------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                                     12234789999999999999999999     88999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3e-48  Score=362.72  Aligned_cols=280  Identities=31%  Similarity=0.520  Sum_probs=204.9

Q ss_pred             ccceEE-EeEeeeccceEEEEEEEc--CCCceEEEEEcccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMA-ERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .+.|.+ .++||+|+||+||+|+++  .+++.||+|++...  .....+|+.+++.++||||+++++++...   ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeE
Confidence            345887 458999999999999965  46889999998654  23456899999999999999999988542   23458


Q ss_pred             EEEEeeccccHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee----eCCCCcEEE
Q 018514          139 NLVLEYVPETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKL  209 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili----~~~~~~vkl  209 (354)
                      ++||||+.++|.+.+......     ...+++..++.++.||+.||+|||++ ||+||||||+|||+    +.++ .+||
T Consensus        96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kl  173 (405)
T 3rgf_A           96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKI  173 (405)
T ss_dssp             EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTT-CEEE
T ss_pred             EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCC-cEEE
Confidence            899999999999888754322     23589999999999999999999999 99999999999999    4445 7999


Q ss_pred             EeccCceecccC----CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------HHH
Q 018514          210 CDFGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQ  276 (354)
Q Consensus       210 ~Dfg~a~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~  276 (354)
                      +|||++......    .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.         .+.
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            999999865432    1223467899999999997766689999999999999999999999976554         478


Q ss_pred             HHHHHHHhCCCCHHHHhccCCCCcc------cC---CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          277 LVEIIKVLGTPTREEIKCMNPNYTE------FK---FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                      +..+...++.+....+.........      +.   ........+........++.+.+||++||++||.+|||++|+|+
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            8889999988887654432211000      00   00000000111112234789999999999999999999999999


Q ss_pred             c
Q 018514          348 S  348 (354)
Q Consensus       348 ~  348 (354)
                      |
T Consensus       334 h  334 (405)
T 3rgf_A          334 D  334 (405)
T ss_dssp             S
T ss_pred             C
Confidence            8

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-48  Score=359.35  Aligned_cols=251  Identities=27%  Similarity=0.442  Sum_probs=207.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++...       .....+|..++..++||||++++++|     .+.
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence            345799999999999999999999999999999998642       12345799999999999999999988     445


Q ss_pred             eEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .++|+||||+. |+|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g-~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCG-HIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCC-CEEEeechh
Confidence            56899999997 5888888754   25799999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecccCCC--ccccccccccccchhccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 018514          215 AKVLVKGEP--NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  286 (354)
Q Consensus       215 a~~~~~~~~--~~~~~g~~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  286 (354)
                      +........  ....+||+.|+|||++..      ...++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  288 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH  288 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence            987644332  234579999999999862      334899999999999999999999999998887777777542100


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCC---CCHHHHhhc
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STAFDAVGS  348 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~R---pta~e~l~~  348 (354)
                                     ..++.         +...+|+++.+||++||+ +|.+|   |+++++++|
T Consensus       289 ---------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          289 ---------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ---------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ---------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                           00110         123479999999999999 99998   599999988

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5e-48  Score=369.36  Aligned_cols=248  Identities=32%  Similarity=0.510  Sum_probs=210.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++...       .....+|+.+++.++||||+++++++     .+.
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~   98 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDK   98 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence            446899999999999999999999999999999998432       33456899999999999999999988     445


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee---CCCCcEEEEe
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN---PHTHQLKLCD  211 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~---~~~~~vkl~D  211 (354)
                      .+.++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++   .++ .+||+|
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~-~~kl~D  172 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDA-NIRIID  172 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTC-CEEECC
T ss_pred             CEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCC-cEEEEe
Confidence            568999999985 887777653    5799999999999999999999999 999999999999994   344 799999


Q ss_pred             ccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       212 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ||++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.+........ 
T Consensus       173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  249 (484)
T 3nyv_A          173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP-  249 (484)
T ss_dssp             TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG-
T ss_pred             eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc-
Confidence            999987665555556789999999999965  38999999999999999999999999988877777776532211111 


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                              ....+++++.+||++||++||.+|||+.++|+|
T Consensus       250 ------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          250 ------------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ------------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                                    113478999999999999999999999999987

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.8e-48  Score=362.00  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=209.2

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .++|++.++||+|+||+||+|+++.+++.||+|++....       ....+|..+++.++||||++++++|     .+..
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence            457999999999999999999999999999999986421       2245799999999999999999988     4455


Q ss_pred             EEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++||||+. |+|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g-~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence            6899999997 4888888753   36799999999999999999999998 999999999999999888 7999999999


Q ss_pred             eecccCCC--ccccccccccccchhcc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          216 KVLVKGEP--NISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       216 ~~~~~~~~--~~~~~g~~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      ........  ....+||+.|+|||++.    +...++.++|||||||++|||++|..||.+.+..+....+......   
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---  299 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER---  299 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc---
Confidence            76644332  22367999999999986    2344899999999999999999999999998888877777542110   


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCC--CCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~--Rpta~e~l~~  348 (354)
                                  +.++.         ....+++++.+||++||+.+|++  |++++|+++|
T Consensus       300 ------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          300 ------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence                        01111         11247999999999999998888  9999999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.9e-47  Score=366.10  Aligned_cols=249  Identities=28%  Similarity=0.439  Sum_probs=207.7

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ...+|++.+.||+|+||+||+|++..++..||+|++...      .....+|+.+++.++||||+++++++     .+..
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~  109 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKR  109 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            345799999999999999999999999999999998543      23456899999999999999999988     4445


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--CcEEEEecc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFG  213 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--~~vkl~Dfg  213 (354)
                      .+++|||||.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++..+  ..+||+|||
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            68999999986 887777654    5689999999999999999999998 999999999999997643  259999999


Q ss_pred             CceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ++.............||+.|+|||++. . .++.++|||||||++|+|++|.+||.+.+..+.+..+..........   
T Consensus       185 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  259 (494)
T 3lij_A          185 LSAVFENQKKMKERLGTAYYIAPEVLR-K-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP---  259 (494)
T ss_dssp             TCEECBTTBCBCCCCSCTTTCCHHHHT-T-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG---
T ss_pred             CCeECCCCccccccCCCcCeeCHHHHc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch---
Confidence            998876665556678999999999985 3 38999999999999999999999999988877777776642222111   


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                            ....+++.+.+||++||+.||.+|||+.++|+|
T Consensus       260 ----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          260 ----------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             ----------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ----------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                                  123478999999999999999999999999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.8e-48  Score=347.06  Aligned_cols=242  Identities=26%  Similarity=0.364  Sum_probs=193.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ++|++.++||+|+||+||+|++..+|+.||||++....      ....+|+..+..+ +||||+++++++.     +...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            57999999999999999999999999999999875421      1222344444444 8999999999883     3445


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++||||++++|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRG-RCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence            8999999999998888765   35799999999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+...   ...+...  ..          
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~--~~----------  269 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQG--YL----------  269 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTT--CC----------
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhcc--CC----------
Confidence            765555556678999999999865  489999999999999999999776654322   1111110  00          


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     ...+...+++++.++|.+||+.||.+|||+.++++|
T Consensus       270 ---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          270 ---------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ---------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                           112234578999999999999999999999999997

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.5e-47  Score=353.22  Aligned_cols=245  Identities=24%  Similarity=0.406  Sum_probs=200.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-------hhHHHHHH-HHHcCCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|++.+.||+|+||+||+|+++.+++.||+|++.....       ...+|..+ ++.++||||+++++++     .+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence            44589999999999999999999999999999999865431       12234444 4667999999999988     44


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+|+||||+.| +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~ikL~DFG  184 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDFG  184 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEeeCc
Confidence            4568999999986 888877653    5689999999999999999999998 999999999999999888 79999999


Q ss_pred             Cceeccc-CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          214 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       214 ~a~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ++..... .......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....+....        
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------  255 (373)
T 2r5t_A          185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------  255 (373)
T ss_dssp             BCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--------
T ss_pred             cccccccCCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------
Confidence            9975332 33345678999999999997655 8999999999999999999999999888777777665520        


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH----HHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----FDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta----~e~l~~  348 (354)
                                           ..++..++..+.++|++||+.||.+||++    .++++|
T Consensus       256 ---------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          256 ---------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             ---------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             ---------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence                                 01234578999999999999999999997    466666

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.6e-47  Score=336.96  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=204.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||+|++...          .....+|+.+++.++||||+++++++.     +
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence            5799999999999999999999999999999988543          234568999999999999999999883     3


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC---cEEEE
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKLC  210 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~---~vkl~  210 (354)
                      ....++||||+. ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.   .+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEE
Confidence            445899999997 5888888653    5689999999999999999999998 9999999999999986642   69999


Q ss_pred             eccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      |||++.............+++.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+......... 
T Consensus       155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  232 (283)
T 3bhy_A          155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE-  232 (283)
T ss_dssp             CCTTCEECC--------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred             ecccceeccCCCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence            999998775555455667899999999996554 899999999999999999999999988776666555442211111 


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                              .....++..+.++|.+||+.||++|||+.++++|
T Consensus       233 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          233 ------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             ------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             ------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence                                    1223478999999999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.9e-47  Score=348.65  Aligned_cols=277  Identities=32%  Similarity=0.592  Sum_probs=218.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++......+....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            457999999999999999999999999999999985322     233479999999999999999987754433344568


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      ++||||+.++|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCC-cEEEEeccccccc
Confidence            99999999999888875     5689999999999999999999998 999999999999999887 7999999999865


Q ss_pred             ccCCC-----------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 018514          219 VKGEP-----------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (354)
Q Consensus       219 ~~~~~-----------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  287 (354)
                      .....           .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            43211           1234679999999998765668999999999999999999999999999888888888887776


Q ss_pred             CHHHHhccCCCC--cc--cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          288 TREEIKCMNPNY--TE--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       288 ~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ............  .+  ...+......+. .....+++++.++|.+||+.||++|||+.++++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            632211000000  00  001111111111 1234589999999999999999999999999997

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.5e-47  Score=353.80  Aligned_cols=254  Identities=26%  Similarity=0.368  Sum_probs=195.5

Q ss_pred             cccceEEE-eEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHH-HHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           63 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        63 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..++|.+. +.||+|+||+||+|.+..+|+.||||++... ....+|+.++ +..+||||++++++|.... .+..++++
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l  136 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI  136 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence            44578877 7899999999999999999999999998643 3455788887 4558999999999874322 34667899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC---CCCcEEEEeccCce
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAK  216 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~---~~~~vkl~Dfg~a~  216 (354)
                      ||||+.| +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.   ++ .+||+|||++.
T Consensus       137 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~  212 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK  212 (400)
T ss_dssp             EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCc-cEEEEeccccc
Confidence            9999985 8888887532  24689999999999999999999998 9999999999999987   44 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCHHHH
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEI  292 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~  292 (354)
                      ............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+...    ....+...         
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~---------  282 (400)
T 1nxk_A          213 ETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---------  282 (400)
T ss_dssp             ECC-----------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT---------
T ss_pred             ccCCCCccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC---------
Confidence            765554455678899999999996554 8999999999999999999999997754322    22222221         


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                              .+.++.   .     ....++.++.+||++||+.||.+|||+.++++|
T Consensus       283 --------~~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 --------QYEFPN---P-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             --------CCCCCT---T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --------cccCCC---c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    001110   1     113478999999999999999999999999988

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.8e-48  Score=364.24  Aligned_cols=245  Identities=26%  Similarity=0.380  Sum_probs=201.0

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++.     +.
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----TH  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ET
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eC
Confidence            4468999999999999999999999999999999986432       22346888899999999999999884     33


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ..+++||||+++ +|...+...    ..+++..++.++.||+.||+|||+ + ||+||||||+|||++.++ .+||+|||
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~-~~kl~DFG  294 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDG-HIKITDFG  294 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSS-CEEECCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCC-CEEEccCC
Confidence            458999999986 777777653    578999999999999999999998 7 999999999999999887 79999999


Q ss_pred             Cceeccc-CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          214 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       214 ~a~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ++..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.....       
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------  366 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------  366 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-------
Confidence            9975332 22334567999999999997655 89999999999999999999999988877666666554210       


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                            .++..+++++.+||.+||+.||.+||     |++++++|
T Consensus       367 ----------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 ----------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----------------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                                  12345789999999999999999999     99999987

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.8e-47  Score=336.86  Aligned_cols=245  Identities=29%  Similarity=0.458  Sum_probs=203.7

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...++|++.+.||+|+||+||+|.+..++..||+|++...       .....+|+.+++.++||||+++++++     .+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   80 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HD   80 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ec
Confidence            4556899999999999999999999999999999998543       22345799999999999999999988     34


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ....++||||+++ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~l~Dfg  154 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFG  154 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTS-CEEECSCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCC-CEEEEecc
Confidence            4558999999995 787777654    5689999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ++...... ......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.....        
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  224 (279)
T 3fdn_A          155 WSVHAPSS-RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--------  224 (279)
T ss_dssp             EESCC---------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------
T ss_pred             ccccCCcc-cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------
Confidence            88654332 234567899999999996554 79999999999999999999999988776666665544210        


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                           .++..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       225 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          225 ---------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                                 1223478999999999999999999999999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=345.90  Aligned_cols=277  Identities=30%  Similarity=0.512  Sum_probs=214.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecC---------
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT---------  131 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---------  131 (354)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++....    ....+|+.+++.++||||+++++++....         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            47999999999999999999999999999999885432    33457999999999999999998763221         


Q ss_pred             CCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          132 EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                      ..+....++||||+.++|.+.+..     .++++..++.++.||+.||+|||++ ||+||||||+||+++.++..+||+|
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEcc
Confidence            123456899999999998888753     5689999999999999999999998 9999999999999986555899999


Q ss_pred             ccCceecccC----CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 018514          212 FGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (354)
Q Consensus       212 fg~a~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  287 (354)
                      ||++......    .......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999865332    122345678999999998765668999999999999999999999999999888888888887776


Q ss_pred             CHHHHhccCCCCcccCCCCc--cCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          288 TREEIKCMNPNYTEFKFPQI--KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ....................  ...+ ...+...++.++.++|++||+.||.+|||+.++++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKP-LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCC-HHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhcCcccccccccCCCCC-hhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            66554332211111000000  0011 112334589999999999999999999999999997

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.5e-47  Score=348.34  Aligned_cols=248  Identities=26%  Similarity=0.411  Sum_probs=209.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------------hhhHHHHHHHHHc-CCCCeeecceeeeecC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  131 (354)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++....            ....+|+.+++.+ +||||+++++++    
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----  169 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY----  169 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence            47999999999999999999998899999999885432            2345799999999 799999999987    


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEE
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                       ......++||||+.| +|.+.+...    ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+
T Consensus       170 -~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          170 -ESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             -EBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEEC
T ss_pred             -eeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEE
Confidence             344558999999986 888887653    5689999999999999999999998 999999999999999887 79999


Q ss_pred             eccCceecccCCCccccccccccccchhccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 018514          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  285 (354)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  285 (354)
                      |||++.............||+.|+|||++.+     ...++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999987766555566789999999999853     23478899999999999999999999988777666666655332


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+....                         ...++..+.++|.+||+.||.+|||+.++++|
T Consensus       323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            222221                         12468999999999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.8e-47  Score=353.88  Aligned_cols=279  Identities=27%  Similarity=0.399  Sum_probs=218.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcC--------CCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD--------HPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~--------h~~iv~~~~~~~~~~~  132 (354)
                      .++|++.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.++        |+||+++++++.... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence            357999999999999999999999999999999997543   34457999999885        788999999875432 


Q ss_pred             CCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--------
Q 018514          133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--------  204 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--------  204 (354)
                      .+..++++||||+++++.+.+....  ...+++..++.++.||+.||+|||++.||+||||||+|||++.++        
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            3566789999999998888877543  256999999999999999999999854899999999999998664        


Q ss_pred             ----------------------------------------CcEEEEeccCceecccCCCccccccccccccchhccCCCC
Q 018514          205 ----------------------------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE  244 (354)
Q Consensus       205 ----------------------------------------~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  244 (354)
                                                              ..+||+|||++......  .....||+.|+|||++.+.. 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-  269 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-  269 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-
Confidence                                                    26999999999876433  34567899999999997765 


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhccCCCCcccC----CCCcc-CCCcc
Q 018514          245 YTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQIK-AHPWH  313 (354)
Q Consensus       245 ~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~  313 (354)
                      ++.++|||||||++|+|++|..||...+      ....+..+.+..+.++...+.........+.    ...+. ..+|.
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            8999999999999999999999998655      4567788888888888776532221111110    00000 00110


Q ss_pred             --------cccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          314 --------KIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       314 --------~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                              ..+....+..+.+||.+||+.||.+|||+.|+|+|
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                    01122345789999999999999999999999997

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-47  Score=341.64  Aligned_cols=255  Identities=20%  Similarity=0.244  Sum_probs=208.0

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++...  .....+|+.+++.+ +|+|++++++++     .+....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeEE
Confidence            34799999999999999999999999999999988543  33456899999999 799999998877     33445889


Q ss_pred             EEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC----cEEEEeccCce
Q 018514          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH----QLKLCDFGSAK  216 (354)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~----~vkl~Dfg~a~  216 (354)
                      ||||++++|.+++...   ..++++..++.++.||+.||+|||++ ||+||||||+||+++.++.    .+||+|||++.
T Consensus        84 v~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           84 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999988999988764   25699999999999999999999998 9999999999999986652    39999999998


Q ss_pred             ecccCCC--------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhC
Q 018514          217 VLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVLG  285 (354)
Q Consensus       217 ~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~  285 (354)
                      .......        .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+   ....+..+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            7654322        23456899999999996655 8999999999999999999999998743   3333444433322


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .++...                        +...+++++.+++.+||+.||++|||+.++++.|+++
T Consensus       239 ~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          239 STPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            222211                        1234789999999999999999999999999988754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-47  Score=369.21  Aligned_cols=249  Identities=27%  Similarity=0.422  Sum_probs=207.2

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ....+|++.+.||+|+||.||+|++..+|+.||+|++...       .....+|+.+++.++||||+++++++     .+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  255 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET  255 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence            3456799999999999999999999999999999998543       12345799999999999999999988     34


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+++||||+.| +|...+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g-~vKL~DFG  331 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHG-HIRISDLG  331 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCC-CeEEEecc
Confidence            4568999999975 8887776532  24599999999999999999999999 999999999999999888 79999999


Q ss_pred             CceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHH
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~  290 (354)
                      ++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.   ...+.......      
T Consensus       332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------  404 (576)
T 2acx_A          332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------  404 (576)
T ss_dssp             TCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred             cceecccCccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence            998776555555678999999999997655 89999999999999999999999987543   22222222210      


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                            ...++..+++++.+||++||+.||.+||     ++.|+++|
T Consensus       405 ----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 ----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                                  0113345899999999999999999999     89999988

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.6e-48  Score=349.56  Aligned_cols=251  Identities=22%  Similarity=0.330  Sum_probs=204.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCc---eEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|++.+.||+|+||+||+|.+..++.   .||||++...     .....+|+.+++.++||||+++++++     .+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  121 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR  121 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            45689999999999999999999986655   4999998643     23345799999999999999999988     34


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ....++||||+.+ +|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg  196 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNL-VCKVSDFG  196 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred             CCccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCC-CEEECCCC
Confidence            4457899999975 888887643   35799999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          214 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       214 ~a~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      ++.........    ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......  
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--  273 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL--  273 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC--
T ss_pred             cccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC--
Confidence            99876443221    2234577899999996555 8999999999999999999 99999888777666655442111  


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                ..+..+++.+.++|.+||+.||.+|||+.++++.|+.+
T Consensus       274 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          274 --------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                                      12235789999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=346.25  Aligned_cols=246  Identities=25%  Similarity=0.454  Sum_probs=200.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...    .....+|+++++.++||||+++++++..     ....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence            35799999999999999999999999999999987542    2345589999999999999999998843     34488


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  158 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENK-NVVVADFGLARLM  158 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence            99999986 888888753   35789999999999999999999999 999999999999999887 7999999999865


Q ss_pred             ccCCCc---------------cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-----HH
Q 018514          219 VKGEPN---------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-----LV  278 (354)
Q Consensus       219 ~~~~~~---------------~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~  278 (354)
                      ......               ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||........     ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~  237 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR  237 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence            433221               1457899999999996654 89999999999999999999999865332110     00


Q ss_pred             HHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ...                               ....+..+++.+.+++.+||+.||++|||+.++++.|+.
T Consensus       238 ~~~-------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~  279 (310)
T 3s95_A          238 GFL-------------------------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET  279 (310)
T ss_dssp             HHH-------------------------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccc-------------------------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            000                               011234578999999999999999999999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.6e-47  Score=343.30  Aligned_cols=245  Identities=26%  Similarity=0.414  Sum_probs=203.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..|...+.||+|+||+||+|++..+|+.||||++...    .....+|+.+++.++||||+++++++..     ....++
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l  119 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELWV  119 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence            3588889999999999999999889999999998543    2345589999999999999999998844     234889


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+.+ +|.+.+..     ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus       120 v~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          120 LMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQIS  192 (321)
T ss_dssp             EECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-cEEEeeeeeeeecc
Confidence            9999986 77776653     4689999999999999999999998 999999999999999887 79999999998764


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+........          
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  261 (321)
T 2c30_A          193 KDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL----------  261 (321)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred             cCccccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc----------
Confidence            432 234567899999999996554 89999999999999999999999988777666555544211000          


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      .....+++.+.++|.+||+.||++|||+.++++|
T Consensus       262 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          262 ----------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             ----------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                            0112478999999999999999999999999997

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-47  Score=353.33  Aligned_cols=254  Identities=21%  Similarity=0.336  Sum_probs=206.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEEc-------CCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~  129 (354)
                      ..++|++.+.||+|+||+||+|++.       .++..||+|++....     ....+|+.+++.+ +||||+++++++. 
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-  157 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-  157 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC-
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc-
Confidence            4468999999999999999999974       245579999986432     2345799999999 8999999999873 


Q ss_pred             cCCCCeeEEEEEEeeccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 018514          130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (354)
Q Consensus       130 ~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~  196 (354)
                          +...+++||||+.+ +|.+++.....            ....+++..++.++.||+.||+|||++ ||+||||||+
T Consensus       158 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~  232 (370)
T 2psq_A          158 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAAR  232 (370)
T ss_dssp             ----SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGG
T ss_pred             ----cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-Ceeccccchh
Confidence                33347899999985 99988876432            124588999999999999999999999 9999999999


Q ss_pred             CeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018514          197 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (354)
Q Consensus       197 Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  272 (354)
                      |||++.++ .+||+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+
T Consensus       233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999887 799999999986644322   22345678899999997655 8999999999999999999 999998877


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ..+....+....                            ....+..++.++.++|.+||+.||.+|||+.+++++|+.+
T Consensus       311 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          311 VEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             GGGHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            665554443311                            0112335789999999999999999999999999998764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.6e-47  Score=345.36  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=201.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++.... ...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence            3457999999999999999999999999999999986532       23457889999999999999999875443 334


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||+.| +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  162 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGI  162 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTS-CEEECCCSC
T ss_pred             cccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCC-CEEEeeccC
Confidence            566899999974 888887653    5689999999999999999999999 999999999999999887 799999999


Q ss_pred             ceecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +........    .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+......++..
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA  241 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc
Confidence            976543321    22356899999999997665 8999999999999999999999999888777666655532222111


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                               ....++.++.++|.+||+.||.+||++.+++.+
T Consensus       242 -------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          242 -------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             -------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -------------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence                                     123478999999999999999999988887765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-47  Score=349.36  Aligned_cols=254  Identities=31%  Similarity=0.455  Sum_probs=203.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ..+|++.+.||+|+||+||+|.+..++..||+|++....         ....+|+.+++.++||||+++++++     .+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence            457999999999999999999999999999999885432         3455799999999999999999988     44


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhc------------------------------------CCCCCHHHHHHHHHHHHH
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKM------------------------------------SQRMPLIYVKLYFYQICR  177 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~------------------------------------~~~~~~~~~~~~~~qi~~  177 (354)
                      ....++||||+.+ +|.+.+......                                    ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            5568999999975 887777421110                                    122467788899999999


Q ss_pred             HHHHHHhcCCceecCCCCCCeeeeCCCC-cEEEEeccCceecccCC-----CccccccccccccchhccCC-CCCCCchh
Q 018514          178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGA-TEYTAAID  250 (354)
Q Consensus       178 ~l~~LH~~~~iiH~Dlkp~Nili~~~~~-~vkl~Dfg~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~-~~~~~~~D  250 (354)
                      ||+|||++ ||+||||||+||+++.++. .+||+|||++.......     ......||+.|+|||++.+. ..++.++|
T Consensus       180 ~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            99999999 9999999999999986542 69999999998654322     12356789999999999642 45899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHH
Q 018514          251 IWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSR  330 (354)
Q Consensus       251 iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~  330 (354)
                      ||||||++|+|++|..||.+.+..+....+..........                         ....+++.+.++|.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-------------------------NYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-------------------------GGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-------------------------ccccCCHHHHHHHHH
Confidence            9999999999999999999988877777766532211111                         112368999999999


Q ss_pred             hcCcCCCCCCCHHHHhhc
Q 018514          331 LLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       331 ~l~~dp~~Rpta~e~l~~  348 (354)
                      ||+.||.+|||+.++++|
T Consensus       314 ~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHS
T ss_pred             HcCCChhHCCCHHHHhcC
Confidence            999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-47  Score=338.38  Aligned_cols=249  Identities=19%  Similarity=0.328  Sum_probs=205.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..+|++.+.||+|+||+||+|.+. ++..||+|++...   .....+|++++++++||||+++++++.     +....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   82 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL   82 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceEE
Confidence            457999999999999999999986 5678999998653   344568999999999999999999883     3344889


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ +|.+.+...   ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  157 (269)
T ss_dssp             EEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred             EEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCC-CEEecccccccccc
Confidence            9999985 788887653   25689999999999999999999998 999999999999998887 79999999997553


Q ss_pred             cCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       220 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ...  ......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+......          
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~----------  226 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------  226 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred             ccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC----------
Confidence            321  223345677899999996555 8999999999999999999 99999888776666555432111          


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                        ..+..+++.+.+++.+||+.||++|||+.+++++|+.+
T Consensus       227 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          227 ------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence                              12234689999999999999999999999999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-47  Score=366.07  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=206.2

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++....       ....+|+.+++.++||||+++++++     .+.
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~  257 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETK  257 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeC
Confidence            4468999999999999999999999999999999985432       2345799999999999999999988     444


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+|+||||+.| +|...+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g-~vkL~DFGl  335 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDG-NVRISDLGL  335 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCC-CEEEeecce
Confidence            558999999985 88888876554456799999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecccCCCc-cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG----VDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~  289 (354)
                      +......... ....||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.    .+....+....     
T Consensus       336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-----  409 (543)
T 3c4z_A          336 AVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-----  409 (543)
T ss_dssp             CEECCTTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-----
T ss_pred             eeeccCCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-----
Confidence            9876544332 3458999999999997654 89999999999999999999999987542    22223322210     


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                              ..++..+++.+.++|++||+.||.+||+     +.++++|
T Consensus       410 ------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          410 ------------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ------------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                                    0123457999999999999999999996     4788876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-47  Score=348.30  Aligned_cols=252  Identities=19%  Similarity=0.210  Sum_probs=204.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+.+++.+ +||||+++++++..     ..+.++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv   83 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMV   83 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEE
Confidence            4799999999999999999999999999999988543  33466899999999 99999999998733     3458899


Q ss_pred             EeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCc-----EEEEeccCce
Q 018514          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----LKLCDFGSAK  216 (354)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~-----vkl~Dfg~a~  216 (354)
                      |||++++|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .     +||+|||++.
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           84 LELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCE
T ss_pred             EEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCC-CCCCceEEEEEcccce
Confidence            999987999988764   36799999999999999999999999 999999999999998776 4     9999999998


Q ss_pred             ecccCCC--------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhC
Q 018514          217 VLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---DQLVEIIKVLG  285 (354)
Q Consensus       217 ~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~  285 (354)
                      .......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..   +.+..+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            7644322        23567899999999997655 899999999999999999999999875433   23333332211


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ..+...                        .....+ ++.+++..||+.||.+||++.++++.|++.
T Consensus       238 ~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          238 ATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            111111                        112234 999999999999999999999999987643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-47  Score=346.78  Aligned_cols=248  Identities=27%  Similarity=0.430  Sum_probs=182.4

Q ss_pred             cceEEE---eEeeeccceEEEEEEEcCCCceEEEEEcccch-hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAE---RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+|.+.   +.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+++.+. ||||+++++++     .+....+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEE
Confidence            467775   78999999999999999999999999986543 45568999999997 99999999988     4455689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC--cEEEEeccCce
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAK  216 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~--~vkl~Dfg~a~  216 (354)
                      +||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.  .+||+|||++.
T Consensus        83 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999986 888888653    6799999999999999999999998 9999999999999976542  69999999998


Q ss_pred             ecccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCC
Q 018514          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-------DQLVEIIKVLGTPT  288 (354)
Q Consensus       217 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~~~  288 (354)
                      ...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..       +.+..+......  
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--  234 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--  234 (325)
T ss_dssp             ECCC----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--
Confidence            654332 234567799999999996555 899999999999999999999999765431       222222111000  


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                             +.......+++++.+||.+||+.||.+|||+.++++|
T Consensus       235 -----------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          235 -----------------------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             -----------------------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             -----------------------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence                                   1111123478999999999999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.6e-47  Score=335.27  Aligned_cols=246  Identities=30%  Similarity=0.430  Sum_probs=198.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++     .+.
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   83 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STP   83 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecC
Confidence            4457999999999999999999999899999999985432       2345799999999999999999987     334


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg~  157 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFGL  157 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred             CeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCC-CEEEeeccc
Confidence            458999999985 888888754    5689999999999999999999999 999999999999999887 799999999


Q ss_pred             ceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      +.............+++.|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------  228 (276)
T 2h6d_A          158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF---------  228 (276)
T ss_dssp             GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---------
Confidence            98765544445567899999999997665457899999999999999999999988766555554433110         


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                          .++..++..+.++|.+||+.||.+|||+.++++|
T Consensus       229 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 --------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                                0223478999999999999999999999999997

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=349.09  Aligned_cols=273  Identities=33%  Similarity=0.586  Sum_probs=217.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCC-CeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~  137 (354)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            47999999999999999999999999999999985431      2345799999999999999999987543221 1123


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +++||||+.++|.+.+.      ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       104 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCSEEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred             EEEEeccccCCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence            58999999998765543      4589999999999999999999999 999999999999999887 799999999976


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  .....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++.+.......
T Consensus       176 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          176 ADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            4322  33457899999999997756689999999999999999999999999999999999999999988776554332


Q ss_pred             CCccc---CCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....   ..+......+. .....+++++.+||.+||+.||.+|||+.++++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11000   01111111121 1234579999999999999999999999999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.1e-47  Score=334.65  Aligned_cols=249  Identities=20%  Similarity=0.306  Sum_probs=205.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+.+++.++||||+++++++     .+....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceEE
Confidence            457999999999999999999875 5677999998654   33456899999999999999999987     34444889


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ +|.+.+....   ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTC-CEEECCTTCEEECC
T ss_pred             EEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCC-CEEEccCccceecc
Confidence            9999975 7888887642   4689999999999999999999998 999999999999999887 79999999998664


Q ss_pred             cCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          220 KGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       220 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ....  .....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+......          
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  224 (268)
T 3sxs_A          156 DDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL----------  224 (268)
T ss_dssp             TTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----------
T ss_pred             hhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC----------
Confidence            4322  12344567899999996555 8999999999999999999 99999888776665554332100          


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                        ..+...++.+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       225 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          225 ------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                              11234689999999999999999999999999999865

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.7e-47  Score=349.17  Aligned_cols=262  Identities=15%  Similarity=0.141  Sum_probs=201.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCC-----CceEEEEEcccchhhhHHHH---------------HHHHHcCCCCeeecc
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDKRYKNREL---------------QTMRLLDHPNVVSLK  124 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~e~---------------~~l~~l~h~~iv~~~  124 (354)
                      .+|++.+.||+|+||+||+|.+..+     ++.||+|++........+|+               ..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4799999999999999999998764     57899999866544333333               445556799999999


Q ss_pred             eeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee--C
Q 018514          125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN--P  202 (354)
Q Consensus       125 ~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~--~  202 (354)
                      +++.... .+..+.++||||++++|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++  .
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEE-TTEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSC
T ss_pred             eeeeecc-CCcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCC
Confidence            9876543 345778999999977998888763   36799999999999999999999999 999999999999998  6


Q ss_pred             CCCcEEEEeccCceecccCCCc--------cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH
Q 018514          203 HTHQLKLCDFGSAKVLVKGEPN--------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (354)
Q Consensus       203 ~~~~vkl~Dfg~a~~~~~~~~~--------~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  274 (354)
                      ++ .+||+|||++.........        ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....
T Consensus       190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            66 7999999999766433211        2345899999999997665 899999999999999999999999864333


Q ss_pred             -HHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          275 -DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       275 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                       .....................                |   ....+++++.+++..||+.||.+||++.++++.|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~----------------~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKC----------------F---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHH----------------S---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHh----------------c---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence             222222222111111111100                0   0134789999999999999999999999999988654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.6e-47  Score=347.41  Aligned_cols=240  Identities=26%  Similarity=0.391  Sum_probs=203.0

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------------hhhHHHHHHHHHcCCCCeeecceeeeec
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFST  130 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~  130 (354)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....            ....+|+.+++.++||||+++++++   
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---   98 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---   98 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            4457999999999999999999999999999999886432            2345799999999999999999988   


Q ss_pred             CCCCeeEEEEEEeecc-c-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEE
Q 018514          131 TEKDELYLNLVLEYVP-E-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~-~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vk  208 (354)
                        .+...+++||||+. | +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+|
T Consensus        99 --~~~~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~k  170 (335)
T 3dls_A           99 --ENQGFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDF-TIK  170 (335)
T ss_dssp             --ECSSEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEE
T ss_pred             --eeCCEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCC-cEE
Confidence              44556889999986 4 777777653    5799999999999999999999999 999999999999999887 799


Q ss_pred             EEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      |+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||.......      .      
T Consensus       171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~------  238 (335)
T 3dls_A          171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------E------  238 (335)
T ss_dssp             ECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------T------
T ss_pred             EeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------h------
Confidence            9999999887666656667899999999999776655889999999999999999999996522100      0      


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                             .....+..+++++.++|.+||+.||.+|||+.++++|
T Consensus       239 -----------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 -----------------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----------------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----------------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                   0001123478999999999999999999999999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6e-47  Score=336.06  Aligned_cols=254  Identities=26%  Similarity=0.373  Sum_probs=209.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|.+...      .....+|+.+++.++||||+++++++...   ...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence            456899999999999999999999999999999998532      23345799999999999999999977542   234


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ceecCCCCCCeeeeCCCCcEEEE
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-----VCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~-----iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                      ..++||||+.+ +|.+.+.........+++..++.++.|++.||+|||+. |     |+||||||+||+++.++ .+||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~-~~kl~  158 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKLG  158 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSS-CEEEC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCC-CEEEe
Confidence            58899999985 99999887666567799999999999999999999998 8     99999999999999887 79999


Q ss_pred             eccCceecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          211 DFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       211 Dfg~a~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      |||++........ .....|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.....    
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----  233 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----  233 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred             cCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----
Confidence            9999876543221 22456899999999997655 89999999999999999999999988776655555544210    


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccC
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFD  350 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~  350 (354)
                                              ..++..++.++.++|.+||+.||.+|||+.++++++.
T Consensus       234 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          234 ------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                                    0122347899999999999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.3e-47  Score=334.73  Aligned_cols=245  Identities=27%  Similarity=0.468  Sum_probs=182.2

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++     .+..
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence            457999999999999999999999999999999985432       3456799999999999999999988     3445


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++||||+++ +|.+.+...   ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~~  159 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNM-NIKIADFGLA  159 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred             eEEEEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence            68999999985 887777653   35789999999999999999999999 999999999999999887 7999999999


Q ss_pred             eecccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          216 KVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       216 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ....... ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||...+....+..+.             
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------  225 (278)
T 3cok_A          160 TQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-------------  225 (278)
T ss_dssp             EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-------------
T ss_pred             eeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-------------
Confidence            8654322 233467899999999986554 7999999999999999999999997655332221110             


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                               ...       ..++..++.++.++|.+||+.||++|||+.++++|
T Consensus       226 ---------~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          226 ---------LAD-------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ---------SSC-------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---------hcc-------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                     000       01234478999999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.3e-47  Score=333.72  Aligned_cols=246  Identities=26%  Similarity=0.445  Sum_probs=192.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..+|++.+.||+|+||+||+|.+  +|+.||+|++...        .....+|+++++.++||||+++++++     .+.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence            34799999999999999999998  5889999988543        13445799999999999999999988     444


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC---ceecCCCCCCeeeeCC-------C
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG---VCHRDIKPQNLLVNPH-------T  204 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~---iiH~Dlkp~Nili~~~-------~  204 (354)
                      ...++||||+.+ +|.+.+.     ...+++..++.++.|++.||+|||++ |   |+||||||+||+++.+       .
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccC
Confidence            558999999985 7766664     35799999999999999999999998 8   9999999999999852       3


Q ss_pred             CcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 018514          205 HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  284 (354)
Q Consensus       205 ~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  284 (354)
                      ..+||+|||++....... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+.......+....
T Consensus       153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  230 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK  230 (271)
T ss_dssp             CCEEECCCCC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred             cceEEccCCccccccccc-ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence            379999999997654332 33567899999999997655 8999999999999999999999998877655544432210


Q ss_pred             CCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                                 +...++..+++.+.+++.+||+.||.+|||+.+++++|++
T Consensus       231 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          231 ---------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                                       1111234578999999999999999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.7e-46  Score=335.02  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=208.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------------hhhhHHHHHHHHHcC-CCCeeecceeee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------------KRYKNRELQTMRLLD-HPNVVSLKHCFF  128 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~e~~~l~~l~-h~~iv~~~~~~~  128 (354)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++...             .....+|+.+++++. ||||+++++++ 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-   93 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-   93 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence            345799999999999999999999999999999998532             123347999999995 99999999988 


Q ss_pred             ecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcE
Q 018514          129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL  207 (354)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~v  207 (354)
                          .+....++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+
T Consensus        94 ----~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~  163 (298)
T 1phk_A           94 ----ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-NI  163 (298)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CE
T ss_pred             ----ccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCC-cE
Confidence                444568999999985 888888753    5689999999999999999999998 999999999999999887 79


Q ss_pred             EEEeccCceecccCCCccccccccccccchhcc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 018514          208 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (354)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  282 (354)
                      ||+|||++.............+++.|+|||++.     ....++.++||||||+++|+|++|..||...+.......+..
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            999999998776555555677899999999985     234478999999999999999999999988777666665554


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .......                         .....++..+.++|.+||+.||.+|||+.++++|
T Consensus       244 ~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          244 GNYQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             TCCCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CCcccCc-------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            3111110                         0112478999999999999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.8e-46  Score=332.71  Aligned_cols=245  Identities=28%  Similarity=0.450  Sum_probs=206.3

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+++++.++||||+++++++     .+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   85 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HD   85 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----Ec
Confidence            3446899999999999999999999999999999998543       23455799999999999999999988     34


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ....++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg  159 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKG-ELKIADFG  159 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTC-CEEECCCT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCC-CEEEeccc
Confidence            4558999999985 888888754    4689999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ++...... ......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+....         
T Consensus       160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------  228 (284)
T 2vgo_A          160 WSVHAPSL-RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD---------  228 (284)
T ss_dssp             TCEECSSS-CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------
T ss_pred             ccccCccc-ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc---------
Confidence            99765432 234567899999999997655 7999999999999999999999998877665554443310         


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                          ..++..++..+.++|.+||+.||.+|||+.++++|
T Consensus       229 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          229 --------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             --------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                                01234478999999999999999999999999987

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=353.56  Aligned_cols=254  Identities=19%  Similarity=0.244  Sum_probs=204.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEE-----cCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ...+|++.+.||+|+||+||+|++     ..++..||||++...     .....+|+.+++.++||||+++++++.    
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----  144 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----  144 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence            345899999999999999999994     456778999998532     223457999999999999999999883    


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--Cc
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQ  206 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--~~  206 (354)
                       +....++||||+.+ +|.+++.....   ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++  ..
T Consensus       145 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          145 -QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCC
T ss_pred             -cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCce
Confidence             33336899999975 99998887542   224689999999999999999999999 999999999999998543  25


Q ss_pred             EEEEeccCceecccC---CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 018514          207 LKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (354)
Q Consensus       207 vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  282 (354)
                      +||+|||++......   .......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999754322   2233456789999999997655 8999999999999999998 9999988877666555543


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ....                            ..+..++..+.++|.+||+.||.+|||+.+++++|+.
T Consensus       302 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          302 GGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            2110                            1223478999999999999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.5e-47  Score=349.74  Aligned_cols=256  Identities=23%  Similarity=0.329  Sum_probs=205.8

Q ss_pred             cccceEEEeEeeeccceEEEEEE-----EcCCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  131 (354)
                      ..++|++.+.||+|+||.||+|+     +..+++.||||++....     ....+|+++++++ +||||+++++++... 
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence            34589999999999999999999     45567899999986532     2356799999999 789999999987432 


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhhc---------------------------------------------------
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKM---------------------------------------------------  159 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~---------------------------------------------------  159 (354)
                         ...+++||||+.+ +|.+++......                                                   
T Consensus        99 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           99 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             ---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence               2236899999985 888888764321                                                   


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC---cc
Q 018514          160 -----------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NI  225 (354)
Q Consensus       160 -----------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~  225 (354)
                                 ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++........   ..
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC-
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhcc
Confidence                       12288999999999999999999999 999999999999999887 799999999976533322   23


Q ss_pred             ccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCC
Q 018514          226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  304 (354)
Q Consensus       226 ~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  304 (354)
                      ...||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+.........+                 
T Consensus       254 ~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  315 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----------------  315 (359)
T ss_dssp             -CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------
T ss_pred             ccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------
Confidence            456788999999997655 8999999999999999998 999998877555554444421111                 


Q ss_pred             CCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       305 ~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                ..+..+++++.+++.+||+.||.+|||+.++++||+.+
T Consensus       316 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          316 ----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                      12234789999999999999999999999999999764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.2e-46  Score=336.73  Aligned_cols=247  Identities=27%  Similarity=0.407  Sum_probs=205.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ..+|.+.+.||+|+||+||+|++..+|+.||+|++....    ....+|+.+++.++||||+++++++     .+....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEE
Confidence            357999999999999999999999999999999986432    3456899999999999999999987     3445589


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee---eCCCCcEEEEeccCc
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA  215 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili---~~~~~~vkl~Dfg~a  215 (354)
                      +||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||++   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~  156 (304)
T 2jam_A           83 LVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENS-KIMITDFGLS  156 (304)
T ss_dssp             EEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred             EEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence            99999985 888877653    5689999999999999999999998 99999999999999   5555 7999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+.......        
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------  226 (304)
T 2jam_A          157 KMEQNG-IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF--------  226 (304)
T ss_dssp             CCCCCB-TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC--------
T ss_pred             eecCCC-ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            754332 334457899999999996554 8999999999999999999999998887766666665532111        


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                       ...+...+++.+.++|.+||+.||.+|||+.++++|
T Consensus       227 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          227 -----------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             -----------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             -----------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                             111234578999999999999999999999999987

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.9e-47  Score=342.63  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=195.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC------
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE------  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------  132 (354)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...     .....+|+.+++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            45799999999999999999999999999999998632     2345689999999999999999998865432      


Q ss_pred             ----------------------------------------------CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCH
Q 018514          133 ----------------------------------------------KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPL  165 (354)
Q Consensus       133 ----------------------------------------------~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~  165 (354)
                                                                    ....++++|||||.+ +|.+.+..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                          123358999999996 88887775432 234567


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCC-------------Cccccccccc
Q 018514          166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------------PNISYICSRY  232 (354)
Q Consensus       166 ~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~g~~~  232 (354)
                      ..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            77899999999999999998 999999999999999887 89999999998765432             1234568999


Q ss_pred             cccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCc
Q 018514          233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW  312 (354)
Q Consensus       233 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (354)
                      |+|||++.+.. ++.++|||||||++|+|++|..|+...  ......+..  ...+.                       
T Consensus       242 y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~--~~~~~-----------------------  293 (332)
T 3qd2_B          242 YMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN--LKFPL-----------------------  293 (332)
T ss_dssp             GSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT--TCCCH-----------------------
T ss_pred             ccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc--cCCCc-----------------------
Confidence            99999997665 899999999999999999987664211  111111111  11111                       


Q ss_pred             ccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          313 HKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       313 ~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                         .....++.+.++|.+||+.||.+|||+.++++|
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence               011246889999999999999999999999987

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.7e-46  Score=334.46  Aligned_cols=245  Identities=27%  Similarity=0.431  Sum_probs=205.0

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...+|.+.+.||+|+||+||+|.+..+++.+|+|++...       .....+|+.+++.++||||+++++++     .+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccC
Confidence            445799999999999999999999999999999988543       23345799999999999999999987     344


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~  161 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGL  161 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCC-CEEEEeccC
Confidence            568999999995 777776653    5789999999999999999999999 999999999999999887 799999999


Q ss_pred             ceecccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          215 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       215 a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      +...... .......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||......+....+....         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------  231 (294)
T 2rku_A          162 ATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------  231 (294)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------
T ss_pred             ceecccCccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc---------
Confidence            9876432 2233457899999999996554 7999999999999999999999998877655544443210         


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                          ..++..+++.+.++|.+||+.||++|||+.++++|
T Consensus       232 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 --------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --------------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                                01233478999999999999999999999999987

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.4e-46  Score=341.11  Aligned_cols=245  Identities=27%  Similarity=0.441  Sum_probs=206.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++     .+.
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecC
Confidence            345799999999999999999999999999999998543       23445799999999999999999988     344


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~  187 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGL  187 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCC-CEEEeeccC
Confidence            568999999995 787776653    5789999999999999999999999 999999999999999887 799999999


Q ss_pred             ceecccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          215 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       215 a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      +...... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||......+....+....         
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------  257 (335)
T 2owb_A          188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------  257 (335)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred             ceecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC---------
Confidence            9876432 2334467899999999997655 7999999999999999999999998877666555544320         


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                              .            .++..+++.+.++|.+||+.||++|||+.++++|
T Consensus       258 --------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          258 --------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             --------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --------C------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    0            1223478999999999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.1e-46  Score=346.41  Aligned_cols=273  Identities=31%  Similarity=0.539  Sum_probs=213.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcC-CC-----CeeecceeeeecCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-HP-----NVVSLKHCFFSTTEK  133 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~  133 (354)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....   ....+|+.+++.++ |+     +|+++++++..    
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~----  127 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF----  127 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE----
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc----
Confidence            3468999999999999999999999999999999997543   23346888888885 55     48888887743    


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--cCCceecCCCCCCeeeeC-CCCcEEEE
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--TIGVCHRDIKPQNLLVNP-HTHQLKLC  210 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~~iiH~Dlkp~Nili~~-~~~~vkl~  210 (354)
                       ....++||||++++|.+.+....  ...+++..++.++.||+.||.|||+  . ||+||||||+|||++. +...+||+
T Consensus       128 -~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~-~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          128 -RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             -TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTT-CEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             -CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCC-CEEcCCCCcccEEEecCCCCcEEEE
Confidence             34589999999999999887643  2458999999999999999999994  5 9999999999999953 22379999


Q ss_pred             eccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      |||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++..
T Consensus       204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CCTTCEETTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eccCceeccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999987643  234567899999999997665 8999999999999999999999999999999999999999988877


Q ss_pred             HHhccCCCCcccCCCCccCCCcc--------------------cccC-----------------CCCCHHHHHHHHHhcC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWH--------------------KIFQ-----------------KRMPPEAVDLVSRLLQ  333 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~-----------------~~~s~~l~~ll~~~l~  333 (354)
                      .+.........  +..+....|.                    ..+.                 ...++++.+||.+||+
T Consensus       281 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          281 ILDQAPKARKF--FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHTTCTTHHHH--EEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHhhHHHHHH--HHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence            65422110000  0000001110                    0000                 0011478999999999


Q ss_pred             cCCCCCCCHHHHhhc
Q 018514          334 YSPNLRSTAFDAVGS  348 (354)
Q Consensus       334 ~dp~~Rpta~e~l~~  348 (354)
                      +||++|||+.|+|+|
T Consensus       359 ~dP~~Rpta~e~L~h  373 (382)
T 2vx3_A          359 YDPKTRIQPYYALQH  373 (382)
T ss_dssp             SCTTTSCCHHHHTTS
T ss_pred             CChhhCCCHHHHhcC
Confidence            999999999999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.3e-47  Score=356.09  Aligned_cols=249  Identities=29%  Similarity=0.447  Sum_probs=193.0

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------------hhhHHHHHHHHHcCCCCeeecceeeeecC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  131 (354)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++....            ....+|+.++++++||||+++++++.   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            457999999999999999999999999999999985432            13457999999999999999999862   


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--CcEE
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLK  208 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--~~vk  208 (354)
                        .. ..++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++  ..+|
T Consensus       211 --~~-~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 --AE-DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             --SS-EEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             --cC-ceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEE
Confidence              22 26899999986 76655543    46799999999999999999999998 999999999999997543  2599


Q ss_pred             EEeccCceecccCCCccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hC
Q 018514          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LG  285 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~  285 (354)
                      |+|||++.............||+.|+|||++.+  ...++.++|||||||++|+|++|..||........+...... ..
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999987655544556789999999999853  344788999999999999999999999875543333332221 11


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ....                         .....+++.+.+||++||+.||.+|||+.++++|
T Consensus       363 ~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          363 NFIP-------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             CCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCc-------------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1111                         1123478999999999999999999999999998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.3e-47  Score=353.41  Aligned_cols=250  Identities=21%  Similarity=0.285  Sum_probs=204.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ...+|++.+.||+|+||.||+|++..+++.||||.+....     ....+|+++++.++||||+++++++.     +...
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCC
Confidence            4468999999999999999999999899999999986431     23457999999999999999999883     3334


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++||||++ |+|.+++....   ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~  261 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKN-VLKISDFGMSR  261 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             cEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCC-cEEECcCCCce
Confidence            789999998 58888887542   4689999999999999999999999 999999999999999887 79999999997


Q ss_pred             ecccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          217 VLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       217 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ........   ....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+......      
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------  334 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL------  334 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            64332111   1223467899999996555 8999999999999999998 99999887765554443321100      


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                            ..+..+++.+.++|.+||+.||.+|||+.++++.|++
T Consensus       335 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          335 ----------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence                                  1233478999999999999999999999999998865

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2e-46  Score=348.40  Aligned_cols=244  Identities=23%  Similarity=0.333  Sum_probs=193.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcC--CCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+|++.+.||+|+||+||+|.+.. ++.||||++....      ....+|+.+++.++  ||||+++++++.     ...
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence            469999999999999999999754 8899999885432      33458999999997  599999999873     334


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .+++|||+.+++|.+++...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++. + .+||+|||++.
T Consensus       130 ~~~lv~E~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~-~-~~kl~DFG~a~  202 (390)
T 2zmd_A          130 YIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-G-MLKLIDFGIAN  202 (390)
T ss_dssp             EEEEEEECCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEESS-S-CEEECCCSSSC
T ss_pred             EEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEEC-C-eEEEEecCccc
Confidence            58999998778999888763    4788999999999999999999998 9999999999999964 4 79999999998


Q ss_pred             ecccCCC---ccccccccccccchhccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHH
Q 018514          217 VLVKGEP---NISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIK  282 (354)
Q Consensus       217 ~~~~~~~---~~~~~g~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~  282 (354)
                      .......   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|..||...... ..+..+..
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  282 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  282 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence            6643322   2345799999999998642          34889999999999999999999999875432 22222221


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .   .                        ....++...+.++.+||.+||+.||.+|||+.++++|
T Consensus       283 ~---~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 P---N------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             T---T------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             c---c------------------------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            0   0                        0011223357899999999999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.7e-46  Score=334.25  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=201.7

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++...      .....+|+..+..+ +||||+++++++..     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----   82 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----   82 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----
Confidence            3456899999999999999999999999999999998642      23345788888888 99999999998843     


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC---------
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT---------  204 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~---------  204 (354)
                      ....++||||+++ +|.+.+.........+++..++.++.||+.||+|||++ ||+||||||+||+++.++         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCccccccc
Confidence            3458899999975 99999987766667899999999999999999999999 999999999999997432         


Q ss_pred             ---------CcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 018514          205 ---------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (354)
Q Consensus       205 ---------~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  275 (354)
                               ..+||+|||.+.......   ...||+.|+|||++.+...++.++|||||||++|+|++|.+|+.....  
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             ccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                     269999999998764332   345899999999997765577899999999999999999987754432  


Q ss_pred             HHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       ...+...                   ..         ..++..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       237 -~~~~~~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 -WHEIRQG-------------------RL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -HHHHHTT-------------------CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -HHHHHcC-------------------CC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence             2222110                   00         11334578999999999999999999999999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-46  Score=342.27  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=202.7

Q ss_pred             ccceEEE-eEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCe
Q 018514           64 TISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  135 (354)
                      .++|.+. +.||+|+||+||+|.+..+|+.||+|++...      .....+|+.+++.+. ||||+++++++     .+.
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~  101 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENT  101 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeC
Confidence            3468887 8999999999999999999999999988643      234557999999985 69999999988     444


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC---CCCcEEEEe
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCD  211 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~---~~~~vkl~D  211 (354)
                      ...++||||+.+ +|.+.+...  ....+++..++.++.||+.||+|||++ ||+||||||+||+++.   ++ .+||+|
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~-~~kL~D  177 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLG-DIKIVD  177 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBC-CEEECC
T ss_pred             CeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCC-cEEEee
Confidence            558999999986 776665432  236789999999999999999999999 9999999999999987   44 799999


Q ss_pred             ccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       212 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ||++.............||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+....+.........  
T Consensus       178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  254 (327)
T 3lm5_A          178 FGMSRKIGHACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE--  254 (327)
T ss_dssp             GGGCEEC---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred             CccccccCCccccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc--
Confidence            99998776555555678999999999996555 899999999999999999999999988877777666553222211  


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                             .....+++.+.++|.+||+.||.+|||++++|+|
T Consensus       255 -----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          255 -----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                                   1123478999999999999999999999999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.1e-46  Score=334.05  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=201.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----------hhhHHHHHHHHHcCCCCeeecceeeeecC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  131 (354)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....           ....+|+.+++.++||||+++++++    
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----   92 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM----   92 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee----
Confidence            3457999999999999999999999999999999984321           3456799999999999999999987    


Q ss_pred             CCCeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeeeCCCC---
Q 018514          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTH---  205 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~--iiH~Dlkp~Nili~~~~~---  205 (354)
                       .+..  ++||||+. ++|.+.+...   ...+++..++.++.|++.||+|||++ |  |+||||||+||+++.++.   
T Consensus        93 -~~~~--~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           93 -HNPP--RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             -TTTT--EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             -cCCC--eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCc
Confidence             2222  58999998 5887777653   35799999999999999999999998 9  999999999999987662   


Q ss_pred             -cEEEEeccCceecccCCCccccccccccccchhccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHH
Q 018514          206 -QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ--LVEII  281 (354)
Q Consensus       206 -~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~  281 (354)
                       .+||+|||++.....  ......||+.|+|||++.. ...++.++|||||||++|+|++|..||...+....  ...+.
T Consensus       166 ~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  243 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR  243 (287)
T ss_dssp             CCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred             eeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence             299999999975432  3345678999999999843 33378899999999999999999999987554332  22221


Q ss_pred             HHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ..                           .+...++..+++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus       244 ~~---------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 EE---------------------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HS---------------------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cc---------------------------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11                           011123445789999999999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4e-47  Score=347.15  Aligned_cols=255  Identities=22%  Similarity=0.284  Sum_probs=207.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ..++|++.+.||+|+||.||+|++.     .+++.||+|++...     .....+|+.+++.++||||+++++++.    
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----  120 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----  120 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc----
Confidence            4468999999999999999999986     34588999998643     234567999999999999999999883    


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKM--------------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~--------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~  191 (354)
                       +....++||||+.+ +|.+++......                    ...+++..++.++.||+.||.|||++ ||+||
T Consensus       121 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~  198 (343)
T 1luf_A          121 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHR  198 (343)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             -cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence             33447899999985 999888764321                    25789999999999999999999999 99999


Q ss_pred             CCCCCCeeeeCCCCcEEEEeccCceecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 018514          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  267 (354)
Q Consensus       192 Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~p  267 (354)
                      ||||+||+++.++ .+||+|||++.......   ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..|
T Consensus       199 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          199 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCc
Confidence            9999999999887 79999999997653322   223456788999999997655 8999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                      |.+.+..+....+.....                            ..++..+++.+.++|++||+.||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            988776665554433100                            0123457899999999999999999999999999


Q ss_pred             ccCcCC
Q 018514          348 SFDSSF  353 (354)
Q Consensus       348 ~l~~~~  353 (354)
                      +|+.+.
T Consensus       329 ~L~~~~  334 (343)
T 1luf_A          329 ILQRMC  334 (343)
T ss_dssp             HHHHTT
T ss_pred             HHHHHH
Confidence            988653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.6e-46  Score=331.32  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=203.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ..|++.+.||+|+||+||+|.+..++..||+|.+....      ....+|+.+++.++||||+++++++.... .+..++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence            35999999999999999999999999999999885432      33457999999999999999999875443 356778


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~--iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ++||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ |  |+||||||+||+++.+.+.+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            999999975 888888654    5689999999999999999999998 8  9999999999999843348999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ..... .......||+.|+|||++.+  .++.++||||||+++|+|++|..||..................         
T Consensus       180 ~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  247 (290)
T 1t4h_A          180 TLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---------  247 (290)
T ss_dssp             GGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---------
T ss_pred             ccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC---------
Confidence            65433 23345678999999998853  3899999999999999999999999886655544433221100         


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                       ...++...++++.++|.+||+.||.+|||+.++++|
T Consensus       248 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          248 -----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                             011234467999999999999999999999999997

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.1e-46  Score=335.34  Aligned_cols=255  Identities=21%  Similarity=0.239  Sum_probs=205.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++...  .....+|+.+++.++|++++..+..+..    .....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEE
Confidence            45799999999999999999999999999999987543  3446689999999999988777665533    23357899


Q ss_pred             EeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee---CCCCcEEEEeccCceec
Q 018514          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~---~~~~~vkl~Dfg~a~~~  218 (354)
                      |||++++|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++   .++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccc
Confidence            999988999888743   25799999999999999999999999 999999999999994   555 7999999999876


Q ss_pred             ccCCC--------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCC
Q 018514          219 VKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTP  287 (354)
Q Consensus       219 ~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~  287 (354)
                      .....        .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+   ....+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            54432        23557899999999997655 8999999999999999999999998743   223333333321111


Q ss_pred             CHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      +...                        +...+++++.+++.+||+.||.+|||+.++++.|+..
T Consensus       238 ~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          238 PIEV------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             CHHH------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             chHH------------------------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            1111                        1234789999999999999999999999999988754

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.6e-47  Score=337.46  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=209.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecC-----------
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT-----------  131 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----------  131 (354)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++........+|+++++.++||||+++++++....           
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence            445799999999999999999999889999999999877777889999999999999999999874311           


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEE
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                      ......+++||||+++ +|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~  164 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTK-QVKIG  164 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEEC
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCC-CEEEC
Confidence            1235568999999996 9998887643  35789999999999999999999998 999999999999999887 79999


Q ss_pred             eccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      |||++.............|++.|+|||.+.+.. ++.++||||||+++|+|++|..||....  .....+..        
T Consensus       165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~--------  233 (284)
T 2a19_B          165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD--------  233 (284)
T ss_dssp             CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT--------
T ss_pred             cchhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc--------
Confidence            999998776655555667899999999997655 8999999999999999999998874211  11111100        


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                             ..++..++..+.++|.+||+.||.+|||+.+++++|..
T Consensus       234 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          234 -----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             -----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                                   01223478999999999999999999999999999764

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1e-46  Score=348.42  Aligned_cols=257  Identities=14%  Similarity=0.124  Sum_probs=183.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc--CCCCeeecceeee-------
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL--DHPNVVSLKHCFF-------  128 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l--~h~~iv~~~~~~~-------  128 (354)
                      .+|++.+.||+|+||+||+|++..+|+.||+|++....       ....+|+.+++.+  +||||++++..+.       
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            35999999999999999999999999999999986532       2234575545444  6999888654332       


Q ss_pred             ecCC------------CCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhcCCcee
Q 018514          129 STTE------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------KLYFYQICRALAYIHNTIGVCH  190 (354)
Q Consensus       129 ~~~~------------~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~------~~~~~qi~~~l~~LH~~~~iiH  190 (354)
                      ....            .....+++||||++++|.+++.....   .+.....      ..++.||+.||+|||++ ||+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK-GLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCcc
Confidence            1111            01155899999999999999987532   2333344      56779999999999998 9999


Q ss_pred             cCCCCCCeeeeCCCCcEEEEeccCceecccCCCccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 018514          191 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFP  269 (354)
Q Consensus       191 ~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~  269 (354)
                      |||||+|||++.++ .+||+|||++......  .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.
T Consensus       218 rDikp~NIll~~~~-~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          218 GHFTPDNLFIMPDG-RLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             TTCSGGGEEECTTS-CEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CcCCHHHEEECCCC-CEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999999887 7999999999865322  2245677999999999651 348999999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          270 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       270 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +.....                    ...+............+.......+++.+.+||.+||+.||++|||+.++++|
T Consensus       295 ~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          295 LVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             BCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            654210                    00011111111111112222234689999999999999999999999999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.1e-47  Score=336.35  Aligned_cols=251  Identities=19%  Similarity=0.269  Sum_probs=203.8

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ....+|++.+.||+|+||+||+|.+. ++..||+|++...   .....+|+++++.++||||+++++++     .+....
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence            34458999999999999999999875 6678999998653   34456899999999999999999988     334448


Q ss_pred             EEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+. ++|.+.+....   ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~  169 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRY  169 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred             EEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCC-CEEEcccccccc
Confidence            89999997 48888886532   5689999999999999999999999 999999999999999887 799999999975


Q ss_pred             cccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          218 LVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       218 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      .....  ......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+......        
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------  240 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------  240 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred             ccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence            53321  122345677899999997555 8999999999999999998 99999888776666655442111        


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                          ..+...++.+.++|.+||+.||.+|||+.+++++|.++
T Consensus       241 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          241 --------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                                11234689999999999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=348.45  Aligned_cols=255  Identities=21%  Similarity=0.321  Sum_probs=207.3

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCC-------CceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeee
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  128 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~  128 (354)
                      ...++|++.+.||+|+||+||+|++..+       +..||+|++....     ....+|+++++.+ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            3446899999999999999999997543       3579999986532     3345799999999 9999999999883


Q ss_pred             ecCCCCeeEEEEEEeeccc-cHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 018514          129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  195 (354)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp  195 (354)
                           .....++||||+.+ +|.+++......            ...+++..++.++.||+.||+|||++ ||+||||||
T Consensus       146 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp  219 (382)
T 3tt0_A          146 -----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAA  219 (382)
T ss_dssp             -----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCG
T ss_pred             -----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCc
Confidence                 33347899999985 999988865421            24689999999999999999999999 999999999


Q ss_pred             CCeeeeCCCCcEEEEeccCceecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 018514          196 QNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGE  271 (354)
Q Consensus       196 ~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~  271 (354)
                      +|||++.++ .+||+|||++.......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.
T Consensus       220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999887 79999999998654332   223445688899999997655 8999999999999999999 99999887


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       272 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      +..+....+.....                            ...+..+++++.++|.+||+.||++|||+.+++++|+.
T Consensus       298 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  349 (382)
T 3tt0_A          298 PVEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  349 (382)
T ss_dssp             CHHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            76555544433210                            11224578999999999999999999999999999875


Q ss_pred             C
Q 018514          352 S  352 (354)
Q Consensus       352 ~  352 (354)
                      +
T Consensus       350 ~  350 (382)
T 3tt0_A          350 I  350 (382)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.3e-47  Score=341.50  Aligned_cols=254  Identities=20%  Similarity=0.332  Sum_probs=206.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ...+|++.+.||+|+||.||+|.+.     .++..||+|++....     ....+|+.+++.++||||+++++++.    
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   96 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS----   96 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe----
Confidence            3458999999999999999999973     455889999986432     33457999999999999999999873    


Q ss_pred             CCeeEEEEEEeecc-ccHHHHHHhhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 018514          133 KDELYLNLVLEYVP-ETVHRVIKHHYK--------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (354)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~--------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~  191 (354)
                       +....++||||+. ++|.+++.....                    ....+++..++.++.||+.||+|||++ ||+||
T Consensus        97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~  174 (314)
T 2ivs_A           97 -QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHR  174 (314)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             -cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CCccc
Confidence             3334789999998 599988876543                    123488999999999999999999999 99999


Q ss_pred             CCCCCCeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 018514          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  267 (354)
Q Consensus       192 Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~p  267 (354)
                      ||||+||+++.++ .+||+|||++........   .....+|+.|+|||.+.+.. ++.++|||||||++|+|++ |..|
T Consensus       175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999887 799999999986644322   22345678899999997655 8999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                      |.+.+.......+.....                            ...+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            988776555444332110                            0122457899999999999999999999999999


Q ss_pred             ccCcC
Q 018514          348 SFDSS  352 (354)
Q Consensus       348 ~l~~~  352 (354)
                      +|+..
T Consensus       305 ~l~~~  309 (314)
T 2ivs_A          305 DLEKM  309 (314)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2e-46  Score=335.25  Aligned_cols=255  Identities=21%  Similarity=0.251  Sum_probs=203.1

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|++...  .....+|+.+++.++|++++..+..+..    .....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEE
Confidence            35799999999999999999999999999999986433  3446689999999999988887766543    23457899


Q ss_pred             EeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee---eCCCCcEEEEeccCceec
Q 018514          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili---~~~~~~vkl~Dfg~a~~~  218 (354)
                      |||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||++   +.++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCC-eEEEecCccceec
Confidence            999988999888753   25699999999999999999999999 99999999999999   5555 7999999999876


Q ss_pred             ccCCC--------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCC
Q 018514          219 VKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGTP  287 (354)
Q Consensus       219 ~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~  287 (354)
                      .....        .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..   ..+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            54322        23457899999999997655 899999999999999999999999874432   2333332221111


Q ss_pred             CHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      +..                        .....+++++.++|.+||+.||++|||+.++++.|+++
T Consensus       238 ~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          238 PIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             CHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hhh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            111                        11234789999999999999999999999999988754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.4e-46  Score=338.19  Aligned_cols=250  Identities=26%  Similarity=0.355  Sum_probs=194.6

Q ss_pred             ccceEEE-eEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .+.|++. +.||+|+||+||+|++..+++.||||++...    .....+|+.+++++ +||||+++++++..     ...
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCE
Confidence            4579985 7899999999999999999999999998543    23456899999885 79999999998843     345


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC--cEEEEeccC
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGS  214 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~--~vkl~Dfg~  214 (354)
                      +++||||+. ++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.  .+||+|||+
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            899999998 5888888764    5689999999999999999999999 9999999999999987652  399999999


Q ss_pred             ceecccCC--------CccccccccccccchhccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH--------
Q 018514          215 AKVLVKGE--------PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV--------  274 (354)
Q Consensus       215 a~~~~~~~--------~~~~~~g~~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------  274 (354)
                      +.......        ......||+.|+|||++.+.    ..++.++|||||||++|+|++|..||.+....        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            87543211        12234589999999998541    33788999999999999999999999875431        


Q ss_pred             -------HHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          275 -------DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       275 -------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                             .....+.......+..                         ....+++.+.+||++||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYEFPDK-------------------------DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCCHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhHHHHHHHHHhccCcccCch-------------------------hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                   1222222211111111                         11247899999999999999999999999999


Q ss_pred             c
Q 018514          348 S  348 (354)
Q Consensus       348 ~  348 (354)
                      |
T Consensus       296 h  296 (316)
T 2ac3_A          296 H  296 (316)
T ss_dssp             S
T ss_pred             C
Confidence            7

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.7e-47  Score=336.73  Aligned_cols=248  Identities=18%  Similarity=0.246  Sum_probs=199.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCC-------ceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETG-------EAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      .++|++.+.||+|+||+||+|.+..++       ..||+|++....    ....+|+.+++.++||||+++++++..   
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC---   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC---
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe---
Confidence            457999999999999999999998777       469999985432    334579999999999999999998843   


Q ss_pred             CCeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCc-----
Q 018514          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----  206 (354)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~-----  206 (354)
                        ....++||||+. ++|.+++....   ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++..     
T Consensus        84 --~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           84 --GDENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             --TTCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             --CCCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCccccccc
Confidence              333689999998 58888887642   4489999999999999999999999 99999999999999877621     


Q ss_pred             --EEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHH
Q 018514          207 --LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV  283 (354)
Q Consensus       207 --vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~i~~~  283 (354)
                        +||+|||++.....   .....+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+. .........
T Consensus       158 ~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~~~~  233 (289)
T 4fvq_A          158 PFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYED  233 (289)
T ss_dssp             CEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHT
T ss_pred             ceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHHhhc
Confidence              99999999864422   234567889999999977566899999999999999999965 55544443 333332221


Q ss_pred             hCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                      .                             ..++...++++.++|.+||+.||.+|||+.+++++|++++
T Consensus       234 ~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          234 R-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             T-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             c-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            0                             0122335788999999999999999999999999998765

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.9e-47  Score=335.50  Aligned_cols=252  Identities=26%  Similarity=0.358  Sum_probs=195.4

Q ss_pred             CccccceEEEeEeeeccceEEEEEEEcCC---CceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           61 PKQTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      .....+|++.+.||+|+||+||+|.+..+   +..||+|.+...     .....+|+.+++.++||||+++++++..   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---   87 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---   87 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---
Confidence            34456899999999999999999998654   456999988542     2334579999999999999999988621   


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                         ...++||||+.+ +|.+.+...   ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|
T Consensus        88 ---~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~D  159 (281)
T 1mp8_A           88 ---NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGD  159 (281)
T ss_dssp             ---SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC
T ss_pred             ---CccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCC-CEEECc
Confidence               126799999996 888888653   24689999999999999999999998 999999999999999887 799999


Q ss_pred             ccCceecccCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          212 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       212 fg~a~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      ||++........  .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.....   
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---  235 (281)
T 1mp8_A          160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---  235 (281)
T ss_dssp             -------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred             cccccccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---
Confidence            999976644322  22345677899999996554 8999999999999999997 9999988777666555533210   


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                               ..++..+++.+.++|.+||+.||.+|||+.+++++|+..
T Consensus       236 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          236 -------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                                     012345789999999999999999999999999998754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-46  Score=369.61  Aligned_cols=245  Identities=27%  Similarity=0.410  Sum_probs=208.0

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|++.+.||+|+||+||+|+++.+++.||||++....       ....+|..++..+ .||+|++++++|     .+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence            3457999999999999999999999999999999986432       2334688888877 799999999888     45


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+|+||||+.| +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g-~ikL~DFG  487 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFG  487 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCC-cEEEeecc
Confidence            5568999999985 888887754    5699999999999999999999999 999999999999999888 79999999


Q ss_pred             Cceecc-cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          214 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       214 ~a~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ++.... .+.......||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..|....        
T Consensus       488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------  558 (674)
T 3pfq_A          488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------  558 (674)
T ss_dssp             TCEECCCTTCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--------
T ss_pred             eeeccccCCcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            998643 333445678999999999996655 8999999999999999999999999988877777765421        


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCH-----HHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----FDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta-----~e~l~~  348 (354)
                                           ..++..+++++.+||++||+.||.+||++     +++++|
T Consensus       559 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          559 ---------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                                 11334589999999999999999999997     889887

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.4e-46  Score=339.23  Aligned_cols=249  Identities=30%  Similarity=0.457  Sum_probs=199.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------------hhhHHHHHHHHHcCCCCeeecceeeeecC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  131 (354)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....            ....+|+++++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            357999999999999999999999999999999885431            234579999999999999999988632  


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC--cEE
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLK  208 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~--~vk  208 (354)
                         .. .++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  .+|
T Consensus        87 ---~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           87 ---ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             ---SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEE
T ss_pred             ---Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEE
Confidence               11 6899999985 88777754    36789999999999999999999998 9999999999999986542  499


Q ss_pred             EEeccCceecccCCCccccccccccccchhcc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHHhC
Q 018514          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE-IIKVLG  285 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~  285 (354)
                      |+|||++.............||+.|+|||++.  +...++.++|||||||++|+|++|..||........+.. +.....
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            99999998764443334567899999999974  344589999999999999999999999987554333322 222111


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ....                         .....++..+.++|.+||+.||.+|||+.++++|
T Consensus       238 ~~~~-------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          238 NFIP-------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             CCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCc-------------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            1111                         1123478999999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-48  Score=358.66  Aligned_cols=278  Identities=19%  Similarity=0.287  Sum_probs=207.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+|++.+.||+|+||+||+|++..+|+.||||++....     ....+|+++++.++||||+++++++...   +....+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCeeE
Confidence            47999999999999999999999999999999986432     3445899999999999999999987432   233478


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee----eCCCCcEEEEeccC
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGS  214 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili----~~~~~~vkl~Dfg~  214 (354)
                      +||||+.+ +|.+.+..... ...+++..++.++.||+.||+|||++ ||+||||||+|||+    +.++ .+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCE-EEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCce-eEEEecCCC
Confidence            99999985 88887765432 33489999999999999999999999 99999999999998    5444 699999999


Q ss_pred             ceecccCCCccccccccccccchhccCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHH
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTAAIDIWSAGCVLAELLLGQPLFPGES----GVDQLVEIIKV  283 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~  283 (354)
                      +.............||+.|+|||++.+.       ..++.++|||||||++|+|++|..||....    ..+.+..+...
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            9877655555567799999999998541       336789999999999999999999997532    33444444432


Q ss_pred             hCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .................++  ..  ..+....+...++..+.++|++||++||++|||+.++++.+++.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~--~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDW--SG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEE--ES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhheeccCCCccc--Cc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            1111111111100100000  00  00001112234567899999999999999999999999887654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.9e-48  Score=357.38  Aligned_cols=247  Identities=16%  Similarity=0.190  Sum_probs=188.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHH---HHHHcCCCCeeecceeee-----
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQ---TMRLLDHPNVVSLKHCFF-----  128 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~---~l~~l~h~~iv~~~~~~~-----  128 (354)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++...       .....+|+.   +++.++||||+++++.+.     
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45799999999999999999999889999999998532       234457884   455568999999984332     


Q ss_pred             --ecC---------CCCee---EEEEEEeeccccHHHHHHhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 018514          129 --STT---------EKDEL---YLNLVLEYVPETVHRVIKHHYKMSQ---RMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (354)
Q Consensus       129 --~~~---------~~~~~---~~~iv~e~~~~~l~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~  191 (354)
                        ...         ..+..   ..++||||++|+|.+++........   .+++..++.++.||+.||+|||++ ||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence              111         01111   2689999999999999987543221   234577888999999999999999 99999


Q ss_pred             CCCCCCeeeeCCCCcEEEEeccCceecccCCCccccccccccccchhccCC----------CCCCCchhHHHHHHHHHHH
Q 018514          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAEL  261 (354)
Q Consensus       192 Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el  261 (354)
                      ||||+|||++.++ .+||+|||++.....  ......| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999887 899999999985422  2334566 999999999765          2489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC
Q 018514          262 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  341 (354)
Q Consensus       262 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt  341 (354)
                      ++|+.||.+.+.......+                                 ......+++++.++|.+||+.||.+|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence            9999999664422111100                                 0011357899999999999999999999


Q ss_pred             HHHHhhc
Q 018514          342 AFDAVGS  348 (354)
Q Consensus       342 a~e~l~~  348 (354)
                      +.++++|
T Consensus       354 ~~e~l~h  360 (377)
T 3byv_A          354 PLQAMET  360 (377)
T ss_dssp             HHHHHTS
T ss_pred             HHHHhhC
Confidence            9999987

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.5e-47  Score=338.68  Aligned_cols=263  Identities=25%  Similarity=0.405  Sum_probs=198.8

Q ss_pred             cccceEEEeEeeeccceEEEEEE----EcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|++.+.||+|+||+||+|+    +..+++.||+|++....    ....+|+.+++.++||||+++++++....   
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            34579999999999999999998    56688999999986532    34458999999999999999999874422   


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+++||||+.+ +|.+.+....   ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Dfg  159 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDFG  159 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCC-eEEEccCc
Confidence            2236899999975 8988887643   4589999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          214 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       214 ~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      ++........    .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.....  ..   ....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~---~~~~~~~~~  233 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDKQ  233 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HH---HHHHCTTCC
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChH--HH---HhhhcCccc
Confidence            9986543321    22345677899999997655 89999999999999999999999864321  11   111111110


Q ss_pred             HH------HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          290 EE------IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       290 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ..      ......             ......+..+++++.++|.+||+.||++|||+.++++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          234 GQMIVFHLIELLKN-------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             THHHHHHHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhHHHHHHHHhc-------------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            00      000000             001112345789999999999999999999999999988753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-46  Score=339.87  Aligned_cols=244  Identities=24%  Similarity=0.343  Sum_probs=193.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCC--CCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+|++.+.||+|+||+||+|.+ .+++.||+|++....      ....+|+.+++.++|  |||+++++++     .+..
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~~   82 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ   82 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeCC
Confidence            4799999999999999999997 468899999885331      334579999999987  9999999987     3445


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ++++|||+.+++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++ ++ .+||+|||++.
T Consensus        83 ~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~-~~kl~DFG~a~  155 (343)
T 3dbq_A           83 YIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DG-MLKLIDFGIAN  155 (343)
T ss_dssp             EEEEEECCCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TT-EEEECCCSSSC
T ss_pred             EEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CC-cEEEeeccccc
Confidence            68999998888999988763    6789999999999999999999999 999999999999998 44 69999999998


Q ss_pred             ecccCCC---ccccccccccccchhccC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHH
Q 018514          217 VLVKGEP---NISYICSRYYRAPELIFG----------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIK  282 (354)
Q Consensus       217 ~~~~~~~---~~~~~g~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~  282 (354)
                      .......   .....||+.|+|||++.+          ...++.++|||||||++|+|++|..||...... ..+..+..
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  235 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  235 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence            6643322   234578999999999853          244788999999999999999999999765432 22222211


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                         .                        .....++...+.++.++|.+||+.||.+|||+.++++|
T Consensus       236 ---~------------------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          236 ---P------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ---T------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---C------------------------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence               0                        01112334467899999999999999999999999988

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1e-46  Score=338.07  Aligned_cols=258  Identities=21%  Similarity=0.314  Sum_probs=198.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-hhhHHHHHHHHH--cCCCCeeecceeeeecCCCCeeEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ..++|++.+.||+|+||+||+|++  +|+.||||++.... ....+|.+++..  ++||||+++++++.... .....++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~   82 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLW   82 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeE
Confidence            345899999999999999999997  78899999986543 233457777766  79999999999865543 3456689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCceecCCCCCCeeeeCCCCcEEEE
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--------NTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--------~~~~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                      +||||+.+ +|.+++..     ..+++..++.++.||+.||+|||        ++ ||+||||||+|||++.++ .+||+
T Consensus        83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~-~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNG-QCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTS-CEEEC
T ss_pred             EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCC-CEEEe
Confidence            99999985 88888853     57899999999999999999999        88 999999999999999887 79999


Q ss_pred             eccCceecccCCCc-----cccccccccccchhccCCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCC
Q 018514          211 DFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLG----------QPLFPG  270 (354)
Q Consensus       211 Dfg~a~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~-----~~~~~DiwslG~il~ell~g----------~~pf~~  270 (354)
                      |||++.........     ....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999765443322     23478999999999966532     44689999999999999999          888865


Q ss_pred             CCc----HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHh
Q 018514          271 ESG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV  346 (354)
Q Consensus       271 ~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l  346 (354)
                      ...    ...+........                 ..+...    ...+....++.+.++|.+||+.||++|||+.+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  294 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQ-----------------QRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK  294 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSC-----------------CCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             cCCCCcchhhhhHHHhccC-----------------CCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence            322    122222211100                 000000    0112233568899999999999999999999999


Q ss_pred             hccCc
Q 018514          347 GSFDS  351 (354)
Q Consensus       347 ~~l~~  351 (354)
                      +.|+.
T Consensus       295 ~~L~~  299 (301)
T 3q4u_A          295 KTLTK  299 (301)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            98864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=335.65  Aligned_cols=249  Identities=27%  Similarity=0.392  Sum_probs=204.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...        .....+|+.+++.++||||+++++++..   .+.
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence            35799999999999999999999999999999998643        2345589999999999999999998743   233


Q ss_pred             eEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ...++||||+.+++.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~-~~kl~dfg~~  156 (305)
T 2wtk_C           81 QKMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGG-TLKISALGVA  156 (305)
T ss_dssp             -CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             CeEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCC-cEEeeccccc
Confidence            4578999999998888777643  36789999999999999999999999 999999999999999887 7999999999


Q ss_pred             eecccCC---CccccccccccccchhccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          216 KVLVKGE---PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       216 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .......   ......||+.|+|||++.+.. .++.++||||||+++|+|++|..||.+.+..+....+.+..       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-------  229 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-------  229 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-------
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-------
Confidence            8664321   223456899999999986533 24779999999999999999999998877666555554310       


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                            ..++..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       230 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ----------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                                  01233478999999999999999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.3e-47  Score=344.18  Aligned_cols=273  Identities=21%  Similarity=0.268  Sum_probs=201.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh---hhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..+|++.+.||+|+||+||+|++  .++.||||++.....   ...+|+.+++.++||||+++++++.... .....+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEEE
Confidence            35799999999999999999997  478999999865432   2345888899999999999999886543 22455789


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CceecCCCCCCeeeeCCCCcEEEE
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---------~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                      ||||+.+ +|.+++..     ..+++..++.++.|++.||+|||+..         ||+||||||+|||++.++ .+||+
T Consensus       100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~  173 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIA  173 (322)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEEC
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEc
Confidence            9999985 89888865     45899999999999999999999742         899999999999999887 79999


Q ss_pred             eccCceecccCCC---ccccccccccccchhccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 018514          211 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (354)
Q Consensus       211 Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  283 (354)
                      |||++........   .....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+........-....
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999976644332   2335789999999999653    23566889999999999999999999875432222111122


Q ss_pred             hCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ...+....+......  ....+.. ...|.   ....++++.++|.+||+.||++|||+.++++.|+.
T Consensus       254 ~~~~~~~~~~~~~~~--~~~~~~~-~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          254 GQHPSLEDMQEVVVH--KKKRPVL-RDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             CSSCCHHHHHHHHTT--SCCCCCC-CGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhc--ccCCCCc-ccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            222222222111000  0000000 00010   11234669999999999999999999999998864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.1e-46  Score=330.69  Aligned_cols=248  Identities=28%  Similarity=0.444  Sum_probs=205.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...      .....+|+++++.++||||+++++++     .+...
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCe
Confidence            45799999999999999999999989999999998543      23455899999999999999999987     33445


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--CcEEEEeccC
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGS  214 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--~~vkl~Dfg~  214 (354)
                      .++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            8999999975 887777653    4689999999999999999999999 999999999999997643  2699999999


Q ss_pred             ceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      +.............+++.|+|||.+.+ . ++.++||||||+++|+|++|..||.+.+..+....+.........     
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  243 (287)
T 2wei_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG-T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-----  243 (287)
T ss_dssp             GGTBCCCSSCSCHHHHHTTCCHHHHTT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----
T ss_pred             ceeecCCCccccccCcccccChHHhcC-C-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----
Confidence            986655544455678999999999854 3 799999999999999999999999988776666555442111110     


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                          .....+++++.++|.+||+.||.+|||+.++++|
T Consensus       244 --------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          244 --------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             --------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence                                0113478999999999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-46  Score=344.55  Aligned_cols=253  Identities=27%  Similarity=0.437  Sum_probs=200.0

Q ss_pred             CccccceEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccc--------hhhhHHHHHHHHHc-CCCCeeecceeee
Q 018514           61 PKQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVVSLKHCFF  128 (354)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~--------~~~~~~e~~~l~~l-~h~~iv~~~~~~~  128 (354)
                      .....+|++.+.||+|+||+||+|++.   .+|+.||||++...        .....+|+.+++.+ .||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            334568999999999999999999984   47899999988542        23345799999999 6999999998873


Q ss_pred             ecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcE
Q 018514          129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL  207 (354)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~v  207 (354)
                      .     ...+++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+
T Consensus       130 ~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~  198 (355)
T 1vzo_A          130 T-----ETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HV  198 (355)
T ss_dssp             E-----TTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CE
T ss_pred             e-----CceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-cE
Confidence            3     3458899999985 888888754    5689999999999999999999998 999999999999999887 79


Q ss_pred             EEEeccCceecccCC--CccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 018514          208 KLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  284 (354)
Q Consensus       208 kl~Dfg~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  284 (354)
                      ||+|||++.......  ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+....
T Consensus       199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  278 (355)
T 1vzo_A          199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  278 (355)
T ss_dssp             EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence            999999998653322  22345789999999999753 347899999999999999999999997543322222222110


Q ss_pred             CCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhcc
Q 018514          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGSF  349 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~l  349 (354)
                      ...                         ...++..++..+.+||.+||+.||.+||     |+.++++|.
T Consensus       279 ~~~-------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          279 LKS-------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHC-------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             hcc-------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            000                         0012345789999999999999999999     999999984

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.8e-46  Score=338.43  Aligned_cols=254  Identities=23%  Similarity=0.337  Sum_probs=206.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEE-----cCCCceEEEEEcccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      ..+|++.+.||+|+||.||+|.+     ..+++.||+|++...     .....+|+.+++++ +||||+++++++..   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence            45799999999999999999985     356789999998643     23455899999999 99999999998833   


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYK--------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~N  197 (354)
                        ....++||||+.+ +|.+.+.....              ....+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus        99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~N  175 (313)
T 1t46_A           99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARN  175 (313)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGG
T ss_pred             --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccce
Confidence              3347899999985 99988876532              123589999999999999999999999 99999999999


Q ss_pred             eeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 018514          198 LLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (354)
Q Consensus       198 ili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  273 (354)
                      |+++.++ .+||+|||++........   .....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+...
T Consensus       176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999887 899999999986644332   12345678899999987655 8999999999999999998 9999988766


Q ss_pred             HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       274 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .............                           ...+..++..+.++|.+||+.||.+|||+.+++++|+..
T Consensus       254 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          254 DSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             SHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            5555544442111                           011234789999999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-46  Score=342.29  Aligned_cols=256  Identities=21%  Similarity=0.302  Sum_probs=205.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  131 (354)
                      ...+|++.+.||+|+||+||+|.+.     .++..||+|++...     .....+|+.+++.+ +||||+++++++..  
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence            3458999999999999999999973     35678999998643     23456899999999 89999999998843  


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKM-------------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~-------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~  191 (354)
                         ....++||||+++ +|.+.+......                   ...+++..++.++.||+.||+|||++ ||+||
T Consensus       121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~  196 (344)
T 1rjb_A          121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHR  196 (344)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEET
T ss_pred             ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence               3347899999985 999888764321                   13478999999999999999999998 99999


Q ss_pred             CCCCCCeeeeCCCCcEEEEeccCceecccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 018514          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  267 (354)
Q Consensus       192 Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~p  267 (354)
                      ||||+||+++.++ .+||+|||++.........   ....+|+.|+|||.+.+.. ++.++|||||||++|+|++ |..|
T Consensus       197 Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          197 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCC
Confidence            9999999999887 8999999999866443321   2345678899999986655 8999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                      |.+......+..+......                           ...+..+++++.++|.+||+.||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             STTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9887665555544442100                           0122347899999999999999999999999999


Q ss_pred             ccCcCC
Q 018514          348 SFDSSF  353 (354)
Q Consensus       348 ~l~~~~  353 (354)
                      +|+..+
T Consensus       328 ~l~~~~  333 (344)
T 1rjb_A          328 FLGCQL  333 (344)
T ss_dssp             HHHHHC
T ss_pred             HHHHHH
Confidence            987643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=340.93  Aligned_cols=261  Identities=14%  Similarity=0.130  Sum_probs=198.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcC---CCceEEEEEcccchhh---------------hHHHHHHHHHcCCCCeeeccee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRY---------------KNRELQTMRLLDHPNVVSLKHC  126 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~---------------~~~e~~~l~~l~h~~iv~~~~~  126 (354)
                      ++|++.+.||+|+||+||+|.+..   ++..+|+|++......               ..+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            479999999999999999999987   7889999988654321               2256777888899999999998


Q ss_pred             eeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC-C
Q 018514          127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT-H  205 (354)
Q Consensus       127 ~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~-~  205 (354)
                      +.... .+..+.++||||++++|.+++...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .
T Consensus       117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEF-KGRSYRFMVMERLGIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEES-SSCEEEEEEEECEEEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTT
T ss_pred             ccccc-CCCcEEEEEEeccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCC
Confidence            86533 346678999999977888877654    3789999999999999999999999 999999999999998654 2


Q ss_pred             cEEEEeccCceecccCCC--------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHH
Q 018514          206 QLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQ  276 (354)
Q Consensus       206 ~vkl~Dfg~a~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~  276 (354)
                      .+||+|||++........        .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+. .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            699999999976643221        13457899999999997664 899999999999999999999999652 22232


Q ss_pred             HHHHHHHh-CCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          277 LVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       277 ~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ........ ...+.....+.                    -...+++++.++|.+||+.||.+|||+.++++.|++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            32222221 12221111110                    0114789999999999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.4e-47  Score=344.24  Aligned_cols=253  Identities=22%  Similarity=0.302  Sum_probs=204.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceE--EEEEcccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..+|++.+.||+|+||.||+|++..++..+  |+|.+...     .....+|+++++++ +||||+++++++.     +.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ET
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eC
Confidence            358999999999999999999998888765  89987542     23456799999999 8999999999883     33


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~  202 (354)
                      ...++||||+++ +|.+.+....            .....+++..++.++.||+.||+|||++ ||+||||||+||+++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  177 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcC
Confidence            458999999975 9998887643            2345799999999999999999999998 9999999999999998


Q ss_pred             CCCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 018514          203 HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (354)
Q Consensus       203 ~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~  281 (354)
                      ++ .+||+|||++.............+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       178 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          178 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CC-eEEEcccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            87 79999999997544333344456688999999996554 7999999999999999998 999998877655444332


Q ss_pred             HHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ...                            ....+..+++.+.++|.+||+.||.+|||+.+++++|+..
T Consensus       256 ~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          256 QGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             GTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            210                            0112234789999999999999999999999999998753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-45  Score=336.56  Aligned_cols=274  Identities=26%  Similarity=0.444  Sum_probs=214.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEE-cCCCceEEEEEcccch---hhhHHHHHHHHHcCCC------CeeecceeeeecCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKC-LETGEAVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTEK  133 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~  133 (354)
                      .++|++.+.||+|+||+||+|.+ ..+++.||+|++....   ....+|+.+++.++|+      +++++++++.     
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-----   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-----   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-----
Confidence            35799999999999999999998 5678999999986543   3455799999888665      4899888873     


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC----------
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----------  203 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~----------  203 (354)
                      ...+.++||||++++|.+.+....  ..++++..++.++.||+.||+|||++ ||+||||||+||+++..          
T Consensus        88 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           88 HHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCcc
Confidence            334589999999889999887643  24689999999999999999999999 99999999999999863          


Q ss_pred             --------CCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 018514          204 --------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (354)
Q Consensus       204 --------~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  275 (354)
                              ...+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    22699999999986433  234567899999999997655 8999999999999999999999999999888


Q ss_pred             HHHHHHHHhCCCCHHHHhccCCCCc----ccCCCCcc---------CCCcc--cccCCCCCHHHHHHHHHhcCcCCCCCC
Q 018514          276 QLVEIIKVLGTPTREEIKCMNPNYT----EFKFPQIK---------AHPWH--KIFQKRMPPEAVDLVSRLLQYSPNLRS  340 (354)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~--~~~~~~~s~~l~~ll~~~l~~dp~~Rp  340 (354)
                      ....+.+..+..+...+........    ...+....         ...+.  .......++++.+||.+||+.||.+||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            8888888888888776554321100    00000000         00000  001122457899999999999999999


Q ss_pred             CHHHHhhc
Q 018514          341 TAFDAVGS  348 (354)
Q Consensus       341 ta~e~l~~  348 (354)
                      |+.|+++|
T Consensus       322 t~~ell~h  329 (339)
T 1z57_A          322 TLREALKH  329 (339)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999988

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9e-47  Score=336.45  Aligned_cols=253  Identities=20%  Similarity=0.324  Sum_probs=209.5

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ....+|++.+.||+|+||+||+|.+..++..||+|++..+.   ....+|+.+++.++||||+++++++     .+....
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   84 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF   84 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence            34568999999999999999999999999999999986543   3455899999999999999999987     334448


Q ss_pred             EEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+. ++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence            89999999 58888887533  35689999999999999999999999 999999999999999887 799999999976


Q ss_pred             cccCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          218 LVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       218 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ......  .....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+.......+....          
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~----------  229 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------  229 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred             ccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----------
Confidence            543322  22345678899999996655 8999999999999999999 999998877655554443311          


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                        ....+..+++.+.++|.+||+.||.+|||+.++++.|+..
T Consensus       230 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          230 ------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence                              1112345789999999999999999999999999988754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4e-46  Score=330.10  Aligned_cols=247  Identities=28%  Similarity=0.369  Sum_probs=200.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++.     +....
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence            357999999999999999999999999999999985432     34567999999999999999999873     33457


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+..    ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||.+..
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~  154 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  154 (276)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCC-CEEEeeCCCccc
Confidence            899999986 77666543    35689999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHh
Q 018514          218 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIK  293 (354)
Q Consensus       218 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~  293 (354)
                      .....   ......|++.|+|||.+.+...++.++||||||+++|+|++|..||........ ...+... ..       
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-------  226 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT-------  226 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CT-------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-cc-------
Confidence            54322   223456899999999997666457899999999999999999999987654322 2222110 00       


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    ...     ....+++.+.++|.+||+.||++|||+.++++|
T Consensus       227 --------------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          227 --------------YLN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --------------TST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------------ccC-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                          000     112478999999999999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.5e-46  Score=340.57  Aligned_cols=259  Identities=20%  Similarity=0.288  Sum_probs=193.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCc---eEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      ...+|++.+.||+|+||+||+|++..++.   .||+|++...      .....+|+.+++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34579999999999999999999877665   7999998643      23455899999999999999999988543322


Q ss_pred             Ce-eEEEEEEeeccc-cHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEE
Q 018514          134 DE-LYLNLVLEYVPE-TVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (354)
Q Consensus       134 ~~-~~~~iv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl  209 (354)
                      +. ...++||||+.+ +|.+.+.....  ....+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~-~~kl  178 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDM-TVCV  178 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCC-CEEE
Confidence            11 123899999986 88888865442  223689999999999999999999999 999999999999999887 7999


Q ss_pred             EeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 018514          210 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  285 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  285 (354)
                      +|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            99999976544322   22345677899999996655 8999999999999999999 9999998877666655543210


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .                            ..+..+++++.++|.+||+.||.+|||+.++++.|+++
T Consensus       258 ~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          258 L----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             C----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0                            12234789999999999999999999999998887654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9e-46  Score=342.00  Aligned_cols=281  Identities=30%  Similarity=0.458  Sum_probs=216.3

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcC-----------CCCeeecceee
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCF  127 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~-----------h~~iv~~~~~~  127 (354)
                      ....+|++.+.||+|+||+||+|++..+++.||||++..+.   ....+|+.++++++           ||||+++++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            34458999999999999999999999999999999987543   34457888888876           89999999987


Q ss_pred             eecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC----
Q 018514          128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----  203 (354)
Q Consensus       128 ~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~----  203 (354)
                      .... .+..++++||||++++|.+.+....  ...+++..++.++.||+.||+|||++.||+||||||+|||++.+    
T Consensus        96 ~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           96 NHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             hccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            5543 3456789999999889999887643  25589999999999999999999984499999999999999532    


Q ss_pred             -CCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------cHHH
Q 018514          204 -THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQ  276 (354)
Q Consensus       204 -~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~  276 (354)
                       ...+||+|||++......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+      ....
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence             226999999999866432  33457899999999997665 8999999999999999999999998654      4567


Q ss_pred             HHHHHHHhCCCCHHHHhccCCCCccc-------CCCCccCCCcc------cccCCCCCHHHHHHHHHhcCcCCCCCCCHH
Q 018514          277 LVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWH------KIFQKRMPPEAVDLVSRLLQYSPNLRSTAF  343 (354)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~  343 (354)
                      +..+...++.++...+.........+       ........+..      ..++..++.++.+||.+||+.||.+|||+.
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            78888888888876554322110000       00000000000      012234567899999999999999999999


Q ss_pred             HHhhc
Q 018514          344 DAVGS  348 (354)
Q Consensus       344 e~l~~  348 (354)
                      |+++|
T Consensus       330 ell~h  334 (373)
T 1q8y_A          330 GLVNH  334 (373)
T ss_dssp             HHHTC
T ss_pred             HHhhC
Confidence            99997

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=339.64  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=187.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcC-CCCeeecceeeeecCC---CCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTE---KDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~---~~~~  136 (354)
                      .+|++.+.||+|+||.||+|++..+|+.||+|++....    ....+|+.+++.+. ||||+++++++.....   .+..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            37999999999999999999999999999999885432    33457999999996 9999999998754332   4566


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~--iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      .+++||||+.|+|.+.+..... ...+++..++.++.||+.||+|||++ |  |+||||||+|||++.++ .+||+|||+
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             eEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            7899999999999988876432 35699999999999999999999998 9  99999999999999887 799999999


Q ss_pred             ceecccCCC-------------ccccccccccccchhcc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 018514          215 AKVLVKGEP-------------NISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (354)
Q Consensus       215 a~~~~~~~~-------------~~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  279 (354)
                      +........             .....||+.|+|||++.  ....++.++|||||||++|+|++|..||...........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            976543221             11445899999999983  233478899999999999999999999976443221110


Q ss_pred             HHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      .                               +........+..+.++|++||+.||.+|||+.+++++|..
T Consensus       265 ~-------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          265 K-------------------------------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             --------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             c-------------------------------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            0                               0001123357889999999999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.9e-45  Score=330.43  Aligned_cols=243  Identities=25%  Similarity=0.391  Sum_probs=204.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ..|++.+.||+|+||+||+|.+..+++.||+|++...     .....+|+.+++.++||||+++++++..     ....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence            4699999999999999999999999999999998543     2445689999999999999999998843     33488


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+++ +|.+.+..     .++++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        97 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQL  169 (303)
T ss_dssp             EEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCC-CEEEeecccceec
Confidence            99999986 77777653     5789999999999999999999998 999999999999999887 7999999999876


Q ss_pred             ccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .... ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...........+....             
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  235 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-------------  235 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------
T ss_pred             CccccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-------------
Confidence            4432 233457899999999996654 8999999999999999999999998877665554443310             


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     ...+...++..+.++|.+||+.||.+|||+.++++|
T Consensus       236 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          236 ---------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ---------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ---------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                           001234578999999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.7e-46  Score=336.56  Aligned_cols=259  Identities=19%  Similarity=0.265  Sum_probs=198.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcC---CCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      ...+|.+.+.||+|+||+||+|.+..   ++..||+|.+....      ....+|+.+++.++||||+++++++......
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            34579999999999999999998765   45589999986431      2345799999999999999999988665444


Q ss_pred             CeeEEEEEEeeccc-cHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEE
Q 018514          134 DELYLNLVLEYVPE-TVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                      +....++||||+.+ +|.+.+....  .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kl~  189 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDM-TVCVA  189 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTS-CEEEC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEEe
Confidence            34456899999995 8888875433  2346799999999999999999999998 999999999999999887 79999


Q ss_pred             eccCceecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 018514          211 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  286 (354)
Q Consensus       211 Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  286 (354)
                      |||++.......   ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+.......+..... 
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-  267 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR-  267 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-
Confidence            999997654332   122345678899999996654 8999999999999999999 8999988777665555433210 


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                 ...+..+++.+.++|.+||+.||.+|||+.+++++|+.+
T Consensus       268 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          268 ---------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             ---------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                                       012345789999999999999999999999999998764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-47  Score=345.89  Aligned_cols=270  Identities=21%  Similarity=0.247  Sum_probs=204.2

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ...++|++.+.||+|+||+||+|++ .+|+.||+|++...    .....+|+.+++.++||||+++++++.     +...
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~  109 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ERNE  109 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CTTC
T ss_pred             HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCe
Confidence            3456899999999999999999996 46889999988543    234568999999999999999999873     3344


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++||||+.+ +|.+.+.........+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~  187 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENF-VPKITDFGISK  187 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCC-CEEEeeccccc
Confidence            7899999985 88777765444445689999999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          217 VLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       217 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+..+.+........     ...  
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~--  259 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VES--  259 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHH--
T ss_pred             ccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhc--
Confidence            643222   123446899999999997655 899999999999999999999999765432211100000     000  


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ....     .............+....+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus       260 ~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          260 HNNG-----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             HTTT-----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccc-----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            0000     01111111111122233567899999999999999999999999998754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-45  Score=338.47  Aligned_cols=273  Identities=25%  Similarity=0.431  Sum_probs=213.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCC-ceEEEEEcccch---hhhHHHHHHHHHcCCCC------eeecceeeeecCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDK---RYKNRELQTMRLLDHPN------VVSLKHCFFSTTEK  133 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~  133 (354)
                      .++|++.+.||+|+||+||+|.+..++ ..||+|++....   ....+|+.+++.++|++      ++.+.+++.     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-----   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-----   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-----
Confidence            357999999999999999999998776 689999986532   34457999999987665      788777763     


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee-------------
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV-------------  200 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili-------------  200 (354)
                      .....++||||+++++.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||+             
T Consensus        93 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           93 FHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eCCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccc
Confidence            334589999999999888877643  25689999999999999999999998 99999999999999             


Q ss_pred             ------eCCCCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH
Q 018514          201 ------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (354)
Q Consensus       201 ------~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  274 (354)
                            +.++ .+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..
T Consensus       170 ~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  4455 799999999986433  234567899999999997655 899999999999999999999999999988


Q ss_pred             HHHHHHHHHhCCCCHHHHhccCCCCcccC----CCCc---------cCCCccc--ccCCCCCHHHHHHHHHhcCcCCCCC
Q 018514          275 DQLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQI---------KAHPWHK--IFQKRMPPEAVDLVSRLLQYSPNLR  339 (354)
Q Consensus       275 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~---------~~~~~~~--~~~~~~s~~l~~ll~~~l~~dp~~R  339 (354)
                      +.+..+.+..+.++...+...........    ++..         ....+..  ......+.++.+||++||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            88899999888888776543321110000    0000         0000000  0011234689999999999999999


Q ss_pred             CCHHHHhhc
Q 018514          340 STAFDAVGS  348 (354)
Q Consensus       340 pta~e~l~~  348 (354)
                      ||+.++++|
T Consensus       326 pt~~e~l~h  334 (355)
T 2eu9_A          326 ITLAEALLH  334 (355)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.9e-46  Score=330.17  Aligned_cols=252  Identities=25%  Similarity=0.343  Sum_probs=201.9

Q ss_pred             CccccceEEEeEeeeccceEEEEEEEcCC---CceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           61 PKQTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      .....+|++.+.||+|+||+||+|.+...   +..||+|.+...     .....+|+.+++.++||||+++++++..   
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   84 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---   84 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---
Confidence            33456899999999999999999987543   346999998653     2345579999999999999999998632   


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                        . ..++||||+.+ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        85 --~-~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~D  156 (281)
T 3cc6_A           85 --E-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPE-CVKLGD  156 (281)
T ss_dssp             --S-SCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETT-EEEECC
T ss_pred             --C-CCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCC-cEEeCc
Confidence              1 14789999995 888888654   35689999999999999999999998 999999999999999887 899999


Q ss_pred             ccCceecccCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          212 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       212 fg~a~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      ||++........  .....+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+....+......  
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~--  233 (281)
T 3cc6_A          157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL--  233 (281)
T ss_dssp             CCGGGCC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC--
T ss_pred             cCCCcccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC--
Confidence            999976543321  22345678899999996554 8999999999999999998 99999877766655554432111  


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                ..+..+++.+.++|.+||+.||.+|||+.+++++|+++
T Consensus       234 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          234 --------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                                      01234789999999999999999999999999998764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.1e-46  Score=333.57  Aligned_cols=253  Identities=25%  Similarity=0.301  Sum_probs=196.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++..     .
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence            3457999999999999999999999999999999986432       334579999999999999999998743     3


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||+.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~-~~kl~Dfg~  180 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADD-FAYLVDFGI  180 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSCCC
T ss_pred             CeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCC-CEEEecCcc
Confidence            458899999986 888888754    5689999999999999999999999 999999999999999887 799999999


Q ss_pred             ceecccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          215 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       215 a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      +.......  ......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+.. .+.........      
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~------  252 (309)
T 2h34_A          181 ASATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIP------  252 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCC------
T ss_pred             CccccccccccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCC------
Confidence            87654332  123456899999999996554 899999999999999999999999876543 22222221100      


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-CHHHHhhccCcCC
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-TAFDAVGSFDSSF  353 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-ta~e~l~~l~~~~  353 (354)
                                         ....+...+++.+.++|.+||+.||.+|| |++++++.|+.++
T Consensus       253 -------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          253 -------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             -------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             -------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence                               01123345789999999999999999999 9999999887654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=331.20  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=201.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHc-CCCCeeecceeeeecCCC-CeeE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK-DELY  137 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~  137 (354)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++...   .....+|+.+++.+ +||||+++++++...... ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            455799999999999999999999999999999998543   34556899999999 799999999988654321 1456


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++||||+.+ +|.+++....  ...+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .+||+|||++.
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~  177 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECCCTTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCC-CEEEeeCcCce
Confidence            8999999986 8888887643  35689999999999999999999999 999999999999999887 79999999987


Q ss_pred             ecccCC-CccccccccccccchhccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          217 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       217 ~~~~~~-~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ...... ......|++.|+|||++..    ...++.++|||||||++|+|++|..||...+....+..+.....      
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------  251 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA------  251 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------
Confidence            654322 2334578999999999852    33488999999999999999999999988776655544433100      


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                   +        ......++..+.++|.+||+.||.+|||+.++++|
T Consensus       252 -------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          252 -------------P--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             -------------C--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -------------c--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                         0        00123478999999999999999999999999997

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-46  Score=341.70  Aligned_cols=249  Identities=22%  Similarity=0.310  Sum_probs=198.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCce----EEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ..+|++.+.||+|+||+||+|.+..+++.    ||+|.+....     ....+|+.+++.++||||+++++++.     +
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----G   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----B
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence            34799999999999999999999888876    6777664321     23457999999999999999999762     1


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                       ...++||||+. ++|.+.+....   ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        87 -~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Dfg  160 (325)
T 3kex_A           87 -SSLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFG  160 (325)
T ss_dssp             -SSEEEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSS-CEEECSCS
T ss_pred             -CccEEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCC-eEEECCCC
Confidence             22678999998 58888876542   4688889999999999999999999 999999999999999887 79999999


Q ss_pred             CceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          214 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       214 ~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      ++........   .....+|..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+.....    
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----  235 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER----  235 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----
T ss_pred             cccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----
Confidence            9986643322   23445677899999997655 8999999999999999999 9999988765554444332100    


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                              ...+..++.++.++|.+||+.||.+|||+.+++++|+.+
T Consensus       236 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          236 ------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             ------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             ------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                                    011233678899999999999999999999999998653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.4e-46  Score=337.77  Aligned_cols=255  Identities=21%  Similarity=0.329  Sum_probs=205.2

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEc-------CCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeee
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  128 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~  128 (354)
                      ...++|++.+.||+|+||+||+|++.       .++..||+|++....     ....+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            34468999999999999999999975       356789999986432     2345799999999 8999999999873


Q ss_pred             ecCCCCeeEEEEEEeeccc-cHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 018514          129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  195 (354)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp  195 (354)
                           +....++||||+.+ +|.+++......            ...+++..++.++.||+.||+|||++ ||+||||||
T Consensus       112 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp  185 (334)
T 2pvf_A          112 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAA  185 (334)
T ss_dssp             -----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSG
T ss_pred             -----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCcc
Confidence                 33447899999985 999888764321            23589999999999999999999999 999999999


Q ss_pred             CCeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 018514          196 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGE  271 (354)
Q Consensus       196 ~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~  271 (354)
                      +||+++.++ .+||+|||++........   .....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.
T Consensus       186 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          186 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            999999887 799999999986644322   22345678899999996655 8999999999999999999 99999887


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       272 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      +..+....+.....                            ...+..++..+.++|.+||+.||.+|||+.+++++|+.
T Consensus       264 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          264 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             CHHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            76655554443210                            01223478999999999999999999999999999876


Q ss_pred             C
Q 018514          352 S  352 (354)
Q Consensus       352 ~  352 (354)
                      +
T Consensus       316 l  316 (334)
T 2pvf_A          316 I  316 (334)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.8e-46  Score=336.36  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=202.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .+|++.+.||+|+||.||+|++..+|+.||+|++...    .....+|+.+++.++||||+++++++.... ......++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            4799999999999999999999999999999988532    234558999999999999999999875432 34566889


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+.+ +|.+.+.........+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence            9999996 99998887665667899999999999999999999999 999999999999999887 79999999987643


Q ss_pred             cCCC----------ccccccccccccchhccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Q 018514          220 KGEP----------NISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGT  286 (354)
Q Consensus       220 ~~~~----------~~~~~g~~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~  286 (354)
                      ....          .....||+.|+|||++.+..  .++.++||||||+++|+|++|..||...... .........   
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---  262 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---  262 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence            2111          11345689999999986543  2688999999999999999999999531100 001111110   


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                    ....          .....+++.+.++|.+||+.||.+|||+.+++++|+..
T Consensus       263 --------------~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          263 --------------QLSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             --------------C--C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             --------------cCCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence                          0000          01234789999999999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=329.48  Aligned_cols=247  Identities=28%  Similarity=0.389  Sum_probs=200.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.+....  ....+|+.+++.++||||+++++++..     ....++||
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~  103 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIVM  103 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEEe
Confidence            47999999999999999999999999999999986543  445689999999999999999998843     33478999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+.+ +|.+++...   ...+++..++.++.||+.||.|||+. ||+|+||||+||+++.++ .+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence            99986 888877643   36799999999999999999999998 999999999999999887 7999999999766443


Q ss_pred             C-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      . ......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+...... .            
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~------------  244 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-T------------  244 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-C------------
T ss_pred             ccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-c------------
Confidence            2 233457899999999996654 899999999999999999999999887765554433321000 0            


Q ss_pred             ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                   ...+..++..+.++|.+||+.||.+|||+.++++|
T Consensus       245 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          245 -------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             -------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                         00123368999999999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.7e-46  Score=338.79  Aligned_cols=248  Identities=22%  Similarity=0.345  Sum_probs=195.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCce----EEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ..+|++.+.||+|+||+||+|++..+++.    ||+|.+...     .....+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence            35799999999999999999999877765    477776432     23456799999999999999999987431    


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                       . .++|++|+. |+|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        90 -~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Dfg  162 (327)
T 3poz_A           90 -T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             -S-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             -C-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCC-CEEEccCc
Confidence             1 567888888 5888887654   35789999999999999999999999 999999999999999887 79999999


Q ss_pred             CceecccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          214 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       214 ~a~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      ++.........   ....+|+.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......   
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---  238 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---  238 (327)
T ss_dssp             HHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred             ceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---
Confidence            99765433322   2344577899999997655 8999999999999999999 99999887765544433321100   


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                               ..+..++..+.+++.+||+.||.+|||+.+++++|+.
T Consensus       239 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~  275 (327)
T 3poz_A          239 -------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             -------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                                     0123468999999999999999999999999998864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.2e-46  Score=339.95  Aligned_cols=267  Identities=20%  Similarity=0.300  Sum_probs=204.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||+||+|.+ .+|+.||+|++....     ....+|+++++.++||||+++++++..     ....
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~  102 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTER  102 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----SSCC
T ss_pred             hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-----CCce
Confidence            45799999999999999999985 468899999986542     245689999999999999999998843     3346


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--GVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ++||||+.+ +|.+.+.........+++..++.++.|++.||+|||++.  ||+||||||+||+++.++ .+||+|||++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~  181 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA  181 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSC
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCccc
Confidence            899999986 899888876655667999999999999999999999853  899999999999999887 7999999999


Q ss_pred             eecccCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCCCH
Q 018514          216 KVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE----SGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       216 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~  289 (354)
                      ........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...    ...........       
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------  253 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-------  253 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-------
T ss_pred             cccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-------
Confidence            87643322  22345899999999996655 899999999999999999999999521    11011111111       


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                             ...................+....+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus       254 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          254 -------GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             -------TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             -------HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence                   00011111111111222222333457899999999999999999999999999753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7e-46  Score=336.02  Aligned_cols=256  Identities=20%  Similarity=0.268  Sum_probs=207.0

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecC
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  131 (354)
                      ....+|++.+.||+|+||.||+|.+.     .+++.||+|.+....     ....+|+.+++.++||||+++++++.   
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---   98 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---   98 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC---
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc---
Confidence            34568999999999999999999876     357889999986432     23457999999999999999999873   


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~  204 (354)
                        +....++||||+.+ +|.+++......      ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++
T Consensus        99 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 --QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC
T ss_pred             --cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCC
Confidence              33347899999985 998888764321      24678999999999999999999999 999999999999999887


Q ss_pred             CcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 018514          205 HQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (354)
Q Consensus       205 ~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  280 (354)
                       .+||+|||++........   .....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus       176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          176 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             -eEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence             799999999976543321   12345688899999996655 8999999999999999999 89999887766555544


Q ss_pred             HHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                      .....                            ...+..++..+.++|.+||+.||.+|||+.+++++|+..+
T Consensus       254 ~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          254 MEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            33100                            0112347899999999999999999999999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-45  Score=348.62  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=203.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ...+|++.+.||+|+||.||+|.+  .|+.||||++....  ....+|+.++++++||||+++++++....    ..+++
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~i  264 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI  264 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEE
Confidence            446799999999999999999998  47799999997543  34568999999999999999999875432    23789


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+.+ +|.+++....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus       265 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCC-CEEEeeCCCccccc
Confidence            9999985 9999887643  23478999999999999999999999 999999999999999887 79999999998543


Q ss_pred             cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..  .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.+...             
T Consensus       341 ~~--~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------------  404 (450)
T 1k9a_A          341 ST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------------  404 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-------------
T ss_pred             cc--ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence            22  22335688899999997655 8999999999999999998 9999988776665554433211             


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                     ...+..+++.+.++|.+||+.||.+|||+.++++.|++
T Consensus       405 ---------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          405 ---------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                           11234578999999999999999999999999998865

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.5e-46  Score=342.07  Aligned_cols=273  Identities=24%  Similarity=0.370  Sum_probs=201.0

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||+||+|.+..++..||+|++...     .....+|+.+++.++||||+++++++..     ....
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence            45799999999999999999999999999999998643     2344579999999999999999998843     3448


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+.+ +|.+.+...    ..+++..+..++.|++.||+|||+..||+||||||+||+++.++ .+||+|||++..
T Consensus       107 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  181 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred             EEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcc
Confidence            899999986 888888764    46899999999999999999999832899999999999999887 799999999875


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc--
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  295 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  295 (354)
                      .... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+...............  
T Consensus       182 ~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          182 LIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HHHH-C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             cccc-cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            5332 233467899999999996654 899999999999999999999999877654433222111111000000000  


Q ss_pred             -CCCCcccCCCCc------------cCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 -NPNYTEFKFPQI------------KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 -~~~~~~~~~~~~------------~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       ......+.....            ............++.++.+||++||+.||.+|||+.++++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence             000000000000            00000111123478999999999999999999999999997

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.4e-46  Score=338.39  Aligned_cols=254  Identities=21%  Similarity=0.305  Sum_probs=206.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCc-----eEEEEEcccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      ..+|++.+.||+|+||+||+|.+..++.     .||+|.+...     .....+|+.+++.+ +||||+++++++.    
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----  120 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT----  120 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe----
Confidence            4579999999999999999999876654     7999988643     23455899999999 8999999999873    


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKM----------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~  201 (354)
                       +....++||||+.+ +|.+.+......          ...+++..++.++.||+.||+|||++ ||+||||||+||+++
T Consensus       121 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          121 -HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT  198 (333)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEE
T ss_pred             -cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEEC
Confidence             33347899999985 999888765421          35689999999999999999999999 999999999999999


Q ss_pred             CCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 018514          202 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (354)
Q Consensus       202 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  277 (354)
                      .++ .+||+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+......+
T Consensus       199 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          199 NGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             GGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             CCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            887 799999999986544332   12345678899999987655 8999999999999999998 99999887665555


Q ss_pred             HHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       278 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ..+......+                           ..+...++.+.++|.+||+.||.+|||+.+++++|+..
T Consensus       277 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          277 YKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            5554431111                           11234689999999999999999999999999998753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-46  Score=356.94  Aligned_cols=253  Identities=20%  Similarity=0.327  Sum_probs=209.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ...+|++.+.||+|+||.||+|.+..++..||||.+...   .....+|+.++++++||||+++++++.     +...++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcEE
Confidence            445799999999999999999999888999999998654   344568999999999999999999883     333478


Q ss_pred             EEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+. |+|.+++....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus       293 lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENH-LVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGG-CEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCC-cEEEeecccceec
Confidence            9999998 58998887543  35689999999999999999999999 999999999999999887 7999999999865


Q ss_pred             ccCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          219 VKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       219 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .....  .....++..|+|||++.... ++.++|||||||++|||++ |..||.+.+..+....+....           
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----------  436 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-----------  436 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            43221  12334567899999996555 8999999999999999999 999998877665554443211           


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                       ....+..+++.+.+||.+||+.||.+|||+.++++.|+..+
T Consensus       437 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          437 -----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                             01123457899999999999999999999999999988754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.7e-46  Score=346.84  Aligned_cols=251  Identities=24%  Similarity=0.337  Sum_probs=193.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|++.+.||+|+||+||+|++.   .++..||||++...     .....+|+.++++++||||+++++++.     +
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~  117 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----K  117 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----e
Confidence            3457999999999999999999976   45778999998643     234557999999999999999999883     3


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ....++||||+. ++|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg  192 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNL-VCKVSDFG  192 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             CCceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCC-CEEECcCc
Confidence            344789999997 5888888653   35689999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          214 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       214 ~a~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      ++.........    ....+++.|+|||++.+.. ++.++|||||||++|||++ |..||...+..+....+......  
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~--  269 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL--  269 (373)
T ss_dssp             ---------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC--
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            99865433211    1223467899999996555 8999999999999999998 99999887766655544332111  


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                ..+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       270 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          270 --------------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             --------------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                                      11234689999999999999999999999999988653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.8e-45  Score=331.58  Aligned_cols=256  Identities=30%  Similarity=0.480  Sum_probs=194.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++..     .
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence            345799999999999999999999999999999988531       2334579999999999999999998844     3


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||+.+ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~-~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCC-CEEEEeccc
Confidence            348899999996 89888887666667899999999999999999999999 999999999999999887 799999999


Q ss_pred             ceecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHH
Q 018514          215 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       215 a~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  292 (354)
                      +........ .....|++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+... ...+........       
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  254 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-------  254 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-------
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-------
Confidence            876543322 23456899999999996654 89999999999999999999999976432 112222111100       


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                 .+.        .....++.++.++|.+||+.||.+|||+.+++++|+.+
T Consensus       255 -----------~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          255 -----------YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             -----------SCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------CCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                       000        01234789999999999999999999999999988653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.7e-46  Score=330.52  Aligned_cols=254  Identities=20%  Similarity=0.284  Sum_probs=193.2

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..++|++.+.||+|+||+||+|++.   ..+|+|++...      .....+|+.+++.++||||++++++. .     ..
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~-----~~   92 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T-----AP   92 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C-----SS
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c-----CC
Confidence            3457999999999999999999863   35999988532      23356799999999999999998854 1     12


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++||||+.+ +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  167 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDN-TVKIGDFGLA  167 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTT-EEEECCCC--
T ss_pred             ccEEEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCC-CEEEccceec
Confidence            26899999985 777777543   35689999999999999999999998 999999999999999887 8999999999


Q ss_pred             eecccC---CCccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          216 KVLVKG---EPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       216 ~~~~~~---~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      ......   .......||+.|+|||++..  ...++.++||||||+++|+|++|..||.+....+.+..+......++. 
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  246 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-  246 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-
Confidence            754321   12234568999999999852  334788999999999999999999999987777766665553211110 


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                            ...+...+++.+.++|.+||+.||.+|||+.++++.|+++.
T Consensus       247 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          247 ----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                                  01122357899999999999999999999999999988653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.2e-46  Score=336.46  Aligned_cols=267  Identities=24%  Similarity=0.324  Sum_probs=204.0

Q ss_pred             ccceEEEeEeeeccceEEEEEE----EcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..+|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+++++.++||||+++++++..   .+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence            3579999999999999999999    46788999999986442    335689999999999999999988753   344


Q ss_pred             eEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||++ ++|.+++....   ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  173 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEA-HVKIADFGL  173 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCGGG
T ss_pred             ceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCC-CEEEccccc
Confidence            56889999996 58888887643   4589999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +........    .....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||......... ........+...
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~  251 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALS  251 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHH
Confidence            987643332    22345788899999996655 799999999999999999999998653321110 000000000000


Q ss_pred             HH-hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          291 EI-KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       291 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                      .. ......             .....+..+++.+.++|.+||+.||.+|||+.+++++|+.++
T Consensus       252 ~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          252 RLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            00 000000             011123457899999999999999999999999999998764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7e-46  Score=326.98  Aligned_cols=249  Identities=19%  Similarity=0.319  Sum_probs=204.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+++++.++||||+++++++..     ....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEE
Confidence            357999999999999999999985 6778999998654   2445689999999999999999998733     334789


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ +|.+++...   ...+++..+..++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  155 (267)
T ss_dssp             EECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred             EEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCC-CEEEcccccccccc
Confidence            9999985 888888654   25689999999999999999999999 999999999999999877 79999999987553


Q ss_pred             cCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       220 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ...  ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+.....           
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-----------  223 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-----------  223 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred             cccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence            221  122345677899999996555 8999999999999999999 8999988776666555533210           


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                       ...+...+..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       224 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          224 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                             011234689999999999999999999999999998753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.4e-45  Score=334.65  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=181.8

Q ss_pred             ccccceEEEe-EeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           62 KQTISYMAER-VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        62 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ...++|.+.+ .||+|+||+||+|.+..+|+.||+|++........+....++.++||||+++++++.... .+..++++
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l  103 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI  103 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence            3456899965 699999999999999999999999999766555554555677889999999999875433 34667899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--CcEEEEeccCcee
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  217 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--~~vkl~Dfg~a~~  217 (354)
                      ||||+.+ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||++..
T Consensus       104 v~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            9999986 8888887543  25799999999999999999999999 999999999999997532  2599999999986


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||..................           
T Consensus       181 ~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  247 (336)
T 3fhr_A          181 TTQN-ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-----------  247 (336)
T ss_dssp             C-----------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred             cccc-ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-----------
Confidence            5432 233567899999999985554 889999999999999999999999765543321111111000           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        .....        .......+++++.+||.+||+.||.+|||+.++++|
T Consensus       248 --~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          248 --GQYGF--------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             -----CC--------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --ccccc--------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              00000        001123478999999999999999999999999987

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-45  Score=325.28  Aligned_cols=250  Identities=14%  Similarity=0.202  Sum_probs=203.3

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ...+|++.+.||+|+||+||+|++  ++..||+|++...      .....+|+.+++.++||||+++++++...   +..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~   82 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP   82 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence            345799999999999999999998  5889999998643      23355799999999999999999987432   124


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~--iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ..++||||+.+ +|.+.+....  ...+++..++.++.||+.||+|||++ |  |+||||||+||+++.++ .++|+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~-~~~l~~~~  158 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDM-TARISMAD  158 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTS-CEEEEGGG
T ss_pred             CeEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCc-ceeEEecc
Confidence            47899999985 9998887532  23689999999999999999999998 9  99999999999999887 79999998


Q ss_pred             CceecccCCCccccccccccccchhccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ++...    ......||+.|+|||.+.+...  ++.++|||||||++|+|++|..||.+.+.......+......     
T Consensus       159 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----  229 (271)
T 3kmu_A          159 VKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-----  229 (271)
T ss_dssp             SCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             ceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-----
Confidence            87543    2234568999999999976542  233799999999999999999999888776665555442111     


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                            ..++..+++.+.++|.+||+.||++|||+.++++.|+.+
T Consensus       230 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          230 ----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                                  112345789999999999999999999999999998754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.3e-46  Score=334.15  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=204.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEE-----cCCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      .++|++.+.||+|+||+||+|++     ..+++.||+|++....     ....+|+.+++.+ +||||+++++++...  
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence            45799999999999999999985     3467889999986532     2345799999999 689999999987432  


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCee
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nil  199 (354)
                        ...+++||||+.+ +|.+++......            ...+++..++.++.||+.||.|||++ ||+||||||+||+
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil  180 (316)
T 2xir_A          104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  180 (316)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEE
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEE
Confidence              2337899999985 898888764321            22388999999999999999999999 9999999999999


Q ss_pred             eeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 018514          200 VNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (354)
Q Consensus       200 i~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  275 (354)
                      ++.++ .+||+|||++........   .....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.....
T Consensus       181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99877 799999999976543322   12345688999999997655 8999999999999999998 999998876554


Q ss_pred             HHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .+.........+                           ..+..+++.+.++|.+||+.||.+|||+.+++++|+.+
T Consensus       259 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          259 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            444333321110                           12234789999999999999999999999999999764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=342.86  Aligned_cols=260  Identities=12%  Similarity=0.109  Sum_probs=201.6

Q ss_pred             cceEEEeEeeeccceEEEEEEEcC--------CCceEEEEEcccchhhhHHHHHHHHHcCCCCeeec-------------
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLE--------TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------------  123 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~-------------  123 (354)
                      ++|++.+.||+|+||.||+|++..        .++.||+|.+... ....+|+++++.++||||+++             
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            479999999999999999999987        4889999998755 456689999999999999984             


Q ss_pred             --ceeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee
Q 018514          124 --KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (354)
Q Consensus       124 --~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~  201 (354)
                        ++++..    +....++||||++++|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++
T Consensus       121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEE
T ss_pred             chhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEc
Confidence              333321    234588999999779999988642  35799999999999999999999999 999999999999999


Q ss_pred             CCCC-cEEEEeccCceecccCCC--------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 018514          202 PHTH-QLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (354)
Q Consensus       202 ~~~~-~vkl~Dfg~a~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  272 (354)
                      .++. .+||+|||++........        .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            7651 699999999976543221        13347899999999996654 8999999999999999999999998754


Q ss_pred             -cHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          273 -GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       273 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                       ....+......+......                ....   ......+++++.++|.+||+.||++|||+.++++.|+.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~----------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGP----------------FVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCC----------------EECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cCHHHHHHHHHhccCChhh----------------hhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence             333333333321111100                0000   00112478999999999999999999999999998865


Q ss_pred             C
Q 018514          352 S  352 (354)
Q Consensus       352 ~  352 (354)
                      +
T Consensus       334 ~  334 (352)
T 2jii_A          334 L  334 (352)
T ss_dssp             H
T ss_pred             H
Confidence            4

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-45  Score=331.06  Aligned_cols=265  Identities=23%  Similarity=0.365  Sum_probs=200.9

Q ss_pred             cceEEEeEeeeccceEEEEEE----EcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..|++.+.||+|+||.||+|+    +..+++.||+|++....     ....+|+.+++.++||||+++++++...   +.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            469999999999999999999    56788999999986432     3456899999999999999999987542   22


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+++||||+.+ +|.+.+....   ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~  172 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFGL  172 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCC-CEEECcccc
Confidence            447899999985 8888886543   5689999999999999999999999 999999999999999887 899999999


Q ss_pred             ceecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +........    .....+|..|+|||.+.+.. ++.++||||||+++|+|++|..|+...     ........+.....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~  246 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQ  246 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGG
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCcccc
Confidence            987654432    22456788899999996655 789999999999999999999886422     11111111111111


Q ss_pred             HH-hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          291 EI-KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       291 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .. .......         ........+..+++.+.++|.+||+.||.+|||+.++++.|+.+
T Consensus       247 ~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          247 MTVTRLVNTL---------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             GHHHHHHHHH---------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCHHHHHHHH---------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            00 0000000         00001112345789999999999999999999999999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=334.93  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=197.0

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCC----ceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ..+|++.+.||+|+||+||+|.+..++    ..||+|.+...     .....+|+.+++.++||||+++++++     .+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SK  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ec
Confidence            347999999999999999999986553    35999998643     22345799999999999999999987     33


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ....++||||+.+ +|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg  192 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDFG  192 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCC
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCC-cEEECCCC
Confidence            4448899999986 888887653   35789999999999999999999999 999999999999999887 79999999


Q ss_pred             CceecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          214 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       214 ~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      ++........    .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......  
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~--  269 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL--  269 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--
T ss_pred             cchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC--
Confidence            9976543321    12234577899999997655 8999999999999999998 99999887766655554332111  


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                ..+..++..+.++|.+||+.||.+||++.+++++|+.+
T Consensus       270 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          270 --------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             --------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                                      01234789999999999999999999999999988653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.3e-45  Score=328.58  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=200.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++...    .....+|+.+++.++||||+++++++..     ....
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeE
Confidence            345799999999999999999999999999999988543    2345579999999999999999998843     3348


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+++ +|...+...   ...+++..++.++.||+.||.|||++ |++||||||+||+++.++ .+||+|||++..
T Consensus        92 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  166 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAK  166 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTS-CEEECCCHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCC-CEEEEECCCCcc
Confidence            999999986 676666543   35699999999999999999999998 999999999999999887 799999998754


Q ss_pred             cccC-CCccccccccccccchhcc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          218 LVKG-EPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       218 ~~~~-~~~~~~~g~~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      .... .......||+.|+|||.+.    ....++.++||||||+++|+|++|..||...+.......+.......     
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----  241 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-----  241 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-----
Confidence            3211 1223457899999999984    34448899999999999999999999999887766665554421100     


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                           ...+..++..+.++|.+||+.||.+|||+.++++|
T Consensus       242 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          242 ---------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ---------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ---------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                                 01123468999999999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-45  Score=349.91  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=206.3

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ...+|++.+.||+|+||+||+|.+. ++..||||++...   .....+|+.+++.++||||+++++++.      ...++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCccE
Confidence            4567999999999999999999985 4678999998653   344568999999999999999998763      11268


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|.+++.....  ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus       259 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTC-CEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCC-cEEEeeCCCceEc
Confidence            99999985 89988875432  3578889999999999999999999 999999999999999887 7999999999765


Q ss_pred             ccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          219 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       219 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ....  ......++..|+|||++.... ++.++|||||||++|||++ |..||.+.+..+....+......+        
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------  405 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP--------  405 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--------
T ss_pred             CCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            3221  112334577899999996555 8999999999999999999 999999888777666665432111        


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                          .+..+++++.++|.+||+.||.+|||+.++++.|++.+
T Consensus       406 --------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          406 --------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             --------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                                12347899999999999999999999999999988754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=330.15  Aligned_cols=248  Identities=27%  Similarity=0.394  Sum_probs=191.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ..+|++.+.||+|+||+||+|++  .++.||+|++....  ....+|+.++++++||||+++++++.     +.  .++|
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence            35799999999999999999997  57889999986543  34568999999999999999988763     22  5789


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---cCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN---TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      |||+.+ +|.+.+..... ...++...+..++.|++.||+|||+   + ||+||||||+||+++.++..+||+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            999985 88888875321 2357888999999999999999999   7 9999999999999998875589999999975


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ....  .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||................+.           
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------  221 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-----------  221 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC-----------
T ss_pred             cccc--cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC-----------
Confidence            5332  23456899999999996654 899999999999999999999999764432211111110000           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                     ...+...++..+.+++.+||+.||.+|||+.+++++|+.
T Consensus       222 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  260 (307)
T 2eva_A          222 ---------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH  260 (307)
T ss_dssp             ---------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence                           001234578999999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.1e-45  Score=328.31  Aligned_cols=248  Identities=21%  Similarity=0.271  Sum_probs=200.5

Q ss_pred             cceEEEe-EeeeccceEEEEEEE--cCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAER-VVGHGSFGVVFQAKC--LETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|.+.+ .||+|+||+||+|.+  ..+++.||+|++...      .....+|+.+++.++||||+++++++ ..     
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~-----   89 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA-----   89 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES-----
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC-----
Confidence            4799998 999999999999954  556789999998643      23455799999999999999999987 21     


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||+.+ +|.+++...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~  163 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGL  163 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCC-cEEEccCCc
Confidence            126899999984 888888753    5689999999999999999999999 999999999999999887 899999999


Q ss_pred             ceecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +.........    ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.... .   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~---  238 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-R---  238 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C---
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C---
Confidence            9876443321    2234568899999996555 7899999999999999999 999998877655544433210 0   


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                              ..++..+++.+.++|.+||+.||.+|||+.++++.|++.|
T Consensus       239 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          239 ------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                                    0123457899999999999999999999999999987643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.3e-46  Score=335.01  Aligned_cols=260  Identities=26%  Similarity=0.370  Sum_probs=189.2

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ...+|++.+.||+|+||+||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++..     ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   87 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KDE   87 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SSC
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cCC
Confidence            3457999999999999999999998899999999885432     234478899999999999999998843     234


Q ss_pred             EEEEEeeccc-cHHHHHHhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEec
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYK----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      .++||||+.+ +|.+.+.....    ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~df  165 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDG-SVQIADF  165 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCC-CEEEEec
Confidence            7899999975 88888875322    235689999999999999999999998 999999999999999887 7999999


Q ss_pred             cCceecccCC------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 018514          213 GSAKVLVKGE------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  286 (354)
Q Consensus       213 g~a~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  286 (354)
                      |++.......      ......||+.|+|||++.+...++.++||||||+++|+|++|..||...+..............
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  245 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP  245 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence            9987553321      1234568999999999865445899999999999999999999999887766554433221110


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...                   ...-.......++.++.++|.+||+.||.+|||+.++++|
T Consensus       246 ~~~-------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          246 SLE-------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CTT-------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccc-------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            000                   0000111234578999999999999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=327.17  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=202.3

Q ss_pred             ccceEEEe-EeeeccceEEEEEEEc--CCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAER-VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .++|.+.+ .||+|+||+||+|.+.  .++..||+|++...     .....+|+++++.++||||+++++++ ..   + 
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~---~-   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA---E-   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES---S-
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC---C-
Confidence            34687777 9999999999999864  46778999998653     23345799999999999999999987 21   1 


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                       ..++||||+.+ +|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        83 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg~  156 (287)
T 1u59_A           83 -ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFGL  156 (287)
T ss_dssp             -SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -CcEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCC-CEEECcccc
Confidence             27899999996 888777543   35689999999999999999999999 999999999999999887 899999999


Q ss_pred             ceecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +........    .....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+.....    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~----  231 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----  231 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc----
Confidence            987643322    12334578899999996555 8999999999999999998 9999988777665554433110    


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                              ..++..+++.+.++|.+||+.||.+|||+.+++++|+.+
T Consensus       232 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          232 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                                    012345789999999999999999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=334.47  Aligned_cols=248  Identities=22%  Similarity=0.339  Sum_probs=195.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceE----EEEEccc-----chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAV----AIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|++.+.||+|+||+||+|.+..+++.+    |+|.+..     ......+|+.+++.++||||+++++++...     
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----   89 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   89 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-----
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-----
Confidence            47999999999999999999998888765    6665532     233456799999999999999999987432     


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      . .++|++|+.+ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kL~DfG~  163 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFGL  163 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCTTC
T ss_pred             C-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCC-CEEEccCcc
Confidence            1 5678888884 888887764   35789999999999999999999999 999999999999999887 799999999


Q ss_pred             ceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +........   .....+|+.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......    
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~----  238 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----  238 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            986543322   22344577899999997655 8999999999999999999 99999887766554444331100    


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                              ..+..++.++.++|.+||+.||.+|||+.++++.|+.+
T Consensus       239 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          239 ------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                                    11234789999999999999999999999999988653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-44  Score=324.95  Aligned_cols=252  Identities=26%  Similarity=0.360  Sum_probs=195.0

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecC--------C
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTT--------E  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~  132 (354)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++....   ....+|+.+++.++||||+++++++....        .
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            457999999999999999999999999999999986543   33457999999999999999999875532        1


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEe
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                      ......++||||+.+ +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCC-CEEEee
Confidence            346678999999985 998888753   24578889999999999999999999 999999999999999887 799999


Q ss_pred             ccCceecccC---------------CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH-
Q 018514          212 FGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD-  275 (354)
Q Consensus       212 fg~a~~~~~~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-  275 (354)
                      ||++......               .......||+.|+|||++.+...++.++|||||||++|+|++   ||....... 
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9999765321               122345689999999999766568999999999999999998   554322222 


Q ss_pred             HHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ....+....                         ..+...+....+..+.++|.+||+.||.+|||+.++++|
T Consensus       237 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          237 ILKKLRSVS-------------------------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHSTT-------------------------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHhccccc-------------------------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            222211100                         011112334578899999999999999999999999997

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-45  Score=350.50  Aligned_cols=257  Identities=21%  Similarity=0.242  Sum_probs=204.2

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ...++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+++++.++|++.+..+..+..    ...+.+
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~   79 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV   79 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence            3446899999999999999999999999999999987533  3346689999999998665555444432    233578


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee---eCCCCcEEEEeccCce
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAK  216 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili---~~~~~~vkl~Dfg~a~  216 (354)
                      +||||+.++|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+|||+   +.++ .+||+|||++.
T Consensus        80 lvme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~  154 (483)
T 3sv0_A           80 LVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK  154 (483)
T ss_dssp             EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTT-CEEECCCTTCE
T ss_pred             EEEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCC-eEEEEeCCcce
Confidence            99999988999988754   35799999999999999999999998 99999999999999   4555 79999999998


Q ss_pred             ecccCCCc--------cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhC
Q 018514          217 VLVKGEPN--------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---DQLVEIIKVLG  285 (354)
Q Consensus       217 ~~~~~~~~--------~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~  285 (354)
                      ........        ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....   ..+..+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            76543321        2567899999999997665 899999999999999999999999875542   22333322211


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .....                        .+...++.++.++|..||+.||.+||++.++++.|+.+
T Consensus       234 ~~~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          234 ATSIE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HSCHH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cccHH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11111                        12234789999999999999999999999999988764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.9e-45  Score=328.40  Aligned_cols=251  Identities=21%  Similarity=0.325  Sum_probs=198.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCC---ceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..+|++.+.||+|+||+||+|.+..++   ..+|+|.+....     ....+|+.++++++||||+++++++...    .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence            347999999999999999999975433   358999875422     3345799999999999999999976432    2


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...++||||+.+ +|.+.+...   ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~  174 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKF-TVKVADFGL  174 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred             CceEEEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCC-CEEECcccc
Confidence            346899999996 888888653   35689999999999999999999999 999999999999999887 799999999


Q ss_pred             ceecccCC-----CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          215 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       215 a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      +.......     ......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |.+||...+..+....+......  
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--  251 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--  251 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC--
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC--
Confidence            97653322     123445678899999996655 8999999999999999999 66778776655554444332110  


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                ..+..++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       252 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          252 --------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                                      11234789999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.2e-45  Score=347.76  Aligned_cols=251  Identities=24%  Similarity=0.317  Sum_probs=201.7

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++...   .....+|+.+++.++||||+++++++..      ...+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence            44679999999999999999999864 467999998653   2445689999999999999999988632      2268


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|.+++....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus       255 iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCC-CEEECCCccceec
Confidence            99999985 8998887533  25689999999999999999999998 999999999999999877 7999999999865


Q ss_pred             ccCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          219 VKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       219 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .....  .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+......         
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------  400 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------  400 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             CCCceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            43221  22344678899999997555 8999999999999999999 99999988776666555432111         


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                         ..+..+++.+.++|.+||+.||.+|||+.++++.|++.+
T Consensus       401 -------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          401 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             -------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                               122347899999999999999999999999999988754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4e-45  Score=324.37  Aligned_cols=250  Identities=22%  Similarity=0.300  Sum_probs=203.7

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ...+|++.+.||+|+||+||+|.+. ++..||+|.+...   .....+|+++++.++||||+++++++..     . ..+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~-~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-PIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-SCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----C-CcE
Confidence            3457999999999999999999974 5678999998653   3445689999999999999999987631     1 268


Q ss_pred             EEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+. ++|.+.+.....  ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARLI  159 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence            9999997 588888765321  3689999999999999999999998 999999999999999887 7999999999876


Q ss_pred             ccCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          219 VKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       219 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .....  .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.....          
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------  228 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------  228 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             cCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----------
Confidence            44321  22345677899999996554 7899999999999999999 9999988777665555433210          


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                        ...+..+++.+.+++.+||+.||++|||+.++++.|++.
T Consensus       229 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence                              112235789999999999999999999999999988764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=327.06  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=183.4

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++....      ....++..+++.++||||+++++++.     +..
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~   97 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNT   97 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCC
Confidence            4568999999999999999999999999999999986432      11223445678889999999999883     344


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++||||+++.+.......   ...+++..++.++.||+.||.|||+ . ||+||||||+||+++.++ .+||+|||++
T Consensus        98 ~~~lv~e~~~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg~~  172 (318)
T 2dyl_A           98 DVFIAMELMGTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERG-QIKLCDFGIS  172 (318)
T ss_dssp             EEEEEECCCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH-CCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             cEEEEEeccCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC-CEEeCCCCHHHEEECCCC-CEEEEECCCc
Confidence            58999999966655554432   3678999999999999999999998 6 999999999999999887 7999999999


Q ss_pred             eecccCCCccccccccccccchhcc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHH
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~  290 (354)
                      .............+++.|+|||++.    ....++.++||||||+++|+|++|..||.... ..+.+..+......    
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----  248 (318)
T 2dyl_A          173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP----  248 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC----
T ss_pred             hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC----
Confidence            7765554455567899999999985    23447899999999999999999999998744 33444444332100    


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     ..       .....+++++.++|.+||+.||.+|||+.++++|
T Consensus       249 ---------------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          249 ---------------LL-------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ---------------CC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ---------------CC-------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                           00       0112478999999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.9e-45  Score=326.41  Aligned_cols=249  Identities=20%  Similarity=0.320  Sum_probs=197.7

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ....+|++.+.||+|+||+||+|.+  +|+.||+|++....  +...+|+.+++.++||||+++++++...    ....+
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~   91 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY   91 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceE
Confidence            3456899999999999999999987  58899999987543  3456899999999999999999976432    23478


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|.+.+.....  ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~  167 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  167 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC----
T ss_pred             EEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCC-cEEEeeccccccc
Confidence            99999986 99888876432  3478899999999999999999998 999999999999999887 7999999998755


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+...              
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~--------------  230 (278)
T 1byg_A          168 SST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------  230 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------------
T ss_pred             ccc--ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--------------
Confidence            332  22345688899999996554 8999999999999999998 99999877655544443221              


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                    +....+..+++.+.++|.+||+.||.+|||+.++++.|+.
T Consensus       231 --------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          231 --------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             --------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence                          0111234578999999999999999999999999998865

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-45  Score=325.80  Aligned_cols=252  Identities=22%  Similarity=0.325  Sum_probs=199.0

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCc---eEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ....|.+.+.||+|+||+||+|.+..++.   .+|+|.+....     ....+|+.+++.++||||+++++++....   
T Consensus        19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   95 (298)
T 3pls_A           19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---   95 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS---
T ss_pred             cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC---
Confidence            33468899999999999999999765544   79999886422     33457999999999999999999874322   


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                       ...++||||+. ++|.+.+...   ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        96 -~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~-~~kl~Dfg  169 (298)
T 3pls_A           96 -GLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESF-TVKVADFG  169 (298)
T ss_dssp             -SCCEEEECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECCTT
T ss_pred             -CCcEEEEecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEeCcCC
Confidence             22478999997 5888887653   36789999999999999999999999 999999999999999887 79999999


Q ss_pred             CceecccC-----CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCC
Q 018514          214 SAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTP  287 (354)
Q Consensus       214 ~a~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~  287 (354)
                      ++......     .......+++.|+|||.+.+.. ++.++||||||+++|+|++| .+||...+..+....+...... 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-  247 (298)
T 3pls_A          170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-  247 (298)
T ss_dssp             SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-
T ss_pred             CcccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-
Confidence            99754332     1223456788999999996555 89999999999999999995 4556555554444433331100 


Q ss_pred             CHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                 ..+..+++.+.+++.+||+.||.+|||+.++++.|+..
T Consensus       248 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          248 ---------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                                       11234789999999999999999999999999988753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.2e-45  Score=330.64  Aligned_cols=256  Identities=23%  Similarity=0.350  Sum_probs=179.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHH-HHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|+. +++.++||||+++++++.     ....
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence            357999999999999999999999999999999986432     12223444 667789999999999884     3345


Q ss_pred             EEEEEeeccccHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++||||+.+++.+.+..... ....+++..+..++.|++.||.|||++.||+||||||+||+++.++ .+||+|||++.
T Consensus        96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~  174 (327)
T 3aln_A           96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISG  174 (327)
T ss_dssp             EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSC
T ss_pred             eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCce
Confidence            889999999998888875332 2467899999999999999999999844999999999999999887 89999999998


Q ss_pred             ecccCCCccccccccccccchhcc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          217 VLVKGEPNISYICSRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ............||+.|+|||++.   ....++.++|||||||++|+|++|..||...+....  .+..           
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~-----------  241 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQ-----------  241 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CC-----------
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHH-----------
Confidence            765544444557899999999983   233489999999999999999999999976432110  0000           


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       ..    ....+     .+.......+++.+.++|.+||+.||.+|||+.++++|
T Consensus       242 -~~----~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          242 -VV----KGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -CC----CSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -Hh----cCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence             00    00000     11111224578999999999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=323.79  Aligned_cols=249  Identities=26%  Similarity=0.433  Sum_probs=195.5

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      |.....||+|+||.||+|.+..++..||+|.+...    .....+|+.+++.++||||+++++++..     ....++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEE
Confidence            44445899999999999999999999999988543    2345679999999999999999998843     34588999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+.+ +|.+.+.... ....+++..++.++.||+.||.|||++ ||+|+||||+||+++...+.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           99 EQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             ECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             EeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            99974 8888776532 234567889999999999999999998 99999999999999973348999999999866432


Q ss_pred             C-CccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          222 E-PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       222 ~-~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      . ......|++.|+|||++.+. ..++.++||||||+++|+|++|..||.................              
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------  242 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--------------  242 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--------------
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--------------
Confidence            2 23345789999999998643 2378899999999999999999999976544332211111100              


Q ss_pred             cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                  +...++..+++++.++|.+||+.||++|||+.++++|
T Consensus       243 ------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          243 ------------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ------------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                        0111334578999999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=340.23  Aligned_cols=252  Identities=20%  Similarity=0.313  Sum_probs=192.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCC---ceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ....|.+.+.||+|+||+||+|.+..++   ..||+|.+...     .....+|+.+++.++||||++++++++..    
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----  162 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----  162 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----
Confidence            3346999999999999999999975432   46899988542     23445799999999999999999976432    


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ....++||||+.+ +|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DFG  237 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFG  237 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             CCCeEEEEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCC-CEEEeecc
Confidence            2236799999985 888888653   25688999999999999999999999 999999999999999887 79999999


Q ss_pred             CceecccCCC-----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 018514          214 SAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  287 (354)
Q Consensus       214 ~a~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  287 (354)
                      ++........     .....+|+.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+.....  
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~--  314 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--  314 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--
Confidence            9976533221     22345678899999997555 8999999999999999999 7788887665554444332100  


Q ss_pred             CHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                ...+..++..+.++|.+||+.||.+|||+.+++++|+..
T Consensus       315 --------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          315 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                                      011234789999999999999999999999999998754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.5e-45  Score=332.28  Aligned_cols=254  Identities=19%  Similarity=0.237  Sum_probs=198.7

Q ss_pred             cccceEEEeEeeeccceEEEEEE-----EcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ...+|++.+.||+|+||.||+|+     +..++..||+|.+...     .....+|+.+++.++||||+++++++..   
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC---
Confidence            44589999999999999999999     4567889999998532     2334579999999999999999998733   


Q ss_pred             CCeeEEEEEEeecc-ccHHHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC--Cc
Q 018514          133 KDELYLNLVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQ  206 (354)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~--~~  206 (354)
                        ....++||||+. ++|.+++......   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..
T Consensus       105 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 --SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCC
T ss_pred             --CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcce
Confidence              334689999996 5999888765422   24589999999999999999999998 999999999999998432  26


Q ss_pred             EEEEeccCceecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 018514          207 LKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (354)
Q Consensus       207 vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  282 (354)
                      +||+|||++.......   ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            9999999987543322   223456788999999996655 8999999999999999998 9999988776555544433


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ...                            ...+..++..+.++|.+||+.||.+|||+.+++++|+.
T Consensus       261 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          261 GGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            110                            01223478999999999999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.2e-45  Score=335.23  Aligned_cols=264  Identities=20%  Similarity=0.348  Sum_probs=202.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---------------------hhhHHHHHHHHHcCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------------------RYKNRELQTMRLLDHPNVV  121 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~e~~~l~~l~h~~iv  121 (354)
                      ..++|++.+.||+|+||.||+|.+  +|+.||+|++....                     ....+|+.+++.++||||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            345799999999999999999998  89999999985432                     4566899999999999999


Q ss_pred             ecceeeeecCCCCeeEEEEEEeeccc-cHHHH------HHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCC
Q 018514          122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRV------IKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDI  193 (354)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~------l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~iiH~Dl  193 (354)
                      ++++++.     +....++||||+.+ +|.++      +...  ....+++..++.++.||+.||.|||+ + ||+||||
T Consensus       107 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl  178 (348)
T 2pml_X          107 TCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDV  178 (348)
T ss_dssp             CCSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCC
T ss_pred             eEEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCC
Confidence            9999883     34468999999996 77665      3221  14679999999999999999999999 8 9999999


Q ss_pred             CCCCeeeeCCCCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCC
Q 018514          194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA-AIDIWSAGCVLAELLLGQPLFPGES  272 (354)
Q Consensus       194 kp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~  272 (354)
                      ||+||+++.++ .+||+|||++...... ......|++.|+|||++.+...++. ++||||||+++|+|++|..||...+
T Consensus       179 ~p~Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          179 KPSNILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             CGGGEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ChHhEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999887 7999999999876443 3345678999999999976644555 9999999999999999999998876


Q ss_pred             c-HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          273 G-VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       273 ~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      . .+....+.......+...        ..+..+ .... -.......+++++.++|.+||+.||.+|||+.++++|
T Consensus       257 ~~~~~~~~i~~~~~~~~~~~--------~~~~~~-~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          257 SLVELFNNIRTKNIEYPLDR--------NHFLYP-LTNK-KSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             CSHHHHHHHTSCCCCCCCSS--------SSSTTT-TCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cHHHHHHHHhccCcCCccch--------hhhhcc-cccc-ccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            6 444444322111100000        000000 0000 0011224588999999999999999999999999997

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.6e-45  Score=331.31  Aligned_cols=240  Identities=26%  Similarity=0.406  Sum_probs=198.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----------hhhHHHHHHHHHcC--CCCeeecceeeeec
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFST  130 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~  130 (354)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++....          ....+|+.+++.++  |+||+++++++   
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~---  117 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---  117 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE---
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE---
Confidence            3457999999999999999999999999999999986432          23457999999996  59999999988   


Q ss_pred             CCCCeeEEEEEEeecc--ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEE
Q 018514          131 TEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vk  208 (354)
                        .+....++|||++.  ++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.+.+.+|
T Consensus       118 --~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          118 --ERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             --ECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEE
T ss_pred             --ecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEE
Confidence              34445889999997  6888888763    5789999999999999999999998 9999999999999994434899


Q ss_pred             EEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      |+|||++...... ......||+.|+|||++.+...++.++||||||+++|+|++|..||...+.      +...     
T Consensus       191 L~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~-----  258 (320)
T 3a99_A          191 LIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-----  258 (320)
T ss_dssp             ECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-----
T ss_pred             EeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc-----
Confidence            9999999876433 334567899999999997666557899999999999999999999965321      1110     


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                              ...+...+++++.++|.+||+.||.+|||+.++++|
T Consensus       259 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          259 ------------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                    001234578999999999999999999999999997

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.3e-45  Score=329.41  Aligned_cols=260  Identities=22%  Similarity=0.282  Sum_probs=199.3

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      |...+.||+|+||+||+|.+  +++.||+|++...        .....+|+.+++.++||||+++++++.     +....
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEe-----cCCce
Confidence            55568999999999999986  6889999988532        234558999999999999999999873     33347


Q ss_pred             EEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++||||+. ++|.+.+.... ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~  182 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDEAF-TAKISDFGLARA  182 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence            89999997 58888876533 245789999999999999999999998 999999999999999887 799999999986


Q ss_pred             cccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          218 LVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       218 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ......   .....||+.|+|||.+.+ . ++.++||||||+++|+|++|..||........+..+..............
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRG-E-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTT-E-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             cccccccccccccCCCcCcCChHHhcC-C-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence            543222   223568999999999854 3 78999999999999999999999987655443333333221111100000


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ....        .      .......+..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       261 ~~~~--------~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          261 IDKK--------M------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             SCSS--------C------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cccc--------c------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            0000        0      001122457899999999999999999999999998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=335.45  Aligned_cols=276  Identities=21%  Similarity=0.309  Sum_probs=195.9

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-hhHHH--HHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-YKNRE--LQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~e--~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ..++|++.+.||+|+||+||+|++  +++.||||++..... ....|  +..+..++||||+++++.+......+...++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            345799999999999999999987  789999999864432 22233  3344558999999998876665556677789


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CceecCCCCCCeeeeCCCCcEEEE
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--------GVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--------~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                      +||||+++ +|.+++..     ...++..++.++.||+.||+|||+..        ||+||||||+|||++.++ .+||+
T Consensus        89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~  162 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVIS  162 (336)
T ss_dssp             EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEEC
T ss_pred             EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEe
Confidence            99999975 89888865     34588899999999999999999742        899999999999999887 79999


Q ss_pred             eccCceecccCC---------CccccccccccccchhccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCC-CCcH
Q 018514          211 DFGSAKVLVKGE---------PNISYICSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGV  274 (354)
Q Consensus       211 Dfg~a~~~~~~~---------~~~~~~g~~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~  274 (354)
                      |||++.......         ......||+.|+|||++.+.      ..++.++|||||||++|||++|..||.. ....
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998664321         12245689999999999653      2356789999999999999999766533 2211


Q ss_pred             HHHHHHHH-HhCCCCHHHHhccC-CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          275 DQLVEIIK-VLGTPTREEIKCMN-PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       275 ~~~~~i~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .....+.. ....+....+.... .......++.    .|..  ...+++.+.++|.+||+.||++|||+.|+++.|+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----cccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            11111111 11122222211110 0000000110    0100  112456899999999999999999999999988764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.1e-45  Score=350.57  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=205.5

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++...   .....+|+++|+.++||||+++++++..      ..++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence            44579999999999999999999864 467999998653   2456689999999999999999988632      2268


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||+.+ +|.+++....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus       338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCC-cEEEcccccceec
Confidence            99999985 8988887533  24689999999999999999999998 999999999999999877 7999999999765


Q ss_pred             ccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          219 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       219 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ....  ......++..|+|||++.... ++.++|||||||++|||++ |..||.+....+.+..+......         
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------  483 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------  483 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             CCCceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            3221  112334577899999997554 8999999999999999999 99999988776666555432111         


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcCC
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF  353 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~~  353 (354)
                                         ..+..++..+.+||.+||+.||.+|||+.++++.|++.+
T Consensus       484 -------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          484 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                               122357899999999999999999999999999988764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-44  Score=322.76  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=193.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcC-CCc--eEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLE-TGE--AVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      .+|++.+.||+|+||+||+|++.. ++.  .||+|++...       .....+|+.+++.++||||+++++++...    
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   93 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   93 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence            479999999999999999998643 333  6899988542       23345799999999999999999987431    


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                       . .++||||+. ++|.+.+....   ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        94 -~-~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Dfg  166 (291)
T 1u46_A           94 -P-MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDFG  166 (291)
T ss_dssp             -S-CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             -C-ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCC-CEEEcccc
Confidence             1 679999998 58888887643   4689999999999999999999999 999999999999999887 79999999


Q ss_pred             CceecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          214 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       214 ~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      ++........    .....+|..|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+....+......+ 
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-  244 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-  244 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC-
Confidence            9987644332    12345677899999996655 7899999999999999999 999998887766555543321000 


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                ..+..++..+.++|.+||+.||.+|||+.+++++|+++
T Consensus       245 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          245 --------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence                                      11234789999999999999999999999999998754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-43  Score=319.52  Aligned_cols=244  Identities=23%  Similarity=0.323  Sum_probs=191.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcC--CCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLD--HPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .+|++.+.||+|+||.||+|.+. +++.||+|++...      .....+|+.+++.++  ||||+++++++     .+..
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~~  101 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ  101 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE-----ECSS
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe-----ecCC
Confidence            47999999999999999999975 5889999998532      133457999999997  59999999987     3344


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      ..++|||+.+++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++. + .+||+|||++.
T Consensus       102 ~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~~  174 (313)
T 3cek_A          102 YIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-G-MLKLIDFGIAN  174 (313)
T ss_dssp             EEEEEECCCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-T-EEEECCCSSSC
T ss_pred             EEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-C-eEEEeeccccc
Confidence            58999998888999988763    5789999999999999999999999 9999999999999974 4 79999999997


Q ss_pred             ecccCCC---ccccccccccccchhccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHH
Q 018514          217 VLVKGEP---NISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIK  282 (354)
Q Consensus       217 ~~~~~~~---~~~~~g~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~  282 (354)
                      .......   .....|++.|+|||.+.+.          ..++.++||||||+++|+|++|..||...... ..+..+..
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  254 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence            6543322   2245689999999998642          34788999999999999999999999765432 22222211


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .                           .....++...+.++.++|.+||+.||.+|||+.++++|
T Consensus       255 ~---------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          255 P---------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             T---------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             c---------------------------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            0                           00111233467899999999999999999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.5e-45  Score=328.53  Aligned_cols=258  Identities=25%  Similarity=0.358  Sum_probs=196.5

Q ss_pred             eEEEeEeeeccceEEEEEEE----cCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           67 YMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      |++.+.||+|+||+||++.+    ..+++.||+|++....     ....+|+++++.++||||+++++++...   +...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence            49999999999999988764    3578899999986542     3356899999999999999999987542   2345


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++||||+.+ +|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDR-LVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCC-CEEECCccccc
Confidence            8899999985 88887764     4589999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH-
Q 018514          217 VLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE-  291 (354)
Q Consensus       217 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-  291 (354)
                      .......    .....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.......     ........... 
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~  256 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQMT  256 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccchh
Confidence            7654432    22345788899999997655 7899999999999999999999986532110     00000000000 


Q ss_pred             ---HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          292 ---IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       292 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                         +.....            .......+..+++++.++|++||+.||.+|||+.++++.|+.+
T Consensus       257 ~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          257 VLRLTELLE------------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHHHHHHHH------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHh------------cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence               000000            0000112345789999999999999999999999999988753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-44  Score=326.38  Aligned_cols=258  Identities=20%  Similarity=0.298  Sum_probs=191.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh-hhHHHHHHHHH--cCCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-YKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .++|++.+.||+|+||.||+|++  +|+.||||++..... ...+|.+++..  ++||||+++++++..... .....++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~l  112 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYL  112 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEE
Confidence            45799999999999999999998  488999999865432 23345555554  489999999998755432 2356899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CceecCCCCCCeeeeCCCCcEEEEec
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-------~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      ||||+.+ +|.+++..     ..+++..++.++.|++.||+|||++.       ||+||||||+||+++.++ .+||+||
T Consensus       113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  186 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  186 (337)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence            9999986 99888864     46899999999999999999999742       899999999999999887 7999999


Q ss_pred             cCceecccCCCc-----cccccccccccchhccCCCCCCCc------hhHHHHHHHHHHHHhC----------CCCCCCC
Q 018514          213 GSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTAA------IDIWSAGCVLAELLLG----------QPLFPGE  271 (354)
Q Consensus       213 g~a~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~------~DiwslG~il~ell~g----------~~pf~~~  271 (354)
                      |++.........     ....||+.|+|||++.+.. +...      +|||||||++|||++|          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999765433222     2457899999999996654 3443      9999999999999999          6666543


Q ss_pred             Cc----HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          272 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       272 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                      ..    .............         ..     ..+       .......+++++.++|.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~---------~~-----~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKKL---------RP-----SFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSCC---------CC-----CCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCchhhhHHHHhhhcc---------Cc-----ccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            21    1111111110000         00     000       00011235678999999999999999999999999


Q ss_pred             ccCcC
Q 018514          348 SFDSS  352 (354)
Q Consensus       348 ~l~~~  352 (354)
                      +|+.+
T Consensus       325 ~L~~l  329 (337)
T 3mdy_A          325 TLAKM  329 (337)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98753

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=352.60  Aligned_cols=248  Identities=24%  Similarity=0.299  Sum_probs=198.8

Q ss_pred             cceEEEe-EeeeccceEEEEEEEcC--CCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAER-VVGHGSFGVVFQAKCLE--TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .++.+.+ .||+|+||+||+|.+..  ++..||||++...     .....+|+++++.++||||+++++++..      .
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------S
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------C
Confidence            3466666 89999999999998753  4567999998653     2345689999999999999999998732      1


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++||||+.+ +|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~-~vkL~DFGla  483 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRH-YAKISDFGLS  483 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCSTT
T ss_pred             CeEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCC-cEEEeeccCc
Confidence            27899999985 788777543   35689999999999999999999999 999999999999999887 8999999999


Q ss_pred             eecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       216 ~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      .........    ....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.....     
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-----  557 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  557 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            765332211    1233467899999996554 8999999999999999998 9999998887776655544211     


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                             ..++..+++++.++|.+||+.||.+|||+.++++.|++.
T Consensus       558 -----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          558 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                                   012345789999999999999999999999999988764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=332.29  Aligned_cols=247  Identities=15%  Similarity=0.134  Sum_probs=192.4

Q ss_pred             ccceEEEeEeeeccceEEEEEE-----EcCCCceEEEEEcccch-hhhHHHHHHHHHcC---CCCeeecceeeeecCCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQDK-RYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~  134 (354)
                      ..+|++.+.||+|+||+||+|.     +..+++.||+|++.... ....+|+.+++.+.   |+||+++++++...    
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~----  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ----  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS----
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC----
Confidence            3579999999999999999994     56789999999986543 34557888888887   89999999988433    


Q ss_pred             eeEEEEEEeecc-ccHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC----------
Q 018514          135 ELYLNLVLEYVP-ETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP----------  202 (354)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~----------  202 (354)
                       ...++||||+. |+|.+++..... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.          
T Consensus       140 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          140 -NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             -SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC-----
T ss_pred             -CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCcccccc
Confidence             33789999998 599998876443 246799999999999999999999998 9999999999999987          


Q ss_pred             -CCCcEEEEeccCceeccc---CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 018514          203 -HTHQLKLCDFGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (354)
Q Consensus       203 -~~~~vkl~Dfg~a~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  278 (354)
                       ++ .+||+|||+|.....   ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......   
T Consensus       218 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          218 LSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             -CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence             55 799999999976532   22234567899999999997665 8999999999999999999999995432100   


Q ss_pred             HHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-CHHHHhhccCc
Q 018514          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-TAFDAVGSFDS  351 (354)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-ta~e~l~~l~~  351 (354)
                                             ..........       ..++.+.+++..||+.+|.+|+ ++.++.+.|++
T Consensus       293 -----------------------~~~~~~~~~~-------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          293 -----------------------CKPEGLFRRL-------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             -----------------------EEECSCCTTC-------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             -----------------------eeechhcccc-------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                                   0000000000       1367899999999999999995 56666555543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=324.44  Aligned_cols=239  Identities=28%  Similarity=0.432  Sum_probs=192.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----------hhhHHHHHHHHHc----CCCCeeecceeee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLL----DHPNVVSLKHCFF  128 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l----~h~~iv~~~~~~~  128 (354)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....          ....+|+.+++++    +||||+++++++ 
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~-  107 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF-  107 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE-
Confidence            3457999999999999999999999999999999985432          2334699999998    899999999987 


Q ss_pred             ecCCCCeeEEEEEEee-cc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeee-CCCC
Q 018514          129 STTEKDELYLNLVLEY-VP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-PHTH  205 (354)
Q Consensus       129 ~~~~~~~~~~~iv~e~-~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~-~~~~  205 (354)
                          .+....++|||| +. ++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++ .++ 
T Consensus       108 ----~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~-  177 (312)
T 2iwi_A          108 ----ETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRG-  177 (312)
T ss_dssp             ---------CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTT-
T ss_pred             ----ecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCC-
Confidence                334457899998 55 5888888763    5689999999999999999999999 999999999999999 455 


Q ss_pred             cEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 018514          206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  285 (354)
Q Consensus       206 ~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  285 (354)
                      .+||+|||++...... ......|++.|+|||++.+....+.++||||||+++|+|++|+.||....      .+...  
T Consensus       178 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~--  248 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--  248 (312)
T ss_dssp             EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT--
T ss_pred             eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh--
Confidence            8999999999876443 33456789999999998766544668999999999999999999996531      11110  


Q ss_pred             CCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     .            ..++..++..+.++|.+||+.||++|||+.++++|
T Consensus       249 ---------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          249 ---------------E------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ---------------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---------------c------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                           0            01234578999999999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.4e-44  Score=352.07  Aligned_cols=245  Identities=22%  Similarity=0.277  Sum_probs=196.6

Q ss_pred             eEEE-eEeeeccceEEEEEEE--cCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           67 YMAE-RVVGHGSFGVVFQAKC--LETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        67 y~~~-~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      +.+. +.||+|+||+||+|.+  ..+++.||||+++...      ....+|+.+++.++||||+++++++.     +. .
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~-~  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-S  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS-S
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC-C
Confidence            4443 4899999999999965  4567889999986432      34558999999999999999999772     11 1


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++||||+.+ +|.+++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~-~~kL~DFGla~  517 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSK  517 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred             EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence            6799999985 88888864    35789999999999999999999998 999999999999999887 89999999997


Q ss_pred             ecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          217 VLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       217 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .......    .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+......     
T Consensus       518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-----  591 (635)
T 4fl3_A          518 ALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-----  591 (635)
T ss_dssp             HTTC-------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred             ccccCccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            6543321    22334578899999996555 8999999999999999998 99999988876665555442111     


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                             ..+..+++++.++|.+||+.||++|||+.++++.|++.
T Consensus       592 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          592 -----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                   12345789999999999999999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=323.91  Aligned_cols=262  Identities=26%  Similarity=0.414  Sum_probs=199.9

Q ss_pred             cccceEEEeEeeeccceEEEEEE----EcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ...+|++.+.||+|+||.||+|+    +..+|+.||+|++....    ....+|+.+++.++||||+++++++...   +
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~  115 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G  115 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---C
Confidence            34579999999999999999998    45678999999986432    3456899999999999999999887432   2


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+++||||+.+ +|.+.+....   ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kL~Dfg  190 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDFG  190 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             CCceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCC-cEEEecCc
Confidence            2347899999985 8888887642   5689999999999999999999998 999999999999999887 89999999


Q ss_pred             CceecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          214 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       214 ~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      ++........    .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||....  ..   ..+..+....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~--~~---~~~~~~~~~~  264 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP--AE---FMRMIGNDKQ  264 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH--HH---HHHHHCTTCC
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH--HH---HHHhhccccc
Confidence            9987644332    12345677899999997655 7899999999999999999999885421  11   1111111110


Q ss_pred             HH------HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          290 EE------IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       290 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ..      .......             .....+..++.++.++|.+||+.||.+|||+.++++.|+.
T Consensus       265 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          265 GQMIVFHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             THHHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhhHHHHHHHhhcC-------------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            00      0000000             0001234578999999999999999999999999998865

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.1e-44  Score=335.75  Aligned_cols=252  Identities=27%  Similarity=0.399  Sum_probs=186.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      .|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++     .+..++++|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEEe
Confidence            57788999999999998754 4579999999986543 3456799999876 899999998887     44556899999


Q ss_pred             eccccHHHHHHhhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC------------CCcEE
Q 018514          144 YVPETVHRVIKHHYKMSQR---MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH------------THQLK  208 (354)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~------------~~~vk  208 (354)
                      ||+|+|.+.+.........   .++..++.++.||+.||+|||++ ||+||||||+|||++.+            ...+|
T Consensus        90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            9999999998764332211   12334678999999999999998 99999999999999753            23799


Q ss_pred             EEeccCceecccCCC-----ccccccccccccchhccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 018514          209 LCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  276 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~-----~~~~~g~~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  276 (354)
                      |+|||++........     .....||+.|+|||++.+      ...++.++|||||||++|+|++ |..||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            999999987654322     124578999999999965      2458999999999999999999 999997654332 


Q ss_pred             HHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          277 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                       ..+......                 .+...     ......+++++.++|.+||+.||.+|||+.++++|
T Consensus       248 -~~i~~~~~~-----------------~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 -SNIIRGIFS-----------------LDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             -HHHHHTCCC-----------------CCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHhcCCCC-----------------ccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence             222221100                 01100     00112356899999999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=337.27  Aligned_cols=247  Identities=24%  Similarity=0.363  Sum_probs=185.2

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCeeEEEEEEe
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~iv~e  143 (354)
                      +|.+.+.||+|+||+||.. ...+|+.||||++... .....+|+.+++.+ +||||+++++++     .+..+.++|||
T Consensus        25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~E   98 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEEE
T ss_pred             EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEEE
Confidence            6999999999999986543 3458899999998643 23456899999999 799999999887     34455899999


Q ss_pred             eccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC----CcEEEEeccCceecc
Q 018514          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCDFGSAKVLV  219 (354)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~----~~vkl~Dfg~a~~~~  219 (354)
                      ||+|+|.+.+....   ..++...++.++.||+.||+|||++ ||+||||||+|||++.++    ..+||+|||++....
T Consensus        99 ~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCAATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCSEEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCCCCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            99999999887643   3344445678999999999999999 999999999999995321    258899999998764


Q ss_pred             cCC----CccccccccccccchhccC--CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 018514          220 KGE----PNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (354)
Q Consensus       220 ~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (354)
                      ...    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||......... .+.   +....   
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~---~~~~~---  247 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILL---GACSL---  247 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHT---TCCCC---
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHh---ccCCc---
Confidence            432    2234678999999999964  3346889999999999999999 89999654432221 111   10000   


Q ss_pred             hccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                  ...       ......+..+.+||.+||+.||.+|||+.++++|
T Consensus       248 ------------~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          248 ------------DCL-------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ------------TTS-------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ------------ccc-------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                        000       0011235678999999999999999999999987

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1e-43  Score=324.45  Aligned_cols=257  Identities=20%  Similarity=0.247  Sum_probs=197.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-hhhHHHHHHHHH--cCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|++.+.||+|+||+||+|++  +|+.||+|++.... ....+|.++++.  ++||||+++++++.... ......++|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence            5799999999999999999998  68999999986543 344578888887  78999999999875433 122358899


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCceecCCCCCCeeeeCCCCcEEEEec
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--------NTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--------~~~~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      |||+.+ +|.+.+..     ..+++..++.++.|++.||+|||        +. ||+||||||+||+++.++ .+||+||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~-~~kL~Df  191 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNG-TCCIADL  191 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTS-CEEECCC
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCC-CEEEEEC
Confidence            999996 89888864     46899999999999999999999        77 999999999999999887 7999999


Q ss_pred             cCceecccCCC-----ccccccccccccchhccCCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 018514          213 GSAKVLVKGEP-----NISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLG----------QPLFPGES  272 (354)
Q Consensus       213 g~a~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~-----~~~~~DiwslG~il~ell~g----------~~pf~~~~  272 (354)
                      |++........     .....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99987654432     234578999999999965532     23689999999999999999          77886543


Q ss_pred             c----HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          273 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       273 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .    ...+.........                 .+.+. ..|   .....+..+.++|.+||+.||.+|||+.+++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~-----------------~~~~~-~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKL-----------------RPNIP-NRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCC-----------------CCCCC-GGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHh-----------------CCCCc-ccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            2    1222221110000                 00000 000   011245689999999999999999999999999


Q ss_pred             cCcC
Q 018514          349 FDSS  352 (354)
Q Consensus       349 l~~~  352 (354)
                      |+.+
T Consensus       331 L~~i  334 (342)
T 1b6c_B          331 LSQL  334 (342)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8753

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=324.83  Aligned_cols=249  Identities=18%  Similarity=0.240  Sum_probs=196.6

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ...+|++.+.||+|+||.||+|.+..   .+|+|++...      .....+|+.+++.++||||+++++++..     ..
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~  102 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PP  102 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----SS
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence            34579999999999999999999743   4999988543      1334579999999999999999998843     33


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++||||+.+ +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++ ++ .+||+|||++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~  176 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NG-KVVITDFGLF  176 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC----CCEECCCSCC
T ss_pred             ceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CC-CEEEeecCCc
Confidence            48899999985 887777543   24689999999999999999999999 999999999999998 44 7999999998


Q ss_pred             eeccc------CCCccccccccccccchhccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 018514          216 KVLVK------GEPNISYICSRYYRAPELIFG--------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (354)
Q Consensus       216 ~~~~~------~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  281 (354)
                      .....      ........|++.|+|||++.+        ...++.++||||||+++|+|++|..||...+.......+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            65421      112234468899999999864        2347889999999999999999999998877665554443


Q ss_pred             HHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .....                   .        .....++.++.++|.+||+.||.+|||+.++++.|+.+
T Consensus       257 ~~~~~-------------------~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l  300 (319)
T 2y4i_B          257 TGMKP-------------------N--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL  300 (319)
T ss_dssp             TTCCC-------------------C--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred             cCCCC-------------------C--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            32100                   0        01124688999999999999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.4e-43  Score=348.86  Aligned_cols=251  Identities=26%  Similarity=0.367  Sum_probs=202.8

Q ss_pred             ccccceEEEeEeeeccceEEEEEEEcCC---CceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           62 KQTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      ....+|++.+.||+|+||+||+|.+..+   +..||+|.+....     ....+|+.+++.++||||+++++++..    
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----  462 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----  462 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            3456899999999999999999998654   4579999876432     344579999999999999999998621    


Q ss_pred             CeeEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEec
Q 018514          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      +  ..++||||+. |+|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus       463 ~--~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~-~vkL~DF  535 (656)
T 2j0j_A          463 N--PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDF  535 (656)
T ss_dssp             S--SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred             C--ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCC-CEEEEec
Confidence            1  2689999999 5888888653   24689999999999999999999999 999999999999999887 8999999


Q ss_pred             cCceecccCCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          213 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       213 g~a~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      |++........  .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+......   
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---  611 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---  611 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            99986543322  12345578899999996554 8999999999999999997 99999988877766666542111   


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                               .++..+++.+.++|.+||+.||.+|||+.++++.|+..
T Consensus       612 -------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          612 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                                     12335789999999999999999999999999998754

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-43  Score=331.24  Aligned_cols=246  Identities=18%  Similarity=0.181  Sum_probs=185.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCC-CCeeecc---------ee-
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDH-PNVVSLK---------HC-  126 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h-~~iv~~~---------~~-  126 (354)
                      ..|+..+.||+|+||+||+|++..+|+.||||++...       .....+|+.+++.++| +|...+.         .. 
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3699999999999999999999999999999988632       2334578888888877 3221111         11 


Q ss_pred             -----------eeecCCCCeeEEEEEEeeccccHHHHHHhh---hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 018514          127 -----------FFSTTEKDELYLNLVLEYVPETVHRVIKHH---YKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD  192 (354)
Q Consensus       127 -----------~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~D  192 (354)
                                 +..........++++|+++.++|.+++...   ......+++..+..++.||+.||+|||++ ||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCC
Confidence                       000000012236788999999998888633   22234577888999999999999999998 999999


Q ss_pred             CCCCCeeeeCCCCcEEEEeccCceecccCCCccccccccccccchhcc---------CCCCCCCchhHHHHHHHHHHHHh
Q 018514          193 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF---------GATEYTAAIDIWSAGCVLAELLL  263 (354)
Q Consensus       193 lkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~---------~~~~~~~~~DiwslG~il~ell~  263 (354)
                      |||+|||++.++ .+||+|||++......  .....| +.|+|||++.         ....++.++|||||||++|+|++
T Consensus       237 iKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          237 LRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999988 6999999998765433  334566 9999999983         33347889999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH
Q 018514          264 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF  343 (354)
Q Consensus       264 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~  343 (354)
                      |+.||...+.......+                       +.          ....+++.+.+||.+||+.||.+|||+.
T Consensus       313 g~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             SSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999765432111000                       00          0124789999999999999999999999


Q ss_pred             HHhhc
Q 018514          344 DAVGS  348 (354)
Q Consensus       344 e~l~~  348 (354)
                      ++++|
T Consensus       360 ~~l~~  364 (413)
T 3dzo_A          360 QAMET  364 (413)
T ss_dssp             HHTTS
T ss_pred             HHHhC
Confidence            99886

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-43  Score=344.93  Aligned_cols=276  Identities=25%  Similarity=0.330  Sum_probs=199.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecC-CCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT-EKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  138 (354)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++...     .....+|+++++.++||||+++++++.... .......
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            5799999999999999999999999999999988643     233457999999999999999988763311 1123446


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC--cEEEEeccCc
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSA  215 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~--~vkl~Dfg~a  215 (354)
                      ++||||+.| +|.+++.... ....+++..++.++.|++.||+|||+. ||+||||||+||+++.++.  .+||+|||++
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            899999975 8888877532 234688899999999999999999998 9999999999999987652  3899999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      .............||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.........   .............
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~---~i~~~~~~~~~~~  247 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG---KVREKSNEHIVVY  247 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST---TCC------CCSC
T ss_pred             cccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh---hhhcccchhhhhh
Confidence            8776665556678999999999996554 89999999999999999999999977543321110   0000000000000


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ........+..  ..++...+...+++.+.++|.+||++||.+|||+.++++|
T Consensus       248 ~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h  298 (676)
T 3qa8_A          248 DDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV  298 (676)
T ss_dssp             CCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred             hhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence            00000111111  1112223344577899999999999999999999998766

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.4e-42  Score=306.55  Aligned_cols=237  Identities=25%  Similarity=0.346  Sum_probs=183.1

Q ss_pred             cccceEEE-eEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHH-HHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           63 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        63 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.... .+..++++
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l   92 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI   92 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEE
Confidence            44578887 7899999999999999999999999998654 3455788887 6669999999999874422 34667899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC---CCCcEEEEeccCce
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAK  216 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~---~~~~vkl~Dfg~a~  216 (354)
                      ||||+.+ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+|||++.
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~  168 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK  168 (299)
T ss_dssp             EECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred             EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCC-cEEEecccccc
Confidence            9999985 9988887643  24699999999999999999999998 9999999999999987   44 79999999986


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ...                      ...++.++|||||||++|+|++|..||.+.+.......+               .
T Consensus       169 ~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---------------~  211 (299)
T 3m2w_A          169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------------K  211 (299)
T ss_dssp             ECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---------------C
T ss_pred             ccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---------------H
Confidence            432                      123688999999999999999999999765432211000               0


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .   ....   ....+.......+++++.++|.+||+.||.+|||+.++++|
T Consensus       212 ~---~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          212 T---RIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             C---SSCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             H---HHhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0   0000   00011111124578999999999999999999999999997

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.2e-41  Score=300.44  Aligned_cols=226  Identities=15%  Similarity=0.065  Sum_probs=177.7

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++..     .
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  103 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----R  103 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----C
Confidence            3457999999999999999999999899999999986432       345679999999999999999998843     3


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ...|+||||+.| +|.+++..     . .....+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+++| 
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g-~~kl~~~~-  174 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDG-DVVLAYPA-  174 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTS-CEEECSCC-
T ss_pred             CcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCC-CEEEEecc-
Confidence            458999999985 88887743     2 35567888999999999999999 999999999999999887 79987443 


Q ss_pred             ceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                                        |++|        ++.++|||||||++|+|++|+.||.+.+....+....             
T Consensus       175 ------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-------------  215 (286)
T 3uqc_A          175 ------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------------  215 (286)
T ss_dssp             ------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-------------
T ss_pred             ------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-------------
Confidence                              3333        6889999999999999999999998755322110000             


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                              .... ........+...+++++.++|.+||+.||.+| |+.++++.|+.
T Consensus       216 --------~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~  262 (286)
T 3uqc_A          216 --------RDTA-GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ  262 (286)
T ss_dssp             --------BCTT-SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred             --------HHhc-cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence                    0000 00000112334589999999999999999999 99999998864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-41  Score=335.35  Aligned_cols=235  Identities=25%  Similarity=0.366  Sum_probs=187.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcC-CCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .++|++.+.||+|+||+||+|.+.. +|+.||||++...     .....+|+.+++.++||||+++++++......+...
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4689999999999999999999976 7899999988532     123457999999999999999999987665545556


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .|+||||++| +|.+.+.      ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+  .+||+|||++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~--~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE--QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC--cEEEEecccch
Confidence            7999999996 6655443      3689999999999999999999999 99999999999999874  69999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+.....                     
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------------  283 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------------  283 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------------
T ss_pred             hcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc---------------------
Confidence            76433   455789999999998654  4889999999999999999998886421100                     


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                             .+.  ..     .....++.+.++|.+||+.||.+||++.+.+.
T Consensus       284 -------~~~--~~-----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  320 (681)
T 2pzi_A          284 -------LPE--DD-----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS  320 (681)
T ss_dssp             -------CCT--TC-----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             -------ccc--cc-----cccccCHHHHHHHhhhccCChhhCCCHHHHHH
Confidence                   000  00     00114688999999999999999997555544

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.8e-42  Score=314.39  Aligned_cols=243  Identities=17%  Similarity=0.153  Sum_probs=178.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------------hhhHHHHHHHHHcC---------CCCeeec
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLD---------HPNVVSL  123 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~---------h~~iv~~  123 (354)
                      ++|++.+.||+|+||+||+|++  +|+.||||++....            ....+|+.+++.++         ||||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999998  78999999986542            44568999998886         6666665


Q ss_pred             ceeeeecC-------------------------CCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHH
Q 018514          124 KHCFFSTT-------------------------EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR  177 (354)
Q Consensus       124 ~~~~~~~~-------------------------~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~  177 (354)
                      .+++....                         ..+...+++||||+.+ ++.+.+..     ..+++..++.++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            55432110                         0014458999999975 45554432     56899999999999999


Q ss_pred             HHHHHH-hcCCceecCCCCCCeeeeCCC-------------------CcEEEEeccCceecccCCCccccccccccccch
Q 018514          178 ALAYIH-NTIGVCHRDIKPQNLLVNPHT-------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE  237 (354)
Q Consensus       178 ~l~~LH-~~~~iiH~Dlkp~Nili~~~~-------------------~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE  237 (354)
                      ||+||| ++ ||+||||||+|||++.++                   ..+||+|||+|+.....    ...||+.|+|||
T Consensus       173 aL~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE  247 (336)
T 2vuw_A          173 SLAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred             HHHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence            999999 88 999999999999998764                   26999999999866432    457899999999


Q ss_pred             hccCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccc
Q 018514          238 LIFGATEYTAAIDIWSAGCV-LAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  315 (354)
Q Consensus       238 ~~~~~~~~~~~~DiwslG~i-l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (354)
                      ++.+..  +.++|||||+++ .+++++|..||.+..... ....+......                  ...    ....
T Consensus       248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~~----~~~~  303 (336)
T 2vuw_A          248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF------------------KTK----CNTP  303 (336)
T ss_dssp             GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC------------------SSC----CCSH
T ss_pred             hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc------------------Ccc----cchh
Confidence            997554  889999998777 777888999984321101 11111111000                  000    0011


Q ss_pred             cCCCCCHHHHHHHHHhcCcCCCCCCCHHHHh-hc
Q 018514          316 FQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV-GS  348 (354)
Q Consensus       316 ~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l-~~  348 (354)
                      ....+++++.+||++||++|     ||.|+| +|
T Consensus       304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            12346889999999999987     999999 77

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=9.2e-33  Score=267.31  Aligned_cols=178  Identities=17%  Similarity=0.090  Sum_probs=124.6

Q ss_pred             EeeeccceEEEEEEEcCCCceEEEEEcccc--------------hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCee
Q 018514           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ..+.|++|.+..++....|+.+|+|.+...              .+.+.+|+++|+++ .|+||+++++++     ++..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            467778888888777778999999998532              12345799999999 699999999988     5666


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..||||||++| +|.+.+...    .++++.   .|+.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg-~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQ-HARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCC-CEEEeecccC
Confidence            69999999997 888888764    556654   5789999999999999 999999999999999888 7999999999


Q ss_pred             eecccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCC
Q 018514          216 KVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  265 (354)
Q Consensus       216 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  265 (354)
                      +..... ....+.+||+.|||||++.+.  +..++|+||+|++++++.++.
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             eeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence            866443 234467899999999999653  577899999999988765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2e-28  Score=235.74  Aligned_cols=178  Identities=17%  Similarity=0.250  Sum_probs=132.9

Q ss_pred             EEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        68 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ...+.||+|+||+||+|..  .+..+++|+....            .+...+|++++++++||||+++..++....   .
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD---N  413 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT---T
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC---c
Confidence            4466899999999999954  6778999975321            122468999999999999996544443322   2


Q ss_pred             eEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                        .++||||++ ++|.+.+..            +..++.|++.||.|||++ ||+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC---eEEEEECcc
Confidence              489999998 588777654            457899999999999999 9999999999999997   699999999


Q ss_pred             ceecccCCC--------ccccccccccccchhccCC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 018514          215 AKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLF  268 (354)
Q Consensus       215 a~~~~~~~~--------~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf  268 (354)
                      ++.......        .....||+.|||||++... ..|+..+|+||..+-..+.+-++.+|
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            987644322        1256789999999999541 23677889999998888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.6e-25  Score=198.26  Aligned_cols=138  Identities=16%  Similarity=0.193  Sum_probs=109.7

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----------------------hhhhHHHHHHHHHcCCCCeeecc
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------------------KRYKNRELQTMRLLDHPNVVSLK  124 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------------------~~~~~~e~~~l~~l~h~~iv~~~  124 (354)
                      |.+.+.||+|+||.||+|.+ .+|+.||+|.++..                      .....+|+.+++.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            55669999999999999999 88999999998532                      223458999999999  5 6666


Q ss_pred             eeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC
Q 018514          125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (354)
Q Consensus       125 ~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~  203 (354)
                      +++..      ...++||||++| +|.+ +.          ......++.|++.||.|||++ ||+||||||+|||++ +
T Consensus       168 ~~~~~------~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          168 KVYAW------EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             CEEEE------ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-T
T ss_pred             eEEec------cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-C
Confidence            65421      225899999986 6655 31          123457899999999999998 999999999999999 6


Q ss_pred             CCcEEEEeccCceecccCCCccccccccccccchhcc
Q 018514          204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF  240 (354)
Q Consensus       204 ~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~  240 (354)
                      + .+||+|||+|..            +..++|||.+.
T Consensus       229 ~-~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 E-GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             T-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             C-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            6 899999999963            33478999873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=5.2e-22  Score=173.56  Aligned_cols=135  Identities=17%  Similarity=0.255  Sum_probs=102.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCce--EEEEEcccch----------------------------hhhHHHHHHHHHc
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQDK----------------------------RYKNRELQTMRLL  115 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~----------------------------~~~~~e~~~l~~l  115 (354)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||+++...                            ....+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            388999999999999999998778988  9999864321                            1345799999999


Q ss_pred             CCCCeeecceeeeecCCCCeeEEEEEEeeccc------cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCc
Q 018514          116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE------TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-NTIGV  188 (354)
Q Consensus       116 ~h~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~------~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~~i  188 (354)
                      .|+++.-. ..+..      ...++||||+++      .|.+....       .++..+..++.|++.+|.||| +. ||
T Consensus       128 ~~~~i~~p-~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~-gi  192 (258)
T 1zth_A          128 KEAGVSVP-QPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA-EL  192 (258)
T ss_dssp             HHTTCCCC-CEEEE------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS-CE
T ss_pred             HhCCCCCC-eEEEc------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC-CE
Confidence            88764221 11111      114799999953      44443221       123457789999999999999 88 99


Q ss_pred             eecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       189 iH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +||||||+|||++.   .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            99999999999987   5999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=1.8e-18  Score=157.38  Aligned_cols=133  Identities=14%  Similarity=0.177  Sum_probs=93.0

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchh--------------------------hhHHHHHHHHHcCCCCe
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------------------------YKNRELQTMRLLDHPNV  120 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~e~~~l~~l~h~~i  120 (354)
                      |++.+.||.|+||.||+|.+ .+|+.||||+++....                          ...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            99999999999999999997 4799999998642100                          01235566666644333


Q ss_pred             eecceeeeecCCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCee
Q 018514          121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (354)
Q Consensus       121 v~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nil  199 (354)
                      .-. ..+.. . .    .+|||||++| .+...          .....+..++.||+.+|.+||+. |||||||||.|||
T Consensus       176 ~vp-~p~~~-~-~----~~LVME~i~G~~L~~l----------~~~~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NIL  237 (397)
T 4gyi_A          176 PVP-EPIAQ-S-R----HTIVMSLVDALPMRQV----------SSVPDPASLYADLIALILRLAKH-GLIHGDFNEFNIL  237 (397)
T ss_dssp             SCC-CEEEE-E-T----TEEEEECCSCEEGGGC----------CCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEE
T ss_pred             CCC-eeeec-c-C----ceEEEEecCCccHhhh----------cccHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEE
Confidence            211 11100 0 1    3689999997 43211          11123567889999999999998 9999999999999


Q ss_pred             eeCCCC---------cEEEEeccCceec
Q 018514          200 VNPHTH---------QLKLCDFGSAKVL  218 (354)
Q Consensus       200 i~~~~~---------~vkl~Dfg~a~~~  218 (354)
                      ++.++.         .+.|+||+.+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            986652         2899999988654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=1e-12  Score=114.58  Aligned_cols=133  Identities=15%  Similarity=0.106  Sum_probs=100.5

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEccc----chhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .|++...++.|+.+.||++..  .+..+++|....    ......+|+.+++.+. +..+++++++..     +....++
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence            588999999999999999975  467899998864    2345678999999985 566777777653     2234789


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-----------------------------------  184 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-----------------------------------  184 (354)
                      ||||++| ++...+.         +......++.++..+|+.||+                                   
T Consensus        88 v~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999998 5443310         111234677899999999998                                   


Q ss_pred             ------------------------cCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          185 ------------------------TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       185 ------------------------~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                                              . .++|+|++|.||+++.+. .+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~-~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEEL-VFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCE-EEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCc-eEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                    3 589999999999998643 56799999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=3.7e-11  Score=104.32  Aligned_cols=133  Identities=16%  Similarity=0.071  Sum_probs=89.7

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-hhhhHHHHHHHHHcCCCC--eeecceeeeecCCCCeeEEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      .|.+....+.|..+.||++.. .+|..+++|..... .....+|+.+++.+.+.+  +++++++..     +....++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEEEE
Confidence            466655445666799999964 56778999987554 234568999999886544  444655542     222368999


Q ss_pred             eeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 018514          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI------------------------------------  186 (354)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~------------------------------------  186 (354)
                      ||++|.... .       ....   ...++.+++..|..||+..                                    
T Consensus        95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999983222 1       1111   1245667777777777641                                    


Q ss_pred             ---------------------CceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          187 ---------------------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       187 ---------------------~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                                           .++|+|++|.||+++.++ .+.|+|||.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                                 299999999999998654 56699999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=6.2e-11  Score=108.18  Aligned_cols=140  Identities=16%  Similarity=0.193  Sum_probs=98.7

Q ss_pred             EEeEeeeccceEEEEEEEcCCCceEEEEEcc--cc-----hhhhHHHHHHHHHcCC--CCeeecceeeeecCCCCeeEEE
Q 018514           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVL--QD-----KRYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        69 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~-----~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ..+.|+.|.++.||++..  .+..+++|+..  ..     .....+|..+++.+..  ..+++++..+.....  ....+
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeE
Confidence            356789999999999985  34678899876  32     2355689999999974  446666665422211  12357


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT----------------------------------  185 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----------------------------------  185 (354)
                      +||||++|....   .  .....++......++.+++..|+.||+.                                  
T Consensus       118 ~vme~v~G~~l~---~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          118 YIMEFVSGRVLW---D--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEEECCCCBCCC---C--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEEecCCeecC---C--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            899999984210   0  1123467778888999999999999971                                  


Q ss_pred             -----------------------CCceecCCCCCCeeeeCCCC-cEEEEeccCcee
Q 018514          186 -----------------------IGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  217 (354)
Q Consensus       186 -----------------------~~iiH~Dlkp~Nili~~~~~-~vkl~Dfg~a~~  217 (354)
                                             ..++|+|++|.||+++.++. .+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                   36999999999999987653 368999999874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=6.2e-11  Score=105.62  Aligned_cols=187  Identities=12%  Similarity=0.154  Sum_probs=112.0

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCCeeecceeeeecC-CCCeeEEEEEEeeccc
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTT-EKDELYLNLVLEYVPE  147 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~iv~e~~~~  147 (354)
                      +.++.|....||++.     ..+++|.....  .....+|..+++.+.+..-+.+...+.... .......|+||++++|
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458999999999873     46899986544  345668999998884322121222221111 1111234789999998


Q ss_pred             -cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 018514          148 -TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-----------------------------------------  185 (354)
Q Consensus       148 -~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------------------------------------  185 (354)
                       .+.....      ..++......++.|++..|+.||+.                                         
T Consensus       101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence             4432221      2356666677777777777777751                                         


Q ss_pred             ----------------CCceecCCCCCCeeeeCC-CCcEEEEeccCceecccCCCccccccccccccchhcc----CCCC
Q 018514          186 ----------------IGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF----GATE  244 (354)
Q Consensus       186 ----------------~~iiH~Dlkp~Nili~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~  244 (354)
                                      ..++|+|++|.||+++.+ +..+.|+||+.+.................-..|+...    ....
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                            147999999999999974 4367899999986532211100000000002222210    0000


Q ss_pred             ---------CCCchhHHHHHHHHHHHHhCCCCC
Q 018514          245 ---------YTAAIDIWSAGCVLAELLLGQPLF  268 (354)
Q Consensus       245 ---------~~~~~DiwslG~il~ell~g~~pf  268 (354)
                               .....+.|+++.++|.+.+|..+|
T Consensus       255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                     112368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.69  E-value=3.5e-07  Score=81.26  Aligned_cols=134  Identities=15%  Similarity=0.065  Sum_probs=81.3

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCC---eeecceeeeecCCCCeeEEEEEEee
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPN---VVSLKHCFFSTTEKDELYLNLVLEY  144 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~iv~e~  144 (354)
                      .+.++.|....||+.     |..+++|+-...  .....+|..+|+.+.+..   +++.+.+..  .  .....++||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEec
Confidence            355788998899988     467889985432  234568999999997532   333333321  1  11224699999


Q ss_pred             ccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 018514          145 VPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT--------------------------------------  185 (354)
Q Consensus       145 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------------------------------------  185 (354)
                      ++| .+.....      ..++......++.++...|+.||+.                                      
T Consensus        95 i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           95 VQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             CCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             cCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            998 4433111      1122333333333333333333321                                      


Q ss_pred             ---------------------CCceecCCCCCCeeeeC---CCCcEEEEeccCceec
Q 018514          186 ---------------------IGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  218 (354)
Q Consensus       186 ---------------------~~iiH~Dlkp~Nili~~---~~~~vkl~Dfg~a~~~  218 (354)
                                           ..++|+|++|.||+++.   ++..+.|+||+.+..-
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                 14699999999999987   3434589999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.48  E-value=2.7e-06  Score=73.94  Aligned_cols=130  Identities=15%  Similarity=0.141  Sum_probs=82.1

Q ss_pred             eeeccce-EEEEEEEcCCCceEEEEEcccch-hhhHHHHHHHHHcCC-CCeeecceeeeecCCCCeeEEEEEEeeccc-c
Q 018514           73 VGHGSFG-VVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPE-T  148 (354)
Q Consensus        73 lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~  148 (354)
                      +..|..+ .||+......+..+++|+-.... ....+|...|+.+.. --+.+++++...     ....++||++++| +
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCcc
Confidence            4445544 79998876677889999875443 345679999988852 224445444422     2236789999998 4


Q ss_pred             HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 018514          149 VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-------------------------------------------  185 (354)
Q Consensus       149 l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-------------------------------------------  185 (354)
                      +.+......        .....+..++...|+.||..                                           
T Consensus       107 ~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            444332110        11223444555555555531                                           


Q ss_pred             --------C------CceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          186 --------I------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       186 --------~------~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                              .      .++|+|+.|.||+++.++ .+-|+||+.+.
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~  222 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence                    0      179999999999999654 56799999885

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.32  E-value=2.6e-06  Score=76.61  Aligned_cols=72  Identities=17%  Similarity=0.297  Sum_probs=39.9

Q ss_pred             eEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCC--CCeeeccee----eeecCCCCeeEEEEEEee
Q 018514           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--PNVVSLKHC----FFSTTEKDELYLNLVLEY  144 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~----~~~~~~~~~~~~~iv~e~  144 (354)
                      +.|+.|..+.||++..  .+..+++|+..........|..+++.+..  -.+++++..    .+.   ......+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~---~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHT--DSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS---KHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEE--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE---EETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEe--CCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE---EECCEEEEEEEe
Confidence            4566677889999975  33458999887654444456777766632  123333321    000   012236789999


Q ss_pred             ccc
Q 018514          145 VPE  147 (354)
Q Consensus       145 ~~~  147 (354)
                      ++|
T Consensus       113 i~G  115 (346)
T 2q83_A          113 IEG  115 (346)
T ss_dssp             CCC
T ss_pred             ecC
Confidence            987

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.32  E-value=3.1e-06  Score=77.94  Aligned_cols=71  Identities=18%  Similarity=0.188  Sum_probs=44.4

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccc-----------hhhhHHHHHHHHHcCC--CC-eeecceeeeecCCCCe
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----------KRYKNRELQTMRLLDH--PN-VVSLKHCFFSTTEKDE  135 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~~~  135 (354)
                      .+.||.|.++.||++....+++.+++|.....           .....+|.++++.+..  +. +++++.+  .   .+.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~~  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CCc
Confidence            46789999999999976556788999975321           1223568888888742  33 3344332  2   111


Q ss_pred             eEEEEEEeeccc
Q 018514          136 LYLNLVLEYVPE  147 (354)
Q Consensus       136 ~~~~iv~e~~~~  147 (354)
                        .++|||+++|
T Consensus       110 --~~lvmE~l~g  119 (397)
T 2olc_A          110 --AVTVMEDLSH  119 (397)
T ss_dssp             --TEEEECCCTT
T ss_pred             --cEEEEEeCCC
Confidence              3689999976

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.23  E-value=4e-06  Score=76.00  Aligned_cols=78  Identities=10%  Similarity=0.077  Sum_probs=48.8

Q ss_pred             EEEeEe-eeccceEEEEEEEc--C----CCceEEEEEcccch-------hhhHHHHHHHHHcCC---CCeeecceeeeec
Q 018514           68 MAERVV-GHGSFGVVFQAKCL--E----TGEAVAIKKVLQDK-------RYKNRELQTMRLLDH---PNVVSLKHCFFST  130 (354)
Q Consensus        68 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h---~~iv~~~~~~~~~  130 (354)
                      ...+.| +.|....+|++...  .    ++..+++|......       ....+|+.+++.+..   -.+++++......
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            334667 78888899998752  0    15678999875433       345689999888742   3455555543211


Q ss_pred             CCCCeeEEEEEEeeccc
Q 018514          131 TEKDELYLNLVLEYVPE  147 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~~  147 (354)
                      ...  ...++||||++|
T Consensus       103 ~~~--g~~~~v~e~l~G  117 (357)
T 3ats_A          103 DVL--GTPFFLMDYVEG  117 (357)
T ss_dssp             TTT--SSCEEEEECCCC
T ss_pred             Ccc--CCceEEEEecCC
Confidence            100  124679999986

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.04  E-value=7e-05  Score=61.83  Aligned_cols=100  Identities=15%  Similarity=0.075  Sum_probs=64.0

Q ss_pred             cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCcccc
Q 018514          148 TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY  227 (354)
Q Consensus       148 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~  227 (354)
                      +|.+.|...   +.+++++++|.++.|.+.+|.-+-.+..-..+=+.|..|++..+| .|.+.+ +.+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            677887765   489999999999999999988762110112333457888898888 566553 1110           


Q ss_pred             ccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCC
Q 018514          228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  265 (354)
Q Consensus       228 ~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  265 (354)
                      .....+.|||...  ...+.+.=|||||+++|..+--.
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence            1122366888763  23578899999999999999643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.86  E-value=7.5e-05  Score=65.86  Aligned_cols=65  Identities=15%  Similarity=0.108  Sum_probs=40.9

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccchh---hhHHHHHHHHHcCCCCe-eecceeeeecCCCCeeEEEEEEeec
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      .+.|+.|....+|++      ..+++|+......   ...+|..+++.+....+ +++++..     .+.  -+++++|+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            577889999999998      4688898754321   23568888887743333 3443322     111  25789999


Q ss_pred             -cc
Q 018514          146 -PE  147 (354)
Q Consensus       146 -~~  147 (354)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             65

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.78  E-value=0.00051  Score=60.02  Aligned_cols=71  Identities=18%  Similarity=0.211  Sum_probs=49.3

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCC---CeeecceeeeecCCCCeeEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHP---NVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ..-.+.+|.|..+.||++.. .+|+.|++|+.....    .....|...|+.|...   .++++++.   .  .    -+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~--~----~~   86 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---D--D----RT   86 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---E--T----TE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---c--C----ce
Confidence            45578899999999999984 578899999865332    3457899999988532   23333322   1  1    25


Q ss_pred             EEEeeccc
Q 018514          140 LVLEYVPE  147 (354)
Q Consensus       140 iv~e~~~~  147 (354)
                      +||||+.+
T Consensus        87 lv~e~l~~   94 (288)
T 3f7w_A           87 LAMEWVDE   94 (288)
T ss_dssp             EEEECCCC
T ss_pred             EEEEeecc
Confidence            78999873

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.59  E-value=0.00046  Score=63.89  Aligned_cols=79  Identities=11%  Similarity=-0.046  Sum_probs=46.6

Q ss_pred             HhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCCcccccc--ccccccchhccCCCC--CCCchhHHHHHHHH
Q 018514          183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATE--YTAAIDIWSAGCVL  258 (354)
Q Consensus       183 H~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~--~~~~~DiwslG~il  258 (354)
                      +.. .++|+|++|.||+++.++  +.|+||+.+..-...........  ...|++|+.......  .....++.++...+
T Consensus       230 ~~~-~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          230 RAQ-ALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             BCC-EEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCC-eEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            344 799999999999998664  99999999875322211111111  133566655421110  11234455777777


Q ss_pred             HHHHhC
Q 018514          259 AELLLG  264 (354)
Q Consensus       259 ~ell~g  264 (354)
                      |+.+.+
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.55  E-value=0.00092  Score=62.47  Aligned_cols=69  Identities=13%  Similarity=0.205  Sum_probs=45.2

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccchh---hhHHHHHHHHHcCCCCe-eecceeeeecCCCCeeEEEEEEeec
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      .+.|+.|....+|++.....+..+++|+......   ...+|..+++.|...++ +++++.+     .+    .+||+|+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~I  183 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEFM  183 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEECC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEee
Confidence            4678889999999998744347889998743321   22579999999975555 3455544     22    2499998


Q ss_pred             cc
Q 018514          146 PE  147 (354)
Q Consensus       146 ~~  147 (354)
                      +|
T Consensus       184 ~G  185 (458)
T 2qg7_A          184 DG  185 (458)
T ss_dssp             CS
T ss_pred             CC
Confidence            86

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.54  E-value=0.00067  Score=62.94  Aligned_cols=69  Identities=17%  Similarity=0.237  Sum_probs=46.3

Q ss_pred             EeEeeeccceEEEEEEEcC-------CCceEEEEEccc-ch-hhhHHHHHHHHHcCCCCe-eecceeeeecCCCCeeEEE
Q 018514           70 ERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQ-DK-RYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~-~~-~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~  139 (354)
                      .+.|+.|....+|++....       .+..+++|+... .. ....+|..+++.+...++ +++++.+     .+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence            4678888889999998642       256899998844 22 344478888888854344 4455443     22    2


Q ss_pred             EEEeeccc
Q 018514          140 LVLEYVPE  147 (354)
Q Consensus       140 iv~e~~~~  147 (354)
                      +|++|++|
T Consensus       149 ~v~e~l~G  156 (429)
T 1nw1_A          149 RLEEYIPS  156 (429)
T ss_dssp             EEECCCCE
T ss_pred             EEEEEeCC
Confidence            78999876

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.54  E-value=0.00085  Score=59.51  Aligned_cols=145  Identities=12%  Similarity=0.039  Sum_probs=75.4

Q ss_pred             EEeEeeeccceEEEEEEEcCCCceEEEEEccc--chhhhHHHHHHHHHcCCCC--eeecceeeeecC--CCCeeEEEEEE
Q 018514           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTT--EKDELYLNLVL  142 (354)
Q Consensus        69 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~--~~~~~~~~iv~  142 (354)
                      -.+.|+.|....+|++... +| .+++|....  .......|+.+++.+....  +++++... ...  .......++++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEEEEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEEEEE
Confidence            3456788888899999752 33 688998865  3345567888888774322  23332210 000  00012357899


Q ss_pred             eeccccH------------HHHH---Hhhh-hcCCC----CCHHHHHHH---------------HHHHHHHHHHHHh---
Q 018514          143 EYVPETV------------HRVI---KHHY-KMSQR----MPLIYVKLY---------------FYQICRALAYIHN---  184 (354)
Q Consensus       143 e~~~~~l------------~~~l---~~~~-~~~~~----~~~~~~~~~---------------~~qi~~~l~~LH~---  184 (354)
                      +|++|..            ...+   .... ....+    .........               ...+...++.+..   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998631            0111   1110 00000    111100000               0113344455542   


Q ss_pred             ---cCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          185 ---TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       185 ---~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                         ..+++|+|+.+.||+++.+. .+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence               12699999999999998754 457999998763

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.48  E-value=0.00065  Score=60.64  Aligned_cols=31  Identities=39%  Similarity=0.543  Sum_probs=26.4

Q ss_pred             CceecCCCCCCeeeeCC---CCcEEEEeccCcee
Q 018514          187 GVCHRDIKPQNLLVNPH---THQLKLCDFGSAKV  217 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~---~~~vkl~Dfg~a~~  217 (354)
                      .++|||+.+.||+++.+   ...+.|+||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            79999999999999864   13699999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.41  E-value=0.00096  Score=60.71  Aligned_cols=138  Identities=17%  Similarity=0.262  Sum_probs=77.1

Q ss_pred             eEeeeccceEEEEEEEcC-------CCceEEEEEccc---chhhhHHHHHHHHHcCCCCe-eecceeeeecCCCCeeEEE
Q 018514           71 RVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQ---DKRYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        71 ~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~---~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~  139 (354)
                      +.|..|....+|++....       ++..+++|+...   ......+|..+++.+...++ +++++.+     .+    .
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----G  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----c
Confidence            457778888899988632       346799998643   22334579988888743222 4454443     33    2


Q ss_pred             EEEeeccc-cHH--------------HHHHhhhhc----CCCCC--HHHHHHHHHHHHH-------------------HH
Q 018514          140 LVLEYVPE-TVH--------------RVIKHHYKM----SQRMP--LIYVKLYFYQICR-------------------AL  179 (354)
Q Consensus       140 iv~e~~~~-~l~--------------~~l~~~~~~----~~~~~--~~~~~~~~~qi~~-------------------~l  179 (354)
                      +||||++| .+.              ..+...-..    .....  ..++..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            79999986 211              111111111    11222  3455555544422                   22


Q ss_pred             HHHHh-------cCCceecCCCCCCeeeeCC---CCcEEEEeccCcee
Q 018514          180 AYIHN-------TIGVCHRDIKPQNLLVNPH---THQLKLCDFGSAKV  217 (354)
Q Consensus       180 ~~LH~-------~~~iiH~Dlkp~Nili~~~---~~~vkl~Dfg~a~~  217 (354)
                      ..|.+       ...++|+|+.+.||+++.+   .+.+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33321       1258999999999999876   23799999998864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.40  E-value=0.00053  Score=62.25  Aligned_cols=69  Identities=12%  Similarity=0.123  Sum_probs=41.0

Q ss_pred             EeEeeeccceEEEEEEEcC--------CCceEEEEEcccchhh---hHHHHHHHHHcCCCCe-eecceeeeecCCCCeeE
Q 018514           70 ERVVGHGSFGVVFQAKCLE--------TGEAVAIKKVLQDKRY---KNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELY  137 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~---~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~  137 (354)
                      .+.|+.|....+|++....        .+..+++|+.......   ..+|..+++.+...++ +++++.+     .+   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~---  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG---  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC---
Confidence            3567788888999998642        1267889987543222   3578888888853333 3444332     21   


Q ss_pred             EEEEEeeccc
Q 018514          138 LNLVLEYVPE  147 (354)
Q Consensus       138 ~~iv~e~~~~  147 (354)
                       ++||+|++|
T Consensus       110 -~~v~e~i~G  118 (369)
T 3c5i_A          110 -GRIEEWLYG  118 (369)
T ss_dssp             -EEEEECCCS
T ss_pred             -cEEEEEecC
Confidence             578999986

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.39  E-value=0.00093  Score=59.14  Aligned_cols=71  Identities=15%  Similarity=0.061  Sum_probs=50.1

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEcccc-hhhhHHHHHHHHHcC---CCCeeecceeeeecCCCCeeEEEEEEeec
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (354)
                      .+.|+.|....+|+...  ++..+++|+.... .....+|...|+.|.   ...+++++....     .....++||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEec
Confidence            46789999999999975  5678889987543 334567888888874   245566655431     123468999999


Q ss_pred             cc
Q 018514          146 PE  147 (354)
Q Consensus       146 ~~  147 (354)
                      +|
T Consensus       114 ~G  115 (312)
T 3jr1_A          114 NK  115 (312)
T ss_dssp             CC
T ss_pred             cC
Confidence            86

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.17  E-value=0.0024  Score=56.65  Aligned_cols=72  Identities=14%  Similarity=-0.008  Sum_probs=43.0

Q ss_pred             EeeeccceEEEEEEEcCCCceEEEEEccc---chhhhHHHHHHHHHcCCCC--eeecceeeeecCC--CCeeEEEEEEee
Q 018514           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTE--KDELYLNLVLEY  144 (354)
Q Consensus        72 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~iv~e~  144 (354)
                      .++ |....||++.. .+|+.+++|....   .......|..+++.+....  +++++..  ....  ......+++|++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence            455 77788998864 3566799999863   2344556888888774222  3443332  1000  011235689999


Q ss_pred             ccc
Q 018514          145 VPE  147 (354)
Q Consensus       145 ~~~  147 (354)
                      ++|
T Consensus       109 i~G  111 (328)
T 1zyl_A          109 VGG  111 (328)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            986

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.85  E-value=0.0014  Score=58.78  Aligned_cols=30  Identities=27%  Similarity=0.546  Sum_probs=26.3

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            699999999999998665 699999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.45  E-value=0.028  Score=51.78  Aligned_cols=69  Identities=13%  Similarity=0.178  Sum_probs=44.3

Q ss_pred             EeEeeeccceEEEEEEEcCC-------CceEEEEEcccchh---hhHHHHHHHHHcCCCCe-eecceeeeecCCCCeeEE
Q 018514           70 ERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~---~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~  138 (354)
                      .+.+..|....+|++.....       +..+++|+......   ...+|..+++.+...++ +++++.+     .+    
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~~----  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----PE----  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----CC----
Confidence            45677788889999986421       57799998754322   23578888888853333 3444322     22    


Q ss_pred             EEEEeeccc
Q 018514          139 NLVLEYVPE  147 (354)
Q Consensus       139 ~iv~e~~~~  147 (354)
                      +.|++|++|
T Consensus       146 ~~I~efI~G  154 (424)
T 3mes_A          146 GRIEEFIDG  154 (424)
T ss_dssp             EEEEECCCS
T ss_pred             CEEEEEeCC
Confidence            578999986

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.51  E-value=0.35  Score=44.01  Aligned_cols=31  Identities=29%  Similarity=0.484  Sum_probs=25.1

Q ss_pred             CceecCCCCCCeeeeC-----CCCcEEEEeccCcee
Q 018514          187 GVCHRDIKPQNLLVNP-----HTHQLKLCDFGSAKV  217 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~-----~~~~vkl~Dfg~a~~  217 (354)
                      .++|+|+.+.||++.+     +...+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            3689999999999942     334799999999874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	354
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-105
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-67
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-66
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-66
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-62
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-61
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-61
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-61
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-60
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-60
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-59
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-58
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-58
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-58
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-57
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-56
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-55
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-53
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-53
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-53
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-52
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-50
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-50
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-49
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-49
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-48
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-46
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-40
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-39
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-37
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-37
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-19

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  310 bits (795), Expect = e-105
 Identities = 207/297 (69%), Positives = 252/297 (84%), Gaps = 3/297 (1%)

Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64

Query: 110 QTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ E KDE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH+  G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T  +A
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 3e-67
 Identities = 70/299 (23%), Positives = 119/299 (39%), Gaps = 31/299 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +     +G G+ GVVF+     +G  +A K +  + +        RELQ +   + P +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                F       E+ +   +E++       +    K + R+P   +      + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +     + HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT 300
            T Y+   DIWS G  L E+ +G+   P       +L+   +V G       +   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 301 EFKF--------------PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
              +                I   P  K+       E  D V++ L  +P  R+     
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 3e-66
 Identities = 94/285 (32%), Positives = 140/285 (49%), Gaps = 21/285 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVV 121
             +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L   F     K  + L  V +++   +          S  +   ++K Y     + L Y
Sbjct: 64  GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H    + HRD+KP NLL++ +   LKL DFG AK         ++   +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT E+   M     
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
              F      P H IF      + +DL+  L  ++P  R TA  A
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 7e-66
 Identities = 92/291 (31%), Positives = 156/291 (53%), Gaps = 20/291 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKN---RELQTMRLLDHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++ +    H N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + LV   +   +++++K      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRAPE 237
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 295
           ++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 296 -NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                     P     PW+++F      +A+DL+ ++L ++P+ R     A
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-62
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 22/296 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 121 VSLKHCFFSTTE---KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           V+L     +      + +  + LV ++     H +      +  +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-----SYICSRY 232
            L YIH    + HRD+K  N+L+      LKL DFG A+     + +      + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 293 KCMNPNYTEFKFPQIKAHP---WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             ++      K   +K        ++      P A+DL+ +LL   P  R  + DA
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  197 bits (501), Expect = 3e-61
 Identities = 86/290 (29%), Positives = 143/290 (49%), Gaps = 21/290 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTM-RLLDHPNVVSLK 124
           Y   R +G G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                  +       LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H+
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
            +G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     
Sbjct: 148 -MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           Y  ++D+WS GC+LA ++  + P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 304 FPQI----KAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
           F  I        W +      Q  + PEA+D + +LL+Y    R TA +A
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 4e-61
 Identities = 95/287 (33%), Positives = 151/287 (52%), Gaps = 18/287 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           +     +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L           E  L LV E++ + + + +         +PLI  K Y +Q+ + LA
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLA 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           + H+   V HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPN 298
            G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             +  FP+     + K+    +  +   L+S++L Y PN R +A  A
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  196 bits (500), Expect = 8e-61
 Identities = 67/284 (23%), Positives = 110/284 (38%), Gaps = 39/284 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   F     +D+  + ++ E++      + +       +M       Y  Q+C+ L ++
Sbjct: 88  LHDAF-----EDDNEMVMIYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 183 HNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
                   D+WS G +   LL G   F GE+  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                             +  +  D + +LL   PN R T   A
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 5e-60
 Identities = 93/289 (32%), Positives = 149/289 (51%), Gaps = 20/289 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y   + VG G++G V  A    TG  VAIKK+ +  + +       REL+ ++ + H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 121 VSLKHCFFS-TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L   F    T  D     LV+ ++   + +++KH     +++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            YIH   G+ HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 300 TEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            +      P+++   +  I      P AV+L+ ++L      R TA +A
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 6e-60
 Identities = 91/289 (31%), Positives = 145/289 (50%), Gaps = 17/289 (5%)

Query: 67  YMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQDKRYKN------RELQTMRLL---D 116
           Y     +G G++G VF+A+ L+  G  VA+K+V      +       RE+  +R L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           HPNVV L      +    E  L LV E+V + +   +    +    +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLL 126

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E++   + Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                  F    A P  K     +     DL+ + L ++P  R +A+ A
Sbjct: 243 VALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 2e-59
 Identities = 90/288 (31%), Positives = 143/288 (49%), Gaps = 18/288 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y     VG G++G V  A   +TG  VA+KK+      +   +   REL+ ++ + H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + L   F      +E     ++ ++         ++    Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           YIH+   + HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 301 EF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                   Q+    +  +F     P AVDL+ ++L    + R TA  A
Sbjct: 252 RNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  191 bits (485), Expect = 1e-58
 Identities = 73/286 (25%), Positives = 111/286 (38%), Gaps = 43/286 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG     K +      DK     E+  M  L HP +++
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   F     +D+  + L+LE++   E   R+    YKMS+      V  Y  Q C  L 
Sbjct: 91  LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE----VINYMRQACEGLK 141

Query: 181 YIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           ++H    + H DIKP+N++        +K+ DFG A  L   E       +  + APE++
Sbjct: 142 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                     D+W+ G +   LL G   F GE  ++ L  + +       +         
Sbjct: 201 DR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------- 252

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                               + PEA D +  LLQ  P  R T  DA
Sbjct: 253 ------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (479), Expect = 2e-58
 Identities = 92/287 (32%), Positives = 144/287 (50%), Gaps = 18/287 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L           +  L LV E+       + K+    +  +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           + H+   V HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           FGA  Y+ +ID+WSAGC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                +P   A         ++     DL+  LL+ +P  R +A +A
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 5e-58
 Identities = 69/292 (23%), Positives = 114/292 (39%), Gaps = 45/292 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 120
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V         T      L +V+EY     +  VI    K  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 180 AYIH----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYR 234
              H        V HRD+KP N+ ++   + +KL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +PE +     Y    DIWS GC+L EL    P F   S  +   +I              
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                 E KF +I               E  ++++R+L      R +  + +
Sbjct: 228 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEIL 264

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 5e-58
 Identities = 69/280 (24%), Positives = 113/280 (40%), Gaps = 31/280 (11%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 128
            +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +   + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 129 STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +     +  L +V+E +    +   I+   +  Q             I  A+ Y+H+ I 
Sbjct: 76  NLYAGRK-CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-IN 131

Query: 188 VCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
           + HRD+KP+NLL         LKL DFG AK         +   + YY APE++    +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
             + D+WS G ++  LL G P F    G+     +   +                +++FP
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------QYEFP 237

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             +           +  E   L+  LL+  P  R T  + 
Sbjct: 238 NPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  187 bits (476), Expect = 5e-58
 Identities = 91/287 (31%), Positives = 149/287 (51%), Gaps = 20/287 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L           +  L LV E++ + + +++         +  +  K +  Q+   +A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIA 114

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           Y H+   V HRD+KPQNLL+N    +LK+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 298
            G+ +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             +  F   +  PW     K +    +DL+S++L+  PN R TA  A
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-58
 Identities = 56/284 (19%), Positives = 116/284 (40%), Gaps = 40/284 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
           +  +G GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            +  + +T K +  + LV E +       +K + K  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 184 -NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
             T  + HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
            +Y  ++D+++ G  + E+   +  +       Q+                         
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------------- 224

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
               + +      F K   PE  +++   ++ + + R +  D +
Sbjct: 225 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-58
 Identities = 73/287 (25%), Positives = 113/287 (39%), Gaps = 44/287 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                             L LEY             +    MP    + +F+Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 238
           +H  IG+ HRDIKP+NLL++   + LK+ DFG A V               +  Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     +   +D+WS G VL  +L G+  +   S   Q     K   T            
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                      +PW KI         + L+ ++L  +P+ R T  D 
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDI 257

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-57
 Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 44/288 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           +     +G G+FG V++A+  ET    A K +     ++      E+  +   DHPN+V 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   F       E  L +++E+             ++ + +    +++   Q   AL Y+
Sbjct: 74  LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG 241
           H+   + HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 242 AT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            T     Y    D+WS G  L E+   +P     + +  L++I                 
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                     K+ P       R      D + + L+ + + R T    
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-57
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 48/287 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           +   R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L   F      D   + L+LEY P      +    +   +        Y  ++  AL
Sbjct: 68  ILRLYGYF-----HDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +Y H+   V HRDIKP+NLL+      LK+ DFG +          +   +  Y  PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G   +   +D+WS G +  E L+G+P F   +  +    I +V                
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            EF FP              +   A DL+SRLL+++P+ R    + +
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (472), Expect = 4e-57
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 49/289 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           +   R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +  + C+       E    LV+EY   +   +++ H K    +  + +    +   + L
Sbjct: 77  TIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 128

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 240 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
               E  Y   +D+WS G    EL   +P     + +  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                       +    +          + V   LQ  P  R T+   +
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 64/284 (22%), Positives = 113/284 (39%), Gaps = 40/284 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDHPNVVSL 123
           YM    +G G FG+V +     + +    K V     D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F     +    L ++ E++    +   I      +  +    +  Y +Q+C AL ++
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFL 118

Query: 183 HNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           H+   + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+   
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
               + A D+WS G ++  LL G   F  E+    +  I+    T   E           
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                           K +  EA+D V RLL      R TA +A
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 3e-55
 Identities = 78/303 (25%), Positives = 127/303 (41%), Gaps = 52/303 (17%)

Query: 60  QPKQTI--SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQ 110
           QP++     +   +++G GSF  V  A+ L T    AIK + +    K        RE  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 170
            M  LDHP  V L   F    + ++LY    L Y     +  +  + +          + 
Sbjct: 61  VMSRLDHPFFVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRF 112

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SY 227
           Y  +I  AL Y+H    + HRD+KP+N+L+N   H +++ DFG+AKVL          S+
Sbjct: 113 YTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170

Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           + +  Y +PEL+        + D+W+ GC++ +L+ G P F   +      +IIK+    
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---- 225

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG 347
                        E+ FP+            +  P+A DLV +LL      R    +  G
Sbjct: 226 -------------EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEG 260

Query: 348 SFD 350
              
Sbjct: 261 YGP 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 4e-55
 Identities = 68/284 (23%), Positives = 117/284 (41%), Gaps = 43/284 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+ G V+ A  + TG+ VAI+++       K     E+  MR   +PN+V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
               +      DEL++  V+EY+                 M    +     +  +AL ++
Sbjct: 82  YLDSY---LVGDELWV--VMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+   V HRDIK  N+L+      +KL DFG    +   +   S +  + Y+ APE++  
Sbjct: 133 HSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP             E
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP-------------E 235

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
            + P            +++     D ++R L      R +A + 
Sbjct: 236 LQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (448), Expect = 1e-53
 Identities = 66/287 (22%), Positives = 112/287 (39%), Gaps = 44/287 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK + +            E+  +  + HPN+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   +        LYL  +++ V    +   I      ++R          +Q+  A+ 
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVSGGELFDRIVEKGFYTERD----ASRLIFQVLDAVK 121

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           Y+H+   + HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE+
Sbjct: 122 YLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     Y+ A+D WS G +   LL G P F  E+      +I+K                
Sbjct: 181 LAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-------- 231

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                            +   +   A D +  L++  P  R T   A
Sbjct: 232 -----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-53
 Identities = 87/299 (29%), Positives = 146/299 (48%), Gaps = 29/299 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+ +  + +       REL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 121 VSLKHCFFS-TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F    T ++   + LV+E +   + +VI+      +      +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQMLCGI 132

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHS-AGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 300 TEF--KFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
             +    P+     + K+F            K    +A DL+S++L   P  R +  DA
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  175 bits (444), Expect = 2e-53
 Identities = 67/299 (22%), Positives = 117/299 (39%), Gaps = 56/299 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------------LQDKRYKNRELQTMR 113
           Y  + ++G G   VV +     T +  A+K +              + +    +E+  +R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 114 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLY 171
            +  HPN++ LK  +     +   +  LV + +    +   +     +S++      +  
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE----TRKI 115

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
              +   +  +H    + HRD+KP+N+L++   + +KL DFG +  L  GE       + 
Sbjct: 116 MRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTP 173

Query: 232 YYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
            Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I      
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------ 227

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                   M+ NY +F  P+                   DLVSR L   P  R TA +A
Sbjct: 228 --------MSGNY-QFGSPEW----------DDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  173 bits (439), Expect = 9e-52
 Identities = 84/316 (26%), Positives = 139/316 (43%), Gaps = 42/316 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 123
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 124 KH----------CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
                         F+    + +++ +V E + E +  +IK +    + +PLIYVK    
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGIPLIYVKQISK 132

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-----QLKLCDFGSAKVLVKGEPNISYI 228
           Q+   L Y+H   G+ H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIK 282
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 283 VLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FQKRMPPEAVDLVS 329
           +LG      ++      T F          ++K  P   +      F K    E  D +S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 330 RLLQYSPNLRSTAFDA 345
            +LQ  P  R+ A   
Sbjct: 310 PMLQLDPRKRADAGGL 325

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  167 bits (425), Expect = 1e-50
 Identities = 63/291 (21%), Positives = 110/291 (37%), Gaps = 43/291 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           Y    ++G G    V  A+ L     VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V++ +              +V+EYV       ++        M            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRA 235
            + H   G+ HRD+KP N++++   + +K+ DFG A+ +     ++    + I +  Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE   G     A  D++S GCVL E+L G+P F G+S V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                                 + +  +   +V + L  +P  R      +
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEM 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-50
 Identities = 68/289 (23%), Positives = 124/289 (42%), Gaps = 49/289 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--------MRLLDHP 118
           ++  +++G GSFG VF A+  +T +  AIK + +D    + +++             +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +  +   F     + +  L  V+EY+       + +H +   +  L     Y  +I   
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L ++H+  G+ +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++ G  +Y  ++D WS G +L E+L+GQ  F G+   +                I+  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
            Y  +                 +  EA DL+ +L    P  R      +
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDI 252

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  168 bits (426), Expect = 9e-50
 Identities = 72/321 (22%), Positives = 130/321 (40%), Gaps = 53/321 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD 116
           +   R++G G FG V+  +  +TG+  A+K + + +            +   L  +   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
            P +V + + F      D+L    +L+ +    +H  +  H   S+      ++ Y  +I
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQHGVFSEAD----MRFYAAEI 116

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
              L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S   +  Y A
Sbjct: 117 ILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMA 173

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR------ 289
           PE++     Y ++ D +S GC+L +LL G   F      D+       L           
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233

Query: 290 EEIK-----CMNPNYTE------FKFPQIKAHP------WHKIFQKRMPPEAVDLVSRLL 332
            E++      +  +             ++K  P      W  +F ++ PP  +       
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG--- 290

Query: 333 QYSPNLRSTAFDAVGSFDSSF 353
               N    AFD +GSFD   
Sbjct: 291 --EVNAAD-AFD-IGSFDEED 307

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  166 bits (422), Expect = 1e-49
 Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 49/280 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPN 119
           +   R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ +   F     +D   + ++++Y+       +    + SQR P    K Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            Y+H+   + +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                Y  +ID WS G ++ E+L G   F   + +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
            E +FP                 +  DL+SRL+    + R
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQR 243

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-49
 Identities = 61/299 (20%), Positives = 114/299 (38%), Gaps = 50/299 (16%)

Query: 62  KQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------REL 109
           ++ +   Y     +G G F VV + +   TG   A K + + +   +          RE+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ + HPNV++L   +     +++  + L+LE V       +       + +      
Sbjct: 65  SILKEIQHPNVITLHEVY-----ENKTDVILILELVA---GGELFDFLAEKESLTEEEAT 116

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNIS 226
            +  QI   + Y+H+   + H D+KP+N+++   N    ++K+ DFG A  +  G    +
Sbjct: 117 EFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
              +  + APE++          D+WS G +   LL G   F G++  + L  +  V   
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
              E                         +       A D + RLL   P  R T  D+
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 4e-48
 Identities = 64/291 (21%), Positives = 109/291 (37%), Gaps = 56/291 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD 116
           Y    ++G G FG V+    +     VAIK V +D+               E+  ++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 117 --HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
                V+ L   F            L+LE       + +         +     + +F+Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           +  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
            PE I     +  +  +WS G +L +++ G   F  +       EII+            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDA 345
                                F++R+  E   L+   L   P+ R T  + 
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-47
 Identities = 53/294 (18%), Positives = 108/294 (36%), Gaps = 49/294 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                         L +V ++    +++  +     +  +  +I +     Q  + + Y+
Sbjct: 70  MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
           H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I
Sbjct: 121 HAK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 240 FG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
                  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++                
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------------- 223

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS 351
               +  P +             P     L++  L+   + R      + S + 
Sbjct: 224 --RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 5e-46
 Identities = 54/299 (18%), Positives = 98/299 (32%), Gaps = 42/299 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 124
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     +   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               +    +  Y  +V+E +  ++          S++  L  V L   Q+   + YIH+
Sbjct: 69  RWCGA----EGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNI--------SYICSRYYR 234
                HRD+KP N L+        +   DFG AK       +         +   +  Y 
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +     G  E +   D+ S G VL    LG   + G     +  +  ++        I+ 
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF 353
           +   Y                     P E    ++       + +         F + F
Sbjct: 240 LCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-45
 Identities = 59/276 (21%), Positives = 105/276 (38%), Gaps = 46/276 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           +++G G+FG V   +   TG   A+K + ++             E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           K+ F      D L        +       +  H    +       + Y  +I  AL Y+H
Sbjct: 71  KYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   V +RDIK +NL+++   H +K+ DFG  K  +     +   C         +    
Sbjct: 123 S-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           +Y  A+D W  G V+ E++ G+  F  +        I+                   E +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           FP            + + PEA  L++ LL+  P  R
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQR 247

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  152 bits (385), Expect = 2e-44
 Identities = 53/292 (18%), Positives = 106/292 (36%), Gaps = 26/292 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 124
           Y   R +G GSFGV+F+   L   + VAIK   +         E +T +LL     +   
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           + F      + L+  LV++ +  ++  ++       ++  +  V +   Q+   +  IH 
Sbjct: 67  YYFGQ----EGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 185 TIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNI--------SYICSRY 232
              + +RDIKP N L+      + + + + DFG  K                 +   +  
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y +     G  E +   D+ + G V    L G   + G        +  ++        +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
           + +   + E +F +   +  +  F     P+   L     +    L +T  +
Sbjct: 238 RELCAGFPE-EFYKYMHYARNLAFDAT--PDYDYLQGLFSKVLERLNTTEDE 286

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 5e-44
 Identities = 52/280 (18%), Positives = 99/280 (35%), Gaps = 45/280 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 128
           + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
               +++  L +V EY+ + ++   ++   +    +    +  +   +C A+ Y+     
Sbjct: 71  ----EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN-N 123

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
             HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++ 
Sbjct: 124 FVHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179

Query: 248 AIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 306
             D+WS G +L E+   G+  +P     D +  + K                  +   P 
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------KMDAPD 223

Query: 307 IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                         PP   +++         +R +     
Sbjct: 224 ------------GCPPAVYEVMKNCWHLDAAMRPSFLQLR 251

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-41
 Identities = 55/293 (18%), Positives = 100/293 (34%), Gaps = 45/293 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 123
                 +G G FG V+          VA+K + Q     +    E   M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    ++ +Y  ++ EY+                ++ +  +     QI   +A+I 
Sbjct: 74  YAVV----TQEPIY--IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFG 241
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 242 ATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
              +T   D+WS G +L E++  G+  +PG +  + +  + +                  
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF 353
                      +  +     P E   L+    +  P  R T        +  F
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-40
 Identities = 63/290 (21%), Positives = 104/290 (35%), Gaps = 45/290 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 ++ +Y+  V EY+ +          +  + + L  +     QI   +AY+   +
Sbjct: 81  V----SEEPIYI--VTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATE 244
              HRD++  N+LV  +    K+ DFG A+++   E            + APE       
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 245 YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           +T   D+WS G +L EL   G+  +PG    + L ++ +    P   E            
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSSF 353
                            P    DL+ +  +  P  R T        +  F
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-40
 Identities = 54/302 (17%), Positives = 107/302 (35%), Gaps = 37/302 (12%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVS 122
           + + +  +G G FG V++ K    GE VA+K     +    ++  E+    +L H N++ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                 +        L LV +Y    ++   +  +      + +  +          LA+
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115

Query: 182 IHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----YIC 229
           +H  I        + HRD+K +N+LV        + D G A         I       + 
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 230 SRYYRAPELIFGA-----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
           ++ Y APE++  +      E     DI++ G V  E+     +  G     QL     V 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233

Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFD 344
             P+ EE++ +          +++ +  ++            ++      +   R TA  
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

Query: 345 AV 346
             
Sbjct: 288 IK 289

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-40
 Identities = 57/286 (19%), Positives = 100/286 (34%), Gaps = 51/286 (17%)

Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 120
             +G GSFGVV + +         +VA+K +  D   +        RE+  M  LDH N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + L     +        + +V E  P     ++    K      L  +  Y  Q+   + 
Sbjct: 74  IRLYGVVLTP------PMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 237
           Y+ +     HRD+  +NLL+      +K+ DFG  + L + + +     +    +     
Sbjct: 126 YLESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 238 LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
                  ++ A D W  G  L E+   GQ  + G +G   L +I K      R E     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE----- 238

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                                   P +  +++ +   + P  R T 
Sbjct: 239 ----------------------DCPQDIYNVMVQCWAHKPEDRPTF 262

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (360), Expect = 3e-40
 Identities = 58/279 (20%), Positives = 109/279 (39%), Gaps = 40/279 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K         E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F   +    +                +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSFKDNSNLYMVM--------EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           + + + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I    
Sbjct: 159 S-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--------EIKCM 295
            Y  A+D W+ G ++ E+  G P F  +  +    +I+                     +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

Query: 296 NPNYTE------FKFPQIKAHP------WHKIFQKRMPP 322
             + T+           IK H       W  I+Q+++  
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEA 312

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (353), Expect = 1e-39
 Identities = 61/296 (20%), Positives = 108/296 (36%), Gaps = 53/296 (17%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVL-----QDKRYKNRELQTMRLLDH 117
               E+V+G G FG V        G+    VAIK +      + +R    E   M   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PNV+ L+      T+   +   ++ E++            +   +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------ 231
            + Y+ + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            + APE I    ++T+A D+WS G V+ E++  G+  +   +  D +  I +    P   
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           +                             P     L+    Q   N R      V
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQIV 284

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-39
 Identities = 48/281 (17%), Positives = 95/281 (33%), Gaps = 43/281 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 127
           + +G G FG+V         + VAIK + +    +     E + M  L HP +V L    
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
               E+  + L  V E++         +            +      +C  +AY+     
Sbjct: 70  ---LEQAPICL--VFEFMEHGCLS--DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-C 121

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEY 245
           V HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
           ++  D+WS G ++ E+     +        ++VE I                        
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                 +     +        +++   +  P  R      +
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLL 253

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-39
 Identities = 52/282 (18%), Positives = 105/282 (37%), Gaps = 45/282 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 127
           + +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L    
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T++  ++  ++ EY+         +  +M  R     +      +C A+ Y+ +   
Sbjct: 69  ---TKQRPIF--IITEYMANGCLL--NYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-Q 120

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--YICSRYYRAPELIFGATEY 245
             HRD+  +N LVN     +K+ DFG ++ ++  E   S        +  PE++   +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 246 TAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  DIW+ G ++ E+  LG+  +   +  +    I + L                    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------------RLYR 222

Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
           P +               +   ++        + R T    +
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILL 252

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-39
 Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 50/288 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKV--------LQDKRYKNRELQTMRLL 115
           +   +V+G G++G VF  + +   +TG+  A+K +         +   +   E Q +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 116 DH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
              P +V+L + F     + E  L+L+L+Y+       +  H    +R     V++Y  +
Sbjct: 86  RQSPFLVTLHYAF-----QTETKLHLILDYIN---GGELFTHLSQRERFTEHEVQIYVGE 137

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC---SR 231
           I  AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y       
Sbjct: 138 IVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           Y     +  G + +  A+D WS G ++ ELL G   F  +   +   EI +         
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------- 246

Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                    + + P          + + M   A DL+ RLL   P  R
Sbjct: 247 ------RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKR 278

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 4e-39
 Identities = 51/287 (17%), Positives = 109/287 (37%), Gaps = 41/287 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
               T +   Y+    E++               Q +  + +     QI  A+ Y+    
Sbjct: 82  C---TREPPFYIIT--EFMTYGNLLDY-LRECNRQEVSAVVLLYMATQISSAMEYLEK-K 134

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--YYRAPELIFGATE 244
              HRD+  +N LV  + H +K+ DFG ++++                + APE +    +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++   D+W+ G +L E+            + Q+ E+++                    + 
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------KDYRMER 237

Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS 351
           P            +  P +  +L+    Q++P+ R +  +   +F++
Sbjct: 238 P------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-38
 Identities = 59/308 (19%), Positives = 108/308 (35%), Gaps = 70/308 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKRYKN-----RELQTM-RLLDHP 118
            +V+G G+FG V  A      +      VA+K + +            EL+ M +L  H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------------- 158
           N+V+L       T    +Y  L+ EY     +   ++   +                   
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
               +    +  + YQ+ + + ++       HRD+  +N+LV      +K+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214

Query: 219 VKGEPNISYICSR---YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
           +     +    +R    + APE +F    YT   D+WS G +L E+  LG   +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 334
               ++I+               N  +   P                 E   ++     +
Sbjct: 274 ANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSCWAF 306

Query: 335 SPNLRSTA 342
               R + 
Sbjct: 307 DSRKRPSF 314

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 4e-38
 Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 52/294 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L     ++T      + L+ + +P     ++ +  +    +   Y+  +  QI + + Y
Sbjct: 75  RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR---YYRAPEL 238
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 239 IFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           I     YT   D+WS G  + EL+  G   + G     ++  I++      +  I     
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPI----- 237

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS 351
                                    +   ++ +      + R    + +  F  
Sbjct: 238 ----------------------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-37
 Identities = 62/289 (21%), Positives = 102/289 (35%), Gaps = 51/289 (17%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVS 122
           +  +G G+FG V Q       +   VAIK + Q     +     RE Q M  LD+P +V 
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L        + + L L  V+E          K      + +P+  V    +Q+   + Y+
Sbjct: 74  LIGVC----QAEALML--VMEMAGGGPLH--KFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRAPEL 238
                  HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + APE 
Sbjct: 126 EEK-NFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 239 IFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           I    ++++  D+WS G  + E L  GQ  +    G + +  I +        E      
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                                  PPE   L+S    Y    R       
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVE 263

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 3e-37
 Identities = 53/286 (18%), Positives = 100/286 (34%), Gaps = 53/286 (18%)

Query: 70  ERVVGHGSFGVVFQAKC--LETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 121
           ++ +G G+FG V +      +  + VA+K +  +            E   M+ LD+P +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +        E +   L  V+E         +  + + ++ +    +    +Q+   + Y
Sbjct: 72  RMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPE 237
           +  +    HRD+  +N+L+    H  K+ DFG +K L   E              + APE
Sbjct: 123 LEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 238 LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I    ++++  D+WS G ++ E    GQ  + G  G +    + K              
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------- 230

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                                   P E  DL++    Y    R   
Sbjct: 231 -------------------CPAGCPREMYDLMNLCWTYDVENRPGF 257

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-36
 Identities = 51/291 (17%), Positives = 105/291 (36%), Gaps = 51/291 (17%)

Query: 70  ERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
             V+G G FG V+    L+        A+K + +            E   M+   HPNV+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           SL         + E    +VL Y+     R        +    +  +  +  Q+ + + +
Sbjct: 92  SLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 236
           + +     HRD+  +N +++     +K+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LAS-KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           E +    ++T   D+WS G +L EL+  G P +P  +  D  V +++             
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                              +  +  P    +++ +       +R +  + V
Sbjct: 250 ---------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 285

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-36
 Identities = 62/307 (20%), Positives = 108/307 (35%), Gaps = 65/307 (21%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKN-----RELQTM-RLLDHP 118
            + +G G+FG V +A        +    VA+K +              EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM--------------SQRM 163
           N+V+L       T      +  + EY     +   ++                      +
Sbjct: 88  NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            L  +  + YQ+ + +A++ +     HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200

Query: 224 NISYICSR---YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 279
            +    +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           +IK                             +  +  +  P E  D++       P  R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 340 STAFDAV 346
            T    V
Sbjct: 293 PTFKQIV 299

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 4e-36
 Identities = 68/287 (23%), Positives = 103/287 (35%), Gaps = 50/287 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHP 118
               R +G G FG V Q   +       AVAIK               +E  TMR  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           ++V L           E  + +++E       R           + L  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAP 236
           LAY+ +     HRDI  +N+LV+ +   +KL DFG ++ +       +        + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           E I     +T+A D+W  G  + E+L+ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                                    PP    L+++   Y P+ R   
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRF 256

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 6e-36
 Identities = 54/294 (18%), Positives = 96/294 (32%), Gaps = 50/294 (17%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLD 116
               ++V+G G FG V++     +       VAIK +      K       E   M    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           H N++ L+             + ++ EY+        K   +      ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC----SRY 232
             + Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           + APE I      +A+ D+WS G V+ E++        E    ++++ I           
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                              +        P     L+ +  Q     R    D V
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-35
 Identities = 56/298 (18%), Positives = 105/298 (35%), Gaps = 56/298 (18%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE--AVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYV 168
           +L             YL L +EY P   +   ++    +            +  +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
             +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
               + A E +   + YT   D+WS G +L E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                         + P                 E  DL+ +  +  P  R +    +
Sbjct: 241 ---------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQIL 277

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (321), Expect = 5e-35
 Identities = 58/311 (18%), Positives = 99/311 (31%), Gaps = 71/311 (22%)

Query: 71  RVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           R +G G+FG VFQA+       E    VA+K + ++          RE   M   D+PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP---------------------ETVHRVIKHHYKM 159
           V              + L  + EY+                        +    +     
Sbjct: 79  V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 160 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 219
              +          Q+   +AY+       HRD+  +N LV  +   +K+ DFG ++ + 
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191

Query: 220 KGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
             +      +      +  PE IF    YT   D+W+ G VL E+   G   + G +  +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
            +  +                          I A P      +  P E  +L+       
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282

Query: 336 PNLRSTAFDAV 346
           P  R +     
Sbjct: 283 PADRPSFCSIH 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 7e-34
 Identities = 61/310 (19%), Positives = 115/310 (37%), Gaps = 66/310 (21%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEA-------VAIKKVLQDKRYKN-----RELQTM-R 113
            +  + +G G+FG V  A+ +   +        VA+K +  D   K+      E++ M  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS------------ 160
           +  H N+++L       T+   LY+  ++EY  +  +   ++                  
Sbjct: 75  IGKHKNIINLLGAC---TQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           +++    +    YQ+ R + Y+ +     HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 221 GEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQ 276
            +      +      + APE +F    YT   D+WS G +L E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 277 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 336
           L +++K                      P                 E   ++       P
Sbjct: 246 LFKLLK---------------EGHRMDKP------------SNCTNELYMMMRDCWHAVP 278

Query: 337 NLRSTAFDAV 346
           + R T    V
Sbjct: 279 SQRPTFKQLV 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 5e-32
 Identities = 56/308 (18%), Positives = 105/308 (34%), Gaps = 62/308 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQD------KRYKNRELQTMRLL 115
               + +G G+FG V +A         T   VA+K + +       +   +     + + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-------------SQR 162
            H NVV+L              L +++E+             +                 
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +     HRD+  +N+L++     +K+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 223 PNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLV 278
             +          + APE IF    YT   D+WS G +L E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
             +K                 T  + P                PE    +       P+ 
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280

Query: 339 RSTAFDAV 346
           R T  + V
Sbjct: 281 RPTFSELV 288

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-29
 Identities = 51/298 (17%), Positives = 105/298 (35%), Gaps = 57/298 (19%)

Query: 70  ERVVGHGSFGVVFQAKC-----LETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            R +G GSFG+V++         E    VAIK V     ++++     E   M+  +  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLI------YVKLYF 172
           VV         ++       +++E +    +   ++         P++       +    
Sbjct: 85  VV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--- 229
            +I   +AY++      HRD+  +N +V      +K+ DFG  + + + +          
Sbjct: 140 GEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 288
              + +PE +     +T   D+WS G VL E+  L +  + G S    L  +++      
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV 346
                                           P    +L+    QY+P +R +  + +
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.3 bits (205), Expect = 1e-19
 Identities = 30/204 (14%), Positives = 56/204 (27%), Gaps = 32/204 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV--------------LQDKRYKNRELQTMRLLD 116
           +++G G    VF     E      +K                     + +         +
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
              +  L+               +++E              K   R+ +         I 
Sbjct: 65  FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             +A  ++   + H D+   N+LV      + + DF  +  +  GE     I  R  R  
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168

Query: 237 ELIFGATEYTAAIDIWSAGCVLAE 260
              F    Y    DI SA   + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	354
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.03
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.02
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.23
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.18
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.63

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-60  Score=433.10  Aligned_cols=283  Identities=71%  Similarity=1.208  Sum_probs=256.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeEEEEEEe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLE  143 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~iv~e  143 (354)
                      .+|+..++||+|+||+||+|++..+|+.||||++..+.....+|+++|++++||||++++++|..... .+..++++|||
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            36999999999999999999999999999999998877777899999999999999999999866543 45678899999


Q ss_pred             eccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccCCC
Q 018514          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (354)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~  223 (354)
                      ||++++...+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||++........
T Consensus       100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_         100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            999988888877666678899999999999999999999998 9999999999999998766899999999988776666


Q ss_pred             ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccC
Q 018514          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  303 (354)
Q Consensus       224 ~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  303 (354)
                      .....||+.|+|||.+.+...++.++|||||||++|||++|++||...+..+.+..+.+.++.+..+.+......+....
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~  258 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK  258 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence            67788999999999988777799999999999999999999999999999999999999999999999998888888888


Q ss_pred             CCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       304 ~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ++.....+|.......+++++.+||.+||++||++||||.|+|+|
T Consensus       259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            888888888888888899999999999999999999999999987

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-59  Score=407.23  Aligned_cols=243  Identities=30%  Similarity=0.471  Sum_probs=209.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++...       .....+|+++++.++||||+++++++     .+..
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence            46899999999999999999999999999999998532       23345799999999999999999998     4455


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++|||||++ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~~kl~DFG~a  153 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFGWS  153 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCC-CEeeccccee
Confidence            68999999995 888887754    5799999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       216 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ...... ......||+.|||||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+.-           
T Consensus       154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----------  220 (263)
T d2j4za1         154 VHAPSS-RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------  220 (263)
T ss_dssp             SCCCCC-CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------
T ss_pred             eecCCC-cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            765433 344668999999999997665 8999999999999999999999998887776666654320           


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                        ..+++.+|+++.+||.+||+.||++|||++|+|+|
T Consensus       221 ------------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 ------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                              01234579999999999999999999999999987

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=410.24  Aligned_cols=244  Identities=25%  Similarity=0.394  Sum_probs=208.6

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      +|++.+.||+|+||+||+|+++.+|+.||||++...    .+...+|+++++.++||||++++++|..     ..++|+|
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~iv   95 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVV   95 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEEE
Confidence            699999999999999999999999999999998543    2345689999999999999999999843     3458999


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      ||||+| +|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|.....
T Consensus        96 mEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP  168 (293)
T ss_dssp             EECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCC-cEeeccchhheeecc
Confidence            999996 77665543     4699999999999999999999998 999999999999999887 799999999987654


Q ss_pred             CC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCCC
Q 018514          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (354)
Q Consensus       221 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (354)
                      .. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+........           
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------  236 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-----------  236 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-----------
T ss_pred             ccccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence            33 345667999999999997655 89999999999999999999999998887777766655311100           


Q ss_pred             cccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                     ..+..+|+++++||.+||+.||.+|||+.|+|+|
T Consensus       237 ---------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         237 ---------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             ---------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             ---------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                           1224579999999999999999999999999987

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-59  Score=409.55  Aligned_cols=248  Identities=28%  Similarity=0.349  Sum_probs=204.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...     .+...+|++++++++||||+++++++.+     ...+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence            45799999999999999999999999999999998543     2345689999999999999999999843     4458


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      |+|||||.| +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|..
T Consensus        79 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~  152 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  152 (271)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCC-CEEEccchhhee
Confidence            999999986 77776653    35799999999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          218 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       218 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      .....   .....+||+.|||||++.+...++.++|||||||++|+|++|++||...+...............       
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------  225 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------  225 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence            64332   23456799999999999877656788999999999999999999998765444333332211000       


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                    ..     ....+|+++.+||.+||+.||++|||++|+++|
T Consensus       226 --------------~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         226 --------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             --------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------------CC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                          00     123478999999999999999999999999997

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-59  Score=408.24  Aligned_cols=251  Identities=26%  Similarity=0.393  Sum_probs=202.2

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++....      +...+|++++++++||||+++++++.+.   ....
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence            357999999999999999999999999999999985432      2345799999999999999999987532   2334


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ceecCCCCCCeeeeCCCCcEEEEe
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-----VCHRDIKPQNLLVNPHTHQLKLCD  211 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~-----iiH~Dlkp~Nili~~~~~~vkl~D  211 (354)
                      +|+|||||++ +|.+++.........+++..++.++.||+.||.|||++ |     |+||||||+|||++.++ .+||+|
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~~~IiHrDiKp~NIll~~~~-~vkl~D  157 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKLGD  157 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC---------CCGGGEEECTTS-CEEECC
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCEEeCcCchhhcCcCCCC-cEEEee
Confidence            7899999985 99998887766678899999999999999999999986 6     99999999999999887 799999


Q ss_pred             ccCceecccCCC-ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          212 FGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       212 fg~a~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      ||+|........ .....||+.|||||++.+.. ++.++|||||||++|||++|..||.+.+..+....+....      
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~------  230 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK------  230 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC------
Confidence            999987654332 34568899999999996655 8999999999999999999999999888777666664421      


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                   .+         .++..+|+++.+||++||+.||.+|||+.|+++|
T Consensus       231 -------------~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         231 -------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                         00         1234579999999999999999999999999987

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-58  Score=405.47  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=208.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      +.|++.+.||+|+||+||+|+++.+|+.||+|++...    .+...+|+++++.++||||+++++++..     ...+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence            4699999999999999999999999999999998543    2345689999999999999999999843     345899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      |||||.+ +|...+...   ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|....
T Consensus        87 vmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNT  161 (288)
T ss_dssp             EEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEECH
T ss_pred             EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCC-CEEEEechhhhccC
Confidence            9999996 777666543   36799999999999999999999999 999999999999999888 79999999997654


Q ss_pred             cCC-CccccccccccccchhccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          220 KGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ... ......||+.|+|||++..    ...|+.++|||||||++|+|++|+.||.+.+..+.+.++.+.....       
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-------  234 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-------  234 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-------
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            322 2235679999999999842    3447899999999999999999999999988888877776531110       


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                         ...+..+|+++.+||++||+.||++|||+.|+++|
T Consensus       235 -------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         235 -------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                               01123578999999999999999999999999997

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-57  Score=397.84  Aligned_cols=247  Identities=22%  Similarity=0.329  Sum_probs=203.6

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      |++.++||+|+||+||+|++..+++.||+|++....      +...+|+++|++++||||+++++++.... .+..++++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            578889999999999999999999999999885432      33458999999999999999999875543 34567899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~--iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      |||||++ +|.+.+...    ..+++..++.++.||+.||+|||++ +  |+||||||+|||++.+.+.+||+|||+|+.
T Consensus        90 vmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999986 888888654    5789999999999999999999998 8  999999999999975433799999999975


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .. ........||+.|||||++.+ . ++.++|||||||++|||++|+.||.+......+.+.+... ..+         
T Consensus       165 ~~-~~~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-~~~---------  231 (270)
T d1t4ha_         165 KR-ASFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKP---------  231 (270)
T ss_dssp             CC-TTSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCC---------
T ss_pred             cc-CCccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-CCC---------
Confidence            43 333446789999999999854 3 8999999999999999999999998766655544333211 111         


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      ..++...++++.+||.+||++||++|||++|+|+|
T Consensus       232 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         232 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                            11234578999999999999999999999999997

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-58  Score=410.07  Aligned_cols=248  Identities=26%  Similarity=0.391  Sum_probs=195.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++....     ....+|+.+|+.++||||+++++++     .+..++|
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            46999999999999999999999999999999985432     2345799999999999999999988     4455689


Q ss_pred             EEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC--CCCcEEEEeccCce
Q 018514          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAK  216 (354)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~--~~~~vkl~Dfg~a~  216 (354)
                      +|||||+ |+|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+||++..  +.+.+||+|||+|.
T Consensus        84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCceEEEeccceeE
Confidence            9999998 588888865    36799999999999999999999998 9999999999999953  22379999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ...........+||+.|||||++.+.. |+.++|||||||++|+|++|..||.+.+..+....+.+....++        
T Consensus       159 ~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------  229 (307)
T d1a06a_         159 MEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD--------  229 (307)
T ss_dssp             --------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC--------
T ss_pred             EccCCCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC--------
Confidence            776655556678999999999997655 89999999999999999999999998887777666655311111        


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                       ......+|+++.+||.+||+.||++|||++|+++|
T Consensus       230 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 -----------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -----------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                             11234589999999999999999999999999997

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-57  Score=403.67  Aligned_cols=242  Identities=31%  Similarity=0.517  Sum_probs=204.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....       ....+|++++++++||||++++++|     .+...
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence            57999999999999999999999999999999985321       2356899999999999999999988     44556


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +|+|||||+| +|.+.+...    +.+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~-~vkl~DFG~a~  156 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTAK  156 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCc-eEEecccccce
Confidence            8999999995 787776654    6799999999999999999999999 999999999999999888 79999999998


Q ss_pred             ecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          217 VLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       217 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+.++.+.-         
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~---------  226 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE---------  226 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC---------
T ss_pred             ecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC---------
Confidence            764332   223467999999999997665 8999999999999999999999999888777776664420         


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhh
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVG  347 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~  347 (354)
                                          ..++..+++++.+||++||+.||++|||++|++.
T Consensus       227 --------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 --------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             --------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                                0133458999999999999999999999998643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-58  Score=407.64  Aligned_cols=269  Identities=35%  Similarity=0.599  Sum_probs=222.1

Q ss_pred             EEeEeeeccceEEEEEEEcCCCceEEEEEcccch---------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        69 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+++.++||||+++++++     .+..+++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence            4678999999999999999999999999985432         2345799999999999999999998     3444589


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +||||+.+++...+...   ...+++..++.+++||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|....
T Consensus        77 ivmE~~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCC-ccccccCccccccC
Confidence            99999998766655432   46789999999999999999999998 999999999999999887 79999999997654


Q ss_pred             cCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ... .....+||+.|+|||++.....++.++|||||||++|||++|.+||.+.++.+++..+.+.++.+....+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            433 3345678999999999977776899999999999999999999999999999999999999999888766544433


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....+......++.. ....+++++.+||++||++||++||||+|+|+|
T Consensus       232 ~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhhhhccCCCCChHH-hcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            3333333333333332 234579999999999999999999999999997

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-57  Score=401.02  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=214.8

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----------hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  132 (354)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++...          .+...+|+.+|++++||||++++++|     
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----   82 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----   82 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            345799999999999999999999999999999988532          23456899999999999999999998     


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC---cEE
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  208 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~---~vk  208 (354)
                      .+..++|+|||||+| +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.   .+|
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EECCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceE
Confidence            455568999999995 888888764    5799999999999999999999999 9999999999999986653   599


Q ss_pred             EEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      |+|||+|.....+.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+.....+
T Consensus       158 l~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1jksa_         158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  236 (293)
T ss_dssp             ECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             ecchhhhhhcCCCccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            99999998876666666778999999999997654 89999999999999999999999999888777777655422222


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .                         .+...+|+++.+||++||+.||++|||++|+++|
T Consensus       237 ~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         237 D-------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             H-------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             c-------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2                         1234579999999999999999999999999987

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-57  Score=412.96  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=214.1

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++....    +...+|+.+|++++||||+++++++.     +...+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence            457999999999999999999999999999999985432    33458999999999999999999984     344589


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC-CCcEEEEeccCcee
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  217 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~-~~~vkl~Dfg~a~~  217 (354)
                      +|||||+| +|.+.+...   ..++++..++.++.||+.||.|||++ ||+||||||+|||++.+ .+.+||+|||+|..
T Consensus       100 ivmE~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEECCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            99999985 888877543   35799999999999999999999999 99999999999999643 23799999999998


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...........||+.|||||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+......++.        
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------  246 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------  246 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC--------
T ss_pred             cccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------
Confidence            76666666788999999999997765 899999999999999999999999998888888877664222211        


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                       .....+|+++.+||.+||+.||++|||++|+|+|
T Consensus       247 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 -----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                             1223479999999999999999999999999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-57  Score=412.26  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=213.5

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...    .....+|+.+|++++||||++++++|     .+...+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            45799999999999999999999999999999998643    23445799999999999999999998     4455689


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC-CCCcEEEEeccCcee
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKV  217 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~-~~~~vkl~Dfg~a~~  217 (354)
                      +|||||+| +|.+.+...   ..++++..++.++.||+.||+|||++ ||+||||||+|||++. +.+.+||+|||+|..
T Consensus       103 ivmE~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         103 LILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeeccccee
Confidence            99999995 776655432   35799999999999999999999998 9999999999999973 233799999999998


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+....++         
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------  248 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------  248 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred             cCCCCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            87666666788999999999997665 89999999999999999999999999888888777766322211         


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                      ......+|+++.+||.+||++||.+|||+.|+|+|
T Consensus       249 ----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 ----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                            11234589999999999999999999999999997

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-57  Score=404.65  Aligned_cols=244  Identities=27%  Similarity=0.429  Sum_probs=205.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      ..|++.+.||+|+||+||+|++..+|+.||||++....       ....+|++++++++|||||++++++..     ...
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence            35999999999999999999999999999999985432       234579999999999999999999843     345


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +|+|||||.++....+...   ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|..
T Consensus        90 ~~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCC-CEEEeecccccc
Confidence            8999999997655444332   36799999999999999999999999 999999999999999887 899999999986


Q ss_pred             cccCCCccccccccccccchhccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ...   .....||+.|||||++.+.  ..|+.++|||||||++|||++|..||.+.+..+.+..+......+.       
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------  234 (309)
T d1u5ra_         165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-------  234 (309)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------
T ss_pred             cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence            533   3356799999999998642  3489999999999999999999999998887777776655311110       


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                          .+..+|+++.+||.+||+.||++|||++|+|+|
T Consensus       235 --------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         235 --------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             --------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                                123478999999999999999999999999987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-57  Score=401.47  Aligned_cols=274  Identities=34%  Similarity=0.602  Sum_probs=223.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...      .....+|++++++++||||++++++|.     +...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence            5799999999999999999999999999999998543      233457999999999999999999984     34458


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      |+||||+.+++...+....  ...+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||.|...
T Consensus        77 ~iv~e~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccC-cceeccCCcceec
Confidence            9999999998777765543  46799999999999999999999998 999999999999999887 7999999999766


Q ss_pred             ccC-CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ... .......||+.|+|||.+.....++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+.....
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            433 3344568899999999987777678999999999999999999999999999999999999888877655432211


Q ss_pred             CCcc-cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~-~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .... ...+......+. .....+|+++.+||++||++||++|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFS-KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             STTCCTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccchh-hhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1100 011111111111 2234588999999999999999999999999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=409.33  Aligned_cols=272  Identities=26%  Similarity=0.398  Sum_probs=202.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++...     .....+|+.+|+.++||||++++++|     .+...+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            45899999999999999999999999999999998543     23445899999999999999999998     344558


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      |+|||||.| +|.+++.+.    ..+++..++.++.||+.||.|||+ + ||+||||||+|||++.++ .+||+|||+|.
T Consensus        80 ~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~-~IiHRDiKP~NILl~~~~-~vkl~DFGla~  153 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRG-EIKLCDFGVSG  153 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH-CCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred             EEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC-CEEccccCHHHeeECCCC-CEEEeeCCCcc
Confidence            999999996 888887654    569999999999999999999996 6 899999999999999888 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhcc
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~  295 (354)
                      ..... .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+. ...+....+.+........
T Consensus       154 ~~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         154 QLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HHHHH-TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             ccCCC-ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            66443 234578999999999998765 99999999999999999999999987654332 1211111111111100000


Q ss_pred             CC-----CCcccCCCC---------ccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NP-----NYTEFKFPQ---------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~-----~~~~~~~~~---------~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..     .......+.         .....+.......+|.++.+||.+||++||.+||||+|+|+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            00     000000000         000001111123468999999999999999999999999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-56  Score=396.81  Aligned_cols=278  Identities=33%  Similarity=0.553  Sum_probs=227.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCC-CceEEEEEcccc------hhhhHHHHHHHHHc---CCCCeeecceeeeecCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQD------KRYKNRELQTMRLL---DHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~------~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~  133 (354)
                      .++|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+++.+   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            45899999999999999999999765 677999998543      12344788877766   799999999998776666


Q ss_pred             CeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+++++|||+.+++........  ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~-~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCC-Ceeecchh
Confidence            778899999999987666554432  46789999999999999999999999 999999999999999887 79999999


Q ss_pred             CceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      ++.............||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+....+.+....+.
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            998766655666788999999999997665 8999999999999999999999999999999999999999998877654


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ........ .+......+ ...+...+++.+.+||++||++||++||||.|+|+|
T Consensus       241 ~~~~~~~~-~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         241 RDVALPRQ-AFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             TTCSSCGG-GSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccchhh-hhccccccc-hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            32221111 111111111 123455689999999999999999999999999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=401.84  Aligned_cols=244  Identities=25%  Similarity=0.391  Sum_probs=210.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...       .....+|+.+|+.++||||++++++|     .+..
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence            35799999999999999999999999999999998643       13345799999999999999999998     5556


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ++|+|||||.| +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g-~vkl~DFG~a  152 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCC-CEEEeecccc
Confidence            69999999995 777777654    6789999999999999999999999 999999999999999888 7999999999


Q ss_pred             eeccc-CCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          216 KVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       216 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      +.... .......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....+...-          
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~----------  221 (337)
T d1o6la_         153 KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------  221 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             cccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC----------
Confidence            86544 33445678999999999997665 8999999999999999999999999988777666665521          


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                         ..+++.+|+++++||++||++||.+|++     ++|+++|
T Consensus       222 -------------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 -------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                               1134558999999999999999999994     9999987

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=399.82  Aligned_cols=250  Identities=25%  Similarity=0.390  Sum_probs=215.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .++|++.+.||+|+||+||+|.++.+|+.||||++....   ....+|+++|+.++||||++++++|.     +...+|+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence            468999999999999999999999999999999996543   33558999999999999999999983     4445899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC-CCcEEEEeccCceec
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  218 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~-~~~vkl~Dfg~a~~~  218 (354)
                      |||||+| +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+ ...+||+|||++...
T Consensus        79 vmE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          79 IFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999996 888877643   24799999999999999999999998 99999999999999753 337999999999887


Q ss_pred             ccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       219 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..........+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+....++...       
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------  226 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------  226 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred             ccCCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh-------
Confidence            6665566778899999999996655 89999999999999999999999999988888888877533333322       


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                                        ...+|+++.+||++||+.||.+|||++|+++|
T Consensus       227 ------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                              23478999999999999999999999999987

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-55  Score=388.71  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=212.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------------hhhHHHHHHHHHcC-CCCeeecceeeeec
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCFFST  130 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~  130 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||||++....             ....+|+.++++++ ||||+++++++   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            57999999999999999999999999999999985421             23457999999997 99999999998   


Q ss_pred             CCCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEE
Q 018514          131 TEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl  209 (354)
                        .+...+|||||||++ +|.+.+...    .++++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEE
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCC-CeEE
Confidence              455568999999985 999888754    5799999999999999999999998 999999999999999887 7999


Q ss_pred             EeccCceecccCCCccccccccccccchhccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 018514          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  284 (354)
Q Consensus       210 ~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  284 (354)
                      +|||++.............||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+.......+...-
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999998776666666789999999999852     3347889999999999999999999999988777777666531


Q ss_pred             CCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ..++                         .....++|+++.+||.+||++||++|||++|+++|
T Consensus       232 ~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         232 YQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             CCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1111                         11223589999999999999999999999999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-55  Score=394.73  Aligned_cols=241  Identities=26%  Similarity=0.454  Sum_probs=207.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++...       .+...+|+.+++.++||||+++++++     .+..+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            5799999999999999999999999999999998543       23345799999999999999999998     44556


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +|+|||||.| ++...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|.
T Consensus        79 ~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g-~vkL~DFG~a~  152 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFAK  152 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred             eeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCC-CEEEecCccce
Confidence            8999999997 55555544    36788999999999999999999999 999999999999999887 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .....  .....||+.|||||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..+...-.           
T Consensus       153 ~~~~~--~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----------  218 (316)
T d1fota_         153 YVPDV--TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----------  218 (316)
T ss_dssp             ECSSC--BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----------
T ss_pred             Eeccc--cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----------
Confidence            76433  34578999999999996655 89999999999999999999999999888777777665210           


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                        .++..+++++.++|.+||+.||.+|+     |++++++|
T Consensus       219 ------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 ------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                              12345789999999999999999996     99999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-56  Score=394.96  Aligned_cols=252  Identities=19%  Similarity=0.297  Sum_probs=206.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||+++.+   .+...+|+++|++++||||+++++++.     +...+++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCeeEE
Confidence            45799999999999999999999999999999998654   334568999999999999999999883     3344789


Q ss_pred             EEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      |||||+ |++...+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCC-cEEEccccceeecC
Confidence            999999 58888776533  36789999999999999999999998 999999999999999887 79999999998654


Q ss_pred             cCCCc--cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          220 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       220 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .....  ....|++.|+|||++.+.. ++.++|||||||++|||++|..||........+.++....             
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-------------  232 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------------  232 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-------------
T ss_pred             CCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-------------
Confidence            43322  2345788999999997665 8999999999999999999776655554444444443321             


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                    +...++..+++++.+||.+||+.||.+|||+.++++.|+..
T Consensus       233 --------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         233 --------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             --------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             --------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                          11123345899999999999999999999999999887654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-55  Score=390.37  Aligned_cols=272  Identities=33%  Similarity=0.612  Sum_probs=219.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...      .....+|+.+|++++||||+++++++..     ....
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCce
Confidence            47999999999999999999985 7899999998543      2345589999999999999999999843     3448


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +++|||+.+++...+...   ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||.|...
T Consensus        76 ~i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCC-CEEecccccceec
Confidence            899999999877766543   37799999999999999999999998 999999999999999887 7999999999765


Q ss_pred             ccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      .... ......+++.|+|||.+.+...++.++|||||||++|||++|++||.+.+..+.+.++.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            4332 234556899999999998777789999999999999999999999999999999999999888887665543221


Q ss_pred             CCc-ccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYT-EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~-~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ... ..........+| ..+...+++.+.+||++||++||++||||.|+|+|
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             STTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhcccccccccCcch-hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111 111111122222 23455689999999999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3e-55  Score=400.31  Aligned_cols=246  Identities=26%  Similarity=0.371  Sum_probs=201.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHH---HHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||||++....       ....+   |+.+++.++||||++++++|     .+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----EE
Confidence            57999999999999999999999999999999985321       11223   45666777899999999988     44


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      ...+|+|||||.| +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g-~iKl~DFG  152 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLG  152 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCC-cEEEeeec
Confidence            4558999999995 888888764    5789999999999999999999999 999999999999999887 79999999


Q ss_pred             CceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 018514          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (354)
Q Consensus       214 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (354)
                      +|...... ......||+.|+|||++.....|+.++|||||||++|+|++|+.||.+.+............ ..      
T Consensus       153 la~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~------  224 (364)
T d1omwa3         153 LACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TM------  224 (364)
T ss_dssp             TCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-SC------
T ss_pred             eeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cC------
Confidence            99876544 34456899999999999766668999999999999999999999998765433322221110 00      


Q ss_pred             ccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCC-----HHHHhhc
Q 018514          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AFDAVGS  348 (354)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpt-----a~e~l~~  348 (354)
                                         ...++..+|+++.+||.+||+.||.+|||     |+|+++|
T Consensus       225 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         225 -------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             -------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                               01133468999999999999999999999     8999988

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-55  Score=396.45  Aligned_cols=243  Identities=27%  Similarity=0.410  Sum_probs=209.2

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++....       ....+|+.+|+.++||||+++++++     .+.
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~  113 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN  113 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccc
Confidence            3468999999999999999999999999999999985321       2345799999999999999999988     445


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+++||||+.+ ++...+...    ..+++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+|||+
T Consensus       114 ~~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g-~ikL~DFG~  187 (350)
T d1rdqe_         114 SNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFGF  187 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             cccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCC-CEEeeecee
Confidence            558899999996 777777654    5799999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       215 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      |+.....  .....||+.|||||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+.....         
T Consensus       188 a~~~~~~--~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------  255 (350)
T d1rdqe_         188 AKRVKGR--TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------  255 (350)
T ss_dssp             CEECSSC--BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             eeecccc--cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC---------
Confidence            9876433  34568999999999997665 89999999999999999999999998887777777755311         


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                                          .++..+++++.+||++||+.||.+|+     |++++++|
T Consensus       256 --------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 --------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                                12345899999999999999999995     99999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=388.46  Aligned_cols=251  Identities=21%  Similarity=0.274  Sum_probs=200.7

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      .++|++.+.||+|+||+||+|+++   ..||||++...      .+.+.+|+.++++++||||+++++++..      ..
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            357999999999999999999853   35999998532      2345579999999999999999987521      12


Q ss_pred             EEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      +++|||||+ |+|.+.+...   ..++++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|.
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred             EEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCC-CEEEcccccee
Confidence            689999999 5888887653   35699999999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCC---CccccccccccccchhccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          217 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       217 ~~~~~~---~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      ......   ......||+.|||||++.+.  ..++.++|||||||++|||+||+.||.+.+....+.........++.  
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~--  230 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD--  230 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC--
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc--
Confidence            654322   22345789999999998643  24789999999999999999999999988777666655553221111  


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                           ...++..+++++.+||.+||+.||.+|||+.+++++|+.
T Consensus       231 ---------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         231 ---------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             ---------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                                 011334578999999999999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9e-55  Score=383.98  Aligned_cols=255  Identities=26%  Similarity=0.396  Sum_probs=205.0

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++....       ....+|+++++.++||||+++++++.... ...
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~   83 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG   83 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence            3457999999999999999999999999999999985431       23457999999999999999999876543 344


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+|+|||||+| +|...+...    +++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||.
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~-~~~l~d~~~  157 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGI  157 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTS-CEEECCCTT
T ss_pred             ceEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccc-cceeehhhh
Confidence            568899999996 777666543    5799999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCC----CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +.......    ......||+.|+|||++.+.. ++.++|||||||++|+|+||++||.+.+..+.+.++......++  
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~--  234 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--  234 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG--
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC--
Confidence            87653332    233567899999999997655 89999999999999999999999998888777776655321111  


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-CHHHHhhccC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-TAFDAVGSFD  350 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-ta~e~l~~l~  350 (354)
                                             ......+|+++.++|.+||++||.+|| |+++++..|.
T Consensus       235 -----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         235 -----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             -----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence                                   112345899999999999999999999 8888887664

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.9e-56  Score=393.85  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=194.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCc---eEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      ..+|++.+.||+|+||+||+|+++.+|+   .||||.+...     .+...+|+++|++++|||||++++++..     .
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~   99 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----S   99 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence            3479999999999999999999877664   5889987532     2345689999999999999999998833     3


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+++|||||++ +|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGl  174 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNL-VCKVSDFGL  174 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             CEEEEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCC-cEEECCccc
Confidence            347899999996 677766643   35689999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCc------cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 018514          215 AKVLVKGEPN------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  287 (354)
Q Consensus       215 a~~~~~~~~~------~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  287 (354)
                      |+........      ....||+.|||||.+.+.. ++.++|||||||++|||+| |..||.+.+..+.+..+......+
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~  253 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP  253 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9866443221      1245688999999997655 8999999999999999998 899999888776666554421111


Q ss_pred             CHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                                  .+..+++++.+|+.+||+.||.+|||+.|+++.|+.+
T Consensus       254 ----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         254 ----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                        2234789999999999999999999999999988753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=385.30  Aligned_cols=246  Identities=19%  Similarity=0.328  Sum_probs=194.9

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      +|++.+.||+|+||+||+|++. +++.||||++..+   .....+|++++++++||||+++++++..     ...+++||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~lv~   79 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVF   79 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEEEE
Confidence            6999999999999999999975 5678999998653   3445689999999999999999998843     33378999


Q ss_pred             eeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      ||+.+ +|.+++...   ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.....
T Consensus        80 E~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             ECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGG-CEEECSCC--------
T ss_pred             EecCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCC-CeEecccchheeccCC
Confidence            99985 787777653   36688999999999999999999998 999999999999999887 7999999999866443


Q ss_pred             CC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          222 EP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       222 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..  .....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||...+..+.+..+......            
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~------------  221 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------------  221 (263)
T ss_dssp             ----------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC------------
T ss_pred             CceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC------------
Confidence            32  22456899999999997665 8999999999999999999 56777766665665555442111            


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                      ..+..+++++.+++.+||+.||++|||+++++++|+.
T Consensus       222 ----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         222 ----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                            1223478999999999999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=395.33  Aligned_cols=259  Identities=25%  Similarity=0.343  Sum_probs=205.5

Q ss_pred             cccceEEEe-EeeeccceEEEEEEEcCCCceEEEEEcccchhhhHHHHHHHHH-cCCCCeeecceeeeecCCCCeeEEEE
Q 018514           63 QTISYMAER-VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        63 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..++|.+.. .||+|+||+||+|++..+|+.||||++... ....+|+.++.+ .+||||++++++|.... ....++|+
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~i   86 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI   86 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEE
Confidence            356799875 599999999999999999999999998643 445679988655 58999999999874422 34677899


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC--CCcEEEEeccCcee
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKV  217 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~--~~~vkl~Dfg~a~~  217 (354)
                      |||||+| +|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+  ...+||+|||+|+.
T Consensus        87 vmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          87 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeee
Confidence            9999985 8998887532  35799999999999999999999998 99999999999999753  23699999999988


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...........||+.|||||++.+.. |+.++|||||||++|+|+||++||.+.+.......+...+..           
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~-----------  231 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-----------  231 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS-----------
T ss_pred             ccCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc-----------
Confidence            77666667788999999999996554 899999999999999999999999876654443333221100           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                        ..+.++        ......+|+++.+||++||+.||++|||+.|+++|
T Consensus       232 --~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 --GQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             --CSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --CCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              000111        11112478999999999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-55  Score=393.51  Aligned_cols=252  Identities=21%  Similarity=0.304  Sum_probs=205.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCc-----eEEEEEcccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      .++|++.+.||+|+||+||+|++..+++     .||+|.+...     .....+|+.++.++ +|||||++++++.    
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~----  111 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----  111 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----
Confidence            3579999999999999999999876543     5899987533     23345799999988 8999999999983    


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYK-------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD  192 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~D  192 (354)
                       +...+++|||||++ +|.+++.....                   ....+++..++.++.||+.||+|||++ ||+|||
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHRD  189 (325)
T d1rjba_         112 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRD  189 (325)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETT
T ss_pred             -eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-Ceeecc
Confidence             33448999999985 99988876432                   124589999999999999999999999 999999


Q ss_pred             CCCCCeeeeCCCCcEEEEeccCceecccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 018514          193 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  268 (354)
Q Consensus       193 lkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf  268 (354)
                      |||+|||++.++ .+||+|||+|+........   ....||+.|||||++.+.. ++.++|||||||++|||+| |.+||
T Consensus       190 lKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         190 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCC
Confidence            999999999887 8999999999876544332   2456799999999997665 8999999999999999998 89999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          269 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       269 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+.+....+.++......                           ...+..+|+++.+||.+||+.||++|||++|++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCC---------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            987776666666553111                           11234578999999999999999999999999999


Q ss_pred             cC
Q 018514          349 FD  350 (354)
Q Consensus       349 l~  350 (354)
                      |.
T Consensus       321 L~  322 (325)
T d1rjba_         321 LG  322 (325)
T ss_dssp             HH
T ss_pred             Hh
Confidence            84

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-55  Score=380.47  Aligned_cols=247  Identities=19%  Similarity=0.268  Sum_probs=206.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|++.++||+|+||+||+|+++ ++..||||+++..   .....+|+.++++++||||+++++++..     ...+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceEEE
Confidence            36999999999999999999984 6788999998653   3455689999999999999999998843     3338999


Q ss_pred             Eeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceeccc
Q 018514          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~  220 (354)
                      |||+. |++...+....   ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.....
T Consensus        78 ~Ey~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence            99998 46676655443   5688999999999999999999998 999999999999999887 799999999976544


Q ss_pred             CCC--ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          221 GEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       221 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  .....||+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+....           
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-----------  220 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-----------  220 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred             CCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            332  22456899999999997665 8999999999999999998 89999988877766665442111           


Q ss_pred             CCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                       ..+...++++.+||++||+.||++|||++++++||.+
T Consensus       221 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         221 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                             1223478999999999999999999999999999865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=388.41  Aligned_cols=243  Identities=27%  Similarity=0.480  Sum_probs=205.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-------hhhHHHHHHHH-HcCCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMR-LLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++..+.       ....+|..++. .++||||+++++++     .+..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            47999999999999999999999999999999986432       12335666554 68999999999998     4455


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+|||||||.+ +|..++...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~-~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCC-ceeccccchh
Confidence            68999999995 888887654    5689999999999999999999999 999999999999999887 7999999999


Q ss_pred             eecccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 018514          216 KVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (354)
Q Consensus       216 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (354)
                      ....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...  .+       
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------  220 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------  220 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence            8654332 334568999999999997665 899999999999999999999999988877777666542  10       


Q ss_pred             cCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHH-HHhhc
Q 018514          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAF-DAVGS  348 (354)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~-e~l~~  348 (354)
                                          .+++.+|+++.+||++||+.||.+|||+. ++++|
T Consensus       221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                                13345899999999999999999999996 78776

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=381.10  Aligned_cols=242  Identities=26%  Similarity=0.412  Sum_probs=201.2

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----------hhhHHHHHHHHHcC--CCCeeecceeeeecCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTE  132 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~  132 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||||++....          ....+|+.++++++  ||||+++++++     
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~-----   78 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-----   78 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence            47999999999999999999999999999999985432          22458999999997  89999999988     


Q ss_pred             CCeeEEEEEEeeccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEE
Q 018514          133 KDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                      .+....++||||+.+  ++...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+.+.+||+
T Consensus        79 ~~~~~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          79 ERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEEC
T ss_pred             eeCCeEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEEC
Confidence            444558999999974  566666543    6799999999999999999999999 999999999999999765589999


Q ss_pred             eccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      |||+|..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+      ++.+.       
T Consensus       154 DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-------  219 (273)
T d1xwsa_         154 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-------  219 (273)
T ss_dssp             CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred             ccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------
Confidence            9999986533 334467899999999999777656788999999999999999999997532      12111       


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc--cCcC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS--FDSS  352 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~--l~~~  352 (354)
                                            ...++..+|+++.+||++||+.||++|||++|+++|  |.+.
T Consensus       220 ----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         220 ----------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             ----------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             ----------------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                                  011334589999999999999999999999999997  5443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-54  Score=390.51  Aligned_cols=275  Identities=33%  Similarity=0.587  Sum_probs=222.4

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCee
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  136 (354)
                      ..+|++++.||+|+||+||+|.++.+|+.||||++....      ....+|+++|+.++||||++++++|..... ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357999999999999999999999999999999986431      234579999999999999999998855432 2344


Q ss_pred             EEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .+|+|||||+.++....+.     .++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|.
T Consensus        97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhccccc-cccccccccee
Confidence            5789999998787776654     5799999999999999999999999 999999999999999888 79999999998


Q ss_pred             ecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       217 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ....  ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.++...+....
T Consensus       170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         170 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            6643  33457789999999999877768999999999999999999999999999999999999999999887665433


Q ss_pred             CCCcc---cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .....   ...+......|.. ....+++++.+||++||++||++||||.|+|+|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             chhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            21100   0122333333332 334689999999999999999999999999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=380.29  Aligned_cols=249  Identities=22%  Similarity=0.298  Sum_probs=201.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..+|++.+.||+|+||+||+|+++ ++..||||++...   .....+|++++++++|||||++++++..    +  .+++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~--~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----C--CeEE
Confidence            357999999999999999999975 5678999998653   3345689999999999999999997621    1  2579


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+.+ +|.+.+....  ..++++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus        85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~  160 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARLIE  160 (272)
T ss_dssp             EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeeccc-ceeeccccceEEcc
Confidence            9999995 7776655433  24689999999999999999999998 999999999999999887 79999999998765


Q ss_pred             cCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       220 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      ...  ......||+.|||||++.+.. ++.++|||||||++|||+|| .+||...+..+.+..+.....           
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-----------  228 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-----------  228 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             CCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence            433  223456889999999997655 89999999999999999995 556666665555555433211           


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                       ...+..+++++.+|+.+||+.||++|||++++++.|++-
T Consensus       229 -----------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         229 -----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                             112345789999999999999999999999999987753

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=387.66  Aligned_cols=276  Identities=32%  Similarity=0.606  Sum_probs=223.1

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      .+|++++.||+|+||+||+|+++.+|+.||||++....     ....+|+.+|+.++||||+++++++.........+++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            47999999999999999999999999999999986432     2345799999999999999999998665545555677


Q ss_pred             EEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      +++++++|+|.+++..     .++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|....
T Consensus        88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCC-CEEEcccCceeecc
Confidence            8888777899988864     4699999999999999999999999 999999999999999887 79999999998764


Q ss_pred             cCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          220 KGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       220 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ....    .....||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+........+..+........
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            4322    334678999999999876666899999999999999999999999999888888888888888877654322


Q ss_pred             CCC---CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          296 NPN---YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       296 ~~~---~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...   ......+.....+|... ...+++++.+||.+||++||.+||||.|+|+|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHH-CTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHh-CCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            110   01112333333444333 33578999999999999999999999999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=382.13  Aligned_cols=248  Identities=25%  Similarity=0.318  Sum_probs=202.2

Q ss_pred             cceEEEeE-eeeccceEEEEEEEcCC--CceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           65 ISYMAERV-VGHGSFGVVFQAKCLET--GEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        65 ~~y~~~~~-lg~G~~g~V~~~~~~~~--~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      ++|.+.+. ||+|+||+||+|.++.+  +..||||++...     ...+.+|+++|++++|||||++++++..    +  
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~--   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----E--   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----S--
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----C--
Confidence            46888885 99999999999987643  457999998542     2345589999999999999999998632    1  


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      .+++|||||++ +|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+|
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGla  156 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFGLS  156 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred             eEEEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCC-ceeeccchhh
Confidence            16899999995 777766543   35799999999999999999999998 999999999999999887 8999999999


Q ss_pred             eecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          216 KVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       216 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +.......    .....||+.|+|||++.+.. ++.++|||||||++|||+| |..||.+.+..+....+.+...     
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-----  230 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  230 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----
T ss_pred             hcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            87644322    22446789999999997665 8999999999999999998 9999998877766655543211     


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                             ..++..+|+++.+||.+||+.||++|||+.++++.|++.
T Consensus       231 -----------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         231 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                   012345899999999999999999999999999887653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-53  Score=385.88  Aligned_cols=273  Identities=30%  Similarity=0.504  Sum_probs=217.0

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc-hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++.. .....+|+++|+.++ ||||++++++|...   ...++++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEEE
Confidence            5799999999999999999999999999999998654 345568999999995 99999999987432   334478999


Q ss_pred             eecccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecccC
Q 018514          143 EYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (354)
Q Consensus       143 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~  221 (354)
                      |||.++ |...       .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.+++.+||+|||+|......
T Consensus       112 e~~~~~~L~~~-------~~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQL-------YQTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGT-------TTSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHH-------hcCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999974 3221       35799999999999999999999999 99999999999999987767999999999887766


Q ss_pred             CCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhccCCCCc
Q 018514          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (354)
Q Consensus       222 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .......+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.... ...+...+...++.+....+........
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence            666777899999999999877778999999999999999999999997654 4556667777766655444322211111


Q ss_pred             ccC----CCCccCCCcccc----cCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          301 EFK----FPQIKAHPWHKI----FQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       301 ~~~----~~~~~~~~~~~~----~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ...    ........|...    ....+++++.+||++||++||++||||+|+|+|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111    111111222221    123478999999999999999999999999997

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=382.89  Aligned_cols=280  Identities=29%  Similarity=0.477  Sum_probs=217.1

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC---CC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KD  134 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~  134 (354)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....      ....+|+++|+.++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            468999999999999999999999999999999985432      234589999999999999999998754321   22


Q ss_pred             eeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..++++||||+.+++.......   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~-~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCC-cEEeeecce
Confidence            3458899999998776655443   46789999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecccCC-----CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 018514          215 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (354)
Q Consensus       215 a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (354)
                      +.......     ......||+.|+|||++.+...++.++|||||||++|||++|++||.+.++...+..+.+..+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97654321     2234578999999999987777999999999999999999999999999999999999999888877


Q ss_pred             HHHhccCCCCcccCCCCccCCC--ccccc-CCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHP--WHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      +.....................  ....+ ....++++.+||.+||++||++||||+|+|+|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            6543332211111111111100  00000 11246789999999999999999999999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=375.26  Aligned_cols=274  Identities=32%  Similarity=0.528  Sum_probs=221.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      ++|++++.||+|+||+||+|++..+|+.||||+++...      ....+|+.+++.++||||+++++++     .+....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence            47999999999999999999999999999999985432      3345899999999999999999988     445558


Q ss_pred             EEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +++++++.++....+...   .+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||.+...
T Consensus        77 ~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCC-ceeeeecchhhcc
Confidence            899999998655544433   46789999999999999999999998 999999999999999887 7999999999876


Q ss_pred             ccCC-CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 018514          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREEIKCMN  296 (354)
Q Consensus       219 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (354)
                      .... ......+++.|+|||.+.....++.++|||||||++|||++|+.|| .+.+..+.+..+....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            5433 3334567888999999977776899999999999999999998774 5566677788888888887766554333


Q ss_pred             CCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ........+..............+++.+.+||++||++||.+||||+|+|+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2222222222222223333455689999999999999999999999999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=374.81  Aligned_cols=247  Identities=22%  Similarity=0.299  Sum_probs=190.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCC----ceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCee
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  136 (354)
                      .|++.+.||+|+||+||+|.++.++    ..||||++...     ...+.+|++++++++|||||++++++..     ..
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-----~~   82 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----YK   82 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SS
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----CC
Confidence            6999999999999999999987654    46999998542     1234589999999999999999998843     33


Q ss_pred             EEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCc
Q 018514          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (354)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a  215 (354)
                      ..++|||||.+ ++...+...   ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGla  157 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  157 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred             ceEEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCC-eEEEcccchh
Confidence            37899999996 555554433   36799999999999999999999998 999999999999999888 7999999999


Q ss_pred             eecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          216 KVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP-LFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       216 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~-pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      +.......    .....||+.|||||++.+.. ++.++|||||||++|||++|.. ||...+..+.+..+.....     
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-----  231 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-----  231 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-----
Confidence            87644322    22346789999999997655 8999999999999999999654 4554554444443322110     


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                             ...+..++.++.++|.+||+.||++|||+.|+++.|+.
T Consensus       232 -----------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         232 -----------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             -----------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence                                   11234478999999999999999999999999998864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=386.24  Aligned_cols=275  Identities=31%  Similarity=0.535  Sum_probs=213.5

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  137 (354)
                      .+|+++++||+|+||+||+|++..+|+.||||++...      .....+|+.++++++||||++++++|..... +...+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            4799999999999999999999999999999998643      1234589999999999999999999854432 34577


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      +|+|||||.+++...+.      ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+|++|||++..
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~-~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCcccccccccc-ceeeechhhhhc
Confidence            99999999998776553      5689999999999999999999999 999999999999999888 799999999987


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...........+|+.|+|||++.+.. +++++||||+||++|+|++|++||.+.+.......+....+.+..+.+.....
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             ------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             cccccccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            76666666778999999999997754 89999999999999999999999999999999999999999988887654432


Q ss_pred             CCcccCC--CCccCCCcccc-----------cCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTEFKF--PQIKAHPWHKI-----------FQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~~~~--~~~~~~~~~~~-----------~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ....+..  +......+...           .....++++.+||++||++||++||||+|+|+|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            2111100  00111111111           112246789999999999999999999999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=376.32  Aligned_cols=244  Identities=22%  Similarity=0.287  Sum_probs=196.2

Q ss_pred             eEEE-eEeeeccceEEEEEEEc--CCCceEEEEEcccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeE
Q 018514           67 YMAE-RVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (354)
Q Consensus        67 y~~~-~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  137 (354)
                      +.+. ++||+|+||+||+|.++  .+++.||||+++..      .....+|+++|++++||||+++++++..     .. 
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~~-   81 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ES-   81 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----SS-
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----CC-
Confidence            3443 47999999999999864  34578999998543      2345589999999999999999998721     11 


Q ss_pred             EEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCce
Q 018514          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (354)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~  216 (354)
                      .++|||||++ +|.+++..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        82 ~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~-~~kl~DFGla~  155 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSK  155 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccC-cccccchhhhh
Confidence            5799999985 78877765    36799999999999999999999998 999999999999999887 89999999998


Q ss_pred             ecccCCC----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          217 VLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       217 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      .......    .....||+.|||||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.+...      
T Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~------  228 (277)
T d1xbba_         156 ALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------  228 (277)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------
T ss_pred             hccccccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            7644322    22346889999999997665 8999999999999999998 8999998877665555433210      


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                            ..++..+|+++.+||.+||+.||.+|||+.++++.|++
T Consensus       229 ----------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         229 ----------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                                  01234578999999999999999999999999887754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=375.87  Aligned_cols=249  Identities=26%  Similarity=0.365  Sum_probs=194.3

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCC---ceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .++|++.+.||+|+||+||+|++..++   ..||||.+...     .....+|+.++++++||||+++++++..      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            357999999999999999999986543   46889987532     2334589999999999999999998721      


Q ss_pred             eEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      ..+++||||+.+ ++..++...   ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~-~~Kl~DfG~  154 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDFGL  154 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred             CeEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCC-cEEEccchh
Confidence            236899999995 666655543   35789999999999999999999999 999999999999999887 899999999


Q ss_pred             ceecccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 018514          215 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (354)
Q Consensus       215 a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (354)
                      |+......  ......||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+......     
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-----  228 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-----  228 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----
T ss_pred             heeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            98654332  223456789999999997655 8999999999999999998 89999988877776666442110     


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                             .++..+|+++.+||.+||+.||.+|||+.|++++|++.
T Consensus       229 -----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         229 -----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                   12345899999999999999999999999999998753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-53  Score=379.05  Aligned_cols=247  Identities=22%  Similarity=0.348  Sum_probs=197.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCc----eEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCe
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .+|++.+.||+|+||+||+|.+..+|+    .||+|++...     .+...+|++++++++|||||++++++...     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            369999999999999999999988876    5888877532     23456899999999999999999987432     


Q ss_pred             eEEEEEEeecc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccC
Q 018514          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (354)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~  214 (354)
                      . .+++++|+. ++|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~-~~kl~DFGl  157 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFGL  157 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred             C-eeEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCC-CeEeecccc
Confidence            2 456677776 5887776654   36799999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 018514          215 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (354)
Q Consensus       215 a~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (354)
                      |+........   ....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+.+....    
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~----  232 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----  232 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC----
T ss_pred             ceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            9876443322   2346799999999997665 8999999999999999998 78999887766655554442111    


Q ss_pred             HHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                              ..+..+++++.+|+.+||+.||.+|||+.+++++|+.
T Consensus       233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence                                    1223478999999999999999999999999998753

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-53  Score=371.35  Aligned_cols=250  Identities=24%  Similarity=0.315  Sum_probs=196.0

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  139 (354)
                      ..++|++.+.||+|+||+||+|+++.+ ..||||++....   ..+.+|+.++++++|||||++++++..    +.  ++
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~----~~--~~   87 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EP--IY   87 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec----CC--eE
Confidence            346899999999999999999998654 579999986443   446689999999999999999998621    11  57


Q ss_pred             EEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceec
Q 018514          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (354)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~  218 (354)
                      +|||||.+ ++...+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+..
T Consensus        88 lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~  163 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLI  163 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred             EEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCC-cEEEcccchhhhc
Confidence            89999996 6666665433  35699999999999999999999999 999999999999999887 7999999999866


Q ss_pred             ccCC--CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 018514          219 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (354)
Q Consensus       219 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (354)
                      ....  ......||+.|+|||.+.... ++.++|||||||++|||++|. +|+.+....+.+..+.+...          
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~----------  232 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------  232 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             cCCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----------
Confidence            4333  223456899999999997655 899999999999999999965 55555555455544433211          


Q ss_pred             CCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                        ...+..+++++.++|.+||+.||++|||++++++.|++.
T Consensus       233 ------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         233 ------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             ------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence                              112345789999999999999999999999999887654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=374.30  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=194.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  133 (354)
                      ++|++.+.||+|+||+||+|++..     +++.||||++....     ....+|...+.++ .|+||+.+++++...   
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~---   89 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---   89 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST---
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC---
Confidence            579999999999999999999754     34689999986432     2334566777666 689999998876432   


Q ss_pred             CeeEEEEEEeecc-ccHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeee
Q 018514          134 DELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (354)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili  200 (354)
                       ...+++|||||+ |+|.+++.....            ....+++..+..++.||+.||.|||++ ||+||||||+|||+
T Consensus        90 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl  167 (299)
T d1ywna1          90 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILL  167 (299)
T ss_dssp             -TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEE
T ss_pred             -CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeE
Confidence             233789999999 588888876442            134589999999999999999999998 99999999999999


Q ss_pred             eCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHH
Q 018514          201 NPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQ  276 (354)
Q Consensus       201 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~  276 (354)
                      +.++ .+||+|||+|+.......   .....||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+.+..+.
T Consensus       168 ~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             CGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             CCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9887 799999999976543322   23457899999999997665 89999999999999999986 578887766565


Q ss_pred             HHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          277 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      +..+......+                           .++..+++++.++|.+||+.||++|||+.|+++||++.
T Consensus       246 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         246 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            55554431111                           12345789999999999999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=368.45  Aligned_cols=248  Identities=21%  Similarity=0.318  Sum_probs=199.2

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEE
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      ..++|++.+.||+|+||.||+|++  +|..||||+++.+  .+...+|++++++++||||+++++++...    ...+++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~l   78 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI   78 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEEE
Confidence            345799999999999999999998  5789999999654  34556899999999999999999987432    223689


Q ss_pred             EEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCceecc
Q 018514          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (354)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~~~  219 (354)
                      ||||+++ +|.+++.....  ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++...
T Consensus        79 v~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~  154 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS  154 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC-----
T ss_pred             EEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCC-CEeecccccceecC
Confidence            9999985 88888865432  3588999999999999999999998 999999999999999888 79999999998653


Q ss_pred             cCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCCC
Q 018514          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (354)
Q Consensus       220 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (354)
                      ..  .....+|..|+|||++.+.. ++.++|||||||++|||+| |++||...+..+....+.+..              
T Consensus       155 ~~--~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~--------------  217 (262)
T d1byga_         155 ST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------  217 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--------------
T ss_pred             CC--CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            32  33456788999999997665 8999999999999999998 788888877666655543211              


Q ss_pred             CcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                    ...++..+++++.+||++||+.||.+|||+.+++++|+.
T Consensus       218 --------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         218 --------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence                          112344578999999999999999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=377.48  Aligned_cols=274  Identities=34%  Similarity=0.560  Sum_probs=218.4

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCeeE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  137 (354)
                      ++|++++.||+|+||+||+|++..+|+.||||++....      ....+|+.+|+.++||||+++++++..... ++...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            47999999999999999999999999999999986432      234589999999999999999998754432 23334


Q ss_pred             EEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      .++++++++|+|.+++..     +++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+|++|||++..
T Consensus        98 ~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~-~~kl~dfg~a~~  170 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  170 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred             EEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccc-cccccccchhcc
Confidence            555555555688887743     5799999999999999999999999 999999999999999887 799999999975


Q ss_pred             cccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCC
Q 018514          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (354)
Q Consensus       218 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ......|++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+.+..+.+..+.......
T Consensus       171 ~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         171 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             CTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             cCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            432  334567899999999987777689999999999999999999999999999999999999988888776543221


Q ss_pred             CCcc---cCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          298 NYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       298 ~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      ....   ..........|... ...+++++.+||++||++||++||||.|+|+|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            1100   01222222333322 34589999999999999999999999999997

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=368.07  Aligned_cols=248  Identities=24%  Similarity=0.321  Sum_probs=195.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCC-C--ceEEEEEcccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLET-G--EAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  134 (354)
                      .+|++.+.||+|+||+||+|++..+ +  ..||||++...       .+...+|+.++++++||||+++++++..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            4699999999999999999987533 2  36899987532       2344689999999999999999998832     


Q ss_pred             eeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEecc
Q 018514          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (354)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg  213 (354)
                      . .+++|||||.+ ++.+.+....   ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~-~vkl~DfG  156 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDFG  156 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             c-chheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhcccccc-ceeeccch
Confidence            1 25799999985 7776665543   5699999999999999999999998 999999999999999887 89999999


Q ss_pred             CceecccCCCc----cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 018514          214 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (354)
Q Consensus       214 ~a~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (354)
                      +++........    ....|+..|+|||.+.+.. ++.++|||||||++|||+| |..||.+.+..+.+..+.+....  
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~--  233 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--  233 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC--
Confidence            99876444322    2345678899999997665 8999999999999999998 89999998887777666542111  


Q ss_pred             HHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                                               ...+..+|+++.+||.+||+.||++|||+.++++.|.+
T Consensus       234 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         234 -------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                                     11234578999999999999999999999999988764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-52  Score=372.91  Aligned_cols=253  Identities=21%  Similarity=0.271  Sum_probs=204.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++...     .....+|++++++++||||+++++++..    
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----   87 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV----   87 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc----
Confidence            4579999999999999999999753     4678999998643     2345689999999999999999998843    


Q ss_pred             CeeEEEEEEeecc-ccHHHHHHhhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 018514          134 DELYLNLVLEYVP-ETVHRVIKHHY--------------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD  192 (354)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~--------------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~D  192 (354)
                       ....+++|||+. |+|.+++....                    .....+++..+..++.|++.||+|||++ +|+|||
T Consensus        88 -~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrD  165 (301)
T d1lufa_          88 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRD  165 (301)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSC
T ss_pred             -CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeE
Confidence             333789999998 58888886432                    1124588999999999999999999998 999999


Q ss_pred             CCCCCeeeeCCCCcEEEEeccCceecccCC---CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCC-CCC
Q 018514          193 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLF  268 (354)
Q Consensus       193 lkp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf  268 (354)
                      |||+|||++.++ .+||+|||+|.......   ......|++.|+|||.+.+.. ++.++|||||||++|||++|. +||
T Consensus       166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCC
Confidence            999999999887 79999999997654332   223456789999999997655 899999999999999999985 788


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhc
Q 018514          269 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGS  348 (354)
Q Consensus       269 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~  348 (354)
                      .+.+..+.+..+.....                   +         ..+..+++++.+||.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~e~~~~v~~~~~-------------------~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~  295 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNI-------------------L---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  295 (301)
T ss_dssp             TTSCHHHHHHHHHTTCC-------------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCC-------------------C---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            88777766665543210                   0         1234588999999999999999999999999999


Q ss_pred             cCcC
Q 018514          349 FDSS  352 (354)
Q Consensus       349 l~~~  352 (354)
                      |+..
T Consensus       296 L~~i  299 (301)
T d1lufa_         296 LQRM  299 (301)
T ss_dssp             HHHT
T ss_pred             HHHh
Confidence            8764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-53  Score=376.49  Aligned_cols=252  Identities=22%  Similarity=0.296  Sum_probs=204.9

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcCCCce--EEEEEccc-----chhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCe
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQ-----DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~-----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  135 (354)
                      .++|++.++||+|+||+||+|+++.+|..  ||||++..     ..+...+|+++|+++ +||||+++++++..     .
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~   83 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R   83 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----C
Confidence            35899999999999999999999888764  67787642     223456899999998 79999999999844     3


Q ss_pred             eEEEEEEeecc-ccHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC
Q 018514          136 LYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (354)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~  202 (354)
                      ..+++||||++ |+|.+++....            .....+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  162 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEcC
Confidence            34899999999 58888886532            2346799999999999999999999999 9999999999999998


Q ss_pred             CCCcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHH
Q 018514          203 HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEII  281 (354)
Q Consensus       203 ~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~i~  281 (354)
                      ++ .+||+|||+|.............||..|+|||.+.+.. ++.++|||||||++|||++|. +||.+.+..+....+.
T Consensus       163 ~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~  240 (309)
T d1fvra_         163 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  240 (309)
T ss_dssp             GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CC-ceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            87 79999999998765555555667899999999997665 899999999999999999965 6787777666555443


Q ss_pred             HHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      +..                            ...++..+++++.+||.+||+.||++|||+.+++++|+.
T Consensus       241 ~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         241 QGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             GTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            211                            011234578999999999999999999999999999865

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-52  Score=368.79  Aligned_cols=254  Identities=21%  Similarity=0.328  Sum_probs=200.1

Q ss_pred             cccceEEEeEeeeccceEEEEEEEcCCC-------ceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeee
Q 018514           63 QTISYMAERVVGHGSFGVVFQAKCLETG-------EAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (354)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~  129 (354)
                      ..++|++.+.||+|+||.||+|++..++       ..||||++..+.     ....+|...+.++ +||||+++++++. 
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-   89 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-   89 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc-
Confidence            3468999999999999999999976554       369999986542     2334678888777 8999999999983 


Q ss_pred             cCCCCeeEEEEEEeeccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 018514          130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (354)
Q Consensus       130 ~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~  196 (354)
                          +....++|||||.+ ++.+++.....            ....+++.+++.++.||+.||+|||++ +|+||||||+
T Consensus        90 ----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~  164 (299)
T d1fgka_          90 ----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAAR  164 (299)
T ss_dssp             ----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             ----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeeccc
Confidence                33447899999995 88888875432            235689999999999999999999999 9999999999


Q ss_pred             CeeeeCCCCcEEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018514          197 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (354)
Q Consensus       197 Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  272 (354)
                      |||++.++ .+||+|||++........   .....+|+.|+|||.+.+.. |+.++|||||||++|||++ |.+||.+.+
T Consensus       165 NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         165 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             GEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            99999887 799999999987654432   23457889999999997655 8999999999999999998 789998777


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      .......+... ..                           ..++..+++++.+||.+||++||++|||+.|+++.|+.+
T Consensus       243 ~~~~~~~i~~~-~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         243 VEELFKLLKEG-HR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHHHHHHHTT-CC---------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcC-CC---------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            65544443221 10                           112345789999999999999999999999999998754

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-51  Score=366.22  Aligned_cols=254  Identities=21%  Similarity=0.254  Sum_probs=198.7

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv~  142 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++|+|++..+..+..    +....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEEEE
Confidence            4799999999999999999999999999999987543  3345689999999998877666554433    233478999


Q ss_pred             eeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeC--CCCcEEEEeccCceeccc
Q 018514          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVK  220 (354)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~--~~~~vkl~Dfg~a~~~~~  220 (354)
                      ||+++++...+...   ...+++..+..++.|++.||+|||++ ||+||||||+|||++.  ....+||+|||+|+....
T Consensus        83 e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEcCCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99999887766543   36799999999999999999999999 9999999999999854  233699999999987654


Q ss_pred             CCC--------ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh---CCCCH
Q 018514          221 GEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL---GTPTR  289 (354)
Q Consensus       221 ~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~  289 (354)
                      ...        .....||+.|||||++.+.. ++.++|||||||++|||++|..||...........+.+..   ..++.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            322        23457999999999997655 8999999999999999999999998765544433332211   01111


Q ss_pred             HHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      .                        .....+|+++.++|.+||+.||++||++.++.+.|++
T Consensus       238 ~------------------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         238 E------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             H------------------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             h------------------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1                        1234578999999999999999999999988776654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=363.31  Aligned_cols=253  Identities=23%  Similarity=0.327  Sum_probs=205.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEc-----CCCceEEEEEcccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  132 (354)
                      .++|++.+.||+|+||.||+|++.     .+++.||||++....     ....+|+.+++.+ +||||+++++++..   
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~---   98 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence            358999999999999999999863     456789999986432     2345799999999 69999999999833   


Q ss_pred             CCeeEEEEEEeeccc-cHHHHHHhhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 018514          133 KDELYLNLVLEYVPE-TVHRVIKHHYK--------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (354)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~N  197 (354)
                        ...+++|||||++ ++..++.....              ....+++..+..++.||+.||+|||++ +++||||||+|
T Consensus        99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~N  175 (311)
T d1t46a_          99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARN  175 (311)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGG
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-Ceeeccccccc
Confidence              3347899999985 88888765432              234689999999999999999999999 99999999999


Q ss_pred             eeeeCCCCcEEEEeccCceecccCCCc---cccccccccccchhccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 018514          198 LLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (354)
Q Consensus       198 ili~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  273 (354)
                      |+++.++ .+|++|||+++........   ....||+.|+|||.+.+.. ++.++|||||||++|||+| |.+||.+.+.
T Consensus       176 Il~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999887 8999999999876543322   2457799999999997655 8999999999999999998 6777877776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       274 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      .+.+.++.+....+.                           .+..+++++.+||.+||++||.+|||+.++++.|+.
T Consensus       254 ~~~~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         254 DSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             SHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            666666655321111                           223478999999999999999999999999998875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=363.62  Aligned_cols=249  Identities=27%  Similarity=0.447  Sum_probs=201.6

Q ss_pred             ccceEEEeEeeeccceEEEEEEEc---CCCceEEEEEcccc--------hhhhHHHHHHHHHcCC-CCeeecceeeeecC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD--------KRYKNRELQTMRLLDH-PNVVSLKHCFFSTT  131 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~--------~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~  131 (354)
                      .++|++.+.||+|+||+||+|++.   .+|+.||||++...        .....+|++++++++| |||+++++++    
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~----   98 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----   98 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence            467999999999999999999874   46889999988532        2334579999999977 8999999888    


Q ss_pred             CCCeeEEEEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEE
Q 018514          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (354)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~  210 (354)
                       .+...++++|||+.+ +|...+...    ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+
T Consensus        99 -~~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~vkL~  171 (322)
T d1vzoa_          99 -QTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLT  171 (322)
T ss_dssp             -EETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEES
T ss_pred             -ccCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCC-CEEEe
Confidence             344458999999995 887777654    5678999999999999999999998 999999999999999887 79999


Q ss_pred             eccCceecccCC--CccccccccccccchhccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 018514          211 DFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (354)
Q Consensus       211 Dfg~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  287 (354)
                      |||++.......  ......|++.|+|||.+.+.. .++.++|||||||++|+|++|..||.+.+.......+.+.....
T Consensus       172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            999998654322  234567899999999996543 47889999999999999999999998876555444444321100


Q ss_pred             CHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCC-----CHHHHhhc
Q 018514          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAFDAVGS  348 (354)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rp-----ta~e~l~~  348 (354)
                      .                         ..++..+|+++.+||++||++||.+||     ||+|+++|
T Consensus       252 ~-------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         252 E-------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             C-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             C-------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            0                         112345899999999999999999999     58999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=361.77  Aligned_cols=253  Identities=20%  Similarity=0.260  Sum_probs=205.8

Q ss_pred             ccceEEEeEeeeccceEEEEEEEcC-----CCceEEEEEcccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 018514           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (354)
Q Consensus        64 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  133 (354)
                      .++|++.+.||+|+||+||+|.+..     ++..||||++....     ....+|+.++++++||||+++++++..    
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec----
Confidence            3589999999999999999999853     35789999986432     234589999999999999999998833    


Q ss_pred             CeeEEEEEEeecc-ccHHHHHHhhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCc
Q 018514          134 DELYLNLVLEYVP-ETVHRVIKHHYK------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (354)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~  206 (354)
                       ....++||||+. |+|.+++.....      ....++...+..++.|++.||.|||++ +|+||||||+|||++.++ .
T Consensus        95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~-~  171 (308)
T d1p4oa_          95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-T  171 (308)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC-C
T ss_pred             -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCc-e
Confidence             333789999998 488777764331      224578899999999999999999998 999999999999999887 7


Q ss_pred             EEEEeccCceecccCCC---ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHH
Q 018514          207 LKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIK  282 (354)
Q Consensus       207 vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~  282 (354)
                      +||+|||+|+.......   .....||+.|+|||.+.+.. ++.++|||||||++|||+|| .+||.+.+..+.+..+.+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999986644322   23346899999999997665 89999999999999999998 588888777776666544


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ...                            ...+..+++.+.++|.+||+.||++|||+.+++++|+..
T Consensus       251 ~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         251 GGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             CCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            211                            112345789999999999999999999999999998764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=359.87  Aligned_cols=248  Identities=19%  Similarity=0.271  Sum_probs=192.2

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCC---ceEEEEEcccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCeeEE
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  138 (354)
                      +...++||+|+||+||+|++..++   ..||||++...     ...+.+|++++++++||||+++++++...    ....
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence            444688999999999999986543   36899988532     23456899999999999999999987543    2347


Q ss_pred             EEEEeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      ++|||||++ ++.+++...   ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~lv~E~~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~  179 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFGLARD  179 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSSGGGCC
T ss_pred             EEEEEEeecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCC-CEEEecccchhh
Confidence            899999996 666666543   35677888999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCCC-----ccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHH
Q 018514          218 LVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE  291 (354)
Q Consensus       218 ~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~  291 (354)
                      ......     .....||+.|+|||.+.+.. ++.++||||||+++|||++|..||...... +....+.... .     
T Consensus       180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-~-----  252 (311)
T d1r0pa_         180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-R-----  252 (311)
T ss_dssp             TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-C-----
T ss_pred             ccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-C-----
Confidence            644322     22356789999999997655 899999999999999999977776554332 2222222210 0     


Q ss_pred             HhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                                            ...+..+++++.+||.+||+.||++|||+.|++++|++.
T Consensus       253 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         253 ----------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                  012234789999999999999999999999999998754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.7e-50  Score=357.72  Aligned_cols=254  Identities=19%  Similarity=0.241  Sum_probs=203.8

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccc--hhhhHHHHHHHHHcCC-CCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  .....+|++.++.++| +|++.+++++     ......++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEEE
Confidence            4799999999999999999999999999999987543  3345689999999976 8999988876     334457899


Q ss_pred             EeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCC----CCcEEEEeccCcee
Q 018514          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----THQLKLCDFGSAKV  217 (354)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~----~~~vkl~Dfg~a~~  217 (354)
                      |||++++|.+.+...   ...++...+..++.|++.||+|||++ ||+||||||+|||++..    .+.+||+|||+|+.
T Consensus        80 me~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          80 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999999998887654   35799999999999999999999998 99999999999999642    33799999999987


Q ss_pred             cccCC--------CccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCC
Q 018514          218 LVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGT  286 (354)
Q Consensus       218 ~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~  286 (354)
                      .....        ......||+.|||||++.+.. ++.++|||||||++|||++|..||.+....   .....+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            64332        223457999999999997655 899999999999999999999999865433   223333322111


Q ss_pred             CCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCcC
Q 018514          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDSS  352 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~~  352 (354)
                      ++..                        .+...+|+++.+++..|+..+|++||+++.+.+.|++.
T Consensus       235 ~~~~------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         235 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CChH------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            1111                        12345789999999999999999999999888776543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-50  Score=355.90  Aligned_cols=270  Identities=19%  Similarity=0.214  Sum_probs=192.3

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccchhh-h--HHHHHHHHHcCCCCeeecceeeeecCCCCeeEEEEE
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-K--NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~--~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~iv  141 (354)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++..+... .  +.|+..+..++||||+++++++.... .....+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            4699999999999999999987  7889999998654322 2  23555556789999999999886654 344568999


Q ss_pred             Eeeccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------cCCceecCCCCCCeeeeCCCCcEEEEec
Q 018514          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--------TIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (354)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--------~~~iiH~Dlkp~Nili~~~~~~vkl~Df  212 (354)
                      ||||.+ +|.+.+..     .++++..+..++.|++.||+|||+        + ||+||||||+|||++.++ .+||+||
T Consensus        80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~-~IvHrDlKp~NILl~~~~-~~Kl~DF  152 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNG-TCCIADL  152 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC-CeeccccCccceEEcCCC-CeEEEec
Confidence            999985 88888875     468899999999999999999996        4 899999999999999887 8999999


Q ss_pred             cCceecccCCC-----ccccccccccccchhccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 018514          213 GSAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (354)
Q Consensus       213 g~a~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  282 (354)
                      |++........     .....||+.|+|||++.+..     .++.++|||||||++|||+||..||............ .
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~  231 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-L  231 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-T
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-c
Confidence            99987654332     23467899999999986542     2567899999999999999998887432211000000 0


Q ss_pred             HhCCCCHHHHhccCCCCcccCCCCccCCCcccccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHhhccCc
Q 018514          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAVGSFDS  351 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l~~l~~  351 (354)
                      ....+....+.....  .....+.+. ..|   ........+.+++.+||+.||++|||+.|++++|+.
T Consensus       232 ~~~~~~~~~~~~~~~--~~~~~p~~~-~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         232 VPSDPSVEEMRKVVC--EQKLRPNIP-NRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             SCSSCCHHHHHHHHT--TSCCCCCCC-GGG---GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHh--ccccCCCCC-ccc---CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            000000000000000  000000000 000   011133569999999999999999999999998864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-46  Score=341.84  Aligned_cols=278  Identities=30%  Similarity=0.472  Sum_probs=204.9

Q ss_pred             cceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch---hhhHHHHHHHHHcC-----------CCCeeecceeeeec
Q 018514           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCFFST  130 (354)
Q Consensus        65 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~  130 (354)
                      ++|+++++||+|+||+||+|++..+|+.||||+++.+.   ....+|+.+++.+.           |+||+++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            46999999999999999999999999999999997653   33457888888775           57899998877443


Q ss_pred             CCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCCC-----
Q 018514          131 TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-----  205 (354)
Q Consensus       131 ~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~~-----  205 (354)
                      . ......++.++++.++.......  .....+++..++.++.||+.||+|||+..||+||||||+|||++.++.     
T Consensus        93 ~-~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 G-PNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             E-TTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             c-ccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            2 23333333444444444433332  334678999999999999999999998339999999999999976542     


Q ss_pred             cEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHH
Q 018514          206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQLVE  279 (354)
Q Consensus       206 ~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~  279 (354)
                      .++++|||.+.....  ......||+.|+|||++.... ++.++||||+||++++|++|+.||...+      ....+..
T Consensus       170 ~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         170 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeeEeeccccccccc--ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            499999999976533  334667999999999997665 8999999999999999999999997543      3456777


Q ss_pred             HHHHhCCCCHHHHhccCCCCccc-------CCCCccCCCccc------ccCCCCCHHHHHHHHHhcCcCCCCCCCHHHHh
Q 018514          280 IIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHK------IFQKRMPPEAVDLVSRLLQYSPNLRSTAFDAV  346 (354)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~s~~l~~ll~~~l~~dp~~Rpta~e~l  346 (354)
                      ....++.++.............+       ........++..      .+....++++.+||.+||++||.+||||+|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            78888888877654322111111       111111111111      12233568899999999999999999999999


Q ss_pred             hc
Q 018514          347 GS  348 (354)
Q Consensus       347 ~~  348 (354)
                      +|
T Consensus       327 ~H  328 (362)
T d1q8ya_         327 NH  328 (362)
T ss_dssp             TC
T ss_pred             cC
Confidence            98

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1e-26  Score=192.26  Aligned_cols=165  Identities=16%  Similarity=0.118  Sum_probs=116.1

Q ss_pred             eEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----------------------hhhHHHHHHHHHcCCCCeeecc
Q 018514           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVVSLK  124 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------~~~~~e~~~l~~l~h~~iv~~~  124 (354)
                      +.+.++||+|+||+||+|++ .+|+.||||+++...                      ....+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            56889999999999999997 478999999764210                      1123578889999999998876


Q ss_pred             eeeeecCCCCeeEEEEEEeeccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeeeCCC
Q 018514          125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (354)
Q Consensus       125 ~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~iiH~Dlkp~Nili~~~~  204 (354)
                      ++.     .    .+++|||+++...          ..++...+..++.|++.+|+|||++ ||+||||||+|||++++ 
T Consensus        81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-
T ss_pred             Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-
Confidence            543     2    2689999997421          1234445678899999999999998 99999999999999965 


Q ss_pred             CcEEEEeccCceecccCCCccccccccccccchhccCCCCCCCchhHHHHHHH
Q 018514          205 HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCV  257 (354)
Q Consensus       205 ~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~i  257 (354)
                       .++|+|||+|..............+.. .-.+.+  .+.|+.++|+||+.--
T Consensus       140 -~~~liDFG~a~~~~~~~~~~~l~rd~~-~~~~~f--~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWREILERDVR-NIITYF--SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHHHHHHHHHH-HHHHHH--HHHHCCCCCHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcHHHHHHHHH-HHHHHH--cCCCCCcccHHHHHHH
Confidence             499999999976532221110000000 001122  1337889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=1.1e-06  Score=73.80  Aligned_cols=76  Identities=17%  Similarity=0.107  Sum_probs=49.1

Q ss_pred             ceEEEeEeeeccceEEEEEEEcCCCceEEEEEcccch----hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCeeEEEE
Q 018514           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (354)
Q Consensus        66 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~i  140 (354)
                      .|++.+..+.++.+.||+...  ++..+++|+.....    ....+|...++.+. +--++++++..     .+....++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence            577777665566678998863  56678888875432    23467888888774 32244554443     22234678


Q ss_pred             EEeecccc
Q 018514          141 VLEYVPET  148 (354)
Q Consensus       141 v~e~~~~~  148 (354)
                      ||++++|.
T Consensus        88 v~~~l~G~   95 (263)
T d1j7la_          88 LMSEADGV   95 (263)
T ss_dssp             EEECCSSE
T ss_pred             EEEecccc
Confidence            99999973

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.03  E-value=1.6e-05  Score=70.93  Aligned_cols=71  Identities=18%  Similarity=0.167  Sum_probs=42.7

Q ss_pred             EeEeeeccceEEEEEEEcCCCceEEEEEccc-----------chhhhHHHHHHHHHcC-C--CCeeecceeeeecCCCCe
Q 018514           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----------DKRYKNRELQTMRLLD-H--PNVVSLKHCFFSTTEKDE  135 (354)
Q Consensus        70 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~~  135 (354)
                      .+.||.|....||++.+..+++.+++|.-..           .......|.+.|+.+. +  ..+++++.+  +   .+.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC
Confidence            4568999999999998777788899996421           1122345888887763 2  234444332  2   111


Q ss_pred             eEEEEEEeeccc
Q 018514          136 LYLNLVLEYVPE  147 (354)
Q Consensus       136 ~~~~iv~e~~~~  147 (354)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              3579999975

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.02  E-value=1.5e-05  Score=66.41  Aligned_cols=69  Identities=16%  Similarity=0.117  Sum_probs=43.1

Q ss_pred             eeecc-ceEEEEEEEcCCCceEEEEEcccch-hhhHHHHHHHHHcCCCC--eeecceeeeecCCCCeeEEEEEEeeccc
Q 018514           73 VGHGS-FGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYVPE  147 (354)
Q Consensus        73 lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~iv~e~~~~  147 (354)
                      +..|. .+.||+... ..+..+++|...... .....|...++.+....  +++++.+..     +....++||++++|
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeeec
Confidence            34444 368999974 456678889775443 34567888888774333  344444331     22236789999986

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.23  E-value=0.001  Score=58.78  Aligned_cols=71  Identities=17%  Similarity=0.220  Sum_probs=45.3

Q ss_pred             eEEEeEeeeccceEEEEEEEcC-------CCceEEEEEcccc--hhhhHHHHHHHHHcCCCCe-eecceeeeecCCCCee
Q 018514           67 YMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDEL  136 (354)
Q Consensus        67 y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~  136 (354)
                      .++ +.|+.|-.=.+|++....       .++.|.+++....  .....+|..+++.+.-.++ +++++++     ++  
T Consensus        45 l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~--  116 (395)
T d1nw1a_          45 LRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG--  116 (395)
T ss_dssp             EEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT--
T ss_pred             eEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC--
Confidence            444 567888888999998642       2356777776422  2234578888888753344 4555554     32  


Q ss_pred             EEEEEEeeccc
Q 018514          137 YLNLVLEYVPE  147 (354)
Q Consensus       137 ~~~iv~e~~~~  147 (354)
                        .+|++|+.|
T Consensus       117 --g~I~efi~g  125 (395)
T d1nw1a_         117 --GRLEEYIPS  125 (395)
T ss_dssp             --EEEECCCCE
T ss_pred             --ceEEEEecc
Confidence              468999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.18  E-value=0.00086  Score=57.60  Aligned_cols=68  Identities=16%  Similarity=-0.026  Sum_probs=38.9

Q ss_pred             eEEEEEEEcCCCceEEEEEcccc---hhhhHHHHHHHHHcCCCCee--ecceeeeecCCCCeeEEEEEEeeccc
Q 018514           79 GVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVV--SLKHCFFSTTEKDELYLNLVLEYVPE  147 (354)
Q Consensus        79 g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~iv~e~~~~  147 (354)
                      -.||++.. .+|..+++|+.+..   ......|...+..|....+.  .....--..........+.++++++|
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            47999984 67888999998653   34455788888877432221  11110000000122346778888875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.63  E-value=0.0073  Score=51.14  Aligned_cols=30  Identities=30%  Similarity=0.257  Sum_probs=26.1

Q ss_pred             CceecCCCCCCeeeeCCCCcEEEEeccCcee
Q 018514          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (354)
Q Consensus       187 ~iiH~Dlkp~Nili~~~~~~vkl~Dfg~a~~  217 (354)
                      |+||+|+.++||+++.+. ..-|+||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~-v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDE-LSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             ccccCCcchhhhhccccc-ceeEeccccccc
Confidence            799999999999999765 568999998863